Novel	O
Algorithms	O
Reveal	O
Streptococcal	O
Transcriptomes	O
and	O
Clues	O
about	O
Undefined	O
Genes	O

Bacteria	O
-	O
host	O
interactions	O
are	O
dynamic	O
processes	O
,	O
and	O
understanding	O
transcriptional	O
responses	O
that	O
directly	O
or	O
indirectly	O
regulate	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
initial	O
infection	O
stages	O
would	O
illuminate	O
the	O
molecular	O
events	O
that	O
result	O
in	O
host	O
colonization	O
.	O

We	O
used	O
oligonucleotide	O
microarrays	O
to	O
monitor	O
(	O
in	O
vitro	O
)	O
differential	O
gene	O
expression	O
in	O
group	B-Organism
A	I-Organism
streptococci	E-Organism
during	O
pharyngeal	O
cell	O
adherence	O
,	O
the	O
first	O
overt	O
infection	O
stage	O
.	O

We	O
present	O
neighbor	O
clustering	O
,	O
a	O
new	O
computational	O
method	O
for	O
further	O
analyzing	O
bacterial	O
microarray	O
data	O
that	O
combines	O
two	O
informative	O
characteristics	O
of	O
bacterial	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
:	O
(	O
1	O
)	O
similar	O
gene	O
expression	O
profiles	O
(	O
i	O
.	O
e	O
.	O
,	O
co	O
-	O
expression	O
)	O
;	O
and	O
(	O
2	O
)	O
physical	O
proximity	O
of	O
genes	O
on	O
the	O
chromosome	O
.	O

This	O
method	O
identifies	O
statistically	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
potentially	O
share	O
common	O
function	O
or	O
regulation	O
by	O
coupling	O
statistically	O
analyzed	O
gene	O
expression	O
profiles	O
with	O
the	O
chromosomal	O
position	O
of	O
genes	O
.	O

We	O
applied	O
this	O
method	O
to	O
our	O
own	O
data	O
and	O
to	O
those	O
of	O
others	O
,	O
and	O
we	O
show	O
that	O
it	O
identified	O
a	O
greater	O
number	O
of	O
differentially	O
expressed	O
genes	O
,	O
facilitating	O
the	O
reconstruction	O
of	O
more	O
multimeric	O
proteins	O
and	O
complete	O
metabolic	O
pathways	O
than	O
would	O
have	O
been	O
possible	O
without	O
its	O
application	O
.	O

We	O
assessed	O
the	O
biological	O
significance	O
of	O
two	O
identified	O
genes	O
by	O
assaying	O
deletion	O
mutants	O
for	O
adherence	O
in	O
vitro	O
and	O
show	O
that	O
neighbor	O
clustering	O
indeed	O
provides	O
biologically	O
relevant	O
data	O
.	O

Neighbor	O
clustering	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
molecular	O
responses	O
of	O
streptococci	S-Organism
during	O
pharyngeal	O
cell	O
adherence	O
.	O

Introduction	O

Microarray	O
technology	O
is	O
now	O
commonly	O
used	O
to	O
reveal	O
genome	O
-	O
wide	O
transcriptional	O
changes	O
in	O
bacterial	O
pathogens	O
during	O
interactions	O
with	O
the	O
host	O
.	O

Several	O
factors	O
,	O
however	O
,	O
limit	O
the	O
power	O
of	O
such	O
analyses	O
,	O
including	O
inadequate	O
statistical	O
analysis	O
and	O
insufficient	O
sample	O
replication	O
,	O
both	O
of	O
which	O
do	O
not	O
account	O
for	O
experimental	O
variability	O
,	O
and	O
often	O
result	O
in	O
arbitrary	O
thresholds	O
for	O
significance	O
[	O
1	O
,	O
2	O
]	O
.	O

In	O
addition	O
,	O
unknown	O
bacterial	O
genes	O
can	O
confound	O
the	O
interpretation	O
of	O
expression	O
profiles	O
,	O
restricting	O
many	O
microarray	O
studies	O
to	O
the	O
differential	O
expression	O
of	O
well	O
-	O
characterized	O
genes	O
.	O

Several	O
methods	O
are	O
available	O
to	O
organize	O
gene	O
expression	O
profiles	O
and	O
to	O
assist	O
in	O
extracting	O
functional	O
or	O
regulatory	O
gene	O
information	O
from	O
microarray	O
datasets	O
.	O

Clustering	O
algorithms	O
group	O
genes	O
by	O
similarities	O
in	O
expression	O
patterns	O
,	O
based	O
on	O
the	O
assumption	O
that	O
co	O
-	O
expressed	O
genes	O
share	O
common	O
function	O
or	O
regulation	O
[	O
3	O
,	O
4	O
]	O
;	O
however	O
,	O
clustering	O
solely	O
by	O
co	O
-	O
expression	O
patterns	O
may	O
not	O
reveal	O
a	O
considerable	O
amount	O
of	O
information	O
contained	O
in	O
array	O
data	O
.	O

These	O
methods	O
often	O
:	O
(	O
1	O
)	O
produce	O
unreliable	O
data	O
by	O
missing	O
known	O
gene	O
members	O
of	O
biological	O
pathways	O
;	O
(	O
2	O
)	O
fail	O
to	O
distinguish	O
truly	O
related	O
gene	O
clusters	O
from	O
coincidental	O
groupings	O
;	O
and	O
(	O
3	O
)	O
identify	O
clusters	O
containing	O
only	O
unknown	O
genes	O
that	O
may	O
lack	O
either	O
common	O
function	O
or	O
regulation	O
,	O
a	O
considerable	O
limitation	O
for	O
genomes	O
containing	O
a	O
large	O
percentage	O
of	O
undefined	O
genes	O
[	O
1	O
,	O
2	O
]	O
.	O

Because	O
no	O
tools	O
exist	O
to	O
interpret	O
unknown	O
gene	O
clusters	O
or	O
to	O
assess	O
their	O
significance	O
and	O
completeness	O
,	O
a	O
significant	O
portion	O
of	O
bacterial	O
expression	O
profiles	O
are	O
not	O
interpretable	O
using	O
current	O
clustering	O
methods	O
.	O

We	O
introduce	O
neighbor	O
clustering	O
as	O
a	O
new	O
tool	O
for	O
analyzing	O
bacterial	O
microarray	O
data	O
that	O
addresses	O
some	O
of	O
these	O
limitations	O
by	O
incorporating	O
the	O
physical	O
position	O
of	O
genes	O
on	O
the	O
bacterial	O
chromosome	O
into	O
the	O
analysis	O
of	O
expression	O
data	O
.	O

Information	O
about	O
gene	O
function	O
and	O
regulation	O
is	O
stored	O
intrinsically	O
in	O
the	O
bacterial	O
genome	O
structure	O
,	O
as	O
genes	O
with	O
common	O
function	O
or	O
regulation	O
tend	O
to	O
be	O
physically	O
proximate	O
on	O
the	O
chromosome	O
and	O
often	O
linked	O
as	O
operons	O
[	O
5	O
,	O
6	O
]	O
.	O

We	O
incorporated	O
these	O
positional	O
data	O
into	O
a	O
series	O
of	O
neighbor	O
clustering	O
algorithms	O
,	O
named	O
GenomeCrawler	O
,	O
that	O
identifies	O
groupings	O
of	O
potentially	O
related	O
genes	O
from	O
array	O
data	O
by	O
combining	O
two	O
informative	O
characteristics	O
of	O
bacterial	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
[	O
3	O
-	O
6	O
]	O
:	O
(	O
1	O
)	O
similar	O
gene	O
expression	O
profiles	O
(	O
i	O
.	O
e	O
.	O
,	O
co	O
-	O
expression	O
)	O
;	O
and	O
(	O
2	O
)	O
physical	O
proximity	O
of	O
genes	O
on	O
the	O
chromosome	O
.	O

The	O
algorithms	O
also	O
recalculate	O
the	O
statistical	O
significance	O
of	O
each	O
gene	O
as	O
a	O
member	O
of	O
a	O
particular	O
cluster	O
,	O
as	O
well	O
as	O
the	O
significance	O
of	O
each	O
resulting	O
grouping	O
as	O
a	O
whole	O
,	O
to	O
ensure	O
accuracy	O
of	O
cluster	O
assignments	O
.	O

This	O
process	O
ultimately	O
identifies	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
likely	O
share	O
common	O
function	O
or	O
regulation	O
.	O

We	O
used	O
this	O
approach	O
to	O
analyze	O
microarray	O
expression	O
data	O
from	O
group	B-Organism
A	I-Organism
streptococci	E-Organism
(	O
Streptococcus	B-Organism
pyogenes	E-Organism
)	O
during	O
adherence	O
to	O
human	S-Organism
pharyngeal	O
cells	O
,	O
the	O
first	O
overt	O
infection	O
step	O
[	O
7	O
]	O
.	O

The	O
ability	O
of	O
all	O
bacterial	O
pathogens	O
to	O
infect	O
the	O
human	S-Organism
host	O
depends	O
upon	O
coordinated	O
regulation	O
of	O
diverse	O
gene	O
sets	O
that	O
are	O
required	O
for	O
survival	O
in	O
host	O
environments	O
.	O

Although	O
recent	O
microarray	O
studies	O
have	O
highlighted	O
the	O
molecular	O
responses	O
of	O
streptococci	S-Organism
in	O
relevant	O
host	O
conditions	O
[	O
8	O
-	O
10	O
]	O
,	O
characterizing	O
differentially	O
expressed	O
loci	O
during	O
pharyngeal	O
cell	O
adherence	O
is	O
critical	O
for	O
understanding	O
the	O
molecular	O
basis	O
for	O
host	O
colonization	O
.	O

Studies	O
from	O
our	O
laboratory	O
[	O
11	O
,	O
12	O
]	O
and	O
others	O
[	O
13	O
]	O
have	O
demonstrated	O
that	O
in	O
vitro	O
association	O
with	O
pharyngeal	O
cells	O
results	O
in	O
streptococcal	O
phage	O
induction	O
and	O
the	O
increased	O
expression	O
of	O
phage	O
-	O
encoded	O
virulence	O
factors	O
.	O

Although	O
the	O
mechanisms	O
mediating	O
these	O
responses	O
are	O
not	O
known	O
,	O
the	O
results	O
of	O
these	O
studies	O
indicate	O
that	O
streptococci	S-Organism
sense	O
and	O
,	O
on	O
a	O
transcriptional	O
level	O
,	O
respond	O
to	O
various	O
signals	O
and	O
cues	O
in	O
the	O
pharyngeal	O
cell	O
environment	O
.	O

We	O
undertook	O
the	O
present	O
study	O
to	O
understand	O
and	O
to	O
assess	O
more	O
accurately	O
the	O
genome	O
-	O
wide	O
transcriptional	O
responses	O
of	O
streptococci	S-Organism
during	O
one	O
of	O
the	O
earliest	O
recognized	O
stages	O
of	O
infection	O
,	O
namely	O
adherence	O
to	O
human	S-Organism
pharyngeal	O
cells	O
.	O

We	O
compared	O
data	O
generated	O
before	O
and	O
after	O
neighbor	O
clustering	O
to	O
show	O
that	O
this	O
method	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
transcription	O
by	O
:	O
(	O
1	O
)	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
than	O
even	O
traditional	O
,	O
rigorous	O
statistical	O
analyses	O
;	O
(	O
2	O
)	O
reconstructing	O
intact	O
biological	O
pathways	O
that	O
statistical	O
significance	O
analysis	O
could	O
not	O
reconstruct	O
;	O
and	O
(	O
3	O
)	O
providing	O
preliminary	O
insight	O
and	O
clues	O
about	O
the	O
function	O
or	O
regulation	O
of	O
uncharacterized	O
genes	O
by	O
associating	O
their	O
co	O
-	O
expression	O
with	O
physically	O
proximate	O
,	O
functionally	O
defined	O
genes	O
.	O

Results	O
/	O
Discussion	O

Adherence	O
-	O
Mediated	O
Differential	O
Expression	O
We	O
developed	O
spotted	O
oligonucleotide	O
arrays	O
of	O
the	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
SF370	E-Organism
(	O
an	O
M1	O
serotype	O
)	O
genome	O
[	O
14	O
]	O
and	O
compared	O
the	O
transcriptomes	O
of	O
streptococci	S-Organism
that	O
adhere	O
to	O
Detroit	O
562	O
human	S-Organism
pharyngeal	O
cells	O
to	O
non	O
-	O
adherent	O
(	O
"	O
associated	O
"	O
)	O
streptococci	S-Organism
within	O
the	O
same	O
experiment	O
.	O

Adherence	O
assays	O
were	O
performed	O
as	O
described	O
[	O
15	O
]	O
with	O
modifications	O
to	O
minimize	O
eukaryotic	O
cell	O
disruption	O
.	O

We	O
replicated	O
experiments	O
independently	O
and	O
used	O
dye	O
-	O
swaps	O
to	O
incorporate	O
biological	O
and	O
technical	O
variation	O
[	O
16	O
,	O
17	O
]	O
.	O

Following	O
filtering	O
and	O
normalization	O
[	O
18	O
,	O
19	O
]	O
,	O
we	O
analyzed	O
data	O
from	O
four	O
biological	O
replicates	O
[	O
16	O
]	O
with	O
robust	O
summary	O
statistics	O
[	O
20	O
]	O
,	O
Bayesian	O
statistics	O
[	O
21	O
,	O
22	O
]	O
,	O
and	O
permutation	O
algorithms	O
[	O
19	O
]	O
to	O
identify	O
genes	O
differentially	O
expressed	O
with	O
significance	O
during	O
pharyngeal	O
cell	O
adherence	O
.	O

This	O
analysis	O
identified	O
79	O
genes	O
(	O
4	O
%	O
of	O
the	O
genome	O
)	O
exhibiting	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
during	O
adherence	O
from	O
1	O
,	O
769	O
open	O
reading	O
frames	O
represented	O
on	O
the	O
array	O
(	O
Table	O
1	O
)	O
.	O

We	O
refer	O
to	O
such	O
genes	O
as	O
"	O
differentially	O
expressed	O
.	O
"	O
We	O
present	O
the	O
entire	O
dataset	O
from	O
all	O
experiments	O
as	O
Table	O
S1	O
.	O

Genes	O
demonstrating	O
upregulation	O
(	O
n	O
=	O
45	O
)	O
and	O
downregulation	O
(	O
n	O
=	O
34	O
)	O
included	O
virulence	O
factors	O
,	O
prophage	O
-	O
encoded	O
transcripts	O
,	O
metabolic	O
genes	O
,	O
and	O
transcriptional	O
regulators	O
(	O
Table	O
2	O
)	O
.	O

Undefined	O
or	O
hypothetical	O
genes	O
comprised	O
27	O
%	O
of	O
differentially	O
expressed	O
genes	O
(	O
n	O
=	O
21	O
;	O
11	O
chromosomally	O
encoded	O
genes	O
,	O
ten	O
phage	O
-	O
encoded	O
genes	O
)	O
.	O

Verification	O
by	O
Quantitative	O
Real	O
-	O
Time	O
PCR	O

We	O
conducted	O
TaqMan	O
(	O
qRT	O
-	O
PCR	O
)	O
analysis	O
[	O
23	O
]	O
of	O
11	O
differentially	O
expressed	O
genes	O
to	O
validate	O
selected	O
microarray	O
hybridization	O
results	O
(	O
see	O
Table	O
S2	O
for	O
genes	O
and	O
primer	O
-	O
probe	O
sequences	O
)	O
.	O

Five	O
genes	O
chosen	O
for	O
validation	O
demonstrated	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
by	O
microarray	O
analysis	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
;	O
two	O
upregulated	O
,	O
three	O
downregulated	O
)	O
.	O

The	O
remaining	O
six	O
genes	O
(	O
four	O
upregulated	O
,	O
two	O
downregulated	O
)	O
did	O
not	O
have	O
significant	O
PF	O
values	O
,	O
but	O
were	O
statistically	O
significant	O
as	O
members	O
of	O
particular	O
neighbor	O
clusters	O
in	O
subsequent	O
analyses	O
(	O
PE	O
<	O
0	O
.	O
05	O
)	O
as	O
detailed	O
in	O
later	O
sections	O
)	O
.	O

We	O
averaged	O
the	O
data	O
to	O
generate	O
a	O
value	O
for	O
each	O
gene	O
,	O
creating	O
a	O
set	O
of	O
11	O
paired	O
values	O
from	O
quantitative	O
real	O
-	O
time	O
(	O
qRT	O
)	O
-	O
PCR	O
and	O
microarray	O
analyses	O
(	O
Table	O
S3	O
)	O
.	O

Results	O
of	O
standard	O
linear	O
regression	O
analysis	O
demonstrated	O
a	O
strong	O
positive	O
correlation	O
(	O
r	O
=	O
0	O
.	O
9	O
)	O
between	O
data	O
obtained	O
using	O
the	O
different	O
techniques	O
(	O
see	O
Figure	O
S1	O
)	O
.	O

Virulence	O
Factors	O

Streptococci	S-Organism
elaborate	O
several	O
factors	O
implicated	O
in	O
infection	O
,	O
including	O
surface	O
-	O
exposed	O
adhesins	O
and	O
secreted	O
toxigenic	O
proteins	O
(	O
reviewed	O
in	O
[	O
7	O
,	O
14	O
,	O
24	O
]	O
)	O
.	O

The	O
initial	O
statistical	O
analysis	O
identified	O
four	O
differentially	O
expressed	O
virulence	O
genes	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Genes	O
encoding	O
streptolysin	O
O	O
(	O
slo	O
or	O
spy0167	O
)	O
and	O
the	O
SpeB	O
protease	O
(	O
spy2039	O
)	O
were	O
downregulated	O
,	O
while	O
genes	O
encoding	O
pyrogenic	O
exotoxin	O
H	O
(	O
speH	O
or	O
spy1008	O
)	O
and	O
a	O
putative	O
fibronectin	O
-	O
binding	O
protein	O
(	O
spy0130	O
)	O
were	O
upregulated	O
.	O

We	O
verified	O
the	O
differential	O
expression	O
of	O
spy2039	O
and	O
spy0130	O
by	O
qRT	O
-	O
PCR	O
.	O

The	O
downregulation	O
of	O
virulence	O
loci	O
during	O
presumably	O
inappropriate	O
stages	O
of	O
infection	O
was	O
not	O
surprising	O
.	O

Streptolysin	O
O	O
is	O
a	O
cytotoxin	O
that	O
damages	O
human	S-Organism
tissue	O
and	O
increases	O
host	O
cell	O
cytotoxicity	O
[	O
7	O
,	O
25	O
]	O
.	O

The	O
resulting	O
cellular	O
damage	O
,	O
particularly	O
to	O
polymorphonuclear	O
leukocytes	O
[	O
26	O
]	O
,	O
decreases	O
internalization	O
and	O
subsequent	O
intracellular	O
killing	O
of	O
streptococci	S-Organism
[	O
27	O
]	O
.	O

Based	O
on	O
its	O
downregulation	O
during	O
adherence	O
,	O
we	O
infer	O
that	O
slo	O
was	O
transcribed	O
during	O
pre	O
-	O
adherence	O
associations	O
,	O
perhaps	O
,	O
as	O
previously	O
reported	O
,	O
to	O
protect	O
streptococci	S-Organism
from	O
phagocytic	O
killing	O
in	O
vivo	O
[	O
27	O
]	O
.	O

However	O
,	O
once	O
adhered	O
,	O
our	O
data	O
suggest	O
that	O
streptococci	S-Organism
downregulate	O
production	O
of	O
this	O
cytotoxin	O
,	O
presumably	O
to	O
prevent	O
further	O
host	O
tissue	O
destruction	O
that	O
could	O
interfere	O
with	O
adherence	O
.	O

SpeB	O
(	O
encoded	O
by	O
spy2039	O
)	O
is	O
a	O
multifunctional	O
cysteine	O
protease	O
implicated	O
in	O
numerous	O
infection	O
strategies	O
[	O
28	O
,	O
29	O
]	O
.	O

Although	O
few	O
studies	O
have	O
examined	O
gene	O
expression	O
patterns	O
during	O
adherence	O
,	O
SpeB	O
production	O
(	O
as	O
detected	O
by	O
Western	O
blot	O
analysis	O
)	O
decreases	O
during	O
co	O
-	O
culture	O
with	O
human	S-Organism
peripheral	O
blood	O
mononuclear	O
cells	O
[	O
30	O
]	O
and	O
in	O
a	O
mouse	S-Organism
infection	O
model	O
[	O
31	O
]	O
.	O

When	O
SpeB	O
expression	O
is	O
limited	O
,	O
several	O
streptococcal	O
proteins	O
necessary	O
for	O
adherence	O
remain	O
intact	O
[	O
24	O
,	O
32	O
,	O
33	O
]	O
;	O
thus	O
,	O
decreased	O
SpeB	O
production	O
(	O
as	O
indicated	O
here	O
)	O
may	O
promote	O
pharyngeal	O
cell	O
attachment	O
.	O

Furthermore	O
,	O
SpeB	O
abolishes	O
internalization	O
(	O
following	O
adherence	O
)	O
of	O
certain	O
streptococcal	B-Organism
strains	E-Organism
by	O
epithelial	O
cells	O
(	O
including	O
Detroit	O
562	O
cells	O
)	O
,	O
a	O
process	O
mediated	O
in	O
part	O
by	O
the	O
fibronectin	O
-	O
binding	O
protein	O
F	O
[	O
34	O
,	O
35	O
]	O
.	O

We	O
observed	O
significant	O
upregulation	O
of	O
the	O
gene	O
spy0130	O
,	O
encoding	O
a	O
protein	O
recently	O
found	O
to	O
be	O
associated	O
with	O
the	O
production	O
of	O
surface	O
-	O
exposed	O
pili	O
on	O
strain	O
SF370	S-Organism
[	O
36	O
]	O
.	O

The	O
protein	O
shares	O
60	O
%	O
sequence	O
similarity	O
to	O
protein	O
F	O
,	O
suggesting	O
that	O
it	O
may	O
coordinate	O
a	O
similar	O
internalization	O
mechanism	O
or	O
may	O
be	O
involved	O
directly	O
in	O
adherence	O
(	O
discussed	O
later	O
in	O
detail	O
)	O
.	O

SpeB	O
downregulation	O
also	O
coincides	O
with	O
increased	O
expression	O
of	O
pyrogenic	O
exotoxins	O
[	O
33	O
,	O
37	O
]	O
that	O
reportedly	O
increase	O
streptococcal	O
survival	O
in	O
vivo	O
.	O

We	O
observed	O
that	O
the	O
exotoxin	O
-	O
encoding	O
speH	O
gene	O
[	O
38	O
]	O
was	O
upregulated	O
.	O

Taken	O
together	O
,	O
our	O
results	O
agree	O
with	O
previous	O
reports	O
on	O
SpeB	O
production	O
during	O
host	O
cell	O
interactions	O
,	O
suggesting	O
that	O
decreased	O
expression	O
may	O
promote	O
streptococcal	O
adherence	O
(	O
by	O
preventing	O
proteolytic	O
degradation	O
of	O
key	O
virulence	O
factors	O
or	O
adhesins	O
)	O
,	O
enhance	O
internalization	O
(	O
perhaps	O
through	O
a	O
fibronectin	O
-	O
mediated	O
pathway	O
)	O
,	O
and	O
increase	O
survival	O
(	O
through	O
increased	O
pyrogenic	O
exotoxin	O
production	O
,	O
discussed	O
below	O
)	O
.	O

Phage	O
-	O
Encoded	O
Genes	O

SF370	S-Organism
contains	O
one	O
inducible	O
prophage	O
(	O
370	O
.	O
1	O
)	O
and	O
three	O
defective	O
prophages	O
(	O
370	O
.	O
2	O
,	O
370	O
.	O
3	O
,	O
and	O
370	O
.	O
4	O
)	O
that	O
produce	O
no	O
infectious	O
phage	O
[	O
39	O
]	O
.	O

We	O
identified	O
11	O
differentially	O
expressed	O
phage	O
370	O
.	O
2	O
genes	O
,	O
suggesting	O
that	O
this	O
defective	O
phage	O
is	O
not	O
transcriptionally	O
silent	O
(	O
Table	O
1	O
)	O
.	O

The	O
speH	O
gene	O
(	O
spy1008	O
)	O
was	O
induced	O
,	O
and	O
the	O
remaining	O
genes	O
,	O
hypothetically	O
involved	O
in	O
replication	O
and	O
regulation	O
[	O
39	O
]	O
,	O
were	O
downregulated	O
.	O

The	O
speH	O
gene	O
encodes	O
a	O
mitogenic	O
exotoxin	O
[	O
38	O
]	O
reportedly	O
induced	O
during	O
polymorphonuclear	O
leukocyte	O
phagocytosis	O
[	O
8	O
]	O
but	O
not	O
implicated	O
previously	O
in	O
adherence	O
.	O

Allelic	O
Replacement	O
of	O
speH	O

Increased	O
expression	O
of	O
speH	O
during	O
pharyngeal	O
cell	O
adherence	O
suggests	O
that	O
the	O
SpeH	O
exotoxin	O
is	O
either	O
necessary	O
for	O
adherence	O
,	O
or	O
is	O
a	O
component	O
of	O
a	O
downstream	O
infection	O
process	O
.	O

Adherence	O
-	O
mediated	O
upregulation	O
of	O
speH	O
is	O
likely	O
not	O
the	O
result	O
of	O
phage	O
induction	O
,	O
as	O
the	O
remaining	O
phage	O
370	O
.	O
2	O
genes	O
identified	O
in	O
our	O
analysis	O
were	O
downregulated	O
.	O

To	O
determine	O
if	O
SpeH	O
plays	O
a	O
direct	O
role	O
in	O
the	O
adherence	O
process	O
,	O
we	O
created	O
a	O
deletion	O
mutant	O
in	O
strain	O
SF370	S-Organism
(	O
SF370DeltaspeH	O
)	O
,	O
which	O
was	O
confirmed	O
by	O
PCR	O
(	O
unpublished	O
data	O
)	O
and	O
RT	O
-	O
PCR	O
(	O
Figure	O
1A	O
)	O
and	O
tested	O
in	O
vitro	O
for	O
adherence	O
to	O
human	S-Organism
pharyngeal	O
cells	O
.	O

We	O
observed	O
no	O
significant	O
difference	O
in	O
adherence	O
between	O
the	O
wild	O
-	O
type	O
(	O
SF370	S-Organism
)	O
and	O
mutant	O
strains	O
(	O
Figure	O
1B	O
)	O
,	O
indicating	O
that	O
SpeH	O
is	O
not	O
involved	O
directly	O
in	O
attachment	O
to	O
the	O
pharyngeal	O
cell	O
.	O

The	O
significant	O
upregulation	O
of	O
the	O
speH	O
gene	O
during	O
adherence	O
suggests	O
that	O
the	O
gene	O
product	O
may	O
function	O
instead	O
during	O
a	O
subsequent	O
stage	O
of	O
infection	O
.	O

Differential	O
Expression	O
of	O
Genes	O
from	O
Diverse	O
Functional	O
Categories	O

We	O
identified	O
a	O
number	O
of	O
genes	O
encoding	O
proteins	O
involved	O
in	O
housekeeping	O
processes	O
(	O
such	O
as	O
carbohydrate	O
and	O
coenzyme	O
metabolism	O
)	O
that	O
were	O
differentially	O
expressed	O
,	O
indicating	O
a	O
shift	O
in	O
metabolic	O
processes	O
due	O
to	O
host	O
cell	O
adherence	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

For	O
example	O
,	O
genes	O
encoding	O
proteins	O
involved	O
in	O
folate	O
biosynthesis	O
[	O
40	O
]	O
were	O
upregulated	O
,	O
suggesting	O
that	O
certain	O
cofactors	O
that	O
may	O
be	O
necessary	O
during	O
adherence	O
were	O
unavailable	O
.	O

Also	O
upregulated	O
were	O
genes	O
encoding	O
subunits	O
of	O
the	O
F0F1	O
ATPase	O
[	O
41	O
]	O
(	O
discussed	O
in	O
more	O
detail	O
later	O
)	O
,	O
which	O
may	O
indicate	O
an	O
acid	O
stress	O
response	O
to	O
maintain	O
cytoplasmic	O
pH	O
or	O
a	O
need	O
to	O
generate	O
ATP	O
in	O
response	O
to	O
increased	O
energy	O
requirements	O
.	O

We	O
also	O
identified	O
the	O
adherence	O
-	O
mediated	O
upregulation	O
of	O
four	O
transcriptional	O
regulators	O
(	O
Table	O
1	O
)	O
,	O
suggestive	O
of	O
an	O
adaptive	O
response	O
to	O
host	O
cell	O
contact	O
that	O
is	O
dynamic	O
and	O
complex	O
.	O

For	O
example	O
,	O
RopB	O
(	O
encoded	O
by	O
spy2042	O
)	O
,	O
a	O
member	O
of	O
the	O
Rgg	O
family	O
of	O
response	O
regulators	O
,	O
interacts	O
with	O
a	O
number	O
of	O
regulatory	O
networks	O
throughout	O
the	O
streptococcal	O
genome	O
(	O
e	O
.	O
g	O
.	O
,	O
mga	O
,	O
csrRS	O
,	O
sagA	O
,	O
and	O
fasBCA	O
)	O
,	O
affecting	O
the	O
transcription	O
of	O
numerous	O
proteins	O
,	O
virulence	O
factors	O
,	O
and	O
two	O
-	O
component	O
regulatory	O
systems	O
[	O
42	O
,	O
43	O
]	O
.	O

Although	O
the	O
delineation	O
of	O
genes	O
influenced	O
by	O
RopB	O
(	O
or	O
any	O
identified	O
transcriptional	O
regulator	O
)	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
,	O
our	O
initial	O
analysis	O
did	O
identify	O
the	O
upregulation	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
encoded	O
by	O
spy1236	O
-	O
1237	O
.	O

The	O
functions	O
of	O
these	O
particular	O
loci	O
are	O
not	O
yet	O
known	O
,	O
and	O
their	O
adherence	O
-	O
mediated	O
upregulation	O
represents	O
new	O
targets	O
in	O
the	O
study	O
of	O
regulators	O
that	O
function	O
during	O
host	O
cell	O
contact	O
.	O

Neighbor	O
Clustering	O

Our	O
initial	O
analysis	O
revealed	O
the	O
differential	O
expression	O
of	O
a	O
wide	O
range	O
of	O
functionally	O
diverse	O
genes	O
and	O
provided	O
insight	O
into	O
the	O
adaptive	O
response	O
of	O
streptococci	O
to	O
host	O
cell	O
contact	O
.	O

However	O
,	O
despite	O
a	O
rigorous	O
statistical	O
approach	O
,	O
this	O
analysis	O
,	O
like	O
many	O
previous	O
microarray	O
studies	O
,	O
identified	O
the	O
differential	O
expression	O
of	O
a	O
large	O
number	O
of	O
unknown	O
genes	O
(	O
n	O
=	O
21	O
)	O
and	O
a	O
number	O
of	O
incomplete	O
biological	O
pathways	O
(	O
e	O
.	O
g	O
.	O
,	O
F0F1	O
ATPase	O
[	O
41	O
]	O
and	O
folate	O
biosynthesis	O
[	O
40	O
]	O
)	O
by	O
failing	O
to	O
detect	O
the	O
differential	O
expression	O
of	O
a	O
number	O
of	O
known	O
gene	O
pathway	O
members	O
(	O
Table	O
1	O
)	O
.	O

To	O
overcome	O
these	O
limitations	O
and	O
to	O
extract	O
more	O
functional	O
information	O
from	O
the	O
array	O
dataset	O
(	O
including	O
more	O
complete	O
biological	O
pathways	O
)	O
,	O
we	O
developed	O
the	O
neighbor	O
clustering	O
algorithms	O
to	O
combine	O
the	O
physical	O
position	O
of	O
genes	O
on	O
the	O
streptococcal	O
chromosome	O
with	O
gene	O
expression	O
data	O
.	O

Neighbor	O
clustering	O
was	O
designed	O
to	O
identify	O
expanded	O
groupings	O
of	O
potentially	O
related	O
genes	O
from	O
our	O
array	O
data	O
by	O
incorporating	O
two	O
reliable	O
predictors	O
of	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
,	O
namely	O
physical	O
proximity	O
and	O
similar	O
expression	O
profiles	O
[	O
5	O
,	O
6	O
]	O
.	O

We	O
implemented	O
this	O
approach	O
by	O
developing	O
an	O
algorithm	O
with	O
dynamic	O
windowing	O
(	O
GenomeCrawler	O
)	O
that	O
sequentially	O
stepped	O
through	O
the	O
microarray	O
data	O
and	O
identified	O
clusters	O
of	O
adjacent	O
genes	O
exhibiting	O
similar	O
fold	O
changes	O
in	O
expression	O
.	O

Because	O
the	O
genome	O
contains	O
many	O
possible	O
clusters	O
,	O
we	O
restricted	O
the	O
algorithm	O
'	O
s	O
search	O
space	O
to	O
identify	O
only	O
spatially	O
related	O
clusters	O
.	O

GenomeCrawler	O
applied	O
a	O
separate	O
permutation	O
algorithm	O
,	O
using	O
the	O
sum	O
of	O
each	O
gene	O
'	O
s	O
t	O
-	O
statistics	O
to	O
calculate	O
adjusted	O
P	O
values	O
(	O
PK	O
)	O
for	O
each	O
cluster	O
,	O
which	O
corresponded	O
to	O
the	O
probability	O
of	O
assembling	O
a	O
cluster	O
by	O
chance	O
.	O

Significance	O
was	O
assigned	O
to	O
clusters	O
with	O
PK	O
<	O
0	O
.	O
05	O
,	O
and	O
the	O
resulting	O
groupings	O
are	O
listed	O
in	O
Table	O
3	O
.	O

Because	O
individual	O
genes	O
could	O
be	O
members	O
of	O
many	O
different	O
significant	O
clusters	O
,	O
GenomeCrawler	O
then	O
applied	O
a	O
distinct	O
permutation	O
algorithm	O
to	O
calculate	O
the	O
probability	O
(	O
PC	O
)	O
that	O
a	O
gene	O
was	O
clustered	O
coincidentally	O
.	O

Calculation	O
of	O
PC	O
values	O
relies	O
on	O
Bayes	O
'	O
Theorem	O
,	O
in	O
which	O
the	O
probability	O
of	O
a	O
gene	O
'	O
s	O
log2	O
-	O
fold	O
change	O
(	O
PF	O
value	O
)	O
is	O
combined	O
with	O
the	O
cluster	O
probability	O
itself	O
(	O
PK	O
value	O
)	O
.	O

We	O
stress	O
that	O
PC	O
reflects	O
the	O
significance	O
of	O
a	O
gene	O
based	O
on	O
its	O
cluster	O
context	O
rather	O
than	O
a	O
recapitulation	O
of	O
PF	O
.	O

This	O
ensures	O
a	O
strong	O
dependency	O
between	O
PF	O
and	O
PC	O
,	O
preventing	O
a	O
gene	O
with	O
a	O
relatively	O
low	O
log2	O
-	O
fold	O
change	O
from	O
being	O
scored	O
as	O
significant	O
simply	O
because	O
it	O
is	O
clustered	O
with	O
a	O
gene	O
with	O
a	O
highly	O
significant	O
PF	O
value	O
.	O

Finally	O
,	O
GenomeCrawler	O
calculated	O
the	O
overall	O
significance	O
of	O
differentially	O
expressed	O
genes	O
(	O
PE	O
values	O
)	O
by	O
integrating	O
differential	O
expression	O
probabilities	O
(	O
PF	O
)	O
and	O
cluster	O
context	O
probabilities	O
(	O
PC	O
)	O
.	O

We	O
developed	O
a	O
plotting	O
application	O
(	O
GenomeSpyer	O
)	O
that	O
represents	O
the	O
chromosome	O
as	O
a	O
linear	O
molecule	O
to	O
visualize	O
GenomeCrawler	O
output	O
,	O
with	O
genes	O
displayed	O
on	O
the	O
x	O
-	O
axis	O
and	O
their	O
log2	O
-	O
fold	O
change	O
magnitudes	O
on	O
the	O
y	O
-	O
axis	O
.	O

Applications	O
and	O
all	O
datasets	O
are	O
available	O
for	O
download	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
rockefeller	O
.	O
edu	O
/	O
vaf	O
/	O
streparray	O
.	O
php	O
.	O

We	O
visually	O
inspected	O
the	O
resulting	O
clusters	O
and	O
disqualified	O
those	O
that	O
violated	O
our	O
neighbor	O
cluster	O
definition	O
(	O
see	O
Methods	O
for	O
details	O
)	O
.	O

All	O
output	O
prior	O
to	O
cluster	O
disqualifications	O
is	O
included	O
for	O
comparison	O
(	O
see	O
Table	O
S4	O
)	O
.	O

Of	O
the	O
309	O
qualifying	O
clusters	O
(	O
Table	O
S5	O
)	O
,	O
197	O
(	O
63	O
.	O
8	O
%	O
)	O
were	O
composed	O
entirely	O
of	O
known	O
,	O
functionally	O
defined	O
genes	O
;	O
however	O
,	O
26	O
(	O
13	O
%	O
)	O
of	O
these	O
were	O
incorrectly	O
assembled	O
,	O
as	O
they	O
contained	O
known	O
genes	O
that	O
are	O
functionally	O
unrelated	O
.	O

Because	O
we	O
did	O
not	O
incorporate	O
functional	O
annotations	O
of	O
genes	O
into	O
the	O
algorithms	O
(	O
i	O
.	O
e	O
.	O
,	O
to	O
keep	O
the	O
analysis	O
"	O
blind	O
"	O
)	O
,	O
we	O
anticipated	O
the	O
possibility	O
that	O
some	O
groupings	O
could	O
be	O
assembled	O
incorrectly	O
despite	O
the	O
statistical	O
framework	O
for	O
assigning	O
clusters	O
.	O

Of	O
the	O
remaining	O
283	O
(	O
91	O
.	O
6	O
%	O
)	O
groupings	O
,	O
a	O
number	O
of	O
differently	O
sized	O
clusters	O
contained	O
the	O
same	O
gene	O
(	O
Table	O
S5	O
)	O
.	O

We	O
report	O
such	O
clusters	O
first	O
by	O
highest	O
significance	O
(	O
lowest	O
PK	O
value	O
)	O
,	O
then	O
by	O
largest	O
number	O
of	O
genes	O
.	O

Thus	O
,	O
if	O
clusters	O
containing	O
a	O
particular	O
gene	O
were	O
of	O
equal	O
significance	O
,	O
we	O
report	O
the	O
cluster	O
with	O
the	O
most	O
gene	O
members	O
.	O

This	O
method	O
identified	O
47	O
significant	O
clusters	O
containing	O
173	O
differentially	O
expressed	O
genes	O
(	O
listed	O
in	O
Table	O
3	O
and	O
visualized	O
in	O
Figures	O
2	O
and	O
S2	O
-	O
S4	O
)	O
,	O
a	O
considerably	O
larger	O
group	O
than	O
could	O
have	O
been	O
compiled	O
using	O
only	O
the	O
initial	O
79	O
significant	O
genes	O
.	O

A	O
total	O
of	O
56	O
of	O
the	O
original	O
79	O
significant	O
genes	O
became	O
components	O
of	O
significant	O
clusters	O
,	O
whereas	O
23	O
remained	O
unclustered	O
.	O

We	O
subdivided	O
all	O
clusters	O
into	O
three	O
qualitative	O
types	O
based	O
on	O
the	O
functional	O
annotation	O
of	O
gene	O
members	O
.	O

We	O
present	O
examples	O
of	O
Type	O
I	O
and	O
II	O
clusters	O
:	O
Type	O
I	O
clusters	O
(	O
n	O
=	O
25	O
)	O
contained	O
only	O
functionally	O
defined	O
and	O
functionally	O
related	O
genes	O
(	O
as	O
reported	O
in	O
published	O
studies	O
)	O
,	O
such	O
as	O
biological	O
pathways	O
components	O
(	O
Figures	O
2B	O
and	O
S2	O
)	O
;	O
Type	O
II	O
clusters	O
(	O
n	O
=	O
20	O
)	O
included	O
both	O
known	O
and	O
unknown	O
genes	O
(	O
Figures	O
2C	O
and	O
S3	O
)	O
.	O

Type	O
III	O
clusters	O
(	O
n	O
=	O
2	O
)	O
were	O
composed	O
entirely	O
of	O
unknown	O
genes	O
(	O
Figures	O
2D	O
and	O
S4	O
)	O
,	O
and	O
are	O
not	O
discussed	O
in	O
detail	O
.	O

Type	O
I	O
Clusters	O
:	O
Intact	O
Metabolic	O
Pathways	O
and	O
Multimeric	O
Proteins	O

We	O
measured	O
the	O
performance	O
of	O
our	O
algorithm	O
by	O
examining	O
whether	O
it	O
identified	O
gene	O
groupings	O
known	O
to	O
be	O
functionally	O
related	O
(	O
Type	O
I	O
clusters	O
)	O
.	O

Only	O
four	O
(	O
16	O
%	O
)	O
of	O
25	O
Type	O
I	O
clusters	O
(	O
spy0080	O
-	O
0081	O
,	O
spy1236	O
-	O
1237	O
,	O
spy1707	O
-	O
1711	O
,	O
spy2041	O
-	O
2042	O
)	O
could	O
have	O
been	O
identified	O
in	O
entirety	O
by	O
significance	O
analysis	O
because	O
all	O
clustered	O
genes	O
exhibited	O
significant	O
differential	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
.	O

A	O
total	O
of	O
11	O
(	O
52	O
.	O
4	O
%	O
)	O
of	O
the	O
remaining	O
21	O
clusters	O
would	O
not	O
have	O
been	O
identified	O
in	O
their	O
entirety	O
without	O
GenomeCrawler	O
because	O
we	O
initially	O
identified	O
significant	O
fold	O
-	O
changes	O
in	O
only	O
a	O
subset	O
of	O
genes	O
necessary	O
to	O
encode	O
particular	O
pathways	O
or	O
loci	O
;	O
this	O
is	O
intuitively	O
unreasonable	O
if	O
all	O
genes	O
are	O
essential	O
for	O
functionality	O
.	O

GenomeCrawler	O
expanded	O
these	O
clusters	O
to	O
contain	O
more	O
genes	O
that	O
encode	O
intact	O
loci	O
(	O
Table	O
3	O
)	O
.	O

For	O
example	O
,	O
we	O
initially	O
identified	O
(	O
Table	O
1	O
)	O
the	O
significant	O
upregulation	O
of	O
three	O
of	O
the	O
five	O
known	O
gene	O
members	O
of	O
the	O
folate	O
biosynthetic	O
pathway	O
[	O
40	O
]	O
(	O
spy1096	O
-	O
1100	O
)	O
,	O
but	O
GenomeCrawler	O
identified	O
a	O
significant	O
cluster	O
containing	O
all	O
five	O
genes	O
(	O
Table	O
3	O
and	O
Figure	O
2B	O
)	O
.	O

We	O
obtained	O
a	O
similar	O
result	O
for	O
the	O
eight	O
-	O
gene	O
operon	O
encoding	O
the	O
F0F1	O
-	O
type	O
proton	O
translocating	O
ATPase	O
[	O
41	O
]	O
(	O
spy0754	O
-	O
0761	O
)	O
.	O

The	O
initial	O
significance	O
analysis	O
identified	O
only	O
four	O
atp	O
genes	O
(	O
Table	O
1	O
)	O
,	O
but	O
neighbor	O
clustering	O
identified	O
a	O
significant	O
cluster	O
containing	O
all	O
eight	O
genes	O
necessary	O
to	O
encode	O
a	O
functional	O
ATPase	O
(	O
Table	O
3	O
)	O
.	O

Each	O
of	O
the	O
11	O
neighbor	O
clusters	O
that	O
could	O
have	O
been	O
only	O
partially	O
identified	O
by	O
our	O
initial	O
analysis	O
alone	O
gained	O
gene	O
members	O
after	O
application	O
of	O
the	O
algorithms	O
and	O
became	O
more	O
complete	O
sets	O
of	O
functionally	O
related	O
genes	O
than	O
initially	O
identified	O
(	O
Table	O
3	O
)	O
.	O

These	O
clusters	O
encompass	O
various	O
metabolic	O
processes	O
,	O
including	O
purine	O
biosynthesis	O
(	O
spy0025	O
-	O
0028	O
)	O
,	O
lactose	O
metabolism	O
(	O
spy1916	O
-	O
1923	O
)	O
,	O
fatty	O
acid	O
biosynthesis	O
(	O
spy1743	O
-	O
1747	O
)	O
,	O
lipoteichoic	O
acid	O
synthesis	O
(	O
spy1308	O
-	O
1312	O
)	O
,	O
and	O
sugar	O
phosphotransferase	O
transport	O
(	O
spy1058	O
-	O
1060	O
)	O
[	O
14	O
]	O
,	O
suggesting	O
that	O
specific	O
changes	O
occur	O
in	O
the	O
streptococcal	O
metabolic	O
program	O
as	O
the	O
bacteria	O
adhere	O
to	O
human	S-Organism
pharyngeal	O
cells	O
in	O
vitro	O
.	O

Notably	O
,	O
the	O
remaining	O
ten	O
Type	O
I	O
clusters	O
were	O
composed	O
entirely	O
of	O
genes	O
that	O
individually	O
were	O
not	O
significant	O
;	O
however	O
,	O
after	O
applying	O
our	O
algorithms	O
,	O
the	O
combined	O
contribution	O
of	O
each	O
gene	O
resulted	O
in	O
a	O
significant	O
cluster	O
.	O

For	O
example	O
,	O
the	O
nine	O
-	O
gene	O
operon	O
that	O
spans	O
genes	O
spy0738	O
-	O
0746	O
encodes	O
streptolysin	O
S	O
,	O
a	O
potent	O
cytolytic	O
toxin	O
that	O
promotes	O
internalization	O
and	O
host	O
tissue	O
dissemination	O
[	O
25	O
,	O
44	O
]	O
.	O

Though	O
the	O
differential	O
expression	O
of	O
the	O
individual	O
genes	O
was	O
not	O
significant	O
following	O
our	O
initial	O
statistical	O
analysis	O
,	O
GenomeCrawler	O
identified	O
a	O
significant	O
downregulated	O
cluster	O
containing	O
all	O
nine	O
genes	O
(	O
Table	O
3	O
)	O
.	O

Adherence	O
-	O
induced	O
downregulation	O
of	O
streptolysin	O
S	O
is	O
consistent	O
with	O
its	O
previously	O
determined	O
role	O
in	O
host	O
cell	O
internalization	O
[	O
25	O
]	O
;	O
however	O
,	O
without	O
neighbor	O
clustering	O
,	O
expression	O
of	O
this	O
operon	O
was	O
not	O
evident	O
immediately	O
.	O

Although	O
individual	O
gene	O
members	O
of	O
Type	O
I	O
clusters	O
may	O
not	O
be	O
statistically	O
significant	O
as	O
a	O
result	O
of	O
technical	O
variability	O
within	O
experiments	O
[	O
17	O
]	O
,	O
the	O
genetic	O
structure	O
of	O
certain	O
Type	O
I	O
operons	O
may	O
provide	O
an	O
alternative	O
explanation	O
.	O

For	O
example	O
,	O
the	O
streptolysin	O
operon	O
encodes	O
an	O
internal	O
terminator	O
downstream	O
of	O
the	O
sagA	O
gene	O
(	O
the	O
first	O
gene	O
in	O
the	O
operon	O
)	O
,	O
which	O
modulates	O
the	O
abundance	O
of	O
particular	O
mRNA	O
species	O
(	O
e	O
.	O
g	O
.	O
,	O
sagA	O
mRNA	O
versus	O
the	O
polycistronic	O
message	O
for	O
all	O
nine	O
genes	O
)	O
under	O
different	O
environmental	O
conditions	O
[	O
45	O
]	O
.	O

If	O
transcription	O
is	O
internally	O
disrupted	O
by	O
such	O
a	O
terminator	O
,	O
the	O
abundance	O
of	O
the	O
sagA	O
transcript	O
may	O
be	O
much	O
greater	O
than	O
the	O
polycistronic	O
message	O
;	O
such	O
disproportionate	O
transcript	O
levels	O
would	O
affect	O
log2	O
-	O
fold	O
change	O
values	O
and	O
impact	O
the	O
statistical	O
significance	O
of	O
individual	O
genes	O
within	O
these	O
types	O
of	O
clusters	O
.	O

Thus	O
,	O
in	O
addition	O
to	O
helping	O
resolve	O
clusters	O
that	O
would	O
not	O
be	O
easily	O
recognized	O
because	O
of	O
experimental	O
technical	O
variability	O
,	O
the	O
neighbor	O
clustering	O
method	O
may	O
help	O
to	O
resolve	O
operons	O
with	O
such	O
internal	O
terminators	O
and	O
regulators	O
.	O

These	O
results	O
demonstrate	O
that	O
neighbor	O
clustering	O
effectively	O
reconstructed	O
a	O
number	O
of	O
complete	O
pathways	O
and	O
loci	O
from	O
processed	O
array	O
data	O
.	O

Importantly	O
,	O
because	O
functional	O
gene	O
data	O
are	O
not	O
incorporated	O
into	O
its	O
algorithms	O
,	O
GenomeCrawler	O
is	O
not	O
biased	O
toward	O
identifying	O
"	O
expected	O
"	O
clusters	O
.	O

Curating	O
the	O
dataset	O
following	O
its	O
application	O
may	O
make	O
the	O
algorithms	O
less	O
user	O
-	O
friendly	O
;	O
however	O
,	O
the	O
elimination	O
of	O
such	O
bias	O
is	O
essential	O
for	O
this	O
type	O
of	O
analysis	O
.	O

Type	O
II	O
Clusters	O

Based	O
on	O
the	O
Type	O
I	O
cluster	O
results	O
,	O
we	O
speculated	O
that	O
genes	O
contained	O
in	O
Type	O
II	O
clusters	O
might	O
be	O
related	O
by	O
function	O
or	O
regulation	O
.	O

Type	O
II	O
groupings	O
contain	O
a	O
combination	O
of	O
both	O
known	O
and	O
unknown	O
gene	O
members	O
and	O
could	O
provide	O
preliminary	O
clues	O
about	O
the	O
function	O
of	O
unknown	O
genes	O
within	O
a	O
particular	O
cluster	O
by	O
associating	O
their	O
expression	O
with	O
neighboring	O
genes	O
of	O
known	O
and	O
defined	O
function	O
.	O

Alternatively	O
,	O
co	O
-	O
expression	O
of	O
genes	O
results	O
from	O
common	O
regulation	O
,	O
and	O
Type	O
II	O
associations	O
may	O
suggest	O
shared	O
regulatory	O
mechanisms	O
for	O
clustered	O
genes	O
.	O

We	O
note	O
,	O
however	O
,	O
that	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
groupings	O
are	O
assigned	O
,	O
experimental	O
evidence	O
is	O
necessary	O
to	O
confirm	O
functional	O
or	O
regulatory	O
relatedness	O
.	O

We	O
do	O
not	O
suggest	O
simply	O
assigning	O
either	O
based	O
on	O
cluster	O
membership	O
;	O
rather	O
,	O
cluster	O
associations	O
may	O
provide	O
some	O
preliminary	O
functional	O
or	O
regulatory	O
clues	O
for	O
gene	O
members	O
.	O

A	O
total	O
of	O
18	O
(	O
90	O
%	O
)	O
of	O
20	O
Type	O
II	O
clusters	O
(	O
Table	O
3	O
and	O
Figure	O
S3	O
)	O
may	O
not	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
:	O
eight	O
(	O
44	O
.	O
4	O
%	O
)	O
of	O
18	O
gained	O
additional	O
gene	O
members	O
;	O
the	O
remaining	O
ten	O
comprised	O
genes	O
that	O
demonstrated	O
significant	O
differential	O
expression	O
only	O
after	O
applying	O
GenomeCrawler	O
.	O

Only	O
two	O
clusters	O
(	O
spy0127	O
-	O
0130	O
and	O
spy1701	O
-	O
1704	O
)	O
could	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
;	O
however	O
,	O
a	O
number	O
of	O
these	O
genes	O
were	O
initially	O
annotated	O
as	O
hypothetical	O
proteins	O
,	O
so	O
a	O
potential	O
relationship	O
between	O
the	O
gene	O
members	O
may	O
not	O
have	O
been	O
readily	O
apparent	O
.	O

The	O
upregulated	O
spy0127	O
-	O
0130	O
cluster	O
is	O
part	O
of	O
a	O
larger	O
genomic	O
region	O
known	O
as	O
FCT	O
(	O
for	O
fibronectin	O
-	O
and	O
collagen	O
-	O
binding	O
proteins	O
and	O
T	O
antigen	O
-	O
encoding	O
loci	O
)	O
,	O
which	O
spans	O
spy0123	O
-	O
0136	O
in	O
the	O
SF370	S-Organism
genome	O
and	O
encodes	O
surface	O
proteins	O
and	O
transcriptional	O
regulators	O
[	O
46	O
]	O
.	O

A	O
search	O
of	O
both	O
the	O
PFAM	O
database	O
[	O
47	O
]	O
(	O
http	O
:	O
/	O
/	O
pfam	O
.	O
wustl	O
.	O
edu	O
)	O
and	O
sortase	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
doe	O
-	O
mbi	O
.	O
ucla	O
.	O
edu	O
/	O
Services	O
/	O
Sortase	O
)	O
predicted	O
that	O
spy0129	O
encodes	O
a	O
sortase	O
enzyme	O
,	O
which	O
are	O
transpeptidases	O
that	O
cleave	O
protein	O
substrates	O
at	O
conserved	O
C	O
-	O
terminal	O
motifs	O
(	O
often	O
LPXTG	O
)	O
and	O
then	O
anchor	O
these	O
proteins	O
to	O
the	O
bacterial	O
cell	O
wall	O
[	O
48	O
,	O
49	O
]	O
.	O

Recently	O
,	O
it	O
was	O
reported	O
that	O
the	O
four	O
genes	O
spanning	O
spy0127	O
-	O
0130	O
encode	O
,	O
and	O
are	O
responsible	O
for	O
,	O
the	O
formation	O
of	O
surface	O
-	O
localized	O
,	O
trypsin	O
-	O
resistant	O
pili	O
that	O
induce	O
protective	O
immunity	O
against	O
a	O
lethal	O
dose	O
of	O
group	B-Organism
A	I-Organism
streptococci	E-Organism
in	O
a	O
mouse	S-Organism
model	O
of	O
infection	O
[	O
36	O
]	O
.	O

This	O
same	O
report	O
provided	O
the	O
first	O
experimental	O
evidence	O
supporting	O
the	O
sortase	O
prediction	O
,	O
indicating	O
that	O
the	O
gene	O
product	O
of	O
spy0129	O
is	O
responsible	O
for	O
the	O
cell	O
-	O
wall	O
sorting	O
of	O
the	O
proteins	O
encoded	O
by	O
both	O
spy0128	O
(	O
annotated	O
as	O
a	O
Cpa	O
homolog	O
[	O
50	O
]	O
)	O
and	O
spy0130	O
(	O
annotated	O
as	O
a	O
protein	O
F	O
homolog	O
[	O
14	O
]	O
)	O
.	O

Furthermore	O
,	O
the	O
spy0128	O
-	O
encoded	O
protein	O
is	O
the	O
structural	O
backbone	O
of	O
the	O
pili	O
,	O
and	O
the	O
gene	O
product	O
of	O
spy0130	O
may	O
be	O
involved	O
in	O
stabilizing	O
the	O
structure	O
[	O
36	O
]	O
.	O

Together	O
with	O
the	O
identification	O
of	O
this	O
cluster	O
by	O
GenomeCrawler	O
,	O
these	O
results	O
prompted	O
us	O
to	O
study	O
this	O
cluster	O
and	O
the	O
contributions	O
of	O
the	O
gene	O
products	O
to	O
pharyngeal	O
cell	O
adherence	O
.	O

We	O
determined	O
experimentally	O
that	O
cluster	O
spy0127	O
-	O
0130	O
is	O
an	O
operon	O
,	O
verifying	O
both	O
related	O
function	O
and	O
regulation	O
of	O
the	O
gene	O
members	O
.	O

Reverse	O
transcription	O
of	O
SF370	S-Organism
RNA	O
,	O
with	O
primer	O
combinations	O
that	O
spanned	O
all	O
four	O
genes	O
,	O
produced	O
cDNA	O
fragments	O
of	O
sizes	O
that	O
could	O
only	O
result	O
from	O
a	O
polycistronic	O
mRNA	O
template	O
(	O
Figure	O
3	O
)	O
.	O

In	O
silico	O
sequence	O
inspection	O
identified	O
a	O
single	O
putative	O
promoter	O
sequence	O
upstream	O
of	O
spy0127	O
(	O
see	O
Table	O
S6	O
)	O
.	O

Although	O
GenomeCrawler	O
is	O
not	O
an	O
operon	O
-	O
identifying	O
algorithm	O
,	O
these	O
results	O
show	O
that	O
it	O
could	O
(	O
1	O
)	O
identify	O
this	O
commonly	O
regulated	O
gene	O
cluster	O
and	O
(	O
2	O
)	O
define	O
the	O
cluster	O
boundaries	O
,	O
excluding	O
other	O
proximate	O
genes	O
,	O
such	O
as	O
an	O
additional	O
sortase	O
-	O
encoding	O
gene	O
,	O
spy0135	O
.	O

Allelic	O
Replacement	O
of	O
spy0129	O

We	O
created	O
a	O
spy0129	O
deletion	O
mutant	O
in	O
strain	O
SF370	S-Organism
(	O
SF370Deltaspy0129	O
)	O
to	O
determine	O
if	O
genes	O
contained	O
within	O
the	O
spy0127	O
-	O
0130	O
cluster	O
were	O
directly	O
involved	O
in	O
adherence	O
to	O
pharyngeal	O
cells	O
.	O

We	O
posited	O
that	O
a	O
deletion	O
in	O
the	O
spy0129	O
sortase	O
gene	O
may	O
have	O
the	O
greatest	O
overall	O
effect	O
on	O
the	O
production	O
and	O
processing	O
of	O
the	O
gene	O
products	O
of	O
this	O
cluster	O
,	O
since	O
both	O
the	O
spy0128	O
and	O
spy0130	O
gene	O
products	O
do	O
not	O
localize	O
to	O
the	O
cell	O
-	O
wall	O
surface	O
in	O
the	O
absence	O
of	O
the	O
sortase	O
enzyme	O
[	O
36	O
]	O
.	O

Allelic	O
replacement	O
created	O
two	O
putative	O
deletion	O
mutants	O
;	O
however	O
,	O
RT	O
-	O
PCR	O
analysis	O
(	O
Figure	O
4A	O
)	O
revealed	O
that	O
only	O
one	O
such	O
clone	O
(	O
SF370Deltaspy0129	O
.	O
2	O
)	O
was	O
a	O
true	O
knock	O
-	O
out	O
for	O
the	O
spy0129	O
gene	O
and	O
useful	O
for	O
further	O
study	O
.	O

Because	O
the	O
gene	O
cluster	O
is	O
also	O
an	O
operon	O
,	O
expression	O
of	O
the	O
downstream	O
gene	O
spy0130	O
,	O
encoding	O
the	O
protein	O
F	O
homolog	O
/	O
pilus	O
protein	O
,	O
was	O
also	O
eliminated	O
in	O
this	O
mutant	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
vitro	O
pharyngeal	O
cell	O
adherence	O
assays	O
revealed	O
that	O
the	O
SF370Deltaspy0129	O
.	O
2	O
mutant	O
was	O
approximately	O
66	O
%	O
less	O
adherent	O
than	O
the	O
parental	O
control	O
strain	O
,	O
SF370	S-Organism
(	O
Figure	O
4B	O
;	O
p	O
=	O
0	O
.	O
03	O
as	O
determined	O
by	O
the	O
Student	O
'	O
s	O
t	O
-	O
test	O
)	O
.	O

These	O
results	O
suggest	O
that	O
either	O
the	O
spy0130	O
gene	O
product	O
is	O
involved	O
directly	O
in	O
adherence	O
,	O
or	O
that	O
due	O
to	O
the	O
elimination	O
of	O
the	O
sortase	O
,	O
the	O
pili	O
,	O
which	O
may	O
function	O
in	O
their	O
entirety	O
as	O
adhesins	O
,	O
were	O
not	O
assembled	O
on	O
the	O
surface	O
of	O
the	O
mutant	O
.	O

Because	O
the	O
spy0129	O
gene	O
product	O
is	O
not	O
expected	O
to	O
be	O
found	O
on	O
the	O
streptococcal	O
surface	O
(	O
i	O
.	O
e	O
.	O
,	O
it	O
lacks	O
a	O
cell	O
-	O
wall	O
anchoring	O
motif	O
)	O
,	O
it	O
is	O
not	O
likely	O
to	O
be	O
involved	O
directly	O
in	O
adherence	O
.	O

We	O
are	O
working	O
to	O
produce	O
an	O
in	O
-	O
frame	O
deletion	O
of	O
spy0128	O
and	O
a	O
spy0130	O
single	O
knock	O
-	O
out	O
mutant	O
to	O
delineate	O
the	O
contribution	O
of	O
each	O
individual	O
clustered	O
gene	O
product	O
to	O
adherence	O
.	O

These	O
results	O
show	O
that	O
neighbor	O
clustering	O
is	O
able	O
to	O
identify	O
biologically	O
relevant	O
gene	O
clusters	O
.	O

This	O
attribute	O
may	O
be	O
particularly	O
important	O
for	O
datasets	O
in	O
which	O
the	O
relationship	O
between	O
clustered	O
genes	O
is	O
not	O
obvious	O
,	O
and	O
may	O
facilitate	O
the	O
organization	O
of	O
larger	O
datasets	O
into	O
more	O
manageable	O
packages	O
.	O

Additional	O
Type	O
II	O
Cluster	O
Example	O

Another	O
cluster	O
,	O
spy1725	O
-	O
1719	O
,	O
contained	O
six	O
genes	O
that	O
together	O
(	O
though	O
not	O
individually	O
)	O
exhibited	O
significant	O
downregulation	O
.	O

The	O
genes	O
spy1724	O
,	O
spy1722	O
,	O
spy1721	O
,	O
and	O
spy1719	O
share	O
transcriptional	O
order	O
and	O
predicted	O
function	O
with	O
homologs	O
in	O
the	O
nusA	O
-	O
infB	O
protein	O
biosynthesis	O
operon	O
of	O
Bacillus	B-Organism
subtilis	E-Organism
and	O
Escherichia	B-Organism
coli	E-Organism
[	O
51	O
]	O
.	O

We	O
examined	O
the	O
spy1725	O
and	O
spy1723	O
gene	O
products	O
(	O
annotated	O
as	O
hypothetical	O
proteins	O
[	O
14	O
]	O
)	O
for	O
similarities	O
with	O
known	O
proteins	O
that	O
might	O
indicate	O
a	O
role	O
for	O
these	O
gene	O
products	O
in	O
protein	O
biosynthesis	O
.	O

BlastP	O
analysis	O
aligned	O
the	O
spy1725	O
gene	O
product	O
,	O
which	O
has	O
homologs	O
in	O
all	O
sequenced	O
streptococcal	O
genomes	O
,	O
with	O
the	O
SP14	O
.	O
3	O
protein	O
from	O
S	B-Organism
.	I-Organism
pneumoniae	E-Organism
[	O
52	O
]	O
(	O
80	O
%	O
sequence	O
similarity	O
;	O
67	O
%	O
identity	O
)	O
.	O

Based	O
on	O
structural	O
characterization	O
,	O
SP14	O
.	O
3	O
is	O
a	O
predicted	O
RNA	O
-	O
binding	O
protein	O
.	O

The	O
spy1723	O
gene	O
product	O
has	O
similar	O
domain	O
structure	O
to	O
the	O
YlxR	O
protein	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	E-Organism
,	O
an	O
RNA	O
-	O
binding	O
protein	O
implicated	O
in	O
transcription	O
termination	O
[	O
53	O
]	O
.	O

These	O
results	O
indicate	O
that	O
both	O
genes	O
likely	O
encode	O
RNA	O
-	O
binding	O
proteins	O
,	O
in	O
agreement	O
with	O
their	O
functionally	O
defined	O
cluster	O
members	O
.	O

Although	O
domain	O
and	O
homology	O
searches	O
yielded	O
the	O
functional	O
predictions	O
,	O
their	O
membership	O
within	O
a	O
protein	O
biosynthetic	O
cluster	O
provided	O
the	O
initial	O
indication	O
of	O
common	O
function	O
or	O
regulation	O
.	O

Neighbor	O
Clustering	O
and	O
Operons	O

Although	O
neighbor	O
clustering	O
is	O
not	O
an	O
operon	O
-	O
predicting	O
method	O
,	O
we	O
wanted	O
to	O
identify	O
additional	O
putative	O
operons	O
among	O
the	O
groupings	O
since	O
neighbor	O
clusters	O
by	O
definition	O
share	O
certain	O
operon	O
characteristics	O
(	O
tandemly	O
arranged	O
genes	O
,	O
separated	O
by	O
<	O
300	O
bp	O
,	O
with	O
similar	O
expression	O
patterns	O
)	O
.	O

Although	O
operon	O
-	O
modeling	O
methods	O
exist	O
[	O
54	O
,	O
55	O
]	O
,	O
we	O
inspected	O
clusters	O
in	O
silico	O
for	O
upstream	O
regulatory	O
elements	O
and	O
identified	O
17	O
candidates	O
,	O
including	O
clusters	O
such	O
as	O
streptolysin	O
S	O
that	O
have	O
been	O
previously	O
confirmed	O
as	O
operons	O
[	O
56	O
]	O
;	O
the	O
spy0127	O
-	O
0130	O
grouping	O
,	O
which	O
was	O
confirmed	O
as	O
an	O
operon	O
in	O
this	O
study	O
;	O
and	O
others	O
that	O
have	O
yet	O
to	O
be	O
verified	O
(	O
Table	O
S6	O
)	O
.	O

Experimental	O
confirmation	O
of	O
each	O
candidate	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
,	O
but	O
Northern	O
blot	O
and	O
RT	O
-	O
PCR	O
analyses	O
could	O
provide	O
such	O
information	O
.	O

Analysis	O
of	O
Previously	O
Published	O
Array	O
Data	O

We	O
applied	O
the	O
statistical	O
analysis	O
and	O
the	O
GenomeCrawler	O
algorithms	O
to	O
data	O
from	O
a	O
recently	O
published	O
streptococcal	O
microarray	O
study	O
that	O
is	O
relevant	O
for	O
comparison	O
to	O
our	O
own	O
data	O
(	O
same	O
streptococcal	B-Organism
strain	E-Organism
,	O
similar	O
array	O
platform	O
)	O
[	O
57	O
]	O
.	O

In	O
this	O
study	O
,	O
the	O
transciptomes	O
of	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
strain	I-Organism
SF370	E-Organism
and	O
an	O
isogenic	O
mutant	O
deficient	O
for	O
the	O
Mga	O
regulon	O
were	O
compared	O
during	O
exponential	O
growth	O
in	O
culture	O
broth	O
.	O

The	O
Mga	O
regulator	O
is	O
a	O
growth	O
-	O
phase	O
mediator	O
of	O
a	O
number	O
of	O
surface	O
-	O
exposed	O
molecules	O
and	O
secreted	O
proteins	O
involved	O
in	O
colonization	O
and	O
immune	O
evasion	O
during	O
infection	O
[	O
58	O
]	O
.	O

Although	O
the	O
authors	O
of	O
that	O
study	O
did	O
not	O
provide	O
a	O
statistical	O
analysis	O
of	O
their	O
data	O
,	O
we	O
compared	O
the	O
published	O
results	O
for	O
the	O
magnitude	O
and	O
direction	O
of	O
fold	O
-	O
changes	O
for	O
each	O
gene	O
reported	O
in	O
this	O
study	O
with	O
those	O
obtained	O
from	O
our	O
initial	O
significance	O
analysis	O
of	O
this	O
dataset	O
(	O
presented	O
as	O
Table	O
S7	O
)	O
.	O

A	O
total	O
of	O
256	O
genes	O
reported	O
in	O
this	O
study	O
were	O
also	O
detected	O
by	O
our	O
analysis	O
,	O
and	O
the	O
magnitude	O
and	O
log2	O
-	O
fold	O
change	O
were	O
found	O
to	O
be	O
in	O
agreement	O
for	O
81	O
%	O
of	O
the	O
genes	O
.	O

We	O
suspect	O
that	O
this	O
discrepancy	O
results	O
from	O
different	O
normalization	O
methods	O
used	O
,	O
or	O
from	O
different	O
methods	O
that	O
were	O
applied	O
to	O
analyze	O
the	O
ratio	O
of	O
signal	O
intensities	O
between	O
sample	O
and	O
control	O
(	O
i	O
.	O
e	O
.	O
,	O
we	O
analyzed	O
the	O
ratios	O
of	O
the	O
median	O
rather	O
than	O
the	O
ratios	O
of	O
the	O
mean	O
[	O
57	O
]	O
)	O
.	O

Although	O
the	O
published	O
report	O
did	O
not	O
include	O
statistical	O
analysis	O
of	O
the	O
data	O
,	O
we	O
note	O
that	O
the	O
statistical	O
analysis	O
that	O
we	O
performed	O
identified	O
four	O
genes	O
with	O
significant	O
log2	O
-	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
<	O
0	O
.	O
05	O
;	O
Table	O
S8	O
)	O
.	O

We	O
applied	O
the	O
GenomeCrawler	O
algorithms	O
to	O
the	O
statistically	O
analyzed	O
dataset	O
,	O
which	O
identified	O
an	O
expanded	O
group	O
of	O
genes	O
(	O
107	O
versus	O
four	O
)	O
contained	O
within	O
36	O
statistically	O
significant	O
clusters	O
(	O
PK	O
<	O
0	O
.	O
05	O
;	O
Table	O
S9	O
)	O
.	O

These	O
groupings	O
included	O
clusters	O
of	O
genes	O
that	O
have	O
been	O
shown	O
previously	O
in	O
streptococci	S-Organism
to	O
be	O
functionally	O
related	O
,	O
indicating	O
that	O
the	O
algorithms	O
were	O
performing	O
as	O
expected	O
.	O

Two	O
of	O
the	O
identified	O
upregulated	O
clusters	O
(	O
spy2009	O
-	O
2010	O
and	O
spy2039	O
-	O
2040	O
)	O
encoding	O
the	O
well	O
-	O
studied	O
virulence	O
factors	O
,	O
C5a	O
peptidase	O
and	O
SpeB	O
,	O
respectively	O
,	O
showed	O
consistently	O
large	O
log2	O
-	O
fold	O
changes	O
of	O
the	O
genes	O
across	O
replicates	O
[	O
57	O
]	O
.	O

GenomeCrawler	O
confirmed	O
these	O
results	O
by	O
identifying	O
both	O
groupings	O
as	O
statistically	O
significant	O
neighbor	O
clusters	O
.	O

GenomeCrawler	O
also	O
identified	O
a	O
number	O
of	O
clusters	O
that	O
contained	O
genes	O
known	O
to	O
share	O
common	O
function	O
or	O
regulation	O
;	O
however	O
,	O
they	O
were	O
not	O
as	O
apparent	O
in	O
the	O
dataset	O
without	O
its	O
application	O
.	O

For	O
example	O
,	O
the	O
algorithm	O
identified	O
a	O
significant	O
neighbor	O
cluster	O
spanning	O
spy0711	O
-	O
0712	O
.	O

This	O
grouping	O
encodes	O
two	O
known	O
virulence	O
factors	O
,	O
pyrogenic	O
exotoxin	O
SpeC	O
and	O
the	O
MF2	O
DNase	O
,	O
previously	O
shown	O
to	O
be	O
commonly	O
regulated	O
as	O
an	O
operon	O
[	O
11	O
]	O
.	O

The	O
algorithm	O
also	O
identified	O
other	O
neighbor	O
clusters	O
containing	O
genes	O
known	O
to	O
be	O
functionally	O
related	O
,	O
including	O
spy0098	O
-	O
0100	O
(	O
encoding	O
the	O
beta	O
and	O
beta	O
'	O
subunits	O
of	O
DNA	O
-	O
dependent	O
RNA	O
polymerase	O
)	O
,	O
spy2159	O
-	O
2160	O
(	O
encoding	O
the	O
50S	O
ribosomal	O
subunit	O
proteins	O
L32	O
and	O
L33	O
)	O
,	O
and	O
spy0741	O
-	O
0746	O
(	O
six	O
of	O
the	O
nine	O
streptolysin	O
S	O
-	O
encoding	O
genes	O
)	O
[	O
14	O
]	O
.	O

Although	O
the	O
analysis	O
of	O
this	O
previously	O
published	O
dataset	O
did	O
not	O
reveal	O
as	O
many	O
intact	O
biological	O
pathways	O
as	O
were	O
identified	O
from	O
the	O
pharyngeal	O
cell	O
adherence	O
data	O
,	O
the	O
inclusion	O
of	O
more	O
replicates	O
in	O
the	O
analysis	O
to	O
increase	O
statistical	O
power	O
could	O
resolve	O
such	O
loci	O
.	O

However	O
,	O
these	O
results	O
provided	O
further	O
supporting	O
evidence	O
that	O
the	O
GenomeCrawler	O
algorithms	O
can	O
identify	O
(	O
1	O
)	O
a	O
larger	O
group	O
of	O
genes	O
than	O
a	O
rigorous	O
statistical	O
analysis	O
alone	O
and	O
(	O
2	O
)	O
biologically	O
relevant	O
groupings	O
in	O
other	O
microarray	O
datasets	O
,	O
even	O
if	O
they	O
contain	O
fewer	O
replicates	O
than	O
presented	O
in	O
our	O
study	O
.	O

Concluding	O
Remarks	O

Although	O
GenomeCrawler	O
improves	O
bacterial	O
array	O
analyses	O
,	O
it	O
has	O
limitations	O
:	O
it	O
cannot	O
identify	O
regulons	O
comprising	O
genes	O
dispersed	O
throughout	O
the	O
genome	O
by	O
virtue	O
of	O
its	O
design	O
,	O
it	O
does	O
not	O
specifically	O
interrogate	O
single	O
-	O
gene	O
operons	O
,	O
and	O
it	O
only	O
applies	O
to	O
genomes	O
with	O
available	O
and	O
accurate	O
experimental	O
information	O
(	O
expression	O
data	O
and	O
gene	O
annotations	O
)	O
.	O

We	O
recognize	O
that	O
incorporating	O
intergenic	O
distance	O
and	O
transcription	O
direction	O
into	O
the	O
algorithms	O
would	O
reduce	O
processing	O
time	O
.	O

Adding	O
available	O
clusters	O
of	O
orthologous	O
groups	O
(	O
COG	O
)	O
information	O
into	O
a	O
downstream	O
processing	O
step	O
could	O
decrease	O
errors	O
by	O
minimizing	O
clustering	O
of	O
unrelated	O
genes	O
.	O

Nonetheless	O
,	O
neighbor	O
clustering	O
provided	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
transcriptome	O
of	O
group	B-Organism
A	I-Organism
streptococci	E-Organism
during	O
adherence	O
to	O
human	S-Organism
pharyngeal	O
cells	O
,	O
a	O
critical	O
step	O
in	O
the	O
infection	O
program	O
of	O
this	O
organism	O
.	O

We	O
found	O
that	O
even	O
a	O
rigorous	O
statistical	O
analysis	O
of	O
well	O
-	O
replicated	O
microarray	O
data	O
produced	O
a	O
dataset	O
that	O
was	O
somewhat	O
limited	O
,	O
although	O
certainly	O
more	O
informative	O
than	O
assigning	O
arbitrary	O
thresholds	O
for	O
significance	O
.	O

As	O
described	O
in	O
other	O
microarray	O
reports	O
,	O
we	O
had	O
initially	O
identified	O
a	O
number	O
of	O
incomplete	O
biological	O
pathways	O
in	O
which	O
we	O
did	O
not	O
detect	O
the	O
differential	O
expression	O
of	O
a	O
number	O
of	O
known	O
pathway	O
members	O
.	O

Neighbor	O
clustering	O
was	O
able	O
to	O
extend	O
the	O
results	O
by	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
and	O
reconstructing	O
more	O
intact	O
biological	O
pathways	O
.	O

Neighbor	O
clustering	O
,	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
it	O
assigns	O
groupings	O
,	O
would	O
be	O
valuable	O
to	O
microarray	O
data	O
analysis	O
only	O
if	O
it	O
produced	O
biologically	O
relevant	O
data	O
.	O

Although	O
biological	O
testing	O
of	O
every	O
identified	O
gene	O
or	O
cluster	O
is	O
unrealistic	O
,	O
we	O
provided	O
evidence	O
,	O
through	O
the	O
creation	O
and	O
testing	O
of	O
isogenic	O
deletion	O
mutants	O
and	O
through	O
the	O
identification	O
of	O
clusters	O
of	O
known	O
,	O
functionally	O
related	O
genes	O
from	O
a	O
published	O
streptococcal	O
array	O
study	O
,	O
that	O
the	O
algorithms	O
produce	O
results	O
that	O
are	O
pertinent	O
to	O
the	O
biology	O
of	O
streptococci	S-Organism
.	O

This	O
may	O
be	O
of	O
particular	O
importance	O
for	O
data	O
in	O
which	O
the	O
relationship	O
between	O
clustered	O
genes	O
is	O
not	O
obvious	O
,	O
and	O
may	O
facilitate	O
the	O
organization	O
of	O
larger	O
datasets	O
into	O
more	O
meaningful	O
packages	O
.	O

It	O
is	O
also	O
possible	O
that	O
GenomeCrawler	O
(	O
in	O
its	O
current	O
form	O
)	O
could	O
be	O
used	O
to	O
interrogate	O
intergenic	O
portions	O
of	O
the	O
genome	O
(	O
such	O
as	O
those	O
encoding	O
small	O
noncoding	O
RNAs	O
or	O
sRNAs	O
)	O
,	O
if	O
probes	O
representing	O
such	O
regions	O
were	O
included	O
on	O
the	O
microarray	O
,	O
and	O
experimental	O
conditions	O
were	O
designed	O
to	O
promote	O
their	O
differential	O
expression	O
.	O

Finally	O
,	O
because	O
of	O
the	O
common	O
architecture	O
of	O
bacterial	O
chromosomes	O
,	O
the	O
neighbor	O
clustering	O
algorithms	O
may	O
be	O
applicable	O
to	O
microarray	O
datasets	O
from	O
other	O
prokaryotes	O
.	O

Porphyromonas	B-Organism
gingivalis	E-Organism
short	O
fimbriae	O
are	O
regulated	O
by	O
a	O
FimS	O
/	O
FimR	O
two	O
-	O
component	O
system	O

Porphyromonas	B-Organism
gingivalis	E-Organism
possesses	O
two	O
distinct	O
fimbriae	O
.	O

The	O
long	O
(	O
FimA	O
)	O
fimbriae	O
have	O
been	O
extensively	O
studied	O
.	O

Expression	O
of	O
the	O
fimA	O
gene	O
is	O
tightly	O
controlled	O
by	O
a	O
two	O
-	O
component	O
system	O
(	O
FimS	O
/	O
FimR	O
)	O
through	O
a	O
cascade	O
regulation	O
.	O

The	O
short	O
(	O
Mfa1	O
)	O
fimbriae	O
are	O
less	O
understood	O
.	O

The	O
authors	O
have	O
recently	O
demonstrated	O
that	O
both	O
fimbriae	O
are	O
required	O
for	O
formation	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
biofilms	O
.	O

Here	O
,	O
the	O
novel	O
finding	O
that	O
FimR	O
,	O
a	O
member	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
is	O
a	O
transcriptional	O
activator	O
of	O
the	O
mfa1	O
gene	O
is	O
promoted	O
.	O

Unlike	O
the	O
regulatory	O
mechanism	O
of	O
FimA	O
by	O
FimR	O
,	O
this	O
regulation	O
of	O
the	O
mfa1	O
gene	O
is	O
accomplished	O
by	O
FimR	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	O
.	O

Introduction	O

Porphyromonas	B-Organism
gingivalis	E-Organism
is	O
a	O
gram	O
-	O
negative	O
bacterium	O
,	O
which	O
is	O
considered	O
to	O
be	O
a	O
major	O
periodontal	O
pathogen	O
(	O
Socransky	O
&	O
Haffajee	O
,	O
2005	O
)	O
.	O

It	O
is	O
also	O
a	O
pathogen	O
that	O
may	O
be	O
involved	O
in	O
coronary	O
heart	O
disease	O
and	O
preterm	O
births	O
(	O
Boggess	O
et	O
al	O
.	O
,	O
2005	O
;	O
Brodala	O
et	O
al	O
.	O
,	O
2005	O
;	O
Chou	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

The	O
ability	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
to	O
initiate	O
a	O
periodontal	O
infection	O
is	O
mainly	O
dependent	O
on	O
the	O
expression	O
of	O
fimbriae	O
(	O
Malek	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Two	O
distinct	O
fimbriae	O
are	O
found	O
on	O
the	O
surface	O
of	O
the	O
organism	O
(	O
Dickinson	O
et	O
al	O
.	O
,	O
1988	O
;	O
Hamada	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

The	O
long	O
(	O
major	O
)	O
filamentous	O
structure	O
is	O
comprised	O
of	O
a	O
FimA	O
subunit	O
protein	O
encoded	O
by	O
the	O
fimA	O
gene	O
.	O

The	O
short	O
(	O
minor	O
)	O
fimbriae	O
are	O
made	O
up	O
of	O
a	O
67	O
kDa	O
protein	O
(	O
Mfa1	O
)	O
.	O

Both	O
fimbriae	O
appear	O
to	O
be	O
involved	O
in	O
bacterial	O
pathogenicity	O
(	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
function	O
of	O
the	O
FimA	O
protein	O
and	O
regulation	O
of	O
fimA	O
expression	O
have	O
been	O
extensively	O
studied	O
.	O

The	O
FimA	O
protein	O
is	O
required	O
for	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
colonization	O
on	O
salivary	O
coated	O
surfaces	O
,	O
and	O
the	O
early	O
colonization	O
of	O
dental	O
plaque	O
(	O
Malek	O
et	O
al	O
.	O
,	O
1994	O
;	O
Levesque	O
et	O
al	O
.	O
,	O
2003	O
;	O
Maeda	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

A	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
fimA	O
mutant	O
shows	O
impaired	O
invasion	O
capability	O
of	O
epithelial	O
cells	O
compared	O
with	O
wild	O
-	O
type	O
strain	O
,	O
suggesting	O
the	O
involvement	O
of	O
FimA	O
in	O
the	O
bacterial	O
interaction	O
with	O
surface	O
receptor	O
(	O
s	O
)	O
on	O
gingival	O
cells	O
(	O
Weinberg	O
et	O
al	O
.	O
,	O
1997	O
)	O
.	O

Earlier	O
studies	O
by	O
the	O
authors	O
showed	O
that	O
FimA	O
expression	O
was	O
modulated	O
by	O
environmental	O
cues	O
,	O
including	O
temperature	O
and	O
hemin	O
concentration	O
,	O
and	O
by	O
the	O
presence	O
of	O
Streptococcus	B-Organism
cristatus	E-Organism
,	O
an	O
early	O
colonizer	O
of	O
dental	O
plaque	O
(	O
Xie	O
et	O
al	O
.	O
,	O
1997	O
,	O
2000b	O
)	O
.	O

FimR	O
,	O
a	O
response	O
regulator	O
of	O
the	O
fimS	O
/	O
fimR	O
two	O
-	O
component	O
system	O
was	O
identified	O
,	O
and	O
FimA	O
expression	O
was	O
found	O
to	O
be	O
dramatically	O
reduced	O
in	O
fimR	O
mutants	O
(	O
Hayashi	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

Investigation	O
of	O
the	O
mechanism	O
of	O
regulation	O
of	O
fimA	O
by	O
FimR	O
indicates	O
that	O
FimR	O
does	O
not	O
bind	O
directly	O
to	O
the	O
fimA	O
promoter	O
,	O
but	O
rather	O
binds	O
to	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
(	O
pg2130	O
)	O
in	O
the	O
fimA	O
cluster	O
,	O
suggesting	O
that	O
PG2130	O
is	O
the	O
FimR	O
target	O
gene	O
,	O
which	O
in	O
turn	O
regulates	O
expression	O
of	O
other	O
genes	O
in	O
the	O
fimA	O
cluster	O
,	O
including	O
the	O
fimA	O
gene	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
short	O
fimbriae	O
(	O
Mfa1	O
)	O
also	O
contribute	O
to	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
colonization	O
.	O

Coadhesion	O
and	O
biofilm	O
development	O
between	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
and	O
Streptococcus	B-Organism
gordonii	E-Organism
require	O
the	O
interaction	O
of	O
Mfa1	O
with	O
streptococcal	O
protein	O
SspB	O
(	O
Park	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

The	O
authors	O
have	O
recently	O
reported	O
that	O
the	O
short	O
fimbriae	O
are	O
required	O
for	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
cell	O
-	O
cell	O
aggregation	O
,	O
an	O
essential	O
step	O
in	O
microcolony	O
formation	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

A	O
mutant	O
with	O
a	O
deficiency	O
in	O
minor	O
fimbriae	O
binds	O
to	O
a	O
saliva	O
-	O
coated	O
surface	O
but	O
does	O
not	O
form	O
microcolonies	O
as	O
the	O
wild	O
-	O
type	O
strain	O
does	O
.	O

Mfa1	O
expression	O
appears	O
to	O
fluctuate	O
under	O
various	O
growth	O
conditions	O
(	O
Masuda	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

In	O
a	O
nutrient	O
-	O
limited	O
medium	O
,	O
expression	O
of	O
FimA	O
and	O
Mfa1	O
are	O
inhibited	O
in	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
,	O
whereas	O
such	O
differences	O
are	O
not	O
found	O
in	O
gingipain	O
expression	O
.	O

A	O
recent	O
study	O
has	O
shown	O
that	O
expression	O
of	O
mfa1	O
is	O
repressed	O
in	O
the	O
presence	O
of	O
some	O
common	O
oral	O
plaque	O
bacteria	O
such	O
as	O
S	B-Organism
.	I-Organism
gordonii	E-Organism
,	O
Streptococcus	B-Organism
sanguinis	E-Organism
and	O
Streptococcus	B-Organism
mitis	E-Organism
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

However	O
,	O
very	O
little	O
is	O
known	O
about	O
regulatory	O
mechanisms	O
of	O
mfa1	O
expression	O
.	O

In	O
this	O
study	O
,	O
it	O
is	O
demonstrated	O
that	O
FimR	O
is	O
a	O
positive	O
regulator	O
of	O
Mfa1	O
expression	O
.	O

Evidence	O
is	O
provided	O
that	O
unlike	O
FimR	O
-	O
dependent	O
fimA	O
expression	O
,	O
FimR	O
regulates	O
mfa1	O
expression	O
by	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	O
.	O

Results	O

Role	O
of	O
FimR	O
in	O
mfa1	O
expression	O
The	O
fimA	O
gene	O
is	O
the	O
only	O
gene	O
known	O
to	O
be	O
tightly	O
controlled	O
by	O
the	O
FimS	O
/	O
FimR	O
system	O
.	O

It	O
was	O
postulated	O
that	O
the	O
expression	O
of	O
other	O
genes	O
may	O
also	O
be	O
controlled	O
by	O
this	O
two	O
component	O
regulatory	O
system	O
.	O

To	O
investigate	O
effects	O
of	O
FimR	O
on	O
expression	O
of	O
the	O
mfa1	O
gene	O
,	O
an	O
insertional	O
fimR	O
mutant	O
was	O
constructed	O
by	O
allelic	O
replacement	O
.	O

Expression	O
of	O
fimA	O
and	O
mfa1	O
in	O
the	O
fimR	O
-	O
mutant	O
was	O
determined	O
using	O
real	O
-	O
time	O
PCR	O
analysis	O
.	O

Statistically	O
significant	O
differences	O
of	O
the	O
level	O
of	O
gene	O
expression	O
in	O
33277	S-Organism
and	O
the	O
fimR	O
-	O
mutant	O
were	O
calculated	O
by	O
a	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

1a	O
,	O
expression	O
of	O
the	O
fimA	O
gene	O
was	O
abolished	O
in	O
the	O
fimR	O
-	O
mutant	O
strain	O
FRE	O
.	O

This	O
result	O
is	O
consistent	O
with	O
previous	O
observations	O
(	O
Hayashi	O
et	O
al	O
.	O
,	O
2000	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
striking	O
finding	O
is	O
that	O
expression	O
of	O
the	O
mfa1	O
gene	O
was	O
also	O
repressed	O
threefold	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
although	O
not	O
to	O
the	O
degree	O
observed	O
with	O
the	O
fimA	O
expression	O
.	O

However	O
,	O
the	O
fimR	O
-	O
mutation	O
had	O
no	O
effect	O
on	O
expression	O
of	O
rgpA	O
,	O
a	O
gene	O
encoding	O
the	O
arginine	O
-	O
specific	O
protease	O
,	O
or	O
the	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
16S	O
RNA	O
gene	O
.	O

This	O
analysis	O
suggests	O
the	O
FimS	O
/	O
FimR	O
system	O
is	O
required	O
for	O
expression	O
of	O
both	O
major	O
and	O
minor	O
fimbriae	O
.	O

To	O
determine	O
production	O
of	O
long	O
(	O
major	O
)	O
and	O
short	O
(	O
minor	O
)	O
fimbriae	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
western	O
blotting	O
was	O
performed	O
with	O
a	O
polyclonal	O
anti	O
-	O
FimA	O
or	O
anti	O
-	O
Mfa1	O
antibody	O
to	O
compare	O
fimbrial	O
production	O
in	O
wild	O
-	O
type	O
strain	O
(	O
33277	S-Organism
)	O
,	O
the	O
fimR	O
-	O
mutant	O
(	O
FRE	S-Organism
)	O
,	O
the	O
fimA	O
-	O
mutant	O
(	O
FAT	S-Organism
)	O
and	O
the	O
mfa1	O
-	O
mutant	O
(	O
MFAE	S-Organism
)	O
.	O

Density	O
of	O
protein	O
bands	O
was	O
determined	O
by	O
UVP	O
Bioimaging	O
System	O
(	O
UVP	O
,	O
CA	O
)	O
.	O

This	O
analysis	O
revealed	O
that	O
the	O
expression	O
of	O
the	O
fimA	O
and	O
mfa1	O
genes	O
was	O
consistent	O
at	O
the	O
mRNA	O
level	O
and	O
protein	O
level	O
(	O
Fig	O
.	O
1b	O
)	O
.	O

FimA	O
protein	O
was	O
not	O
detectable	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
while	O
a	O
50	O
%	O
lower	O
level	O
of	O
Mfa1	O
protein	O
was	O
found	O
in	O
the	O
fimR	O
-	O
mutant	O
compared	O
with	O
that	O
in	O
wild	O
-	O
type	O
strain	O
33277	S-Organism
.	O

Similarly	O
,	O
there	O
was	O
no	O
apparent	O
change	O
in	O
RgpA	O
production	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
which	O
was	O
detected	O
by	O
anti	O
-	O
RgpA	O
serum	O
.	O

Identification	O
of	O
the	O
transcriptional	O
start	O
site	O
of	O
the	O
mfa1	O
gene	O

To	O
identify	O
the	O
promoter	O
region	O
of	O
mfa1	O
,	O
the	O
transcriptional	O
start	O
site	O
was	O
first	O
determined	O
.	O

The	O
RACE	O
experiment	O
was	O
first	O
conducted	O
with	O
mfa1	O
-	O
specific	O
reverse	O
primers	O
MfaTSR1	O
located	O
at	O
135	O
bp	O
up	O
-	O
stream	O
of	O
the	O
potential	O
start	O
codon	O
and	O
MfaTSR2	O
located	O
at	O
37	O
bp	O
downstream	O
of	O
the	O
potential	O
start	O
codon	O
(	O
Fig	O
.	O
2a	O
)	O
.	O

The	O
transcriptional	O
start	O
site	O
(	O
the	O
A	O
)	O
of	O
mfa1	O
was	O
at	O
434	O
bp	O
upstream	O
from	O
the	O
potential	O
start	O
codon	O
(	O
Fig	O
.	O
2b	O
)	O
.	O

To	O
verify	O
the	O
result	O
,	O
the	O
RACE	O
experiment	O
was	O
repeated	O
with	O
mfa1	O
-	O
specific	O
reverse	O
primers	O
MfaTSR3	O
and	O
MfaTSR4	O
located	O
at	O
237	O
bp	O
upstream	O
of	O
the	O
potential	O
start	O
codon	O
.	O

The	O
same	O
transcriptional	O
start	O
site	O
was	O
identified	O
.	O

To	O
confirm	O
the	O
result	O
of	O
RACE	O
,	O
reverse	O
-	O
transcriptional	O
PCR	O
using	O
three	O
sets	O
of	O
primers	O
was	O
performed	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

2c	O
,	O
the	O
PCR	O
product	O
was	O
generated	O
only	O
with	O
primers	O
MfaTSF1	O
(	O
corresponding	O
to	O
+	O
6	O
to	O
+	O
25	O
)	O
and	O
MfaTSR5	O
(	O
+	O
805	O
to	O
+	O
824	O
)	O
.	O

There	O
was	O
no	O
PCR	O
product	O
generated	O
from	O
RT	O
-	O
PCR	O
using	O
the	O
primers	O
(	O
MfaTSF3	O
,	O
from	O
-	O
139	O
to	O
-	O
121	O
or	O
MfaTSF2	O
,	O
from	O
-	O
66	O
to	O
-	O
47	O
)	O
which	O
correspond	O
to	O
the	O
DNA	O
sequences	O
upstream	O
from	O
the	O
transcriptional	O
start	O
site	O
.	O

This	O
transcriptional	O
start	O
site	O
is	O
390	O
bp	O
upstream	O
of	O
the	O
site	O
previously	O
reported	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

It	O
is	O
likely	O
that	O
mfa1	O
gene	O
possesses	O
two	O
functional	O
promoters	O
,	O
which	O
are	O
also	O
detected	O
in	O
the	O
fimA	O
gene	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

Binding	O
of	O
FimR	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	O

The	O
previous	O
study	O
has	O
shown	O
that	O
the	O
mechanism	O
of	O
FimR	O
activation	O
of	O
the	O
fimA	O
gene	O
involves	O
a	O
regulatory	O
cascade	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

It	O
was	O
postulated	O
that	O
different	O
mechanisms	O
might	O
be	O
involved	O
in	O
FimR	O
-	O
mediated	O
mfa1	O
expression	O
,	O
since	O
expression	O
regulation	O
of	O
mfa1	O
by	O
FimR	O
was	O
not	O
controlled	O
as	O
tightly	O
as	O
observed	O
for	O
fimA	O
expression	O
.	O

One	O
possibility	O
is	O
that	O
FimR	O
modulates	O
mfa1	O
expression	O
by	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
were	O
performed	O
.	O

The	O
mfa1	O
promoter	O
(	O
positioned	O
from	O
+	O
18	O
to	O
-	O
138	O
)	O
,	O
fimA	O
promoter	O
(	O
positioned	O
from	O
-	O
22	O
to	O
-	O
190	O
)	O
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
)	O
and	O
mfa1	O
coding	O
DNA	O
(	O
positioned	O
from	O
+	O
1253	O
to	O
+	O
1373	O
)	O
were	O
generated	O
by	O
PCR	O
with	O
the	O
5	O
'	O
biotin	O
-	O
labeled	O
primers	O
(	O
Table	O
1	O
)	O
.	O

The	O
recombinant	O
FimR	O
(	O
rFimR	O
)	O
was	O
expressed	O
in	O
pET	O
expression	O
system	O
and	O
purified	O
from	O
E	B-Organism
.	I-Organism
coli	E-Organism
.	O

The	O
rHGP44	O
protein	O
,	O
a	O
binding	O
domain	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
gingipains	O
(	O
Xie	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
expressed	O
in	O
the	O
same	O
system	O
and	O
purified	O
by	O
the	O
same	O
procedures	O
as	O
rFimR	O
was	O
used	O
as	O
a	O
control	O
.	O

Cold	O
competitor	O
chase	O
experiments	O
with	O
a	O
100	O
-	O
fold	O
excess	O
of	O
unlabeled	O
DNA	O
probe	O
as	O
a	O
specific	O
competitor	O
were	O
also	O
used	O
to	O
demonstrate	O
the	O
specificity	O
of	O
rFimR	O
binding	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

3	O
,	O
the	O
DNA	O
fragment	O
of	O
the	O
mfa1	O
promoter	O
region	O
was	O
shifted	O
in	O
the	O
presence	O
of	O
the	O
rFimR	O
.	O

Retarded	O
mfa1	O
promoter	O
-	O
rFimR	O
complex	O
was	O
detected	O
with	O
as	O
little	O
as	O
10	O
pmol	O
muL	O
-	O
1	O
rFimR	O
(	O
Fig	O
.	O
3	O
)	O
.	O

As	O
the	O
concentration	O
of	O
rFimR	O
increased	O
,	O
the	O
retarded	O
protein	O
-	O
DNA	O
complex	O
became	O
evident	O
,	O
with	O
complete	O
loss	O
of	O
the	O
mfa1	O
promoter	O
DNA	O
.	O

The	O
unlabeled	O
mfa1	O
promoter	O
fragments	O
effectively	O
competed	O
with	O
the	O
labeled	O
fragment	O
,	O
suggesting	O
a	O
specific	O
interaction	O
between	O
rFimA	O
and	O
the	O
mfa1	O
promoter	O
.	O

To	O
investigate	O
the	O
role	O
of	O
phosphorylation	O
of	O
FimR	O
in	O
its	O
binding	O
to	O
the	O
mfa1	O
promoter	O
region	O
,	O
EMSA	O
experiments	O
were	O
also	O
performed	O
with	O
the	O
phosphorylated	O
rFimR	O
.	O

No	O
significant	O
difference	O
was	O
detected	O
in	O
the	O
level	O
of	O
DNA	O
binding	O
between	O
the	O
phosphorylated	O
rFimR	O
and	O
unphosphorylated	O
rFimR	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
agreement	O
with	O
a	O
previous	O
report	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
rFimR	O
did	O
not	O
bind	O
to	O
the	O
fimA	O
promoter	O
region	O
,	O
suggesting	O
that	O
regulation	O
of	O
fimA	O
expression	O
by	O
FimR	O
is	O
through	O
a	O
different	O
mechanism	O
.	O

Moreover	O
,	O
incubation	O
of	O
rHGP44	O
with	O
mfa1	O
promoter	O
fragment	O
did	O
not	O
retard	O
the	O
DNA	O
movement	O
in	O
polyacrylamide	O
gel	O
.	O

There	O
was	O
also	O
no	O
DNA	O
shift	O
detected	O
when	O
rFimR	O
was	O
incubated	O
with	O
the	O
coding	O
region	O
of	O
mfa1	O
.	O

These	O
data	O
clearly	O
show	O
that	O
FimR	O
protein	O
can	O
bind	O
specifically	O
to	O
the	O
mfa1	O
promoter	O
region	O
,	O
acting	O
as	O
an	O
activator	O
of	O
mfa1	O
transcription	O
.	O

EMSA	O
experiments	O
were	O
also	O
performed	O
to	O
examine	O
whether	O
the	O
rFimR	O
binds	O
to	O
the	O
other	O
promoter	O
region	O
identified	O
by	O
Park	O
et	O
al	O
.	O

(	O
2006	O
)	O
.	O

The	O
biotin	O
-	O
labeled	O
DNA	O
fragment	O
corresponding	O
to	O
this	O
promoter	O
region	O
did	O
not	O
shift	O
in	O
the	O
presence	O
of	O
the	O
rFimA	O
protein	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
only	O
the	O
promoter	O
identified	O
here	O
is	O
involved	O
for	O
mfa1	O
expression	O
mediated	O
by	O
FimR	O
.	O

Discussion	O

The	O
two	O
-	O
component	O
regulatory	O
system	O
is	O
a	O
major	O
mechanism	O
of	O
signal	O
transduction	O
and	O
is	O
widespread	O
in	O
bacteria	O
.	O

Six	O
putative	O
two	O
-	O
component	O
regulatory	O
systems	O
were	O
detected	O
by	O
surveying	O
the	O
P	B-Organism
.	I-Organism
gingivalis	I-Organism
W83	E-Organism
genome	O
database	O
for	O
homologues	O
of	O
the	O
two	O
-	O
component	O
sensor	O
histidine	O
kinase	O
(	O
Hasegawa	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

Although	O
most	O
target	O
genes	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
two	O
-	O
component	O
systems	O
are	O
unknown	O
,	O
the	O
role	O
of	O
the	O
FimS	O
/	O
FimR	O
in	O
expression	O
of	O
the	O
fimA	O
gene	O
is	O
well	O
defined	O
.	O

Expression	O
of	O
minor	O
fimbriae	O
(	O
mfa1	O
)	O
in	O
a	O
fimR	O
mutanthas	O
been	O
investigated	O
.	O

A	O
comparison	O
of	O
the	O
transcriptional	O
level	O
of	O
the	O
mfa1	O
in	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
wild	O
-	O
type	O
strain	O
and	O
in	O
the	O
fimR	O
mutant	O
indicates	O
that	O
the	O
FimS	O
/	O
FimR	O
system	O
is	O
a	O
positive	O
regulator	O
for	O
the	O
mfa1	O
gene	O
,	O
although	O
the	O
system	O
controls	O
two	O
fimbrial	O
genes	O
at	O
different	O
levels	O
.	O

It	O
is	O
hypothesized	O
that	O
the	O
FimS	O
/	O
FimR	O
system	O
regulates	O
expression	O
of	O
each	O
fimbrial	O
gene	O
through	O
a	O
unique	O
mechanism	O
.	O

The	O
previous	O
study	O
suggested	O
that	O
regulation	O
of	O
fimA	O
expression	O
by	O
FimR	O
is	O
through	O
a	O
regulation	O
cascade	O
involving	O
interaction	O
of	O
FimR	O
and	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
in	O
the	O
fimA	O
cluster	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

Here	O
it	O
is	O
demonstrated	O
that	O
FimR	O
binds	O
directly	O
to	O
the	O
promoter	O
region	O
of	O
the	O
mfa1	O
gene	O
,	O
suggesting	O
a	O
direct	O
role	O
of	O
FimR	O
in	O
activation	O
of	O
mfa1	O
expression	O
.	O

It	O
has	O
also	O
been	O
reported	O
previously	O
that	O
the	O
transcriptional	O
activity	O
of	O
fimA	O
was	O
reduced	O
in	O
the	O
fimA	O
mutant	O
,	O
indicating	O
multiple	O
levels	O
of	O
control	O
of	O
fimA	O
expression	O
in	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
(	O
Xie	O
et	O
al	O
.	O
,	O
2000a	O
)	O
.	O

This	O
may	O
explain	O
the	O
much	O
tighter	O
control	O
of	O
fimA	O
expression	O
by	O
FimR	O
.	O

However	O
,	O
the	O
possibility	O
cannot	O
be	O
excluded	O
that	O
other	O
regulatory	O
elements	O
are	O
also	O
involved	O
in	O
expression	O
of	O
the	O
mfa1	O
gene	O
.	O

A	O
two	O
-	O
component	O
regulatory	O
system	O
typically	O
contains	O
a	O
membrane	O
-	O
bound	O
histidine	O
kinase	O
sensor	O
and	O
a	O
cytosolic	O
response	O
regulator	O
.	O

Phosphorylation	O
,	O
mediated	O
by	O
histidine	O
kinase	O
at	O
a	O
specific	O
aspartate	O
residue	O
,	O
activates	O
DNA	O
-	O
binding	O
activity	O
of	O
the	O
response	O
regulator	O
and	O
initiates	O
the	O
corresponding	O
cellular	O
response	O
.	O

However	O
,	O
no	O
apparent	O
difference	O
was	O
found	O
in	O
DNA	O
-	O
binding	O
affinity	O
between	O
rFimRs	O
with	O
or	O
without	O
acetyl	O
phosphate	O
treatment	O
.	O

Observation	O
suggests	O
that	O
different	O
mechanisms	O
may	O
be	O
involved	O
in	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
FimR	O
activation	O
.	O

Activation	O
of	O
a	O
regulatory	O
protein	O
not	O
corresponding	O
to	O
phosphorylation	O
was	O
also	O
observed	O
in	O
Streptococcus	B-Organism
mutans	E-Organism
(	O
Biswas	O
&	O
Biswas	O
,	O
2006	O
)	O
.	O

Phosphorylation	O
of	O
CovR	O
,	O
a	O
global	O
response	O
regulator	O
,	O
had	O
no	O
effect	O
on	O
its	O
DNA	O
-	O
binding	O
affinity	O
.	O

The	O
fact	O
that	O
FimR	O
was	O
not	O
activated	O
by	O
phosphorylation	O
may	O
also	O
be	O
due	O
to	O
the	O
short	O
lifetime	O
of	O
the	O
phosphorylated	O
state	O
,	O
which	O
has	O
been	O
observed	O
in	O
other	O
bacteria	O
(	O
Stock	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

The	O
transcriptional	O
start	O
site	O
of	O
the	O
mfa1	O
gene	O
located	O
at	O
434	O
bp	O
upstream	O
of	O
the	O
putative	O
start	O
codon	O
was	O
detected	O
,	O
which	O
is	O
also	O
390	O
bp	O
upstream	O
of	O
the	O
site	O
previously	O
reported	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
transcriptional	O
site	O
revealed	O
here	O
is	O
confirmed	O
by	O
RT	O
-	O
PCR	O
analysis	O
.	O

Data	O
of	O
this	O
study	O
suggest	O
that	O
transcription	O
of	O
the	O
mfa1	O
gene	O
originated	O
at	O
a	O
distal	O
upstream	O
transcriptional	O
start	O
site	O
and	O
read	O
through	O
the	O
promoter	O
region	O
suggested	O
by	O
Park	O
et	O
al	O
.	O

(	O
2006	O
)	O
.	O

Moreover	O
,	O
FimR	O
appears	O
to	O
act	O
on	O
the	O
promoter	O
region	O
identified	O
here	O
,	O
suggesting	O
that	O
this	O
promoter	O
may	O
make	O
significant	O
contributions	O
toward	O
mfa1	O
expression	O
through	O
the	O
FimS	O
/	O
FimR	O
system	O
.	O

Gene	O
expression	O
under	O
the	O
control	O
of	O
two	O
promoters	O
is	O
not	O
uncommon	O
in	O
bacteria	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
two	O
promoters	O
direct	O
transcription	O
of	O
acs	O
encoding	O
,	O
an	O
acetate	O
-	O
scavenging	O
enzyme	O
required	O
for	O
fitness	O
during	O
periods	O
of	O
carbon	O
starvation	O
-	O
the	O
distal	O
acsP1	O
and	O
the	O
proximal	O
acsP2	O
(	O
Beatty	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

It	O
is	O
suggested	O
that	O
each	O
promoter	O
may	O
interact	O
with	O
different	O
regulatory	O
elements	O
.	O

Two	O
promoter	O
regions	O
in	O
the	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
fimA	O
gene	O
were	O
also	O
reported	O
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

A	O
cascade	O
regulation	O
starting	O
with	O
FimR	O
appears	O
to	O
act	O
on	O
the	O
upstream	O
promoter	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
observations	O
that	O
FimR	O
binds	O
only	O
to	O
the	O
upstream	O
promoter	O
region	O
of	O
the	O
mfa1	O
gene	O
and	O
that	O
activity	O
of	O
the	O
downstream	O
promoter	O
is	O
inhibited	O
by	O
S	B-Organism
.	I-Organism
gordonii	E-Organism
,	O
S	B-Organism
.	I-Organism
sanguinis	E-Organism
and	O
S	B-Organism
.	I-Organism
mitis	E-Organism
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
imply	O
the	O
complexity	O
of	O
regulation	O
of	O
mfa1	O
expression	O
.	O

It	O
is	O
possible	O
that	O
two	O
promoters	O
of	O
mfa1	O
are	O
regulated	O
in	O
response	O
to	O
different	O
environmental	O
signals	O
.	O

The	O
hypothesis	O
is	O
currently	O
under	O
investigation	O
.	O

In	O
conclusion	O
,	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
fimbriae	O
play	O
a	O
predominant	O
role	O
in	O
the	O
attachment	O
of	O
the	O
organism	O
to	O
a	O
variety	O
of	O
oral	O
surfaces	O
(	O
Lamont	O
&	O
Jenkinson	O
,	O
2000	O
;	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
although	O
other	O
surface	O
proteins	O
,	O
such	O
as	O
gingipains	O
,	O
may	O
also	O
be	O
involved	O
in	O
the	O
bacterial	O
colonization	O
(	O
Tokuda	O
et	O
al	O
.	O
,	O
1996	O
;	O
Chen	O
et	O
al	O
.	O
,	O
2001	O
)	O
.	O

It	O
has	O
been	O
recently	O
reported	O
by	O
the	O
authors	O
that	O
both	O
major	O
fimbriae	O
and	O
minor	O
fimbriae	O
contribute	O
to	O
the	O
formation	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
biofilm	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Major	O
fimbriae	O
are	O
required	O
for	O
initial	O
attachment	O
and	O
the	O
minor	O
fimbriae	O
appear	O
to	O
play	O
an	O
important	O
role	O
in	O
microcolony	O
formation	O
by	O
facilitating	O
cell	O
-	O
cell	O
interactions	O
.	O

The	O
data	O
presented	O
here	O
provide	O
evidence	O
that	O
these	O
two	O
distinct	O
fimbriae	O
are	O
under	O
the	O
control	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
:	O
FimS	O
/	O
FimR	O
.	O

Expression	O
of	O
major	O
fimbriae	O
(	O
FimA	O
)	O
is	O
extremely	O
low	O
in	O
the	O
fimR	O
mutant	O
,	O
and	O
minor	O
fimbriae	O
production	O
in	O
this	O
mutant	O
is	O
inhibited	O
by	O
least	O
50	O
%	O
.	O

Therefore	O
,	O
it	O
is	O
proposed	O
that	O
FimR	O
can	O
be	O
an	O
attractive	O
target	O
for	O
inhibition	O
of	O
P	B-Organism
.	I-Organism
gingivalis	E-Organism
colonization	O
.	O

Control	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
ESAT	O
-	O
6	O
Secretion	O
and	O
Specific	O
T	O
Cell	O
Recognition	O
by	O
PhoP	O

Analysis	O
of	O
mycobacterial	B-Organism
strains	E-Organism
that	O
have	O
lost	O
their	O
ability	O
to	O
cause	O
disease	O
is	O
a	O
powerful	O
approach	O
to	O
identify	O
yet	O
unknown	O
virulence	O
determinants	O
and	O
pathways	O
involved	O
in	O
tuberculosis	O
pathogenesis	O
.	O

Two	O
of	O
the	O
most	O
widely	O
used	O
attenuated	O
strains	O
in	O
the	O
history	O
of	O
tuberculosis	O
research	O
are	O
Mycobacterium	B-Organism
bovis	I-Organism
BCG	E-Organism
(	O
BCG	S-Organism
)	O
and	O
Mycobacterium	B-Organism
tuberculosis	I-Organism
H37Ra	E-Organism
(	O
H37Ra	S-Organism
)	O
,	O
which	O
both	O
lost	O
their	O
virulence	O
during	O
in	O
vitro	O
serial	O
passage	O
.	O

Whereas	O
the	O
attenuation	O
of	O
BCG	S-Organism
is	O
due	O
mainly	O
to	O
loss	O
of	O
the	O
ESAT	O
-	O
6	O
secretion	O
system	O
,	O
ESX	O
-	O
1	O
,	O
the	O
reason	O
why	O
H37Ra	S-Organism
is	O
attenuated	O
remained	O
unknown	O
.	O

However	O
,	O
here	O
we	O
show	O
that	O
a	O
point	O
mutation	O
(	O
S219L	O
)	O
in	O
the	O
predicted	O
DNA	O
binding	O
region	O
of	O
the	O
regulator	O
PhoP	O
is	O
involved	O
in	O
the	O
attenuation	O
of	O
H37Ra	S-Organism
via	O
a	O
mechanism	O
that	O
impacts	O
on	O
the	O
secretion	O
of	O
the	O
major	O
T	O
cell	O
antigen	O
ESAT	O
-	O
6	O
.	O

Only	O
H37Ra	S-Organism
"	O
knock	O
-	O
ins	O
"	O
that	O
carried	O
an	O
integrated	O
cosmid	O
with	O
the	O
wild	O
-	O
type	O
phoP	O
gene	O
from	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
H37Rv	E-Organism
showed	O
changes	O
in	O
colony	O
morphology	O
,	O
increased	O
virulence	O
,	O
ESAT	O
-	O
6	O
secretion	O
,	O
and	O
induction	O
of	O
specific	O
T	O
cell	O
responses	O
,	O
whereas	O
other	O
H37Ra	S-Organism
constructs	O
did	O
not	O
.	O

This	O
finding	O
established	O
a	O
link	O
between	O
the	O
PhoP	O
regulator	O
and	O
ESAT	O
-	O
6	O
secretion	O
that	O
opens	O
exciting	O
new	O
perspectives	O
for	O
elucidating	O
virulence	O
regulation	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
.	O

Introduction	O

125	O
years	O
of	O
intense	O
research	O
on	O
the	O
major	O
human	S-Organism
pathogen	O
Mycobacterium	B-Organism
tuberculosis	E-Organism
have	O
passed	O
since	O
its	O
discovery	O
by	O
Robert	O
Koch	O
,	O
resulting	O
in	O
a	O
huge	O
body	O
of	O
knowledge	O
.	O

In	O
spite	O
of	O
the	O
great	O
progress	O
that	O
has	O
been	O
made	O
in	O
the	O
understanding	O
of	O
some	O
basic	O
features	O
of	O
its	O
pathogenesis	O
,	O
tuberculosis	O
remains	O
a	O
major	O
threat	O
to	O
human	S-Organism
life	O
in	O
most	O
parts	O
of	O
the	O
world	O
.	O

Indeed	O
,	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
has	O
retained	O
many	O
secrets	O
of	O
its	O
so	O
successful	O
pathogenic	O
lifecycle	O
.	O

Among	O
the	O
different	O
possibilities	O
to	O
obtain	O
new	O
insight	O
into	O
the	O
mechanisms	O
employed	O
by	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
to	O
infect	O
its	O
host	O
,	O
the	O
analysis	O
of	O
attenuated	O
strains	O
is	O
one	O
promising	O
approach	O
,	O
and	O
there	O
are	O
some	O
well	O
-	O
documented	O
examples	O
of	O
laboratory	O
-	O
attenuated	O
strains	O
.	O

One	O
of	O
them	O
is	O
the	O
"	O
Bacille	B-Organism
de	I-Organism
Calmette	I-Organism
et	I-Organism
Guerin	E-Organism
"	O
(	O
BCG	S-Organism
)	O
,	O
which	O
was	O
originally	O
derived	O
in	O
1921	O
from	O
a	O
virulent	O
Mycobacterium	B-Organism
bovis	E-Organism
strain	O
by	O
230	O
passages	O
on	O
potato	O
-	O
glycerol	O
-	O
ox	O
bile	O
medium	O
[	O
1	O
]	O
.	O

The	O
genetic	O
lesions	O
of	O
BCG	S-Organism
have	O
recently	O
been	O
determined	O
[	O
2	O
-	O
4	O
]	O
,	O
revealing	O
that	O
the	O
loss	O
of	O
region	O
of	O
difference	O
1	O
(	O
RD1	O
)	O
,	O
which	O
encodes	O
part	O
of	O
the	O
ESX	O
-	O
1	O
secretion	O
system	O
[	O
5	O
]	O
,	O
was	O
one	O
of	O
the	O
key	O
events	O
in	O
its	O
attenuation	O
.	O

Another	O
famous	O
example	O
of	O
an	O
attenuated	O
strain	O
is	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
H37Ra	E-Organism
(	O
"	O
a	O
"	O
for	O
avirulent	O
)	O
(	O
H37Ra	S-Organism
)	O
.	O

This	O
strain	O
was	O
obtained	O
in	O
1934	O
by	O
serial	O
passage	O
of	O
patient	S-Organism
isolate	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
H37	E-Organism
through	O
media	O
with	O
different	O
pHs	O
[	O
6	O
]	O
and	O
since	O
then	O
has	O
been	O
widely	O
used	O
in	O
many	O
laboratories	O
in	O
the	O
world	O
.	O

Despite	O
its	O
long	O
use	O
,	O
the	O
reasons	O
for	O
its	O
stable	O
attenuation	O
have	O
not	O
yet	O
been	O
elucidated	O
.	O

As	O
H37Ra	S-Organism
is	O
derived	O
from	O
the	O
same	O
parent	O
strain	O
as	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
H37Rv	E-Organism
(	O
"	O
v	O
"	O
for	O
virulent	O
)	O
(	O
H37Rv	S-Organism
)	O
,	O
the	O
sequenced	O
paradigm	O
strain	O
of	O
tuberculosis	O
research	O
[	O
7	O
]	O
,	O
genomic	O
comparisons	O
of	O
the	O
attenuated	O
and	O
virulent	O
variants	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
H37	E-Organism
are	O
particularly	O
interesting	O
and	O
have	O
the	O
potential	O
to	O
identify	O
subtle	O
genetic	O
changes	O
that	O
might	O
be	O
responsible	O
for	O
the	O
phenotypic	O
differences	O
observed	O
between	O
the	O
two	O
strains	O
.	O

In	O
a	O
previous	O
study	O
we	O
have	O
tried	O
to	O
reveal	O
these	O
determinants	O
[	O
8	O
]	O
,	O
but	O
the	O
methods	O
employed	O
only	O
identified	O
large	O
genetic	O
polymorphisms	O
,	O
associated	O
with	O
IS6110	O
,	O
which	O
were	O
not	O
found	O
to	O
be	O
responsible	O
for	O
the	O
attenuation	O
of	O
H37Ra	S-Organism
[	O
8	O
]	O
.	O

In	O
another	O
study	O
,	O
Pascopella	O
et	O
al	O
.	O

[	O
9	O
]	O
transformed	O
a	O
cosmid	O
library	O
of	O
H37Rv	S-Organism
into	O
H37Ra	S-Organism
and	O
then	O
selected	O
for	O
clones	O
that	O
were	O
enriched	O
on	O
passage	O
through	O
the	O
mouse	S-Organism
.	O

A	O
number	O
of	O
overlapping	O
cosmid	O
clones	O
that	O
gave	O
enhanced	O
growth	O
and	O
survival	O
in	O
the	O
spleens	O
of	O
infected	O
mice	S-Organism
relative	O
to	O
that	O
of	O
wild	O
-	O
type	O
H37Ra	S-Organism
were	O
identified	O
[	O
9	O
]	O
.	O

However	O
,	O
the	O
effects	O
of	O
these	O
complementation	O
attempts	O
on	O
virulence	O
remained	O
limited	O
,	O
and	O
no	O
sequence	O
information	O
was	O
described	O
,	O
which	O
makes	O
it	O
difficult	O
now	O
to	O
identify	O
the	O
genes	O
implicated	O
.	O

H37Ra	S-Organism
was	O
also	O
the	O
subject	O
of	O
extensive	O
micro	O
-	O
array	O
based	O
analyses	O
,	O
including	O
whole	O
genome	O
comparative	O
DNA	O
/	O
DNA	O
analyses	O
[	O
10	O
]	O
and	O
transcriptional	O
studies	O
[	O
11	O
,	O
12	O
]	O
,	O
which	O
have	O
identified	O
some	O
candidate	O
genes	O
that	O
were	O
consistently	O
downregulated	O
.	O

However	O
,	O
a	O
definitive	O
conclusion	O
about	O
the	O
molecular	O
determinants	O
of	O
the	O
attenuation	O
could	O
not	O
be	O
drawn	O
.	O

As	O
all	O
these	O
previous	O
attempts	O
have	O
failed	O
to	O
identify	O
the	O
genetic	O
basis	O
for	O
the	O
attenuation	O
,	O
we	O
subjected	O
H37Ra	S-Organism
to	O
microarray	O
-	O
based	O
DNA	O
re	O
-	O
sequencing	O
(	O
NimbleGen	O
Systems	O
)	O
.	O

This	O
technique	O
has	O
previously	O
permitted	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
of	O
a	O
PA	O
-	O
824	O
drug	O
resistant	O
mutant	O
strain	O
of	O
H37Rv	S-Organism
to	O
be	O
detected	O
[	O
13	O
]	O
.	O

This	O
approach	O
was	O
combined	O
with	O
gene	O
"	O
knock	O
-	O
in	O
"	O
strategies	O
,	O
to	O
complement	O
selected	O
lesions	O
,	O
that	O
allowed	O
recombinant	O
H37Ra	S-Organism
strains	O
to	O
be	O
engineered	O
,	O
whose	O
virulence	O
and	O
immunogenicity	O
were	O
then	O
evaluated	O
in	O
in	O
vitro	O
,	O
ex	O
vivo	O
and	O
animal	O
models	O
.	O

This	O
strategy	O
led	O
us	O
to	O
identify	O
and	O
characterize	O
a	O
point	O
mutation	O
in	O
the	O
phoP	O
/	O
phoR	O
two	O
-	O
component	O
regulatory	O
system	O
of	O
H37Ra	S-Organism
that	O
has	O
uncovered	O
novel	O
regulatory	O
links	O
,	O
which	O
impact	O
on	O
the	O
secretion	O
and	O
T	O
cell	O
recognition	O
of	O
the	O
major	O
T	O
cell	O
antigens	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
.	O

Results	O

Microarray	O
-	O
Based	O
Comparative	O
Genome	O
Sequencing	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
H37Ra	E-Organism
The	O
genome	O
-	O
wide	O
comparative	O
mutational	O
analysis	O
of	O
H37Ra	S-Organism
and	O
H37Rv	S-Organism
was	O
carried	O
out	O
by	O
NimbleGen	O
Systems	O
following	O
a	O
previously	O
published	O
method	O
[	O
13	O
]	O
.	O

Putative	O
SNPs	O
with	O
high	O
probability	O
scores	O
were	O
separated	O
into	O
synonymous	O
and	O
non	O
-	O
synonymous	O
SNPs	O
of	O
which	O
the	O
latter	O
were	O
verified	O
by	O
conventional	O
dye	O
terminator	O
cycle	O
sequencing	O
.	O

By	O
this	O
combined	O
approach	O
we	O
identified	O
13	O
non	O
-	O
synonymous	O
SNPs	O
that	O
differed	O
between	O
the	O
H37Ra	S-Organism
and	O
H37Rv	S-Organism
strains	O
used	O
(	O
Table	O
S1	O
)	O
.	O

We	O
were	O
particularly	O
interested	O
in	O
a	O
C	O
to	O
T	O
mutation	O
responsible	O
for	O
the	O
serine	O
to	O
leucine	O
replacement	O
at	O
position	O
219	O
,	O
S219L	O
,	O
of	O
the	O
two	O
-	O
component	O
regulator	O
PhoP	O
as	O
this	O
protein	O
is	O
well	O
known	O
for	O
its	O
involvement	O
in	O
the	O
virulent	O
phenotype	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
14	O
]	O
.	O

Importantly	O
,	O
on	O
inspection	O
of	O
the	O
structure	O
of	O
the	O
PhoP	O
-	O
ortholog	O
from	O
Bacillus	B-Organism
subtilis	E-Organism
,	O
it	O
was	O
found	O
that	O
the	O
equivalent	O
residue	O
Ser	O
207	O
is	O
a	O
main	O
residue	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
,	O
helix	O
alpha3	O
[	O
15	O
]	O
.	O

For	O
the	O
other	O
13	O
genes	O
we	O
found	O
no	O
indication	O
that	O
would	O
identify	O
them	O
as	O
potential	O
virulence	O
genes	O
,	O
as	O
none	O
of	O
them	O
belong	O
to	O
the	O
5	O
%	O
of	O
genes	O
that	O
were	O
previously	O
determined	O
by	O
transposon	O
site	O
hybridization	O
(	O
TraSH	O
)	O
as	O
being	O
essential	O
for	O
in	O
vivo	O
growth	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
16	O
]	O
.	O

While	O
writing	O
this	O
article	O
,	O
the	O
whole	O
genome	O
sequence	O
of	O
H37Ra	S-Organism
became	O
publicly	O
available	O
(	O
NC	O
_	O
009525	O
)	O
,	O
and	O
comparison	O
of	O
the	O
SNP	O
data	O
obtained	O
from	O
the	O
H37Ra	S-Organism
strain	O
used	O
in	O
our	O
laboratory	O
(	O
Table	O
S1	O
)	O
with	O
the	O
NC	O
_	O
009525	O
data	O
,	O
showed	O
that	O
some	O
differences	O
existed	O
between	O
the	O
H37Ra	S-Organism
strains	O
,	O
a	O
phenomenon	O
which	O
was	O
also	O
previously	O
observed	O
for	O
BCG	S-Organism
[	O
4	O
]	O
and	O
H37Rv	S-Organism
[	O
17	O
]	O
.	O

Nevertheless	O
,	O
the	O
S129L	O
mutation	O
in	O
PhoP	O
,	O
which	O
we	O
consider	O
an	O
important	O
SNP	O
involved	O
in	O
the	O
attenuation	O
and	O
reduced	O
immunogenicity	O
of	O
H37Ra	S-Organism
,	O
is	O
identical	O
in	O
all	O
H37Ra	S-Organism
strains	O
.	O

Rationale	O
for	O
Knock	O
-	O
Ins	O

To	O
evaluate	O
the	O
phenotypic	O
effect	O
of	O
the	O
different	O
SNPs	O
and	O
to	O
assess	O
their	O
potential	O
contribution	O
to	O
the	O
attenuation	O
process	O
,	O
we	O
undertook	O
functional	O
genomic	O
analyses	O
using	O
knock	O
-	O
ins	O
of	O
H37Ra	S-Organism
,	O
as	O
described	O
previously	O
[	O
18	O
]	O
.	O

Clones	O
spanning	O
the	O
different	O
genomic	O
regions	O
of	O
non	O
-	O
synonymous	O
SNPs	O
were	O
selected	O
from	O
an	O
ordered	O
H37Rv	S-Organism
library	O
of	O
integrating	O
shuttle	O
cosmids	O
[	O
7	O
,	O
19	O
]	O
and	O
individually	O
electroporated	O
into	O
H37Ra	S-Organism
,	O
where	O
they	O
inserted	O
stably	O
into	O
the	O
attB	O
site	O
.	O

By	O
this	O
approach	O
we	O
obtained	O
appropriately	O
complemented	O
transformants	O
for	O
the	O
SNPs	O
in	O
genes	O
fadE5	O
,	O
rpsL	O
,	O
and	O
phoP	O
(	O
Table	O
S1	O
)	O
,	O
using	O
cosmids	O
I230	O
,	O
I563	O
,	O
and	O
I36	O
,	O
respectively	O
.	O

Based	O
on	O
the	O
known	O
role	O
of	O
phoP	O
in	O
virulence	O
[	O
14	O
]	O
,	O
the	O
H37Ra	S-Organism
strain	O
complemented	O
with	O
I36	O
(	O
H37Ra	O
:	O
:	O
phoP	O
)	O
was	O
accorded	O
highest	O
priority	O
for	O
further	O
molecular	O
characterization	O
and	O
functional	O
analyses	O
,	O
whereas	O
the	O
two	O
other	O
recombinants	O
(	O
H37Ra	O
:	O
:	O
fadE5	O
,	O
H37Ra	O
:	O
:	O
rpsL	O
)	O
served	O
as	O
controls	O
.	O

Figure	O
S1	O
shows	O
part	O
of	O
the	O
nucleotide	O
sequence	O
of	O
a	O
PCR	O
-	O
amplified	O
fragment	O
obtained	O
from	O
H37Ra	O
:	O
:	O
phoP	O
.	O

It	O
is	O
clearly	O
visible	O
that	O
at	O
nucleotide	O
position	O
656	O
of	O
phoP	O
two	O
peaks	O
exist	O
,	O
one	O
originating	O
from	O
the	O
SNP	O
present	O
in	O
H37Ra	S-Organism
and	O
one	O
from	O
the	O
integrated	O
cosmid	O
I36	O
carrying	O
the	O
H37Rv	S-Organism
wild	O
-	O
type	O
copy	O
of	O
phoP	O
.	O

Similar	O
results	O
were	O
also	O
obtained	O
for	O
the	O
SNPs	O
in	O
fadE5	O
and	O
rpsL	O
using	O
cosmids	O
I230	O
and	O
I563	O
,	O
respectively	O
(	O
Figure	O
S1	O
)	O
.	O

Correct	O
integration	O
of	O
I36	O
was	O
also	O
confirmed	O
by	O
Southern	O
blot	O
.	O

As	O
depicted	O
in	O
Figure	O
S2	O
,	O
hybridization	O
of	O
SpeI	O
-	O
digested	O
genomic	O
DNA	O
with	O
a	O
32P	O
labeled	O
phoP	O
probe	O
resulted	O
in	O
two	O
bands	O
of	O
different	O
sizes	O
,	O
one	O
corresponding	O
to	O
the	O
SpeI	O
fragment	O
harboring	O
the	O
H37Ra	S-Organism
phoP	O
gene	O
(	O
50	O
kb	O
)	O
,	O
and	O
the	O
other	O
to	O
the	O
larger	O
SpeI	O
fragment	O
created	O
by	O
integration	O
of	O
the	O
I36	O
cosmid	O
into	O
the	O
genome	O
of	O
H37Ra	S-Organism
at	O
the	O
attB	O
site	O
.	O

The	O
successful	O
integration	O
of	O
the	O
cosmid	O
was	O
also	O
reflected	O
by	O
a	O
change	O
in	O
colony	O
morphology	O
that	O
is	O
shown	O
in	O
Figure	O
S3	O
.	O

Indeed	O
,	O
Steenken	O
and	O
colleagues	O
originally	O
selected	O
the	O
H37Ra	S-Organism
mutants	O
mainly	O
on	O
the	O
basis	O
of	O
the	O
changes	O
in	O
colony	O
morphology	O
[	O
6	O
]	O
.	O

Ex	O
Vivo	O
Virulence	O
Studies	O

Changes	O
in	O
the	O
regulatory	O
potential	O
of	O
a	O
pathogen	O
are	O
often	O
accompanied	O
by	O
altered	O
virulence	O
.	O

In	O
a	O
first	O
attempt	O
to	O
determine	O
the	O
virulence	O
of	O
the	O
complemented	O
H37Ra	S-Organism
knock	O
-	O
in	O
strains	O
relative	O
to	O
wild	O
-	O
type	O
H37Ra	S-Organism
and	O
H37Rv	S-Organism
,	O
bone	O
marrow	O
-	O
derived	O
murine	O
macrophages	O
(	O
BMM	O
)	O
were	O
infected	O
with	O
the	O
different	O
strains	O
at	O
a	O
multiplicity	O
of	O
infection	O
(	O
MOI	O
)	O
of	O
1	O
:	O
1	O
and	O
10	O
:	O
1	O
bacteria	O
per	O
cell	O
.	O

As	O
depicted	O
in	O
Figure	O
1	O
,	O
macrophages	O
were	O
able	O
to	O
control	O
ex	O
vivo	O
growth	O
of	O
H37Ra	S-Organism
,	O
but	O
failed	O
to	O
control	O
growth	O
of	O
H37Rv	S-Organism
,	O
confirming	O
results	O
from	O
Freeman	O
and	O
colleagues	O
[	O
20	O
]	O
.	O

When	O
H37Ra	S-Organism
knock	O
-	O
ins	O
were	O
tested	O
,	O
important	O
differences	O
in	O
their	O
ex	O
vivo	O
growth	O
characteristics	O
were	O
found	O
.	O

Whereas	O
H37Ra	O
:	O
:	O
fadE5	O
(	O
Figure	O
1	O
)	O
and	O
H37Ra	O
:	O
:	O
rpsL	O
(	O
unpublished	O
data	O
)	O
showed	O
very	O
little	O
or	O
no	O
growth	O
over	O
the	O
7	O
-	O
d	O
period	O
,	O
the	O
H37Ra	O
:	O
:	O
phoP	O
mutant	O
grew	O
more	O
vigorously	O
,	O
with	O
a	O
7	O
.	O
5	O
-	O
fold	O
increase	O
in	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
over	O
the	O
7	O
-	O
d	O
period	O
.	O

From	O
these	O
experiments	O
we	O
concluded	O
that	O
complementation	O
of	O
H37Ra	S-Organism
with	O
the	O
phoP	O
wild	O
-	O
type	O
copy	O
partially	O
restored	O
its	O
virulence	O
,	O
but	O
not	O
to	O
the	O
extent	O
of	O
the	O
fully	O
virulent	O
H37Rv	S-Organism
strain	O
.	O

Virulence	O
Studies	O
of	O
H37Ra	S-Organism
Complemented	O
Mutants	O
in	O
a	O
Mouse	S-Organism
Model	O

Further	O
assessment	O
of	O
the	O
in	O
vivo	O
growth	O
of	O
different	O
H37Ra	S-Organism
knock	O
-	O
in	O
strains	O
was	O
carried	O
out	O
by	O
intravenous	O
infection	O
of	O
severe	B-Organism
combined	I-Organism
immuno	I-Organism
-	I-Organism
deficient	I-Organism
(	I-Organism
SCID	I-Organism
)	I-Organism
mice	E-Organism
.	O

Complementation	O
of	O
H37Ra	S-Organism
with	O
the	O
PhoP	O
-	O
expressing	O
cosmid	O
increased	O
the	O
virulence	O
of	O
the	O
H37Ra	O
:	O
:	O
phoP	O
recombinant	O
relative	O
to	O
H37Ra	S-Organism
,	O
resulting	O
in	O
a	O
1	O
.	O
0	O
log	O
and	O
0	O
.	O
5	O
log	O
increase	O
in	O
CFU	O
number	O
in	O
lungs	O
and	O
spleens	O
,	O
respectively	O
.	O

In	O
contrast	O
,	O
no	O
effects	O
on	O
the	O
virulence	O
were	O
observed	O
when	O
H37Ra	S-Organism
was	O
complemented	O
with	O
fadE5	O
(	O
Figure	O
2	O
)	O
or	O
rpsL	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
as	O
already	O
observed	O
in	O
macrophages	O
,	O
integration	O
of	O
phoP	O
did	O
not	O
restore	O
levels	O
of	O
virulence	O
to	O
those	O
of	O
the	O
reference	O
strain	O
H37Rv	S-Organism
(	O
Figure	O
2	O
)	O
.	O

This	O
situation	O
is	O
also	O
reflected	O
in	O
the	O
sizes	O
of	O
spleens	O
,	O
which	O
correlate	O
with	O
the	O
CFU	O
data	O
in	O
spleens	O
(	O
Figure	O
S4	O
)	O
.	O

Together	O
with	O
the	O
data	O
from	O
the	O
macrophage	O
infection	O
assay	O
,	O
the	O
results	O
from	O
the	O
mouse	S-Organism
infection	O
show	O
that	O
the	O
S219L	O
mutation	O
in	O
the	O
phoP	O
gene	O
definitely	O
represents	O
one	O
genetic	O
lesion	O
that	O
contributed	O
to	O
the	O
attenuation	O
of	O
the	O
H37Ra	S-Organism
strain	O
.	O

Link	O
between	O
Mutation	O
in	O
phoP	O
and	O
Secretion	O
of	O
ESAT	O
-	O
6	O

As	O
PhoP	O
fulfills	O
important	O
regulatory	O
functions	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
21	O
,	O
22	O
]	O
,	O
it	O
was	O
of	O
primary	O
interest	O
to	O
identify	O
and	O
study	O
potential	O
effector	O
molecules	O
whose	O
involvement	O
in	O
host	O
pathogen	O
interaction	O
were	O
influenced	O
by	O
the	O
point	O
mutation	O
in	O
phoP	O
of	O
H37Ra	S-Organism
.	O

Since	O
secreted	O
proteins	O
of	O
the	O
ESX	O
-	O
1	O
system	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
constitute	O
a	O
major	O
interface	O
between	O
the	O
bacterium	O
and	O
its	O
host	O
[	O
23	O
]	O
,	O
we	O
analyzed	O
the	O
different	O
strains	O
for	O
their	O
potential	O
to	O
induce	O
T	O
cell	O
responses	O
against	O
ESAT	O
-	O
6	O
and	O
its	O
binding	O
partner	O
,	O
the	O
10	O
-	O
kD	O
culture	O
filtrate	O
protein	O
CFP	O
-	O
10	O
.	O

Groups	O
of	O
C57BL	B-Organism
/	I-Organism
6	I-Organism
mice	E-Organism
were	O
subcutaneously	O
inoculated	O
with	O
H37Rv	S-Organism
,	O
H37Ra	S-Organism
,	O
or	O
one	O
of	O
three	O
recombinant	O
H37Ra	S-Organism
strains	O
complemented	O
with	O
phoP	O
,	O
fadE5	O
,	O
or	O
rpsL	O
,	O
respectively	O
.	O

Two	O
weeks	O
after	O
vaccination	O
we	O
assessed	O
the	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
production	O
of	O
splenocytes	O
mounted	O
against	O
ESX	O
-	O
1	O
antigens	O
or	O
controls	O
.	O

As	O
anticipated	O
,	O
all	O
tested	O
strains	O
induced	O
IFN	O
-	O
gamma	O
production	O
in	O
response	O
to	O
purified	O
protein	O
derivative	O
(	O
PPD	O
)	O
but	O
not	O
to	O
a	O
control	O
peptide	O
(	O
Mal	O
-	O
E	O
)	O
,	O
indicating	O
successful	O
vaccination	O
(	O
Figure	O
3	O
)	O
.	O

Most	O
importantly	O
,	O
the	O
various	O
strains	O
differed	O
extensively	O
in	O
their	O
potential	O
to	O
induce	O
antigen	O
specific	O
T	O
cell	O
responses	O
towards	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
.	O

As	O
shown	O
in	O
Figure	O
3	O
,	O
splenocytes	O
from	O
mice	S-Organism
that	O
were	O
inoculated	O
with	O
H37Rv	S-Organism
produced	O
high	O
amounts	O
of	O
IFN	O
-	O
gamma	O
upon	O
stimulation	O
with	O
ESAT	O
-	O
6	O
or	O
CFP	O
-	O
10	O
,	O
whereas	O
the	O
responses	O
of	O
H37Ra	S-Organism
,	O
H37Ra	O
:	O
:	O
fadE5	O
,	O
and	O
H37Ra	O
:	O
:	O
rpsL	O
infected	O
mice	S-Organism
were	O
extremely	O
weak	O
.	O

In	O
contrast	O
,	O
splenocytes	O
from	O
H37Ra	O
:	O
:	O
phoP	O
inoculated	O
mice	S-Organism
showed	O
very	O
strong	O
IFN	O
-	O
gamma	O
production	O
in	O
response	O
to	O
incubation	O
with	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
.	O

Exactly	O
the	O
same	O
trend	O
was	O
observed	O
when	O
a	O
highly	O
sensitive	O
T	O
cell	O
hybridoma	O
assay	O
was	O
used	O
to	O
investigate	O
ESAT	O
-	O
6	O
secretion	O
.	O

This	O
test	O
is	O
based	O
on	O
the	O
presentation	O
of	O
the	O
immunodominant	O
epitope	O
contained	O
in	O
the	O
first	O
20	O
amino	O
acids	O
of	O
ESAT	O
-	O
6	O
by	O
H37Ra	S-Organism
,	O
recombinant	O
H37Ra	S-Organism
,	O
or	O
H37Rv	S-Organism
infected	O
bone	O
marrow	O
-	O
derived	O
dendritic	O
cells	O
(	O
BM	O
-	O
DC	O
)	O
to	O
an	O
ESAT	B-Organism
-	I-Organism
6	E-Organism
-	O
specific	O
T	O
cell	O
hybridoma	O
(	O
NB11	O
)	O
,	O
restricted	O
by	O
I	O
-	O
Ab	O
.	O

Figure	O
4A	O
shows	O
that	O
infection	O
of	O
BM	O
-	O
DC	O
with	O
H37Ra	S-Organism
or	O
H37Ra	O
:	O
:	O
rpsL	O
induced	O
no	O
stimulation	O
of	O
the	O
hybridoma	O
as	O
judged	O
by	O
IL	O
-	O
2	O
production	O
,	O
while	O
H37Ra	O
:	O
:	O
phoP	O
or	O
H37Rv	S-Organism
triggered	O
high	O
amounts	O
of	O
IL	O
-	O
2	O
production	O
in	O
this	O
very	O
sensitive	O
and	O
specific	O
test	O
.	O

All	O
strains	O
behaved	O
comparably	O
towards	O
the	O
Ag85A	O
:	O
241	O
-	O
260	O
control	O
,	O
emphasizing	O
the	O
specificity	O
of	O
the	O
observed	O
phenomenon	O
for	O
ESAT	O
-	O
6	O
(	O
Figure	O
4B	O
)	O
.	O

To	O
further	O
evaluate	O
the	O
involvement	O
of	O
phoP	O
and	O
the	O
ESX	O
-	O
1	O
system	O
in	O
immunogenicity	O
,	O
C57BL	B-Organism
/	I-Organism
6	I-Organism
mice	E-Organism
were	O
vaccinated	O
with	O
additional	O
strains	O
.	O

Firstly	O
,	O
we	O
constructed	O
a	O
partially	O
diploid	O
H37Ra	S-Organism
knock	O
-	O
in	O
strain	O
carrying	O
cosmid	O
RD1	O
-	O
ppe68	O
-	O
ko	O
that	O
,	O
in	O
BCG	S-Organism
yields	O
the	O
greatest	O
amounts	O
of	O
ESAT	O
-	O
6	O
expression	O
and	O
secretion	O
[	O
24	O
]	O
.	O

However	O
,	O
in	O
H37Ra	S-Organism
the	O
presence	O
of	O
this	O
cosmid	O
could	O
not	O
increase	O
the	O
weak	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
T	O
cell	O
responses	O
(	O
Figure	O
3B	O
)	O
in	O
the	O
splenocyte	O
IFN	O
-	O
gamma	O
assay	O
.	O

Secondly	O
,	O
we	O
also	O
tested	O
the	O
previously	O
described	O
M	O
.	O
tuberculosis	O
MT103	O
phoP	O
knock	O
-	O
out	O
(	O
ko	O
)	O
strain	O
SO2	O
[	O
14	O
,	O
25	O
]	O
in	O
this	O
assay	O
and	O
found	O
that	O
this	O
strain	O
induced	O
a	O
potent	O
PPD	O
response	O
as	O
previously	O
reported	O
[	O
25	O
]	O
.	O

However	O
,	O
in	O
comparison	O
to	O
the	O
corresponding	O
MT103	S-Organism
wild	O
-	O
type	O
strain	O
,	O
the	O
SO2	S-Organism
strain	O
showed	O
a	O
strongly	O
reduced	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
specific	O
T	O
cell	O
response	O
,	O
corresponding	O
to	O
a	O
similar	O
low	O
level	O
as	O
the	O
H37Ra	S-Organism
strain	O
(	O
Figure	O
3B	O
)	O
.	O

Altogether	O
,	O
our	O
data	O
obtained	O
from	O
multiple	O
replicate	O
experiments	O
indicate	O
that	O
a	O
direct	O
link	O
exists	O
between	O
a	O
fully	O
functional	O
PhoP	O
and	O
the	O
ability	O
to	O
generate	O
T	O
cell	O
responses	O
against	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
.	O

Functional	O
Characterization	O
of	O
Knock	O
-	O
In	O
Mutants	O

We	O
have	O
previously	O
shown	O
that	O
antigen	O
-	O
specific	O
IFN	O
-	O
gamma	O
production	O
of	O
splenocytes	O
is	O
a	O
reliable	O
readout	O
system	O
to	O
evaluate	O
whether	O
or	O
not	O
ESAT	O
-	O
6	O
was	O
secreted	O
by	O
recombinant	O
strains	O
[	O
23	O
,	O
24	O
,	O
26	O
]	O
.	O

Thus	O
,	O
in	O
order	O
to	O
determine	O
the	O
reason	O
for	O
the	O
observed	O
failure	O
of	O
H37Ra	S-Organism
to	O
induce	O
ESAT	O
-	O
6	O
-	O
specific	O
responses	O
,	O
H37Rv	S-Organism
and	O
H37Ra	S-Organism
strains	O
were	O
tested	O
for	O
their	O
potential	O
to	O
express	O
and	O
secrete	O
ESAT	O
-	O
6	O
in	O
vitro	O
.	O

The	O
western	O
blot	O
analysis	O
presented	O
in	O
Figure	O
5	O
shows	O
that	O
the	O
cell	O
lysates	O
of	O
H37Ra	S-Organism
and	O
H37Ra	O
:	O
:	O
rpsL	O
contain	O
large	O
amounts	O
of	O
ESAT	O
-	O
6	O
,	O
indicating	O
that	O
the	O
antigen	O
is	O
properly	O
expressed	O
.	O

However	O
,	O
hardly	O
any	O
ESAT	O
-	O
6	O
was	O
present	O
in	O
the	O
culture	O
filtrates	O
of	O
these	O
cultures	O
,	O
indicating	O
that	O
these	O
strains	O
were	O
unable	O
to	O
secrete	O
ESAT	O
-	O
6	O
under	O
the	O
in	O
vitro	O
conditions	O
employed	O
in	O
spite	O
of	O
proper	O
expression	O
.	O

Similar	O
results	O
were	O
obtained	O
for	O
H37Ra	O
:	O
:	O
fadE5	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
,	O
from	O
examination	O
of	O
the	O
western	O
blots	O
of	O
M	O
.	O
tuberculosis	O
H37Ra	O
:	O
:	O
phoP	O
and	O
H37Rv	S-Organism
it	O
is	O
clear	O
that	O
a	O
large	O
portion	O
of	O
their	O
ESAT	O
-	O
6	O
protein	O
is	O
secreted	O
into	O
the	O
culture	O
filtrates	O
.	O

Analysis	O
of	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
MT103	I-Organism
phoP	I-Organism
ko	I-Organism
strain	I-Organism
SO2	E-Organism
showed	O
strong	O
expression	O
of	O
ESAT	O
-	O
6	O
,	O
but	O
only	O
very	O
little	O
secreted	O
ESAT	O
-	O
6	O
(	O
Figure	O
5	O
)	O
.	O

In	O
a	O
previous	O
report	O
[	O
25	O
]	O
,	O
the	O
presence	O
of	O
ESAT	O
-	O
6	O
in	O
cell	O
free	O
extracts	O
was	O
described	O
for	O
this	O
strain	O
,	O
but	O
no	O
secretion	O
assay	O
was	O
performed	O
.	O

Together	O
,	O
our	O
findings	O
correlate	O
perfectly	O
with	O
the	O
in	O
vivo	O
data	O
described	O
above	O
and	O
suggest	O
that	O
the	O
lack	O
of	O
ESAT	O
-	O
6	O
specific	O
T	O
cell	O
recognition	O
for	O
H37Ra	S-Organism
,	O
H37Ra	O
:	O
:	O
fadE5	O
,	O
H37Ra	O
:	O
:	O
rpsL	O
,	O
and	O
SO2	S-Organism
is	O
not	O
caused	O
by	O
a	O
loss	O
of	O
ESAT	O
-	O
6	O
expression	O
,	O
but	O
rather	O
due	O
to	O
a	O
failure	O
of	O
(	O
phoP	O
dependent	O
)	O
ESAT	O
-	O
6	O
secretion	O
.	O

The	O
observation	O
that	O
knocking	O
-	O
in	O
the	O
ESX	O
-	O
1	O
region	O
of	O
H37Rv	S-Organism
into	O
H37Ra	S-Organism
(	O
H37Ra	O
:	O
:	O
RD1	O
-	O
ppe68	O
-	O
ko	O
)	O
,	O
and	O
the	O
resultant	O
diploidy	O
,	O
did	O
not	O
improve	O
the	O
ESAT	O
-	O
6	O
-	O
specific	O
T	O
cell	O
responses	O
(	O
Figure	O
3B	O
)	O
,	O
further	O
argues	O
that	O
PhoP	O
-	O
dependent	O
ESAT	O
-	O
secretion	O
might	O
be	O
regulated	O
via	O
a	O
mechanism	O
that	O
lies	O
outside	O
the	O
RD1	O
region	O
.	O

As	O
closer	O
inspection	O
of	O
the	O
available	O
literature	O
on	O
transcriptional	O
analyses	O
of	O
a	O
H37Rv	O
-	O
phoP	O
ko	O
strain	O
[	O
21	O
]	O
and	O
H37Ra	S-Organism
[	O
12	O
]	O
suggested	O
that	O
the	O
expression	O
of	O
gene	O
cluster	O
rv3612c	O
-	O
rv3616c	O
is	O
reduced	O
in	O
both	O
strains	O
,	O
we	O
evaluated	O
the	O
expression	O
level	O
of	O
rv3614c	O
in	O
H37Rv	S-Organism
,	O
H37Ra	S-Organism
,	O
and	O
H37Ra	O
:	O
:	O
phoP	O
by	O
quantitative	O
real	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
.	O

In	O
previous	O
studies	O
rv3614c	O
,	O
rv3615c	O
,	O
rv3616c	O
(	O
espA	O
)	O
were	O
independently	O
shown	O
to	O
be	O
essential	O
for	O
proper	O
ESAT	O
-	O
6	O
secretion	O
[	O
27	O
,	O
28	O
]	O
.	O

We	O
confirmed	O
the	O
trend	O
that	O
rv3614c	O
was	O
expressed	O
much	O
lower	O
in	O
H37Ra	S-Organism
compared	O
to	O
H37Rv	S-Organism
by	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6	O
)	O
,	O
whereas	O
expression	O
of	O
rv3614c	O
in	O
H37Ra	O
:	O
:	O
phoP	O
was	O
restored	O
to	O
wild	O
-	O
type	O
levels	O
,	O
suggesting	O
that	O
the	O
rv3612c	O
-	O
rv3616c	O
gene	O
cluster	O
is	O
regulated	O
by	O
PhoP	O
.	O

Interestingly	O
,	O
expression	O
of	O
phoP	O
was	O
higher	O
in	O
H37Ra	S-Organism
than	O
in	O
H37Rv	S-Organism
(	O
Figure	O
6	O
)	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
data	O
from	O
a	O
previous	O
transcriptional	O
study	O
[	O
12	O
]	O
and	O
suggest	O
that	O
the	O
proposed	O
ability	O
of	O
PhoP	O
to	O
downregulate	O
its	O
own	O
expression	O
[	O
22	O
]	O
is	O
affected	O
by	O
the	O
S219L	O
phoP	O
mutation	O
[	O
29	O
]	O
.	O

They	O
also	O
indicate	O
that	O
it	O
is	O
not	O
a	O
lack	O
of	O
phoP	O
expression	O
that	O
is	O
causing	O
the	O
phoP	O
-	O
associated	O
effects	O
in	O
H37Ra	S-Organism
.	O

Discussion	O

The	O
attenuated	O
H37Ra	S-Organism
strain	O
was	O
obtained	O
at	O
the	O
Trudeau	O
Institute	O
in	O
the	O
1930s	O
in	O
an	O
attempt	O
to	O
dissociate	O
virulent	O
and	O
avirulent	O
forms	O
of	O
the	O
tubercle	B-Organism
bacillus	I-Organism
H37	E-Organism
.	O

Steenken	O
et	O
al	O
.	O
have	O
shown	O
that	O
the	O
virulence	O
of	O
the	O
H37	S-Organism
strain	O
was	O
associated	O
with	O
colony	O
morphology	O
and	O
that	O
the	O
avirulent	O
variant	O
H37Ra	S-Organism
failed	O
to	O
propagate	O
in	O
an	O
ordinarily	O
susceptible	O
host	O
while	O
the	O
virulent	O
variant	O
H37Rv	S-Organism
was	O
able	O
to	O
proliferate	O
[	O
6	O
]	O
.	O

Although	O
these	O
different	O
H37	S-Organism
daughter	O
strains	O
have	O
been	O
available	O
for	O
many	O
years	O
now	O
and	O
belong	O
to	O
the	O
standard	O
strain	O
collections	O
of	O
almost	O
every	O
tuberculosis	O
diagnostic	O
or	O
research	O
laboratory	O
in	O
the	O
world	O
[	O
30	O
,	O
31	O
]	O
,	O
the	O
genetic	O
basis	O
of	O
the	O
decreased	O
virulence	O
of	O
H37Ra	S-Organism
remained	O
unknown	O
.	O

The	O
identification	O
of	O
the	O
amino	O
acid	O
change	O
S219L	O
in	O
the	O
predicted	O
DNA	O
binding	O
region	O
of	O
the	O
C	O
-	O
terminal	O
effector	O
domain	O
of	O
PhoP	O
[	O
15	O
,	O
22	O
]	O
in	O
H37Ra	S-Organism
was	O
therefore	O
a	O
particularly	O
exciting	O
finding	O
that	O
has	O
the	O
potential	O
to	O
explain	O
part	O
of	O
the	O
attenuation	O
of	O
the	O
H37Ra	S-Organism
strain	O
and	O
to	O
elucidate	O
the	O
PhoP	O
/	O
PhoR	O
associated	O
complex	O
regulatory	O
network	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
.	O

In	O
the	O
bacterial	O
world	O
the	O
PhoP	O
/	O
PhoR	O
like	O
two	O
-	O
component	O
systems	O
are	O
widely	O
distributed	O
and	O
fulfill	O
a	O
large	O
variety	O
of	O
functions	O
including	O
sensing	O
phosphate	O
and	O
magnesium	O
[	O
32	O
,	O
33	O
]	O
,	O
or	O
regulating	O
virulence	O
genes	O
[	O
34	O
]	O
.	O

For	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
,	O
several	O
studies	O
have	O
described	O
a	O
link	O
between	O
the	O
inactivation	O
of	O
phoP	O
and	O
loss	O
of	O
virulence	O
,	O
suggesting	O
that	O
the	O
phoP	O
gene	O
is	O
required	O
for	O
intracellular	O
growth	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
14	O
,	O
25	O
]	O
.	O

It	O
was	O
also	O
found	O
that	O
the	O
PhoP	O
-	O
PhoR	O
system	O
controls	O
the	O
biosynthesis	O
of	O
polyketide	O
-	O
derived	O
lipids	O
[	O
35	O
]	O
and	O
determines	O
the	O
amount	O
of	O
triacylated	O
and	O
monoacylated	O
lipoarabinomannans	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
36	O
]	O
.	O

However	O
,	O
according	O
to	O
very	O
recent	O
information	O
,	O
these	O
polyketide	O
-	O
derived	O
(	O
Pks2	O
-	O
4	O
)	O
lipids	O
do	O
not	O
have	O
a	O
strong	O
impact	O
on	O
the	O
virulence	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
29	O
]	O
.	O

Finally	O
,	O
microarray	O
-	O
based	O
trancriptome	O
analysis	O
using	O
the	O
wild	O
-	O
type	O
versus	O
a	O
phoP	O
ko	O
mutant	O
of	O
H37Rv	S-Organism
has	O
provided	O
an	O
overview	O
of	O
the	O
transcriptional	O
regulation	O
linked	O
to	O
PhoP	O
[	O
21	O
]	O
.	O

That	O
study	O
identified	O
44	O
genes	O
in	O
the	O
phoP	O
-	O
ko	O
strain	O
that	O
were	O
expressed	O
at	O
least	O
2	O
.	O
5	O
-	O
fold	O
lower	O
in	O
the	O
mutant	O
than	O
their	O
counterparts	O
in	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
wild	O
-	O
type	O
strain	O
.	O

Most	O
interestingly	O
,	O
about	O
two	O
thirds	O
of	O
these	O
44	O
genes	O
were	O
also	O
found	O
substantially	O
lower	O
expressed	O
in	O
H37Ra	S-Organism
in	O
comparison	O
to	O
H37Rv	S-Organism
,	O
when	O
the	O
transcriptional	O
profiles	O
of	O
H37Ra	S-Organism
and	O
H37Rv	S-Organism
cultures	O
grown	O
in	O
various	O
media	O
were	O
examined	O
[	O
12	O
]	O
.	O

This	O
finding	O
argues	O
that	O
the	O
PhoP	O
S219L	O
mutation	O
likely	O
has	O
a	O
broad	O
impact	O
on	O
gene	O
regulation	O
in	O
H37Ra	S-Organism
with	O
effects	O
similar	O
to	O
those	O
seen	O
for	O
complete	O
inactivation	O
of	O
phoP	O
.	O

Among	O
the	O
genes	O
expressed	O
at	O
low	O
level	O
in	O
the	O
phoP	O
-	O
ko	O
strain	O
and	O
in	O
H37Ra	S-Organism
were	O
several	O
that	O
are	O
involved	O
in	O
lipid	O
metabolism	O
;	O
for	O
example	O
,	O
the	O
polyketide	O
synthases	O
pks2	O
(	O
rv3825c	O
)	O
or	O
the	O
Pks	O
-	O
associated	O
protein	O
papA1	O
(	O
rv3824c	O
)	O
.	O

There	O
were	O
also	O
several	O
ppe	O
genes	O
that	O
seem	O
to	O
be	O
regulated	O
by	O
phoP	O
but	O
not	O
ppe68	O
[	O
21	O
]	O
.	O

In	O
addition	O
,	O
NirA	O
(	O
Rv2391	O
)	O
,	O
a	O
putative	O
nitrite	O
reductase	O
and	O
MmpL10	O
-	O
FadD21	O
(	O
Rv1183	O
-	O
85c	O
)	O
,	O
which	O
were	O
all	O
identified	O
by	O
TraSH	O
analysis	O
as	O
potentially	O
implicated	O
in	O
virulence	O
[	O
16	O
]	O
,	O
seem	O
to	O
be	O
regulated	O
by	O
PhoP	O
[	O
12	O
,	O
21	O
]	O
.	O

However	O
,	O
the	O
most	O
striking	O
link	O
in	O
relation	O
to	O
our	O
results	O
on	O
phoP	O
and	O
ESAT	O
-	O
6	O
secretion	O
that	O
was	O
revealed	O
by	O
these	O
two	O
transcriptional	O
analyses	O
,	O
were	O
the	O
data	O
on	O
gene	O
cluster	O
rv3612c	O
-	O
rv3616c	O
.	O

Closer	O
inspection	O
of	O
the	O
data	O
published	O
in	O
the	O
corresponding	O
supplemental	O
materials	O
showed	O
that	O
rv3612c	O
-	O
rv3616c	O
were	O
strongly	O
downregulated	O
in	O
the	O
H37Rv	O
phoP	O
ko	O
mutant	O
as	O
well	O
as	O
in	O
H37Ra	S-Organism
[	O
12	O
,	O
21	O
]	O
.	O

These	O
transcriptome	O
data	O
corroborate	O
our	O
results	O
obtained	O
by	O
quantitative	O
RT	O
-	O
PCR	O
using	O
probe	O
rv3614c	O
,	O
which	O
showed	O
that	O
gene	O
rv3614c	O
was	O
definitely	O
expressed	O
much	O
lower	O
in	O
H37Ra	S-Organism
than	O
in	O
H37Rv	S-Organism
and	O
H37Ra	O
:	O
:	O
phoP	O
strains	O
(	O
Figure	O
6	O
)	O
.	O

Since	O
in	O
previous	O
,	O
independent	O
studies	O
it	O
has	O
been	O
demonstrated	O
that	O
functions	O
of	O
the	O
rv3614c	O
-	O
rv3616c	O
(	O
espA	O
)	O
gene	O
cluster	O
were	O
essential	O
for	O
the	O
secretion	O
of	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
[	O
27	O
,	O
28	O
]	O
,	O
it	O
is	O
quite	O
probable	O
that	O
the	O
lack	O
of	O
ESAT	O
-	O
6	O
-	O
specific	O
T	O
cell	O
responses	O
observed	O
for	O
strains	O
H37Ra	S-Organism
and	O
SO2	S-Organism
(	O
Figure	O
3	O
)	O
might	O
be	O
caused	O
by	O
the	O
insufficient	O
expression	O
of	O
rv3612c	O
-	O
rv3616c	O
,	O
which	O
results	O
from	O
the	O
lack	O
of	O
a	O
fully	O
functional	O
PhoP	O
in	O
these	O
strains	O
.	O

Moreover	O
,	O
the	O
expression	O
values	O
of	O
genes	O
rv3612c	O
-	O
rv3616c	O
in	O
H37Rv	S-Organism
described	O
in	O
the	O
article	O
by	O
Gao	O
et	O
al	O
.	O

[	O
12	O
]	O
show	O
substantial	O
differences	O
between	O
cultures	O
grown	O
in	O
roller	O
bottles	O
relative	O
to	O
cultures	O
grown	O
in	O
shake	O
flasks	O
,	O
arguing	O
that	O
this	O
gene	O
cluster	O
might	O
be	O
regulated	O
by	O
environmental	O
conditions	O
through	O
the	O
PhoP	O
/	O
PhoR	O
system	O
.	O

It	O
is	O
not	O
clear	O
yet	O
which	O
factors	O
might	O
contribute	O
to	O
this	O
effect	O
.	O

However	O
,	O
upregulation	O
of	O
phoP	O
and	O
rv3614c	O
-	O
rv3616c	O
was	O
observed	O
after	O
incubation	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
in	O
5mM	O
H2O2	O
[	O
37	O
]	O
.	O

Furthermore	O
,	O
rv3614c	O
-	O
rv3616c	O
were	O
reported	O
to	O
be	O
transiently	O
upregulated	O
in	O
the	O
phagosome	O
and	O
under	O
acidic	O
stress	O
[	O
38	O
]	O
.	O

Altogether	O
,	O
from	O
these	O
reports	O
it	O
seems	O
plausible	O
that	O
the	O
pleiotropic	O
regulator	O
PhoP	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
rv3612c	O
-	O
rv3616c	O
expression	O
and	O
thereby	O
influences	O
ESAT	O
-	O
6	O
secretion	O
and	O
virulence	O
[	O
16	O
]	O
,	O
but	O
to	O
unambiguously	O
answer	O
this	O
question	O
,	O
virulence	O
tests	O
with	O
recombinant	O
H37Ra	S-Organism
and	O
/	O
or	O
phoP	O
ko	O
strains	O
that	O
express	O
rv3616c	O
-	O
3612c	O
under	O
a	O
constitutive	O
promoter	O
or	O
a	O
tetracycline	O
inducable	O
expression	O
system	O
[	O
39	O
]	O
will	O
be	O
needed	O
.	O

Construction	O
of	O
such	O
strains	O
has	O
recently	O
been	O
initiated	O
as	O
a	O
first	O
step	O
of	O
a	O
future	O
study	O
to	O
gain	O
deeper	O
insight	O
into	O
signaling	O
events	O
and	O
regulation	O
of	O
the	O
ESX	O
-	O
1	O
secretion	O
system	O
in	O
different	O
tubercle	B-Organism
bacilli	E-Organism
,	O
including	O
members	O
of	O
the	O
putative	O
progenitor	O
species	O
Mycobacterium	B-Organism
prototuberculosis	E-Organism
[	O
40	O
]	O
.	O

As	O
in	O
previous	O
DNA	O
/	O
DNA	O
microarray	O
analyses	O
[	O
10	O
]	O
,	O
and	O
from	O
inspection	O
of	O
the	O
very	O
recently	O
released	O
genome	O
sequence	O
of	O
H37Ra	S-Organism
,	O
no	O
significant	O
differences	O
in	O
the	O
ESX	O
-	O
1	O
encoding	O
region	O
were	O
found	O
,	O
the	O
assumption	O
that	O
the	O
observed	O
lack	O
of	O
ESAT	O
-	O
6	O
secretion	O
in	O
H37Ra	S-Organism
may	O
be	O
caused	O
by	O
factors	O
outside	O
of	O
the	O
RD1	O
region	O
is	O
very	O
plausible	O
.	O

In	O
contrast	O
,	O
in	O
another	O
transcriptome	O
analysis	O
,	O
Mostowy	O
and	O
colleagues	O
[	O
11	O
]	O
found	O
several	O
genes	O
of	O
the	O
RD1	O
region	O
,	O
including	O
that	O
encoding	O
ESAT	O
-	O
6	O
,	O
among	O
the	O
genes	O
that	O
were	O
at	O
least	O
2	O
.	O
5	O
-	O
fold	O
lower	O
expressed	O
in	O
H37Ra	S-Organism
than	O
in	O
H37Rv	S-Organism
.	O

Our	O
results	O
obtained	O
for	O
ESAT	O
-	O
6	O
expression	O
(	O
Figure	O
5	O
)	O
and	O
the	O
transcriptome	O
data	O
from	O
Gao	O
and	O
colleagues	O
[	O
12	O
]	O
argue	O
against	O
direct	O
downregulation	O
of	O
ESAT	O
-	O
6	O
in	O
H37Ra	S-Organism
.	O

However	O
,	O
it	O
is	O
also	O
possible	O
that	O
the	O
observed	O
differences	O
may	O
be	O
caused	O
by	O
variations	O
of	O
in	O
vitro	O
culture	O
conditions	O
.	O

In	O
conclusion	O
,	O
in	O
this	O
work	O
we	O
report	O
the	O
identification	O
and	O
profound	O
consequences	O
of	O
the	O
PhoP	O
S219L	O
mutation	O
on	O
the	O
widely	O
used	O
H37Ra	S-Organism
strain	O
.	O

BLASTP	O
comparisons	O
of	O
the	O
PhoP	O
sequence	O
showed	O
that	O
the	O
predicted	O
DNA	O
binding	O
region	O
,	O
where	O
the	O
mutation	O
occurred	O
,	O
is	O
perfectly	O
conserved	O
among	O
a	O
wide	O
range	O
of	O
actinobacteria	O
,	O
with	O
H37Ra	S-Organism
being	O
the	O
only	O
strain	O
showing	O
such	O
a	O
mutation	O
.	O

By	O
complementation	O
with	O
the	O
wild	O
-	O
type	O
copy	O
of	O
PhoP	O
,	O
we	O
obtained	O
a	O
significant	O
increase	O
in	O
virulence	O
in	O
ex	O
vivo	O
and	O
animal	O
models	O
as	O
well	O
as	O
restoration	O
of	O
ESAT	O
-	O
6	O
secretion	O
and	O
the	O
accompanying	O
antigen	O
-	O
specific	O
immunological	O
recognition	O
by	O
sensitized	O
splenocytes	O
or	O
T	O
cell	O
hybridomas	O
.	O

It	O
should	O
be	O
mentioned	O
here	O
that	O
the	O
SO2	O
phoP	O
ko	O
strain	O
,	O
which	O
showed	O
strong	O
ESAT	O
-	O
6	O
expression	O
but	O
little	O
ESAT	O
-	O
6	O
secretion	O
(	O
Figure	O
5	O
)	O
,	O
induced	O
only	O
very	O
reduced	O
ESAT	O
-	O
6	O
-	O
specific	O
T	O
cell	O
responses	O
(	O
Figure	O
3	O
)	O
.	O

This	O
strain	O
was	O
previously	O
used	O
to	O
vaccinate	O
mice	S-Organism
and	O
guinea	B-Organism
pigs	E-Organism
and	O
conferred	O
good	O
protection	O
against	O
a	O
challenge	O
with	O
virulent	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
25	O
]	O
.	O

As	O
ESAT	O
-	O
6	O
-	O
specific	O
T	O
cell	O
responses	O
induced	O
by	O
this	O
strain	O
are	O
low	O
,	O
ESAT	O
-	O
6	O
-	O
based	O
IFN	O
-	O
gamma	O
production	O
assays	O
might	O
be	O
used	O
to	O
differentiate	O
between	O
vaccination	O
with	O
SO2	O
and	O
infection	O
with	O
wild	O
-	O
type	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
.	O

With	O
its	O
well	O
documented	O
role	O
in	O
virulence	O
and	O
strong	O
T	O
cell	O
antigenicity	O
,	O
ESAT	O
-	O
6	O
is	O
one	O
of	O
the	O
most	O
important	O
proteins	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
involved	O
in	O
host	O
pathogen	O
interaction	O
[	O
5	O
,	O
41	O
-	O
43	O
]	O
.	O

However	O
,	O
as	O
previously	O
observed	O
in	O
complementation	O
studies	O
of	O
BCG	S-Organism
[	O
18	O
]	O
,	O
the	O
level	O
of	O
virulence	O
displayed	O
by	O
the	O
phoP	O
complemented	O
H37Ra	O
strain	O
was	O
still	O
substantially	O
below	O
that	O
of	O
wild	O
-	O
type	O
H37Rv	S-Organism
,	O
arguing	O
that	O
the	O
strong	O
attenuation	O
of	O
the	O
H37Ra	S-Organism
strain	O
is	O
likely	O
based	O
on	O
several	O
different	O
genetic	O
lesions	O
,	O
such	O
as	O
the	O
one	O
responsible	O
for	O
the	O
absence	O
of	O
phthiocerol	O
dimycocerosates	O
(	O
PDIM	O
)	O
[	O
29	O
]	O
,	O
that	O
were	O
probably	O
introduced	O
into	O
this	O
strain	O
during	O
years	O
of	O
continued	O
culture	O
following	O
the	O
original	O
event	O
of	O
attenuation	O
described	O
by	O
Steenken	O
et	O
al	O
.	O
in	O
1934	O
[	O
6	O
]	O
.	O

Indeed	O
,	O
preliminary	O
comparison	O
of	O
the	O
4	O
.	O
4	O
-	O
Mb	O
genome	O
of	O
H37Rv	S-Organism
[	O
7	O
]	O
(	O
NC	O
_	O
000962	O
)	O
with	O
the	O
recently	O
accessible	O
H37Ra	S-Organism
genome	O
(	O
NC	O
_	O
009525	O
)	O
revealed	O
194	O
differences	O
,	O
including	O
126	O
SNPs	O
,	O
16	O
deletions	O
,	O
27	O
insertions	O
,	O
and	O
25	O
substitutions	O
.	O

At	O
present	O
,	O
we	O
do	O
not	O
know	O
how	O
many	O
of	O
these	O
differences	O
actually	O
contribute	O
to	O
the	O
attenuation	O
of	O
H37Ra	S-Organism
,	O
and	O
it	O
also	O
remains	O
to	O
be	O
determined	O
how	O
many	O
differences	O
exist	O
among	O
the	O
various	O
H37Ra	S-Organism
strains	O
that	O
are	O
presently	O
used	O
in	O
the	O
worldwide	O
tuberculosis	O
research	O
laboratories	O
.	O

The	O
link	O
described	O
here	O
between	O
mutation	O
of	O
phoP	O
and	O
consequences	O
on	O
ESAT	O
-	O
6	O
secretion	O
,	O
however	O
,	O
appears	O
to	O
be	O
one	O
factor	O
that	O
significantly	O
contributes	O
to	O
attenuation	O
.	O

Finally	O
,	O
it	O
is	O
intriguing	O
that	O
both	O
BCG	S-Organism
and	O
H37Ra	S-Organism
,	O
the	O
two	O
most	O
often	O
used	O
attenuated	O
tubercle	B-Organism
bacilli	E-Organism
,	O
are	O
attenuated	O
for	O
reasons	O
linked	O
to	O
loss	O
of	O
ESAT	O
-	O
6	O
functions	O
.	O

Thus	O
,	O
our	O
results	O
once	O
more	O
emphasize	O
the	O
great	O
importance	O
of	O
the	O
ESX	O
-	O
1	O
system	O
for	O
tubercle	B-Organism
bacilli	E-Organism
and	O
provide	O
important	O
new	O
information	O
about	O
the	O
phoP	O
-	O
associated	O
virulence	O
regulation	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
.	O

Comparative	O
analysis	O
of	O
the	O
Photorhabdus	B-Organism
luminescens	E-Organism
and	O
the	O
Yersinia	B-Organism
enterocolitica	E-Organism
genomes	O
:	O
uncovering	O
candidate	O
genes	O
involved	O
in	O
insect	O
pathogenicity	O

Background	O
Photorhabdus	B-Organism
luminescens	E-Organism
and	O
Yersinia	B-Organism
enterocolitica	E-Organism
are	O
both	O
enteric	O
bacteria	O
which	O
are	O
associated	O
with	O
insects	O
.	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
lives	O
in	O
symbiosis	O
with	O
soil	O
nematodes	O
and	O
is	O
highly	O
pathogenic	O
towards	O
insects	O
but	O
not	O
to	O
humans	S-Organism
.	O

In	O
contrast	O
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
is	O
widely	O
found	O
in	O
the	O
environment	O
and	O
mainly	O
known	O
to	O
cause	O
gastroenteritis	O
in	O
men	S-Organism
,	O
but	O
has	O
only	O
recently	O
been	O
shown	O
to	O
be	O
also	O
toxic	O
for	O
insects	O
.	O

It	O
is	O
expected	O
that	O
both	O
pathogens	O
share	O
an	O
overlap	O
of	O
genetic	O
determinants	O
that	O
play	O
a	O
role	O
within	O
the	O
insect	O
host	O
.	O

Results	O
A	O
selective	O
genome	O
comparison	O
was	O
applied	O
.	O

Proteins	O
belonging	O
to	O
the	O
class	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
quorum	O
sensing	O
,	O
universal	O
stress	O
proteins	O
,	O
and	O
c	O
-	O
di	O
-	O
GMP	O
signalling	O
have	O
been	O
analysed	O
.	O

The	O
interorganismic	O
synopsis	O
of	O
selected	O
regulatory	O
systems	O
uncovered	O
common	O
and	O
distinct	O
signalling	O
mechanisms	O
of	O
both	O
pathogens	O
used	O
for	O
perception	O
of	O
signals	O
within	O
the	O
insect	O
host	O
.	O

Particularly	O
,	O
a	O
new	O
class	O
of	O
LuxR	O
-	O
like	O
regulators	O
was	O
identified	O
,	O
which	O
might	O
be	O
involved	O
in	O
detecting	O
insect	O
-	O
specific	O
molecules	O
.	O

In	O
addition	O
,	O
the	O
genetic	O
overlap	O
unravelled	O
a	O
two	O
-	O
component	O
system	O
that	O
is	O
unique	O
for	O
the	O
genera	O
Photorhabdus	S-Organism
and	O
Yersinia	S-Organism
and	O
is	O
therefore	O
suggested	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
pathogen	O
-	O
insect	O
relationship	O
.	O

Our	O
analysis	O
also	O
highlights	O
factors	O
of	O
both	O
pathogens	O
that	O
are	O
expressed	O
at	O
low	O
temperatures	O
as	O
encountered	O
in	O
insects	O
in	O
contrast	O
to	O
higher	O
(	O
body	O
)	O
temperature	O
,	O
providing	O
evidence	O
that	O
temperature	O
is	O
a	O
yet	O
under	O
-	O
investigated	O
environmental	O
signal	O
for	O
bacterial	O
adaptation	O
to	O
various	O
hosts	O
.	O

Common	O
degradative	O
metabolic	O
pathways	O
are	O
described	O
that	O
might	O
be	O
used	O
to	O
explore	O
nutrients	O
within	O
the	O
insect	O
gut	O
or	O
hemolymph	O
,	O
thus	O
enabling	O
the	O
proliferation	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
in	O
their	O
invertebrate	O
hosts	O
.	O

A	O
strikingly	O
higher	O
number	O
of	O
genes	O
encoding	O
insecticidal	O
toxins	O
and	O
other	O
virulence	O
factors	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
compared	O
to	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
correlates	O
with	O
the	O
higher	O
virulence	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
towards	O
insects	O
,	O
and	O
suggests	O
a	O
putative	O
broader	O
insect	O
host	O
spectrum	O
of	O
this	O
pathogen	O
.	O

Conclusion	O
A	O
set	O
of	O
factors	O
shared	O
by	O
the	O
two	O
pathogens	O
was	O
identified	O
including	O
those	O
that	O
are	O
involved	O
in	O
the	O
host	O
infection	O
process	O
,	O
in	O
persistence	O
within	O
the	O
insect	O
,	O
or	O
in	O
host	O
exploitation	O
.	O

Some	O
of	O
them	O
might	O
have	O
been	O
selected	O
during	O
the	O
association	O
with	O
insects	O
and	O
then	O
adapted	O
to	O
pathogenesis	O
in	O
mammalian	O
hosts	O
.	O

Background	O

Pathogenicity	O
as	O
well	O
as	O
symbiosis	O
plays	O
a	O
key	O
role	O
in	O
the	O
interaction	O
of	O
bacteria	O
with	O
their	O
hosts	O
including	O
invertebrates	O
.	O

Despite	O
the	O
relevance	O
of	O
this	O
relationship	O
for	O
the	O
evolution	O
of	O
bacterial	O
pathogenicity	O
,	O
few	O
studies	O
have	O
addressed	O
this	O
subject	O
at	O
the	O
genomic	O
level	O
.	O

We	O
therefore	O
decided	O
to	O
perform	O
a	O
comparative	O
study	O
of	O
the	O
genomes	O
of	O
Photorhabdus	B-Organism
luminescens	E-Organism
and	O
Yersinia	B-Organism
enterocolitica	E-Organism
.	O

The	O
former	O
bacterium	O
is	O
a	O
representative	O
of	O
pathogens	O
highly	O
virulent	O
towards	O
insects	O
,	O
but	O
apathogenic	O
against	O
men	S-Organism
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
an	O
example	O
of	O
a	O
primarily	O
human	S-Organism
pathogen	O
,	O
also	O
confers	O
toxicity	O
to	O
insects	O
,	O
but	O
is	O
less	O
toxic	O
towards	O
these	O
hosts	O
than	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Members	O
of	O
the	O
genus	O
Yersinia	S-Organism
are	O
primarily	O
considered	O
as	O
mammalian	O
pathogens	O
.	O

However	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
,	O
a	O
blood	O
-	O
borne	O
pathogen	O
and	O
the	O
etiological	O
agent	O
of	O
human	S-Organism
plague	O
,	O
has	O
long	O
been	O
known	O
to	O
be	O
transmitted	O
by	O
insects	O
,	O
specifically	O
by	O
rat	S-Organism
fleas	O
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
strains	O
have	O
been	O
isolated	O
from	O
flies	O
that	O
are	O
assumed	O
to	O
play	O
an	O
important	O
role	O
in	O
food	O
contamination	O
by	O
this	O
pathogen	O
[	O
1	O
-	O
3	O
]	O
,	O
and	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
strains	O
were	O
recovered	O
from	O
fly	O
larvae	O
isolated	O
in	O
the	O
wild	O
[	O
4	O
]	O
.	O

More	O
recent	O
data	O
strongly	O
support	O
the	O
idea	O
that	O
yersiniae	O
are	O
capable	O
to	O
interact	O
with	O
insects	O
.	O

Loci	O
encoding	O
the	O
insecticidal	O
toxin	O
complexes	O
(	O
Tc	O
)	O
have	O
been	O
identified	O
in	O
the	O
genomes	O
of	O
Y	B-Organism
.	I-Organism
pestis	I-Organism
KIM	E-Organism
[	O
5	O
]	O
,	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
[	O
6	O
]	O
,	O
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
[	O
7	O
]	O
.	O

Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
,	O
in	O
contrast	O
to	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
,	O
has	O
been	O
shown	O
to	O
be	O
orally	O
toxic	O
to	O
flea	O
[	O
8	O
]	O
.	O

This	O
toxicity	O
revealed	O
to	O
be	O
independent	O
of	O
tc	O
genes	O
,	O
suggesting	O
that	O
loss	O
of	O
one	O
or	O
more	O
insect	O
gut	O
toxins	O
is	O
a	O
critical	O
step	O
in	O
the	O
change	O
of	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
lifestyle	O
compared	O
with	O
the	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
and	O
thus	O
in	O
evolution	O
of	O
flea	O
-	O
borne	O
transmission	O
[	O
8	O
]	O
.	O

While	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
have	O
diverged	O
within	O
the	O
last	O
200	O
million	O
years	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
has	O
emerged	O
from	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
only	O
1	O
,	O
500	O
-	O
20	O
,	O
000	O
years	O
ago	O
[	O
9	O
]	O
.	O

Bacterial	O
lysates	O
both	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
are	O
toxic	O
for	O
Manduca	B-Organism
sexta	E-Organism
neonates	O
,	O
and	O
significant	O
levels	O
of	O
natively	O
or	O
heterologously	O
expressed	O
toxins	O
were	O
observed	O
in	O
both	O
species	O
at	O
15degreesC	O
,	O
but	O
not	O
at	O
mammalian	O
body	O
temperature	O
[	O
7	O
,	O
10	O
]	O
.	O

Furthermore	O
,	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
have	O
been	O
demonstrated	O
to	O
adhere	O
to	O
and	O
invade	O
cultivated	O
insect	O
cells	O
[	O
10	O
]	O
.	O

Thus	O
,	O
the	O
interaction	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
with	O
insects	O
is	O
an	O
important	O
link	O
in	O
the	O
ecological	O
range	O
of	O
bacteria	O
-	O
host	O
interactions	O
extending	O
from	O
entomopathogenic	O
to	O
humanpathogenic	O
bacteria	O
.	O

In	O
contrast	O
,	O
Photorhabdus	B-Organism
luminescens	E-Organism
is	O
predominantly	O
an	O
insect	O
pathogenic	O
enterobacterium	O
which	O
maintains	O
a	O
mutualistic	O
interaction	O
with	O
heterorhabditid	B-Organism
nematodes	E-Organism
,	O
and	O
can	O
infect	O
a	O
wide	O
range	O
of	O
insects	O
[	O
11	O
,	O
12	O
]	O
.	O

Interestingly	O
,	O
another	O
Photorhabdus	S-Organism
species	O
,	O
P	B-Organism
.	I-Organism
asymbiotica	E-Organism
,	O
has	O
been	O
described	O
as	O
a	O
human	S-Organism
pathogen	O
.	O

It	O
was	O
isolated	O
from	O
human	S-Organism
clinical	O
specimens	O
where	O
the	O
cells	O
caused	O
locally	O
invasive	O
soft	O
tissue	O
infections	O
[	O
13	O
,	O
14	O
]	O
.	O

It	O
is	O
assumed	O
that	O
these	O
strains	O
are	O
associated	O
with	O
spiders	O
,	O
because	O
spider	O
bites	O
where	O
attended	O
with	O
Photorhabdus	S-Organism
human	S-Organism
infections	O
[	O
15	O
]	O
.	O

However	O
,	O
bacteria	O
of	O
the	O
species	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
exclusively	O
known	O
to	O
be	O
associated	O
with	O
nematodes	O
and	O
insects	O
.	O

Generally	O
,	O
the	O
bacteria	O
colonise	O
the	O
gut	O
of	O
the	O
infective	O
juvenile	O
stage	O
of	O
the	O
nematode	O
Heterorhabditis	B-Organism
bacteriophora	E-Organism
.	O

Upon	O
entering	O
an	O
insect	O
host	O
,	O
the	O
nematodes	O
release	O
the	O
bacteria	O
by	O
regurgiation	O
directly	O
into	O
the	O
insect	O
hemocoel	O
,	O
the	O
open	O
circulatory	O
system	O
of	O
the	O
insect	O
.	O

Once	O
inside	O
the	O
hemocoel	O
,	O
the	O
bacteria	O
replicate	O
rapidly	O
and	O
establish	O
a	O
lethal	O
septemica	O
in	O
the	O
host	O
by	O
the	O
production	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
insecticidal	O
toxin	O
complexes	O
that	O
kill	O
the	O
insect	O
within	O
48	O
hours	O
.	O

Bioconversion	O
of	O
the	O
insect	O
'	O
s	O
body	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
produces	O
a	O
rich	O
food	O
source	O
for	O
the	O
bacteria	O
as	O
well	O
as	O
for	O
the	O
nematodes	O
.	O

Nematode	O
reproduction	O
is	O
supported	O
by	O
the	O
bacteria	O
,	O
probably	O
by	O
providing	O
essential	O
nutrients	O
that	O
are	O
required	O
for	O
efficient	O
nematode	O
proliferation	O
[	O
16	O
]	O
.	O

Further	O
properties	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
the	O
production	O
of	O
many	O
antimicrobial	O
substances	O
to	O
defend	O
the	O
insect	O
cadaver	O
from	O
bacterial	O
competitors	O
,	O
and	O
glowing	O
due	O
to	O
bacterial	O
luciferase	O
production	O
.	O

When	O
the	O
insect	O
cadaver	O
is	O
depleted	O
,	O
the	O
nematodes	O
and	O
bacteria	O
reassociate	O
and	O
emerge	O
from	O
the	O
carcass	O
in	O
search	O
of	O
a	O
new	O
insect	O
host	O
(	O
Fig	O
.	O
1	O
,	O
right	O
circle	O
)	O
[	O
17	O
,	O
18	O
]	O
.	O

Photorhabdus	S-Organism
species	O
exist	O
in	O
two	O
forms	O
,	O
designated	O
as	O
primary	O
and	O
secondary	O
phenotypic	O
colony	O
variants	O
,	O
which	O
differ	O
in	O
morphological	O
and	O
physiological	O
traits	O
.	O

Primary	O
variants	O
are	O
found	O
to	O
produce	O
extracellular	O
protease	O
,	O
extracellular	O
lipase	O
,	O
intracellular	O
protein	O
crystals	O
CipA	O
and	O
CipB	O
,	O
antibiotics	O
,	O
and	O
are	O
bioluminescent	O
.	O

Secondary	O
variants	O
lack	O
protease	O
,	O
lipase	O
and	O
antibiotic	O
activity	O
,	O
and	O
bioluminescence	O
is	O
strongly	O
decreased	O
.	O

They	O
also	O
differ	O
in	O
colony	O
morphology	O
,	O
pigmentation	O
,	O
dye	O
adsorption	O
,	O
metabolism	O
,	O
and	O
the	O
ability	O
to	O
support	O
growth	O
and	O
reproduction	O
of	O
the	O
nematodes	O
.	O

It	O
is	O
assumed	O
that	O
primary	O
variants	O
correspond	O
to	O
the	O
nematode	O
-	O
associated	O
form	O
,	O
and	O
secondary	O
variants	O
to	O
the	O
insect	O
-	O
associated	O
form	O
of	O
the	O
bacteria	O
[	O
19	O
,	O
20	O
]	O
.	O

Therefore	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
serves	O
as	O
an	O
ideal	O
model	O
to	O
study	O
the	O
switch	O
from	O
a	O
symbiotic	O
state	O
with	O
nematodes	O
to	O
one	O
in	O
which	O
the	O
bacterium	O
is	O
pathogenic	O
to	O
insects	O
[	O
21	O
,	O
22	O
]	O
.	O

In	O
the	O
following	O
comparative	O
genome	O
analysis	O
,	O
we	O
examined	O
the	O
extent	O
to	O
which	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
share	O
factors	O
that	O
are	O
probably	O
attributed	O
to	O
insect	O
association	O
.	O

We	O
identified	O
genes	O
and	O
the	O
corresponding	O
proteins	O
involved	O
in	O
signalling	O
,	O
regulation	O
,	O
pathogenicity	O
,	O
as	O
well	O
as	O
in	O
metabolism	O
,	O
and	O
suggest	O
their	O
possible	O
function	O
during	O
colonization	O
and	O
infection	O
of	O
non	O
-	O
mammals	O
.	O

The	O
results	O
obtained	O
not	O
only	O
improve	O
our	O
understanding	O
of	O
the	O
biology	O
of	O
both	O
pathogens	O
,	O
but	O
also	O
reveal	O
some	O
implications	O
on	O
the	O
evolution	O
of	O
invertebrate	O
and	O
vertebrate	O
virulence	O
factors	O
.	O

Results	O
and	O
Discussion	O

The	O
genomes	O
of	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
ssp	I-Organism
.	I-Organism
laumondii	I-Organism
TT01	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	I-Organism
8081	E-Organism
have	O
completely	O
been	O
sequenced	O
.	O

The	O
genome	O
of	O
the	O
latter	O
strain	O
has	O
a	O
size	O
of	O
~	O
4	O
.	O
6	O
Mbp	O
and	O
encodes	O
4037	O
putative	O
proteins	O
[	O
23	O
]	O
.	O

Its	O
genome	O
size	O
is	O
exceeded	O
by	O
the	O
~	O
5	O
.	O
7	O
Mbp	O
genome	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
encoding	O
4839	O
putative	O
proteins	O
[	O
24	O
]	O
.	O

To	O
uncover	O
candidate	O
genes	O
which	O
are	O
involved	O
in	O
insect	O
pathogenicity	O
,	O
a	O
total	O
of	O
424	O
(	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
)	O
and	O
386	O
(	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
)	O
genes	O
and	O
proteins	O
predicted	O
to	O
belong	O
to	O
one	O
of	O
the	O
functional	O
categories	O
described	O
in	O
the	O
text	O
were	O
analysed	O
for	O
their	O
presence	O
or	O
absence	O
in	O
both	O
organisms	O
,	O
and	O
for	O
their	O
degree	O
of	O
similarity	O
.	O

House	O
-	O
keeping	O
genes	O
and	O
genes	O
of	O
unknown	O
function	O
were	O
not	O
considered	O
.	O

The	O
set	O
of	O
shared	O
genes	O
or	O
proteins	O
,	O
respectively	O
,	O
indicates	O
mechanisms	O
of	O
regulation	O
,	O
virulence	O
and	O
metabolic	O
pathways	O
similar	O
for	O
both	O
pathogens	O
,	O
and	O
moreover	O
unraveled	O
novel	O
candidate	O
genes	O
/	O
proteins	O
which	O
presumably	O
are	O
involved	O
in	O
insect	O
association	O
and	O
/	O
or	O
pathogenicity	O
.	O

Proteins	O
which	O
are	O
solely	O
present	O
in	O
either	O
one	O
of	O
the	O
organisms	O
suggest	O
a	O
distinct	O
function	O
of	O
these	O
factors	O
,	O
or	O
different	O
strategies	O
followed	O
by	O
the	O
two	O
pathogens	O
during	O
their	O
life	O
cycles	O
.	O

Sensing	O
,	O
signalling	O
,	O
and	O
regulation	O
Bacteria	O
have	O
evolved	O
several	O
regulation	O
mechanisms	O
to	O
ensure	O
a	O
proper	O
answer	O
to	O
changing	O
environments	O
.	O

Upon	O
entering	O
their	O
insect	O
hosts	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
challenged	O
by	O
varying	O
and	O
detrimental	O
surrounding	O
conditions	O
which	O
they	O
have	O
to	O
sense	O
and	O
adapt	O
to	O
for	O
further	O
persistence	O
.	O

In	O
addition	O
,	O
both	O
pathogens	O
must	O
be	O
capable	O
to	O
withstand	O
the	O
insect	O
'	O
s	O
immune	O
response	O
.	O

In	O
the	O
following	O
chapter	O
we	O
compare	O
sensing	O
and	O
regulating	O
mechanisms	O
of	O
the	O
two	O
insect	O
-	O
associated	O
organisms	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
thus	O
identifying	O
strategies	O
which	O
might	O
be	O
important	O
for	O
insect	O
colonization	O
and	O
pathogenicity	O
.	O

Two	O
-	O
component	O
signal	O
transduction	O
To	O
sense	O
their	O
environment	O
and	O
to	O
react	O
rapidly	O
to	O
changing	O
surrounding	O
conditions	O
,	O
bacteria	O
have	O
evolved	O
so	O
called	O
two	O
-	O
component	O
systems	O
(	O
TCSs	O
)	O
[	O
25	O
]	O
which	O
have	O
been	O
found	O
to	O
be	O
involved	O
in	O
the	O
control	O
of	O
virulence	O
or	O
symbiosis	O
,	O
in	O
metabolite	O
utilization	O
,	O
and	O
also	O
in	O
the	O
adaptation	O
to	O
various	O
stress	O
factors	O
[	O
26	O
]	O
.	O

A	O
basic	O
TCS	O
consists	O
of	O
two	O
proteins	O
,	O
a	O
sensor	O
histidine	O
kinase	O
and	O
a	O
response	O
regulator	O
performing	O
a	O
His	O
-	O
Asp	O
phosphotransfer	O
.	O

The	O
consisting	O
domains	O
or	O
proteins	O
can	O
also	O
be	O
organized	O
as	O
more	O
complex	O
systems	O
using	O
a	O
His	O
-	O
Asp	O
-	O
His	O
-	O
Asp	O
phosphorelay	O
.	O

The	O
number	O
of	O
TCSs	O
ranges	O
from	O
zero	O
in	O
Mycoplasma	B-Organism
genitalium	E-Organism
to	O
80	O
in	O
Syncheocystes	B-Organism
spp	E-Organism
.	O

[	O
25	O
,	O
27	O
]	O
.	O

Eighteen	O
of	O
these	O
TCSs	O
are	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
and	O
28	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
of	O
which	O
17	O
are	O
shared	O
by	O
both	O
organisms	O
(	O
Fig	O
.	O
2	O
,	O
depicted	O
in	O
grey	O
)	O
.	O

The	O
additional	O
set	O
of	O
eleven	O
TCSs	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
Fig	O
.	O
2	O
,	O
shown	O
in	O
red	O
)	O
might	O
reflect	O
the	O
high	O
number	O
of	O
different	O
environments	O
this	O
pathogen	O
is	O
exposed	O
to	O
during	O
its	O
life	O
cycle	O
,	O
namely	O
soil	O
,	O
water	O
and	O
invertebrates	O
as	O
well	O
as	O
mammalian	O
hosts	O
.	O

In	O
contrast	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
cells	O
are	O
primarily	O
restricted	O
to	O
symbiosis	O
with	O
the	O
nematode	O
species	O
H	B-Organism
.	I-Organism
bacteriophora	E-Organism
and	O
the	O
insect	O
larvae	O
as	O
hosts	O
,	O
thus	O
encountering	O
a	O
more	O
homeostatic	O
milieu	O
.	O

Among	O
the	O
eleven	O
TCSs	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
not	O
shared	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
duplicates	O
of	O
the	O
CitA	O
/	O
CitB	O
system	O
(	O
YE2505	O
/	O
YE2506	O
and	O
YE2654	O
/	O
YE2655	O
)	O
and	O
of	O
the	O
LytS	O
/	O
LytR	O
system	O
(	O
YE1228	O
/	O
YE1227	O
and	O
YE4014	O
/	O
YE4015	O
)	O
.	O

The	O
principal	O
biological	O
reason	O
for	O
this	O
redundancy	O
remains	O
unclear	O
.	O

Interestingly	O
,	O
one	O
TCS	O
(	O
Plu0102	O
/	O
Plu103	O
and	O
YE4185	O
/	O
YE4186	O
)	O
is	O
unique	O
for	O
the	O
genera	O
Photorhabdus	S-Organism
and	O
Yersinia	S-Organism
.	O

Both	O
sensor	O
kinases	O
Plu0102	O
and	O
YE4185	O
are	O
of	O
moderate	O
similarity	O
(	O
31	O
.	O
5	O
%	O
identity	O
,	O
48	O
.	O
5	O
%	O
homology	O
)	O
.	O

They	O
are	O
anchored	O
to	O
the	O
membrane	O
with	O
one	O
transmembrane	O
domain	O
,	O
and	O
have	O
a	O
large	O
periplasmic	O
sensing	O
domain	O
which	O
is	O
proposed	O
to	O
bind	O
a	O
specific	O
ligand	O
.	O

Therefore	O
,	O
Plu0102	O
and	O
YE4185	O
are	O
interesting	O
candidates	O
for	O
unravelling	O
invertebrate	O
-	O
specific	O
signals	O
.	O

The	O
putative	O
target	O
genes	O
of	O
Plu0102	O
/	O
Plu0103	O
and	O
Ye4185	O
/	O
Ye4186	O
,	O
plu0104	O
and	O
ye4187	O
,	O
respectively	O
,	O
are	O
homologues	O
and	O
encode	O
putative	O
secreted	O
proteins	O
which	O
might	O
act	O
in	O
a	O
similar	O
,	O
yet	O
unknown	O
manner	O
.	O

All	O
TCSs	O
present	O
in	O
both	O
organisms	O
are	O
depicted	O
in	O
grey	O
in	O
Fig	O
.	O

2	O
,	O
and	O
include	O
PhoP	O
/	O
PhoQ	O
,	O
and	O
AstS	O
/	O
AstR	O
(	O
BvgS	O
/	O
BvgR	O
)	O
which	O
have	O
been	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
[	O
28	O
]	O
.	O

The	O
role	O
of	O
PhoP	O
/	O
PhoQ	O
in	O
regulating	O
virulence	O
gene	O
expression	O
has	O
been	O
characterized	O
mainly	O
in	O
Salmonella	S-Organism
species	O
,	O
but	O
has	O
also	O
been	O
shown	O
,	O
in	O
addition	O
to	O
three	O
other	O
TCSs	O
,	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
[	O
29	O
,	O
30	O
]	O
.	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
this	O
TCS	O
controls	O
the	O
expression	O
of	O
the	O
pbgPE	O
operon	O
which	O
is	O
involved	O
in	O
lipid	O
A	O
modification	O
and	O
thus	O
plays	O
a	O
role	O
in	O
colonization	O
and	O
infection	O
of	O
the	O
invertebrate	O
hosts	O
[	O
18	O
,	O
31	O
]	O
.	O

Furthermore	O
,	O
PhoP	O
has	O
also	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
[	O
32	O
]	O
,	O
but	O
its	O
function	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
during	O
its	O
insect	O
-	O
associated	O
phase	O
remains	O
hypothetical	O
.	O

The	O
AstS	O
/	O
AstR	O
TCS	O
is	O
required	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
[	O
28	O
]	O
.	O

BvgS	O
/	O
BvgR	O
is	O
the	O
TCS	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
that	O
corresponds	O
to	O
AstS	O
/	O
AstR	O
.	O

Because	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
is	O
not	O
known	O
to	O
switch	O
to	O
another	O
phenotypic	O
variant	O
,	O
the	O
possible	O
role	O
in	O
virulence	O
regulation	O
still	O
remains	O
to	O
be	O
elucidated	O
.	O

Both	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
produce	O
the	O
KdpD	O
/	O
KdpE	O
system	O
that	O
regulates	O
K	O
+	O
homeostasis	O
and	O
osmotic	O
stress	O
.	O

It	O
has	O
recently	O
been	O
found	O
that	O
the	O
Kdp	O
-	O
system	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
is	O
important	O
for	O
insect	O
pathogenicity	O
(	O
S	O
.	O
E	O
.	O
Reynolds	O
and	O
N	O
.	O
R	O
.	O
Waterfield	O
,	O
University	O
of	O
Bath	O
,	O
UK	O
,	O
personal	O
communication	O
)	O
.	O

Therefore	O
,	O
the	O
KdpD	O
/	O
KdpE	O
system	O
is	O
also	O
a	O
further	O
candidate	O
system	O
which	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
insecticidal	O
activity	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

The	O
only	O
TCS	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
absent	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
is	O
TctE	O
/	O
TctD	O
(	O
Fig	O
.	O
2	O
,	O
marked	O
in	O
blue	O
)	O
,	O
which	O
,	O
however	O
,	O
is	O
found	O
in	O
the	O
genomes	O
of	O
Y	B-Organism
.	I-Organism
intermedia	E-Organism
and	O
Y	B-Organism
.	I-Organism
frederiksenii	E-Organism
.	O

Beside	O
these	O
microorganisms	O
,	O
TctE	O
/	O
TctD	O
homologues	O
controlling	O
the	O
transport	O
of	O
tricarboxylic	O
acid	O
(	O
see	O
section	O
"	O
Tricarboxylate	O
utilization	O
"	O
)	O
are	O
present	O
in	O
the	O
genera	O
Salmonella	S-Organism
,	O
Burkholderia	S-Organism
,	O
Agrobacterium	S-Organism
,	O
Bordetella	S-Organism
,	O
Collinsella	S-Organism
,	O
Xylella	S-Organism
,	O
Xanthomonas	S-Organism
,	O
and	O
Pseudomonas	S-Organism
,	O
particularly	O
P	B-Organism
.	I-Organism
entomophila	E-Organism
,	O
all	O
of	O
which	O
are	O
found	O
in	O
association	O
with	O
eukaryotes	O
.	O

To	O
summarize	O
,	O
the	O
comparison	O
of	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
the	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
TCSs	O
reveals	O
a	O
basal	O
set	O
of	O
signal	O
sensing	O
mechanisms	O
which	O
are	O
used	O
by	O
both	O
organisms	O
.	O

Whether	O
the	O
stimulons	O
or	O
regulons	O
which	O
are	O
regulated	O
by	O
these	O
sets	O
of	O
TCSs	O
are	O
also	O
similar	O
remains	O
to	O
be	O
examined	O
.	O

In	O
comparison	O
to	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
uses	O
an	O
expanded	O
set	O
of	O
TCSs	O
,	O
possibly	O
to	O
adapt	O
to	O
its	O
various	O
hosts	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Quorum	O
sensing	O
-	O
like	O
gene	O
regulation	O

Regulation	O
by	O
AHL	O
-	O
LuxR	O
-	O
like	O
receptors	O
Virulence	O
,	O
bioluminescence	O
,	O
mutualism	O
,	O
antibiotic	O
production	O
and	O
biofilm	O
formation	O
are	O
often	O
regulated	O
by	O
LuxI	O
/	O
LuxR	O
quorum	O
sensing	O
systems	O
in	O
Gram	O
-	O
negative	O
bacteria	O
.	O

They	O
produce	O
membrane	O
diffusible	O
signalling	O
molecules	O
,	O
acyl	O
homoserine	O
lactones	O
(	O
AHLs	O
)	O
,	O
which	O
are	O
sensed	O
by	O
the	O
receptor	O
/	O
regulator	O
LuxR	O
when	O
exceeding	O
a	O
threshold	O
concentration	O
.	O

These	O
AHLs	O
are	O
produced	O
by	O
an	O
autoinductor	O
synthase	O
named	O
LuxI	O
.	O

Upon	O
autoinductor	O
-	O
binding	O
,	O
the	O
receptor	O
LuxR	O
binds	O
to	O
the	O
promoter	O
/	O
operator	O
regions	O
of	O
the	O
target	O
genes	O
or	O
operons	O
,	O
resulting	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
in	O
response	O
to	O
the	O
cell	O
number	O
[	O
33	O
]	O
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
possesses	O
a	O
typical	O
quorum	O
sensing	O
pair	O
of	O
homologues	O
,	O
YenI	O
/	O
YenR	O
(	O
YE1600	O
/	O
YE1599	O
)	O
,	O
and	O
it	O
has	O
recently	O
been	O
shown	O
that	O
swimming	O
and	O
swarming	O
motility	O
is	O
regulated	O
by	O
3	O
-	O
oxo	O
-	O
C6	O
-	O
AHL	O
and	O
C6	O
-	O
AHL	O
,	O
which	O
are	O
synthesized	O
by	O
YenI	O
[	O
34	O
]	O
.	O

In	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
,	O
the	O
production	O
of	O
YspI	O
and	O
YspR	O
,	O
the	O
homologues	O
of	O
YenI	O
and	O
YenR	O
,	O
is	O
induced	O
at	O
26degreesC	O
(	O
Table	O
1	O
)	O
.	O

Moreover	O
,	O
we	O
identified	O
a	O
second	O
AHL	O
-	O
LuxR	O
regulator	O
,	O
YE1026	O
,	O
which	O
lacks	O
a	O
separate	O
AHL	O
synthase	O
(	O
Fig	O
.	O
3	O
)	O
.	O

It	O
is	O
not	O
known	O
if	O
this	O
receptor	O
also	O
binds	O
the	O
AHLs	O
produced	O
by	O
YenI	O
.	O

In	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
two	O
genes	O
encoding	O
putative	O
AHL	O
-	O
LuxR	O
-	O
like	O
receptors	O
,	O
plu0320	O
and	O
plu4562	O
,	O
but	O
no	O
luxI	O
genes	O
are	O
present	O
(	O
Fig	O
.	O
3	O
)	O
.	O

This	O
suggests	O
that	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
does	O
not	O
produce	O
its	O
own	O
AHL	O
signalling	O
molecule	O
,	O
but	O
might	O
be	O
able	O
to	O
sense	O
those	O
produced	O
by	O
other	O
bacteria	O
and	O
therefore	O
to	O
detect	O
mixed	O
microbial	O
communities	O
as	O
demonstrated	O
for	O
Salmonella	B-Organism
enterica	E-Organism
and	O
Escherichia	B-Organism
coli	E-Organism
[	O
35	O
-	O
37	O
]	O
.	O

A	O
similar	O
function	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
might	O
be	O
provided	O
by	O
YE1026	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
Sodalis	B-Organism
glossinidius	I-Organism
strain	I-Organism
morsitans	E-Organism
,	O
an	O
endosymbiont	O
of	O
the	O
tse	B-Organism
tse	I-Organism
fly	I-Organism
Glossina	I-Organism
morsitans	I-Organism
morsitans	E-Organism
[	O
38	O
]	O
,	O
also	O
has	O
two	O
pontential	O
AHL	O
-	O
LuxR	O
receptors	O
,	O
SG1740	O
and	O
SG0285	O
,	O
but	O
no	O
luxI	O
homologue	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Instead	O
of	O
producing	O
AHLs	O
to	O
regulate	O
quorum	O
dependent	O
genes	O
,	O
a	O
common	O
strategy	O
of	O
insect	O
-	O
colonizing	O
bacteria	O
might	O
be	O
the	O
detection	O
of	O
AHLs	O
as	O
a	O
signal	O
for	O
the	O
presence	O
of	O
other	O
bacteria	O
such	O
as	O
those	O
colonizing	O
the	O
insect	O
intestinal	O
tract	O
or	O
living	O
in	O
soil	O
.	O

Regulation	O
by	O
AI	O
-	O
2	O

Beside	O
AHL	O
,	O
other	O
putative	O
quorum	O
sensing	O
signalling	O
molecules	O
have	O
been	O
identified	O
.	O

One	O
of	O
them	O
is	O
autoinductor	O
2	O
(	O
AI	O
-	O
2	O
)	O
,	O
furanosyl	O
borate	O
diester	O
,	O
which	O
is	O
synthesized	O
by	O
the	O
luxS	O
product	O
[	O
39	O
,	O
40	O
]	O
of	O
which	O
homologues	O
are	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
plu1253	O
,	O
ye0839	O
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
the	O
luxS	O
pathway	O
negatively	O
controls	O
the	O
expression	O
of	O
genes	O
for	O
carbapenem	O
antibiotic	O
biosynthesis	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
[	O
41	O
]	O
.	O

Overall	O
,	O
more	O
than	O
300	O
AI	O
-	O
2	O
regulated	O
genes	O
involved	O
in	O
regulation	O
,	O
metabolic	O
activity	O
,	O
stress	O
response	O
and	O
pathogenicity	O
are	O
known	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
[	O
42	O
]	O
.	O

For	O
example	O
,	O
the	O
expression	O
of	O
tcdA1	O
and	O
tccC1	O
encoding	O
subunits	O
of	O
the	O
insecticidal	O
toxin	O
complexes	O
and	O
the	O
production	O
of	O
mcf2	O
encoding	O
the	O
"	O
Makes	O
caterpillar	O
floppy	O
"	O
toxin	O
was	O
identified	O
to	O
be	O
luxS	O
dependent	O
.	O

The	O
DeltaluxS	O
mutant	O
also	O
showed	O
decreased	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
cytotoxic	O
protein	O
CcdB	O
,	O
the	O
hemolysin	O
secretion	O
protein	O
HlyD	O
(	O
Plu0635	O
)	O
,	O
and	O
the	O
toxin	O
ABC	O
transporter	O
subunits	O
RtxD	O
/	O
RtxB	O
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
see	O
chapter	O
2	O
)	O
,	O
suggesting	O
their	O
possible	O
regulation	O
by	O
AI	O
-	O
2	O
also	O
in	O
this	O
bacterium	O
.	O

Furthermore	O
,	O
the	O
P	O
.	O
luminescens	O
luxS	O
-	O
negative	O
strain	O
exhibited	O
decreased	O
biofilm	O
formation	O
,	O
increased	O
type	O
IV	O
/	O
V	O
pilus	O
-	O
dependent	O
twitching	O
motility	O
,	O
and	O
attenuated	O
virulence	O
against	O
insect	O
larvae	O
[	O
42	O
]	O
.	O

Taken	O
together	O
,	O
a	O
similar	O
and	O
AI	O
-	O
2	O
dependent	O
mechanism	O
for	O
the	O
regulation	O
of	O
insect	O
colonization	O
and	O
insect	O
pathogenicity	O
might	O
be	O
used	O
by	O
both	O
organisms	O
.	O

Whether	O
they	O
sense	O
self	O
-	O
produced	O
or	O
external	O
AI	O
-	O
2	O
,	O
or	O
a	O
combination	O
of	O
both	O
,	O
indicating	O
a	O
quorum	O
sensing	O
mechanism	O
or	O
a	O
regulation	O
similar	O
to	O
AHL	O
as	O
described	O
above	O
,	O
remains	O
to	O
be	O
elucidated	O
.	O

Regulation	O
by	O
PAS	O
_	O
4	O
/	O
LuxR	O
-	O
like	O
receptors	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
the	O
amount	O
of	O
luxR	O
-	O
like	O
genes	O
is	O
overrepresented	O
with	O
39	O
copies	O
in	O
the	O
genome	O
.	O

35	O
of	O
these	O
potential	O
LuxR	O
-	O
like	O
receptors	O
exhibit	O
PAS	O
_	O
4	O
signal	O
binding	O
domains	O
instead	O
of	O
an	O
AHL	O
-	O
binding	O
domain	O
,	O
and	O
two	O
have	O
a	O
signalling	O
domain	O
with	O
a	O
yet	O
unidentified	O
motif	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Most	O
of	O
the	O
genes	O
are	O
located	O
in	O
two	O
large	O
gene	O
clusters	O
(	O
plu0918	O
-	O
0925	O
and	O
plu2001	O
-	O
2019	O
)	O
.	O

Interestingly	O
,	O
eleven	O
of	O
those	O
LuxR	O
-	O
like	O
receptors	O
are	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
of	O
which	O
five	O
are	O
located	O
in	O
a	O
cluster	O
(	O
ye0035	O
-	O
0039	O
)	O
.	O

Nine	O
of	O
these	O
have	O
a	O
so	O
-	O
called	O
PAS	O
_	O
4	O
signal	O
binding	O
domains	O
of	O
yet	O
unknown	O
function	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
there	O
is	O
only	O
one	O
bacterium	O
else	O
,	O
the	O
insect	O
colonizing	O
S	B-Organism
.	I-Organism
glossinidius	E-Organism
,	O
whose	O
genome	O
also	O
carries	O
a	O
series	O
of	O
unclustered	O
genes	O
coding	O
for	O
PAS	O
_	O
4	O
/	O
LuxR	O
-	O
like	O
receptors	O
,	O
indicating	O
that	O
this	O
kind	O
of	O
receptors	O
plays	O
a	O
role	O
during	O
insect	O
infection	O
.	O

PAS	O
-	O
domains	O
have	O
been	O
suspected	O
to	O
act	O
as	O
insect	O
juvenile	O
hormone	O
(	O
JH	O
)	O
receptors	O
in	O
the	O
fruit	B-Organism
fly	I-Organism
Drosophila	I-Organism
melanogaster	E-Organism
[	O
43	O
,	O
44	O
]	O
.	O

The	O
methoprene	O
-	O
tolerant	O
gene	O
(	O
met	O
,	O
also	O
called	O
Resistance	O
to	O
Juvenile	O
Hormone	O
Rst1JH	O
)	O
of	O
D	B-Organism
.	I-Organism
melanogaster	E-Organism
encodes	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
transcriptional	O
regulator	O
combined	O
with	O
a	O
PAS	O
_	O
3	O
domain	O
[	O
45	O
]	O
.	O

Met	O
has	O
been	O
shown	O
to	O
bind	O
JH	O
at	O
physiological	O
concentrations	O
and	O
is	O
therefore	O
suspected	O
to	O
act	O
as	O
a	O
JH	O
receptor	O
[	O
46	O
,	O
47	O
]	O
.	O

Therefore	O
,	O
the	O
potential	O
PAS	O
_	O
4	O
/	O
LuxR	O
-	O
like	O
receptors	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
and	O
S	B-Organism
.	I-Organism
glossinidius	E-Organism
might	O
sense	O
JH	O
or	O
other	O
eukaryotic	O
hormones	O
of	O
the	O
insect	O
to	O
adapt	O
their	O
gene	O
expression	O
to	O
the	O
insect	O
host	O
.	O

The	O
high	O
number	O
of	O
35	O
highly	O
homologous	O
receptor	O
proteins	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
might	O
be	O
the	O
reason	O
for	O
the	O
wide	O
insect	O
host	O
spectrum	O
this	O
pathogen	O
is	O
capable	O
to	O
infect	O
.	O

Although	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
protein	O
extracts	O
confer	O
toxicity	O
against	O
M	B-Organism
.	I-Organism
sexta	E-Organism
larvae	O
[	O
7	O
]	O
,	O
its	O
host	O
spectrum	O
still	O
remains	O
to	O
be	O
defined	O
.	O

The	O
difference	O
in	O
the	O
number	O
of	O
the	O
uncommon	O
LuxR	O
-	O
like	O
receptors	O
(	O
35	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
nine	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
)	O
gives	O
rise	O
to	O
speculations	O
that	O
the	O
insect	O
host	O
spectrum	O
is	O
constricted	O
for	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
compared	O
with	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

This	O
hypothesis	O
is	O
underlined	O
by	O
the	O
fact	O
that	O
not	O
more	O
than	O
five	O
PAS	O
_	O
4	O
/	O
LuxR	O
-	O
like	O
receptors	O
are	O
present	O
in	O
S	B-Organism
.	I-Organism
glossinidius	E-Organism
for	O
which	O
only	O
one	O
insect	O
host	O
has	O
been	O
reported	O
.	O

Regulation	O
by	O
uncommon	O
LuxR	O
-	O
like	O
receptors	O

LuxR	O
-	O
like	O
receptors	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
with	O
a	O
yet	O
unidentified	O
signalling	O
binding	O
-	O
site	O
are	O
YE2705	O
and	O
YE3014	O
,	O
both	O
of	O
which	O
are	O
also	O
present	O
in	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
(	O
YPO2955	O
and	O
YPO2593	O
)	O
and	O
in	O
S	B-Organism
.	I-Organism
glossinidius	E-Organism
(	O
SGP1	O
_	O
007	O
,	O
SG1174	O
,	O
SG1480	O
,	O
and	O
SG1698	O
)	O
,	O
but	O
not	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
Fig	O
.	O
3	O
)	O
.	O

It	O
might	O
be	O
possible	O
that	O
signalling	O
molecules	O
of	O
mammals	O
and	O
hormones	O
of	O
adult	O
insects	O
are	O
sensed	O
via	O
these	O
receptors	O
by	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
S	B-Organism
.	I-Organism
glossinidius	E-Organism
,	O
respectively	O
,	O
hosts	O
which	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
does	O
not	O
specifically	O
interact	O
with	O
during	O
its	O
life	O
cycle	O
.	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
two	O
LuxR	O
-	O
like	O
receptors	O
with	O
a	O
yet	O
unidentified	O
signalling	O
binding	O
site	O
are	O
present	O
,	O
Plu4274	O
and	O
Plu1817	O
,	O
the	O
latter	O
of	O
which	O
is	O
shared	O
by	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
YE1621	O
)	O
,	O
but	O
not	O
by	O
S	B-Organism
.	I-Organism
glossinidius	E-Organism
.	O

Universal	O
stress	O
proteins	O

Universal	O
stress	O
proteins	O
(	O
Usp	O
)	O
are	O
small	O
soluble	O
proteins	O
found	O
in	O
bacteria	O
,	O
archaea	O
and	O
plants	O
.	O

The	O
production	O
of	O
these	O
proteins	O
is	O
induced	O
upon	O
global	O
stress	O
conditions	O
such	O
as	O
nutrient	O
starvation	O
,	O
heat	O
stress	O
,	O
osmotic	O
stress	O
,	O
oxidative	O
stress	O
,	O
or	O
the	O
presence	O
of	O
toxic	O
compounds	O
.	O

The	O
protein	O
family	O
is	O
divided	O
into	O
the	O
UspA	O
subfamily	O
and	O
the	O
UspFG	O
subfamily	O
.	O

The	O
functional	O
mechanism	O
of	O
these	O
Usp	O
proteins	O
is	O
not	O
known	O
[	O
48	O
]	O
.	O

Because	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
exposed	O
to	O
those	O
stresses	O
upon	O
infecting	O
and	O
colonizing	O
the	O
insect	O
host	O
,	O
we	O
compared	O
their	O
set	O
of	O
Usp	O
proteins	O
(	O
Table	O
2	O
)	O
.	O

Both	O
genomes	O
share	O
an	O
UspA	O
-	O
like	O
(	O
Plu0121	O
and	O
YE4050	O
)	O
and	O
an	O
UspE	O
-	O
like	O
(	O
Plu2178	O
and	O
YE2076	O
)	O
homologue	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
the	O
sequence	O
motif	O
of	O
Usp	O
proteins	O
is	O
not	O
highly	O
conserved	O
:	O
UspA	O
and	O
UspC	O
show	O
a	O
sequence	O
identity	O
of	O
37	O
%	O
and	O
a	O
homology	O
of	O
57	O
%	O
,	O
for	O
example	O
.	O

In	O
contrast	O
,	O
the	O
UspA	O
and	O
the	O
UspE	O
homologues	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
nearly	O
similar	O
,	O
indicating	O
that	O
an	O
identical	O
stress	O
response	O
is	O
regulated	O
by	O
these	O
proteins	O
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
also	O
present	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
namely	O
PA4352	O
and	O
PA3309	O
,	O
a	O
tandem	O
-	O
type	O
Usp	O
protein	O
and	O
a	O
UspA	O
-	O
like	O
protein	O
,	O
respectively	O
.	O

They	O
are	O
essential	O
for	O
survival	O
under	O
anaerobic	O
growth	O
and	O
therefore	O
biofilm	O
formation	O
,	O
a	O
situation	O
cells	O
are	O
exposed	O
to	O
when	O
colonizing	O
the	O
cystic	O
fibrosis	O
lung	O
in	O
hosts	O
[	O
49	O
,	O
50	O
]	O
.	O

The	O
Usp	O
homologues	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
might	O
also	O
be	O
important	O
during	O
infection	O
of	O
the	O
insect	O
host	O
.	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
expression	O
of	O
UspA	O
has	O
been	O
shown	O
to	O
be	O
under	O
control	O
of	O
the	O
AstS	O
/	O
AstR	O
TCS	O
,	O
which	O
is	O
important	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
[	O
28	O
]	O
.	O

It	O
is	O
discussed	O
that	O
the	O
AstS	O
/	O
AstR	O
-	O
system	O
prevents	O
or	O
delays	O
phenotypic	O
variation	O
by	O
protecting	O
the	O
cell	O
from	O
stress	O
[	O
18	O
]	O
.	O

Because	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
produces	O
the	O
corresponding	O
TCS	O
BvgS	O
/	O
BvgR	O
,	O
but	O
is	O
not	O
known	O
to	O
switch	O
to	O
another	O
phenotypic	O
variant	O
,	O
the	O
possible	O
role	O
of	O
UspA	O
in	O
global	O
regulation	O
still	O
remains	O
to	O
be	O
elucidated	O
.	O

Phenotypic	O
variation	O
and	O
thus	O
the	O
switch	O
between	O
mutualism	O
and	O
pathogenicity	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
is	O
proposed	O
to	O
be	O
regulated	O
by	O
a	O
Ner	O
-	O
like	O
and	O
a	O
HexA	O
-	O
like	O
regulator	O
that	O
repress	O
primary	O
variant	O
specific	O
genes	O
in	O
the	O
stage	O
of	O
the	O
secondary	O
variant	O
[	O
17	O
]	O
.	O

Therefore	O
,	O
UspA	O
might	O
have	O
a	O
global	O
importance	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
notifying	O
stress	O
and	O
transmitting	O
signals	O
for	O
HexA	O
[	O
18	O
]	O
.	O

In	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
the	O
transcriptional	O
repressor	O
RovM	O
(	O
YE1343	O
)	O
is	O
similar	O
to	O
HexA	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
61	O
%	O
identity	O
and	O
75	O
%	O
homology	O
)	O
,	O
and	O
has	O
only	O
recently	O
been	O
shown	O
to	O
control	O
cell	O
invasion	O
,	O
virulence	O
and	O
motility	O
in	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
[	O
51	O
-	O
53	O
]	O
.	O

This	O
fact	O
suggests	O
a	O
similar	O
UspA	O
-	O
dependent	O
regulatory	O
mechanism	O
used	O
by	O
the	O
two	O
bacteria	O
compared	O
here	O
.	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
but	O
not	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
produces	O
two	O
members	O
of	O
the	O
UspFG	O
family	O
,	O
the	O
UspG	O
homologues	O
Plu2030	O
and	O
Plu2032	O
(	O
Tab	O
.	O
2	O
)	O
,	O
indicating	O
a	O
global	O
stress	O
response	O
induced	O
by	O
those	O
Usp	O
proteins	O
that	O
is	O
different	O
in	O
both	O
organisms	O
.	O

It	O
is	O
known	O
that	O
UspG	O
of	O
E	B-Organism
.	I-Organism
coli	E-Organism
interacts	O
with	O
the	O
chaperonin	O
GroEL	O
[	O
54	O
]	O
,	O
which	O
promotes	O
the	O
correct	O
folding	O
of	O
many	O
cytosolic	O
proteins	O
[	O
55	O
]	O
.	O

A	O
GroEL	O
homologue	O
is	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
Plu4134	O
)	O
which	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
UspG	O
homologues	O
might	O
interact	O
with	O
.	O

In	O
contrast	O
to	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
encodes	O
another	O
member	O
of	O
the	O
UspA	O
subfamily	O
,	O
the	O
UspC	O
homologue	O
YE2583	O
(	O
Tab	O
.	O
2	O
)	O
,	O
which	O
is	O
not	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Therefore	O
,	O
an	O
UspC	O
mediated	O
stress	O
response	O
is	O
not	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
insect	O
pathogenicity	O
.	O

Summarizing	O
,	O
the	O
set	O
of	O
the	O
shared	O
and	O
different	O
Usp	O
proteins	O
reveals	O
a	O
partially	O
similar	O
and	O
a	O
partially	O
different	O
(	O
fine	O
)	O
-	O
regulation	O
of	O
the	O
global	O
stress	O
response	O
modules	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

This	O
pattern	O
corresponds	O
to	O
the	O
overlapping	O
life	O
cycles	O
of	O
both	O
pathogens	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
UspA	O
and	O
the	O
UspE	O
homologues	O
are	O
predicted	O
here	O
to	O
be	O
relevant	O
for	O
insect	O
infection	O
,	O
whereas	O
UspC	O
is	O
assumed	O
be	O
more	O
important	O
for	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
in	O
other	O
environments	O
/	O
hosts	O
.	O

The	O
two	O
UspG	O
homologues	O
might	O
constitute	O
a	O
set	O
of	O
Usp	O
proteins	O
that	O
play	O
a	O
specific	O
role	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
infection	O
or	O
in	O
symbiosis	O
with	O
the	O
nematode	O
host	O
.	O

Regulation	O
via	O
c	O
-	O
di	O
-	O
GMP	O
as	O
a	O
second	O
messenger	O

Cyclic	O
diguanylate	O
(	O
c	O
-	O
di	O
-	O
GMP	O
)	O
is	O
a	O
bacterial	O
second	O
messenger	O
that	O
activates	O
biofilm	O
formation	O
while	O
inhibiting	O
motility	O
,	O
thus	O
regulating	O
the	O
switch	O
between	O
a	O
planktonic	O
and	O
a	O
sessile	O
lifestyle	O
.	O

In	O
addition	O
to	O
phenotypes	O
that	O
affect	O
virulence	O
properties	O
indirectly	O
,	O
c	O
-	O
di	O
-	O
GMP	O
can	O
also	O
directly	O
regulate	O
virulence	O
factors	O
[	O
56	O
,	O
57	O
]	O
.	O

Proteins	O
containing	O
a	O
so	O
-	O
called	O
GGDEF	O
domain	O
are	O
responsible	O
for	O
the	O
synthesis	O
of	O
c	O
-	O
di	O
-	O
GMP	O
,	O
and	O
those	O
with	O
a	O
so	O
-	O
called	O
EAL	O
domain	O
for	O
its	O
degradation	O
.	O

The	O
expression	O
and	O
activity	O
of	O
those	O
GGDEF	O
and	O
EAL	O
domain	O
containing	O
proteins	O
is	O
regulated	O
by	O
factors	O
with	O
a	O
PilZ	O
domain	O
that	O
binds	O
c	O
-	O
di	O
-	O
GMP	O
.	O

The	O
PilZ	O
domain	O
is	O
found	O
as	O
a	O
stand	O
-	O
alone	O
domain	O
or	O
in	O
combination	O
with	O
GGDEF	O
,	O
EAL	O
and	O
other	O
domains	O
,	O
thus	O
assumed	O
to	O
function	O
also	O
as	O
an	O
allosteric	O
domain	O
to	O
control	O
other	O
regulatory	O
enzymes	O
[	O
58	O
,	O
59	O
]	O
.	O

In	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
we	O
identified	O
22	O
putative	O
proteins	O
containing	O
GGDEF	O
and	O
EAL	O
domains	O
.	O

Eleven	O
of	O
these	O
proteins	O
solely	O
contain	O
a	O
GGDEF	O
-	O
domain	O
and	O
six	O
solely	O
an	O
EAL	O
-	O
domain	O
,	O
and	O
both	O
domains	O
are	O
found	O
in	O
tandem	O
in	O
five	O
proteins	O
.	O

The	O
protein	O
AdrA	O
(	O
YE3010	O
,	O
GGDEF	O
domain	O
)	O
is	O
annotated	O
as	O
a	O
putative	O
diguanylate	O
cyclase	O
,	O
YE2278	O
(	O
GGDEF	O
+	O
EAL	O
)	O
as	O
a	O
putative	O
phosphodiesterase	O
,	O
YE3818	O
(	O
GGDEF	O
)	O
as	O
a	O
putative	O
regulator	O
,	O
and	O
YE3806	O
(	O
GGDEF	O
+	O
EAL	O
)	O
as	O
a	O
putative	O
exported	O
protein	O
.	O

All	O
other	O
GGDEF	O
and	O
EAL	O
domain	O
-	O
containing	O
proteins	O
are	O
of	O
unknown	O
function	O
.	O

Furthermore	O
,	O
two	O
proteins	O
with	O
PilZ	O
domain	O
exist	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
namely	O
YE3197	O
and	O
BcsA	O
(	O
YE4074	O
)	O
,	O
a	O
putative	O
cellulose	O
synthase	O
.	O

Cellulose	O
synthesis	O
in	O
bacteria	O
has	O
been	O
identified	O
to	O
be	O
important	O
for	O
the	O
protection	O
from	O
chemical	O
or	O
mechanical	O
stress	O
by	O
forming	O
a	O
hydrophobic	O
extracellular	O
matrix	O
[	O
60	O
]	O
.	O

The	O
expression	O
of	O
two	O
of	O
those	O
EAL	O
-	O
domain	O
containing	O
proteins	O
,	O
YE4063	O
and	O
YE1324	O
,	O
is	O
induced	O
at	O
low	O
temperature	O
(	O
Tab	O
.	O
1	O
)	O
.	O

These	O
two	O
factors	O
might	O
therefore	O
be	O
important	O
for	O
insect	O
colonization	O
instead	O
for	O
virulence	O
against	O
mammals	O
.	O

The	O
presence	O
of	O
c	O
-	O
di	O
-	O
GMP	O
mediated	O
regulation	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
is	O
therefore	O
suggested	O
to	O
play	O
a	O
central	O
role	O
in	O
switching	O
from	O
biofilm	O
formation	O
to	O
the	O
human	S-Organism
as	O
well	O
as	O
to	O
the	O
insect	O
environment	O
.	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
contains	O
no	O
protein	O
with	O
GGDEF	O
,	O
EAL	O
or	O
PilZ	O
domain	O
.	O

This	O
phenomenon	O
is	O
quite	O
surprising	O
,	O
because	O
with	O
few	O
exceptions	O
such	O
as	O
Helicobacter	B-Organism
pylori	E-Organism
,	O
nearly	O
all	O
pathogenic	O
bacteria	O
use	O
c	O
-	O
di	O
-	O
GMP	O
as	O
a	O
second	O
messenger	O
.	O

It	O
has	O
been	O
reported	O
that	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
forms	O
biofilms	O
in	O
vitro	O
,	O
and	O
that	O
a	O
luxS	O
-	O
deficient	O
mutant	O
unable	O
to	O
synthesize	O
the	O
quorum	O
-	O
sensing	O
inducer	O
AI	O
-	O
2	O
showed	O
a	O
decreased	O
biofilm	O
formation	O
[	O
42	O
]	O
.	O

The	O
lack	O
of	O
these	O
protein	O
domains	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
reveals	O
that	O
c	O
-	O
di	O
-	O
GMP	O
signalling	O
plays	O
a	O
major	O
role	O
in	O
pathogenic	O
bacteria	O
when	O
colonizing	O
a	O
mammalian	O
host	O
,	O
and	O
a	O
minor	O
for	O
invertebrate	O
colonization	O
of	O
entomopathogenic	O
or	O
entomoinfecting	O
bacteria	O
.	O

Virulence	O
factors	O

So	O
-	O
called	O
offensive	O
virulence	O
factors	O
actively	O
contribute	O
to	O
a	O
successful	O
infection	O
by	O
colonization	O
of	O
and	O
toxicity	O
towards	O
the	O
host	O
organism	O
.	O

We	O
compared	O
both	O
genomes	O
with	O
respect	O
to	O
genes	O
encoding	O
toxins	O
,	O
adhesins	O
or	O
invasines	O
that	O
are	O
common	O
to	O
both	O
pathogens	O
.	O

All	O
virulence	O
factors	O
described	O
in	O
the	O
following	O
are	O
summarized	O
in	O
Fig	O
.	O

4	O
.	O

Toxins	O
Insecticidal	O
toxins	O
The	O
insecticidal	O
toxin	O
complex	O
(	O
Tc	O
)	O
proteins	O
were	O
first	O
purified	O
from	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
[	O
61	O
]	O
.	O

Tc	O
homologues	O
have	O
also	O
been	O
described	O
to	O
be	O
present	O
in	O
Yersinia	S-Organism
spp	O
.	O
and	O
in	O
other	O
insect	O
-	O
associated	O
bacteria	O
such	O
as	O
Serratia	B-Organism
entomophila	E-Organism
and	O
Xenorhabdus	B-Organism
nematophilus	E-Organism
[	O
62	O
,	O
63	O
]	O
.	O

The	O
respective	O
genes	O
encoding	O
four	O
high	O
molecular	O
weight	O
toxin	O
complexes	O
are	O
termed	O
tca	O
,	O
tcb	O
,	O
tcc	O
and	O
tcd	O
.	O

Further	O
experiments	O
supported	O
the	O
hypothesis	O
that	O
TccC	O
-	O
like	O
proteins	O
might	O
act	O
as	O
universal	O
activators	O
of	O
,	O
or	O
chaperons	O
for	O
,	O
different	O
toxin	O
proteins	O
,	O
while	O
Tca	O
-	O
like	O
and	O
Tcd	O
-	O
like	O
proteins	O
contribute	O
predominantly	O
to	O
the	O
oral	O
toxicity	O
of	O
bacterial	O
supernatants	O
[	O
17	O
]	O
.	O

It	O
is	O
speculated	O
that	O
the	O
Tc	O
toxins	O
are	O
active	O
against	O
different	O
tissues	O
within	O
individual	O
hosts	O
,	O
namely	O
Tcb	O
against	O
hemocytes	O
and	O
Tcd	O
and	O
Tca	O
against	O
cells	O
of	O
the	O
insect	O
gut	O
.	O

In	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
the	O
insecticidal	O
toxin	O
genes	O
are	O
located	O
on	O
a	O
distinct	O
genomic	O
island	O
termed	O
tc	O
-	O
PAIYe	O
of	O
21	O
kb	O
,	O
and	O
are	O
low	O
-	O
temperature	O
induced	O
[	O
7	O
]	O
.	O

Similar	O
islands	O
in	O
which	O
regulatory	O
genes	O
are	O
followed	O
by	O
three	O
tca	O
genes	O
,	O
phage	O
-	O
related	O
genes	O
and	O
one	O
or	O
two	O
tccC	O
genes	O
,	O
are	O
present	O
in	O
the	O
genomes	O
of	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	I-Organism
IP32953	E-Organism
and	O
Y	B-Organism
.	I-Organism
pestis	I-Organism
KIM	E-Organism
.	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
the	O
insecticidal	O
genes	O
are	O
organized	O
in	O
the	O
tcd	O
island	O
harbouring	O
nine	O
tcd	O
-	O
and	O
tcc	O
-	O
like	O
genes	O
and	O
several	O
non	O
tc	O
-	O
like	O
genes	O
,	O
while	O
further	O
nine	O
tcc	O
-	O
like	O
genes	O
are	O
scattered	O
over	O
the	O
chromosome	O
[	O
24	O
]	O
.	O

The	O
reason	O
for	O
the	O
over	O
-	O
represence	O
of	O
tc	O
-	O
like	O
genes	O
in	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
genome	O
might	O
reflect	O
the	O
different	O
strategies	O
followed	O
by	O
both	O
bacteria	O
within	O
insects	O
,	O
namely	O
the	O
rapid	O
killing	O
for	O
exploiting	O
the	O
victim	O
as	O
a	O
food	O
source	O
in	O
case	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
and	O
infection	O
of	O
and	O
persistance	O
within	O
the	O
invertebrate	O
host	O
as	O
possibly	O
preferred	O
by	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Hemolysins	O
or	O
hemagglutinin	O
-	O
related	O
proteins	O

These	O
extracellular	O
toxins	O
target	O
red	O
blood	O
cells	O
to	O
provide	O
access	O
to	O
iron	O
,	O
but	O
often	O
show	O
activity	O
against	O
immune	O
cells	O
,	O
thus	O
contributing	O
to	O
the	O
bacterial	O
response	O
to	O
the	O
immune	O
system	O
of	O
hosts	O
,	O
including	O
phagocytosis	O
by	O
insect	O
blood	O
cells	O
[	O
64	O
]	O
.	O

Hemolysins	O
or	O
surface	O
-	O
associated	O
adhesins	O
,	O
together	O
with	O
their	O
transporters	O
,	O
are	O
sometimes	O
organized	O
as	O
two	O
-	O
partner	O
secretion	O
(	O
TPS	O
)	O
systems	O
,	O
a	O
specialized	O
mechanism	O
for	O
the	O
delivery	O
of	O
large	O
exoproteins	O
[	O
65	O
]	O
.	O

TPS	O
systems	O
have	O
been	O
characterized	O
mainly	O
in	O
pathogenic	O
bacteria	O
,	O
but	O
are	O
also	O
present	O
in	O
other	O
microorganisms	O
.	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
TPS	O
systems	O
include	O
the	O
calcium	O
-	O
independent	O
hemolysin	O
PhlA	O
that	O
is	O
transported	O
through	O
the	O
outer	O
membrane	O
and	O
activated	O
by	O
PhlB	O
.	O

Remarkably	O
,	O
their	O
expression	O
is	O
induced	O
by	O
low	O
iron	O
concentration	O
as	O
encountered	O
in	O
the	O
insect	O
host	O
,	O
and	O
phlA	O
/	O
phlB	O
are	O
up	O
-	O
regulated	O
at	O
18degreesC	O
compared	O
to	O
28degreesC	O
in	O
Y	B-Organism
.	I-Organism
ruckeri	E-Organism
[	O
66	O
]	O
.	O

Eight	O
other	O
TPS	O
systems	O
are	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
namely	O
Plu0225	O
/	O
Plu0226	O
,	O
Plu0548	O
/	O
Plu0549	O
,	O
Plu1149	O
/	O
Plu1150	O
,	O
Plu1367	O
/	O
Plu1368	O
,	O
Plu3064	O
/	O
Plu3065	O
,	O
Plu3125	O
-	O
3127	O
/	O
3128	O
,	O
Plu3667	O
/	O
Plu3668	O
,	O
and	O
Plu3718	O
/	O
Plu3719	O
,	O
and	O
further	O
three	O
genes	O
for	O
which	O
the	O
partner	O
locus	O
has	O
not	O
been	O
identified	O
(	O
Fig	O
.	O
4	O
)	O
.	O

In	O
the	O
genome	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
only	O
three	O
complete	O
TPS	O
systems	O
are	O
present	O
,	O
namely	O
YE0479	O
/	O
YE0480	O
,	O
YE2407	O
/	O
YE2408	O
,	O
(	O
YE4084	O
)	O
YE4085	O
/	O
YE4086	O
,	O
and	O
YE3454	O
which	O
lacks	O
the	O
activator	O
partner	O
.	O

Except	O
YE0479	O
/	O
YE0480	O
,	O
all	O
have	O
counterparts	O
in	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
genome	O
.	O

Recently	O
,	O
we	O
have	O
shown	O
that	O
a	O
luciferase	O
reporter	O
insertion	O
into	O
YE0480	O
is	O
induced	O
at	O
low	O
temperature	O
[	O
67	O
]	O
,	O
indicating	O
that	O
this	O
TPS	O
system	O
might	O
contribute	O
to	O
insect	O
pathogenicity	O
and	O
possibly	O
to	O
the	O
host	O
-	O
specificity	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

The	O
genomes	O
of	O
both	O
pathogens	O
also	O
carry	O
three	O
and	O
five	O
,	O
respectively	O
,	O
further	O
hemolysin	O
/	O
hemagglutinin	O
-	O
related	O
proteins	O
which	O
are	O
absent	O
in	O
the	O
other	O
pathogen	O
(	O
Fig	O
.	O
4	O
)	O
.	O

FhaC	O
which	O
belongs	O
to	O
a	O
family	O
of	O
hemolysin	O
activator	O
proteins	O
related	O
to	O
ShlA	O
from	O
Serratia	B-Organism
marcescens	E-Organism
is	O
present	O
in	O
both	O
pathogens	O
and	O
also	O
induced	O
at	O
low	O
temperature	O
[	O
67	O
]	O
.	O

The	O
genome	O
sequence	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
exhibits	O
more	O
toxin	O
genes	O
than	O
found	O
in	O
any	O
other	O
bacterial	O
genome	O
sequenced	O
yet	O
,	O
including	O
the	O
genome	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Hemolysin	O
-	O
related	O
factors	O
and	O
their	O
transporters	O
discussed	O
above	O
are	O
an	O
example	O
for	O
this	O
redundancy	O
.	O

However	O
,	O
the	O
majority	O
of	O
these	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
toxins	O
exhibit	O
highly	O
significant	O
similarities	O
to	O
those	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
suggesting	O
common	O
progenitors	O
of	O
hemolysins	O
.	O

It	O
is	O
therefore	O
tempting	O
to	O
speculate	O
that	O
hemolytic	O
activities	O
of	O
bacteria	O
had	O
been	O
evolved	O
during	O
the	O
association	O
with	O
insects	O
and	O
then	O
adapted	O
to	O
mammalian	O
hosts	O
.	O

Although	O
it	O
can	O
not	O
be	O
excluded	O
that	O
the	O
hemolysins	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
act	O
on	O
the	O
immune	O
systems	O
of	O
both	O
the	O
insect	O
and	O
the	O
mammalian	O
host	O
,	O
the	O
genetic	O
overlap	O
of	O
this	O
group	O
of	O
virulence	O
factor	O
between	O
both	O
pathogens	O
,	O
and	O
the	O
low	O
-	O
temperature	O
expression	O
of	O
YE0479	O
/	O
YE0480	O
and	O
fhaC	O
,	O
indicates	O
the	O
presence	O
of	O
insect	O
-	O
specific	O
hemolysins	O
in	O
the	O
genome	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Repeats	O
-	O
in	O
-	O
toxin	O
(	O
RTX	O
)	O
and	O
other	O
toxins	O

RTX	O
proteins	O
constitute	O
another	O
family	O
of	O
toxins	O
that	O
may	O
contribute	O
to	O
the	O
insecticidal	O
activity	O
of	O
the	O
two	O
pathogens	O
.	O

A	O
putative	O
RTX	O
-	O
family	O
toxin	O
transporter	O
is	O
common	O
to	O
both	O
pathogens	O
(	O
YE1998	O
-	O
2000	O
,	O
Plu0634	O
/	O
Plu0635	O
)	O
.	O

The	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
genome	O
comprises	O
a	O
gene	O
cluster	O
encoding	O
RTX	O
proteins	O
,	O
namely	O
plu1330	O
-	O
1369	O
.	O

Further	O
RTX	O
toxins	O
are	O
encoded	O
by	O
plu3217	O
,	O
plu3324	O
(	O
both	O
RTX	O
A	O
-	O
family	O
)	O
,	O
plu4117	O
(	O
own	O
family	O
)	O
,	O
and	O
plu3668	O
(	O
RTX	O
cytotoxin	O
)	O
,	O
none	O
of	O
which	O
is	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

This	O
pathogen	O
produces	O
only	O
one	O
RTX	O
protein	O
(	O
YE1322	O
)	O
for	O
which	O
a	O
truncated	O
homologue	O
is	O
found	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
Plu3209	O
)	O
.	O

Other	O
examples	O
of	O
toxins	O
common	O
for	O
both	O
bacterial	O
species	O
compared	O
here	O
are	O
homologues	O
of	O
XaxAB	O
,	O
an	O
apoptotic	O
AB	O
toxin	O
of	O
X	B-Organism
.	I-Organism
nematophila	E-Organism
[	O
68	O
]	O
,	O
and	O
proteins	O
encoded	O
by	O
the	O
macrophage	O
toxin	O
(	O
mt	O
)	O
-	O
like	O
genes	O
Plu2288	O
and	O
Plu0359	O
with	O
high	O
similarity	O
to	O
YE2685	O
.	O
cnf	O
encoding	O
the	O
cytonecrosis	O
factor	O
-	O
like	O
toxin	O
is	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
YE2091	O
)	O
and	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
ssp	I-Organism
.	I-Organism
akhurstii	I-Organism
strain	I-Organism
W14	E-Organism
,	O
but	O
not	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
ssp	I-Organism
.	I-Organism
laumondii	I-Organism
strain	I-Organism
TT01	E-Organism
(	O
Fig	O
.	O
4	O
)	O
.	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
produces	O
a	O
series	O
of	O
proteins	O
similar	O
to	O
toxins	O
that	O
have	O
been	O
identified	O
in	O
other	O
bacteria	O
,	O
but	O
are	O
absent	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Examples	O
identified	O
are	O
Txp40	O
,	O
a	O
40	O
kD	O
insecticidal	O
toxin	O
[	O
69	O
]	O
,	O
the	O
nematicidal	O
toxin	O
(	O
Xnp2	O
)	O
first	O
described	O
in	O
X	B-Organism
.	I-Organism
bovienii	E-Organism
(	O
accession	O
number	O
AJ296651	O
.	O
1	O
)	O
,	O
galA	O
(	O
plu0840	O
)	O
similar	O
to	O
the	O
enterotoxin	O
Ast	O
of	O
Aeromonas	B-Organism
hydrophila	E-Organism
which	O
is	O
involved	O
in	O
carbohydrate	O
transport	O
and	O
metabolism	O
[	O
70	O
]	O
,	O
and	O
two	O
dermonecrotizing	O
toxin	O
-	O
(	O
dnt	O
-	O
)	O
like	O
factors	O
(	O
plu2400	O
and	O
plu2420	O
)	O
.	O

In	O
addition	O
,	O
neither	O
the	O
crystal	O
proteins	O
encoded	O
by	O
cipA	O
and	O
cipB	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
nor	O
a	O
Bt	O
-	O
like	O
toxin	O
(	O
plu1537	O
)	O
could	O
be	O
found	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

A	O
cytonecrosis	O
factor	O
(	O
CNF	O
)	O
-	O
like	O
protein	O
,	O
Pnf	O
,	O
was	O
identified	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
ssp	I-Organism
.	I-Organism
akhurstii	I-Organism
strain	I-Organism
W14	E-Organism
,	O
but	O
not	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
ssp	I-Organism
.	I-Organism
laumondii	I-Organism
strain	I-Organism
TT01	E-Organism
.	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
the	O
two	O
paralogs	O
plu4092	O
and	O
plu4436	O
encode	O
juvenile	O
hormone	O
esterases	O
(	O
JHE	O
)	O
for	O
which	O
insect	O
toxicity	O
has	O
already	O
been	O
demonstrated	O
[	O
24	O
]	O
.	O

Additionally	O
,	O
neither	O
the	O
locus	O
mcf	O
that	O
confers	O
insecticidal	O
activity	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
towards	O
M	B-Organism
.	I-Organism
sexta	E-Organism
[	O
71	O
]	O
by	O
inducing	O
apoptosis	O
[	O
72	O
]	O
,	O
nor	O
the	O
homologous	O
gene	O
locus	O
mcf2	O
(	O
plu3128	O
)	O
[	O
73	O
]	O
are	O
present	O
in	O
the	O
genome	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Most	O
of	O
these	O
toxins	O
probably	O
contribute	O
to	O
the	O
higher	O
insect	O
toxicity	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
against	O
the	O
tobacco	B-Organism
hornworm	E-Organism
in	O
comparison	O
with	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

No	O
homologues	O
of	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
gene	O
coding	O
for	O
enhancin	O
(	O
YPO0339	O
)	O
could	O
be	O
found	O
for	O
which	O
a	O
role	O
in	O
flea	O
colonization	O
was	O
predicted	O
[	O
74	O
]	O
.	O

We	O
also	O
identified	O
several	O
virulence	O
genes	O
and	O
operons	O
that	O
are	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
but	O
not	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
suggesting	O
that	O
they	O
have	O
been	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
from	O
other	O
bacteria	O
and	O
do	O
not	O
play	O
a	O
role	O
in	O
bacteria	O
-	O
insect	O
association	O
.	O

Examples	O
are	O
SopB	O
,	O
a	O
host	O
cell	O
invasion	O
factor	O
translocated	O
via	O
the	O
type	O
-	O
III	O
secretion	O
system	O
that	O
is	O
present	O
in	O
the	O
emerging	O
human	S-Organism
pathogen	O
P	B-Organism
.	I-Organism
asymbiotica	E-Organism
,	O
but	O
not	O
in	O
the	O
insect	O
pathogen	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
[	O
14	O
]	O
,	O
a	O
putative	O
effector	O
protein	O
(	O
YE2447	O
)	O
with	O
proteolytic	O
activity	O
,	O
and	O
a	O
homologue	O
of	O
SrfA	O
which	O
is	O
negatively	O
regulated	O
by	O
PhoP	O
in	O
S	B-Organism
.	I-Organism
typhimurium	E-Organism
[	O
75	O
]	O
.	O

The	O
SrfA	O
homologue	O
has	O
been	O
demonstrated	O
to	O
be	O
up	O
-	O
regulated	O
by	O
environmental	O
temperature	O
[	O
67	O
]	O
.	O

Other	O
virulence	O
factors	O
absent	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
the	O
opg	O
cluster	O
(	O
YE1604	O
-	O
1606	O
)	O
and	O
ProP	O
(	O
YE3594	O
)	O
,	O
both	O
involved	O
in	O
osmoprotection	O
[	O
76	O
]	O
,	O
cellulose	O
biosynthesis	O
(	O
YE4072	O
-	O
4078	O
)	O
associated	O
with	O
protection	O
from	O
chemical	O
and	O
mechanical	O
stress	O
[	O
60	O
]	O
,	O
the	O
methionine	O
-	O
salvage	O
pathway	O
(	O
YE3228	O
-	O
3235	O
)	O
also	O
involved	O
in	O
AHL	O
production	O
[	O
23	O
]	O
,	O
the	O
putative	O
ADP	O
-	O
ribosyltransferase	O
toxin	O
encoded	O
by	O
ytxAB	O
(	O
ye2124	O
/	O
ye2123	O
)	O
[	O
77	O
]	O
,	O
and	O
the	O
Yersinia	S-Organism
heat	O
-	O
stable	O
toxin	O
Yst	O
[	O
78	O
]	O
which	O
is	O
stronger	O
expressed	O
at	O
28degreesC	O
than	O
at	O
37degreesC	O
(	O
Table	O
1	O
)	O
.	O

Summarizing	O
,	O
the	O
large	O
variety	O
of	O
diverse	O
toxins	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
but	O
absent	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
might	O
contribute	O
to	O
the	O
higher	O
toxicity	O
towards	O
insects	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
in	O
comparison	O
to	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Toxins	O
only	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
its	O
pathogenicity	O
towards	O
mammalians	O
,	O
and	O
some	O
of	O
them	O
might	O
have	O
been	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
.	O

Examples	O
of	O
those	O
factors	O
are	O
shown	O
in	O
Fig	O
.	O

5	O
.	O

Adhesins	O
and	O
invasins	O

Colonization	O
and	O
penetration	O
of	O
epithelial	O
cells	O
,	O
and	O
interaction	O
with	O
immune	O
cells	O
,	O
are	O
key	O
steps	O
during	O
the	O
host	O
infection	O
by	O
pathogens	O
.	O

Many	O
of	O
the	O
pathogen	O
-	O
receptor	O
molecules	O
such	O
as	O
Toll	O
-	O
like	O
receptors	O
or	O
integrins	O
are	O
conserved	O
between	O
invertebrates	O
and	O
mammalians	O
[	O
79	O
]	O
.	O

We	O
therefore	O
investigated	O
if	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
that	O
interact	O
with	O
the	O
midgut	O
of	O
diverse	O
hosts	O
use	O
the	O
same	O
adhesion	O
and	O
invasive	O
factors	O
.	O

The	O
most	O
prominent	O
protein	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
involved	O
in	O
attachment	O
to	O
and	O
invasion	O
of	O
mammalian	O
cells	O
is	O
Ail	O
(	O
YE1820	O
)	O
that	O
is	O
homologue	O
to	O
three	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
proteins	O
encoded	O
by	O
plu2481	O
,	O
plu2480	O
,	O
and	O
plu1967	O
,	O
and	O
InvA	O
(	O
YE2564	O
)	O
with	O
high	O
similarity	O
to	O
Plu2057	O
.	O

Further	O
invasin	O
genes	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
with	O
counterparts	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
ysaV	O
(	O
ye3546	O
/	O
plu3761	O
)	O
and	O
invF	O
(	O
ye3549	O
/	O
plu3775	O
)	O
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
genes	O
not	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
ye1873	O
encoding	O
the	O
adhesin	O
YadA	O
which	O
is	O
maximally	O
expressed	O
at	O
37degreesC	O
,	O
and	O
the	O
invasin	O
genes	O
invE	O
,	O
ysaH	O
,	O
ye3550	O
,	O
and	O
ye3555	O
.	O

The	O
function	O
of	O
the	O
latter	O
two	O
in	O
cell	O
recognition	O
is	O
predicted	O
,	O
but	O
has	O
not	O
yet	O
been	O
demonstrated	O
experimentally	O
.	O

In	O
contrast	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
produces	O
several	O
factors	O
involved	O
in	O
host	O
cell	O
interaction	O
without	O
homologues	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
namely	O
Plu2096	O
which	O
is	O
similar	O
to	O
lectin	O
PA	O
-	O
I	O
,	O
Plu1561	O
with	O
strong	O
homology	O
to	O
a	O
Ca2	O
+	O
dependent	O
adhesion	O
molecule	O
,	O
the	O
adhesin	O
Plu2433	O
similar	O
to	O
a	O
virulence	O
factor	O
of	O
the	O
Gram	O
-	O
negative	O
plant	O
pathogen	O
Erwinia	B-Organism
carotovora	E-Organism
,	O
EvF	O
,	O
which	O
is	O
involved	O
in	O
colonisation	O
of	O
the	O
D	B-Organism
.	I-Organism
melanogaster	E-Organism
gut	O
epithelium	O
[	O
80	O
]	O
,	O
and	O
the	O
putative	O
invasin	O
Plu2064	O
.	O

In	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
eleven	O
fimbrial	O
gene	O
cluster	O
have	O
been	O
identified	O
,	O
four	O
of	O
which	O
(	O
V	O
,	O
VII	O
,	O
IX	O
and	O
X	O
)	O
are	O
also	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Unique	O
for	O
the	O
human	S-Organism
pathogen	O
in	O
comparison	O
to	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
are	O
the	O
two	O
fimbrial	O
gene	O
cluster	O
ye2664	O
-	O
2668	O
and	O
ye2692	O
-	O
2700	O
,	O
both	O
of	O
yet	O
hypothetical	O
function	O
.	O

Thus	O
,	O
invasin	O
and	O
adhesin	O
homologues	O
similar	O
in	O
the	O
two	O
pathogens	O
might	O
contribute	O
to	O
the	O
infection	O
of	O
insect	O
or	O
mammalian	O
hosts	O
,	O
but	O
candidates	O
for	O
insect	O
-	O
and	O
mammalian	O
-	O
specific	O
colonization	O
factors	O
have	O
also	O
been	O
revealed	O
by	O
the	O
genome	O
comparison	O
performed	O
here	O
.	O

Defensive	O
mechanisms	O

Antimicrobials	O
The	O
production	O
of	O
antibiotics	O
is	O
mainly	O
restricted	O
to	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
whereas	O
factors	O
combating	O
antimicrobial	O
host	O
substances	O
play	O
an	O
important	O
role	O
during	O
the	O
infection	O
process	O
of	O
both	O
pathogens	O
compared	O
here	O
.	O

In	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
ssp	I-Organism
.	I-Organism
laumondii	I-Organism
strain	I-Organism
TT01	E-Organism
,	O
many	O
loci	O
involved	O
in	O
the	O
defense	O
of	O
the	O
insect	O
cadaver	O
against	O
different	O
microbial	O
competitors	O
are	O
present	O
,	O
including	O
nearly	O
50	O
genes	O
encoding	O
proteins	O
such	O
as	O
polyketide	O
and	O
peptide	O
synthases	O
putatively	O
involved	O
in	O
antibiotic	O
synthesis	O
and	O
efflux	O
.	O

Interestingly	O
,	O
none	O
of	O
these	O
genes	O
showed	O
significant	O
similarities	O
to	O
sequences	O
of	O
the	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
genome	O
.	O

Phage	O
-	O
derived	O
bacteriocins	O
in	O
entomopathogenic	O
bacteria	O
are	O
also	O
presumed	O
to	O
eliminate	O
competing	O
bacteria	O
.	O

More	O
than	O
twenty	O
colicin	O
/	O
pyocin	O
-	O
like	O
factors	O
and	O
putative	O
immunity	O
proteins	O
are	O
unique	O
to	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
in	O
comparison	O
to	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Remarkable	O
exceptions	O
are	O
the	O
toxin	O
/	O
antitoxin	O
system	O
ccdA	O
/	O
ccdB	O
,	O
the	O
tolQRAB	O
/	O
pal	O
operon	O
involved	O
in	O
group	O
A	O
colicin	O
translocation	O
,	O
and	O
a	O
colicin	O
production	O
and	O
secretion	O
system	O
(	O
Plu3168	O
/	O
Plu3869	O
;	O
YE0791	O
/	O
YE1314	O
)	O
.	O

Recently	O
,	O
it	O
was	O
reported	O
that	O
PrtS	O
(	O
Plu1382	O
)	O
secreted	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
a	O
metalloprotease	O
without	O
counterpart	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
specifically	O
induces	O
melanization	O
of	O
the	O
hemolymph	O
,	O
probably	O
to	O
circumvent	O
the	O
innate	O
immune	O
response	O
of	O
the	O
insect	O
[	O
81	O
]	O
.	O

Oxygenases	O
and	O
hydrolases	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
produces	O
proteins	O
similar	O
to	O
monooxygenases	O
,	O
dioxygenases	O
and	O
hydroxylases	O
that	O
have	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
rapid	O
elimination	O
of	O
insect	O
polyphenols	O
or	O
in	O
the	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
generated	O
by	O
the	O
invaded	O
host	O
[	O
24	O
]	O
.	O

Examples	O
are	O
the	O
product	O
of	O
plu4258	O
,	O
adjacent	O
to	O
a	O
gene	O
encoding	O
glutathione	O
transferase	O
(	O
plu4259	O
)	O
,	O
a	O
putative	O
steroid	O
monooxygenase	O
(	O
Plu4232	O
)	O
,	O
and	O
a	O
glycine	O
oxidase	O
(	O
Plu2242	O
)	O
,	O
all	O
of	O
which	O
have	O
no	O
counterparts	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Factors	O
present	O
in	O
both	O
pathogens	O
are	O
two	O
monooxigenases	O
encoded	O
by	O
ye1945	O
/	O
hpaC	O
(	O
plu0974	O
)	O
and	O
ye3394	O
/	O
plu3599	O
,	O
and	O
two	O
hydroxylases	O
encoded	O
by	O
ubiH	O
(	O
ye3395	O
/	O
plu3600	O
)	O
and	O
ubiF	O
(	O
ye2984	O
/	O
plu1313	O
)	O
.	O

It	O
is	O
therefore	O
possible	O
that	O
the	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
homologues	O
of	O
these	O
enzymes	O
are	O
involved	O
in	O
persistence	O
within	O
the	O
insect	O
,	O
a	O
mechanism	O
which	O
is	O
also	O
used	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Secretion	O
and	O
exoenzymes	O

In	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
two	O
type	O
-	O
III	O
secretion	O
systems	O
(	O
T3SS	O
)	O
essential	O
for	O
virulence	O
in	O
the	O
mammalian	O
host	O
are	O
encoded	O
on	O
pYV	O
and	O
by	O
the	O
ysa	O
operon	O
(	O
YE3533	O
-	O
3561	O
)	O
[	O
23	O
,	O
82	O
]	O
.	O

The	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
genome	O
encodes	O
one	O
T3SS	O
which	O
is	O
highly	O
similar	O
to	O
the	O
plasmid	O
-	O
encoded	O
T3SS	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
probably	O
involved	O
in	O
the	O
secretion	O
of	O
virulence	O
proteins	O
or	O
in	O
immunomodulation	O
of	O
the	O
insect	O
response	O
to	O
an	O
infection	O
.	O

Interestingly	O
,	O
the	O
T3SS	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
has	O
recently	O
been	O
demonstrated	O
to	O
translocate	O
insecticidal	O
toxins	O
,	O
providing	O
evidence	O
that	O
they	O
support	O
the	O
transmission	O
of	O
the	O
plague	O
agent	O
by	O
insects	O
[	O
83	O
]	O
.	O

Furthermore	O
,	O
the	O
flagellar	O
export	O
apparatus	O
of	O
Y	B-Organism
.	I-Organism
pseudotuberculosis	E-Organism
functions	O
as	O
a	O
secretion	O
system	O
for	O
the	O
virulence	O
-	O
associated	O
phospholipase	O
YplA	O
[	O
84	O
]	O
.	O

The	O
typical	O
effector	O
proteins	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
also	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

The	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
Lop	O
effector	O
proteins	O
are	O
homologs	O
of	O
the	O
Yop	O
effector	O
proteins	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
[	O
85	O
]	O
.	O

The	O
LopT	O
effector	O
protein	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
can	O
be	O
injected	O
by	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
into	O
mammal	O
cells	O
[	O
86	O
]	O
,	O
underlining	O
the	O
idea	O
that	O
both	O
T3SS	O
act	O
similarly	O
.	O

Furthermore	O
,	O
we	O
found	O
homologues	O
of	O
the	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
low	O
-	O
calcium	O
-	O
response	O
genes	O
(	O
lcrH	O
,	O
lcrV	O
,	O
and	O
lrcD	O
)	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
plu3757	O
,	O
plu3758	O
,	O
sctV	O
)	O
which	O
further	O
supports	O
this	O
hypothesis	O
.	O

The	O
fact	O
that	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
a	O
second	O
T3SS	O
(	O
Ysa	O
)	O
is	O
not	O
shared	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
confirms	O
its	O
solely	O
role	O
in	O
human	S-Organism
pathogenicity	O
[	O
87	O
]	O
.	O

Both	O
P	B-Organism
.	I-Organism
luminesens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
share	O
a	O
Sec	O
protein	O
translocation	O
system	O
that	O
belongs	O
to	O
the	O
type	O
-	O
II	O
secretion	O
systems	O
(	O
T2SS	O
)	O
.	O

These	O
are	O
substrate	O
-	O
specific	O
secretion	O
machineries	O
that	O
share	O
a	O
similar	O
architecture	O
and	O
secretion	O
mechanism	O
[	O
88	O
]	O
.	O

Proteins	O
secreted	O
by	O
these	O
systems	O
are	O
mainly	O
virulence	O
determinants	O
such	O
as	O
exotoxins	O
like	O
the	O
Cholera	O
toxin	O
of	O
Vibrio	B-Organism
cholerae	E-Organism
,	O
pili	O
,	O
and	O
S	O
-	O
layer	O
components	O
(	O
see	O
[	O
89	O
]	O
for	O
review	O
)	O
.	O

Additionally	O
to	O
the	O
Sec	O
-	O
system	O
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
produces	O
a	O
T2SS	O
named	O
Yts1	O
,	O
which	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
in	O
mice	S-Organism
[	O
90	O
]	O
.	O

Because	O
there	O
is	O
no	O
counterpart	O
of	O
Yts1	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
one	O
can	O
speculate	O
that	O
the	O
major	O
parts	O
of	O
type	O
-	O
II	O
dependent	O
secreted	O
proteins	O
which	O
are	O
important	O
for	O
insect	O
association	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
translocated	O
via	O
the	O
Sec	O
system	O
.	O

Recently	O
,	O
a	O
novel	O
protein	O
secretion	O
mechanism	O
translocating	O
proteins	O
without	O
an	O
N	O
-	O
terminal	O
leader	O
sequence	O
has	O
been	O
described	O
,	O
termed	O
type	O
-	O
VI	O
secretion	O
system	O
,	O
T6SS	O
(	O
see	O
[	O
91	O
]	O
for	O
review	O
)	O
.	O

The	O
genes	O
encoding	O
these	O
kinds	O
of	O
secretion	O
systems	O
were	O
named	O
vas	O
(	O
virulence	O
associated	O
secretion	O
)	O
,	O
and	O
homologues	O
are	O
widespread	O
in	O
Gram	O
-	O
negative	O
bacteria	O
.	O

VAS	O
-	O
dependent	O
secretion	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Vibrio	B-Organism
cholerae	E-Organism
[	O
92	O
]	O
as	O
well	O
as	O
for	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
[	O
93	O
]	O
,	O
and	O
T6SS	O
are	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
virulence	O
in	O
many	O
Gram	O
-	O
negative	O
bacteria	O
[	O
91	O
]	O
.	O

P	B-Organism
.	I-Organism
luminescens	E-Organism
as	O
well	O
as	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
harbour	O
homologues	O
of	O
the	O
vas	O
genes	O
,	O
indicating	O
that	O
several	O
proteins	O
involved	O
in	O
virulence	O
are	O
secreted	O
via	O
this	O
pathway	O
.	O

Both	O
pathogens	O
secrete	O
lipases	O
and	O
proteases	O
that	O
are	O
assumed	O
to	O
contribute	O
to	O
immunosuppression	O
,	O
degradation	O
of	O
insect	O
tissues	O
or	O
antibacterial	O
peptides	O
,	O
and	O
host	O
bioconversion	O
(	O
Fig	O
.	O
4	O
)	O
.	O

One	O
of	O
those	O
exoenzymes	O
is	O
the	O
phospholipase	O
A	O
(	O
YplA	O
)	O
with	O
an	O
accessory	O
protein	O
(	O
YplB	O
)	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
YE1005	O
/	O
YE1006	O
)	O
which	O
are	O
also	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
Plu3370	O
/	O
Plu3369	O
)	O
.	O

YplA	O
contributes	O
to	O
pathogenesis	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
in	O
a	O
mouse	S-Organism
model	O
[	O
94	O
]	O
,	O
suggesting	O
a	O
role	O
in	O
virulence	O
against	O
insects	O
for	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
homologue	O
.	O

Remarkably	O
,	O
yplA	O
is	O
induced	O
at	O
low	O
temperature	O
(	O
Table	O
1	O
)	O
,	O
and	O
its	O
expression	O
is	O
known	O
to	O
be	O
regulated	O
by	O
the	O
master	O
regulator	O
FlhDC	O
[	O
94	O
]	O
,	O
indicating	O
that	O
YplA	O
plays	O
a	O
role	O
in	O
pathogenicity	O
both	O
against	O
human	S-Organism
and	O
insect	O
hosts	O
.	O

Two	O
additional	O
phospholipases	O
are	O
present	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
namely	O
PdlA	O
(	O
YE0203	O
)	O
and	O
PdlB	O
(	O
YE0207	O
)	O
,	O
the	O
latter	O
one	O
a	O
homologue	O
of	O
Plu4619	O
.	O

This	O
overlap	O
is	O
another	O
example	O
for	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
enzymes	O
probably	O
involved	O
rather	O
in	O
the	O
association	O
with	O
invertebrates	O
than	O
in	O
pathogenicity	O
towards	O
mammalians	O
.	O

Plu1971	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
is	O
a	O
protein	O
which	O
contains	O
two	O
phospholipase	O
D	O
motifs	O
.	O

Furthermore	O
,	O
it	O
shares	O
homologies	O
to	O
the	O
plasmid	O
(	O
pMT1	O
)	O
-	O
encoded	O
murine	S-Organism
toxin	O
(	O
Ymt	O
)	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
.	O

It	O
was	O
suggested	O
that	O
ymt	O
has	O
been	O
acquired	O
by	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
from	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
or	O
a	O
close	O
relative	O
[	O
24	O
]	O
.	O

Ymt	O
is	O
essential	O
for	O
flea	O
colonization	O
by	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
and	O
is	O
regulated	O
by	O
AHL	O
both	O
in	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
[	O
95	O
]	O
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
R	O
.	O
Heermann	O
,	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
Ymt	O
is	O
also	O
required	O
for	O
insect	O
colonization	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Due	O
to	O
its	O
absence	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
Ymt	O
is	O
another	O
example	O
for	O
the	O
high	O
diversity	O
of	O
genetic	O
determinants	O
that	O
are	O
used	O
by	O
closely	O
related	O
bacterial	O
pathogens	O
to	O
interact	O
with	O
their	O
insect	O
hosts	O
.	O

There	O
are	O
several	O
other	O
exoenzymes	O
present	O
either	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
or	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
which	O
do	O
not	O
have	O
a	O
homologue	O
counterpart	O
in	O
the	O
other	O
bacterium	O
.	O

Examples	O
are	O
the	O
ten	O
triacylglycerol	O
lipases	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
or	O
the	O
three	O
identified	O
lipases	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

However	O
,	O
homologies	O
are	O
observed	O
for	O
six	O
secreted	O
proteases	O
of	O
both	O
organisms	O
.	O

Among	O
them	O
is	O
PrtA	O
(	O
Plu0655	O
/	O
YE4052	O
)	O
,	O
a	O
zinc	O
metalloprotease	O
that	O
is	O
involved	O
in	O
the	O
immunosuppressive	O
activity	O
of	O
X	B-Organism
.	I-Organism
nematophila	E-Organism
[	O
96	O
]	O
,	O
and	O
that	O
has	O
also	O
been	O
shown	O
to	O
be	O
involved	O
in	O
insect	O
gut	O
colonization	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
[	O
97	O
]	O
.	O

Further	O
examples	O
for	O
shared	O
proteases	O
are	O
another	O
Zn	O
-	O
dependent	O
protease	O
(	O
Plu0306	O
/	O
YE4066	O
)	O
,	O
the	O
protease	O
III	O
(	O
Plu0631	O
/	O
YE3311	O
)	O
,	O
and	O
DegQ	O
/	O
DegS	O
(	O
YE3744	O
/	O
YE3745	O
/	O
Plu4018	O
/	O
Plu4022	O
)	O
.	O

The	O
high	O
number	O
of	O
homologs	O
in	O
both	O
organisms	O
suggests	O
an	O
important	O
and	O
similar	O
role	O
of	O
these	O
exoproteases	O
in	O
the	O
infection	O
process	O
.	O

We	O
also	O
identified	O
two	O
proteases	O
in	O
each	O
pathogen	O
(	O
Plu4291	O
,	O
Plu0631	O
,	O
YE0320	O
,	O
and	O
YE2087	O
)	O
without	O
a	O
homologue	O
in	O
the	O
other	O
bacterium	O
.	O

We	O
speculate	O
that	O
these	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
proteases	O
could	O
be	O
involved	O
in	O
the	O
infection	O
process	O
in	O
mammals	O
,	O
whereas	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
proteases	O
are	O
rather	O
used	O
for	O
nutrient	O
bioconversion	O
than	O
for	O
the	O
infection	O
process	O
.	O

Metabolism	O

While	O
many	O
specific	O
virulence	O
factors	O
,	O
which	O
enable	O
the	O
microbes	O
to	O
overcome	O
the	O
various	O
physical	O
and	O
biochemical	O
barriers	O
of	O
the	O
infected	O
hosts	O
,	O
have	O
been	O
investigated	O
in	O
detail	O
,	O
little	O
attention	O
has	O
been	O
given	O
to	O
the	O
metabolic	O
requirements	O
and	O
substrate	O
availability	O
of	O
bacteria	O
in	O
vivo	O
.	O

Both	O
in	O
insects	O
and	O
mammals	O
,	O
pathogens	O
get	O
access	O
to	O
host	O
-	O
specific	O
nutrients	O
,	O
but	O
also	O
encounter	O
substrate	O
limitations	O
such	O
as	O
low	O
iron	O
concentration	O
.	O

In	O
this	O
chapter	O
,	O
we	O
focus	O
on	O
metabolic	O
pathways	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
absent	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
induced	O
at	O
low	O
temperature	O
,	O
or	O
already	O
known	O
to	O
be	O
virulence	O
-	O
associated	O
.	O

Degradative	O
pathways	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
share	O
loci	O
encoding	O
several	O
common	O
degradation	O
pathways	O
that	O
are	O
absent	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
K	I-Organism
-	I-Organism
12	E-Organism
,	O
including	O
the	O
urease	O
operon	O
(	O
ureABCEFGD	O
)	O
,	O
the	O
genes	O
involved	O
in	O
myo	O
-	O
inositol	O
degradation	O
,	O
and	O
the	O
histidine	O
degradation	O
operon	O
(	O
hutHUCGI	O
)	O
.	O

These	O
pathways	O
might	O
help	O
the	O
bacteria	O
to	O
gain	O
access	O
to	O
sufficient	O
amounts	O
of	O
substrates	O
and	O
thus	O
to	O
proliferate	O
in	O
the	O
hemolymph	O
of	O
the	O
insect	O
larvae	O
.	O

We	O
recently	O
reported	O
that	O
the	O
genes	O
of	O
the	O
urease	O
operon	O
as	O
well	O
as	O
a	O
histidine	O
ammonia	O
lyase	O
(	O
ye3021	O
/	O
plu1240	O
)	O
,	O
which	O
deaminates	O
histidine	O
to	O
urocanic	O
acid	O
,	O
are	O
highly	O
induced	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
upon	O
temperature	O
decrease	O
[	O
67	O
]	O
.	O

Beside	O
arginine	O
(	O
5	O
.	O
17	O
mumol	O
/	O
g	O
)	O
,	O
lysine	O
(	O
12	O
.	O
23	O
mumol	O
/	O
g	O
)	O
,	O
serine	O
(	O
6	O
.	O
77	O
mumol	O
/	O
g	O
)	O
and	O
proline	O
(	O
6	O
.	O
40	O
mumol	O
/	O
g	O
)	O
,	O
histidine	O
(	O
5	O
.	O
04	O
mumol	O
/	O
g	O
)	O
is	O
the	O
most	O
abundant	O
free	O
amino	O
acids	O
in	O
the	O
Hyalophora	B-Organism
gloveri	E-Organism
fat	O
body	O
[	O
98	O
]	O
.	O

The	O
synthesis	O
of	O
vitamin	O
B12	O
that	O
occurs	O
only	O
anaerobically	O
is	O
required	O
for	O
the	O
degradation	O
of	O
1	O
,	O
2	O
-	O
propanediol	O
by	O
the	O
products	O
of	O
the	O
pdu	O
operon	O
,	O
as	O
well	O
as	O
of	O
ethanolamine	O
by	O
the	O
eutABC	O
-	O
encoded	O
enzymes	O
.	O

The	O
cobalamine	O
-	O
dependent	O
anaerobic	O
growth	O
of	O
Salmonella	B-Organism
typhimurium	E-Organism
on	O
both	O
these	O
substrates	O
has	O
been	O
shown	O
to	O
be	O
supported	O
by	O
the	O
alternative	O
electron	O
acceptor	O
tetrathionate	O
whose	O
respiration	O
is	O
facilitated	O
by	O
the	O
tetrathionate	O
reductase	O
gene	O
cluster	O
ttr	O
[	O
99	O
,	O
100	O
]	O
.	O

Beside	O
S	B-Organism
.	I-Organism
typhimurium	E-Organism
,	O
all	O
these	O
genetic	O
determinants	O
were	O
found	O
only	O
in	O
few	O
other	O
bacteria	O
,	O
namely	O
the	O
human	S-Organism
pathogens	O
Listeria	B-Organism
monocytogenes	E-Organism
,	O
and	O
Clostridium	B-Organism
perfringens	E-Organism
[	O
101	O
]	O
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
carries	O
the	O
genes	O
encoding	O
tetrathionate	O
reductase	O
(	O
ttrABC	O
)	O
and	O
the	O
TCS	O
TtrRS	O
(	O
YE1613	O
-	O
1617	O
)	O
.	O

The	O
gene	O
clusters	O
for	O
cobalamin	O
synthesis	O
and	O
propanediol	O
degradation	O
are	O
located	O
on	O
a	O
40	O
-	O
kb	O
genomic	O
island	O
(	O
ye2707	O
-	O
2750	O
)	O
,	O
but	O
the	O
eutABC	O
operon	O
is	O
missing	O
.	O

Propanediol	O
degradation	O
by	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
might	O
also	O
be	O
supported	O
by	O
YE4187	O
with	O
a	O
putative	O
GlcG	O
domain	O
which	O
is	O
predicted	O
to	O
be	O
involved	O
in	O
glycolate	O
and	O
propanediol	O
utilization	O
.	O

The	O
cobalamine	O
synthesis	O
genes	O
and	O
the	O
eutABC	O
operon	O
,	O
but	O
not	O
ttrC	O
,	O
ttrR	O
,	O
ttrS	O
and	O
the	O
propanediol	O
utilization	O
gene	O
cluster	O
,	O
are	O
also	O
present	O
in	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
suggesting	O
the	O
degradation	O
of	O
phosphatidylethanolamine	O
as	O
additional	O
energy	O
source	O
in	O
the	O
insect	O
host	O
[	O
102	O
]	O
.	O

Further	O
metabolic	O
genes	O
common	O
to	O
both	O
pathogens	O
are	O
dctA	O
responsible	O
for	O
transport	O
of	O
C4	O
-	O
dicarboxylates	O
across	O
the	O
membrane	O
,	O
the	O
UhpABC	O
regulatory	O
system	O
controlling	O
the	O
hexose	O
phosphate	O
transport	O
by	O
UhpT	O
,	O
and	O
the	O
three	O
Mg2	O
+	O
transport	O
systems	O
CorA	O
,	O
MgtA	O
and	O
MgtB	O
.	O

The	O
uhpABC	O
operon	O
as	O
well	O
as	O
mgtC	O
encoding	O
the	O
Mg2	O
+	O
transport	O
ATPase	O
subunit	O
have	O
been	O
found	O
to	O
be	O
induced	O
at	O
low	O
temperature	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
[	O
67	O
]	O
,	O
indicating	O
a	O
relevance	O
for	O
these	O
metabolic	O
genes	O
for	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
during	O
insect	O
infection	O
.	O

Another	O
gene	O
,	O
gltP	O
encoding	O
a	O
glutamate	O
-	O
aspartate	O
symporter	O
,	O
is	O
also	O
up	O
-	O
regulated	O
at	O
low	O
temperature	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
but	O
lacks	O
a	O
counterpart	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Furthermore	O
,	O
both	O
insecticidal	O
bacteria	O
produce	O
a	O
chitin	O
-	O
binding	O
-	O
like	O
protein	O
(	O
Plu2352	O
,	O
YE3576	O
)	O
,	O
but	O
chitinase	O
-	O
like	O
proteins	O
(	O
Plu2235	O
,	O
Plu2458	O
and	O
Plu2461	O
)	O
are	O
without	O
homologues	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

This	O
fact	O
correlates	O
once	O
more	O
with	O
the	O
separate	O
lifestyle	O
of	O
both	O
bacteria	O
,	O
e	O
.	O
g	O
.	O
association	O
with	O
the	O
host	O
and	O
persistence	O
for	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
and	O
association	O
and	O
bioconversion	O
of	O
the	O
insect	O
in	O
case	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Iron	O
uptake	O

Bacteria	O
use	O
two	O
different	O
strategies	O
to	O
acquire	O
sufficient	O
amounts	O
of	O
iron	O
,	O
namely	O
the	O
expression	O
and	O
secretion	O
of	O
high	O
-	O
affinity	O
iron	O
-	O
binding	O
compounds	O
called	O
siderophores	O
,	O
and	O
the	O
production	O
of	O
receptors	O
for	O
iron	O
carriers	O
such	O
as	O
heme	O
.	O

Genes	O
involved	O
in	O
the	O
biosynthesis	O
,	O
transport	O
and	O
regulation	O
of	O
the	O
siderophore	O
yersiniabactin	O
are	O
clustered	O
in	O
the	O
high	O
pathogenicity	O
island	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
[	O
103	O
]	O
and	O
have	O
counterparts	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
(	O
plu2316	O
-	O
2324	O
)	O
.	O

Remarkably	O
,	O
yersiniabactin	O
is	O
absent	O
in	O
all	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
strains	O
beside	O
biovar	O
1B	S-Organism
.	O

Present	O
in	O
both	O
bacterial	O
organisms	O
compared	O
here	O
are	O
also	O
genes	O
encoding	O
a	O
hemine	O
uptake	O
system	O
(	O
ye0323	O
-	O
0332	O
/	O
plu2631	O
-	O
2636	O
)	O
,	O
the	O
YfeABCD	O
transporter	O
system	O
of	O
chelated	O
iron	O
,	O
the	O
ferrous	O
(	O
Fe2	O
+	O
)	O
iron	O
transporter	O
proteins	O
FeoAB	O
,	O
the	O
AfuABC	O
/	O
SfuABC	O
ferric	O
(	O
Fe3	O
+	O
)	O
transporter	O
,	O
the	O
enterobactin	O
and	O
its	O
transporter	O
(	O
FepBDCG	O
)	O
,	O
the	O
FecABCDE	O
ABC	O
transporter	O
system	O
,	O
and	O
several	O
putative	O
hemin	O
/	O
siderophore	O
/	O
iron	O
uptake	O
proteins	O
(	O
YE1459	O
-	O
1461	O
/	O
Plu2850	O
-	O
2852	O
)	O
,	O
YE3190	O
/	O
Plu2853	O
,	O
and	O
YE0555	O
/	O
Plu3738	O
)	O
.	O

The	O
proteins	O
encoded	O
by	O
the	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
fecIRABCDE	O
operon	O
are	O
similar	O
to	O
the	O
components	O
of	O
the	O
E	B-Organism
.	I-Organism
coli	E-Organism
Fe3	O
+	O
-	O
dicitrate	O
transport	O
system	O
.	O

Homologues	O
are	O
present	O
in	O
the	O
genome	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
but	O
scattered	O
over	O
the	O
chromosome	O
.	O

In	O
addition	O
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
produces	O
two	O
heme	O
-	O
protein	O
acquisition	O
sytems	O
(	O
YE0123	O
-	O
126	O
,	O
YE2180	O
-	O
2182	O
)	O
,	O
a	O
second	O
SfuABC	O
system	O
,	O
the	O
ferrichrome	O
binding	O
and	O
transport	O
proteins	O
(	O
YE0730	O
-	O
0732	O
)	O
,	O
a	O
putative	O
siderophore	O
(	O
YE0704	O
)	O
,	O
and	O
a	O
hemin	O
storage	O
system	O
(	O
YE2481	O
-	O
2484	O
)	O
.	O

None	O
of	O
these	O
iron	O
acquisition	O
systems	O
is	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
which	O
in	O
contrast	O
produces	O
the	O
siderophore	O
photobactin	O
[	O
104	O
]	O
.	O

Furthermore	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
encodes	O
two	O
putative	O
heme	O
-	O
binding	O
hemopexin	O
-	O
like	O
proteins	O
,	O
the	O
photopexins	O
PpxA	O
(	O
Plu4242	O
)	O
and	O
PpxB	O
(	O
Plu4243	O
)	O
,	O
which	O
are	O
the	O
first	O
hemopexins	O
found	O
in	O
bacteria	O
.	O

It	O
is	O
suggested	O
that	O
the	O
photopexins	O
may	O
be	O
used	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
to	O
scavenge	O
iron	O
containing	O
compounds	O
from	O
insects	O
[	O
105	O
]	O
.	O

Interestingly	O
,	O
three	O
gene	O
loci	O
involved	O
in	O
iron	O
acquisition	O
,	O
namely	O
the	O
genes	O
encoding	O
the	O
hemin	O
storage	O
system	O
,	O
the	O
yersiniabactin	O
and	O
the	O
enterobactin	O
transporter	O
FepG	O
,	O
have	O
been	O
demonstrated	O
to	O
be	O
up	O
-	O
regulated	O
upon	O
temperature	O
decrease	O
in	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
or	O
Y	B-Organism
.	I-Organism
ruckeri	E-Organism
,	O
respectively	O
(	O
Table	O
1	O
)	O
.	O

This	O
large	O
set	O
of	O
iron	O
,	O
hemin	O
,	O
heme	O
and	O
siderophore	O
transporters	O
underlines	O
the	O
importance	O
of	O
iron	O
availability	O
for	O
the	O
life	O
cycles	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

It	O
also	O
indicates	O
that	O
iron	O
acquisition	O
is	O
a	O
prerequisite	O
for	O
the	O
infection	O
process	O
of	O
pathogenic	O
bacteria	O
not	O
only	O
in	O
mammalian	O
,	O
but	O
also	O
in	O
invertebrate	O
hosts	O
,	O
and	O
underlines	O
the	O
suggestion	O
that	O
genetic	O
determinants	O
of	O
invertebrate	O
pathogens	O
such	O
as	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
include	O
the	O
progenitors	O
of	O
virulence	O
factors	O
against	O
vertebrates	O
[	O
79	O
,	O
106	O
]	O
.	O

Tricarboxylate	O
utilization	O

The	O
TctE	O
/	O
TctD	O
system	O
is	O
the	O
only	O
TCS	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
without	O
homologue	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
(	O
see	O
section	O
"	O
Two	O
-	O
component	O
signal	O
transduction	O
"	O
,	O
Fig	O
.	O
2	O
)	O
.	O

It	O
controls	O
the	O
expression	O
of	O
the	O
tctCBA	O
operon	O
encoding	O
the	O
tricarboxylic	O
acid	O
transport	O
system	O
TctCBA	O
[	O
107	O
]	O
.	O

The	O
transporter	O
is	O
supposed	O
to	O
facilitate	O
uptake	O
of	O
citrate	O
,	O
fluorocitrate	O
,	O
isocitrate	O
and	O
cis	O
-	O
acconitate	O
for	O
aerobic	O
utilization	O
[	O
108	O
,	O
109	O
]	O
.	O

The	O
Na	O
+	O
dependent	O
citrate	O
symporter	O
CitS	O
of	O
S	B-Organism
.	I-Organism
enterica	E-Organism
,	O
which	O
the	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
protein	O
YE2507	O
is	O
homologous	O
to	O
,	O
is	O
induced	O
by	O
the	O
CitA	O
/	O
CitB	O
system	O
for	O
fermentation	O
of	O
citrate	O
under	O
anoxic	O
conditions	O
[	O
110	O
]	O
,	O
indicating	O
a	O
general	O
difference	O
of	O
citrate	O
utilization	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

While	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
explores	O
citrate	O
for	O
anaerobic	O
metabolism	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
specific	O
uptake	O
of	O
citrate	O
and	O
other	O
tricarboxylic	O
acids	O
by	O
TctCBA	O
is	O
used	O
by	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
upon	O
entering	O
the	O
insect	O
host	O
where	O
enough	O
citrate	O
is	O
available	O
.	O

The	O
specific	O
up	O
-	O
regulation	O
of	O
the	O
tricarboxylic	O
acid	O
cycle	O
(	O
TCA	O
)	O
enzymes	O
within	O
a	O
host	O
has	O
also	O
been	O
described	O
for	O
other	O
microorganisms	O
.	O

For	O
example	O
,	O
sucA	O
encoding	O
a	O
subunit	O
of	O
alpha	O
-	O
ketoglutarate	O
synthase	O
and	O
acnA	O
encoding	O
the	O
aconitase	O
have	O
been	O
found	O
to	O
be	O
induced	O
in	O
V	B-Organism
.	I-Organism
cholerae	E-Organism
during	O
host	O
infection	O
[	O
111	O
,	O
112	O
]	O
,	O
and	O
a	O
complete	O
TCA	O
cycle	O
is	O
also	O
required	O
for	O
S	B-Organism
.	I-Organism
typhimurium	E-Organism
virulence	O
[	O
113	O
]	O
.	O

We	O
also	O
observed	O
induction	O
of	O
sucA	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
in	O
the	O
insect	O
host	O
Galleria	B-Organism
mellonella	E-Organism
(	O
R	O
.	O
Heermann	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
finding	O
underlines	O
the	O
hypothesis	O
that	O
the	O
citric	O
cycle	O
enzymes	O
used	O
under	O
aerobic	O
conditions	O
are	O
up	O
-	O
regulated	O
as	O
a	O
specific	O
adaptation	O
of	O
the	O
metabolic	O
activity	O
in	O
the	O
nutrient	O
rich	O
insect	O
host	O
.	O

To	O
guarantee	O
an	O
optimal	O
amount	O
of	O
tricarboxylic	O
acids	O
within	O
the	O
cell	O
,	O
TctE	O
might	O
specifically	O
sense	O
the	O
presence	O
of	O
tricarboxylic	O
acids	O
and	O
/	O
or	O
signals	O
of	O
the	O
host	O
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
,	O
in	O
contrast	O
exhibit	O
upregulation	O
of	O
all	O
TCA	O
genes	O
upon	O
temperature	O
shift	O
from	O
26degreesC	O
to	O
37degreesC	O
[	O
114	O
,	O
115	O
]	O
.	O

Therefore	O
,	O
it	O
is	O
obvious	O
that	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
use	O
different	O
sensing	O
and	O
utilization	O
strategies	O
for	O
tricarboxylates	O
.	O

Temperature	O
-	O
dependent	O
genes	O

Temperature	O
is	O
a	O
key	O
environmental	O
signal	O
to	O
enable	O
bacterial	O
adaptation	O
to	O
diverse	O
hosts	O
.	O

In	O
Yersinia	S-Organism
,	O
temperature	O
-	O
dependent	O
gene	O
expression	O
has	O
been	O
described	O
to	O
be	O
an	O
important	O
theme	O
in	O
bacterial	O
mechanisms	O
of	O
pathogenesis	O
towards	O
humans	S-Organism
[	O
116	O
]	O
.	O

However	O
,	O
the	O
biological	O
role	O
of	O
genes	O
repressed	O
at	O
body	O
temperature	O
,	O
but	O
induced	O
at	O
environmental	O
temperature	O
,	O
has	O
been	O
underinvestigated	O
so	O
far	O
.	O

By	O
data	O
mining	O
,	O
we	O
identified	O
32	O
genes	O
or	O
gene	O
loci	O
of	O
Yersinia	B-Organism
spp	I-Organism
.	E-Organism
that	O
exhibit	O
stronger	O
expression	O
with	O
temperature	O
decrease	O
(	O
Table	O
1	O
)	O
.	O

19	O
of	O
them	O
have	O
a	O
homologue	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

Most	O
genes	O
belong	O
to	O
the	O
groups	O
of	O
offensive	O
virulence	O
factors	O
,	O
regulators	O
,	O
and	O
metabolic	O
enzymes	O
.	O

The	O
data	O
have	O
derived	O
from	O
expression	O
profiling	O
in	O
vitro	O
and	O
cannot	O
directly	O
be	O
translated	O
to	O
the	O
in	O
vivo	O
situation	O
.	O

Moreover	O
,	O
several	O
genes	O
induced	O
at	O
lower	O
temperature	O
such	O
as	O
inv	O
,	O
yst	O
or	O
yplA	O
affect	O
the	O
virulence	O
properties	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
in	O
mice	S-Organism
[	O
87	O
]	O
.	O

However	O
,	O
low	O
temperature	O
-	O
dependent	O
expression	O
of	O
the	O
genes	O
in	O
Table	O
1	O
suggests	O
that	O
they	O
also	O
play	O
a	O
role	O
during	O
the	O
insect	O
stage	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
or	O
that	O
they	O
have	O
evolved	O
from	O
bacteria	O
-	O
insect	O
interaction	O
and	O
then	O
adapted	O
to	O
pathogenicity	O
towards	O
mammals	O
.	O

Some	O
of	O
these	O
low	O
temperature	O
-	O
induced	O
genes	O
are	O
restricted	O
to	O
a	O
narrow	O
spectrum	O
of	O
bacterial	O
genera	O
such	O
as	O
Burkholderia	S-Organism
,	O
Pseudomonas	S-Organism
,	O
Serratia	S-Organism
,	O
or	O
Erwinia	S-Organism
,	O
all	O
of	O
which	O
are	O
known	O
to	O
be	O
associated	O
with	O
soil	O
,	O
plants	O
or	O
insects	O
.	O

Other	O
genes	O
of	O
Table	O
1	O
are	O
present	O
in	O
a	O
broader	O
range	O
of	O
bacteria	O
,	O
and	O
their	O
expression	O
might	O
depend	O
on	O
regulatory	O
mechanisms	O
different	O
from	O
that	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

This	O
pathogen	O
is	O
non	O
-	O
motile	O
at	O
body	O
temperature	O
,	O
and	O
a	O
connection	O
between	O
motility	O
and	O
virulence	O
is	O
well	O
-	O
documented	O
[	O
116	O
,	O
117	O
]	O
.	O

For	O
example	O
,	O
a	O
non	O
-	O
motile	O
flhDC	O
mutant	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
secretes	O
larger	O
amounts	O
of	O
Yop	O
proteins	O
encoded	O
by	O
the	O
pYV	O
plasmid	O
than	O
the	O
wild	O
-	O
type	O
bacteria	O
[	O
118	O
]	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
flagellar	O
master	O
-	O
operon	O
of	O
X	B-Organism
.	I-Organism
nematophila	E-Organism
regulates	O
the	O
expression	O
of	O
a	O
novel	O
hemolysin	O
which	O
is	O
required	O
for	O
full	O
virulence	O
of	O
X	B-Organism
.	I-Organism
nematophila	E-Organism
against	O
insects	O
[	O
119	O
]	O
.	O

We	O
therefore	O
speculate	O
that	O
motility	O
essentially	O
contributes	O
to	O
the	O
control	O
of	O
the	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
switch	O
between	O
two	O
pathogenicity	O
phases	O
towards	O
mammalians	O
and	O
invertebrates	O
[	O
120	O
]	O
.	O

In	O
evolutionary	O
terms	O
,	O
environmental	O
temperature	O
,	O
but	O
not	O
37degreesC	O
,	O
appears	O
as	O
the	O
ancient	O
signal	O
for	O
the	O
expression	O
of	O
many	O
genes	O
involved	O
in	O
pathogenicity	O
,	O
confirming	O
the	O
idea	O
that	O
the	O
biological	O
function	O
of	O
many	O
virulence	O
factors	O
has	O
been	O
evolved	O
during	O
the	O
association	O
of	O
bacteria	O
with	O
poikilothermic	O
organisms	O
(	O
see	O
below	O
)	O
.	O

Evolution	O
of	O
pathogenicity	O

It	O
has	O
been	O
suggested	O
that	O
bacteria	O
-	O
invertebrate	O
interactions	O
do	O
not	O
only	O
play	O
a	O
role	O
in	O
the	O
transmission	O
of	O
human	S-Organism
pathogens	O
but	O
have	O
also	O
shaped	O
their	O
evolution	O
[	O
79	O
]	O
.	O

We	O
identified	O
several	O
common	O
loci	O
representing	O
ancestral	O
clusters	O
of	O
genes	O
important	O
in	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
pathogenesis	O
that	O
might	O
have	O
evolved	O
during	O
the	O
association	O
of	O
bacteria	O
with	O
invertebrates	O
,	O
the	O
so	O
-	O
called	O
"	O
pre	O
-	O
vertebrate	O
"	O
pathosphere	O
[	O
121	O
]	O
and	O
then	O
been	O
adapted	O
to	O
more	O
recent	O
pathologies	O
in	O
mammalians	O
.	O

Examples	O
are	O
yersiniabactin	S-Organism
,	O
quorum	O
sensing	O
-	O
like	O
regulators	O
,	O
or	O
the	O
urease	O
operon	O
.	O

The	O
complexity	O
of	O
this	O
evolutionary	O
concept	O
is	O
also	O
demonstrated	O
by	O
the	O
fact	O
that	O
the	O
immune	O
systems	O
both	O
of	O
invertebrates	O
and	O
vertebrates	O
are	O
based	O
on	O
phagocytic	O
cells	O
that	O
are	O
attacked	O
by	O
hemolysins	O
,	O
T3SS	O
effector	O
proteins	O
,	O
and	O
many	O
other	O
toxins	O
described	O
above	O
.	O

Thus	O
,	O
it	O
can	O
not	O
be	O
excluded	O
that	O
these	O
virulence	O
factors	O
are	O
able	O
to	O
act	O
on	O
both	O
immune	O
systems	O
[	O
121	O
]	O
.	O

The	O
fact	O
that	O
P	B-Organism
.	I-Organism
asymbiotica	E-Organism
has	O
been	O
found	O
to	O
be	O
pathogenic	O
against	O
humans	S-Organism
[	O
14	O
]	O
strengthens	O
this	O
hypothesis	O
.	O

Thus	O
,	O
P	B-Organism
.	I-Organism
asymbiotica	E-Organism
might	O
be	O
an	O
evolutionary	O
link	O
that	O
is	O
evolving	O
from	O
an	O
insect	O
to	O
a	O
mammal	O
-	O
pathogen	O
.	O

Another	O
example	O
that	O
might	O
enlighten	O
the	O
evolution	O
of	O
bacterial	O
pathogenicity	O
is	O
the	O
plasticity	O
zone	O
(	O
PZ	O
)	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
a	O
199	O
kb	O
key	O
locus	O
for	O
high	O
pathogenicity	O
that	O
includes	O
YAPIYe	O
,	O
secretion	O
systems	O
,	O
hydrogenase	O
loci	O
essential	O
for	O
gut	O
colonization	O
of	O
S	B-Organism
.	I-Organism
typhimurium	E-Organism
and	O
H	B-Organism
.	I-Organism
pylori	E-Organism
[	O
122	O
]	O
,	O
and	O
iron	O
acquisition	O
systems	O
.	O

A	O
second	O
flagellar	O
cluster	O
,	O
Flag	O
-	O
2	O
,	O
is	O
also	O
located	O
within	O
the	O
PZ	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
biotypes	O
2	O
-	O
5	O
[	O
120	O
]	O
.	O

It	O
is	O
assumed	O
that	O
the	O
PZ	O
has	O
not	O
been	O
acquired	O
by	O
a	O
single	O
event	O
of	O
gene	O
transfer	O
,	O
but	O
through	O
a	O
series	O
of	O
independent	O
insertions	O
[	O
23	O
]	O
.	O

A	O
comparison	O
of	O
the	O
PZ	O
sequence	O
with	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
is	O
depicted	O
in	O
Fig	O
.	O

5	O
.	O

A	O
region	O
highly	O
similar	O
to	O
YAPIYe	O
is	O
the	O
genome	O
island	O
plu0958	O
-	O
1166	O
carrying	O
a	O
hemolysin	O
,	O
hypothetical	O
genes	O
,	O
the	O
toxin	O
/	O
antitoxin	O
system	O
CcdA	O
/	O
CcdB	O
,	O
and	O
the	O
type	O
IV	O
pilus	O
.	O

Only	O
few	O
other	O
genes	O
or	O
operons	O
of	O
the	O
PZ	O
are	O
also	O
present	O
in	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
,	O
namely	O
a	O
chitinase	O
,	O
two	O
iron	O
acquisition	O
systems	O
,	O
and	O
three	O
ysa	O
genes	O
,	O
thus	O
confirming	O
the	O
idea	O
of	O
a	O
patchwork	O
of	O
horizontally	O
acquired	O
genes	O
within	O
the	O
PZ	O
[	O
23	O
]	O
.	O

However	O
,	O
given	O
the	O
extensive	O
transfer	O
of	O
virulence	O
factors	O
between	O
bacteria	O
,	O
the	O
history	O
of	O
pathogen	O
evolution	O
still	O
requires	O
further	O
investigation	O
.	O

Conclusion	O

The	O
comparison	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
at	O
the	O
genomic	O
level	O
performed	O
here	O
provides	O
the	O
database	O
for	O
a	O
better	O
understanding	O
of	O
the	O
genetic	O
basis	O
for	O
their	O
distinct	O
behaviour	O
towards	O
invertebrates	O
and	O
mammals	O
.	O

Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
is	O
expected	O
to	O
switch	O
between	O
two	O
pathogenicity	O
phases	O
against	O
insects	O
and	O
mammalians	O
,	O
while	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
must	O
contain	O
the	O
modulators	O
and	O
regulators	O
necessary	O
to	O
change	O
the	O
bacterium	O
from	O
a	O
state	O
of	O
symbiosis	O
with	O
nematodes	O
to	O
pathogenicity	O
against	O
insects	O
,	O
and	O
also	O
from	O
symbiosis	O
-	O
proficient	O
primary	O
variants	O
to	O
symbiosis	O
-	O
deficient	O
secondary	O
variants	O
[	O
17	O
]	O
.	O

Those	O
adaptational	O
processes	O
must	O
be	O
precisely	O
regulated	O
by	O
the	O
bacteria	O
.	O

It	O
was	O
assumed	O
that	O
there	O
are	O
parallels	O
in	O
the	O
regulation	O
of	O
pathogenicity	O
in	O
mammals	O
and	O
insect	O
pathogens	O
[	O
41	O
,	O
123	O
]	O
.	O

However	O
,	O
molecular	O
components	O
of	O
the	O
regulatory	O
networks	O
controlling	O
pathogenicity	O
and	O
mutualism	O
have	O
recently	O
been	O
demonstrated	O
to	O
be	O
very	O
different	O
between	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
and	O
X	B-Organism
.	I-Organism
nematophilus	E-Organism
with	O
similar	O
life	O
cycles	O
[	O
124	O
]	O
.	O

Dissecting	O
the	O
genomes	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
for	O
putative	O
key	O
regulators	O
,	O
we	O
identified	O
factor	O
groups	O
(	O
AI	O
-	O
2	O
,	O
PAS	O
-	O
4	O
/	O
LuxR	O
like	O
receptors	O
)	O
possibly	O
involved	O
in	O
pathogen	O
-	O
insect	O
association	O
only	O
,	O
those	O
with	O
members	O
contributing	O
to	O
either	O
insect	O
or	O
mammalian	O
pathogenicity	O
(	O
QS	O
,	O
TKS	O
,	O
Usp	O
)	O
,	O
and	O
c	O
-	O
di	O
-	O
GMP	O
signalling	O
probably	O
not	O
involved	O
in	O
regulation	O
of	O
activities	O
against	O
insects	O
.	O

Certainly	O
,	O
the	O
question	O
whether	O
fundamental	O
differences	O
in	O
regulatory	O
networks	O
reflect	O
how	O
each	O
of	O
these	O
two	O
bacteria	O
specifically	O
interacts	O
with	O
either	O
the	O
insect	O
or	O
the	O
human	S-Organism
host	O
remains	O
to	O
be	O
addressed	O
in	O
more	O
detail	O
.	O

Bioconversion	O
of	O
its	O
insect	O
hosts	O
is	O
an	O
important	O
stage	O
in	O
the	O
lifecycle	O
of	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
.	O

This	O
fact	O
might	O
explain	O
the	O
high	O
number	O
of	O
antibacterial	O
factors	O
directed	O
against	O
possible	O
competitors	O
that	O
are	O
going	O
to	O
colonize	O
the	O
same	O
insect	O
cadaver	O
or	O
that	O
are	O
already	O
present	O
in	O
the	O
insect	O
gut	O
flora	O
[	O
17	O
]	O
.	O

However	O
,	O
no	O
corresponding	O
determinants	O
were	O
identified	O
in	O
the	O
genome	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
.	O

Moreover	O
,	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
is	O
pathogenic	O
to	O
a	O
variety	O
of	O
insect	O
larvae	O
,	O
and	O
a	O
dose	O
of	O
<	O
5	O
colony	O
-	O
forming	O
units	O
directly	O
injected	O
into	O
the	O
blood	O
system	O
is	O
sufficient	O
to	O
kill	O
within	O
48	O
-	O
72	O
h	O
[	O
124	O
]	O
.	O

In	O
contrast	O
,	O
only	O
highly	O
concentrated	O
protein	O
extracts	O
of	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
are	O
toxic	O
for	O
M	B-Organism
.	I-Organism
sexta	E-Organism
[	O
7	O
]	O
,	O
and	O
a	O
low	O
insect	O
larvae	O
mortality	O
has	O
been	O
observed	O
following	O
injection	O
of	O
approximately	O
3	O
.	O
5	O
x	O
106	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
cells	O
into	O
the	O
hemolymph	O
(	O
T	O
.	O
M	O
.	O
Fuchs	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
data	O
strongly	O
suggests	O
that	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
,	O
similar	O
to	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
,	O
has	O
developed	O
a	O
strategy	O
to	O
infect	O
and	O
proliferate	O
in	O
insects	O
,	O
and	O
use	O
these	O
organisms	O
rather	O
as	O
transmission	O
vectors	O
than	O
as	O
pure	O
nutrient	O
source	O
.	O

Summarizing	O
,	O
Y	B-Organism
.	I-Organism
enterocolitica	E-Organism
and	O
P	B-Organism
.	I-Organism
luminescens	E-Organism
have	O
evolved	O
partially	O
different	O
and	O
partially	O
similar	O
and	O
therefore	O
probably	O
conserved	O
mechanisms	O
to	O
detect	O
and	O
to	O
react	O
on	O
the	O
insect	O
host	O
.	O

Up	O
to	O
the	O
present	O
time	O
,	O
we	O
are	O
far	O
away	O
from	O
understanding	O
the	O
complexity	O
of	O
bacteria	O
-	O
invertebrate	O
interactions	O
.	O

With	O
the	O
genome	O
comparison	O
carried	O
out	O
here	O
,	O
however	O
,	O
we	O
uncovered	O
several	O
genes	O
which	O
are	O
promising	O
candidate	O
genes	O
involved	O
in	O
insect	O
association	O
and	O
pathogenicity	O
,	O
and	O
therefore	O
created	O
a	O
promising	O
basis	O
for	O
future	O
experimental	O
work	O
.	O

The	O
GraRS	O
regulatory	O
system	O
controls	O
Staphylococcus	B-Organism
aureus	E-Organism
susceptibility	O
to	O
antimicrobial	O
host	O
defenses	O

Background	O
Modification	O
of	O
teichoic	O
acids	O
with	O
D	O
-	O
alanine	O
by	O
the	O
products	O
of	O
the	O
dlt	O
operon	O
protects	O
Gram	B-Organism
-	I-Organism
positive	I-Organism
bacteria	E-Organism
against	O
major	O
antimicrobial	O
host	O
defense	O
molecules	O
such	O
as	O
defensins	O
,	O
cathelicidins	O
,	O
myeloperoxidase	O
or	O
phospholipase	O
.	O

The	O
graRS	O
regulatory	O
genes	O
have	O
recently	O
been	O
implicated	O
in	O
the	O
control	O
of	O
D	O
-	O
alanylation	O
in	O
Staphylococcus	B-Organism
aureus	E-Organism
.	O

Results	O
To	O
determine	O
the	O
impact	O
of	O
the	O
GraRS	O
regulatory	O
system	O
on	O
resistance	O
to	O
antimicrobial	O
host	O
defense	O
mechanisms	O
and	O
virulence	O
of	O
S	B-Organism
.	I-Organism
aureus	E-Organism
,	O
we	O
compared	O
inactivation	O
of	O
S	B-Organism
.	I-Organism
aureus	I-Organism
SA113	I-Organism
wild	I-Organism
type	E-Organism
and	O
its	O
isogenic	O
graRS	O
deletion	O
mutant	O
by	O
the	O
human	O
cathelicidin	O
LL	O
-	O
37	O
or	O
human	O
neutrophil	O
granulocytes	O
in	O
vitro	O
,	O
and	O
the	O
ability	O
to	O
cause	O
infection	O
in	O
vivo	O
.	O

We	O
show	O
here	O
that	O
graRS	O
deletion	O
considerably	O
alters	O
bacterial	O
surface	O
charge	O
,	O
increases	O
susceptibility	O
to	O
killing	O
by	O
human	S-Organism
neutrophils	O
or	O
the	O
defense	O
peptide	O
LL	O
-	O
37	O
,	O
and	O
attenuates	O
virulence	O
of	O
S	B-Organism
.	I-Organism
aureus	E-Organism
in	O
a	O
mouse	S-Organism
infection	O
model	O
.	O

Conclusion	O
Our	O
results	O
indicate	O
that	O
S	B-Organism
.	I-Organism
aureus	E-Organism
can	O
regulate	O
its	O
surface	O
properties	O
in	O
order	O
to	O
overcome	O
innate	O
host	O
defenses	O
.	O

Background	O

Staphylococcus	B-Organism
aureus	E-Organism
,	O
a	O
frequent	O
cause	O
of	O
human	S-Organism
infections	O
,	O
is	O
highly	O
resistant	O
to	O
antimicrobial	O
factors	O
of	O
the	O
innate	O
immune	O
system	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAMPs	O
)	O
[	O
1	O
,	O
2	O
]	O
which	O
are	O
produced	O
by	O
epithelial	O
cells	O
and	O
neutrophils	O
[	O
3	O
,	O
4	O
]	O
.	O

These	O
peptides	O
generally	O
contain	O
10	O
-	O
50	O
amino	O
acids	O
and	O
have	O
positive	O
net	O
charges	O
[	O
5	O
]	O
.	O

Due	O
to	O
their	O
cationic	O
properties	O
,	O
CAMPs	O
can	O
easily	O
bind	O
to	O
the	O
highly	O
negatively	O
charged	O
bacterial	O
cell	O
envelope	O
and	O
inactivate	O
bacteria	O
,	O
e	O
.	O
g	O
.	O
by	O
forming	O
pores	O
in	O
the	O
bacterial	O
membrane	O
leading	O
to	O
bacterial	O
lysis	O
[	O
6	O
]	O
.	O

S	B-Organism
.	I-Organism
aureus	E-Organism
has	O
evolved	O
mechanisms	O
to	O
alter	O
the	O
anionic	O
charge	O
of	O
cell	O
surface	O
components	O
to	O
gain	O
resistance	O
to	O
a	O
broad	O
variety	O
of	O
cationic	O
antimicrobial	O
factors	O
such	O
as	O
CAMPs	O
[	O
7	O
]	O
,	O
phospholipase	O
A2	O
[	O
8	O
]	O
,	O
myeloperoxidase	O
[	O
9	O
]	O
,	O
or	O
lysozyme	O
[	O
10	O
]	O
.	O

One	O
such	O
mechanism	O
is	O
based	O
upon	O
modification	O
of	O
phospholipids	O
in	O
the	O
cytoplasmic	O
membrane	O
by	O
introducing	O
a	O
positively	O
charged	O
lysyl	O
group	O
into	O
anionic	O
phosphatidylglycerol	O
by	O
the	O
MprF	O
protein	O
,	O
thereby	O
neutralizing	O
the	O
net	O
charge	O
of	O
the	O
membrane	O
surface	O
[	O
11	O
,	O
12	O
]	O
.	O

A	O
similar	O
reaction	O
is	O
mediated	O
by	O
products	O
of	O
the	O
dltABCD	O
operon	O
,	O
which	O
are	O
responsible	O
for	O
attachment	O
of	O
positively	O
charged	O
D	O
-	O
alanine	O
residues	O
into	O
negatively	O
charged	O
phosphate	O
groups	O
in	O
the	O
backbone	O
of	O
teichoic	O
acids	O
[	O
7	O
,	O
9	O
]	O
.	O

Mechanisms	O
involved	O
in	O
the	O
regulation	O
of	O
these	O
resistance	O
factors	O
are	O
not	O
yet	O
well	O
understood	O
in	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Herbert	O
et	O
al	O
.	O
recently	O
found	O
that	O
the	O
S	B-Organism
.	I-Organism
aureus	E-Organism
two	O
-	O
component	O
regulatory	O
system	O
graRS	O
positively	O
regulates	O
expression	O
of	O
the	O
dlt	O
operon	O
.	O

In	O
a	O
S	O
.	O
aureus	O
SA113	O
graRS	O
deletion	O
mutant	O
,	O
the	O
content	O
of	O
D	O
-	O
alanine	O
in	O
teichoic	O
acids	O
was	O
reduced	O
by	O
47	O
%	O
and	O
the	O
mutant	O
showed	O
reduced	O
resistance	O
to	O
various	O
antibiotics	O
including	O
polymyxin	O
B	O
,	O
gallidermin	O
,	O
and	O
vancomycin	O
[	O
10	O
,	O
13	O
]	O
.	O

Accordingly	O
,	O
graRS	O
have	O
previously	O
been	O
implicated	O
in	O
regulation	O
of	O
vancomycin	O
intermediary	O
resistance	O
[	O
14	O
]	O
.	O

As	O
the	O
dlt	O
operon	O
plays	O
a	O
key	O
role	O
in	O
S	B-Organism
.	I-Organism
aureus	E-Organism
resistance	O
to	O
cationic	O
antimicrobial	O
host	O
molecules	O
,	O
the	O
graRS	O
system	O
may	O
be	O
important	O
in	O
evasion	O
of	O
host	O
defense	O
mechanisms	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
and	O
neutrophil	O
killing	O
.	O

Results	O

The	O
graRS	O
mutant	O
shows	O
altered	O
cell	O
surface	O
charge	O
but	O
unaltered	O
lysyl	O
-	O
phosphatidylglycerol	O
(	O
LPG	O
)	O
content	O
In	O
order	O
to	O
study	O
if	O
reduced	O
expression	O
of	O
the	O
dlt	O
operon	O
upon	O
graRS	O
disruption	O
results	O
in	O
altered	O
cell	O
surface	O
charge	O
,	O
we	O
compared	O
binding	O
of	O
the	O
red	O
-	O
coloured	O
,	O
cationic	O
protein	O
cytochrome	O
c	O
to	O
wild	O
type	O
S	B-Organism
.	I-Organism
aureus	I-Organism
SA113	E-Organism
(	O
WT	O
)	O
,	O
the	O
isogenic	O
graRS	O
mutant	O
,	O
and	O
the	O
plasmid	B-Organism
-	I-Organism
complemented	I-Organism
mutant	E-Organism
.	O

The	O
graRS	O
mutant	O
bound	O
significantly	O
more	O
cytochrome	O
c	O
than	O
the	O
WT	O
or	O
the	O
complemented	O
mutant	O
(	O
Fig	O
.	O
1A	O
)	O
,	O
which	O
is	O
in	O
accordance	O
with	O
the	O
recently	O
described	O
reduced	O
content	O
of	O
D	O
-	O
alanine	O
residues	O
in	O
the	O
teichoic	O
acids	O
of	O
the	O
mutant	O
[	O
10	O
]	O
.	O

To	O
analyse	O
whether	O
increased	O
binding	O
of	O
cytochrome	O
c	O
by	O
the	O
graRS	O
mutant	O
is	O
in	O
fact	O
due	O
to	O
altered	O
cell	O
surface	O
charge	O
by	O
decreased	O
teichoic	O
acid	O
alanylation	O
or	O
the	O
altered	O
expression	O
of	O
other	O
surface	O
-	O
exposed	O
molecules	O
,	O
we	O
also	O
examined	O
binding	O
of	O
cytochrome	O
c	O
to	O
a	O
dltA	O
deletion	O
mutant	O
,	O
which	O
completely	O
lacks	O
D	O
-	O
alanine	O
substitution	O
of	O
teichoic	O
acids	O
[	O
7	O
]	O
,	O
and	O
a	O
dltA	O
/	O
graRS	O
double	O
deletion	O
mutant	O
,	O
which	O
was	O
generated	O
by	O
transducing	O
the	O
graRS	O
mutation	O
into	O
the	O
dltA	O
mutant	O
.	O

Due	O
to	O
the	O
high	O
binding	O
capacities	O
of	O
the	O
dltA	O
and	O
the	O
dltA	O
/	O
graRS	O
mutant	O
we	O
modified	O
the	O
conditions	O
in	O
order	O
to	O
prevent	O
limitation	O
of	O
applied	O
cytochrome	O
c	O
.	O

Deletion	O
of	O
the	O
graRS	O
genes	O
in	O
the	O
dlt	B-Organism
mutant	E-Organism
background	O
did	O
not	O
lead	O
to	O
further	O
increased	O
binding	O
of	O
cytochrome	O
c	O
compared	O
to	O
the	O
dltA	O
mutant	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

This	O
finding	O
indicates	O
that	O
the	O
increased	O
binding	O
of	O
cytochrome	O
c	O
by	O
the	O
graRS	O
mutant	O
is	O
due	O
to	O
decreased	O
alanylation	O
of	O
teichoic	O
acids	O
and	O
that	O
the	O
resulting	O
surface	O
charge	O
alteration	O
does	O
not	O
result	O
from	O
other	O
regulatory	O
effects	O
mediated	O
by	O
GraRS	O
.	O

Increased	O
binding	O
of	O
cationic	O
proteins	O
may	O
also	O
result	O
from	O
reduced	O
mprF	O
expression	O
and	O
,	O
accordingly	O
,	O
reduced	O
lysylphosphatidylglycerol	O
(	O
LPG	O
)	O
content	O
.	O

To	O
control	O
for	O
this	O
possibility	O
,	O
we	O
compared	O
patterns	O
of	O
membrane	O
lipids	O
from	O
log	O
-	O
phase	O
bacteria	O
by	O
thin	O
-	O
layer	O
chromatography	O
.	O

The	O
amounts	O
of	O
LPG	O
from	O
WT	O
and	O
graRS	O
mutant	O
were	O
indistinguishable	O
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
corroborates	O
recent	O
findings	O
that	O
mprF	O
is	O
not	O
among	O
the	O
graRS	O
-	O
regulated	O
genes	O
in	O
S	B-Organism
.	I-Organism
aureus	I-Organism
SA113	E-Organism
[	O
10	O
]	O
.	O

The	O
graRS	O
mutant	O
is	O
more	O
susceptible	O
to	O
killing	O
by	O
LL	O
-	O
37	O
and	O
human	S-Organism
neutrophil	O
granulocytes	O
in	O
vitro	O
In	O
an	O
attempt	O
to	O
test	O
whether	O
the	O
increased	O
affinity	O
of	O
the	O
graRS	O
mutant	O
to	O
cationic	O
molecules	O
leads	O
to	O
higher	O
susceptibility	O
to	O
human	S-Organism
host	O
defense	O
peptides	O
,	O
we	O
compared	O
inactivation	O
of	O
WT	O
and	O
graRS	O
mutant	O
by	O
the	O
human	S-Organism
cathelicidin	O
LL	O
-	O
37	O
.	O

This	O
antimicrobial	O
peptide	O
is	O
active	O
against	O
S	B-Organism
.	I-Organism
aureus	E-Organism
at	O
high	O
concentrations	O
or	O
long	O
exposure	O
[	O
15	O
]	O
but	O
in	O
this	O
experiment	O
we	O
chose	O
conditions	O
under	O
which	O
the	O
LL	O
-	O
37	O
did	O
not	O
affect	O
viability	O
of	O
the	O
S	B-Organism
.	I-Organism
aureus	E-Organism
WT	O
.	O

Accordingly	O
,	O
the	O
WT	O
and	O
complemented	B-Organism
mutant	I-Organism
strains	E-Organism
showed	O
no	O
significant	O
decrease	O
in	O
CFU	O
following	O
LL	O
-	O
37	O
exposure	O
,	O
whereas	O
the	O
number	O
of	O
graRS	O
mutant	O
bacteria	O
recovered	O
was	O
only	O
25	O
%	O
of	O
the	O
original	O
inoculum	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Next	O
we	O
investigated	O
whether	O
the	O
graRS	O
mutant	O
is	O
killed	O
faster	O
than	O
the	O
parental	O
strain	O
by	O
human	S-Organism
neutrophils	O
,	O
which	O
produce	O
high	O
amounts	O
of	O
LL	O
-	O
37	O
and	O
other	O
CAMPs	O
as	O
components	O
of	O
their	O
antibacterial	O
killing	O
arsenal	O
.	O

The	O
graRS	O
mutant	O
was	O
killed	O
by	O
neutrophils	O
considerably	O
faster	O
than	O
the	O
WT	O
strain	O
.	O

After	O
15	O
and	O
30	O
min	O
,	O
the	O
recovered	O
CFU	O
of	O
the	O
graRS	O
mutant	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
the	O
WT	O
(	O
Fig	O
2B	O
)	O
.	O

Of	O
note	O
,	O
our	O
previous	O
studies	O
had	O
shown	O
that	O
altered	O
alanylation	O
of	O
teichoic	O
acids	O
does	O
not	O
affect	O
the	O
rate	O
of	O
PMN	O
phagocytosis	O
[	O
9	O
]	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
graRS	O
-	O
mediated	O
control	O
of	O
CAMP	O
resistance	O
mechanisms	O
is	O
of	O
importance	O
for	O
S	B-Organism
.	I-Organism
aureus	E-Organism
evasion	O
from	O
neutrophil	O
killing	O
.	O

Deletion	O
of	O
graRS	O
leads	O
to	O
attenuated	O
virulence	O
in	O
a	O
mouse	S-Organism
infection	O
model	O

To	O
investigate	O
the	O
impact	O
of	O
reduced	O
resistance	O
of	O
the	O
graRS	O
mutant	O
to	O
neutrophil	O
and	O
CAMP	O
-	O
mediated	O
killing	O
on	O
the	O
ability	O
of	O
the	O
bacteria	O
to	O
cause	O
infections	O
in	O
vivo	O
,	O
we	O
compared	O
the	O
virulence	O
of	O
WT	O
and	O
mutant	O
bacteria	O
in	O
a	O
mouse	S-Organism
challenge	O
model	O
.	O

Therefore	O
female	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
(	O
12	O
to	O
15	O
weeks	O
old	O
)	O
were	O
infected	O
with	O
S	B-Organism
.	I-Organism
aureus	E-Organism
WT	O
or	O
graRS	O
mutant	O
bacteria	O
.	O

72	O
h	O
after	O
infection	O
numbers	O
of	O
CFU	O
/	O
kidney	O
were	O
determined	O
.	O

Significantly	O
less	O
bacteria	O
were	O
detected	O
in	O
the	O
kidneys	O
of	O
animals	O
,	O
which	O
had	O
been	O
infected	O
with	O
the	O
graRS	O
mutant	O
than	O
those	O
infected	O
with	O
the	O
WT	O
bacteria	O
.	O

(	O
Fig	O
.	O
3	O
)	O
This	O
finding	O
is	O
in	O
coincidence	O
with	O
the	O
increased	O
susceptibility	O
to	O
clearance	O
by	O
CAMPs	O
and	O
neutrophils	O
,	O
corroborating	O
the	O
central	O
importance	O
of	O
these	O
host	O
factors	O
in	O
innate	O
defense	O
.	O

Incompetence	O
of	O
Neutrophils	O
to	O
Invasive	B-Organism
Group	I-Organism
A	I-Organism
streptococcus	E-Organism
Is	O
Attributed	O
to	O
Induction	O
of	O
Plural	O
Virulence	O
Factors	O
by	O
Dysfunction	O
of	O
a	O
Regulator	O

Group	B-Organism
A	I-Organism
streptococcus	E-Organism
(	O
GAS	S-Organism
)	O
causes	O
variety	O
of	O
diseases	O
ranging	O
from	O
common	O
pharyngitis	O
to	O
life	O
-	O
threatening	O
severe	O
invasive	O
diseases	O
,	O
including	O
necrotizing	O
fasciitis	O
and	O
streptococcal	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O

The	O
characteristic	O
of	O
invasive	B-Organism
GAS	E-Organism
infections	O
has	O
been	O
thought	O
to	O
attribute	O
to	O
genetic	O
changes	O
in	O
bacteria	O
,	O
however	O
,	O
no	O
clear	O
evidence	O
has	O
shown	O
due	O
to	O
lack	O
of	O
an	O
intriguingly	O
study	O
using	O
serotype	O
-	O
matched	O
isolates	O
from	O
clinical	O
severe	O
invasive	B-Organism
GAS	E-Organism
infections	O
.	O

In	O
addition	O
,	O
rare	O
outbreaks	O
of	O
invasive	O
infections	O
and	O
their	O
distinctive	O
pathology	O
in	O
which	O
infectious	O
foci	O
without	O
neutrophil	O
infiltration	O
hypothesized	O
us	O
invasive	B-Organism
GAS	E-Organism
could	O
evade	O
host	O
defense	O
,	O
especially	O
neutrophil	O
functions	O
.	O

Herein	O
we	O
report	O
that	O
a	O
panel	O
of	O
serotype	O
-	O
matched	O
GAS	S-Organism
,	O
which	O
were	O
clinically	O
isolated	O
from	O
severe	O
invasive	O
but	O
not	O
from	O
non	O
-	O
invaive	O
infections	O
,	O
could	O
abrogate	O
functions	O
of	O
human	S-Organism
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
at	O
least	O
two	O
independent	O
ways	O
;	O
due	O
to	O
inducing	O
necrosis	O
to	O
PMN	O
by	O
enhanced	O
production	O
of	O
a	O
pore	O
-	O
forming	O
toxin	O
streptolysin	O
O	O
(	O
SLO	O
)	O
and	O
due	O
to	O
impairment	O
of	O
PMN	O
migration	O
via	O
digesting	O
interleukin	O
-	O
8	O
,	O
a	O
PMN	O
attracting	O
chemokine	O
,	O
by	O
increased	O
production	O
of	O
a	O
serine	O
protease	O
ScpC	O
.	O

Expression	O
of	O
genes	O
was	O
upregulated	O
by	O
a	O
loss	O
of	O
repressive	O
function	O
with	O
the	O
mutation	O
of	O
csrS	O
gene	O
in	O
the	O
all	O
emm49	O
severe	O
invasive	B-Organism
GAS	E-Organism
isolates	O
.	O

The	O
csrS	O
mutants	O
from	O
clinical	O
severe	O
invasive	B-Organism
GAS	E-Organism
isolates	O
exhibited	O
high	O
mortality	O
and	O
disseminated	O
infection	O
with	O
paucity	O
of	O
neutrophils	O
,	O
a	O
characteristic	O
pathology	O
seen	O
in	O
human	S-Organism
invasive	B-Organism
GAS	E-Organism
infection	O
,	O
in	O
a	O
mouse	S-Organism
model	O
.	O

However	O
,	O
GAS	S-Organism
which	O
lack	O
either	O
SLO	O
or	O
ScpC	O
exhibit	O
much	O
less	O
mortality	O
than	O
the	O
csrS	O
-	O
mutated	O
parent	O
invasive	O
GAS	O
isolate	O
to	O
the	O
infected	O
mice	S-Organism
.	O

These	O
results	O
suggest	O
that	O
the	O
abilities	O
of	O
GAS	S-Organism
to	O
abrogate	O
PMN	O
functions	O
can	O
determine	O
the	O
onset	O
and	O
severity	O
of	O
invasive	B-Organism
GAS	E-Organism
infection	O
.	O

Introduction	O

Streptococcus	B-Organism
pyogenes	E-Organism
(	O
group	B-Organism
A	I-Organism
streptococcus	E-Organism
;	O
GAS	S-Organism
)	O
is	O
one	O
of	O
the	O
most	O
common	O
human	S-Organism
pathogens	O
.	O

It	O
causes	O
a	O
wide	O
variety	O
of	O
infections	O
ranging	O
from	O
uncomplicated	O
pharyngitis	O
and	O
skin	O
infections	O
to	O
severe	O
and	O
even	O
life	O
-	O
threatening	O
manifestations	O
,	O
such	O
as	O
necrotizing	O
fasciitis	O
(	O
NF	O
)	O
and	O
streptococcal	O
toxic	O
shock	O
-	O
like	O
syndrome	O
(	O
STSS	O
)	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
with	O
high	O
mortality	O
rates	O
ranging	O
from	O
20	O
%	O
to	O
60	O
%	O
[	O
3	O
]	O
.	O

Several	O
streptococcal	O
virulence	O
factors	O
,	O
including	O
streptolysin	O
,	O
and	O
M	O
protein	O
,	O
have	O
been	O
reported	O
to	O
be	O
involved	O
in	O
these	O
diseases	O
,	O
by	O
genetic	O
studies	O
or	O
animal	O
-	O
passaged	O
models	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
[	O
4	O
]	O
-	O
[	O
6	O
]	O
.	O

However	O
,	O
which	O
of	O
factors	O
are	O
involved	O
in	O
pathogenesis	O
mediated	O
by	O
clinically	O
isolated	O
severe	O
invasive	B-Organism
GAS	E-Organism
remains	O
obscure	O
.	O

The	O
strains	O
of	O
emm1	O
genotype	O
,	O
among	O
more	O
than	O
100	O
emm	O
genes	O
encoding	O
the	O
serotype	O
-	O
determinant	O
M	O
protein	O
,	O
are	O
the	O
predominant	O
cause	O
of	O
severe	O
GAS	S-Organism
infections	O
in	O
Japan	O
[	O
7	O
]	O
.	O

Recently	O
,	O
GAS	O
with	O
diverse	O
emm	O
genotypes	O
,	O
especially	O
,	O
emm49	O
-	O
genotype	O
,	O
have	O
been	O
isolated	O
from	O
patients	S-Organism
of	O
severe	O
invasive	B-Organism
GAS	E-Organism
infections	O
since	O
2000	O
;	O
however	O
,	O
these	O
genotypes	O
were	O
not	O
isolated	O
before	O
1999	O
in	O
Japan	O
[	O
8	O
]	O
.	O

Therefore	O
,	O
emm49	O
GAS	O
isolated	O
from	O
invasive	O
infections	O
seems	O
to	O
acquire	O
the	O
novel	O
or	O
altered	O
virulence	O
factors	O
by	O
mutations	O
,	O
genomic	O
additions	O
,	O
or	O
deletions	O
.	O

Epidemiological	O
and	O
pathological	O
findings	O
,	O
including	O
sporadic	O
incidents	O
of	O
severe	O
invasive	B-Organism
GAS	E-Organism
infections	O
[	O
9	O
]	O
,	O
high	O
frequency	O
of	O
severe	O
invasive	O
infections	O
in	O
immunocompromised	O
host	O
[	O
9	O
]	O
,	O
and	O
aggregation	O
of	O
bacteria	O
and	O
a	O
paucity	O
of	O
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
foci	O
of	O
invasive	B-Organism
GAS	E-Organism
infection	O
[	O
10	O
]	O
suggest	O
that	O
host	O
defense	O
factors	O
play	O
an	O
important	O
role	O
in	O
the	O
onset	O
of	O
invasive	O
infections	O
.	O

These	O
findings	O
led	O
us	O
to	O
postulate	O
that	O
invasive	B-Organism
GAS	E-Organism
infections	O
hampered	O
host	O
innate	O
immune	O
defense	O
,	O
especially	O
on	O
PMN	O
,	O
providing	O
the	O
front	O
-	O
line	O
defense	O
against	O
GAS	S-Organism
infection	O
by	O
quick	O
recruitment	O
to	O
infection	O
site	O
and	O
clearance	O
of	O
bacteria	O
following	O
phagocytosis	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
.	O

So	O
far	O
,	O
using	O
animal	O
-	O
passaged	O
GAS	B-Organism
mutants	E-Organism
,	O
gene	B-Organism
-	I-Organism
manipulated	I-Organism
GAS	E-Organism
,	O
many	O
virulence	O
-	O
associated	O
molecules	O
are	O
pointed	O
out	O
to	O
play	O
some	O
roles	O
in	O
the	O
bacterial	O
evasion	O
from	O
phagocytic	O
ingestion	O
by	O
neutrophils	O
[	O
13	O
]	O
.	O

However	O
,	O
restricted	O
availability	O
of	O
clinical	O
isolates	O
with	O
the	O
same	O
serotypes	O
fail	O
to	O
elucidate	O
direct	O
relationship	O
between	O
definitive	O
genetic	O
changes	O
in	O
clinically	O
isolated	O
severe	O
invasive	B-Organism
GAS	E-Organism
and	O
the	O
lack	O
of	O
PMN	O
at	O
the	O
site	O
of	O
bacterial	O
growth	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
aimed	O
to	O
explore	O
the	O
crucial	O
factors	O
in	O
the	O
pathogenesis	O
of	O
severe	O
invasive	B-Organism
GAS	E-Organism
infections	O
in	O
the	O
context	O
of	O
PMN	O
-	O
GAS	O
relationship	O
,	O
using	O
a	O
panel	O
of	O
emm49	O
clinical	O
isolates	O
from	O
patients	S-Organism
with	O
or	O
without	O
severe	O
invasive	O
infection	O
,	O
and	O
their	O
gene	O
-	O
manipulated	O
mutants	O
.	O

We	O
now	O
show	O
a	O
direct	O
and	O
previously	O
unrecognized	O
link	O
between	O
functional	O
loss	O
of	O
a	O
factor	O
CsrS	O
of	O
two	O
-	O
component	O
sensor	O
/	O
regulator	O
system	O
(	O
CsrS	O
/	O
CsrR	O
:	O
also	O
known	O
as	O
CovS	O
/	O
CovR	O
)	O
and	O
escape	O
from	O
killing	O
by	O
PMN	O
via	O
inducing	O
necrosis	O
to	O
them	O
and	O
digesting	O
IL	O
-	O
8	O
,	O
a	O
PMN	O
-	O
attracting	O
chemokine	O
.	O

We	O
further	O
determined	O
CsrS	O
mutations	O
in	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
was	O
essential	O
to	O
control	O
the	O
expression	O
of	O
various	O
virulence	O
genes	O
and	O
contributed	O
to	O
the	O
in	O
vivo	O
virulence	O
and	O
disease	O
-	O
specific	O
pathophysiology	O
in	O
a	O
mouse	S-Organism
model	O
.	O

These	O
data	O
may	O
participate	O
in	O
prediction	O
of	O
GAS	S-Organism
potential	O
for	O
future	O
invasive	O
infection	O
as	O
well	O
as	O
risk	O
assessment	O
of	O
patients	S-Organism
by	O
measuring	O
PMN	O
function	O
.	O

Results	O

Group	B-Organism
A	I-Organism
streptococcus	E-Organism
isolates	O
from	O
severe	O
invasive	O
infections	O
is	O
resistant	O
to	O
killing	O
by	O
human	S-Organism
PMN	O
To	O
examine	O
whether	O
emm49	O
GAS	O
isolated	O
from	O
severe	O
invasive	O
infection	O
might	O
alter	O
human	S-Organism
PMN	O
function	O
,	O
we	O
performed	O
phagocytosis	O
assay	O
in	O
vitro	O
.	O

As	O
non	O
-	O
opsonized	O
GAS	S-Organism
was	O
resistant	O
to	O
the	O
phagocytosis	O
by	O
PMN	O
[	O
14	O
]	O
,	O
we	O
opsonized	O
GAS	S-Organism
with	O
human	S-Organism
plasma	O
in	O
advance	O
to	O
the	O
assay	O
.	O

As	O
shown	O
in	O
Figure	O
1A	O
,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
GAS	S-Organism
that	O
were	O
isolated	O
from	O
non	O
-	O
invasive	O
and	O
severe	O
invasive	O
infections	O
in	O
phagocytosis	O
by	O
PMN	O
(	O
p	O
=	O
0	O
.	O
5556	O
)	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
1B	O
,	O
in	O
vitro	O
killing	O
assay	O
revealed	O
that	O
PMN	O
killed	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
,	O
resulting	O
in	O
15	O
-	O
42	O
%	O
of	O
initial	O
number	O
of	O
bacteria	O
,	O
but	O
not	O
invasive	B-Organism
GAS	E-Organism
(	O
p	O
=	O
0	O
.	O
019	O
)	O
.	O

The	O
similar	O
results	O
were	O
obtained	O
when	O
opsonized	O
with	O
either	O
FCS	O
or	O
human	S-Organism
serum	O
regardless	O
of	O
complements	O
immobilization	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
were	O
common	O
among	O
all	O
PMN	O
donors	O
.	O

These	O
data	O
indicated	O
that	O
clinically	O
isolated	O
severe	O
invasive	B-Organism
GAS	E-Organism
were	O
phagocytosed	O
,	O
but	O
escaped	O
from	O
killing	O
by	O
human	S-Organism
PMN	O
.	O

Severe	O
invasive	B-Organism
GAS	E-Organism
rapidly	O
induce	O
necrosis	O
to	O
human	S-Organism
PMN	O

In	O
an	O
acute	O
bacterial	O
infection	O
,	O
PMN	O
were	O
quickly	O
recruited	O
at	O
the	O
site	O
of	O
infectious	O
foci	O
according	O
to	O
the	O
gradient	O
of	O
chemoattractants	O
.	O

Therefore	O
,	O
we	O
examined	O
whether	O
GAS	S-Organism
clinically	O
isolated	O
from	O
severe	O
invasive	O
infections	O
could	O
affect	O
the	O
migration	O
ability	O
of	O
PMN	O
in	O
response	O
to	O
chemokines	O
.	O

As	O
a	O
model	O
of	O
local	O
infection	O
of	O
the	O
initial	O
phase	O
,	O
we	O
utilized	O
a	O
transwell	O
system	O
and	O
added	O
IL	O
-	O
8	O
and	O
GAS	S-Organism
in	O
culture	O
medium	O
within	O
the	O
lower	O
wells	O
.	O

PMN	O
were	O
applied	O
in	O
the	O
upper	O
wells	O
and	O
subsequently	O
incubated	O
for	O
90	O
min	O
.	O

As	O
shown	O
in	O
Figure	O
2A	O
and	O
2B	O
,	O
a	O
substantial	O
number	O
of	O
PMN	O
,	O
consisted	O
largely	O
of	O
viable	O
cells	O
,	O
was	O
detected	O
in	O
the	O
lower	O
wells	O
consisted	O
of	O
IL	O
-	O
8	O
and	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
,	O
as	O
a	O
control	O
.	O

Contrarily	O
,	O
number	O
of	O
PMN	O
was	O
significantly	O
low	O
in	O
the	O
presence	O
of	O
severe	O
invasive	B-Organism
GAS	E-Organism
(	O
p	O
=	O
0	O
.	O
016	O
)	O
compared	O
to	O
that	O
of	O
control	O
culture	O
.	O

Flow	O
cytometry	O
analysis	O
suggested	O
that	O
although	O
PMN	O
was	O
detected	O
in	O
the	O
lower	O
well	O
consisted	O
of	O
IL	O
-	O
8	O
and	O
severe	O
invasive	B-Organism
GAS	E-Organism
,	O
but	O
most	O
of	O
them	O
were	O
dead	O
as	O
defined	O
by	O
propidium	O
iodine	O
staining	O
(	O
p	O
=	O
0	O
.	O
016	O
)	O
(	O
Figure	O
2A	O
and	O
2C	O
)	O
demonstrating	O
that	O
severe	O
invasive	B-Organism
GAS	E-Organism
affected	O
survival	O
of	O
PMN	O
and	O
its	O
migration	O
activity	O
in	O
a	O
transwell	O
system	O
.	O

PMN	O
were	O
killed	O
by	O
streptolysin	O
O	O
(	O
SLO	O
)	O
from	O
severe	O
invasive	B-Organism
GAS	E-Organism

PMN	O
death	O
was	O
induced	O
shortly	O
after	O
encounter	O
with	O
severe	O
invasive	B-Organism
GAS	E-Organism
,	O
and	O
PMN	O
were	O
not	O
in	O
apoptotic	O
death	O
because	O
of	O
low	O
frequency	O
of	O
cells	O
positive	O
for	O
annexin	O
V	O
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
was	O
seen	O
in	O
the	O
case	O
of	O
cytolysin	O
-	O
dependent	O
cell	O
injury	O
[	O
15	O
]	O
.	O

GAS	S-Organism
produce	O
two	O
cytolysins	O
that	O
may	O
contribute	O
to	O
pathogenesis	O
.	O

Streptolysin	O
S	O
(	O
SLS	O
)	O
is	O
an	O
oxygen	O
-	O
stable	O
beta	O
-	O
hemolysin	O
and	O
Streptolysin	O
O	O
(	O
SLO	O
)	O
is	O
a	O
pore	O
-	O
forming	O
cholesterol	O
-	O
binding	O
toxin	O
[	O
16	O
]	O
.	O

Therefore	O
,	O
to	O
know	O
the	O
mechanism	O
underlying	O
GAS	S-Organism
-	O
mediated	O
killing	O
of	O
PMN	O
,	O
we	O
investigated	O
whether	O
SLO	O
produced	O
by	O
invasive	B-Organism
GAS	E-Organism
affect	O
survival	O
of	O
PMN	O
in	O
an	O
in	O
vitro	O
migration	O
assay	O
system	O
.	O

Figure	O
3A	O
shows	O
that	O
PMN	O
killing	O
by	O
invasive	B-Organism
GAS	E-Organism
was	O
blocked	O
by	O
anti	O
-	O
SLO	O
Ab	O
in	O
culture	O
medium	O
within	O
lower	O
wells	O
of	O
a	O
transwell	O
system	O
(	O
p	O
=	O
0	O
.	O
018	O
compared	O
with	O
control	O
Ig	O
)	O
,	O
at	O
similar	O
extent	O
by	O
adding	O
free	O
cholesterol	O
in	O
the	O
medium	O
(	O
data	O
not	O
shown	O
)	O
.	O

Furthermore	O
,	O
an	O
SLO	O
deficient	O
mutant	O
from	O
a	O
STSS	O
isolate	O
NIH230	S-Organism
(	O
NIH230slo	O
)	O
lost	O
the	O
killing	O
activity	O
for	O
PMN	O
(	O
Figure	O
3A	O
)	O
,	O
thereby	O
,	O
strongly	O
suggesting	O
that	O
SLO	O
is	O
a	O
key	O
element	O
for	O
PMN	O
killing	O
mediated	O
by	O
invasive	B-Organism
GAS	E-Organism
.	O

Contrarily	O
,	O
SLS	O
-	O
deficient	O
mutant	O
from	O
NIH230	S-Organism
strain	O
(	O
NIH230sagA	O
)	O
killed	O
PMN	O
,	O
as	O
efficiently	O
as	O
did	O
parent	O
strain	O
,	O
indicating	O
that	O
SLS	O
is	O
dispensable	O
for	O
killing	O
of	O
PMN	O
mediated	O
by	O
invasive	B-Organism
GAS	E-Organism
.	O

SLO	O
and	O
SLS	O
double	O
mutant	O
GAS	O
from	O
NIH230	S-Organism
strain	O
(	O
NIH230slosagA	O
)	O
displayed	O
the	O
killing	O
activity	O
indistinguishable	O
from	O
that	O
of	O
NIH230slo	O
,	O
confirming	O
the	O
primarily	O
role	O
of	O
SLO	O
for	O
GAS	S-Organism
-	O
mediated	O
PMN	O
killing	O
.	O

As	O
shown	O
in	O
Figure	O
3B	O
,	O
incubation	O
of	O
PMN	O
with	O
supernatant	O
from	O
co	O
-	O
culture	O
of	O
IL	O
-	O
8	O
and	O
invasive	S-Organism
or	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
did	O
not	O
affect	O
PMN	O
viability	O
,	O
suggesting	O
that	O
severe	O
invasive	B-Organism
GAS	E-Organism
causes	O
PMN	O
killing	O
following	O
encounter	O
with	O
bacteria	O
in	O
a	O
contact	O
-	O
dependent	O
manner	O
.	O

To	O
confirm	O
that	O
SLO	O
activity	O
is	O
increased	O
in	O
invasive	B-Organism
GAS	E-Organism
strain	O
,	O
we	O
measured	O
SLO	O
hemolytic	O
activity	O
of	O
GAS	S-Organism
strains	O
used	O
in	O
this	O
study	O
.	O

As	O
shown	O
in	O
Figure	O
3C	O
,	O
SLO	O
activity	O
of	O
severe	O
invasive	O
isolate	O
NIH230	S-Organism
is	O
increased	O
as	O
twice	O
as	O
that	O
of	O
non	B-Organism
-	I-Organism
invasive	I-Organism
strain	I-Organism
1566	E-Organism
(	O
p	O
=	O
0	O
.	O
017	O
)	O
.	O

Impaired	O
migration	O
of	O
PMN	O
is	O
due	O
to	O
degradation	O
of	O
IL	O
-	O
8	O
by	O
serine	O
proteinase	O
ScpC	O

Although	O
NIH230slo	O
lost	O
the	O
killing	O
activity	O
for	O
PMN	O
,	O
migration	O
of	O
PMN	O
in	O
response	O
to	O
IL	O
-	O
8	O
in	O
a	O
transwell	O
system	O
was	O
not	O
restored	O
in	O
the	O
presence	O
of	O
this	O
mutant	O
(	O
Figure	O
4A	O
)	O
,	O
thereby	O
,	O
suggesting	O
that	O
severe	O
invasive	B-Organism
GAS	E-Organism
blocks	O
PMN	O
migration	O
by	O
influence	O
on	O
IL	O
-	O
8	O
activity	O
.	O

Therefore	O
,	O
we	O
quantified	O
the	O
amount	O
of	O
IL	O
-	O
8	O
in	O
culture	O
before	O
and	O
after	O
co	O
-	O
culture	O
with	O
clinically	O
isolated	O
GAS	S-Organism
or	O
its	B-Organism
mutants	E-Organism
.	O

Figure	O
4B	O
shows	O
that	O
the	O
amount	O
of	O
IL	O
-	O
8	O
was	O
significantly	O
reduced	O
by	O
60	O
-	O
min	O
co	O
-	O
culture	O
with	O
NIH230	S-Organism
,	O
as	O
well	O
as	O
NIH230slo	O
,	O
but	O
not	O
with	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	I-Organism
1556	E-Organism
.	O

As	O
previous	O
reports	O
suggested	O
that	O
the	O
GAS	S-Organism
envelope	O
peptidase	O
ScpC	O
(	O
also	O
known	O
as	O
SpyCEP	O
)	O
degrades	O
the	O
CXC	O
chemokines	O
,	O
such	O
as	O
human	S-Organism
IL	O
-	O
8	O
,	O
Groalpha	O
,	O
murine	S-Organism
KC	O
and	O
MIP	O
-	O
2	O
[	O
17	O
]	O
-	O
[	O
19	O
]	O
,	O
we	O
established	O
a	O
NIH230	B-Organism
mutant	E-Organism
deficient	O
with	O
ScpC	O
(	O
NIH230scpC	O
)	O
and	O
analyzed	O
the	O
property	O
in	O
a	O
PMN	O
migration	O
assay	O
.	O

The	O
results	O
showed	O
that	O
NIH230scpC	O
neither	O
digested	O
IL	O
-	O
8	O
,	O
like	O
1566	B-Organism
strain	E-Organism
,	O
(	O
Figure	O
4B	O
)	O
nor	O
abrogated	O
the	O
migration	O
of	O
PMN	O
in	O
response	O
to	O
IL	O
-	O
8	O
,	O
comparable	O
to	O
1566	B-Organism
strain	E-Organism
(	O
Figure	O
4A	O
)	O
,	O
whereas	O
the	O
mutant	O
killed	O
the	O
migrated	O
PMN	O
as	O
well	O
as	O
the	O
parent	B-Organism
strain	I-Organism
NIH230	E-Organism
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
demonstrate	O
that	O
clinically	O
isolated	O
invasive	B-Organism
GAS	E-Organism
impaired	O
PMN	O
recruitment	O
and	O
its	O
survival	O
,	O
as	O
a	O
result	O
of	O
productions	O
of	O
ScpC	O
and	O
SLO	O
,	O
respectively	O
.	O

Enhanced	O
expression	O
of	O
the	O
slo	O
and	O
the	O
scpC	O
genes	O
in	O
severe	O
invasive	B-Organism
GAS	E-Organism
is	O
attributed	O
to	O
mutation	O
of	O
a	O
transcriptional	O
regulator	O
CsrS	O

Although	O
sequences	O
of	O
the	O
slo	O
gene	O
and	O
the	O
scpC	O
gene	O
were	O
identical	O
among	O
clinically	O
isolated	O
non	B-Organism
-	I-Organism
invasive	E-Organism
and	O
severe	O
invasive	B-Organism
GAS	E-Organism
(	O
data	O
not	O
shown	O
)	O
,	O
Figure	O
5A	O
shows	O
that	O
the	O
slo	O
and	O
the	O
scpC	O
genes	O
were	O
expressed	O
in	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
greater	O
in	O
extent	O
than	O
those	O
in	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
.	O

The	O
expression	O
of	O
the	O
other	O
virulence	O
-	O
associated	O
genes	O
,	O
such	O
as	O
IgG	O
degrading	O
protease	O
of	O
GAS	O
,	O
Mac	O
-	O
1	O
-	O
like	O
protein	O
(	O
mac	O
)	O
,	O
nicotine	O
adenine	O
dinucleotide	O
glycohydrolase	O
(	O
nga	O
)	O
,	O
polysaccharide	O
capsule	O
production	O
(	O
hasA	O
)	O
,	O
and	O
C5a	O
peptidase	O
(	O
scpA	O
)	O
,	O
was	O
also	O
upregulted	O
in	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
,	O
greater	O
than	O
that	O
detected	O
in	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
(	O
Figure	O
5A	O
)	O
.	O

Contrarily	O
,	O
the	O
levels	O
of	O
streptococcal	O
pyrogenic	O
endotoxin	O
(	O
speB	O
)	O
,	O
SLS	O
(	O
sagA	O
)	O
,	O
and	O
mitogenic	O
factor	O
(	O
speF	O
)	O
genes	O
were	O
downregulated	O
in	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
,	O
compared	O
to	O
that	O
found	O
in	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
(	O
Figure	O
5A	O
and	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
demonstrate	O
the	O
prominent	O
changes	O
in	O
the	O
transcriptional	O
profile	O
of	O
several	O
virulence	O
-	O
associated	O
genes	O
,	O
including	O
the	O
slo	O
and	O
the	O
scpC	O
,	O
in	O
the	O
all	O
severe	O
invasive	B-Organism
GAS	E-Organism
.	O

Mutation	O
of	O
csrR	O
or	O
csrS	O
can	O
cause	O
significant	O
alterations	O
in	O
virulence	O
in	O
mouse	S-Organism
models	O
of	O
infection	O
,	O
either	O
increasing	O
lethality	O
or	O
the	O
severity	O
of	O
localized	O
soft	O
tissue	O
lesions	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
.	O

GAS	S-Organism
isolates	O
from	O
mice	S-Organism
with	O
severe	O
invasive	O
disease	O
had	O
mutations	O
in	O
csrS	O
,	O
raising	O
the	O
notion	O
that	O
CsrR	O
/	O
S	O
function	O
is	O
important	O
in	O
modulating	O
gene	O
expression	O
during	O
infection	O
.	O

Therefore	O
,	O
we	O
analyzed	O
the	O
linkage	O
between	O
the	O
csrS	O
and	O
/	O
or	O
csrR	O
genes	O
and	O
the	O
property	O
of	O
invasive	B-Organism
GAS	E-Organism
infection	O
by	O
sequencing	O
these	O
genes	O
in	O
the	O
emm49	O
strains	O
used	O
in	O
this	O
study	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
csrR	O
gene	O
was	O
identical	O
in	O
all	O
the	O
isolates	O
,	O
and	O
that	O
of	O
the	O
csrS	O
gene	O
was	O
identical	O
among	O
the	O
all	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
isolates	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
5B	O
,	O
the	O
csrS	O
genes	O
of	O
all	O
clinically	O
isolated	O
severe	O
invasive	B-Organism
GAS	E-Organism
had	O
a	O
deletion	O
,	O
a	O
point	O
mutation	O
,	O
or	O
an	O
insertion	O
,	O
thereby	O
,	O
resulting	O
in	O
the	O
creation	O
of	O
translational	O
stop	O
codons	O
(	O
NIH147	S-Organism
,	O
NIH226	S-Organism
,	O
NIH230	S-Organism
,	O
and	O
NIH269	S-Organism
)	O
or	O
in	O
a	O
mutation	O
in	O
the	O
presumed	O
kinase	O
domain	O
(	O
NIH200	S-Organism
)	O
.	O

In	O
order	O
to	O
clarify	O
the	O
role	O
of	O
CsrS	O
regarding	O
expression	O
of	O
the	O
virulence	O
-	O
associated	O
genes	O
and	O
resistance	O
to	O
PMN	O
killing	O
,	O
we	O
introduced	O
the	O
intact	O
csrS	O
gene	O
of	O
the	O
1566	S-Organism
strain	O
into	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
(	O
see	O
Figure	O
5A	O
)	O
.	O

The	O
csrS	O
-	O
introduced	O
severe	O
invasive	O
GAS	O
reduced	O
the	O
expression	O
levels	O
of	O
the	O
slo	O
and	O
the	O
scpC	O
genes	O
,	O
comparable	O
to	O
those	O
detected	O
in	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
.	O

In	O
contrast	O
,	O
the	O
expression	O
of	O
speB	O
was	O
upregulated	O
to	O
the	O
level	O
observed	O
in	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
(	O
Figure	O
5A	O
)	O
.	O

In	O
parallel	O
with	O
the	O
expression	O
profile	O
of	O
slo	O
and	O
scpC	O
in	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
,	O
introduction	O
of	O
the	O
intact	O
csrS	O
gene	O
into	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
restored	O
the	O
susceptibility	O
to	O
the	O
killing	O
by	O
PMN	O
(	O
p	O
=	O
0	O
.	O
015	O
compared	O
with	O
severe	O
invasive	O
isolates	O
+	O
CsrS	O
)	O
(	O
Figure	O
6A	O
)	O
,	O
abrogated	O
the	O
inhibition	O
of	O
PMN	O
migration	O
by	O
degradation	O
of	O
IL	O
-	O
8	O
(	O
p	O
=	O
0	O
.	O
002	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	O
)	O
(	O
Figure	O
4A	O
,	O
4B	O
,	O
and	O
6B	O
)	O
,	O
and	O
diminished	O
the	O
killing	O
activity	O
for	O
PMN	O
by	O
necrosis	O
(	O
p	O
=	O
0	O
.	O
00016	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	O
)	O
(	O
Figure	O
3A	O
,	O
3C	O
,	O
and	O
6C	O
)	O
,	O
These	O
results	O
strongly	O
suggest	O
that	O
mutations	O
in	O
the	O
csrS	O
gene	O
correspond	O
to	O
the	O
immunocompromized	O
activity	O
in	O
the	O
severe	O
invasive	O
isolates	O
,	O
associated	O
with	O
inhibition	O
of	O
PMN	O
recruitment	O
and	O
survival	O
.	O

csrS	O
mutation	O
is	O
important	O
in	O
the	O
pathogenesis	O
of	O
invasive	O
infections	O
in	O
a	O
mouse	S-Organism
model	O

In	O
order	O
to	O
elucidate	O
the	O
role	O
of	O
csrS	O
,	O
in	O
infections	O
in	O
vivo	O
,	O
we	O
compared	O
the	O
virulence	O
of	O
GAS	S-Organism
isolates	O
using	O
a	O
mouse	S-Organism
model	O
which	O
infected	O
GAS	S-Organism
intraperitoneally	O
.	O

The	O
non	B-Organism
-	I-Organism
invasive	I-Organism
1566	E-Organism
strain	O
displayed	O
the	O
LD50	O
value	O
approximately	O
100	O
-	O
fold	O
higher	O
than	O
that	O
of	O
the	O
severe	O
invasive	B-Organism
NIH230	E-Organism
strain	O
(	O
Table	O
1	O
)	O
,	O
whereas	O
a	O
csrS	O
deletion	O
(	O
1566DeltacsrS	O
)	O
caused	O
an	O
increase	O
in	O
the	O
LD50	O
value	O
comparable	O
to	O
that	O
of	O
the	O
NIH230	S-Organism
strain	O
.	O

Consistently	O
,	O
an	O
introduction	O
of	O
the	O
intact	O
csrS	O
gene	O
into	O
the	O
NIH230	S-Organism
strain	O
(	O
NIH230	O
:	O
:	O
csrS	O
+	O
)	O
reduced	O
the	O
LD50	O
value	O
to	O
the	O
level	O
observed	O
in	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
strain	E-Organism
.	O

These	O
results	O
indicate	O
that	O
csrS	O
is	O
an	O
important	O
virulence	O
factor	O
in	O
the	O
mouse	S-Organism
model	O
of	O
lethal	O
infections	O
.	O

As	O
shown	O
in	O
Figure	O
7A	O
,	O
the	O
NIH230	S-Organism
strain	O
caused	O
bacteremia	O
in	O
mice	S-Organism
24	O
h	O
after	O
intraperitoneal	O
injection	O
whereas	O
the	O
bacteremia	O
was	O
barely	O
detected	O
in	O
mice	S-Organism
infected	O
with	O
NIH230	O
:	O
:	O
csrS	O
+	O
as	O
well	O
as	O
the	O
1566	S-Organism
strain	O
(	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
non	B-Organism
-	I-Organism
invasive	E-Organism
isolates	O
,	O
and	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	O
)	O
.	O

Histopathologically	O
,	O
in	O
the	O
mice	S-Organism
injected	O
with	O
the	O
NIH230	S-Organism
strain	O
,	O
bacteria	O
formed	O
clusters	O
in	O
interstitial	O
tissues	O
in	O
the	O
kidneys	O
and	O
the	O
lungs	O
,	O
accompanied	O
congestion	O
and	O
no	O
inflammatory	O
cells	O
at	O
infectious	O
foci	O
(	O
Figure	O
7B	O
,	O
7C	O
and	O
data	O
not	O
shown	O
)	O
.	O

Contrarily	O
,	O
no	O
significant	O
pathological	O
alterations	O
were	O
observed	O
in	O
the	O
mice	S-Organism
injected	O
with	O
the	O
1566	S-Organism
and	O
NIH230	O
:	O
:	O
csrS	O
+	O
strains	O
(	O
Figure	O
7B	O
and	O
7C	O
)	O
.	O

Figure	O
7D	O
shows	O
that	O
subcutaneous	O
infection	O
of	O
NIH230	S-Organism
formed	O
the	O
infected	O
lesions	O
with	O
area	O
significantly	O
larger	O
than	O
those	O
of	O
1566	S-Organism
and	O
NIH230	O
:	O
:	O
csrS	O
+	O
.	O

These	O
results	O
suggest	O
that	O
the	O
invasive	B-Organism
GAS	E-Organism
isolates	O
are	O
more	O
virulent	O
in	O
vivo	O
than	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
,	O
and	O
impair	O
PMN	O
function	O
in	O
vivo	O
,	O
owing	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
mutations	O
in	O
the	O
csrS	O
gene	O
.	O

scpC	O
and	O
slo	O
are	O
insufficient	O
singly	O
for	O
the	O
pathogenesis	O
of	O
invasive	O
infections	O

Finally	O
,	O
we	O
assessed	O
the	O
influence	O
of	O
enhanced	O
expression	O
of	O
the	O
scpC	O
or	O
the	O
slo	O
gene	O
on	O
the	O
virulence	O
in	O
a	O
mouse	S-Organism
model	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
NIH230scpC	O
and	O
NIH230slo	O
exerted	O
the	O
LD50	O
value	O
3	O
-	O
10	O
fold	O
lower	O
than	O
that	O
of	O
the	O
non	B-Organism
-	I-Organism
invasive	I-Organism
isolate	I-Organism
1566	E-Organism
,	O
but	O
10	O
-	O
30	O
fold	O
higher	O
than	O
that	O
of	O
severe	O
invasive	O
isolates	O
.	O

Subcutaneous	O
inoculation	O
of	O
NIH230scpC	O
and	O
NIH230slo	O
yielded	O
the	O
local	O
infected	O
lesions	O
with	O
area	O
comparable	O
to	O
those	O
of	O
1566	S-Organism
and	O
NIH230	O
:	O
:	O
csrS	O
+	O
during	O
the	O
course	O
of	O
infection	O
(	O
Figure	O
7D	O
)	O
.	O

These	O
results	O
suggest	O
that	O
enhanced	O
expression	O
of	O
ScpC	O
and	O
SLO	O
in	O
invasive	B-Organism
GAS	E-Organism
plays	O
an	O
important	O
role	O
in	O
vivo	O
virulence	O
of	O
GAS	S-Organism
infection	O
.	O

Discussion	O

It	O
have	O
been	O
demonstrated	O
that	O
CsrS	O
/	O
R	O
is	O
a	O
member	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
systems	O
for	O
regulating	O
the	O
multipe	O
virulence	O
factors	O
of	O
GAS	S-Organism
,	O
by	O
using	O
genetically	B-Organism
-	I-Organism
manipulated	I-Organism
GAS	E-Organism
mutants	O
[	O
20	O
]	O
.	O

The	O
present	O
study	O
demonstrate	O
that	O
the	O
loss	O
-	O
of	O
-	O
functional	O
mutations	O
in	O
csrS	O
gene	O
which	O
were	O
accumulated	O
in	O
clinically	O
isolated	O
GAS	S-Organism
from	O
patients	S-Organism
with	O
severe	O
invasive	O
infections	O
,	O
but	O
not	O
with	O
emm	O
-	O
matched	O
non	O
-	O
invasive	O
strains	O
.	O

The	O
csrS	O
mutations	O
enhanced	O
the	O
expression	O
of	O
scpC	O
and	O
slo	O
,	O
associated	O
with	O
the	O
evasion	O
of	O
PMN	O
functions	O
and	O
in	O
vivo	O
virulence	O
.	O

Introduction	O
of	O
the	O
intact	O
csrS	O
gene	O
into	O
the	O
severe	O
invasive	B-Organism
GAS	E-Organism
restored	O
the	O
susceptibility	O
to	O
the	O
killing	O
by	O
PMN	O
and	O
abrogated	O
the	O
activity	O
for	O
inhibition	O
of	O
PMN	O
recruitment	O
and	O
survival	O
,	O
thus	O
,	O
demonstrating	O
an	O
instructional	O
role	O
of	O
the	O
loss	O
-	O
of	O
-	O
functional	O
mutations	O
in	O
csrS	O
gene	O
for	O
the	O
evasion	O
of	O
PMN	O
functions	O
,	O
providing	O
unique	O
pathophysiology	O
of	O
invasive	O
GAS	S-Organism
infections	O
.	O

Previous	O
studies	O
using	O
animal	O
-	O
passaged	O
GAS	S-Organism
have	O
shown	O
that	O
mutations	O
in	O
both	O
csrS	O
and	O
csrR	O
gene	O
are	O
important	O
for	O
the	O
invasive	O
phenotype	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
and	O
mutation	O
frequency	O
of	O
csrS	O
and	O
csrR	O
seems	O
to	O
be	O
the	O
same	O
[	O
21	O
]	O
.	O

However	O
,	O
the	O
severe	O
invasive	O
isolates	O
analyzed	O
in	O
this	O
study	O
accumulated	O
mutations	O
in	O
the	O
csrS	O
gene	O
but	O
not	O
in	O
the	O
csrR	O
gene	O
(	O
Figure	O
5B	O
and	O
data	O
not	O
shown	O
)	O
.	O

Then	O
we	O
further	O
examined	O
whether	O
severe	O
invasive	O
isolates	O
of	O
other	O
than	O
emm49	O
genotype	O
have	O
the	O
mutation	O
of	O
the	O
csrS	O
and	O
the	O
csrR	O
genes	O
.	O

The	O
frequency	O
of	O
the	O
mutation	O
in	O
the	O
csrS	O
gene	O
is	O
higher	O
than	O
that	O
in	O
csrR	O
(	O
csrS	O
mutation	O
:	O
csrR	O
mutation	O
=	O
59	O
:	O
19	O
)	O
(	O
manuscript	O
in	O
preparation	O
)	O
,	O
suggesting	O
the	O
csrS	O
mutation	O
is	O
more	O
important	O
in	O
comparison	O
with	O
that	O
of	O
csrR	O
in	O
the	O
clinical	O
isolates	O
regardless	O
of	O
emm	O
genotypes	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
some	O
human	S-Organism
invasive	O
disease	O
-	O
associated	O
genes	O
[	O
5	O
]	O
including	O
slo	O
was	O
enhanced	O
in	O
the	O
csrS	O
mutant	O
(	O
Figure	O
5B	O
)	O
,	O
but	O
not	O
in	O
the	O
csrR	O
mutant	O
[	O
20	O
]	O
.	O

On	O
the	O
contrary	O
of	O
a	O
dogma	O
that	O
CsrS	O
/	O
R	O
is	O
a	O
definitive	O
member	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
which	O
involve	O
a	O
coordinate	O
pair	O
of	O
proteins	O
known	O
as	O
the	O
sensor	O
kinase	O
and	O
the	O
response	O
regulator	O
[	O
20	O
]	O
,	O
CsrS	O
may	O
transmit	O
a	O
signal	O
not	O
only	O
to	O
CsrR	O
but	O
also	O
to	O
other	O
regulators	O
.	O

This	O
dominant	O
role	O
of	O
CsrS	O
is	O
the	O
first	O
important	O
observation	O
in	O
this	O
study	O
,	O
and	O
its	O
mutation	O
is	O
possibly	O
more	O
important	O
than	O
that	O
of	O
csrR	O
in	O
terms	O
of	O
etiopathogenesis	O
of	O
human	S-Organism
severe	O
invasive	O
diseases	O
.	O

Numbers	O
of	O
studies	O
has	O
pointed	O
out	O
virulent	O
factors	O
to	O
evade	O
host	O
defense	O
using	O
genetically	O
-	O
manipulated	O
GAS	S-Organism
and	O
animal	O
models	O
[	O
18	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
,	O
although	O
the	O
significance	O
of	O
each	O
factor	O
to	O
invasive	O
infection	O
is	O
diverse	O
and	O
sometimes	O
controversial	O
,	O
perhaps	O
due	O
to	O
lack	O
of	O
proper	O
non	O
-	O
invasive	O
counterpart	O
.	O

As	O
examples	O
,	O
SpeB	O
[	O
22	O
]	O
and	O
SLS	O
[	O
23	O
]	O
have	O
been	O
proposed	O
as	O
an	O
invasive	O
infection	O
-	O
associated	O
factor	O
by	O
its	O
cytotoxic	O
effect	O
,	O
however	O
,	O
speB	O
and	O
sagA	O
expression	O
is	O
not	O
enhanced	O
in	O
any	O
csrS	O
-	O
mutated	O
severe	O
invasive	O
GAS	O
isolate	O
used	O
in	O
this	O
study	O
and	O
others	O
[	O
5	O
]	O
,	O
[	O
24	O
]	O
.	O

Furthermore	O
,	O
SLS	O
hemolytic	O
activity	O
of	O
invasive	B-Organism
GAS	E-Organism
is	O
significantly	O
decreased	O
as	O
compared	O
with	O
non	B-Organism
-	I-Organism
invasive	I-Organism
strains	E-Organism
(	O
data	O
not	O
shown	O
)	O
and	O
SLS	O
-	O
deletion	O
in	O
invasive	O
GAS	O
did	O
not	O
affect	O
PMN	O
survival	O
at	O
all	O
,	O
excluding	O
the	O
possibility	O
for	O
the	O
role	O
of	O
SLS	O
in	O
PMN	O
necrosis	O
seen	O
in	O
this	O
study	O
.	O

Extracellular	O
deoxyribonuclease	O
(	O
DNase	O
)	O
is	O
a	O
virulence	O
factor	O
that	O
protects	O
emm1	O
type	O
GAS	O
against	O
neutrophil	O
killing	O
by	O
degrading	O
the	O
DNA	O
framework	O
of	O
neutrophil	O
extracelluar	O
traps	O
(	O
NETs	O
)	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

However	O
,	O
we	O
confirmed	O
that	O
addition	O
of	O
DNase	O
in	O
the	O
culture	O
did	O
not	O
alter	O
the	O
level	O
of	O
PI	O
-	O
positive	O
PMN	O
,	O
meaning	O
bright	O
PI	O
staining	O
of	O
PMN	O
is	O
not	O
due	O
to	O
release	O
of	O
NETs	O
from	O
PMN	O
(	O
Figure	O
S1A	O
)	O
.	O

DNase	O
activity	O
of	O
the	O
emm49	O
severe	O
invasive	O
GAS	O
was	O
lower	O
than	O
that	O
of	O
non	B-Organism
-	I-Organism
invasive	I-Organism
GAS	E-Organism
(	O
Figure	O
S1B	O
)	O
,	O
possibly	O
due	O
to	O
the	O
difference	O
of	O
emm	O
type	O
.	O

The	O
expression	O
of	O
DNase	O
as	O
well	O
as	O
the	O
slo	O
and	O
the	O
scpC	O
genes	O
in	O
emm1	O
-	O
genotype	O
strains	O
was	O
enhanced	O
under	O
the	O
csrS	O
mutation	O
[	O
5	O
]	O
.	O

These	O
suggest	O
that	O
DNase	O
may	O
be	O
important	O
but	O
redundant	O
for	O
induction	O
of	O
invasive	O
diseases	O
.	O

Therefore	O
,	O
the	O
second	O
important	O
observation	O
in	O
the	O
present	O
study	O
is	O
that	O
an	O
essential	O
requirement	O
of	O
csrS	O
mutation	O
for	O
invasive	O
infection	O
is	O
associated	O
with	O
increased	O
expression	O
of	O
ScpC	O
and	O
SLO	O
and	O
in	O
vitro	O
evasion	O
of	O
PMN	O
functions	O
,	O
though	O
we	O
do	O
not	O
exclude	O
the	O
possibility	O
that	O
other	O
CsrS	O
-	O
regulating	O
factors	O
contribute	O
to	O
the	O
escape	O
of	O
invasive	B-Organism
GAS	E-Organism
from	O
host	O
defense	O
.	O

SLO	O
and	O
ScpC	O
independently	O
enable	O
GAS	S-Organism
to	O
escape	O
from	O
PMN	O
functions	O
;	O
Present	O
data	O
using	O
clinical	O
isolated	O
GAS	S-Organism
and	O
a	O
scpC	O
-	O
deletion	O
mutant	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
show	O
that	O
enhanced	O
production	O
of	O
serine	O
proteinase	O
ScpC	O
in	O
virulent	O
GAS	S-Organism
is	O
essential	O
to	O
impair	O
PMN	O
migration	O
in	O
vitro	O
by	O
degradation	O
of	O
IL	O
-	O
8	O
,	O
as	O
others	O
partially	O
have	O
demonstrated	O
[	O
17	O
]	O
-	O
[	O
19	O
]	O
.	O

The	O
present	O
study	O
also	O
uncovers	O
that	O
increased	O
activity	O
of	O
SLO	O
from	O
invasive	O
GAS	S-Organism
isolates	O
induces	O
rapid	O
and	O
extensive	O
necrosis	O
to	O
human	S-Organism
PMN	O
.	O

SLO	O
is	O
a	O
cholesterol	O
-	O
binding	O
pore	O
-	O
forming	O
hemolysin	O
as	O
well	O
as	O
cytotoxic	O
for	O
other	O
cells	O
[	O
15	O
]	O
.	O

A	O
study	O
has	O
demonstrated	O
SLO	O
from	O
invasive	O
GAS	S-Organism
lyse	O
PMN	O
[	O
27	O
]	O
,	O
however	O
this	O
effect	O
is	O
likely	O
due	O
to	O
complement	O
activation	O
by	O
SLO	O
[	O
28	O
]	O
or	O
PMN	O
activation	O
[	O
29	O
]	O
but	O
not	O
due	O
to	O
cytotoxity	O
of	O
SLO	O
itself	O
as	O
judged	O
by	O
their	O
flow	O
cytometry	O
profiles	O
which	O
are	O
distinct	O
from	O
ours	O
(	O
Figure	O
2A	O
)	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
observed	O
that	O
SLO	O
concentration	O
in	O
a	O
short	O
-	O
time	O
culture	O
with	O
severe	O
invasive	B-Organism
GAS	E-Organism
did	O
not	O
reach	O
the	O
threshold	O
level	O
to	O
kill	O
PMN	O
by	O
formation	O
of	O
pores	O
(	O
data	O
not	O
shown	O
)	O
and	O
that	O
PMN	O
did	O
not	O
undergo	O
necrosis	O
upon	O
incubation	O
with	O
culture	O
media	O
of	O
severe	O
invasive	B-Organism
GAS	E-Organism
(	O
Figure	O
3B	O
)	O
,	O
leading	O
to	O
the	O
novel	O
possibility	O
that	O
PMN	O
are	O
probably	O
killed	O
following	O
encounter	O
with	O
invasive	B-Organism
GAS	E-Organism
in	O
a	O
contact	O
-	O
dependent	O
manner	O
.	O

PMN	O
-	O
binding	O
GAS	S-Organism
may	O
make	O
a	O
small	O
interface	O
containing	O
a	O
high	O
concentration	O
of	O
SLO	O
between	O
bacteria	O
and	O
PMN	O
,	O
which	O
resembles	O
to	O
killing	O
mechanism	O
of	O
killer	O
cells	O
to	O
target	O
cells	O
[	O
30	O
]	O
.	O

Collaboration	O
of	O
SLO	O
with	O
other	O
toxins	O
may	O
be	O
critical	O
to	O
induce	O
PMN	O
necrosis	O
as	O
similarly	O
mechanism	O
has	O
been	O
reported	O
[	O
31	O
]	O
,	O
although	O
it	O
remains	O
to	O
be	O
examined	O
whether	O
there	O
exist	O
explore	O
interaction	O
-	O
associated	O
molecules	O
on	O
both	O
host	O
and	O
bacterial	O
membrane	O
is	O
needed	O
.	O

In	O
contrast	O
to	O
the	O
previous	O
view	O
[	O
18	O
]	O
,	O
we	O
observed	O
that	O
both	O
of	O
ScpC	O
and	O
SLO	O
together	O
,	O
but	O
not	O
each	O
of	O
them	O
,	O
mediated	O
sufficient	O
in	O
vivo	O
virulence	O
(	O
Table	O
1	O
)	O
,	O
thus	O
compatible	O
with	O
the	O
notion	O
that	O
plural	O
virulence	O
-	O
associated	O
factors	O
under	O
the	O
regulation	O
of	O
csrS	O
abrogate	O
PMN	O
bactericidal	O
functions	O
and	O
induce	O
invasive	O
diseases	O
in	O
in	O
vivo	O
animal	O
model	O
.	O

Consistently	O
,	O
the	O
high	O
mortality	O
and	O
histopathological	O
findings	O
which	O
lacks	O
PMN	O
infiltration	O
in	O
mice	S-Organism
tissues	O
infected	O
with	O
csrS	O
-	O
mutated	O
GAS	O
(	O
Figure	O
7	O
)	O
are	O
similar	O
to	O
those	O
seen	O
in	O
clinical	O
invasive	B-Organism
GAS	E-Organism
infections	O
[	O
32	O
]	O
.	O

Thus	O
,	O
these	O
results	O
suggest	O
that	O
the	O
ability	O
of	O
incompetence	O
for	O
PMN	O
functions	O
by	O
individual	O
GAS	S-Organism
strain	O
may	O
determine	O
the	O
induction	O
and	O
clinical	O
outcome	O
of	O
invasive	O
diseases	O
.	O

Several	O
clinical	O
reports	O
seem	O
to	O
support	O
this	O
hypothesis	O
;	O
Leukocytopenia	O
seen	O
in	O
patients	S-Organism
with	O
STSS	O
is	O
more	O
severe	O
than	O
that	O
with	O
non	O
-	O
STSS	O
[	O
33	O
]	O
,	O
and	O
invasive	B-Organism
GAS	E-Organism
-	O
infected	O
patients	S-Organism
with	O
leukocytopenia	O
show	O
worse	O
prognosis	O
than	O
those	O
without	O
leukocytopenia	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

Furthermore	O
,	O
predisposing	O
factors	O
for	O
severe	O
invasive	B-Organism
GAS	E-Organism
infection	O
[	O
9	O
]	O
,	O
such	O
as	O
diabetes	O
mellitus	O
[	O
35	O
]	O
,	O
liver	O
cirrhosis	O
[	O
36	O
]	O
,	O
and	O
congestive	O
heart	O
failure	O
[	O
37	O
]	O
are	O
known	O
to	O
impair	O
PMN	O
function	O
.	O

These	O
evidences	O
suggest	O
that	O
the	O
level	O
of	O
PMN	O
function	O
is	O
one	O
of	O
the	O
critical	O
factors	O
to	O
determine	O
the	O
threshold	O
for	O
the	O
onset	O
of	O
invasive	B-Organism
GAS	E-Organism
infection	O
,	O
which	O
may	O
be	O
the	O
reason	O
for	O
rare	O
outbreaks	O
of	O
invasive	B-Organism
GAS	E-Organism
infections	O
.	O

Thus	O
,	O
enhanced	O
expression	O
of	O
virulence	O
factors	O
that	O
could	O
evade	O
PMN	O
function	O
is	O
a	O
key	O
issue	O
at	O
first	O
step	O
to	O
cause	O
invasive	O
bacterial	O
infections	O
.	O

A	O
further	O
study	O
in	O
which	O
collates	O
clinical	O
with	O
bacterial	O
/	O
immunological	O
data	O
may	O
provide	O
with	O
novel	O
clues	O
for	O
early	O
diagnosis	O
and	O
therapeutics	O
of	O
invasive	O
bacterial	O
infections	O
.	O

Extracellular	O
DNA	O
Chelates	O
Cations	O
and	O
Induces	O
Antibiotic	O
Resistance	O
in	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
Biofilms	O

Biofilms	O
are	O
surface	O
-	O
adhered	O
bacterial	O
communities	O
encased	O
in	O
an	O
extracellular	O
matrix	O
composed	O
of	O
DNA	O
,	O
bacterial	O
polysaccharides	O
and	O
proteins	O
,	O
which	O
are	O
up	O
to	O
1000	O
-	O
fold	O
more	O
antibiotic	O
resistant	O
than	O
planktonic	O
cultures	O
.	O

To	O
date	O
,	O
extracellular	O
DNA	O
has	O
been	O
shown	O
to	O
function	O
as	O
a	O
structural	O
support	O
to	O
maintain	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
biofilm	O
architecture	O
.	O

Here	O
we	O
show	O
that	O
DNA	O
is	O
a	O
multifaceted	O
component	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
.	O

At	O
physiologically	O
relevant	O
concentrations	O
,	O
extracellular	O
DNA	O
has	O
antimicrobial	O
activity	O
,	O
causing	O
cell	O
lysis	O
by	O
chelating	O
cations	O
that	O
stabilize	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
the	O
outer	O
membrane	O
(	O
OM	O
)	O
.	O

DNA	O
-	O
mediated	O
killing	O
occurred	O
within	O
minutes	O
,	O
as	O
a	O
result	O
of	O
perturbation	O
of	O
both	O
the	O
outer	O
and	O
inner	O
membrane	O
(	O
IM	O
)	O
and	O
the	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
genomic	O
DNA	O
.	O

Sub	O
-	O
inhibitory	O
concentrations	O
of	O
DNA	O
created	O
a	O
cation	O
-	O
limited	O
environment	O
that	O
resulted	O
in	O
induction	O
of	O
the	O
PhoPQ	O
-	O
and	O
PmrAB	O
-	O
regulated	O
cationic	O
antimicrobial	O
peptide	O
resistance	O
operon	O
PA3552	O
-	O
PA3559	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
.	O

Furthermore	O
,	O
DNA	O
-	O
induced	O
expression	O
of	O
this	O
operon	O
resulted	O
in	O
up	O
to	O
2560	O
-	O
fold	O
increased	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
and	O
640	O
-	O
fold	O
increased	O
resistance	O
to	O
aminoglycosides	O
,	O
but	O
had	O
no	O
effect	O
on	O
beta	O
-	O
lactam	O
and	O
fluoroquinolone	O
resistance	O
.	O

Thus	O
,	O
the	O
presence	O
of	O
extracellular	O
DNA	O
in	O
the	O
biofilm	O
matrix	O
contributes	O
to	O
cation	O
gradients	O
,	O
genomic	O
DNA	O
release	O
and	O
inducible	O
antibiotic	O
resistance	O
.	O

DNA	O
-	O
rich	O
environments	O
,	O
including	O
biofilms	O
and	O
other	O
infection	O
sites	O
like	O
the	O
CF	O
lung	O
,	O
are	O
likely	O
the	O
in	O
vivo	O
environments	O
where	O
extracellular	O
pathogens	O
such	O
as	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
encounter	O
cation	O
limitation	O
.	O

Introduction	O

Pseudomonas	B-Organism
aeruginosa	E-Organism
is	O
an	O
opportunistic	O
pathogen	O
capable	O
of	O
causing	O
both	O
acute	O
and	O
chronic	O
infections	O
.	O

It	O
is	O
the	O
third	O
-	O
leading	O
cause	O
of	O
nosocomial	O
infections	O
and	O
is	O
the	O
predominant	O
pathogen	O
associated	O
with	O
morbidity	O
and	O
mortality	O
of	O
CF	O
patients	S-Organism
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

The	O
biofilm	O
-	O
forming	O
ability	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
and	O
indeed	O
other	O
bacteria	O
,	O
is	O
thought	O
to	O
contribute	O
to	O
their	O
ability	O
to	O
thrive	O
in	O
hostile	O
host	O
environments	O
and	O
result	O
in	O
chronic	O
infection	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Biofilms	O
are	O
multicellular	O
surface	O
-	O
associated	O
microbial	O
communities	O
encased	O
in	O
an	O
extracellular	O
matrix	O
which	O
display	O
a	O
characteristic	O
structure	O
and	O
increased	O
resistance	O
to	O
antimicrobial	O
compounds	O
and	O
environmental	O
stresses	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
are	O
up	O
to	O
1000	O
-	O
fold	O
more	O
antibiotic	O
tolerant	O
than	O
planktonic	O
cells	O
,	O
to	O
single	O
and	O
combination	O
antibiotics	O
[	O
5	O
]	O
-	O
[	O
7	O
]	O
.	O

As	O
acute	O
CF	O
exacerbations	O
caused	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
are	O
often	O
treated	O
with	O
combination	O
antibiotic	O
therapy	O
[	O
8	O
]	O
-	O
[	O
10	O
]	O
,	O
the	O
increased	O
resistance	O
of	O
biofilms	O
to	O
combination	O
antibiotics	O
is	O
of	O
direct	O
clinical	O
relevance	O
.	O

Eighty	O
five	O
percent	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
strains	O
isolated	O
from	O
the	O
lungs	O
of	O
CF	O
patients	S-Organism
with	O
advanced	O
stages	O
of	O
disease	O
have	O
a	O
distinctive	O
mucoid	O
colony	O
morphology	O
[	O
11	O
]	O
.	O

This	O
mucoid	O
phenotype	O
is	O
a	O
result	O
of	O
overproduction	O
of	O
the	O
alginate	O
exopolysaccharide	O
(	O
EPS	O
)	O
[	O
1	O
]	O
,	O
[	O
12	O
]	O
.	O

Alginate	O
production	O
has	O
been	O
shown	O
to	O
inhibit	O
phagocytic	O
killing	O
of	O
Pseudomonas	S-Organism
,	O
to	O
protect	O
from	O
antibiotic	O
exposure	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
and	O
is	O
associated	O
with	O
poor	O
prognosis	O
for	O
the	O
infected	O
patients	S-Organism
[	O
15	O
]	O
,	O
[	O
16	O
]	O
.	O

The	O
direct	O
observation	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
microcolonies	O
encased	O
in	O
an	O
alginate	O
matrix	O
in	O
microscopy	O
studies	O
of	O
CF	O
bronchial	O
samples	O
[	O
17	O
]	O
,	O
along	O
with	O
a	O
large	O
body	O
of	O
additional	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
[	O
7	O
]	O
,	O
[	O
18	O
]	O
-	O
[	O
21	O
]	O
suggests	O
that	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
forms	O
biofilms	O
in	O
the	O
lungs	O
of	O
CF	O
patients	S-Organism
.	O

The	O
mechanisms	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
are	O
distinct	O
from	O
the	O
well	O
studied	O
intrinsic	O
resistance	O
mechanisms	O
such	O
as	O
drug	O
efflux	O
,	O
drug	O
inactivation	O
,	O
membrane	O
permeability	O
and	O
target	O
site	O
alterations	O
.	O

Although	O
the	O
basis	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
is	O
not	O
fully	O
understood	O
,	O
it	O
is	O
likely	O
that	O
multiple	O
mechanisms	O
operate	O
simultaneously	O
in	O
biofilms	O
to	O
contribute	O
to	O
antibiotic	O
resistance	O
.	O

Cells	O
in	O
a	O
biofilm	O
may	O
be	O
protected	O
from	O
antibiotic	O
exposure	O
due	O
to	O
the	O
restricted	O
penetration	O
of	O
antibiotics	O
through	O
the	O
biofilm	O
matrix	O
[	O
19	O
]	O
.	O

However	O
,	O
while	O
the	O
biofilm	O
matrix	O
may	O
limit	O
diffusion	O
initially	O
for	O
certain	O
antibiotics	O
such	O
as	O
beta	O
-	O
lactams	O
and	O
aminoglycosides	O
[	O
14	O
]	O
,	O
[	O
22	O
]	O
,	O
the	O
penetration	O
of	O
fluoroquinolones	O
occurs	O
immediately	O
and	O
without	O
delay	O
[	O
23	O
]	O
-	O
[	O
25	O
]	O
.	O

The	O
rate	O
of	O
diffusion	O
through	O
the	O
matrix	O
is	O
presumably	O
dependent	O
on	O
binding	O
of	O
the	O
antibiotic	O
molecules	O
to	O
the	O
EPS	O
matrix	O
.	O

Once	O
the	O
matrix	O
becomes	O
saturated	O
,	O
diffusion	O
and	O
antimicrobial	O
activity	O
of	O
the	O
drug	O
will	O
resume	O
[	O
26	O
]	O
.	O

It	O
is	O
the	O
general	O
consensus	O
that	O
reduced	O
diffusion	O
through	O
the	O
biofilm	O
matrix	O
only	O
provides	O
a	O
short	O
-	O
term	O
protective	O
effect	O
and	O
does	O
not	O
play	O
a	O
significant	O
role	O
during	O
long	O
-	O
term	O
antibiotic	O
exposure	O
[	O
26	O
]	O
.	O

Other	O
resistance	O
mechanisms	O
include	O
the	O
presence	O
of	O
subpopulations	O
of	O
multidrug	O
tolerant	O
persister	O
cells	O
[	O
27	O
]	O
-	O
[	O
29	O
]	O
,	O
drug	O
indifference	O
of	O
slow	O
-	O
growing	O
,	O
nutrient	O
-	O
limited	O
cells	O
[	O
30	O
]	O
,	O
and	O
unique	O
resistance	O
mechanisms	O
specifically	O
associated	O
with	O
biofilms	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
.	O

Despite	O
the	O
fact	O
that	O
biofilms	O
are	O
recognized	O
as	O
the	O
predominant	O
mode	O
of	O
bacterial	O
growth	O
in	O
nature	O
and	O
are	O
responsible	O
for	O
the	O
majority	O
of	O
refractory	O
bacterial	O
infections	O
[	O
19	O
]	O
,	O
little	O
is	O
known	O
regarding	O
the	O
mechanisms	O
of	O
biofilm	O
-	O
specific	O
antibiotic	O
resistance	O
.	O

Furthering	O
our	O
understanding	O
of	O
the	O
mechanisms	O
underlying	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
will	O
significantly	O
improve	O
the	O
treatment	O
options	O
available	O
to	O
patients	S-Organism
with	O
chronic	O
bacterial	O
infections	O
.	O

Signal	O
transduction	O
systems	O
have	O
been	O
documented	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
biofilm	O
formation	O
in	O
multiple	O
bacterial	O
species	O
including	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
S	B-Organism
.	I-Organism
aureus	E-Organism
,	O
E	B-Organism
.	I-Organism
coli	E-Organism
and	O
V	B-Organism
.	I-Organism
fischeri	E-Organism
[	O
33	O
]	O
-	O
[	O
38	O
]	O
.	O

These	O
two	O
component	O
systems	O
(	O
TCS	O
)	O
are	O
comprised	O
of	O
an	O
membrane	O
-	O
anchored	O
histidine	O
kinase	O
sensor	O
and	O
a	O
cytoplasmic	O
response	O
regulator	O
.	O

After	O
detecting	O
specific	O
environmental	O
signals	O
,	O
a	O
signal	O
transduction	O
cascade	O
is	O
initiated	O
that	O
results	O
in	O
phosphorylation	O
of	O
the	O
response	O
regulator	O
,	O
which	O
activates	O
or	O
represses	O
the	O
necessary	O
target	O
genes	O
.	O

A	O
number	O
of	O
regulatory	O
systems	O
that	O
influence	O
biofilm	O
formation	O
have	O
been	O
described	O
.	O

These	O
include	O
,	O
but	O
are	O
not	O
limited	O
to	O
,	O
the	O
global	O
virulence	O
factor	O
regulator	O
GacA	O
,	O
mutation	O
of	O
which	O
results	O
in	O
a	O
10	O
-	O
fold	O
decrease	O
in	O
biofilm	O
formation	O
and	O
failure	O
to	O
form	O
microcolony	O
structures	O
[	O
33	O
]	O
.	O

Additionally	O
,	O
the	O
hybrid	O
sensor	O
kinases	O
,	O
LadS	O
and	O
RetS	O
appear	O
to	O
work	O
upstream	O
of	O
GacA	O
to	O
possibly	O
control	O
the	O
switch	O
to	O
a	O
biofilm	O
lifestyle	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

Mutations	O
in	O
algR	O
,	O
a	O
response	O
regulator	O
protein	O
required	O
for	O
synthesis	O
of	O
alginate	O
,	O
which	O
is	O
a	O
major	O
component	O
of	O
the	O
matrix	O
of	O
biofilms	O
in	O
the	O
cystic	O
fibrosis	O
lung	O
[	O
1	O
]	O
results	O
in	O
a	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
strain	O
that	O
has	O
decreased	O
type	O
IV	O
pili	O
-	O
dependent	O
motility	O
and	O
biofilm	O
formation	O
[	O
39	O
]	O
.	O

The	O
three	O
-	O
component	O
system	O
SadARS	O
which	O
regulates	O
the	O
formation	O
of	O
mature	O
microcolonies	O
[	O
40	O
]	O
and	O
PvrR	O
,	O
a	O
response	O
regulator	O
involved	O
in	O
the	O
switch	O
from	O
planktonic	O
to	O
antibiotic	O
-	O
resistant	O
biofilm	O
cells	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
are	O
additional	O
examples	O
of	O
regulators	O
of	O
biofilm	O
formation	O
[	O
41	O
]	O
.	O

During	O
the	O
course	O
of	O
an	O
infection	O
,	O
one	O
of	O
the	O
first	O
lines	O
of	O
defense	O
encountered	O
by	O
colonizing	O
bacteria	O
is	O
the	O
production	O
of	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAPs	O
)	O
by	O
a	O
variety	O
of	O
host	O
cells	O
including	O
neutrophils	O
,	O
platelets	O
and	O
epithelia	O
.	O

CAPs	O
are	O
short	O
,	O
amphipathic	O
peptides	O
that	O
bind	O
to	O
and	O
disrupt	O
both	O
the	O
outer	O
and	O
cytoplasmic	O
membranes	O
resulting	O
in	O
cell	O
death	O
.	O

The	O
broad	O
-	O
spectrum	O
antimicrobial	O
activity	O
of	O
CAPs	O
against	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
bacteria	O
accounts	O
for	O
their	O
role	O
as	O
an	O
essential	O
component	O
of	O
the	O
innate	O
immune	O
response	O
of	O
humans	S-Organism
,	O
animals	O
and	O
insects	O
.	O

Cationic	O
peptides	O
,	O
which	O
have	O
antimicrobial	O
and	O
immunomodulatory	O
activities	O
,	O
are	O
being	O
developed	O
as	O
a	O
promising	O
new	O
class	O
of	O
therapeutically	O
relevant	O
drugs	O
[	O
42	O
]	O
.	O

In	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
resistance	O
to	O
CAPs	O
is	O
inducible	O
by	O
the	O
PhoPQ	O
and	O
PmrAB	O
TCSs	O
,	O
both	O
of	O
which	O
are	O
activated	O
independently	O
in	O
response	O
to	O
limiting	O
Mg2	O
+	O
[	O
43	O
]	O
-	O
[	O
46	O
]	O
.	O

Under	O
conditions	O
of	O
limiting	O
magnesium	O
,	O
PhoP	O
and	O
PmrA	O
bind	O
to	O
the	O
promoter	O
of	O
the	O
CAP	O
resistance	O
operon	O
PA3552	O
-	O
PA3559	O
(	O
arnBCADTEF	O
-	O
ugd	O
)	O
and	O
induce	O
its	O
expression	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
.	O

These	O
genes	O
encode	O
an	O
LPS	O
modification	O
pathway	O
required	O
for	O
the	O
addition	O
of	O
aminoarabinose	O
to	O
lipid	O
A	O
,	O
which	O
reduces	O
the	O
OM	O
permeability	O
to	O
CAPs	O
[	O
48	O
]	O
.	O

The	O
PhoPQ	O
and	O
PmrAB	O
regulatory	O
systems	O
are	O
well	O
studied	O
in	O
planktonic	O
cultures	O
and	O
have	O
been	O
shown	O
to	O
induce	O
modest	O
resistance	O
to	O
CAPs	O
(	O
8	O
-	O
fold	O
)	O
under	O
low	O
Mg2	O
+	O
conditions	O
[	O
45	O
]	O
.	O

However	O
,	O
while	O
the	O
PA3552	O
-	O
PA3559	O
operon	O
has	O
been	O
reported	O
to	O
be	O
expressed	O
in	O
biofilms	O
cultivated	O
in	O
flowcells	O
,	O
and	O
is	O
required	O
for	O
survival	O
in	O
response	O
to	O
colistin	O
treatment	O
[	O
49	O
]	O
,	O
little	O
else	O
is	O
known	O
regarding	O
these	O
systems	O
and	O
the	O
role	O
they	O
may	O
play	O
in	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
.	O

The	O
extracellular	O
matrix	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
includes	O
extracellular	O
DNA	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
multiple	O
bacterial	O
exopolysaccharides	O
and	O
host	O
proteins	O
[	O
4	O
]	O
,	O
[	O
52	O
]	O
.	O

Extracellular	O
DNA	O
,	O
which	O
is	O
a	O
matrix	O
component	O
of	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacterial	O
biofilms	O
[	O
51	O
]	O
,	O
[	O
53	O
]	O
,	O
functions	O
to	O
maintain	O
the	O
3D	O
biofilm	O
architecture	O
by	O
acting	O
as	O
a	O
cell	O
-	O
cell	O
interconnecting	O
compound	O
[	O
50	O
]	O
.	O

Genomic	O
DNA	O
has	O
been	O
shown	O
to	O
localize	O
to	O
the	O
biofilm	O
surface	O
,	O
surrounding	O
the	O
mushroom	O
-	O
shaped	O
microcolonies	O
[	O
51	O
]	O
.	O

DNA	O
in	O
the	O
biofilm	O
matrix	O
is	O
likely	O
released	O
by	O
dead	O
bacteria	O
or	O
immune	O
cells	O
.	O

It	O
has	O
been	O
reported	O
that	O
prophage	O
-	O
mediated	O
cell	O
death	O
is	O
an	O
important	O
mechanism	O
in	O
the	O
differentiation	O
and	O
dispersal	O
of	O
biofilms	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

Additional	O
sources	O
of	O
DNA	O
in	O
biofilms	O
may	O
include	O
the	O
quorum	O
sensing	O
regulated	O
release	O
of	O
DNA	O
[	O
51	O
]	O
and	O
/	O
or	O
DNA	O
contained	O
within	O
outer	O
membrane	O
vesicles	O
(	O
OMV	O
)	O
that	O
bleb	O
and	O
are	O
released	O
from	O
the	O
OM	O
of	O
living	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
cells	O
[	O
56	O
]	O
,	O
[	O
57	O
]	O
.	O

Furthermore	O
,	O
while	O
a	O
specific	O
mechanism	O
of	O
DNA	O
release	O
has	O
not	O
been	O
reported	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
it	O
is	O
possible	O
that	O
such	O
a	O
method	O
may	O
exist	O
,	O
similar	O
to	O
the	O
autolysin	O
-	O
mediated	O
DNA	O
release	O
observed	O
in	O
Staphylococcus	B-Organism
epidermidis	E-Organism
biofilms	O
[	O
53	O
]	O
.	O

In	O
this	O
study	O
we	O
sought	O
to	O
examine	O
if	O
the	O
presence	O
of	O
DNA	O
in	O
biofilms	O
may	O
contribute	O
to	O
biofilm	O
-	O
specific	O
antibiotic	O
resistance	O
.	O

Here	O
we	O
identify	O
a	O
novel	O
cation	O
chelating	O
property	O
of	O
DNA	O
,	O
which	O
has	O
several	O
important	O
consequences	O
for	O
biofilm	O
physiology	O
and	O
antibiotic	O
resistance	O
in	O
biofilms	O
.	O

Results	O

Extracellular	O
DNA	O
has	O
antimicrobial	O
activity	O
To	O
study	O
the	O
role	O
of	O
the	O
matrix	O
component	O
DNA	O
on	O
biofilm	O
formation	O
and	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
,	O
we	O
first	O
examined	O
the	O
influence	O
of	O
extracellular	O
DNA	O
on	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
growth	O
in	O
rich	O
and	O
defined	O
media	O
,	O
LB	O
and	O
BM2	O
,	O
respectively	O
.	O

Addition	O
of	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
(	O
5	O
mg	O
/	O
ml	O
)	O
or	O
greater	O
extracellular	O
DNA	O
to	O
LB	O
or	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
or	O
greater	O
DNA	O
to	O
BM2	O
media	O
inhibited	O
growth	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
(	O
Fig	O
1A	O
and	O
1B	O
)	O
.	O

The	O
kinetics	O
of	O
killing	O
by	O
extracellular	O
DNA	O
was	O
determined	O
by	O
measuring	O
the	O
loss	O
of	O
luminescence	O
from	O
a	O
chromosomally	O
-	O
tagged	O
luminescent	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
strain	O
,	O
PAO1	B-Organism
:	I-Organism
:	I-Organism
p16Slux	E-Organism
.	O

DNA	O
-	O
mediated	O
killing	O
was	O
fast	O
,	O
within	O
minutes	O
,	O
as	O
measured	O
by	O
the	O
rapid	O
loss	O
of	O
luminescence	O
upon	O
exposure	O
to	O
1	O
.	O
25	O
%	O
(	O
w	O
/	O
v	O
)	O
DNA	O
,	O
or	O
greater	O
(	O
Fig	O
1C	O
)	O
.	O

Killing	O
was	O
dose	O
-	O
dependent	O
,	O
with	O
faster	O
killing	O
observed	O
as	O
the	O
DNA	O
concentration	O
increased	O
(	O
Fig	O
1C	O
)	O
.	O

The	O
rapid	O
decrease	O
in	O
luminescence	O
corresponded	O
with	O
a	O
loss	O
of	O
bacterial	O
viability	O
,	O
as	O
determined	O
by	O
plating	O
(	O
Fig	O
1D	O
)	O
.	O

One	O
percent	O
(	O
w	O
/	O
v	O
)	O
extracellular	O
DNA	O
in	O
LB	O
also	O
inhibited	O
the	O
growth	O
of	O
Escherichia	B-Organism
coli	E-Organism
,	O
Staphylococcus	B-Organism
aureus	E-Organism
and	O
Burkholderia	B-Organism
cenocepacia	E-Organism
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
the	O
antimicrobial	O
activity	O
of	O
DNA	O
is	O
not	O
unique	O
to	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
.	O

Extracellular	O
DNA	O
induces	O
cell	O
death	O
by	O
membrane	O
perturbation	O
and	O
cell	O
lysis	O

DNA	O
is	O
a	O
highly	O
anionic	O
polymer	O
due	O
to	O
the	O
phosphates	O
in	O
the	O
deoxyribose	O
backbone	O
.	O

This	O
property	O
,	O
in	O
combination	O
with	O
the	O
fast	O
-	O
killing	O
observed	O
in	O
response	O
to	O
extracellular	O
DNA	O
led	O
us	O
to	O
hypothesize	O
that	O
addition	O
of	O
exogenous	O
DNA	O
resulted	O
in	O
the	O
loss	O
of	O
membrane	O
integrity	O
through	O
cation	O
chelation	O
,	O
in	O
a	O
manner	O
similar	O
to	O
that	O
observed	O
with	O
the	O
known	O
cation	O
chelator	O
EDTA	O
[	O
58	O
]	O
.	O

The	O
OM	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
contains	O
a	O
20	O
:	O
1	O
ratio	O
of	O
Mg2	O
+	O
:	O
Ca2	O
+	O
cations	O
[	O
59	O
]	O
,	O
which	O
bind	O
to	O
and	O
stabilize	O
LPS	O
in	O
the	O
outer	O
leaflet	O
of	O
the	O
OM	O
[	O
58	O
]	O
.	O

EDTA	O
treatment	O
of	O
cells	O
resulted	O
in	O
chelation	O
and	O
removal	O
of	O
divalent	O
cations	O
from	O
the	O
OM	O
,	O
leading	O
to	O
disruption	O
of	O
the	O
OM	O
[	O
58	O
]	O
.	O

To	O
determine	O
the	O
effect	O
of	O
DNA	O
on	O
membrane	O
integrity	O
,	O
microscopic	O
analysis	O
in	O
response	O
to	O
lethal	O
concentrations	O
of	O
DNA	O
and	O
relevant	O
controls	O
was	O
performed	O
.	O

Lipoproteins	O
are	O
lipid	O
-	O
modified	O
proteins	O
anchored	O
in	O
the	O
outer	O
leaflet	O
of	O
the	O
IM	O
or	O
the	O
inner	O
leaflet	O
of	O
the	O
OM	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	E-Organism
cells	O
producing	O
mCherry	O
fluorescent	O
membrane	O
-	O
anchored	O
lipoproteins	O
(	O
lipoChFP	O
)	O
that	O
are	O
localized	O
to	O
either	O
the	O
OM	O
or	O
IM	O
[	O
60	O
]	O
,	O
[	O
61	O
]	O
were	O
used	O
as	O
markers	O
of	O
OM	O
and	O
IM	O
integrity	O
.	O

LipoChFP	O
-	O
labelled	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
cells	O
showed	O
dramatic	O
membrane	O
perturbations	O
when	O
exposed	O
to	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
DNA	O
,	O
but	O
showed	O
uniform	O
membrane	O
staining	O
patterns	O
in	O
untreated	O
cells	O
(	O
Fig	O
2A	O
)	O
.	O

The	O
OM	O
perturbations	O
in	O
DNA	O
-	O
exposed	O
cells	O
included	O
regions	O
of	O
patchy	O
fluorescence	O
and	O
the	O
release	O
of	O
OMVs	O
,	O
while	O
the	O
IM	O
perturbations	O
were	O
visualized	O
simply	O
as	O
patchy	O
and	O
irregular	O
regions	O
of	O
membrane	O
fluorescence	O
(	O
Fig	O
2A	O
)	O
.	O

EDTA	O
,	O
the	O
known	O
cation	O
chelator	O
caused	O
comparable	O
IM	O
and	O
OM	O
perturbations	O
as	O
those	O
observed	O
in	O
cells	O
exposed	O
to	O
extracellular	O
DNA	O
.	O

Propidium	O
iodide	O
(	O
PI	O
)	O
stains	O
extracellular	O
DNA	O
and	O
DNA	O
in	O
dead	O
cells	O
.	O

PI	O
staining	O
was	O
observed	O
in	O
cells	O
exposed	O
to	O
DNA	O
and	O
EDTA	O
,	O
confirming	O
that	O
this	O
treatment	O
was	O
lethal	O
(	O
Fig	O
2B	O
)	O
.	O

PI	O
staining	O
also	O
revealed	O
the	O
presence	O
of	O
long	O
strands	O
of	O
genomic	O
DNA	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
the	O
loss	O
of	O
membrane	O
integrity	O
,	O
cell	O
lysis	O
and	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
DNA	O
(	O
Fig	O
2B	O
)	O
.	O

The	O
DNA	O
released	O
by	O
lysed	O
cells	O
formed	O
a	O
mesh	O
-	O
like	O
coating	O
surrounding	O
and	O
connecting	O
individual	O
bacterial	O
cells	O
(	O
Fig	O
2B	O
)	O
.	O

Degradation	O
of	O
these	O
strands	O
by	O
DNAse	O
treatment	O
of	O
lysed	O
cells	O
confirmed	O
that	O
these	O
fibres	O
were	O
composed	O
of	O
DNA	O
(	O
Fig	O
S1	O
)	O
.	O

Pseudomonas	S-Organism
specific	O
semi	O
-	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
was	O
also	O
performed	O
to	O
confirm	O
that	O
the	O
DNA	O
released	O
following	O
DNA	O
or	O
EDTA	O
treated	O
cells	O
was	O
in	O
fact	O
genomic	O
DNA	O
from	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
(	O
Fig	O
2C	O
)	O
.	O

Buffer	O
treated	O
control	O
cells	O
showed	O
intense	O
green	O
staining	O
with	O
syto9	O
(	O
indicating	O
viability	O
)	O
and	O
a	O
lack	O
of	O
PI	O
staining	O
(	O
indicating	O
no	O
dead	O
/	O
dying	O
cells	O
or	O
DNA	O
release	O
)	O
(	O
Fig	O
S1	O
)	O
.	O

DNA	O
has	O
cation	O
chelating	O
activity	O

The	O
observation	O
that	O
DNA	O
disrupted	O
the	O
integrity	O
of	O
the	O
cell	O
envelope	O
causing	O
cell	O
lysis	O
suggested	O
that	O
DNA	O
was	O
acting	O
as	O
a	O
cation	O
chelator	O
.	O

To	O
confirm	O
that	O
DNA	O
-	O
mediated	O
killing	O
was	O
a	O
result	O
of	O
cation	O
chelation	O
,	O
excess	O
Mg2	O
+	O
,	O
Ca2	O
+	O
,	O
Mn2	O
+	O
,	O
and	O
Zn2	O
+	O
were	O
added	O
to	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
cultures	O
.	O

The	O
rapidity	O
of	O
DNA	O
-	O
induced	O
cell	O
death	O
ruled	O
out	O
the	O
possibility	O
that	O
death	O
,	O
or	O
lack	O
of	O
growth	O
,	O
was	O
simply	O
due	O
to	O
cation	O
starvation	O
.	O

Addition	O
of	O
excess	O
cations	O
to	O
planktonic	O
cultures	O
inhibited	O
the	O
fast	O
-	O
acting	O
antimicrobial	O
effects	O
of	O
DNA	O
(	O
Fig	O
3A	O
)	O
.	O

Protection	O
was	O
measured	O
in	O
response	O
to	O
a	O
range	O
of	O
cation	O
concentrations	O
,	O
where	O
the	O
highest	O
concentration	O
tested	O
was	O
that	O
which	O
remained	O
soluble	O
in	O
the	O
presence	O
of	O
DNA	O
(	O
3	O
.	O
125	O
-	O
25	O
mM	O
)	O
.	O

The	O
concentration	O
at	O
which	O
maximal	O
protection	O
was	O
obtained	O
for	O
each	O
cation	O
is	O
represented	O
in	O
Fig	O
3A	O
(	O
25	O
mM	O
Mg2	O
+	O
;	O
6	O
.	O
25	O
mM	O
Ca2	O
+	O
;	O
6	O
.	O
25	O
Mn2	O
+	O
;	O
3	O
.	O
125	O
mM	O
Zn2	O
+	O
)	O
.	O

Kill	O
curve	O
assays	O
indicated	O
that	O
the	O
addition	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
provided	O
protection	O
from	O
DNA	O
-	O
induced	O
lysis	O
,	O
however	O
,	O
the	O
addition	O
of	O
Zn2	O
+	O
did	O
not	O
protect	O
from	O
DNA	O
-	O
mediated	O
killing	O
(	O
Fig	O
3A	O
)	O
.	O

In	O
a	O
similar	O
manner	O
,	O
the	O
addition	O
of	O
excess	O
Mg2	O
+	O
,	O
Ca2	O
+	O
and	O
Mn2	O
+	O
restored	O
growth	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
in	O
BM2	O
media	O
.	O

Only	O
partial	O
restoration	O
of	O
growth	O
was	O
observed	O
in	O
the	O
presence	O
of	O
Zn2	O
+	O
(	O
Fig	O
3B	O
)	O
.	O

The	O
increased	O
protection	O
observed	O
following	O
addition	O
of	O
Mg2	O
+	O
and	O
Ca2	O
+	O
is	O
likely	O
due	O
to	O
their	O
importance	O
in	O
membrane	O
integrity	O
where	O
they	O
function	O
to	O
stabilize	O
the	O
OM	O
by	O
crosslinking	O
adjacent	O
LPS	O
molecules	O
[	O
58	O
]	O
.	O

Cations	O
play	O
diverse	O
physiologically	O
important	O
roles	O
within	O
a	O
cell	O
;	O
from	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
and	O
co	O
-	O
factors	O
for	O
enzymes	O
to	O
the	O
stabilization	O
of	O
macromolecules	O
within	O
the	O
cell	O
[	O
62	O
]	O
.	O

Since	O
Mg2	O
+	O
limitation	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
CAP	O
resistance	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
[	O
44	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
47	O
]	O
,	O
we	O
sought	O
to	O
determine	O
if	O
Mg2	O
+	O
chelation	O
by	O
DNA	O
may	O
account	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
the	O
increased	O
antibiotic	O
resistance	O
observed	O
in	O
biofilms	O
.	O

Extracellular	O
DNA	O
induces	O
expression	O
of	O
the	O
PA3552	O
-	O
PA3559	O
CAP	O
resistance	O
operon	O
in	O
planktonic	O
cultures	O

In	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
the	O
PhoPQ	O
and	O
PmrAB	O
-	O
controlled	O
response	O
to	O
magnesium	O
limitation	O
includes	O
the	O
induction	O
of	O
the	O
PA3552	O
and	O
its	O
neighbouring	O
genes	O
.	O

The	O
genes	O
PA3552	O
-	O
PA3559	O
are	O
co	O
-	O
regulated	O
under	O
low	O
Mg2	O
+	O
conditions	O
and	O
are	O
thought	O
to	O
be	O
organized	O
as	O
an	O
operon	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
.	O

These	O
genes	O
encode	O
an	O
LPS	O
modification	O
pathway	O
required	O
for	O
the	O
addition	O
of	O
aminoarabinose	O
to	O
lipid	O
A	O
,	O
which	O
reduces	O
the	O
OM	O
permeability	O
to	O
CAPs	O
,	O
thus	O
conferring	O
resistance	O
[	O
48	O
]	O
.	O

To	O
determine	O
if	O
extracellular	O
DNA	O
imposes	O
Mg2	O
+	O
limitation	O
,	O
we	O
measured	O
the	O
gene	O
expression	O
of	O
a	O
chromosomally	O
encoded	O
transcriptional	O
lux	O
(	O
bioluminescence	O
)	O
fusion	O
to	O
PA3553	O
,	O
as	O
a	O
measure	O
of	O
the	O
CAP	O
resistance	O
operon	O
expression	O
in	O
planktonic	O
cultures	O
.	O

PA3553	O
:	O
:	O
lux	O
expression	O
was	O
strongly	O
induced	O
(	O
up	O
to	O
10	O
-	O
fold	O
)	O
by	O
sub	O
-	O
inhibitory	O
concentrations	O
of	O
low	O
molecular	O
weight	O
salmon	O
sperm	O
DNA	O
(	O
Fig	O
4A	O
)	O
.	O

Induction	O
of	O
the	O
CAP	O
resistance	O
operon	O
was	O
dose	O
-	O
dependent	O
with	O
increasing	O
DNA	O
concentrations	O
up	O
to	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
DNA	O
,	O
at	O
which	O
growth	O
is	O
inhibited	O
(	O
Fig	O
4A	O
)	O
.	O

Addition	O
of	O
excess	O
Mg2	O
+	O
(	O
5	O
mM	O
)	O
to	O
the	O
growth	O
medium	O
completely	O
repressed	O
the	O
expression	O
of	O
PA3553	O
in	O
cultures	O
supplemented	O
with	O
DNA	O
,	O
except	O
at	O
the	O
highest	O
DNA	O
concentration	O
tested	O
(	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
(	O
Fig	O
4B	O
)	O
.	O

A	O
similar	O
induction	O
profile	O
of	O
PA3553	O
:	O
:	O
lux	O
was	O
observed	O
following	O
exposure	O
to	O
high	O
molecular	O
weight	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
genomic	O
DNA	O
(	O
not	O
shown	O
)	O
or	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
genomic	O
DNA	O
that	O
was	O
mechanically	O
sheared	O
by	O
sonication	O
(	O
Fig	O
4C	O
)	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	E-Organism
genomic	O
DNA	O
inhibited	O
growth	O
at	O
similar	O
concentrations	O
as	O
salmon	S-Organism
sperm	O
DNA	O
.	O

Thus	O
,	O
the	O
ability	O
of	O
extracellular	O
DNA	O
to	O
chelate	O
magnesium	O
is	O
independent	O
of	O
origin	O
and	O
molecular	O
weight	O
,	O
indicating	O
that	O
chelation	O
is	O
a	O
general	O
property	O
of	O
this	O
negatively	O
charged	O
polymer	O
.	O

To	O
ensure	O
that	O
induction	O
of	O
PA3553	O
expression	O
was	O
specific	O
to	O
the	O
ability	O
of	O
DNA	O
to	O
chelate	O
cations	O
,	O
DNAse	O
treated	O
DNA	O
was	O
assessed	O
for	O
its	O
ability	O
to	O
induce	O
PA3553	O
gene	O
expression	O
(	O
Fig	O
4D	O
)	O
.	O

DNAse	O
treated	O
DNA	O
failed	O
to	O
induce	O
PA3553	O
gene	O
expression	O
.	O

However	O
the	O
addition	O
of	O
DNAse	O
buffer	O
to	O
cells	O
in	O
our	O
buffer	O
control	O
experiment	O
also	O
abolished	O
induction	O
of	O
PA3553	O
.	O

This	O
is	O
due	O
to	O
the	O
addition	O
of	O
excess	O
Mg2	O
+	O
ions	O
as	O
part	O
of	O
the	O
DNAse	O
buffer	O
,	O
which	O
is	O
required	O
for	O
DNAse	O
activity	O
.	O

Thus	O
,	O
it	O
is	O
impossible	O
to	O
determine	O
conclusively	O
if	O
DNAse	O
treatment	O
of	O
DNA	O
abolished	O
PA3553	O
gene	O
expression	O
.	O

Expression	O
of	O
the	O
CAP	O
resistance	O
operon	O
PA3552	O
-	O
PA3559	O
is	O
induced	O
in	O
biofilms	O
in	O
response	O
to	O
extracellular	O
DNA	O

To	O
determine	O
the	O
influence	O
of	O
extracellular	O
DNA	O
on	O
PA3553	O
gene	O
expression	O
in	O
biofilms	O
,	O
DNA	O
-	O
enriched	O
biofilms	O
were	O
cultivated	O
on	O
the	O
surface	O
of	O
polystyrene	O
pegs	O
.	O

Consistent	O
with	O
previous	O
reports	O
that	O
DNA	O
is	O
a	O
component	O
of	O
biofilms	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
we	O
observed	O
DNA	O
in	O
24	O
h	O
old	O
peg	O
-	O
adhered	O
biofilms	O
(	O
Fig	O
5A	O
and	O
5B	O
)	O
.	O

Double	O
staining	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
with	O
syto9	O
(	O
stains	O
viable	O
cells	O
green	O
)	O
and	O
the	O
extracellular	O
DNA	O
stain	O
DDAO	O
(	O
red	O
)	O
[	O
51	O
]	O
was	O
used	O
to	O
visualize	O
DNA	O
as	O
a	O
loose	O
lattice	O
in	O
biofilms	O
formed	O
on	O
polystyrene	O
pegs	O
after	O
24	O
h	O
(	O
Fig	O
5A	O
)	O
.	O

DNA	O
was	O
also	O
visualized	O
(	O
PI	O
stained	O
)	O
as	O
a	O
mesh	O
-	O
like	O
DNA	O
matrix	O
in	O
1	O
day	O
-	O
old	O
peg	O
-	O
adhered	O
biofilm	O
monolayers	O
(	O
Fig	O
5B	O
)	O
,	O
which	O
resembled	O
the	O
thread	O
-	O
like	O
projections	O
of	O
genomic	O
DNA	O
observed	O
in	O
DNA	O
or	O
EDTA	O
-	O
lysed	O
cells	O
(	O
Fig	O
2B	O
)	O
.	O

These	O
localization	O
patterns	O
of	O
extracellular	O
DNA	O
are	O
suggestive	O
of	O
DNA	O
gradients	O
within	O
biofilms	O
.	O

Biofilm	O
formation	O
was	O
inhibited	O
at	O
extracellular	O
DNA	O
concentrations	O
>	O
/	O
=	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
(	O
Fig	O
6A	O
)	O
.	O

This	O
is	O
consistent	O
with	O
the	O
observed	O
growth	O
inhibition	O
of	O
planktonic	O
cells	O
at	O
similar	O
DNA	O
concentrations	O
(	O
Fig	O
1A	O
)	O
.	O

One	O
-	O
day	O
old	O
PA3553	O
:	O
:	O
lux	O
biofilms	O
were	O
washed	O
to	O
remove	O
non	O
-	O
adhered	O
cells	O
and	O
gene	O
expression	O
was	O
measured	O
from	O
the	O
cells	O
adhered	O
to	O
the	O
polystyrene	O
peg	O
surface	O
.	O

PA3553	O
gene	O
expression	O
was	O
strongly	O
induced	O
,	O
up	O
to	O
20	O
-	O
fold	O
,	O
in	O
peg	O
-	O
adhered	O
biofilms	O
,	O
with	O
the	O
highest	O
induction	O
at	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
extracellular	O
DNA	O
(	O
Fig	O
6B	O
)	O
.	O

Although	O
gene	O
expression	O
was	O
measured	O
in	O
a	O
mutant	O
background	O
,	O
both	O
PAO1	S-Organism
and	O
PA3553	O
:	O
:	O
lux	O
had	O
similar	O
biofilm	O
phenotypes	O
in	O
each	O
condition	O
tested	O
(	O
Fig	O
6A	O
)	O
.	O

In	O
biofilms	O
cultivated	O
in	O
the	O
presence	O
of	O
extracellular	O
DNA	O
supplemented	O
with	O
excess	O
Mg2	O
+	O
(	O
5	O
mM	O
)	O
,	O
PA3553	O
gene	O
expression	O
was	O
completely	O
repressed	O
(	O
data	O
not	O
shown	O
)	O
.	O

DNA	O
chelation	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
but	O
not	O
Zn2	O
+	O
induces	O
PA3553	O
expression	O

At	O
lethal	O
concentrations	O
,	O
extracellular	O
DNA	O
induced	O
cell	O
lysis	O
by	O
chelating	O
cations	O
from	O
the	O
OM	O
.	O

This	O
antimicrobial	O
activity	O
can	O
be	O
prevented	O
if	O
DNA	O
is	O
pre	O
-	O
loaded	O
with	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
,	O
but	O
not	O
Zn2	O
+	O
,	O
prior	O
to	O
treatment	O
of	O
cells	O
(	O
Fig	O
3A	O
and	O
3B	O
)	O
.	O

To	O
determine	O
the	O
specificity	O
of	O
cation	O
chelation	O
,	O
flame	O
atomic	O
absorption	O
spectroscopy	O
was	O
employed	O
to	O
quantitate	O
DNA	O
-	O
dependent	O
removal	O
of	O
cations	O
from	O
buffer	O
containing	O
known	O
concentrations	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
,	O
Mn2	O
+	O
or	O
Zn2	O
+	O
and	O
a	O
combination	O
of	O
all	O
four	O
cations	O
.	O

DNA	O
was	O
capable	O
of	O
binding	O
all	O
four	O
cations	O
at	O
similar	O
levels	O
(	O
80	O
-	O
88	O
%	O
)	O
,	O
whether	O
alone	O
(	O
Fig	O
7A	O
)	O
or	O
in	O
combination	O
(	O
data	O
not	O
shown	O
)	O
.	O

To	O
ensure	O
binding	O
was	O
specific	O
to	O
DNA	O
a	O
negative	O
control	O
was	O
included	O
.	O

The	O
concentration	O
of	O
Mg2	O
+	O
that	O
bound	O
to	O
the	O
column	O
in	O
the	O
absence	O
of	O
DNA	O
is	O
indicated	O
.	O

At	O
sub	O
-	O
lethal	O
concentrations	O
,	O
extracellular	O
DNA	O
imposes	O
a	O
cation	O
limitation	O
that	O
leads	O
to	O
induction	O
of	O
PA3553	O
(	O
Fig	O
4A	O
)	O
,	O
which	O
can	O
be	O
repressed	O
by	O
excess	O
Mg2	O
+	O
(	O
Fig	O
4B	O
)	O
,	O
indicating	O
that	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
senses	O
Mg2	O
+	O
.	O

The	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
PhoQ	O
sensor	O
kinase	O
protein	O
has	O
been	O
shown	O
to	O
bind	O
to	O
and	O
be	O
repressed	O
by	O
Mg2	O
+	O
and	O
Ca2	O
+	O
cations	O
[	O
63	O
]	O
,	O
[	O
64	O
]	O
.	O

Under	O
limiting	O
Mg2	O
+	O
conditions	O
,	O
the	O
addition	O
of	O
excess	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
,	O
but	O
not	O
Zn2	O
+	O
,	O
repressed	O
PA3553	O
expression	O
(	O
Fig	O
7B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
can	O
sense	O
the	O
presence	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
and	O
that	O
chelation	O
of	O
these	O
same	O
cations	O
by	O
DNA	O
results	O
in	O
induction	O
of	O
the	O
PA3552	O
-	O
PA3559	O
LPS	O
modification	O
operon	O
.	O

DNA	O
induces	O
resistance	O
to	O
CAPs	O
and	O
aminoglycosides	O

To	O
determine	O
if	O
DNA	O
-	O
induced	O
expression	O
of	O
PA3552	O
-	O
PA3559	O
resulted	O
in	O
increased	O
resistance	O
to	O
antimicrobials	O
,	O
antibiotic	O
susceptibility	O
testing	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
grown	O
in	O
the	O
presence	O
and	O
absence	O
of	O
extracellular	O
DNA	O
was	O
performed	O
.	O

Biofilms	O
were	O
cultivated	O
on	O
96	O
-	O
well	O
format	O
,	O
polystyrene	O
pegs	O
submerged	O
in	O
BM2	O
defined	O
media	O
,	O
with	O
or	O
without	O
sub	O
-	O
inhibitory	O
concentrations	O
of	O
extracellular	O
DNA	O
(	O
0	O
.	O
75	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
,	O
and	O
challenged	O
with	O
antibiotics	O
.	O

After	O
antibiotic	O
challenge	O
,	O
this	O
assay	O
allows	O
for	O
determination	O
of	O
both	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
planktonic	O
cultures	O
and	O
the	O
minimum	O
biofilm	O
eradication	O
concentration	O
(	O
MBEC	O
)	O
.	O

Consistent	O
with	O
previous	O
results	O
reporting	O
on	O
the	O
antibiotic	O
resistance	O
phenotype	O
of	O
bacterial	O
biofilms	O
[	O
6	O
]	O
,	O
[	O
19	O
]	O
,	O
the	O
MBEC	O
values	O
of	O
biofilms	O
cultivated	O
in	O
magnesium	O
-	O
replete	O
conditions	O
and	O
treated	O
with	O
CAPs	O
(	O
polymyxin	O
B	O
,	O
colistin	O
)	O
or	O
aminoglycosides	O
(	O
gentamycin	O
,	O
tobramycin	O
)	O
were	O
up	O
to	O
64	O
-	O
fold	O
higher	O
than	O
the	O
MIC	O
values	O
of	O
planktonic	O
cultures	O
(	O
Table	O
1	O
)	O
.	O

The	O
MBEC	O
values	O
of	O
biofilms	O
supplemented	O
with	O
extracellular	O
DNA	O
were	O
8	O
and	O
64	O
-	O
fold	O
more	O
CAP	O
and	O
aminoglycoside	O
resistant	O
than	O
biofilms	O
without	O
exogenous	O
DNA	O
,	O
respectively	O
(	O
Table	O
1	O
)	O
.	O

DNA	O
-	O
enriched	O
biofilms	O
were	O
dramatically	O
more	O
resistant	O
than	O
planktonic	O
cultures	O
,	O
up	O
to	O
256	O
-	O
fold	O
,	O
and	O
this	O
resistance	O
phenotype	O
to	O
CAPs	O
and	O
aminoglycosides	O
was	O
also	O
observed	O
in	O
planktonic	O
cultures	O
supplemented	O
with	O
DNA	O
.	O

The	O
simple	O
addition	O
of	O
sub	O
-	O
inhibitory	O
DNA	O
amounts	O
to	O
planktonic	O
cultures	O
closely	O
simulated	O
the	O
resistance	O
-	O
inducing	O
effects	O
of	O
DNA	O
in	O
a	O
biofilm	O
(	O
Table	O
1	O
)	O
.	O

The	O
MIC	O
values	O
for	O
polymyxin	O
B	O
and	O
gentamicin	O
are	O
equal	O
to	O
1	O
microg	O
/	O
ml	O
and	O
2	O
microg	O
/	O
ml	O
,	O
respectively	O
,	O
using	O
the	O
standard	O
microbroth	O
dilution	O
method	O
for	O
antimicrobial	O
susceptibility	O
testing	O
(	O
National	O
Committee	O
on	O
Clinical	O
Laboratory	O
Standards	O
(	O
NCCLS	O
)	O
protocol	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
depending	O
on	O
the	O
method	O
used	O
to	O
determine	O
the	O
MIC	O
(	O
CBD	O
or	O
NCCLS	O
protocol	O
)	O
,	O
DNA	O
-	O
enriched	O
biofilms	O
can	O
be	O
up	O
to	O
2560	O
-	O
fold	O
more	O
polymyxin	O
B	O
resistant	O
and	O
up	O
to	O
640	O
-	O
fold	O
more	O
aminoglycoside	O
resistant	O
than	O
planktonic	O
cultures	O
.	O

DNA	O
-	O
enriched	O
biofilms	O
did	O
not	O
show	O
an	O
increased	O
tolerance	O
to	O
ceftazidime	O
(	O
beta	O
-	O
lactam	O
)	O
or	O
ciprofloxacin	O
(	O
fluoroquinolone	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Since	O
extracellular	O
DNA	O
is	O
a	O
natural	O
matrix	O
component	O
of	O
PAO1	S-Organism
biofilms	O
(	O
Fig	O
5A	O
and	O
5B	O
)	O
,	O
DNA	O
-	O
induced	O
antibiotic	O
resistance	O
is	O
likely	O
to	O
be	O
a	O
phenomenon	O
unique	O
to	O
biofilms	O
or	O
other	O
DNA	O
rich	O
environments	O
.	O

The	O
presence	O
of	O
DNA	O
in	O
peg	O
-	O
cultivated	O
biofilms	O
(	O
Fig	O
5A	O
)	O
,	O
grown	O
in	O
the	O
absence	O
of	O
exogenous	O
DNA	O
,	O
likely	O
contributes	O
to	O
the	O
increased	O
antibiotic	O
resistance	O
generally	O
observed	O
in	O
biofilms	O
(	O
Table	O
1	O
)	O
.	O

We	O
have	O
shown	O
previously	O
that	O
the	O
PA3552	O
-	O
PA3559	O
operon	O
is	O
required	O
for	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
in	O
planktonic	O
cultures	O
grown	O
in	O
limiting	O
magnesium	O
conditions	O
[	O
47	O
]	O
.	O

To	O
determine	O
if	O
DNA	O
-	O
induced	O
resistance	O
requires	O
these	O
genes	O
in	O
biofilms	O
,	O
the	O
resistance	O
phenotype	O
of	O
the	O
PA3553	O
:	O
:	O
lux	O
mutant	O
was	O
determined	O
.	O

PA3553	O
:	O
:	O
lux	O
had	O
no	O
significant	O
DNA	O
-	O
induced	O
CAP	O
resistance	O
in	O
biofilm	O
or	O
planktonic	O
cultures	O
,	O
confirming	O
that	O
these	O
genes	O
are	O
essential	O
for	O
CAP	O
resistance	O
in	O
the	O
presence	O
of	O
extracellular	O
DNA	O
(	O
Table	O
1	O
)	O
.	O

The	O
PA3553	O
mutant	O
also	O
displayed	O
decreased	O
DNA	O
-	O
induced	O
resistance	O
to	O
aminoglycosides	O
compared	O
to	O
PAO1	S-Organism
.	O

The	O
differences	O
observed	O
between	O
CAP	O
and	O
aminoglycoside	O
resistance	O
in	O
PA3553	O
:	O
:	O
lux	O
suggests	O
that	O
DNA	O
-	O
induced	O
resistance	O
to	O
aminoglycosides	O
is	O
not	O
limited	O
to	O
PA3553	O
induction	O
.	O

The	O
biofilms	O
formed	O
by	O
the	O
PA3553	O
:	O
:	O
lux	O
mutant	O
were	O
unaltered	O
compared	O
to	O
PAO1	S-Organism
biofilms	O
under	O
these	O
conditions	O
,	O
ensuring	O
that	O
the	O
difference	O
observed	O
was	O
not	O
due	O
to	O
an	O
altered	O
biofilm	O
phenotype	O
(	O
Fig	O
6B	O
)	O
.	O

The	O
CAP	O
resistance	O
phenotype	O
of	O
biofilms	O
grown	O
in	O
limiting	O
magnesium	O
(	O
20	O
microM	O
)	O
was	O
similar	O
to	O
biofilms	O
grown	O
in	O
DNA	O
,	O
confirming	O
that	O
DNA	O
imposes	O
a	O
magnesium	O
limitation	O
stress	O
(	O
Table	O
2	O
)	O
.	O

Biofilms	O
that	O
were	O
exposed	O
to	O
DNA	O
during	O
either	O
the	O
cultivation	O
or	O
challenge	O
stages	O
only	O
,	O
showed	O
similar	O
resistance	O
profiles	O
to	O
biofilms	O
grown	O
and	O
challenged	O
in	O
magnesium	O
-	O
replete	O
conditions	O
(	O
Tables	O
1	O
-	O
2	O
)	O
.	O

Therefore	O
,	O
the	O
DNA	O
-	O
induced	O
resistance	O
of	O
biofilms	O
requires	O
both	O
the	O
cultivation	O
and	O
challenge	O
under	O
cation	O
-	O
limiting	O
conditions	O
.	O

These	O
latter	O
two	O
observations	O
rule	O
out	O
the	O
possibility	O
that	O
negatively	O
charged	O
DNA	O
simply	O
interacts	O
with	O
cationic	O
antimicrobial	O
peptides	O
and	O
prevents	O
their	O
access	O
to	O
bacterial	O
cells	O
.	O

Discussion	O

Infections	O
caused	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
continue	O
to	O
be	O
a	O
leading	O
cause	O
of	O
mortality	O
among	O
immunocompromised	O
patients	S-Organism
.	O

The	O
ability	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
to	O
form	O
biofilms	O
promotes	O
survival	O
of	O
the	O
bacteria	O
in	O
the	O
presence	O
of	O
antimicrobials	O
and	O
host	O
defense	O
mechanisms	O
and	O
is	O
thought	O
to	O
contribute	O
significantly	O
to	O
its	O
ability	O
to	O
survive	O
long	O
-	O
term	O
within	O
the	O
hostile	O
environment	O
of	O
chronically	O
-	O
infected	O
patients	S-Organism
.	O

Understanding	O
the	O
mechanisms	O
underlying	O
antibiotic	O
resistance	O
and	O
especially	O
biofilm	O
-	O
specific	O
antimicrobial	O
resistance	O
is	O
of	O
significant	O
importance	O
in	O
the	O
development	O
of	O
new	O
treatment	O
options	O
and	O
/	O
or	O
strategies	O
.	O

We	O
have	O
identified	O
a	O
novel	O
mechanism	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
in	O
which	O
the	O
presence	O
of	O
DNA	O
in	O
the	O
extracellular	O
matrix	O
of	O
biofilms	O
creates	O
a	O
localized	O
cation	O
-	O
limited	O
environment	O
that	O
is	O
detected	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
leading	O
to	O
the	O
induction	O
of	O
LPS	O
modification	O
genes	O
and	O
resistance	O
to	O
antimicrobials	O
.	O

Magnesium	O
limitation	O
has	O
long	O
been	O
known	O
as	O
an	O
in	O
vitro	O
signal	O
that	O
induces	O
resistance	O
to	O
CAPs	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
[	O
59	O
]	O
.	O

As	O
an	O
intracellular	O
pathogen	O
,	O
the	O
PhoPQ	O
system	O
of	O
Salmonella	B-Organism
typhimurium	E-Organism
is	O
activated	O
by	O
limiting	O
magnesium	O
in	O
vitro	O
and	O
phoP	O
-	O
regulated	O
genes	O
are	O
also	O
induced	O
after	O
invasion	O
of	O
macrophages	O
and	O
epithelial	O
cells	O
[	O
65	O
]	O
.	O

These	O
observations	O
suggested	O
that	O
Mg2	O
+	O
is	O
limiting	O
within	O
host	O
cells	O
,	O
but	O
it	O
was	O
recently	O
shown	O
that	O
vacuole	O
acidification	O
and	O
low	O
pH	O
is	O
the	O
crucial	O
environmental	O
trigger	O
of	O
PhoPQ	O
activation	O
[	O
66	O
]	O
.	O

Many	O
extracellular	O
pathogens	O
possess	O
homologs	O
of	O
the	O
cation	O
-	O
sensing	O
PhoPQ	O
TCS	O
that	O
responds	O
to	O
magnesium	O
limitation	O
and	O
induces	O
genes	O
necessary	O
for	O
surviving	O
this	O
environmental	O
challenge	O
[	O
65	O
]	O
.	O

However	O
,	O
to	O
date	O
the	O
identification	O
of	O
a	O
relevant	O
in	O
vivo	O
environment	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
which	O
is	O
cation	O
limited	O
has	O
remained	O
elusive	O
.	O

We	O
have	O
demonstrated	O
that	O
DNA	O
-	O
rich	O
environments	O
,	O
such	O
as	O
biofilms	O
,	O
are	O
cation	O
limited	O
.	O

While	O
Mg2	O
+	O
limitation	O
has	O
been	O
identified	O
as	O
a	O
signal	O
involved	O
in	O
induced	O
resistance	O
to	O
aminoglycosides	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
[	O
59	O
]	O
,	O
the	O
contribution	O
of	O
the	O
PhoPQ	O
-	O
regulated	O
LPS	O
modifications	O
has	O
not	O
been	O
clearly	O
determined	O
.	O

PhoQ	O
mutants	O
,	O
which	O
constitutively	O
express	O
phoP	O
and	O
are	O
constitutively	O
resistant	O
to	O
cationic	O
antimicrobial	O
peptides	O
,	O
are	O
also	O
more	O
resistant	O
to	O
aminoglycosides	O
[	O
43	O
]	O
.	O

In	O
S	B-Organism
.	I-Organism
typhimurium	E-Organism
,	O
PhoPQ	O
regulates	O
multiple	O
LPS	O
modifications	O
that	O
decrease	O
the	O
OM	O
permeability	O
to	O
membrane	O
cationic	O
dyes	O
,	O
bile	O
salts	O
and	O
antibiotics	O
,	O
including	O
gentamicin	O
[	O
67	O
]	O
.	O

We	O
report	O
here	O
that	O
DNA	O
-	O
induces	O
aminoglycoside	O
resistance	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
,	O
and	O
this	O
resistance	O
is	O
partially	O
dependent	O
on	O
the	O
LPS	O
modification	O
operon	O
PA3552	O
-	O
PA3559	O
.	O

The	O
aminoarabinose	O
modification	O
likely	O
blocks	O
the	O
self	O
-	O
promoted	O
uptake	O
of	O
aminoglycosides	O
,	O
which	O
normally	O
bind	O
and	O
displace	O
cations	O
that	O
crosslink	O
adjacent	O
LPS	O
molecules	O
[	O
68	O
]	O
.	O

Previous	O
reports	O
have	O
documented	O
the	O
involvement	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
PmrAB	O
[	O
49	O
]	O
and	O
the	O
E	B-Organism
.	I-Organism
coli	E-Organism
PmrAB	O
homologs	O
BasRS	O
[	O
69	O
]	O
in	O
regulating	O
the	O
formation	O
of	O
an	O
antimicrobial	O
peptide	O
-	O
tolerant	O
subpopulation	O
within	O
biofilms	O
.	O

In	O
pure	O
culture	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
,	O
genomic	O
DNA	O
localizes	O
throughout	O
the	O
biofilm	O
surface	O
monolayer	O
and	O
surrounds	O
the	O
mushroom	O
-	O
shaped	O
microcolonies	O
[	O
51	O
]	O
.	O

This	O
coincides	O
with	O
the	O
localization	O
of	O
a	O
CAP	O
-	O
tolerant	O
subpopulation	O
of	O
bacteria	O
that	O
expresses	O
the	O
PA3552	O
-	O
PA3559	O
operon	O
along	O
the	O
surface	O
of	O
mushroom	O
-	O
structured	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
[	O
49	O
]	O
.	O

To	O
date	O
,	O
it	O
was	O
thought	O
unlikely	O
that	O
a	O
biofilm	O
environment	O
may	O
be	O
cation	O
limited	O
.	O

However	O
,	O
our	O
data	O
indicates	O
that	O
the	O
presence	O
of	O
DNA	O
in	O
biofilms	O
does	O
indeed	O
result	O
in	O
a	O
cation	O
-	O
limited	O
environment	O
,	O
resulting	O
in	O
the	O
induction	O
of	O
the	O
LPS	O
modification	O
operon	O
PA3552	O
-	O
PA3559	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
report	O
to	O
identify	O
the	O
antimicrobial	O
properties	O
of	O
DNA	O
.	O

Above	O
certain	O
concentrations	O
(	O
approximately0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
extracellular	O
DNA	O
inhibited	O
planktonic	O
growth	O
and	O
biofilm	O
formation	O
.	O

Recently	O
,	O
a	O
novel	O
host	O
defense	O
mechanism	O
was	O
discovered	O
whereby	O
stimulated	O
neutrophils	O
ejected	O
a	O
mesh	O
-	O
like	O
net	O
of	O
intracellular	O
DNA	O
and	O
proteins	O
that	O
functions	O
to	O
trap	O
and	O
kill	O
pathogens	O
[	O
70	O
]	O
.	O

The	O
antimicrobial	O
property	O
of	O
neutrophil	O
nets	O
was	O
attributed	O
to	O
DNA	O
-	O
associated	O
histones	O
and	O
other	O
antimicrobial	O
peptides	O
[	O
70	O
]	O
.	O

However	O
,	O
our	O
results	O
demonstrate	O
that	O
above	O
certain	O
concentrations	O
,	O
the	O
DNA	O
itself	O
is	O
antimicrobial	O
due	O
to	O
cation	O
chelation	O
.	O

In	O
principle	O
,	O
cation	O
chelation	O
by	O
DNA	O
is	O
similar	O
to	O
another	O
recently	O
identified	O
host	O
defense	O
mechanism	O
,	O
where	O
the	O
Mn2	O
+	O
and	O
Zn2	O
+	O
metal	O
chelation	O
properties	O
of	O
the	O
host	O
innate	O
-	O
immune	O
protein	O
calprotectin	O
was	O
shown	O
to	O
limit	O
Staphylococcus	B-Organism
aureus	E-Organism
growth	O
in	O
tissue	O
abscesses	O
[	O
71	O
]	O
.	O

Staining	O
of	O
peg	O
-	O
adhered	O
biofilms	O
indicated	O
that	O
DNA	O
was	O
present	O
throughout	O
the	O
biofilm	O
.	O

(	O
Fig	O
5B	O
)	O
.	O

This	O
data	O
supports	O
the	O
hypothesis	O
that	O
the	O
release	O
of	O
genomic	O
DNA	O
by	O
lysed	O
cells	O
following	O
exposure	O
to	O
inhibitory	O
concentrations	O
of	O
extracellular	O
DNA	O
may	O
result	O
in	O
a	O
continual	O
release	O
of	O
DNA	O
by	O
dying	O
cells	O
and	O
a	O
DNA	O
gradient	O
within	O
the	O
biofilm	O
.	O

Our	O
observation	O
that	O
DNA	O
imposes	O
a	O
cation	O
gradient	O
in	O
biofilm	O
is	O
also	O
consistent	O
with	O
previous	O
reports	O
of	O
oxygen	O
and	O
nutrient	O
gradients	O
within	O
biofilms	O
,	O
which	O
result	O
in	O
diverse	O
physiological	O
cellular	O
states	O
within	O
a	O
biofilm	O
community	O
[	O
72	O
]	O
.	O

Although	O
DNA	O
is	O
toxic	O
at	O
high	O
concentrations	O
,	O
it	O
functions	O
as	O
a	O
double	O
-	O
edged	O
sword	O
whereby	O
sub	O
-	O
inhibitory	O
DNA	O
concentrations	O
serve	O
to	O
protect	O
bacteria	O
from	O
antibiotic	O
exposure	O
,	O
either	O
from	O
the	O
host	O
immune	O
response	O
or	O
from	O
antimicrobial	O
treatment	O
.	O

It	O
has	O
previously	O
been	O
reported	O
that	O
Mg2	O
+	O
concentrations	O
within	O
the	O
airway	O
surface	O
fluid	O
are	O
high	O
(	O
2	O
.	O
2	O
mM	O
)	O
[	O
73	O
]	O
,	O
[	O
74	O
]	O
.	O

However	O
,	O
sputum	O
samples	O
from	O
the	O
lungs	O
of	O
CF	O
patients	S-Organism
have	O
very	O
high	O
concentrations	O
of	O
DNA	O
,	O
up	O
to	O
20	O
mg	O
/	O
ml	O
(	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
[	O
75	O
]	O
,	O
[	O
76	O
]	O
.	O

It	O
is	O
likely	O
that	O
within	O
the	O
CF	O
lung	O
,	O
localized	O
cation	O
limited	O
environments	O
exist	O
within	O
DNA	O
-	O
rich	O
microcolonies	O
.	O

It	O
is	O
also	O
known	O
that	O
CF	O
airway	O
fluid	O
contains	O
high	O
levels	O
of	O
neutrophil	O
defensins	O
[	O
77	O
]	O
and	O
that	O
sub	O
-	O
lethal	O
doses	O
of	O
CAPs	O
induce	O
PA3553	O
gene	O
expression	O
,	O
although	O
independently	O
of	O
PhoPQ	O
and	O
PmrAB	O
[	O
45	O
]	O
.	O

Therefore	O
,	O
it	O
appears	O
that	O
there	O
are	O
multiple	O
environmental	O
signals	O
in	O
the	O
CF	O
lung	O
that	O
can	O
induce	O
the	O
expression	O
the	O
PA3552	O
-	O
PA3559	O
operon	O
,	O
which	O
may	O
explain	O
why	O
many	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
CF	O
isolates	O
show	O
LPS	O
modifications	O
such	O
as	O
aminoarabinose	O
addition	O
to	O
lipid	O
A	O
[	O
78	O
]	O
.	O

As	O
many	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
strains	O
isolated	O
from	O
the	O
CF	O
lung	O
overproduce	O
the	O
negatively	O
charged	O
EPS	O
alginate	O
,	O
we	O
hypothesized	O
that	O
alginate	O
may	O
also	O
be	O
a	O
relevant	O
in	O
vivo	O
signal	O
inducing	O
expression	O
of	O
the	O
PA3552	O
-	O
PA3559	O
operon	O
.	O

However	O
,	O
induction	O
of	O
PA3553	O
gene	O
expression	O
does	O
not	O
occur	O
in	O
the	O
presence	O
of	O
alginate	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
observation	O
that	O
DNA	O
is	O
present	O
in	O
the	O
lungs	O
of	O
CF	O
patients	S-Organism
has	O
prompted	O
the	O
use	O
of	O
DNAseI	O
as	O
a	O
therapeutic	O
agent	O
to	O
reduce	O
the	O
sputum	O
viscosity	O
and	O
improve	O
lung	O
function	O
[	O
75	O
]	O
,	O
[	O
76	O
]	O
.	O

However	O
,	O
our	O
data	O
suggests	O
that	O
the	O
success	O
of	O
DNAseI	O
therapy	O
may	O
,	O
in	O
part	O
,	O
be	O
attributed	O
to	O
the	O
degradation	O
of	O
DNA	O
and	O
subsequent	O
disarming	O
of	O
the	O
PhoPQ	O
/	O
PmrAB	O
response	O
and	O
antibiotic	O
resistance	O
mechanisms	O
.	O

While	O
previous	O
studies	O
have	O
shown	O
the	O
biofilm	O
matrix	O
to	O
function	O
as	O
a	O
diffusion	O
barrier	O
to	O
antibiotics	O
,	O
these	O
results	O
demonstrate	O
a	O
novel	O
function	O
of	O
the	O
biofilm	O
matrix	O
component	O
DNA	O
,	O
where	O
the	O
cation	O
chelating	O
properties	O
of	O
DNA	O
in	O
biofilms	O
induces	O
resistance	O
to	O
host	O
-	O
derived	O
or	O
therapeutic	O
antimicrobials	O
.	O

Furthermore	O
,	O
these	O
findings	O
indicate	O
that	O
DNA	O
-	O
rich	O
environments	O
,	O
such	O
as	O
bacterial	O
biofilms	O
or	O
the	O
CF	O
lung	O
,	O
may	O
represent	O
the	O
natural	O
setting	O
where	O
bacterial	O
growth	O
is	O
cation	O
limited	O
,	O
and	O
highlight	O
the	O
importance	O
of	O
the	O
PhoPQ	O
/	O
PmrAB	O
controlled	O
response	O
and	O
LPS	O
modifications	O
in	O
antibiotic	O
resistance	O
in	O
biofilms	O
.	O

The	O
Two	O
-	O
Component	O
Regulatory	O
System	O
VicRK	O
is	O
Important	O
to	O
Virulence	O
of	O
Streptococcus	B-Organism
equi	I-Organism
Subspecies	I-Organism
equi	E-Organism

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	O
to	O
virulence	O
of	O
the	O
horse	S-Organism
pathogen	O
Streptococcus	B-Organism
equi	I-Organism
subspecies	I-Organism
equi	E-Organism
and	O
the	O
potential	O
of	O
a	O
vicK	O
mutant	O
as	O
a	O
live	O
vaccine	O
candidate	O
using	O
mouse	S-Organism
infection	O
models	O
.	O

The	O
vicK	O
gene	O
was	O
deleted	O
by	O
gene	O
replacement	O
.	O

The	O
DeltavicK	O
mutant	O
is	O
attenuated	O
in	O
virulence	O
in	O
both	O
subcutaneous	O
and	O
intranasal	O
infections	O
in	O
mice	S-Organism
.	O

DeltavicK	O
grows	O
less	O
slowly	O
than	O
the	O
parent	O
strain	O
but	O
retains	O
the	O
ability	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
to	O
resist	O
to	O
phagocytosis	O
by	O
polymorphoneuclear	O
leukocytes	O
,	O
suggesting	O
that	O
the	O
vicK	O
deletion	O
causes	O
growth	O
defect	O
.	O

DeltavicK	O
infection	O
protects	O
mice	S-Organism
against	O
reinfection	O
with	O
a	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
strain	O
.	O

Intranasal	O
DeltavicK	O
infection	O
induces	O
production	O
of	O
anti	O
-	O
SeM	O
mucosal	O
IgA	O
and	O
systemic	O
IgG	O
.	O

These	O
results	O
indicate	O
that	O
VicRK	O
is	O
important	O
to	O
S	B-Organism
.	I-Organism
equi	E-Organism
growth	O
and	O
virulence	O
and	O
suggest	O
that	O
DeltavicK	O
has	O
the	O
potential	O
to	O
be	O
developed	O
as	O
a	O
live	O
S	B-Organism
.	I-Organism
equi	E-Organism
vaccine	O
.	O

INTRODUCTION	O

Bacterial	O
pathogens	O
produce	O
many	O
two	O
-	O
component	O
regulatory	O
systems	O
to	O
regulate	O
gene	O
expression	O
by	O
specific	O
environmental	O
signals	O
[	O
1	O
]	O
.	O

These	O
systems	O
consist	O
of	O
membrane	O
protein	O
sensors	O
and	O
cognate	O
cytoplasmic	O
response	O
regulators	O
.	O

The	O
regulator	O
is	O
phosphorylated	O
by	O
the	O
sensor	O
in	O
response	O
to	O
a	O
specific	O
signal	O
,	O
activating	O
or	O
repressing	O
the	O
transcription	O
of	O
target	O
genes	O
.	O

The	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	O
or	O
YycFG	O
is	O
specific	O
for	O
Gram	O
-	O
positive	O
bacteria	O
.	O

The	O
regulator	O
component	O
VicR	O
is	O
essential	O
in	O
Bacillus	B-Organism
subtilis	E-Organism
[	O
2	O
]	O
,	O
Staphylococcus	B-Organism
aureus	E-Organism
[	O
3	O
]	O
,	O
and	O
Streptococcus	B-Organism
pneumoniae	E-Organism
[	O
4	O
-	O
5	O
]	O
but	O
appears	O
not	O
to	O
be	O
essential	O
in	O
Streptococcus	B-Organism
pyogenes	E-Organism
[	O
6	O
]	O
.	O

The	O
deletion	O
of	O
the	O
vicK	O
gene	O
can	O
be	O
readily	O
inactivated	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	E-Organism
[	O
7	O
]	O
,	O
Streptococcus	B-Organism
mutans	E-Organism
[	O
8	O
]	O
,	O
and	O
S	B-Organism
.	I-Organism
pyogenes	E-Organism
[	O
6	O
]	O
but	O
not	O
in	O
B	B-Organism
.	I-Organism
subtilis	E-Organism
[	O
2	O
]	O
and	O
S	B-Organism
.	I-Organism
aureus	E-Organism
[	O
3	O
]	O
.	O

Conditional	O
and	O
unconditional	O
vicRK	O
mutants	O
display	O
various	O
phenotypes	O
,	O
including	O
defects	O
in	O
morphology	O
and	O
cell	O
wall	O
synthesis	O
,	O
decreased	O
competence	O
,	O
sensitivity	O
to	O
antibiotics	O
and	O
fatty	O
acids	O
,	O
defects	O
in	O
biofilm	O
formation	O
,	O
and	O
attenuated	O
virulence	O
,	O
growth	O
defect	O
,	O
and	O
sensitivity	O
to	O
osmotic	O
pressure	O
[	O
3	O
,	O
6	O
,	O
8	O
-	O
11	O
]	O
.	O

The	O
vicRK	O
system	O
of	O
Gram	O
-	O
positive	O
bacterium	O
Streptococcus	B-Organism
equi	I-Organism
subspecies	I-Organism
equi	E-Organism
(	O
S	B-Organism
.	I-Organism
equi	E-Organism
)	O
has	O
not	O
been	O
studied	O
.	O

This	O
pathogen	O
causes	O
equine	S-Organism
strangles	O
,	O
a	O
highly	O
contagious	O
purulent	O
lymphadenitis	O
[	O
12	O
-	O
13	O
]	O
.	O

The	O
infection	O
initially	O
causes	O
nasal	O
discharge	O
and	O
fever	O
and	O
,	O
then	O
,	O
leads	O
to	O
abscess	O
formation	O
in	O
local	O
lymph	O
nodes	O
,	O
causing	O
respiratory	O
difficulty	O
.	O

Although	O
the	O
infection	O
at	O
the	O
lymph	O
nodes	O
cause	O
massive	O
infiltration	O
of	O
polymorphoneuclear	O
leukocytes	O
(	O
PMNs	O
)	O
[	O
14	O
]	O
,	O
S	B-Organism
.	I-Organism
equi	E-Organism
resists	O
phagocytosis	O
by	O
PMNs	O
and	O
rapidly	O
multiplies	O
,	O
forming	O
an	O
abscess	O
of	O
large	O
numbers	O
of	O
degenerating	O
PMNs	O
and	O
long	O
chains	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
[	O
15	O
]	O
.	O

The	O
hyaluronic	O
acid	O
capsule	O
and	O
S	B-Organism
.	I-Organism
equi	E-Organism
M	O
-	O
like	O
protein	O
(	O
SeM	O
)	O
are	O
both	O
required	O
for	O
the	O
resistance	O
to	O
phagocytosis	O
by	O
PMNs	O
[	O
16	O
-	O
17	O
]	O
.	O

Most	O
horses	S-Organism
recovered	O
from	O
strangles	O
have	O
immunity	O
against	O
S	B-Organism
.	I-Organism
equi	E-Organism
reinfection	O
for	O
up	O
to	O
5	O
years	O
[	O
18	O
]	O
.	O

It	O
is	O
believed	O
that	O
the	O
immunity	O
is	O
mediated	O
by	O
mucosal	O
antibodies	O
specific	O
to	O
SeM	O
and	O
other	O
protective	O
antigens	O
.	O

An	O
intranasal	O
vaccine	O
made	O
of	O
live	O
attenuated	O
strain	O
has	O
been	O
used	O
in	O
USA	O
,	O
which	O
lacks	O
the	O
hyaluronic	O
acid	O
capsule	O
,	O
and	O
various	O
adverse	O
effects	O
,	O
including	O
pharyngeal	O
lymphadenopathy	O
,	O
limb	O
edema	O
,	O
and	O
bastard	O
strangles	O
abscesses	O
,	O
have	O
been	O
reported	O
[	O
15	O
]	O
.	O

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
VicRK	O
to	O
S	B-Organism
.	I-Organism
equi	E-Organism
virulence	O
and	O
the	O
potential	O
of	O
a	O
vicK	O
deletion	O
mutant	O
as	O
a	O
live	O
vaccine	O
using	O
mouse	S-Organism
infection	O
models	O
.	O

We	O
found	O
that	O
the	O
vicK	O
deletion	O
attenuated	O
S	B-Organism
.	I-Organism
equi	E-Organism
virulence	O
in	O
mouse	S-Organism
models	O
of	O
subcutaneous	O
and	O
intranasal	O
infections	O
and	O
that	O
infection	O
with	O
a	O
vicK	O
deletion	O
mutant	O
confers	O
protection	O
against	O
subsequent	O
infection	O
with	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
and	O
induces	O
production	O
of	O
mucosal	O
and	O
systemic	O
immunoglobins	O
to	O
SeM	O
in	O
nasal	O
infection	O
.	O

RESULTS	O

S	O
.	O
equi	O
vicK	O
Deletion	O
Mutant	O
The	O
S	B-Organism
.	I-Organism
equi	E-Organism
vicRK	O
genes	O
were	O
found	O
by	O
blasting	O
the	O
S	B-Organism
.	I-Organism
equi	E-Organism
genome	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
sanger	O
.	O
ac	O
.	O
uk	O
/	O
Projects	O
/	O
S	O
_	O
equi	O
)	O
with	O
the	O
S	B-Organism
.	I-Organism
pyogenes	E-Organism
vicRK	O
sequence	O
.	O

Gene	O
replacement	O
strategy	O
was	O
used	O
to	O
generate	O
vicK	O
-	O
deletion	O
mutant	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
vector	O
pGRV	O
has	O
two	O
genes	O
aad	O
and	O
cmR	O
for	O
selections	O
with	O
spectinomycin	O
and	O
chloramphenicol	O
,	O
respectively	O
.	O

The	O
two	O
upstream	O
and	O
downstream	O
flanking	O
fragments	O
of	O
the	O
internal	O
vicK	O
fragment	O
from	O
Tyr151	O
to	O
Ser427	O
to	O
be	O
deleted	O
were	O
cloned	O
at	O
the	O
upstream	O
and	O
downstream	O
ends	O
of	O
the	O
aad	O
gene	O
,	O
respectively	O
,	O
resulting	O
in	O
suicide	O
plasmid	O
pGRV	O
-	O
DeltavicK	O
.	O

Single	O
crossover	O
between	O
one	O
flanking	O
fragment	O
in	O
pGRV	O
-	O
DeltavicK	O
and	O
the	O
homologous	O
region	O
in	O
the	O
genome	O
would	O
lead	O
to	O
the	O
insertion	O
of	O
the	O
whole	O
plasmid	O
into	O
S	B-Organism
.	I-Organism
equi	E-Organism
genome	O
,	O
resulting	O
in	O
strains	O
resistant	O
to	O
both	O
spectinomycin	O
and	O
chloramphenicol	O
.	O

Double	O
crossoverat	O
both	O
of	O
the	O
flanking	O
fragments	O
would	O
lead	O
to	O
the	O
replacement	O
of	O
the	O
vicK	O
internal	O
fragment	O
with	O
the	O
aad	O
gene	O
,	O
resulting	O
in	O
vicK	O
deletion	O
strains	O
with	O
resistance	O
only	O
to	O
spectinomycin	O
.	O

The	O
colonies	O
on	O
spectinomycin	O
agar	O
plates	O
were	O
tested	O
for	O
resistance	O
to	O
chloramphenicol	O
.	O

Three	O
putative	O
DeltavicK	O
strains	O
,	O
which	O
were	O
spectinomycin	O
-	O
resistant	O
and	O
chloramphenicol	O
-	O
sensitive	O
,	O
were	O
obtained	O
.	O

PCR	O
analyses	O
using	O
the	O
primers	O
located	O
beyond	O
the	O
deleted	O
fragment	O
resulted	O
in	O
the	O
PCR	O
product	O
from	O
these	O
strains	O
that	O
were	O
expectedly	O
bigger	O
than	O
that	O
from	O
the	O
wild	O
-	O
type	O
strain	O
because	O
the	O
replacing	O
fragment	O
was	O
bigger	O
than	O
the	O
displaced	O
vicK	O
fragment	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

DNA	O
sequencing	O
confirmed	O
the	O
desired	O
deletion	O
.	O

One	O
deletion	O
strain	O
was	O
randomly	O
chosen	O
for	O
further	O
characterization	O
.	O

Growth	O
of	O
DeltavicK	O
in	O
THY	O
and	O
Rabbit	O
Blood	O

The	O
growth	O
curve	O
of	O
the	O
DeltavicK	O
mutant	O
in	O
THY	O
displays	O
a	O
longer	O
early	O
growth	O
phase	O
and	O
smaller	O
slope	O
in	O
the	O
exponential	O
growth	O
phase	O
than	O
that	O
of	O
the	O
parent	O
strain	O
(	O
Fig	O
.	O
2A	O
)	O
,	O
indicating	O
that	O
the	O
vicK	O
deletion	O
detrimentally	O
affects	O
S	B-Organism
.	I-Organism
equi	E-Organism
growth	O
.	O

The	O
effect	O
of	O
the	O
deletion	O
on	O
S	B-Organism
.	I-Organism
equi	E-Organism
growth	O
in	O
blood	O
was	O
also	O
examined	O
.	O

The	O
wild	O
-	O
type	O
and	O
DeltavicK	O
S	O
.	O
equi	O
strains	O
were	O
inoculated	O
into	O
1	O
ml	O
heparinized	O
rabbit	O
blood	O
at	O
an	O
inoculum	O
of	O
approximately	O
20	O
,	O
000	O
cfu	O
.	O

The	O
samples	O
were	O
incubated	O
for	O
4	O
h	O
,	O
and	O
the	O
numbers	O
of	O
the	O
bacteria	O
in	O
the	O
samples	O
and	O
inocula	O
at	O
time	O
zero	O
were	O
determined	O
by	O
plating	O
.	O

The	O
growth	O
factors	O
,	O
the	O
ratio	O
of	O
cfu	O
in	O
the	O
sample	O
at	O
4	O
h	O
over	O
cfu	O
at	O
time	O
zero	O
,	O
were	O
250	O
and	O
66	O
for	O
the	O
wild	O
type	O
and	O
DeltavicK	O
strains	O
,	O
respectively	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Thus	O
,	O
the	O
DeltavicK	O
mutant	O
has	O
significantly	O
reduced	O
ability	O
to	O
grow	O
in	O
rabbit	O
blood	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

No	O
Effect	O
of	O
the	O
vicK	O
Deletion	O
on	O
Resistance	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
to	O
Phagocytosis	O
by	O
PMNs	O

To	O
determine	O
whether	O
the	O
DeltavicK	O
deletion	O
affects	O
the	O
resistance	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
to	O
phagocytosis	O
by	O
PMNs	O
,	O
the	O
phagocytosis	O
of	O
wild	O
-	O
type	O
and	O
DeltavicK	O
bacteria	O
by	O
PMNs	O
in	O
non	O
-	O
immune	O
horse	O
and	O
rabbit	O
blood	O
was	O
compared	O
.	O

FITC	O
-	O
labeled	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
,	O
DeltavicK	O
mutant	O
,	O
and	O
S	O
.	O
pyogenes	O
spy1718	O
:	O
:	O
aad	O
mutant	O
were	O
incubated	O
with	O
heparinized	O
horse	O
or	O
rabbit	O
blood	O
for	O
5	O
and	O
15	O
min	O
,	O
and	O
percentages	O
of	O
PMNs	O
associated	O
with	O
fluorescent	O
bacteria	O
were	O
quantified	O
using	O
flow	O
cytometry	O
analysis	O
.	O

The	O
spy1718	O
:	O
:	O
aad	O
mutant	O
of	O
S	B-Organism
.	I-Organism
pyogenes	E-Organism
,	O
which	O
is	O
no	O
longer	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
was	O
used	O
as	O
a	O
positive	O
control	O
in	O
the	O
assay	O
.	O

The	O
percentages	O
of	O
PMNs	O
with	O
associated	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
and	O
spy1718	O
:	O
:	O
aad	O
were	O
low	O
and	O
high	O
,	O
respectively	O
,	O
indicating	O
that	O
the	O
assay	O
worked	O
well	O
to	O
evaluate	O
resistance	O
of	O
the	O
bacteria	O
to	O
phagocytosis	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
percentages	O
of	O
PMNs	O
associated	O
with	O
wild	O
-	O
type	O
and	O
DeltavicK	O
bacteria	O
at	O
both	O
time	O
points	O
and	O
in	O
both	O
horse	O
and	O
rabbit	O
blood	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
the	O
DeltavicK	O
mutant	O
retains	O
the	O
ability	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
to	O
resist	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

Attenuation	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
Virulence	O
by	O
vicK	O
Deletion	O

Group	O
of	O
8	O
mice	S-Organism
were	O
subcutaneously	O
inoculated	O
with	O
1	O
.	O
1	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
or	O
DeltavicK	O
mutant	O
strains	O
.	O

Seven	O
of	O
the	O
8	O
mice	S-Organism
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
strain	O
died	O
,	O
whereas	O
7	O
of	O
the	O
8	O
mice	S-Organism
inoculated	O
with	O
DeltavicK	O
survived	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

The	O
infection	O
was	O
performed	O
in	O
a	O
model	O
of	O
intranasal	O
infection	O
as	O
well	O
.	O

All	O
the	O
8	O
mice	S-Organism
infected	O
with	O
DeltavicK	O
survived	O
,	O
whereas	O
5	O
of	O
the	O
8	O
mice	S-Organism
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
strain	O
died	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
vicK	O
deletion	O
significantly	O
attenuated	O
S	B-Organism
.	I-Organism
equi	E-Organism
virulence	O
in	O
both	O
mouse	S-Organism
models	O
of	O
subcutaneous	O
(	O
P	O
=	O
0	O
.	O
0066	O
)	O
and	O
nasal	O
(	O
P	O
=	O
0	O
.	O
0085	O
)	O
infections	O
.	O

DeltavicK	O
Infection	O
Confers	O
Protection	O
of	O
Mice	S-Organism
against	O
Reinfection	O
with	O
Wild	O
-	O
Type	O
S	B-Organism
.	I-Organism
equi	E-Organism

To	O
test	O
whether	O
DeltavicK	O
infection	O
confers	O
immunity	O
against	O
S	B-Organism
.	I-Organism
equi	E-Organism
infection	O
,	O
the	O
seven	O
mice	S-Organism
recovered	O
from	O
the	O
subcutaneous	O
DeltavicK	O
infection	O
was	O
reinfected	O
subcutaneously	O
with	O
1	O
.	O
5	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
30	O
days	O
after	O
the	O
first	O
infection	O
and	O
monitored	O
for	O
18	O
days	O
.	O

Six	O
of	O
the	O
7	O
mice	S-Organism
survived	O
the	O
reinfection	O
(	O
Fig	O
.	O
4A	O
)	O
,	O
suggesting	O
that	O
the	O
DeltavicK	O
infection	O
induces	O
immunity	O
against	O
S	B-Organism
.	I-Organism
equi	E-Organism
infection	O
.	O

Intranasal	O
DeltavicK	O
Infection	O
Induces	O
SeM	O
-	O
Specific	O
Mucosal	O
IgA	O
and	O
Systemic	O
IgG	O

To	O
examine	O
the	O
humoral	O
immune	O
responses	O
in	O
the	O
intranasal	O
DeltavicK	O
infection	O
,	O
nasal	O
wash	O
and	O
serum	O
samples	O
were	O
collected	O
from	O
the	O
8	O
mice	S-Organism
infected	O
intranasally	O
with	O
DeltavicK	O
and	O
3	O
surviving	O
mice	S-Organism
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
30	O
days	O
after	O
infection	O
.	O

Half	O
of	O
the	O
nasal	O
wash	O
samples	O
from	O
the	O
mice	S-Organism
infected	O
with	O
DeltavicK	O
had	O
similar	O
levels	O
of	O
SeM38	O
-	O
260	O
-	O
IgA	O
reactivity	O
with	O
those	O
from	O
the	O
mice	S-Organism
infected	O
with	O
the	O
wild	O
-	O
type	O
strains	O
.	O

Similarly	O
,	O
these	O
4	O
mice	S-Organism
with	O
higher	O
IgA	O
levels	O
also	O
had	O
higher	O
levels	O
of	O
SeM	O
-	O
specific	O
systemic	O
IgG	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

Western	O
blotting	O
analysis	O
was	O
used	O
to	O
confirm	O
the	O
presence	O
of	O
SeM	O
-	O
specific	O
IgG	O
.	O

The	O
wild	O
-	O
type	O
sera	O
and	O
5	O
of	O
the	O
8	O
DeltavicK	O
samples	O
had	O
strong	O
immunoreactions	O
with	O
SeM38	O
-	O
260	O
in	O
Western	O
blotting	O
analysis	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

Thus	O
,	O
the	O
DeltavicK	O
mutant	O
has	O
the	O
ability	O
to	O
induce	O
mucosal	O
and	O
systemic	O
immune	O
responses	O
,	O
though	O
there	O
was	O
host	O
variation	O
in	O
these	O
responses	O
caused	O
by	O
DeltavicK	O
infection	O
.	O

DISCUSSION	O

VicK	O
is	O
essential	O
in	O
B	B-Organism
.	I-Organism
subtilis	E-Organism
[	O
2	O
]	O
and	O
S	B-Organism
.	I-Organism
aureus	E-Organism
[	O
3	O
]	O
but	O
not	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	E-Organism
[	O
7	O
]	O
,	O
S	B-Organism
.	I-Organism
mutans	E-Organism
[	O
8	O
]	O
,	O
and	O
S	B-Organism
.	I-Organism
pyogenes	E-Organism
[	O
6	O
]	O
.	O

We	O
successfully	O
deleted	O
the	O
vicK	O
gene	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
.	O

Thus	O
,	O
VicK	O
is	O
not	O
essential	O
in	O
S	B-Organism
.	I-Organism
equi	E-Organism
.	O

However	O
,	O
the	O
DeltavicK	O
mutant	O
is	O
attenuated	O
in	O
virulence	O
in	O
both	O
mouse	S-Organism
models	O
of	O
subcutaneous	O
and	O
intranasal	O
S	B-Organism
.	I-Organism
equi	E-Organism
infections	O
,	O
indicating	O
that	O
VicRK	O
is	O
important	O
to	O
virulence	O
.	O

The	O
results	O
provide	O
the	O
further	O
evidence	O
for	O
the	O
importance	O
of	O
VicRK	O
to	O
virulence	O
of	O
Gram	O
-	O
positive	O
pathogens	O
.	O

S	O
.	O
equi	O
DeltavicK	O
mutant	O
does	O
not	O
grow	O
as	O
well	O
as	O
the	O
wild	O
-	O
type	O
strain	O
in	O
both	O
THY	O
and	O
blood	O
,	O
suggesting	O
that	O
the	O
vicK	O
deletion	O
causes	O
defect	O
in	O
growth	O
,	O
a	O
plausible	O
reason	O
that	O
likely	O
contributes	O
to	O
the	O
attenuation	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
virulence	O
in	O
the	O
mouse	S-Organism
infection	O
models	O
.	O

This	O
suggestion	O
is	O
further	O
supported	O
by	O
the	O
observations	O
that	O
both	O
the	O
wild	O
-	O
type	O
and	O
DeltavicK	O
mutant	O
strains	O
are	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
which	O
suggest	O
that	O
VicRK	O
is	O
not	O
required	O
for	O
the	O
evasion	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
to	O
the	O
innate	O
immunity	O
.	O

As	O
introduced	O
earlier	O
,	O
the	O
various	O
phenotypes	O
have	O
been	O
described	O
for	O
the	O
vicRK	O
mutants	O
of	O
the	O
various	O
pathogens	O
.	O

Whether	O
the	O
phenotypes	O
are	O
specific	O
to	O
particular	O
organisms	O
is	O
not	O
known	O
.	O

The	O
phenotypes	O
of	O
the	O
S	O
.	O
equi	O
DeltavicK	O
mutant	O
are	O
similar	O
to	O
those	O
of	O
the	O
S	O
.	O
pyogenes	O
DeltavicK	O
mutant	O
[	O
6	O
]	O
,	O
suggesting	O
that	O
the	O
growth	O
defect	O
phenotype	O
may	O
be	O
a	O
common	O
feature	O
of	O
the	O
vicRK	O
mutants	O
of	O
various	O
Gram	O
-	O
positive	O
pathogens	O
.	O

The	O
DeltavicK	O
mutant	O
appears	O
to	O
possess	O
the	O
properties	O
of	O
a	O
potential	O
live	O
vaccine	O
.	O

First	O
,	O
it	O
is	O
attenuated	O
in	O
virulence	O
in	O
the	O
mouse	S-Organism
infection	O
models	O
.	O

Secondly	O
,	O
DeltavicK	O
inoculation	O
protects	O
mice	S-Organism
against	O
subsequent	O
infection	O
with	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism
equi	E-Organism
.	O

Thirdly	O
,	O
most	O
of	O
the	O
mice	S-Organism
with	O
intranasal	O
DeltavicK	O
infection	O
produce	O
mucosal	O
IgA	O
and	O
systemic	O
IgG	O
specific	O
to	O
protective	O
antigen	O
SeM	O
.	O

However	O
,	O
whether	O
DeltavicK	O
can	O
be	O
an	O
effective	O
live	O
vaccine	O
and	O
whether	O
the	O
DeltavicK	O
mutant	O
has	O
any	O
advantages	O
over	O
the	O
current	O
live	O
S	B-Organism
.	I-Organism
equi	E-Organism
vaccine	O
require	O
the	O
test	O
of	O
the	O
mutant	O
in	O
horses	S-Organism
since	O
S	B-Organism
.	I-Organism
equi	E-Organism
does	O
not	O
naturally	O
infect	O
mice	S-Organism
.	O

We	O
hope	O
to	O
perform	O
this	O
expensive	O
test	O
in	O
future	O
when	O
funds	O
are	O
available	O

Coordinated	O
Regulation	O
of	O
Virulence	O
during	O
Systemic	O
Infection	O
of	O
Salmonella	B-Organism
enterica	I-Organism
Serovar	I-Organism
Typhimurium	E-Organism

To	O
cause	O
a	O
systemic	O
infection	O
,	O
Salmonella	S-Organism
must	O
respond	O
to	O
many	O
environmental	O
cues	O
during	O
mouse	S-Organism
infection	O
and	O
express	O
specific	O
subsets	O
of	O
genes	O
in	O
a	O
temporal	O
and	O
spatial	O
manner	O
,	O
but	O
the	O
regulatory	O
pathways	O
are	O
poorly	O
established	O
.	O

To	O
unravel	O
how	O
micro	O
-	O
environmental	O
signals	O
are	O
processed	O
and	O
integrated	O
into	O
coordinated	O
action	O
,	O
we	O
constructed	O
in	O
-	O
frame	O
non	O
-	O
polar	O
deletions	O
of	O
83	O
regulators	O
inferred	O
to	O
play	O
a	O
role	O
in	O
Salmonella	B-Organism
enteriditis	I-Organism
Typhimurium	E-Organism
(	O
STM	S-Organism
)	O
virulence	O
and	O
tested	O
them	O
in	O
three	O
virulence	O
assays	O
(	O
intraperitoneal	O
[	O
i	O
.	O
p	O
.	O
]	O
,	O
and	O
intragastric	O
[	O
i	O
.	O
g	O
.	O
]	O
infection	O
in	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
,	O
and	O
persistence	O
in	O
129X1	B-Organism
/	I-Organism
SvJ	I-Organism
mice	E-Organism
)	O
.	O

Overall	O
,	O
35	O
regulators	O
were	O
identified	O
whose	O
absence	O
attenuated	O
virulence	O
in	O
at	O
least	O
one	O
assay	O
,	O
and	O
of	O
those	O
,	O
14	O
regulators	O
were	O
required	O
for	O
systemic	O
mouse	S-Organism
infection	O
,	O
the	O
most	O
stringent	O
virulence	O
assay	O
.	O

As	O
a	O
first	O
step	O
towards	O
understanding	O
the	O
interplay	O
between	O
a	O
pathogen	O
and	O
its	O
host	O
from	O
a	O
systems	O
biology	O
standpoint	O
,	O
we	O
focused	O
on	O
these	O
14	O
genes	O
.	O

Transcriptional	O
profiles	O
were	O
obtained	O
for	O
deletions	O
of	O
each	O
of	O
these	O
14	O
regulators	O
grown	O
under	O
four	O
different	O
environmental	O
conditions	O
.	O

These	O
results	O
,	O
as	O
well	O
as	O
publicly	O
available	O
transcriptional	O
profiles	O
,	O
were	O
analyzed	O
using	O
both	O
network	O
inference	O
and	O
cluster	O
analysis	O
algorithms	O
.	O

The	O
analysis	O
predicts	O
a	O
regulatory	O
network	O
in	O
which	O
all	O
14	O
regulators	O
control	O
the	O
same	O
set	O
of	O
genes	O
necessary	O
for	O
Salmonella	S-Organism
to	O
cause	O
systemic	O
infection	O
.	O

We	O
tested	O
the	O
regulatory	O
model	O
by	O
expressing	O
a	O
subset	O
of	O
the	O
regulators	O
in	O
trans	O
and	O
monitoring	O
transcription	O
of	O
7	O
known	O
virulence	O
factors	O
located	O
within	O
Salmonella	S-Organism
pathogenicity	O
island	O
2	O
(	O
SPI	O
-	O
2	O
)	O
.	O

These	O
experiments	O
validated	O
the	O
regulatory	O
model	O
and	O
showed	O
that	O
the	O
response	O
regulator	O
SsrB	O
and	O
the	O
MarR	O
type	O
regulator	O
,	O
SlyA	O
,	O
are	O
the	O
terminal	O
regulators	O
in	O
a	O
cascade	O
that	O
integrates	O
multiple	O
signals	O
.	O

Furthermore	O
,	O
experiments	O
to	O
demonstrate	O
epistatic	O
relationships	O
showed	O
that	O
SsrB	O
can	O
replace	O
SlyA	O
and	O
,	O
in	O
some	O
cases	O
,	O
SlyA	O
can	O
replace	O
SsrB	O
for	O
expression	O
of	O
SPI	O
-	O
2	O
encoded	O
virulence	O
factors	O
.	O

Introduction	O

Gastrointestinal	O
infections	O
are	O
the	O
second	O
most	O
common	O
cause	O
of	O
childhood	O
mortality	O
in	O
the	O
developing	O
world	O
and	O
Typhoid	O
alone	O
(	O
caused	O
by	O
serovar	O
Typhi	S-Organism
)	O
is	O
estimated	O
to	O
result	O
in	O
500	O
,	O
000	O
deaths	O
per	O
year	O
[	O
1	O
]	O
.	O

In	O
addition	O
to	O
fluid	O
and	O
electrolyte	O
loss	O
,	O
non	O
-	O
typhoidal	O
Salmonella	S-Organism
often	O
results	O
in	O
septicemia	O
in	O
children	S-Organism
and	O
in	O
HIV	S-Organism
infected	O
adults	O
in	O
developing	O
countries	O
with	O
a	O
fatality	O
rate	O
of	O
25	O
%	O
or	O
greater	O
[	O
2	O
]	O
.	O

Salmonella	B-Organism
enteriditis	I-Organism
serotype	I-Organism
Typhimurium	E-Organism
(	O
referred	O
to	O
simply	O
as	O
Salmonella	S-Organism
or	O
Typhimurium	S-Organism
below	O
)	O
is	O
a	O
paradigm	O
for	O
understanding	O
intracellular	O
pathogenesis	O
because	O
of	O
its	O
established	O
genetics	O
and	O
simple	O
and	O
inexpensive	O
animal	O
model	O
-	O
the	O
mouse	S-Organism
.	O

All	O
strains	O
of	O
Salmonella	B-Organism
enteriditis	E-Organism
share	O
at	O
least	O
95	O
%	O
sequence	O
identity	O
;	O
the	O
differences	O
are	O
associated	O
with	O
growth	O
in	O
a	O
specific	O
host	O
or	O
survival	O
in	O
an	O
environmental	O
niche	O
.	O

More	O
than	O
4	O
%	O
of	O
the	O
entire	O
genome	O
is	O
required	O
for	O
Typhimurium	S-Organism
to	O
infect	O
the	O
mouse	S-Organism
[	O
3	O
]	O
.	O

These	O
genes	O
are	O
widely	O
distributed	O
around	O
the	O
entire	O
circular	O
chromosome	O
including	O
many	O
genes	O
not	O
involved	O
in	O
metabolic	O
processes	O
nor	O
required	O
for	O
growth	O
under	O
laboratory	O
conditions	O
.	O

Numerous	O
studies	O
have	O
assigned	O
a	O
small	O
fraction	O
of	O
these	O
genes	O
to	O
specific	O
steps	O
in	O
mouse	S-Organism
infection	O
but	O
most	O
are	O
still	O
a	O
mystery	O
.	O

Many	O
virulence	O
genes	O
are	O
attributable	O
to	O
horizontally	O
acquired	O
DNA	O
sequences	O
that	O
are	O
not	O
present	O
in	O
nonpathogenic	O
but	O
related	O
bacteria	O
.	O

These	O
regions	O
include	O
two	O
40	O
kb	O
stretches	O
of	O
DNA	O
termed	O
Salmonella	S-Organism
pathogenicity	O
islands	O
1	O
(	O
SPI	O
-	O
1	O
)	O
and	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
4	O
]	O
-	O
[	O
9	O
]	O
.	O

SPI	O
-	O
1	O
and	O
SPI	O
-	O
2	O
encode	O
a	O
secretion	O
apparatus	O
resembling	O
a	O
needle	O
and	O
related	O
to	O
the	O
bacterial	O
flagella	O
that	O
uses	O
the	O
proton	O
motive	O
force	O
to	O
secrete	O
proteins	O
directly	O
into	O
the	O
cytoplasm	O
of	O
the	O
eukaryotic	O
cell	O
[	O
10	O
]	O
.	O

Secretion	O
can	O
take	O
place	O
from	O
extracellular	O
bacteria	O
that	O
are	O
juxtaposed	O
to	O
the	O
surface	O
of	O
the	O
cell	O
or	O
from	O
intracellular	O
bacteria	O
located	O
in	O
vacuoles	O
.	O

The	O
two	O
type	O
III	O
secretion	O
systems	O
are	O
expressed	O
under	O
different	O
environmental	O
conditions	O
and	O
play	O
distinct	O
roles	O
in	O
pathogenesis	O
.	O

SPI	O
-	O
2	O
is	O
known	O
to	O
be	O
required	O
for	O
systemic	O
infection	O
whereas	O
SPI	O
-	O
1	O
plays	O
an	O
essential	O
role	O
during	O
intestinal	O
infection	O
and	O
in	O
mouse	S-Organism
persistence	O
[	O
11	O
]	O
-	O
[	O
14	O
]	O
.	O

During	O
the	O
course	O
of	O
systemic	O
infection	O
in	O
mice	S-Organism
,	O
bacteria	O
are	O
found	O
within	O
neutrophils	O
,	O
monocytes	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
but	O
are	O
not	O
found	O
extracellularly	O
until	O
the	O
last	O
one	O
or	O
two	O
days	O
immediately	O
before	O
death	O
of	O
the	O
mouse	S-Organism
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O

How	O
Salmonella	S-Organism
survives	O
and	O
replicates	O
within	O
the	O
host	O
and	O
how	O
it	O
expresses	O
virulence	O
genes	O
at	O
the	O
appropriate	O
time	O
during	O
systemic	O
infection	O
is	O
little	O
understood	O
and	O
the	O
subject	O
of	O
this	O
work	O
.	O

Technological	O
advances	O
in	O
the	O
last	O
10	O
years	O
such	O
as	O
microarrays	O
,	O
whole	O
genome	O
sequences	O
,	O
and	O
global	O
proteomics	O
have	O
provided	O
a	O
more	O
complete	O
picture	O
of	O
gene	O
expression	O
for	O
a	O
number	O
of	O
bacteria	O
.	O

The	O
goal	O
of	O
the	O
current	O
work	O
is	O
to	O
develop	O
a	O
predictive	O
model	O
for	O
host	O
-	O
pathogen	O
interactions	O
that	O
will	O
provide	O
insight	O
into	O
how	O
Salmonella	S-Organism
responds	O
to	O
specific	O
conditions	O
in	O
the	O
host	O
.	O

This	O
approach	O
was	O
based	O
on	O
identification	O
of	O
regulators	O
that	O
were	O
necessary	O
for	O
Salmonella	S-Organism
to	O
cause	O
a	O
systemic	O
infection	O
and	O
transcriptional	O
profiling	O
of	O
isogenic	O
derivatives	O
missing	O
the	O
regulator	O
under	O
a	O
variety	O
of	O
growth	O
conditions	O
.	O

The	O
transcriptional	O
profiles	O
provided	O
more	O
than	O
300	O
,	O
000	O
data	O
point	O
,	O
necessitating	O
computer	O
analysis	O
.	O

We	O
have	O
used	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
;	O
[	O
18	O
]	O
)	O
to	O
directly	O
compare	O
multiple	O
network	O
algorithms	O
.	O

The	O
network	O
inference	O
algorithm	O
that	O
we	O
have	O
used	O
is	O
the	O
context	O
likelihood	O
of	O
relatedness	O
(	O
CLR	O
)	O
to	O
analyze	O
the	O
gene	O
expression	O
profiles	O
[	O
19	O
]	O
.	O

CLR	O
is	O
an	O
extension	O
of	O
the	O
relevance	O
network	O
class	O
of	O
machine	O
learning	O
algorithms	O
[	O
20	O
]	O
and	O
provides	O
the	O
highest	O
precision	O
of	O
several	O
algorithms	O
tested	O
[	O
19	O
]	O
.	O

At	O
a	O
60	O
%	O
true	O
positive	O
rate	O
,	O
CLR	O
identified	O
1	O
,	O
079	O
regulatory	O
interactions	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
of	O
which	O
338	O
were	O
in	O
previously	O
known	O
networks	O
and	O
741	O
were	O
novel	O
predictions	O
(	O
ibid	O
)	O
.	O

The	O
analysis	O
of	O
our	O
data	O
provided	O
a	O
testable	O
regulatory	O
hierarchy	O
and	O
a	O
list	O
of	O
genes	O
with	O
similar	O
expression	O
profiles	O
as	O
described	O
below	O
.	O

Results	O

Salmonella	S-Organism
regulators	O
required	O
for	O
systemic	O
mouse	S-Organism
infection	O
Typhimurium	S-Organism
encodes	O
a	O
surfeit	O
of	O
regulators	O
(	O
more	O
than	O
330	O
based	O
on	O
annotation	O
cited	O
in	O
NCBI	O
)	O
presumably	O
because	O
it	O
can	O
survive	O
and	O
replicate	O
in	O
many	O
different	O
environments	O
,	O
cause	O
infection	O
in	O
diverse	O
hosts	O
,	O
and	O
can	O
use	O
multiple	O
carbon	O
sources	O
and	O
terminal	O
electron	O
acceptors	O
.	O

We	O
focused	O
on	O
83	O
regulators	O
presumed	O
to	O
play	O
roles	O
in	O
virulence	O
,	O
based	O
on	O
published	O
data	O
including	O
negative	O
selection	O
experiments	O
[	O
13	O
]	O
,	O
[	O
21	O
]	O
-	O
[	O
23	O
]	O
.	O

We	O
constructed	O
non	O
-	O
polar	O
in	O
-	O
frame	O
deletions	O
in	O
which	O
each	O
regulator	O
gene	O
was	O
replaced	O
with	O
a	O
"	O
scar	O
"	O
sequence	O
using	O
bacteriophage	B-Organism
lambda	E-Organism
-	O
mediated	O
recombination	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
.	O

The	O
list	O
of	O
83	O
regulator	O
genes	O
is	O
provided	O
in	O
Supporting	O
Information	O
(	O
Table	O
S1	O
)	O
.	O

For	O
the	O
two	O
-	O
component	O
regulator	O
ssrA	O
/	O
ssrB	O
we	O
constructed	O
in	O
-	O
frame	O
deletions	O
missing	O
ssrA	O
,	O
ssrB	O
or	O
both	O
;	O
for	O
the	O
other	O
two	O
two	O
-	O
component	O
regulators	O
,	O
phoP	O
/	O
phoQ	O
and	O
ompR	O
/	O
envZ	O
,	O
both	O
the	O
signal	O
sensor	O
and	O
response	O
regulator	O
were	O
deleted	O
.	O

As	O
an	O
initial	O
screen	O
two	O
4	O
-	O
6	O
weeks	O
-	O
old	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
were	O
infected	O
intraperitoneally	O
(	O
i	O
.	O
p	O
.	O
)	O
with	O
200	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
of	O
each	O
deleted	O
strain	O
(	O
about	O
100x	O
the	O
LD50	O
)	O
.	O

Mutations	O
that	O
resulted	O
in	O
either	O
no	O
deaths	O
,	O
one	O
death	O
,	O
or	O
delayed	O
death	O
of	O
infected	O
mice	S-Organism
were	O
retested	O
with	O
groups	O
of	O
5	O
mice	S-Organism
at	O
the	O
same	O
dose	O
(	O
Figure	O
1A	O
)	O
.	O

Based	O
on	O
this	O
preliminary	O
screen	O
we	O
chose	O
the	O
regulators	O
spvR	O
,	O
fruR	O
,	O
himD	O
,	O
phoP	O
/	O
phoQ	O
,	O
ssrA	O
/	O
ssrB	O
,	O
slyA	O
,	O
hnr	O
,	O
rpoE	O
,	O
smpB	O
,	O
csrA	O
,	O
rpoS	O
,	O
crp	O
,	O
ompR	O
/	O
envZ	O
,	O
and	O
hfq	O
for	O
further	O
investigation	O
(	O
see	O
Figure	O
1	O
and	O
Table	O
1	O
for	O
references	O
and	O
descriptions	O
;	O
a	O
complete	O
list	O
of	O
virulence	O
phenotypes	O
is	O
provided	O
in	O
Table	O
S1	O
)	O
.	O

It	O
is	O
possible	O
that	O
additional	O
regulators	O
would	O
be	O
identified	O
if	O
a	O
larger	O
group	O
of	O
mice	S-Organism
were	O
used	O
in	O
the	O
initial	O
screen	O
.	O

The	O
LD50	O
for	O
each	O
of	O
the	O
mutants	O
was	O
computed	O
as	O
shown	O
in	O
Figure	O
1B	O
.	O

Compared	O
to	O
the	O
parental	O
strain	O
(	O
ATCC14028	S-Organism
)	O
,	O
which	O
has	O
an	O
LD50	O
of	O
1	O
-	O
2	O
cfu	O
,	O
all	O
of	O
the	O
derivatives	O
were	O
attenuated	O
for	O
virulence	O
.	O

The	O
14	O
deletion	O
strains	O
lacking	O
regulators	O
reported	O
in	O
this	O
study	O
were	O
selected	O
from	O
i	O
.	O
p	O
.	O

BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
infection	O
to	O
eliminate	O
other	O
regulators	O
required	O
only	O
for	O
gastrointestinal	O
infection	O
or	O
persistence	O
but	O
most	O
of	O
these	O
strains	O
were	O
avirulent	O
in	O
another	O
strain	O
of	O
mice	S-Organism
(	O
129X1	B-Organism
/	I-Organism
SvJ	E-Organism
)	O
and	O
by	O
other	O
route	O
(	O
intragastric	O
)	O
of	O
infection	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Therefore	O
the	O
regulators	O
investigated	O
in	O
this	O
study	O
might	O
be	O
considered	O
the	O
most	O
central	O
regulators	O
for	O
virulence	O
.	O

In	O
the	O
other	O
virulence	O
assays	O
,	O
the	O
83	O
derivatives	O
were	O
tested	O
for	O
virulence	O
by	O
intragastric	O
(	O
i	O
.	O
g	O
.	O
)	O
BALB	B-Organism
/	I-Organism
c	E-Organism
infection	O
and	O
by	O
a	O
more	O
sensitive	O
competitive	O
index	O
(	O
CI	O
)	O
experiment	O
.	O

In	O
the	O
competitive	O
index	O
experiment	O
all	O
mutants	O
were	O
co	O
-	O
administered	O
to	O
129X1	B-Organism
/	I-Organism
SvJ	I-Organism
mice	E-Organism
and	O
the	O
number	O
of	O
each	O
surviving	O
mutant	O
bacteria	O
was	O
determined	O
7	O
days	O
after	O
i	O
.	O
p	O
.	O
inoculation	O
.	O

BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
are	O
missing	O
natural	O
resistance	O
-	O
associated	O
macrophage	O
protein	O
(	O
Nramp1	O
)	O
and	O
thus	O
succumb	O
to	O
Typhimurium	S-Organism
infection	O
within	O
a	O
week	O
when	O
mice	S-Organism
are	O
infected	O
i	O
.	O
p	O
.	O
with	O
less	O
than	O
10	O
bacteria	O
of	O
the	O
strain	O
employed	O
here	O
(	O
14028	O
)	O
.	O

Unlike	O
BALB	B-Organism
/	I-Organism
c	E-Organism
,	O
129X1	B-Organism
/	I-Organism
SvJ	I-Organism
mice	E-Organism
have	O
a	O
functional	O
copy	O
of	O
Nramp1	O
and	O
the	O
bacteria	O
persist	O
for	O
several	O
weeks	O
without	O
killing	O
the	O
mouse	S-Organism
[	O
13	O
]	O
,	O
[	O
26	O
]	O
.	O

The	O
CI	O
test	O
identified	O
30	O
(	O
out	O
of	O
83	O
)	O
regulator	O
mutants	O
that	O
were	O
attenuated	O
in	O
comparison	O
to	O
the	O
wild	O
type	O
control	O
(	O
see	O
Table	O
S1	O
)	O
.	O

The	O
14	O
derivatives	O
chosen	O
for	O
this	O
study	O
were	O
among	O
those	O
showing	O
the	O
poorest	O
survival	O
by	O
comparison	O
to	O
the	O
parent	O
in	O
this	O
competitive	O
index	O
experiment	O
.	O

The	O
14	O
regulators	O
identified	O
were	O
diverse	O
and	O
included	O
alternative	O
sigma	O
factors	O
(	O
rpoS	O
and	O
rpoE	O
)	O
,	O
two	O
-	O
component	O
regulators	O
(	O
ompR	O
/	O
envZ	O
,	O
phoP	O
/	O
phoQ	O
,	O
and	O
ssrA	O
/	O
ssrB	O
)	O
,	O
a	O
response	O
regulator	O
for	O
which	O
the	O
signal	O
sensor	O
is	O
unknown	O
(	O
hnr	O
or	O
mviA	O
)	O
,	O
post	O
-	O
transcriptional	O
regulators	O
(	O
csrA	O
,	O
hfq	O
and	O
smpB	O
)	O
,	O
a	O
bending	O
protein	O
essential	O
for	O
some	O
types	O
of	O
recombination	O
(	O
ihf	O
)	O
and	O
an	O
assortment	O
of	O
other	O
DNA	O
binding	O
proteins	O
(	O
fruR	O
,	O
spvR	O
,	O
crp	O
,	O
and	O
slyA	O
)	O
.	O

Transcription	O
profiling	O
was	O
carried	O
out	O
for	O
isogenic	O
deletion	O
mutants	O
in	O
each	O
of	O
these	O
14	O
genes	O
under	O
four	O
different	O
conditions	O
and	O
analyzed	O
to	O
infer	O
a	O
regulatory	O
hierarchy	O
during	O
systemic	O
infection	O
.	O

Salmonella	S-Organism
transcription	O
profiles	O
for	O
the	O
following	O
regulators	O
have	O
already	O
been	O
reported	O
:	O
rpoE	O
[	O
27	O
]	O
;	O
phoP	O
/	O
phoQ	O
[	O
28	O
]	O
;	O
ssrA	O
/	O
ssrB	O
[	O
29	O
]	O
;	O
csrA	O
[	O
30	O
]	O
;	O
slyA	O
[	O
31	O
]	O
;	O
ihf	O
[	O
32	O
]	O
;	O
hfq	O
[	O
33	O
]	O
.	O

Our	O
results	O
closely	O
match	O
these	O
published	O
results	O
.	O

The	O
large	O
degree	O
of	O
attenuation	O
we	O
observed	O
for	O
an	O
spvR	O
mutation	O
following	O
i	O
.	O
p	O
.	O
infection	O
was	O
surprising	O
,	O
as	O
most	O
studies	O
had	O
limited	O
its	O
effect	O
to	O
the	O
i	O
.	O
g	O
.	O
route	O
of	O
infection	O
.	O

To	O
validate	O
this	O
result	O
we	O
complemented	O
the	O
spvR	O
mutation	O
in	O
trans	O
and	O
found	O
complete	O
complementation	O
in	O
mouse	S-Organism
virulence	O
(	O
Figure	O
S1	O
)	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
others	O
are	O
most	O
likely	O
related	O
to	O
the	O
different	O
strains	O
of	O
Salmonella	S-Organism
used	O
in	O
the	O
studies	O
[	O
34	O
]	O
.	O

For	O
the	O
other	O
mutations	O
we	O
have	O
mobilized	O
the	O
mutation	O
into	O
a	O
new	O
genetic	O
background	O
by	O
P22	O
transduction	O
to	O
ensure	O
that	O
there	O
is	O
no	O
secondary	O
mutation	O
that	O
influences	O
the	O
results	O
[	O
35	O
]	O
.	O

The	O
ability	O
of	O
Salmonella	S-Organism
to	O
survive	O
and	O
replicate	O
in	O
macrophages	O
is	O
necessary	O
but	O
not	O
sufficient	O
for	O
mouse	S-Organism
virulence	O

Previous	O
work	O
demonstrated	O
that	O
Salmonella	S-Organism
mutants	O
that	O
were	O
unable	O
to	O
survive	O
within	O
elicited	O
peritoneal	O
macrophages	O
were	O
attenuated	O
for	O
virulence	O
during	O
systemic	O
mouse	S-Organism
infection	O
[	O
36	O
]	O
.	O

In	O
fact	O
,	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
analysis	O
of	O
infected	O
blood	O
and	O
spleen	O
using	O
Salmonella	S-Organism
that	O
expresses	O
green	O
fluorescent	O
protein	O
does	O
not	O
identify	O
any	O
extracellular	O
bacteria	O
[	O
16	O
]	O
,	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

Salmonella	S-Organism
is	O
within	O
blood	O
monocytes	O
and	O
in	O
other	O
WBC	O
in	O
the	O
spleen	O
including	O
neutrophils	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
in	O
these	O
reports	O
(	O
ibid	O
)	O
.	O

It	O
is	O
possible	O
that	O
growth	O
in	O
cells	O
types	O
other	O
than	O
macrophages	O
is	O
necessary	O
for	O
Salmonella	S-Organism
to	O
cause	O
a	O
systemic	O
infection	O
in	O
mice	S-Organism
following	O
i	O
.	O
p	O
.	O
administration	O
.	O

Thus	O
,	O
some	O
of	O
the	O
regulatory	O
mutations	O
described	O
here	O
may	O
affect	O
growth	O
in	O
cells	O
types	O
other	O
than	O
macrophages	O
.	O

We	O
therefore	O
wished	O
to	O
determine	O
if	O
there	O
is	O
a	O
direct	O
relationship	O
between	O
growth	O
in	O
macrophages	O
and	O
mouse	S-Organism
virulence	O
.	O

In	O
these	O
studies	O
we	O
used	O
primary	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDM	O
)	O
from	O
the	O
same	O
strain	O
of	O
mouse	S-Organism
as	O
used	O
in	O
the	O
original	O
identification	O
of	O
attenuated	O
regulatory	O
mutants	O
(	O
BALB	B-Organism
/	I-Organism
c	E-Organism
)	O
.	O

The	O
identical	O
number	O
of	O
input	O
bacteria	O
and	O
the	O
identical	O
number	O
of	O
macrophages	O
were	O
used	O
in	O
every	O
infection	O
experiment	O
.	O

As	O
observed	O
by	O
others	O
,	O
following	O
phagocytosis	O
there	O
is	O
some	O
bacterial	O
killing	O
that	O
varied	O
from	O
strain	O
to	O
strain	O
followed	O
by	O
intracellular	O
growth	O
.	O

We	O
monitored	O
the	O
number	O
of	O
intracellular	O
bacteria	O
at	O
an	O
early	O
time	O
(	O
30	O
min	O
)	O
to	O
determine	O
the	O
number	O
of	O
bacteria	O
internalized	O
(	O
Figure	O
2	O
)	O
.	O

Even	O
at	O
the	O
shortest	O
time	O
few	O
intracellular	O
bacteria	O
were	O
recovered	O
from	O
macrophage	O
infection	O
with	O
an	O
rpoE	O
mutant	O
,	O
suggesting	O
that	O
this	O
strain	O
is	O
very	O
sensitive	O
to	O
microbicidal	O
factors	O
released	O
by	O
macrophages	O
on	O
contact	O
with	O
bacteria	O
or	O
doesn	O
'	O
t	O
get	O
internalized	O
very	O
well	O
.	O

At	O
2	O
.	O
0	O
hrs	O
post	O
infection	O
there	O
was	O
a	O
decrease	O
in	O
bacterial	O
numbers	O
that	O
varied	O
from	O
strain	O
to	O
strain	O
presumably	O
reflecting	O
variation	O
in	O
the	O
sensitivity	O
to	O
bacterial	O
killing	O
by	O
the	O
oxidative	O
burst	O
,	O
acidic	O
pH	O
,	O
and	O
antimicrobial	O
peptides	O
.	O

Finally	O
,	O
at	O
18	O
hrs	O
bacterial	O
numbers	O
were	O
enumerated	O
to	O
monitor	O
intracellular	O
replication	O
as	O
well	O
as	O
the	O
ability	O
to	O
withstand	O
nitrous	O
oxide	O
oxidation	O
and	O
other	O
late	O
antimicrobial	O
factors	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

No	O
effect	O
was	O
found	O
at	O
any	O
time	O
point	O
for	O
a	O
mutant	O
in	O
the	O
plasmid	O
-	O
encoded	O
regulator	O
spvR	O
in	O
murine	S-Organism
macrophages	O
in	O
agreement	O
with	O
other	O
investigators	O
[	O
41	O
]	O
,	O
[	O
42	O
]	O
.	O

Small	O
differences	O
in	O
intracellular	O
growth	O
were	O
observed	O
for	O
ssrA	O
/	O
ssrB	O
and	O
slyA	O
compared	O
to	O
the	O
parent	O
although	O
larger	O
differences	O
have	O
been	O
observed	O
previously	O
[	O
43	O
]	O
-	O
[	O
45	O
]	O
perhaps	O
reflecting	O
BMDM	O
preparation	O
techniques	O
,	O
bacterial	O
strain	O
differences	O
,	O
or	O
opsonization	O
differences	O
[	O
46	O
]	O
.	O

Mutations	O
of	O
himD	O
,	O
rpoE	O
,	O
crp	O
,	O
or	O
hfq	O
drastically	O
reduce	O
the	O
number	O
of	O
viable	O
bacteria	O
that	O
can	O
be	O
recovered	O
from	O
macrophages	O
even	O
at	O
short	O
times	O
(	O
Figure	O
2	O
)	O
.	O

These	O
results	O
also	O
demonstrated	O
that	O
growth	O
in	O
macrophages	O
per	O
se	O
does	O
not	O
duplicate	O
in	O
vivo	O
infection	O
and	O
that	O
some	O
regulator	O
mutants	O
that	O
were	O
totally	O
avirulent	O
in	O
the	O
mouse	S-Organism
showed	O
no	O
differences	O
in	O
growth	O
in	O
these	O
primary	O
macrophages	O
.	O

Transcription	O
profiling	O
of	O
avirulent	O
strains	O

Because	O
some	O
of	O
the	O
Typhimurium	S-Organism
regulator	O
mutants	O
survived	O
so	O
poorly	O
within	O
macrophages	O
that	O
preparing	O
mRNA	O
from	O
intracellular	O
bacteria	O
was	O
not	O
possible	O
we	O
have	O
used	O
in	O
vitro	O
growth	O
conditions	O
that	O
duplicate	O
some	O
of	O
the	O
intracellular	O
conditions	O
(	O
low	O
pH	O
,	O
minimal	O
media	O
;	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
)	O
.	O

The	O
14	O
virulence	O
regulators	O
,	O
whose	O
absence	O
was	O
identified	O
by	O
attenuated	O
virulence	O
in	O
vivo	O
in	O
this	O
study	O
,	O
presumably	O
sense	O
specific	O
environmental	O
signals	O
within	O
the	O
host	O
and	O
respond	O
by	O
expressing	O
the	O
appropriate	O
complement	O
of	O
virulence	O
factors	O
.	O

However	O
the	O
specific	O
environmental	O
signals	O
are	O
not	O
known	O
and	O
therefore	O
each	O
strain	O
was	O
grown	O
in	O
four	O
different	O
conditions	O
;	O
to	O
log	O
phase	O
or	O
stationary	O
phase	O
in	O
Luria	O
-	O
Bertani	O
(	O
LB	O
)	O
broth	O
and	O
in	O
a	O
low	O
pH	O
/	O
low	O
magnesium	O
,	O
minimal	O
medium	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

Two	O
different	O
minimal	O
media	O
conditions	O
were	O
used	O
depending	O
only	O
on	O
pre	O
-	O
growth	O
conditions	O
as	O
described	O
in	O
the	O
Materials	O
and	O
Methods	O
(	O
called	O
acidic	O
minimal	O
media	O
(	O
AMM	O
)	O
1	O
and	O
AMM2	O
here	O
)	O
;	O
these	O
conditions	O
are	O
identical	O
to	O
conditions	O
previously	O
reported	O
for	O
expression	O
of	O
SPI	O
-	O
2	O
;	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

The	O
fate	O
of	O
intracellular	O
Typhimurium	S-Organism
is	O
determined	O
by	O
pre	O
-	O
growth	O
conditions	O
prior	O
to	O
macrophage	O
infection	O
and	O
for	O
that	O
reason	O
we	O
used	O
both	O
conditions	O
AMM1	O
and	O
2	O
[	O
49	O
]	O
.	O

To	O
identify	O
global	O
transcriptional	O
changes	O
for	O
each	O
regulator	O
,	O
mRNAs	O
were	O
isolated	O
from	O
each	O
strain	O
grown	O
under	O
the	O
four	O
conditions	O
,	O
converted	O
to	O
cDNA	O
,	O
and	O
used	O
to	O
probe	O
a	O
spotted	O
non	O
-	O
redundant	O
pan	O
-	O
Salmonella	S-Organism
orf	O
microarray	O
using	O
hybridization	O
of	O
total	O
genomic	O
Salmonella	S-Organism
DNA	O
as	O
an	O
internal	O
control	O
[	O
50	O
]	O
.	O

Each	O
microarray	O
was	O
probed	O
with	O
RNA	O
from	O
the	O
parent	O
or	O
an	O
isogenic	O
deletion	O
of	O
one	O
of	O
the	O
regulator	O
mutants	O
prepared	O
from	O
bacterial	O
cells	O
grown	O
under	O
one	O
of	O
the	O
four	O
conditions	O
.	O

In	O
all	O
there	O
were	O
4	O
biological	O
replicates	O
of	O
the	O
parent	O
strain	O
but	O
one	O
for	O
each	O
mutant	O
under	O
each	O
growth	O
condition	O
.	O

Transcriptional	O
profiles	O
were	O
significantly	O
different	O
from	O
the	O
parent	O
for	O
known	O
virulence	O
factors	O
required	O
during	O
systemic	O
infection	O
,	O
but	O
only	O
if	O
cells	O
were	O
grown	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM1	O
or	O
AMM2	O
;	O
see	O
Figure	O
3	O
;	O
complete	O
microarray	O
data	O
available	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
ohsu	O
.	O
edu	O
/	O
microbiology	O
/	O
heffron	O
/	O
r01	O
.	O
html	O
)	O
.	O

Z	O
-	O
scores	O
(	O
(	O
score	O
-	O
mean	O
)	O
/	O
standard	O
deviation	O
)	O
were	O
computed	O
for	O
each	O
gene	O
in	O
the	O
Typhimurium	S-Organism
genome	O
in	O
each	O
mutant	O
background	O
under	O
each	O
growth	O
condition	O
(	O
Table	O
S2	O
)	O
.	O

Statistical	O
analysis	O
of	O
the	O
complete	O
transcriptional	O
data	O
for	O
gene	O
expression	O
in	O
AMM1	O
identified	O
at	O
least	O
237	O
genes	O
that	O
were	O
reduced	O
4	O
-	O
fold	O
or	O
more	O
in	O
common	O
comparing	O
the	O
mutations	O
to	O
the	O
parent	O
strain	O
(	O
at	O
least	O
3	O
standard	O
deviation	O
based	O
on	O
the	O
technical	O
replicates	O
)	O
.	O

Because	O
transcription	O
is	O
reduced	O
in	O
the	O
mutant	O
compared	O
to	O
the	O
parent	O
,	O
it	O
suggests	O
that	O
normally	O
the	O
regulator	O
activates	O
transcription	O
of	O
these	O
genes	O
as	O
is	O
shown	O
dramatically	O
in	O
Figure	O
3	O
for	O
all	O
SPI	O
-	O
2	O
encoded	O
virulence	O
genes	O
.	O

Conversely	O
,	O
only	O
45	O
genes	O
showed	O
a	O
4	O
-	O
fold	O
or	O
more	O
up	O
-	O
regulation	O
in	O
the	O
mutant	O
backgrounds	O
when	O
cells	O
were	O
prepared	O
under	O
the	O
same	O
growth	O
condition	O
,	O
suggesting	O
that	O
the	O
regulator	O
normally	O
represses	O
these	O
genes	O
.	O

A	O
more	O
precise	O
statistical	O
analysis	O
of	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
SPI	O
-	O
2	O
is	O
provided	O
below	O
(	O
Table	O
2	O
)	O
.	O

All	O
in	O
all	O
,	O
these	O
results	O
suggest	O
that	O
the	O
normal	O
function	O
of	O
each	O
of	O
the	O
14	O
regulators	O
is	O
to	O
activate	O
transcription	O
of	O
virulence	O
factors	O
necessary	O
for	O
systemic	O
infection	O
but	O
only	O
under	O
specific	O
environmental	O
conditions	O
.	O

Acidic	O
minimal	O
media	O
(	O
AMM1	O
)	O
provides	O
the	O
best	O
induction	O
condition	O
of	O
those	O
that	O
were	O
examined	O
.	O

Validation	O
of	O
SPI	O
-	O
2	O
regulation	O

SPI	O
-	O
2	O
encodes	O
a	O
type	O
III	O
secretion	O
system	O
and	O
secreted	O
effectors	O
required	O
for	O
systemic	O
mouse	S-Organism
infection	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

To	O
assess	O
the	O
effects	O
of	O
growth	O
conditions	O
on	O
expression	O
of	O
the	O
SPI	O
-	O
2	O
secretion	O
apparatus	O
we	O
constructed	O
a	O
lacZ	O
transcriptional	O
fusion	O
to	O
ssaG	O
,	O
a	O
component	O
of	O
the	O
secretion	O
apparatus	O
,	O
and	O
tested	O
expression	O
in	O
each	O
mutant	O
background	O
under	O
each	O
of	O
the	O
four	O
growth	O
conditions	O
.	O

At	O
the	O
same	O
time	O
we	O
determined	O
transcript	O
levels	O
via	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
,	O
using	O
transcripts	O
from	O
rpoD	O
and	O
gyrB	O
as	O
controls	O
[	O
51	O
]	O
.	O

We	O
observed	O
that	O
the	O
results	O
determined	O
by	O
these	O
two	O
methods	O
matched	O
closely	O
(	O
Figure	O
S2	O
)	O
and	O
that	O
the	O
level	O
of	O
transcription	O
of	O
ssaG	O
was	O
highest	O
when	O
Salmonella	S-Organism
was	O
grown	O
in	O
minimal	O
acidic	O
media	O
.	O

In	O
agreement	O
with	O
the	O
microarrays	O
,	O
the	O
effect	O
of	O
these	O
regulators	O
on	O
ssaG	O
expression	O
was	O
minimal	O
if	O
the	O
bacteria	O
were	O
grown	O
in	O
rich	O
media	O
(	O
LB	O
broth	O
)	O
.	O

Because	O
the	O
type	O
III	O
secretion	O
system	O
and	O
associated	O
virulence	O
factors	O
encoded	O
within	O
SPI	O
-	O
2	O
were	O
most	O
highly	O
expressed	O
in	O
acidic	O
minimal	O
media	O
we	O
therefore	O
focused	O
on	O
growth	O
in	O
this	O
media	O
and	O
used	O
qRT	O
-	O
PCR	O
to	O
measure	O
transcript	O
levels	O
.	O

To	O
validate	O
the	O
transcriptional	O
profiles	O
we	O
prepared	O
RNA	O
from	O
mutants	O
and	O
parent	O
bacteria	O
grown	O
in	O
acidic	O
minimal	O
medium	O
and	O
used	O
as	O
template	O
for	O
qRT	O
-	O
PCR	O
.	O

Six	O
promoters	O
have	O
been	O
identified	O
for	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
(	O
see	O
Figure	O
4	O
;	O
[	O
52	O
]	O
)	O
.	O

We	O
monitored	O
transcription	O
of	O
seven	O
genes	O
within	O
SPI	O
-	O
2	O
,	O
covering	O
each	O
operon	O
at	O
least	O
once	O
,	O
and	O
used	O
gyrB	O
transcript	O
as	O
an	O
internal	O
control	O
.	O

We	O
observed	O
a	O
decrease	O
in	O
transcription	O
of	O
all	O
7	O
genes	O
in	O
11	O
of	O
the	O
14	O
mutants	O
.	O

The	O
three	O
exceptions	O
were	O
spvR	O
,	O
fruR	O
,	O
and	O
rpoS	O
.	O

Strains	O
containing	O
mutations	O
in	O
phoP	O
/	O
phoQ	O
,	O
ssrA	O
/	O
ssrB	O
,	O
slyA	O
,	O
and	O
ompR	O
/	O
envZ	O
showed	O
at	O
least	O
100	O
-	O
fold	O
decreases	O
in	O
transcription	O
of	O
all	O
SPI	O
-	O
2	O
genes	O
(	O
Figure	O
4	O
)	O
.	O

Mutations	O
of	O
ihf	O
(	O
himD	O
)	O
and	O
csrA	O
showed	O
an	O
intermediate	O
level	O
of	O
8	O
-	O
16	O
-	O
fold	O
decreased	O
transcription	O
whereas	O
hnr	O
,	O
rpoE	O
,	O
smpB	O
,	O
crp	O
and	O
hfq	O
showed	O
a	O
modest	O
decrease	O
of	O
2	O
-	O
8	O
-	O
fold	O
.	O

The	O
results	O
of	O
this	O
analysis	O
are	O
generally	O
concordant	O
with	O
the	O
microarray	O
results	O
although	O
the	O
dynamic	O
range	O
was	O
larger	O
for	O
qRT	O
-	O
PCR	O
than	O
for	O
the	O
microarrays	O
as	O
has	O
been	O
observed	O
before	O
[	O
53	O
]	O
.	O

Note	O
that	O
rpoE	O
and	O
hfq	O
mutants	O
showed	O
a	O
dramatic	O
reduction	O
in	O
macrophage	O
survival	O
,	O
but	O
little	O
difference	O
in	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
during	O
growth	O
in	O
AMM	O
.	O

It	O
has	O
recently	O
been	O
reported	O
that	O
the	O
translational	O
regulator	O
Hfq	O
,	O
regulates	O
translation	O
of	O
RpoE	O
explaining	O
in	O
part	O
why	O
the	O
two	O
mutations	O
behave	O
similarly	O
[	O
54	O
]	O
.	O

Furthermore	O
,	O
Hfq	O
regulates	O
translation	O
of	O
more	O
than	O
20	O
%	O
of	O
all	O
Salmonella	S-Organism
proteins	O
explaining	O
why	O
a	O
mutation	O
in	O
this	O
gene	O
has	O
such	O
a	O
dramatic	O
phenotype	O
(	O
[	O
54	O
]	O
;	O
Charles	O
Ansong	O
,	O
Hyunjin	O
Yoon	O
,	O
Steffen	O
Porwollik	O
,	O
Heather	O
Mottaz	O
-	O
Brewer	O
,	O
Briana	O
Ogata	O
-	O
Petritis	O
,	O
Navdeep	O
Jaitly	O
,	O
Joshua	O
N	O
.	O
Adkins	O
,	O
Michael	O
McClelland	O
,	O
Fred	O
Heffron	O
,	O
and	O
Richard	O
D	O
.	O
Smith	O
;	O
Global	O
systems	O
-	O
level	O
analysis	O
of	O
small	O
RNA	O
-	O
mediated	O
translational	O
regulation	O
:	O
Implications	O
for	O
virulence	O
and	O
global	O
protein	O
translation	O
;	O
Submitted	O
)	O
.	O

Cluster	O
analysis	O
identifies	O
additional	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
known	O
virulence	O
factors	O

The	O
results	O
from	O
the	O
microarray	O
analysis	O
identified	O
many	O
genes	O
that	O
appeared	O
to	O
be	O
coordinately	O
regulated	O
including	O
all	O
SPI	O
-	O
2	O
encoded	O
genes	O
that	O
are	O
part	O
of	O
the	O
type	O
III	O
secretion	O
system	O
(	O
Table	O
S2	O
)	O
.	O

We	O
searched	O
for	O
additional	O
previously	O
unidentified	O
virulence	O
factors	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
that	O
show	O
the	O
same	O
pattern	O
of	O
expression	O
as	O
those	O
located	O
within	O
SPI	O
-	O
2	O
.	O

A	O
systematic	O
way	O
of	O
identifying	O
co	O
-	O
regulation	O
is	O
with	O
one	O
of	O
several	O
computer	O
algorithms	O
that	O
group	O
genes	O
together	O
if	O
their	O
expression	O
is	O
similarly	O
changed	O
under	O
like	O
conditions	O
.	O

The	O
diverse	O
growth	O
conditions	O
used	O
in	O
this	O
study	O
,	O
as	O
well	O
as	O
differences	O
between	O
isogenic	O
strains	O
containing	O
mutations	O
in	O
virulence	O
regulators	O
,	O
make	O
our	O
data	O
set	O
ideal	O
for	O
this	O
type	O
of	O
analysis	O
.	O

In	O
addition	O
,	O
we	O
also	O
performed	O
cluster	O
analysis	O
using	O
public	O
data	O
sets	O
acquired	O
from	O
the	O
NIH	O
sponsored	O
public	O
repository	O
of	O
microarray	O
data	O
,	O
gene	O
expression	O
omnibus	O
(	O
GEO	O
)	O
.	O

We	O
chose	O
120	O
transcriptional	O
profiles	O
from	O
GEO	O
that	O
were	O
derived	O
by	O
extracting	O
RNA	O
from	O
the	O
same	O
parent	O
Salmonella	S-Organism
strain	O
grown	O
under	O
a	O
wide	O
variety	O
of	O
culture	O
conditions	O
(	O
GSE2456	O
;	O
G	O
.	O
Yun	O
et	O
al	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Expression	O
profiles	O
for	O
all	O
genes	O
were	O
uploaded	O
to	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
[	O
18	O
]	O
)	O
.	O

SEBINI	O
incorporates	O
statistical	O
and	O
network	O
algorithms	O
into	O
a	O
framework	O
for	O
network	O
inference	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

To	O
detect	O
dependencies	O
among	O
genes	O
over	O
different	O
conditions	O
we	O
employed	O
the	O
context	O
likelihood	O
of	O
relatedness	O
algorithm	O
(	O
CLR	O
;	O
[	O
19	O
]	O
)	O
,	O
which	O
is	O
a	O
plugin	O
for	O
SEBINI	O
.	O

The	O
results	O
were	O
visualized	O
as	O
a	O
network	O
of	O
similarity	O
relationships	O
using	O
Cytoscape	O
[	O
57	O
]	O
.	O

A	O
recent	O
study	O
with	O
E	B-Organism
.	I-Organism
coli	E-Organism
shows	O
that	O
the	O
CLR	O
algorithm	O
was	O
the	O
most	O
accurate	O
in	O
computing	O
the	O
correct	O
network	O
for	O
experimentally	O
verified	O
regulatory	O
interactions	O
[	O
19	O
]	O
.	O

The	O
results	O
shown	O
in	O
Figure	O
5	O
use	O
a	O
force	O
-	O
directed	O
network	O
layout	O
algorithm	O
where	O
genes	O
(	O
shown	O
as	O
small	O
colored	O
circles	O
)	O
are	O
generally	O
closer	O
together	O
when	O
their	O
statistical	O
association	O
,	O
and	O
thus	O
degree	O
of	O
predicted	O
co	O
-	O
regulation	O
,	O
is	O
stronger	O
(	O
the	O
cutoff	O
for	O
the	O
genes	O
shown	O
is	O
5	O
standard	O
deviations	O
from	O
the	O
mean	O
or	O
greater	O
;	O
p	O
<	O
.	O
0001	O
)	O
.	O

All	O
SPI	O
-	O
2	O
secretion	O
apparatus	O
genes	O
as	O
well	O
as	O
associated	O
effectors	O
and	O
chaperones	O
were	O
found	O
to	O
very	O
tightly	O
cluster	O
in	O
the	O
network	O
.	O

In	O
support	O
of	O
this	O
conclusion	O
,	O
the	O
cluster	O
analyses	O
based	O
on	O
our	O
data	O
and	O
based	O
on	O
publicly	O
available	O
data	O
sets	O
are	O
consistent	O
.	O

The	O
cluster	O
analysis	O
identified	O
92	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
the	O
SPI	O
-	O
2	O
encoded	O
type	O
III	O
secretion	O
system	O
but	O
not	O
located	O
within	O
SPI	O
-	O
2	O
.	O

This	O
includes	O
known	O
SPI	O
-	O
2	O
secreted	O
effectors	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
as	O
well	O
as	O
many	O
genes	O
for	O
which	O
no	O
function	O
has	O
been	O
assigned	O
(	O
all	O
total	O
123	O
genes	O
;	O
see	O
Table	O
2	O
)	O
.	O

Several	O
of	O
these	O
genes	O
are	O
A	O
+	O
T	O
rich	O
(	O
>	O
60	O
%	O
compared	O
to	O
48	O
%	O
for	O
the	O
Salmonella	S-Organism
chromosome	O
)	O
and	O
located	O
within	O
sequences	O
that	O
are	O
not	O
present	O
in	O
close	O
relatives	O
of	O
Salmonella	S-Organism
suggesting	O
that	O
they	O
may	O
be	O
unidentified	O
secreted	O
effectors	O
or	O
other	O
virulence	O
determinants	O
that	O
have	O
been	O
acquired	O
from	O
other	O
pathogens	O
.	O

All	O
in	O
all	O
,	O
the	O
implication	O
of	O
the	O
cluster	O
data	O
is	O
that	O
the	O
genes	O
shown	O
in	O
Table	O
2	O
are	O
co	O
-	O
regulated	O
with	O
SPI	O
-	O
2	O
.	O

One	O
interesting	O
point	O
is	O
that	O
the	O
algorithm	O
does	O
not	O
distinguish	O
between	O
positive	O
and	O
negative	O
regulation	O
only	O
that	O
it	O
is	O
coincident	O
.	O

We	O
analyzed	O
expression	O
of	O
each	O
of	O
the	O
123	O
genes	O
and	O
found	O
that	O
only	O
two	O
genes	O
(	O
pepA	O
and	O
mopB	O
)	O
are	O
negatively	O
regulated	O
;	O
the	O
remaining	O
121	O
are	O
positively	O
regulated	O
.	O

Computer	O
aided	O
analysis	O
of	O
the	O
regulatory	O
network	O

The	O
fact	O
that	O
all	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
biological	O
functions	O
during	O
infection	O
suggests	O
they	O
could	O
be	O
part	O
of	O
a	O
coordinated	O
network	O
.	O

Acidic	O
minimal	O
medium	O
is	O
a	O
well	O
-	O
established	O
in	O
vitro	O
condition	O
for	O
SPI	O
-	O
2	O
expression	O
;	O
accordingly	O
,	O
we	O
focused	O
on	O
examining	O
regulation	O
of	O
genes	O
expressed	O
under	O
these	O
conditions	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
,	O
[	O
58	O
]	O
.	O

To	O
identify	O
coordinated	O
regulation	O
we	O
compared	O
expression	O
of	O
each	O
regulator	O
in	O
each	O
mutant	O
background	O
when	O
grown	O
in	O
minimal	O
acidic	O
medium	O
(	O
Figure	O
6A	O
)	O
.	O

RNA	O
samples	O
were	O
prepared	O
from	O
three	O
separate	O
cultures	O
and	O
used	O
as	O
a	O
template	O
in	O
separate	O
qRT	O
-	O
PCR	O
experiments	O
.	O

A	O
matrix	O
with	O
14	O
mutants	O
in	O
columns	O
and	O
14	O
regulatory	O
genes	O
and	O
SPI	O
-	O
2	O
genes	O
(	O
6	O
genes	O
except	O
for	O
ssrB	O
as	O
used	O
in	O
Figure	O
4	O
)	O
in	O
rows	O
was	O
constructed	O
based	O
on	O
qRT	O
-	O
PCR	O
data	O
and	O
z	O
-	O
scores	O
were	O
calculated	O
based	O
on	O
average	O
and	O
standard	O
deviations	O
from	O
columns	O
and	O
rows	O
.	O

A	O
network	O
among	O
regulators	O
and	O
SPI	O
-	O
2	O
was	O
mapped	O
as	O
described	O
in	O
Lee	O
et	O
al	O
.	O
by	O
sorting	O
out	O
values	O
that	O
changed	O
in	O
a	O
specific	O
mutant	O
background	O
[	O
59	O
]	O
.	O

We	O
visualized	O
the	O
resulting	O
relationships	O
using	O
Cytoscape	O
[	O
57	O
]	O
.	O

Nodes	O
indicate	O
regulators	O
or	O
SPI	O
-	O
2	O
and	O
red	O
and	O
blue	O
arrows	O
indicate	O
activation	O
and	O
repression	O
respectively	O
(	O
see	O
Figure	O
6B	O
)	O
.	O

In	O
the	O
computed	O
network	O
multiple	O
regulators	O
act	O
both	O
directly	O
and	O
indirectly	O
to	O
control	O
SPI	O
-	O
2	O
expression	O
.	O

However	O
,	O
direct	O
or	O
indirect	O
regulation	O
cannot	O
be	O
distinguished	O
without	O
additional	O
experimental	O
verification	O
.	O

So	O
,	O
in	O
Figure	O
6B	O
all	O
regulatory	O
effects	O
on	O
SPI	O
-	O
2	O
have	O
been	O
removed	O
except	O
for	O
those	O
mediated	O
directly	O
by	O
slyA	O
and	O
ssrB	O
based	O
on	O
additional	O
genetic	O
data	O
as	O
described	O
below	O
.	O

The	O
network	O
suggests	O
that	O
both	O
slyA	O
and	O
ssrA	O
/	O
ssrB	O
could	O
coordinate	O
regulation	O
of	O
SPI	O
-	O
2	O
and	O
other	O
virulence	O
factors	O
by	O
integrating	O
signals	O
from	O
multiple	O
regulators	O
as	O
was	O
tested	O
next	O
.	O

An	O
overall	O
network	O
was	O
also	O
generated	O
by	O
integrating	O
4	O
data	O
sets	O
;	O
two	O
CLR	O
algorithm	O
data	O
from	O
the	O
complete	O
microarray	O
results	O
and	O
GSE2456	O
public	O
microarray	O
database	O
and	O
two	O
matrix	O
analysis	O
data	O
from	O
the	O
transcription	O
profiles	O
and	O
qRT	O
-	O
PCR	O
results	O
(	O
Figure	O
S3	O
;	O
the	O
limitation	O
is	O
that	O
no	O
distinction	O
is	O
made	O
between	O
positive	O
and	O
negative	O
regulation	O
in	O
CLR	O
algorithm	O
data	O
)	O
.	O

The	O
consensus	O
network	O
combining	O
all	O
data	O
reported	O
in	O
this	O
study	O
includes	O
the	O
network	O
computed	O
from	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6B	O
)	O
in	O
part	O
and	O
suggests	O
a	O
predictive	O
regulatory	O
cascade	O
that	O
merits	O
a	O
test	O
.	O

SsrB	O
can	O
complement	O
other	O
regulators	O
of	O
SPI	O
-	O
2	O
transcription	O

SsrB	O
binds	O
within	O
SPI	O
-	O
2	O
and	O
activates	O
SPI	O
-	O
2	O
genes	O
for	O
transcription	O
.	O

However	O
the	O
location	O
of	O
binding	O
sites	O
varies	O
suggesting	O
that	O
SsrB	O
regulation	O
is	O
unusual	O
[	O
52	O
]	O
.	O

Some	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
been	O
previously	O
shown	O
to	O
directly	O
regulate	O
ssrA	O
/	O
ssrB	O
;	O
OmpR	O
binding	O
to	O
PssrA	O
/	O
ssrB	O
[	O
60	O
]	O
,	O
[	O
61	O
]	O
;	O
SlyA	O
binding	O
to	O
PssrA	O
[	O
62	O
]	O
;	O
PhoP	O
binding	O
to	O
PssrB	O
[	O
45	O
]	O
.	O

To	O
distinguish	O
direct	O
from	O
indirect	O
effects	O
,	O
we	O
carried	O
out	O
epistasis	O
experiments	O
and	O
determined	O
if	O
ssrB	O
expression	O
could	O
suppress	O
the	O
phenotype	O
of	O
the	O
other	O
regulators	O
of	O
SPI	O
-	O
2	O
expression	O
.	O

Each	O
isogenic	O
derivative	O
was	O
transformed	O
with	O
either	O
pBAD30SsrB	O
or	O
the	O
empty	O
vector	O
control	O
.	O

We	O
investigated	O
the	O
same	O
seven	O
SPI	O
-	O
2	O
genes	O
as	O
in	O
the	O
qRT	O
-	O
PCR	O
assays	O
above	O
,	O
and	O
results	O
are	O
shown	O
in	O
Figure	O
7A	O
[	O
52	O
]	O
.	O

Expression	O
of	O
an	O
episomal	O
copy	O
of	O
ssrB	O
resulted	O
in	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
in	O
each	O
mutant	O
background	O
,	O
suggesting	O
that	O
SsrB	O
is	O
epistatic	O
to	O
other	O
regulators	O
for	O
SPI	O
-	O
2	O
transcription	O
.	O

This	O
result	O
is	O
in	O
agreement	O
with	O
the	O
model	O
shown	O
in	O
Figure	O
6	O
where	O
all	O
positive	O
regulation	O
takes	O
place	O
via	O
either	O
ssrB	O
or	O
slyA	O
or	O
both	O
as	O
tested	O
further	O
below	O
.	O

Furthermore	O
,	O
SsrB	O
could	O
complement	O
all	O
three	O
deletions	O
DeltassrB	O
,	O
DeltassrA	O
,	O
and	O
DeltassrA	O
/	O
ssrB	O
(	O
Figure	O
7B	O
)	O
,	O
suggesting	O
that	O
over	O
-	O
expression	O
of	O
SsrB	O
may	O
compensate	O
for	O
differences	O
in	O
phosphorylation	O
that	O
normally	O
play	O
a	O
role	O
in	O
regulation	O
[	O
52	O
]	O
.	O

SlyA	O
can	O
complement	O
other	O
regulators	O
for	O
SPI	O
-	O
2	O
expression	O

The	O
number	O
of	O
inputs	O
at	O
each	O
regulator	O
shown	O
in	O
Figure	O
6B	O
corresponds	O
to	O
the	O
number	O
of	O
regulators	O
that	O
directly	O
or	O
indirectly	O
control	O
its	O
expression	O
.	O

The	O
number	O
of	O
regulators	O
that	O
act	O
on	O
slyA	O
was	O
surprising	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
confirmed	O
that	O
slyA	O
transcription	O
was	O
reduced	O
in	O
11	O
of	O
14	O
mutant	O
backgrounds	O
(	O
Figure	O
6A	O
)	O
.	O

slyA	O
transcriptional	O
activation	O
by	O
PhoP	O
has	O
been	O
reported	O
[	O
63	O
]	O
,	O
[	O
64	O
]	O
.	O

The	O
complementation	O
result	O
suggests	O
that	O
many	O
of	O
the	O
regulators	O
may	O
function	O
on	O
SPI	O
-	O
2	O
through	O
SlyA	O
activation	O
of	O
ssrB	O
or	O
alternatively	O
via	O
both	O
regulators	O
(	O
slyA	O
and	O
ssrB	O
)	O
acting	O
together	O
.	O

To	O
determine	O
epistatic	O
relationships	O
,	O
we	O
introduced	O
a	O
slyA	O
-	O
expressing	O
plasmid	O
,	O
pBAD30SlyA	O
,	O
into	O
each	O
regulatory	O
mutant	O
and	O
examined	O
complementation	O
in	O
each	O
mutant	O
background	O
compared	O
to	O
an	O
empty	O
vector	O
control	O
(	O
Figure	O
7C	O
)	O
.	O

The	O
construct	O
strongly	O
complemented	O
ompR	O
/	O
envZ	O
,	O
phoP	O
/	O
phoQ	O
,	O
csrA	O
and	O
himD	O
,	O
suggesting	O
that	O
the	O
effect	O
of	O
these	O
regulators	O
on	O
SPI	O
-	O
2	O
expression	O
may	O
be	O
indirect	O
via	O
regulation	O
of	O
slyA	O
.	O

Surprisingly	O
,	O
the	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
depended	O
upon	O
slyA	O
even	O
in	O
an	O
ssrA	O
/	O
ssrB	O
deleted	O
strain	O
.	O

This	O
suggests	O
that	O
slyA	O
can	O
regulate	O
expression	O
of	O
SPI	O
-	O
2	O
in	O
a	O
way	O
that	O
is	O
independent	O
of	O
ssrB	O
.	O

To	O
test	O
this	O
possibility	O
we	O
constructed	O
double	O
deletions	O
of	O
ssrAB	O
/	O
ompRenvZ	O
,	O
ssrAB	O
/	O
phoPQ	O
,	O
ssrAB	O
/	O
csrA	O
and	O
ssrAB	O
/	O
himD	O
.	O

As	O
shown	O
in	O
Figure	O
7D	O
,	O
slyA	O
is	O
capable	O
of	O
activating	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
independently	O
of	O
ssrB	O
,	O
ompR	O
/	O
envZ	O
,	O
phoP	O
/	O
phoQ	O
,	O
csrA	O
and	O
himD	O
(	O
ihf	O
)	O
,	O
although	O
the	O
effects	O
are	O
not	O
as	O
strong	O
as	O
ssrB	O
.	O

Furthermore	O
there	O
was	O
a	O
clear	O
dichotomy	O
in	O
expression	O
between	O
the	O
first	O
two	O
SPI	O
-	O
2	O
operons	O
encoding	O
ssaB	O
-	O
ssaE	O
and	O
sseA	O
-	O
sseG	O
and	O
the	O
operons	O
further	O
downstream	O
(	O
ssaG	O
-	O
ssaQ	O
)	O
suggesting	O
that	O
slyA	O
may	O
act	O
at	O
different	O
sites	O
within	O
SPI	O
-	O
2	O
.	O

However	O
,	O
these	O
experiments	O
are	O
based	O
on	O
over	O
-	O
expression	O
of	O
slyA	O
that	O
may	O
complicate	O
the	O
analysis	O
because	O
of	O
binding	O
to	O
sites	O
that	O
would	O
normally	O
not	O
be	O
occupied	O
.	O

Discussion	O

During	O
systemic	O
mouse	S-Organism
infection	O
,	O
Salmonella	S-Organism
processes	O
multiple	O
environmental	O
cues	O
via	O
more	O
than	O
14	O
regulators	O
We	O
performed	O
virulence	O
assays	O
on	O
83	O
regulators	O
previously	O
identified	O
as	O
required	O
for	O
Salmonella	B-Organism
enteriditis	E-Organism
virulence	O
by	O
one	O
or	O
more	O
negative	O
selection	O
experiments	O
in	O
various	O
hosts	O
including	O
calves	S-Organism
,	O
chickens	S-Organism
,	O
and	O
mice	S-Organism
[	O
13	O
]	O
,	O
[	O
21	O
]	O
-	O
[	O
23	O
]	O
.	O

The	O
mutant	O
strains	O
devoid	O
of	O
83	O
regulators	O
were	O
tested	O
in	O
three	O
mouse	S-Organism
virulence	O
assays	O
to	O
identify	O
a	O
subset	O
of	O
14	O
that	O
were	O
most	O
highly	O
attenuated	O
in	O
a	O
systemic	O
mouse	S-Organism
infection	O
model	O
.	O

These	O
14	O
regulators	O
are	O
very	O
diverse	O
including	O
alternative	O
sigma	O
factors	O
(	O
rpoS	O
and	O
rpoE	O
)	O
,	O
two	O
-	O
component	O
regulators	O
(	O
ompR	O
/	O
envZ	O
,	O
phoP	O
/	O
phoQ	O
,	O
and	O
ssrA	O
/	O
ssrB	O
)	O
,	O
post	O
-	O
transcriptional	O
regulators	O
(	O
csrA	O
,	O
hfq	O
and	O
smpB	O
)	O
,	O
a	O
bending	O
protein	O
(	O
ihf	O
)	O
and	O
an	O
assortment	O
of	O
other	O
DNA	O
binding	O
proteins	O
(	O
fruR	O
,	O
spvR	O
,	O
crp	O
,	O
slyA	O
,	O
and	O
hnr	O
;	O
see	O
Table	O
1	O
for	O
references	O
)	O
.	O

Salmonella	S-Organism
follows	O
a	O
short	O
course	O
of	O
infection	O
after	O
intraperitoneal	O
infection	O
,	O
as	O
we	O
have	O
used	O
here	O
,	O
passing	O
through	O
the	O
lymph	O
nodes	O
in	O
the	O
peritoneal	O
cavity	O
to	O
the	O
blood	O
stream	O
and	O
then	O
colonizing	O
and	O
replicating	O
within	O
the	O
spleen	O
and	O
liver	O
.	O

During	O
this	O
entire	O
trip	O
the	O
bacteria	O
are	O
located	O
within	O
cells	O
either	O
neutrophiles	O
or	O
monocytes	O
although	O
at	O
lower	O
numbers	O
in	O
B	O
and	O
T	O
cells	O
and	O
dendritic	O
cells	O
of	O
every	O
subclass	O
[	O
16	O
]	O
,	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
,	O
[	O
65	O
]	O
,	O
[	O
66	O
]	O
.	O

Because	O
the	O
bacteria	O
are	O
exclusively	O
intracellular	O
we	O
tested	O
the	O
hypothesis	O
that	O
replication	O
in	O
macrophages	O
could	O
be	O
a	O
surrogate	O
for	O
systemic	O
mouse	S-Organism
infection	O
.	O

Mutations	O
that	O
were	O
attenuated	O
for	O
growth	O
in	O
primary	O
macrophages	O
were	O
also	O
attenuated	O
in	O
the	O
mouse	S-Organism
but	O
the	O
converse	O
was	O
not	O
always	O
true	O
.	O

Next	O
,	O
we	O
used	O
expression	O
profiling	O
to	O
define	O
the	O
regulatory	O
pathways	O
.	O

Transcriptional	O
profiles	O
from	O
intracellular	O
bacteria	O
at	O
different	O
times	O
after	O
infection	O
are	O
likely	O
to	O
match	O
most	O
closely	O
the	O
environments	O
encountered	O
by	O
Salmonella	S-Organism
during	O
infection	O
.	O

However	O
,	O
isolation	O
of	O
RNA	O
from	O
intracellular	O
bacteria	O
was	O
not	O
used	O
because	O
we	O
wished	O
to	O
test	O
a	O
spectrum	O
of	O
regulatory	O
mutants	O
several	O
of	O
which	O
simply	O
did	O
not	O
survive	O
within	O
cells	O
long	O
enough	O
to	O
allow	O
RNA	O
preparation	O
.	O

RNA	O
was	O
therefore	O
prepared	O
using	O
four	O
laboratory	O
growth	O
conditions	O
two	O
of	O
which	O
partially	O
mimic	O
the	O
intracellular	O
environment	O
(	O
acidic	O
minimal	O
media	O
)	O
.	O

We	O
compared	O
the	O
transcriptional	O
profiles	O
we	O
observed	O
using	O
laboratory	O
growth	O
conditions	O
that	O
mimic	O
intracellular	O
conditions	O
,	O
to	O
those	O
that	O
have	O
been	O
performed	O
during	O
intracellular	O
replication	O
within	O
J774	O
macrophage	O
like	O
cells	O
.	O

We	O
computed	O
the	O
z	O
-	O
score	O
for	O
each	O
Salmonella	S-Organism
gene	O
from	O
our	O
data	O
and	O
from	O
the	O
data	O
provided	O
by	O
Eriksson	O
et	O
al	O
.	O

[	O
67	O
]	O
thus	O
providing	O
a	O
value	O
that	O
can	O
be	O
compared	O
across	O
different	O
experiments	O
.	O

To	O
compare	O
the	O
two	O
sets	O
of	O
data	O
we	O
subtracted	O
the	O
z	O
-	O
scores	O
computed	O
from	O
our	O
data	O
for	O
AMM1	O
from	O
that	O
computed	O
from	O
expression	O
profiles	O
of	O
intracellular	O
Salmonella	S-Organism
.	O

As	O
the	O
expression	O
pattern	O
changes	O
with	O
time	O
after	O
infection	O
we	O
computed	O
the	O
difference	O
for	O
each	O
time	O
as	O
well	O
as	O
an	O
average	O
for	O
all	O
three	O
-	O
time	O
points	O
reported	O
(	O
4	O
,	O
8	O
,	O
and	O
12	O
hours	O
after	O
infection	O
)	O
.	O

There	O
were	O
102	O
genes	O
where	O
the	O
difference	O
in	O
z	O
-	O
score	O
was	O
2	O
or	O
greater	O
,	O
and	O
54	O
genes	O
of	O
102	O
were	O
annotated	O
as	O
putative	O
,	O
hypothetical	O
,	O
or	O
conserved	O
hypothetical	O
.	O

Four	O
of	O
the	O
5	O
most	O
strongly	O
differentially	O
induced	O
genes	O
include	O
magnesium	O
transporters	O
(	O
mgtB	O
and	O
mgtC	O
)	O
,	O
an	O
acid	O
shock	O
protein	O
(	O
STM1485	O
)	O
,	O
and	O
a	O
high	O
affinity	O
phosphate	O
transporter	O
(	O
pstS	O
)	O
suggesting	O
that	O
the	O
acidic	O
minimal	O
media	O
we	O
used	O
may	O
not	O
be	O
low	O
enough	O
in	O
magnesium	O
,	O
phosphate	O
,	O
or	O
may	O
not	O
be	O
sufficiently	O
acidic	O
.	O

Many	O
genes	O
are	O
transcribed	O
inside	O
cells	O
but	O
may	O
be	O
only	O
weakly	O
transcribed	O
or	O
not	O
at	O
all	O
transcribed	O
in	O
acidic	O
minimal	O
media	O
.	O

Examples	O
of	O
such	O
genes	O
include	O
sifA	O
and	O
the	O
operon	O
STM3117	O
-	O
3120	O
.	O

This	O
operon	O
encodes	O
some	O
of	O
the	O
most	O
abundantly	O
expressed	O
proteins	O
by	O
intracellular	O
Salmonella	S-Organism
.	O

This	O
result	O
is	O
striking	O
,	O
given	O
that	O
STM3117	O
-	O
3120	O
are	O
not	O
transcribed	O
under	O
a	O
variety	O
of	O
in	O
vitro	O
conditions	O
including	O
AMM1	O
and	O
2	O
and	O
the	O
many	O
conditions	O
corresponding	O
to	O
the	O
transcriptional	O
profiles	O
reported	O
for	O
microarrays	O
archived	O
in	O
GEO	O
(	O
[	O
68	O
]	O
,	O
J	O
.	O
McDermott	O
and	O
L	O
Shi	O
,	O
Unpubl	O
.	O
Obs	O
.	O
)	O
.	O

The	O
nature	O
of	O
the	O
inducing	O
signal	O
(	O
s	O
)	O
that	O
results	O
in	O
expression	O
of	O
these	O
genes	O
during	O
intracellular	O
growth	O
is	O
not	O
known	O
.	O

The	O
regulatory	O
network	O
controlling	O
expression	O
of	O
the	O
genes	O
necessary	O
for	O
systemic	O
infection	O
is	O
complex	O
.	O

In	O
our	O
transcriptional	O
network	O
each	O
pink	O
node	O
represents	O
a	O
regulator	O
(	O
Figure	O
6	O
B	O
)	O
and	O
lines	O
represent	O
positive	O
or	O
negative	O
transcriptional	O
interactions	O
(	O
positive	O
in	O
red	O
and	O
negative	O
in	O
blue	O
)	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	E-Organism
most	O
regulation	O
has	O
been	O
shown	O
to	O
follow	O
one	O
of	O
three	O
motifs	O
:	O
feedforward	O
in	O
which	O
a	O
regulator	O
controls	O
a	O
second	O
regulator	O
,	O
single	O
input	O
in	O
which	O
a	O
regulator	O
uniquely	O
controls	O
a	O
set	O
of	O
downstream	O
genes	O
,	O
and	O
so	O
called	O
dense	O
overlapping	O
regulons	O
in	O
which	O
there	O
are	O
multiple	O
regulatory	O
inputs	O
to	O
a	O
single	O
operon	O
[	O
69	O
]	O
.	O

A	O
feedforward	O
loop	O
can	O
act	O
as	O
an	O
electronic	O
"	O
AND	O
-	O
gate	O
"	O
preventing	O
expression	O
except	O
when	O
two	O
or	O
more	O
signals	O
are	O
sensed	O
as	O
we	O
see	O
for	O
slyA	O
(	O
upstream	O
)	O
and	O
ssrB	O
(	O
downstream	O
)	O
;	O
fruR	O
(	O
upstream	O
)	O
and	O
crp	O
(	O
downstream	O
)	O
.	O

Many	O
of	O
these	O
predicted	O
relationships	O
have	O
been	O
demonstrated	O
already	O
but	O
some	O
are	O
new	O
and	O
merit	O
further	O
investigation	O
.	O

The	O
single	O
input	O
motif	O
is	O
found	O
in	O
systems	O
of	O
genes	O
that	O
form	O
a	O
protein	O
complex	O
such	O
as	O
both	O
of	O
the	O
type	O
III	O
secretion	O
systems	O
in	O
Salmonella	S-Organism
.	O

For	O
SPI	O
-	O
2	O
ssrB	O
plays	O
this	O
role	O
and	O
for	O
SPI	O
-	O
1	O
hilA	O
is	O
the	O
central	O
regulator	O
.	O

The	O
multiple	O
promoters	O
located	O
within	O
SPI	O
-	O
2	O
presumably	O
respond	O
to	O
differences	O
in	O
ssrB	O
/	O
slyA	O
activation	O
,	O
perhaps	O
establishing	O
part	O
of	O
the	O
temporal	O
order	O
of	O
expression	O
following	O
phagocytosis	O
of	O
Salmonella	S-Organism
.	O

There	O
are	O
other	O
regulators	O
required	O
for	O
systemic	O
infection	O
in	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
,	O
including	O
those	O
whose	O
absence	O
reduces	O
viability	O
without	O
a	O
compensating	O
mutation	O
(	O
hns	O
;	O
[	O
70	O
]	O
)	O
,	O
those	O
that	O
require	O
deletion	O
of	O
two	O
unlinked	O
genes	O
for	O
inactivation	O
(	O
ppGpp	O
;	O
reviewed	O
in	O
[	O
71	O
]	O
and	O
ydgT	O
/	O
hha	O
[	O
48	O
]	O
)	O
,	O
or	O
those	O
that	O
were	O
simply	O
missed	O
in	O
the	O
screens	O
(	O
STM0410	O
;	O
[	O
72	O
]	O
)	O
;	O
these	O
regulators	O
will	O
be	O
included	O
in	O
subsequent	O
analyses	O
.	O

What	O
are	O
the	O
signals	O
being	O
sensed	O
during	O
systemic	O
infection	O
and	O
how	O
are	O
they	O
integrated	O
to	O
express	O
virulence	O
factors	O
appropriately	O
?	O

There	O
have	O
been	O
several	O
studies	O
to	O
identify	O
environmental	O
factors	O
that	O
regulate	O
expression	O
of	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
.	O

Carbon	O
limitation	O
,	O
low	O
concentrations	O
of	O
Mg2	O
+	O
or	O
Ca2	O
+	O
[	O
73	O
]	O
,	O
and	O
acidic	O
pH	O
[	O
47	O
]	O
,	O
[	O
61	O
]	O
induce	O
SPI	O
-	O
2	O
expression	O
in	O
vitro	O
.	O

Inside	O
professional	O
phagocytic	O
cells	O
divalent	O
cation	O
concentrations	O
and	O
the	O
presence	O
of	O
defensin	O
-	O
like	O
molecules	O
signal	O
through	O
phoP	O
/	O
phoQ	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
,	O
and	O
acidic	O
pH	O
and	O
osmolarity	O
signal	O
through	O
ompR	O
/	O
envZ	O
[	O
76	O
]	O
.	O

OmpR	O
has	O
been	O
shown	O
to	O
respond	O
to	O
acidic	O
pH	O
via	O
cadC	O
[	O
77	O
]	O
.	O

The	O
signal	O
(	O
s	O
)	O
received	O
by	O
SsrA	O
,	O
the	O
sensor	O
of	O
the	O
SsrA	O
/	O
SsrB	O
system	O
,	O
is	O
not	O
yet	O
established	O
.	O

It	O
is	O
surprising	O
that	O
over	O
-	O
expression	O
of	O
ssrB	O
can	O
compensate	O
for	O
a	O
deletion	O
of	O
ssrA	O
or	O
ssrA	O
/	O
ssrB	O
.	O

Previous	O
results	O
have	O
shown	O
that	O
a	O
conservative	O
replacement	O
of	O
the	O
amino	O
acid	O
that	O
is	O
the	O
essential	O
phosphate	O
acceptor	O
eliminated	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
suggesting	O
that	O
SsrB	O
requires	O
phosphorylation	O
for	O
activity	O
.	O

Yet	O
,	O
expression	O
of	O
ssrB	O
without	O
ssrA	O
results	O
in	O
expression	O
of	O
all	O
7	O
SPI	O
-	O
2	O
genes	O
examined	O
(	O
Figure	O
7A	O
)	O
.	O

It	O
is	O
possible	O
that	O
SsrB	O
can	O
be	O
phosphorylated	O
from	O
other	O
sources	O
as	O
noted	O
by	O
Walthers	O
et	O
al	O
.	O

[	O
52	O
]	O
or	O
that	O
the	O
over	O
-	O
expression	O
results	O
in	O
dimerization	O
and	O
self	O
activation	O
similar	O
to	O
what	O
has	O
been	O
observed	O
for	O
PhoP	O
[	O
78	O
]	O
.	O

Mutations	O
in	O
rpoE	O
,	O
smpB	O
,	O
rpoS	O
,	O
and	O
hfq	O
showed	O
only	O
small	O
decreases	O
in	O
SPI	O
-	O
2	O
gene	O
transcription	O
during	O
growth	O
in	O
minimal	O
acidic	O
media	O
but	O
some	O
of	O
them	O
showed	O
large	O
defects	O
in	O
survival	O
assays	O
performed	O
in	O
murine	S-Organism
macrophages	O
.	O

For	O
rpoE	O
and	O
rpoS	O
it	O
is	O
possible	O
that	O
the	O
environmental	O
conditions	O
that	O
distinguish	O
growth	O
in	O
minimal	O
media	O
from	O
those	O
in	O
the	O
SCV	S-Organism
inside	O
hosts	O
are	O
sensed	O
via	O
these	O
two	O
alternative	O
sigma	O
factors	O
.	O

Figure	O
6B	O
shows	O
that	O
there	O
is	O
a	O
close	O
relationship	O
between	O
these	O
two	O
regulators	O
and	O
that	O
they	O
can	O
both	O
affect	O
each	O
other	O
through	O
the	O
ompR	O
/	O
envZ	O
two	O
-	O
component	O
regulator	O
.	O

Post	O
-	O
transcriptional	O
SPI	O
-	O
2	O
regulation	O
is	O
a	O
likely	O
explanation	O
for	O
the	O
large	O
intracellular	O
growth	O
defects	O
observed	O
in	O
the	O
mutant	O
smpB	O
and	O
hfq	O
derivatives	O
despite	O
relative	O
small	O
transcriptional	O
effects	O
.	O

Strains	O
containing	O
mutations	O
in	O
spvR	O
and	O
hnr	O
showed	O
comparable	O
survival	O
levels	O
to	O
wild	O
-	O
type	O
in	O
macrophages	O
from	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	E-Organism
despite	O
the	O
fact	O
that	O
they	O
are	O
attenuated	O
in	O
the	O
same	O
mouse	S-Organism
strain	O
.	O

Perhaps	O
these	O
regulators	O
are	O
selected	O
during	O
growth	O
in	O
other	O
cell	O
types	O
or	O
within	O
phagocytic	O
cells	O
that	O
are	O
activated	O
as	O
a	O
consequence	O
of	O
the	O
inflammatory	O
response	O
generated	O
by	O
the	O
bacteria	O
.	O

SlyA	O
and	O
SsrA	O
/	O
SsrB	O
together	O
activate	O
transcription	O
of	O
the	O
SPI	O
-	O
2	O
encoded	O
secretion	O
apparatus	O

SlyA	O
is	O
a	O
DNA	O
-	O
binding	O
protein	O
with	O
high	O
affinity	O
for	O
inverted	O
repeat	O
sequences	O
[	O
79	O
]	O
and	O
the	O
binding	O
ability	O
of	O
SlyA	O
to	O
the	O
ssrA	O
promoter	O
region	O
was	O
previously	O
reported	O
[	O
62	O
]	O
.	O

SlyA	O
binds	O
to	O
a	O
specific	O
palindromic	O
sequence	O
,	O
but	O
also	O
to	O
other	O
binding	O
sites	O
that	O
do	O
not	O
fit	O
a	O
consensus	O
sequence	O
[	O
79	O
]	O
,	O
[	O
80	O
]	O
.	O

Similarly	O
SsrB	O
binds	O
upstream	O
of	O
ssrA	O
in	O
a	O
region	O
of	O
the	O
promoter	O
typical	O
of	O
response	O
regulators	O
but	O
has	O
no	O
obvious	O
recognition	O
site	O
and	O
binds	O
within	O
the	O
operons	O
that	O
encode	O
structural	O
components	O
of	O
the	O
type	O
III	O
secretion	O
system	O
[	O
52	O
]	O
,	O
[	O
81	O
]	O
.	O

Four	O
nucleoid	O
-	O
like	O
proteins	O
in	O
enteric	O
bacteria	O
,	O
H	O
-	O
NS	O
,	O
StpA	O
,	O
Hha	O
,	O
and	O
YdgT	O
have	O
a	O
predilection	O
for	O
binding	O
to	O
A	O
+	O
T	O
rich	O
sequences	O
and	O
repress	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
(	O
rev	O
.	O
in	O
[	O
14	O
]	O
)	O
.	O

These	O
proteins	O
have	O
a	O
degenerate	O
recognition	O
sequence	O
and	O
the	O
ability	O
to	O
polymerize	O
along	O
and	O
bridge	O
adjacent	O
stretches	O
of	O
DNA	O
repressing	O
transcription	O
apparently	O
by	O
occlusion	O
of	O
RNA	O
polymerase	O
.	O

It	O
has	O
been	O
shown	O
that	O
virulence	O
regulator	O
slyA	O
,	O
and	O
close	O
homologues	O
rovA	O
[	O
82	O
]	O
and	O
toxT	O
[	O
83	O
]	O
act	O
to	O
relieve	O
the	O
repression	O
caused	O
by	O
H	O
-	O
NS	O
at	O
specific	O
promoters	O
[	O
48	O
]	O
,	O
[	O
70	O
]	O
,	O
[	O
84	O
]	O
,	O
[	O
85	O
]	O
.	O

SPI	O
-	O
2	O
regulation	O
by	O
SsrB	O
and	O
SlyA	O
may	O
be	O
explained	O
in	O
a	O
similar	O
mechanism	O
where	O
both	O
SlyA	O
and	O
SsrB	O
counteract	O
the	O
silencing	O
activity	O
of	O
H	O
-	O
NS	O
/	O
YdgT	O
/	O
Hha	O
by	O
competing	O
for	O
binding	O
to	O
the	O
same	O
target	O
sequences	O
or	O
by	O
altering	O
the	O
structure	O
of	O
the	O
DNA	O
to	O
promote	O
transcription	O
for	O
SPI	O
-	O
2	O
.	O

Walthers	O
et	O
al	O
.	O

[	O
52	O
]	O
and	O
Feng	O
et	O
al	O
.	O

[	O
81	O
]	O
found	O
that	O
there	O
was	O
no	O
consensus	O
SsrB	O
binding	O
site	O
or	O
distance	O
relative	O
to	O
the	O
transcription	O
start	O
sites	O
and	O
Walthers	O
(	O
ibid	O
)	O
proposes	O
that	O
different	O
promoters	O
may	O
be	O
activated	O
by	O
distinct	O
SsrB	O
mechanisms	O
.	O

Our	O
results	O
support	O
this	O
conclusion	O
and	O
extend	O
the	O
observation	O
to	O
slyA	O
at	O
least	O
for	O
specific	O
SPI	O
-	O
2	O
transcripts	O
.	O

A	O
proposed	O
mechanism	O
for	O
activation	O
is	O
that	O
SlyA	O
competes	O
with	O
a	O
repressor	O
for	O
binding	O
to	O
the	O
promoter	O
and	O
subsequently	O
facilitates	O
RNA	O
polymerase	O
access	O
[	O
80	O
]	O
.	O

This	O
model	O
is	O
supported	O
by	O
SlyA	O
binding	O
sites	O
that	O
are	O
located	O
downstream	O
of	O
transcriptional	O
start	O
sites	O
[	O
31	O
]	O
,	O
[	O
86	O
]	O
,	O
which	O
is	O
unusual	O
for	O
a	O
traditional	O
transcriptional	O
activator	O
.	O

In	O
agreement	O
with	O
this	O
model	O
,	O
SlyA	O
and	O
PhoP	O
counteract	O
H	O
-	O
NS	O
silencing	O
at	O
pagC	O
[	O
85	O
]	O
,	O
[	O
87	O
]	O
.	O

Thus	O
,	O
one	O
explanation	O
for	O
the	O
transcription	O
we	O
observe	O
following	O
over	O
-	O
expression	O
of	O
ssrB	O
or	O
slyA	O
may	O
be	O
that	O
both	O
SlyA	O
and	O
SsrB	O
counteract	O
binding	O
of	O
small	O
nucleoid	O
-	O
like	O
proteins	O
including	O
both	O
H	O
-	O
NS	O
and	O
YdgD	O
/	O
Hha	O
in	O
this	O
A	O
+	O
T	O
rich	O
SPI	O
-	O
2	O
region	O
[	O
70	O
]	O
.	O

This	O
possibility	O
may	O
be	O
reflected	O
in	O
the	O
differences	O
in	O
expression	O
of	O
the	O
five	O
operons	O
within	O
SPI	O
-	O
2	O
following	O
ssrB	O
and	O
slyA	O
over	O
-	O
expression	O
.	O

Clustering	O
analysis	O
and	O
co	O
-	O
expression	O

The	O
complex	O
regulatory	O
network	O
suggested	O
by	O
these	O
studies	O
has	O
been	O
partially	O
confirmed	O
.	O

Complete	O
elucidation	O
of	O
the	O
virulence	O
pathways	O
must	O
include	O
proteomic	O
studies	O
to	O
identify	O
steps	O
that	O
require	O
translational	O
regulation	O
,	O
binding	O
studies	O
to	O
distinguish	O
direct	O
from	O
indirect	O
effects	O
and	O
additional	O
regulators	O
not	O
included	O
in	O
this	O
preliminary	O
group	O
of	O
14	O
.	O

In	O
this	O
study	O
,	O
cluster	O
analysis	O
was	O
used	O
to	O
identify	O
genes	O
that	O
show	O
similar	O
expression	O
profiles	O
under	O
a	O
variety	O
of	O
environmental	O
conditions	O
and	O
from	O
the	O
isogenic	O
Salmonella	S-Organism
regulatory	O
mutants	O
we	O
describe	O
.	O

The	O
average	O
G	O
+	O
C	O
content	O
of	O
the	O
92	O
genes	O
outside	O
of	O
SPI	O
-	O
2	O
that	O
show	O
the	O
same	O
regulation	O
as	O
SPI	O
-	O
2	O
is	O
47	O
%	O
while	O
the	O
average	O
for	O
Salmonella	S-Organism
is	O
52	O
%	O
(	O
p	O
<	O
e	O
-	O
25	O
)	O
.	O

Most	O
of	O
these	O
genes	O
are	O
not	O
found	O
in	O
closely	O
related	O
non	O
-	O
pathogenic	O
bacteria	O
(	O
overall	O
comparison	O
eliminating	O
SPI	O
-	O
2	O
genes	O
p	O
<	O
e	O
-	O
15	O
)	O
.	O

Thus	O
application	O
of	O
the	O
CLR	O
algorithm	O
identified	O
a	O
very	O
interesting	O
group	O
of	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
SPI	O
-	O
2	O
and	O
were	O
horizontally	O
transferred	O
to	O
Salmonella	S-Organism
.	O

Analysis	O
of	O
microarrays	O
and	O
other	O
expression	O
data	O
was	O
used	O
to	O
construct	O
a	O
predictive	O
model	O
for	O
how	O
the	O
regulators	O
may	O
interact	O
and	O
coordinate	O
regulation	O
within	O
the	O
host	O
.	O

A	O
few	O
of	O
the	O
predictions	O
have	O
been	O
verified	O
and	O
more	O
are	O
being	O
tested	O
.	O

The	O
construction	O
of	O
a	O
complete	O
interaction	O
network	O
describing	O
both	O
the	O
host	O
and	O
pathogen	O
is	O
a	O
long	O
-	O
term	O
goal	O
of	O
this	O
and	O
other	O
related	O
research	O
efforts	O
.	O

Mycobacterium	B-Organism
tuberculosis	E-Organism
Universal	O
Stress	O
Protein	O
Rv2623	O
Regulates	O
Bacillary	O
Growth	O
by	O
ATP	O
-	O
Binding	O
:	O
Requirement	O
for	O
Establishing	O
Chronic	O
Persistent	O
Infection	O

Tuberculous	O
latency	O
and	O
reactivation	O
play	O
a	O
significant	O
role	O
in	O
the	O
pathogenesis	O
of	O
tuberculosis	O
,	O
yet	O
the	O
mechanisms	O
that	O
regulate	O
these	O
processes	O
remain	O
unclear	O
.	O

The	O
Mycobacterium	B-Organism
tuberculosis	E-Organism
universal	O
stress	O
protein	O
(	O
USP	O
)	O
homolog	O
,	O
rv2623	O
,	O
is	O
among	O
the	O
most	O
highly	O
induced	O
genes	O
when	O
the	O
tubercle	B-Organism
bacillus	E-Organism
is	O
subjected	O
to	O
hypoxia	O
and	O
nitrosative	O
stress	O
,	O
conditions	O
thought	O
to	O
promote	O
latency	O
.	O

Induction	O
of	O
rv2623	O
also	O
occurs	O
when	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
encounters	O
conditions	O
associated	O
with	O
growth	O
arrest	O
,	O
such	O
as	O
the	O
intracellular	O
milieu	O
of	O
macrophages	O
and	O
in	O
the	O
lungs	O
of	O
mice	S-Organism
with	O
chronic	O
tuberculosis	O
.	O

Therefore	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
Rv2623	O
regulates	O
tuberculosis	O
latency	O
.	O

We	O
observed	O
that	O
an	O
Rv2623	O
-	O
deficient	O
mutant	O
fails	O
to	O
establish	O
chronic	O
tuberculous	O
infection	O
in	O
guinea	B-Organism
pigs	E-Organism
and	O
mice	S-Organism
,	O
exhibiting	O
a	O
hypervirulence	O
phenotype	O
associated	O
with	O
increased	O
bacterial	O
burden	O
and	O
mortality	O
.	O

Consistent	O
with	O
this	O
in	O
vivo	O
growth	O
-	O
regulatory	O
role	O
,	O
constitutive	O
overexpression	O
of	O
rv2623	O
attenuates	O
mycobacterial	O
growth	O
in	O
vitro	O
.	O

Biochemical	O
analysis	O
of	O
purified	O
Rv2623	O
suggested	O
that	O
this	O
mycobacterial	O
USP	O
binds	O
ATP	O
,	O
and	O
the	O
2	O
.	O
9	O
-	O
A	O
-	O
resolution	O
crystal	O
structure	O
revealed	O
that	O
Rv2623	O
engages	O
ATP	O
in	O
a	O
novel	O
nucleotide	O
-	O
binding	O
pocket	O
.	O

Structure	O
-	O
guided	O
mutagenesis	O
yielded	O
Rv2623	O
mutants	O
with	O
reduced	O
ATP	O
-	O
binding	O
capacity	O
.	O

Analysis	O
of	O
mycobacteria	S-Organism
overexpressing	O
these	O
mutants	O
revealed	O
that	O
the	O
in	O
vitro	O
growth	O
-	O
inhibitory	O
property	O
of	O
Rv2623	O
correlates	O
with	O
its	O
ability	O
to	O
bind	O
ATP	O
.	O

Together	O
,	O
the	O
results	O
indicate	O
that	O
i	O
)	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
regulates	O
mycobacterial	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
ii	O
)	O
Rv2623	O
is	O
required	O
for	O
the	O
entry	O
of	O
the	O
tubercle	B-Organism
bacillus	E-Organism
into	O
the	O
chronic	O
phase	O
of	O
infection	O
in	O
the	O
host	O
;	O
in	O
addition	O
,	O
iii	O
)	O
Rv2623	O
binds	O
ATP	O
;	O
and	O
iv	O
)	O
the	O
growth	O
-	O
regulatory	O
attribute	O
of	O
this	O
USP	O
is	O
dependent	O
on	O
its	O
ATP	O
-	O
binding	O
activity	O
.	O

We	O
propose	O
that	O
Rv2623	O
may	O
function	O
as	O
an	O
ATP	O
-	O
dependent	O
signaling	O
intermediate	O
in	O
a	O
pathway	O
that	O
promotes	O
persistent	O
infection	O
.	O

Introduction	O

Mycobacterium	B-Organism
tuberculosis	E-Organism
,	O
one	O
of	O
the	O
most	O
successful	O
human	S-Organism
pathogens	O
,	O
infects	O
one	O
-	O
third	O
of	O
the	O
world	O
'	O
s	O
population	O
,	O
causing	O
nearly	O
two	O
million	O
deaths	O
per	O
year	O
[	O
1	O
]	O
.	O

Epidemiological	O
data	O
estimate	O
that	O
,	O
in	O
the	O
immunocompetent	O
host	O
,	O
only	O
approximately10	O
%	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
infection	O
progress	O
to	O
active	O
pulmonary	O
disease	O
.	O

The	O
remaining	O
90	O
%	O
of	O
the	O
infected	O
individuals	O
are	O
asymptomatic	O
,	O
and	O
are	O
generally	O
believed	O
to	O
harbor	O
latent	O
bacilli	O
that	O
can	O
reactivate	O
to	O
cause	O
tuberculous	O
diseases	O
,	O
sometimes	O
decades	O
after	O
the	O
initial	O
infection	O
.	O

Recrudescence	O
of	O
latent	O
bacilli	O
contributes	O
significantly	O
to	O
the	O
incidence	O
of	O
adult	O
tuberculosis	O
[	O
2	O
]	O
,	O
yet	O
the	O
physiological	O
state	O
of	O
latent	O
bacilli	O
and	O
the	O
signals	O
that	O
promote	O
dormancy	O
in	O
the	O
host	O
remain	O
incompletely	O
defined	O
.	O

Understanding	O
the	O
dynamic	O
interaction	O
between	O
host	O
and	O
pathogen	O
during	O
the	O
establishment	O
of	O
persistent	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
infection	O
will	O
guide	O
the	O
design	O
of	O
novel	O
treatment	O
for	O
the	O
latently	O
infected	O
population	O
.	O

An	O
intracellular	O
pathogen	O
,	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
must	O
possess	O
a	O
finely	O
tuned	O
signaling	O
network	O
to	O
sense	O
and	O
transduce	O
complex	O
environmental	O
signals	O
,	O
ensuring	O
survival	O
of	O
the	O
bacilli	O
within	O
host	O
cells	O
.	O

Nitric	O
oxide	O
(	O
NO	O
)	O
produced	O
by	O
infected	O
macrophages	O
and	O
relative	O
hypoxia	O
are	O
signals	O
likely	O
to	O
be	O
encountered	O
within	O
tuberculous	O
lesions	O
that	O
are	O
believed	O
,	O
based	O
on	O
in	O
vitro	O
studies	O
,	O
to	O
promote	O
latency	O
by	O
prompting	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
dormancy	O
response	O
.	O

Exposure	O
to	O
these	O
stimuli	O
results	O
in	O
the	O
induction	O
of	O
approximately50	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
genes	O
,	O
designated	O
the	O
dormancy	O
regulon	O
,	O
via	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
DosR	O
-	O
DosS	O
(	O
see	O
Table	O
S1	O
for	O
accession	O
numbers	O
)	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

Among	O
this	O
set	O
of	O
genes	O
is	O
rv2623	O
,	O
one	O
of	O
eight	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
genes	O
annotated	O
as	O
containing	O
the	O
universal	O
stress	O
protein	O
(	O
USP	O
)	O
domain	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Members	O
of	O
this	O
ancient	O
and	O
conserved	O
family	O
of	O
proteins	O
are	O
found	O
in	O
all	O
forms	O
of	O
life	O
and	O
can	O
be	O
induced	O
by	O
a	O
variety	O
of	O
environmental	O
stresses	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

However	O
,	O
the	O
roles	O
of	O
USP	O
proteins	O
in	O
microbial	O
pathogenesis	O
are	O
incompletely	O
understood	O
.	O

Interestingly	O
,	O
rv2623	O
is	O
one	O
of	O
the	O
most	O
strongly	O
induced	O
transcripts	O
of	O
the	O
dormancy	O
regulon	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

Increased	O
expression	O
of	O
rv2623	O
was	O
also	O
observed	O
following	O
phagocytosis	O
by	O
macrophages	O
[	O
10	O
]	O
and	O
in	O
the	O
lungs	O
of	O
chronically	O
infected	O
mice	S-Organism
[	O
11	O
]	O
,	O
supporting	O
a	O
functional	O
role	O
during	O
persistent	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
infection	O
.	O

The	O
present	O
study	O
reveals	O
that	O
:	O
i	O
)	O
deletion	O
of	O
rv2623	O
confers	O
hypervirulence	O
on	O
the	O
tubercle	B-Organism
bacillus	E-Organism
in	O
animal	O
models	O
,	O
suggesting	O
that	O
expression	O
of	O
Rv2623	O
may	O
be	O
conducive	O
to	O
the	O
establishment	O
of	O
persistence	O
in	O
vivo	O
;	O
ii	O
)	O
overexpression	O
of	O
Rv2623	O
results	O
in	O
growth	O
retardation	O
of	O
recipient	O
strains	O
in	O
vitro	O
,	O
further	O
supporting	O
a	O
growth	O
-	O
regulatory	O
role	O
;	O
iii	O
)	O
Rv2623	O
binds	O
ATP	O
;	O
and	O
finally	O
,	O
through	O
mutagenesis	O
study	O
guided	O
by	O
crystallographic	O
analysis	O
of	O
Rv2623	O
(	O
the	O
first	O
such	O
study	O
for	O
a	O
tandem	O
-	O
domain	O
USP	O
)	O
,	O
we	O
show	O
that	O
iv	O
)	O
the	O
growth	O
-	O
regulating	O
attribute	O
of	O
this	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
USP	O
is	O
linked	O
to	O
its	O
ATP	O
-	O
binding	O
capacity	O
.	O

Results	O

Mycobacterium	B-Organism
tuberculosis	E-Organism
Rv2623	O
regulates	O
growth	O
in	O
vitro	O
An	O
rv2623	O
-	O
deletion	O
mutant	O
of	O
the	O
virulent	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
Erdman	I-Organism
strain	E-Organism
was	O
generated	O
by	O
specialized	O
transduction	O
[	O
12	O
]	O
.	O

The	O
rv2623	O
-	O
specific	O
allelic	O
exchange	O
construct	O
was	O
delivered	O
via	O
recombinant	O
mycobacteriophage	O
phAE159	O
and	O
transformants	O
were	O
analyzed	O
by	O
Southern	O
blot	O
,	O
confirming	O
replacement	O
of	O
rv2623	O
with	O
the	O
hyg	O
gene	O
,	O
which	O
confers	O
hygromycin	O
resistance	O
(	O
Figure	O
1A	O
)	O
.	O

Aliquots	O
of	O
a	O
single	O
knockout	O
clone	O
,	O
designated	O
as	O
Deltarv2623	O
,	O
were	O
stored	O
at	O
-	O
70degreesC	O
.	O

Deletion	O
of	O
rv2623	O
is	O
not	O
likely	O
to	O
affect	O
transcription	O
of	O
neighboring	O
genes	O
,	O
given	O
the	O
sequence	O
-	O
confirmed	O
precise	O
excision	O
of	O
the	O
rv2623	O
coding	O
region	O
and	O
the	O
gene	O
organization	O
at	O
the	O
rv2623	O
locus	O
(	O
the	O
downstream	O
rv2624c	O
is	O
transcribed	O
in	O
the	O
direction	O
opposite	O
to	O
that	O
of	O
rv2623	O
)	O
(	O
Figure	O
1B	O
)	O
.	O

Deletion	O
of	O
specific	O
USPs	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
results	O
in	O
growth	O
defects	O
in	O
vitro	O
[	O
8	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

For	O
example	O
,	O
an	O
E	B-Organism
.	I-Organism
coli	E-Organism
strain	O
deficient	O
for	O
UspA	O
exhibits	O
reduced	O
survival	O
in	O
stationary	O
phase	O
culture	O
[	O
14	O
]	O
.	O

However	O
,	O
the	O
in	O
vitro	O
growth	O
kinetics	O
of	O
Deltarv2623	O
M	O
.	O
tuberculosis	O
in	O
OADC	O
-	O
supplemented	O
Middlebrook	O
7H9	O
or	O
minimal	O
Sauton	O
'	O
s	O
medium	O
is	O
comparable	O
to	O
that	O
of	O
wildtype	O
Erdman	S-Organism
up	O
to	O
14	O
days	O
post	O
-	O
inoculation	O
(	O
Figure	O
2A	O
)	O
.	O

We	O
reasoned	O
that	O
a	O
potential	O
growth	O
-	O
regulating	O
attribute	O
of	O
Rv2623	O
might	O
be	O
masked	O
by	O
functional	O
redundancy	O
among	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
USP	O
homologs	O
.	O

Indeed	O
,	O
partial	O
functional	O
overlap	O
has	O
been	O
demonstrated	O
among	O
the	O
E	B-Organism
.	I-Organism
coli	E-Organism
USPs	O
[	O
9	O
]	O
,	O
[	O
15	O
]	O
.	O

We	O
therefore	O
examined	O
the	O
effect	O
of	O
overexpression	O
of	O
this	O
USP	O
in	O
the	O
rapidly	O
growing	O
M	B-Organism
.	I-Organism
smegmatis	I-Organism
strain	I-Organism
mc2155	E-Organism
[	O
16	O
]	O
.	O

As	O
seen	O
in	O
Figure	O
2B	O
,	O
constitutive	O
overexpression	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
rv2623	O
using	O
the	O
multi	O
-	O
copy	O
plasmid	O
pMV261	O
resulted	O
in	O
growth	O
deficiency	O
of	O
the	O
recipient	O
strain	O
both	O
on	O
solid	O
medium	O
(	O
Middlebrook	O
7H10	O
agar	O
)	O
and	O
in	O
the	O
liquid	O
medium	O
-	O
based	O
BD	O
BACTEC	O
9000MB	O
system	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
regulates	O
mycobacterial	O
growth	O
in	O
vitro	O
.	O

Rv2623	O
regulates	O
mycobacterial	O
growth	O
in	O
vivo	O

Although	O
USP	O
family	O
proteins	O
are	O
expressed	O
by	O
many	O
bacterial	O
pathogens	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
to	O
date	O
,	O
there	O
has	O
only	O
been	O
one	O
in	O
vivo	O
study	O
,	O
which	O
showed	O
that	O
a	O
Salmonella	S-Organism
USP	O
promotes	O
virulence	O
in	O
mice	S-Organism
[	O
17	O
]	O
.	O

The	O
observation	O
that	O
Rv2623	O
modulates	O
mycobacterial	O
growth	O
in	O
vitro	O
prompted	O
us	O
to	O
examine	O
the	O
effect	O
of	O
this	O
USP	O
on	O
the	O
in	O
vivo	O
kinetics	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
infection	O
.	O

Low	O
dose	O
aerosol	O
infection	O
of	O
outbred	O
Hartley	O
guinea	B-Organism
pigs	E-Organism
with	O
approximately30	O
CFU	O
revealed	O
a	O
clear	O
growth	O
advantage	O
of	O
the	O
Deltarv2623	O
mutant	O
strain	O
relative	O
to	O
wildtype	O
.	O

As	O
early	O
as	O
20	O
days	O
post	O
-	O
infection	O
,	O
the	O
number	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
bacilli	O
present	O
in	O
the	O
lungs	O
of	O
Deltarv2623	O
-	O
infected	O
guinea	O
pigs	O
was	O
approximately10	O
-	O
fold	O
higher	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
than	O
those	O
infected	O
with	O
wildtype	O
Erdman	S-Organism
,	O
and	O
continued	O
to	O
rise	O
,	O
attaining	O
a	O
15	O
-	O
fold	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
difference	O
by	O
60	O
days	O
post	O
-	O
infection	O
(	O
Figure	O
3A	O
)	O
.	O

Guinea	B-Organism
pigs	E-Organism
are	O
able	O
to	O
control	O
the	O
growth	O
of	O
Erdman	B-Organism
bacilli	E-Organism
following	O
the	O
onset	O
of	O
adaptive	O
immunity	O
at	O
approximately3	O
weeks	O
post	O
-	O
infection	O
,	O
as	O
evident	O
by	O
the	O
relatively	O
stable	O
pulmonary	O
bacterial	O
burden	O
beyond	O
the	O
3	O
week	O
time	O
point	O
,	O
yet	O
levels	O
of	O
Deltarv2623	O
bacilli	O
continued	O
to	O
increase	O
at	O
a	O
reduced	O
but	O
steady	O
rate	O
resulting	O
in	O
a	O
rapidly	O
progressing	O
infection	O
.	O

Moreover	O
,	O
Deltarv2623	O
-	O
infected	O
guinea	O
pigs	O
were	O
moribund	O
at	O
60	O
days	O
post	O
-	O
infection	O
,	O
while	O
those	O
challenged	O
with	O
wildtype	O
Erdman	S-Organism
remained	O
relatively	O
healthy	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
mutant	O
strain	O
is	O
hypervirulent	O
in	O
this	O
model	O
.	O

Finally	O
,	O
complementation	O
with	O
a	O
single	O
integrated	O
copy	O
of	O
rv2623	O
expressed	O
from	O
a	O
constitutive	O
mycobacterial	O
promoter	O
(	O
Deltarv2623	O
attB	O
:	O
:	O
Phsp60Rv2623	O
)	O
abrogated	O
the	O
growth	O
advantage	O
of	O
the	O
deletion	O
mutant	O
(	O
Figure	O
3A	O
)	O
.	O

Also	O
consistent	O
with	O
the	O
fulminate	O
disease	O
progression	O
displayed	O
by	O
Deltarv2623	O
-	O
infected	O
guinea	O
pigs	O
are	O
the	O
more	O
severe	O
pathological	O
changes	O
observed	O
as	O
early	O
as	O
20	O
days	O
post	O
-	O
infection	O
in	O
the	O
lungs	O
of	O
these	O
animals	O
,	O
as	O
assessed	O
by	O
histopathological	O
studies	O
,	O
including	O
the	O
semi	O
-	O
quantitative	O
Total	O
Lung	O
Score	O
analysis	O
(	O
Figure	O
3B	O
and	O
Protocol	O
S1	O
)	O
.	O

Overall	O
,	O
the	O
progression	O
of	O
pulmonic	O
lesions	O
was	O
accelerated	O
in	O
Deltarv2623	O
-	O
infected	O
animals	O
compared	O
to	O
those	O
infected	O
with	O
wildtype	O
Erdman	S-Organism
,	O
accompanied	O
by	O
more	O
extensive	O
necrosis	O
and	O
widespread	O
fibrosis	O
.	O

This	O
increase	O
in	O
lung	O
pathology	O
was	O
also	O
largely	O
reversed	O
in	O
animals	O
infected	O
with	O
the	O
complemented	O
Deltarv2623	O
attB	O
:	O
:	O
Phsp60Rv2623	O
strain	O
(	O
Figure	O
3B	O
and	O
C	O
)	O
.	O

Results	O
of	O
the	O
complementation	O
experiments	O
were	O
further	O
validated	O
using	O
a	O
complemented	O
strain	O
Deltarv2623	O
attB	O
:	O
:	O
Prv2623Rv2623	O
,	O
whose	O
expression	O
of	O
the	O
wildtype	O
universal	O
stress	O
protein	O
is	O
driven	O
by	O
the	O
native	O
rv2623	O
promoter	O
[	O
18	O
]	O
(	O
Figure	O
3D	O
and	O
E	O
)	O
.	O

In	O
contrast	O
to	O
the	O
result	O
of	O
the	O
guinea	B-Organism
pig	E-Organism
study	O
,	O
we	O
observed	O
no	O
difference	O
in	O
the	O
kinetics	O
of	O
infection	O
between	O
C57BL	B-Organism
/	I-Organism
6	I-Organism
mice	E-Organism
infected	O
with	O
wildtype	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
,	O
Deltarv2623	O
,	O
or	O
the	O
attB	O
:	O
:	O
Phsp60	O
Rv2623	O
complemented	O
strain	O
in	O
a	O
low	O
dose	O
aerogenic	O
model	O
[	O
19	O
]	O
,	O
as	O
assessed	O
by	O
lung	O
bacterial	O
burden	O
(	O
Figure	O
4A	O
)	O
.	O

However	O
,	O
the	O
mouse	S-Organism
is	O
a	O
relatively	O
resistant	O
host	O
to	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
,	O
particularly	O
in	O
strains	O
such	O
as	O
C57BL	B-Organism
/	I-Organism
6	E-Organism
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

In	O
fact	O
,	O
evidence	O
exists	O
that	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
triggers	O
an	O
immune	O
response	O
in	O
mice	S-Organism
that	O
is	O
in	O
excess	O
of	O
that	O
required	O
for	O
controlling	O
the	O
infection	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

Thus	O
,	O
the	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	O
observed	O
in	O
the	O
susceptible	O
guinea	B-Organism
pig	E-Organism
model	O
could	O
have	O
been	O
masked	O
in	O
the	O
C57BL	B-Organism
/	I-Organism
6	I-Organism
mice	E-Organism
.	O

Consequently	O
,	O
we	O
examined	O
the	O
virulence	O
of	O
Deltarv2623	O
in	O
the	O
relatively	O
susceptible	O
C3H	B-Organism
/	I-Organism
HeJ	I-Organism
mouse	E-Organism
strain	O
[	O
24	O
]	O
.	O

Indeed	O
,	O
the	O
Deltarv2623	O
mutant	O
was	O
markedly	O
more	O
virulent	O
relative	O
to	O
wildtype	O
Erdman	B-Organism
M	I-Organism
.	I-Organism
tuberculosis	E-Organism
following	O
aerogenic	O
infection	O
,	O
as	O
assessed	O
by	O
the	O
mean	O
survival	O
time	O
of	O
C3H	B-Organism
/	I-Organism
HeJ	I-Organism
mice	E-Organism
infected	O
with	O
these	O
strains	O
(	O
62	O
and	O
25	O
.	O
5	O
days	O
post	O
infection	O
for	O
Erdman	S-Organism
-	O
and	O
Deltarv2623	O
-	O
infected	O
mice	O
,	O
respectively	O
,	O
p	O
=	O
0	O
.	O
0014	O
;	O
Figure	O
4B	O
)	O
.	O

In	O
agreement	O
with	O
the	O
survival	O
data	O
,	O
quantification	O
of	O
tissue	O
bacterial	O
burden	O
revealed	O
a	O
growth	O
advantage	O
for	O
the	O
Rv2623	O
-	O
deficient	O
mutant	O
relative	O
to	O
wildtype	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
Erdman	E-Organism
(	O
Figure	O
4C	O
)	O
.	O

Manifestation	O
of	O
this	O
hypervirulence	O
phenotype	O
is	O
apparent	O
as	O
early	O
as	O
3	O
weeks	O
post	O
-	O
infection	O
,	O
with	O
the	O
lung	O
bacterial	O
burden	O
of	O
mice	S-Organism
infected	O
with	O
Deltarv2623	O
M	O
.	O
tuberculosis	O
approximately100	O
fold	O
higher	O
than	O
that	O
in	O
the	O
wildtype	O
-	O
infected	O
animals	O
.	O

As	O
in	O
the	O
guinea	B-Organism
pig	E-Organism
studies	O
,	O
results	O
of	O
complementation	O
experiments	O
involving	O
the	O
reintroduction	O
of	O
a	O
single	O
copy	O
of	O
wildtype	O
rv2623	O
into	O
Deltarv2623	O
M	O
.	O
tuberculosis	O
reverses	O
the	O
hypervirulence	O
(	O
Figure	O
4C	O
)	O
exhibited	O
in	O
the	O
C3H	B-Organism
/	I-Organism
HeJ	E-Organism
model	O
,	O
thus	O
indicating	O
that	O
the	O
observed	O
growth	O
phenotype	O
of	O
the	O
tubercle	B-Organism
bacillus	E-Organism
deficient	O
for	O
the	O
universal	O
stress	O
protein	O
is	O
rv2623	O
-	O
specific	O
.	O

Finally	O
,	O
survival	O
of	O
Deltarv2623	O
-	O
infected	O
mice	O
was	O
also	O
significantly	O
reduced	O
in	O
another	O
susceptible	O
mouse	S-Organism
strain	O
,	O
C3HeB	B-Organism
/	I-Organism
FeJ	E-Organism
(	O
Figure	O
S1	O
)	O
.	O

Together	O
,	O
the	O
animal	O
studies	O
provide	O
strong	O
evidence	O
that	O
Rv2623	O
regulates	O
the	O
growth	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
in	O
vivo	O
:	O
in	O
the	O
absence	O
of	O
Rv2623	O
,	O
the	O
tubercle	B-Organism
bacillus	E-Organism
fails	O
to	O
establish	O
a	O
chronic	O
persistent	O
infection	O
,	O
exhibiting	O
a	O
hypervirulent	O
phenotype	O
.	O

Effects	O
of	O
environmental	O
stress	O
on	O
growth	O
of	O
M	O
.	O
tuberculosis	O
Deltarv2623	O
in	O
vitro	O

Although	O
the	O
functions	O
of	O
universal	O
stress	O
proteins	O
have	O
yet	O
to	O
be	O
completely	O
defined	O
,	O
there	O
is	O
evidence	O
that	O
many	O
USPs	O
play	O
differential	O
roles	O
in	O
protecting	O
microbes	O
against	O
various	O
environmental	O
stresses	O
[	O
9	O
]	O
.	O

Therefore	O
,	O
the	O
hypervirulence	O
of	O
Deltarv2623	O
in	O
guinea	B-Organism
pigs	E-Organism
and	O
susceptible	O
mice	S-Organism
is	O
intriguing	O
;	O
if	O
Rv2623	O
provides	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
protection	O
against	O
stress	O
,	O
it	O
might	O
be	O
expected	O
that	O
the	O
Rv2623	O
-	O
deficient	O
mutant	O
would	O
be	O
attenuated	O
in	O
vivo	O
.	O

The	O
growth	O
kinetics	O
and	O
survival	O
of	O
the	O
Deltarv2623	O
strain	O
was	O
examined	O
under	O
various	O
stress	O
conditions	O
,	O
including	O
those	O
likely	O
to	O
be	O
present	O
during	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
infection	O
.	O

These	O
included	O
oxidative	O
stress	O
(	O
superoxide	O
anion	O
,	O
O2	O
-	O
)	O
,	O
DNA	O
damage	O
(	O
UV	O
irradiation	O
,	O
mitomycin	O
C	O
)	O
,	O
heat	O
shock	O
(	O
53degreesC	O
)	O
,	O
and	O
acidic	O
culture	O
(	O
pH	O
4	O
.	O
0	O
)	O
.	O

The	O
use	O
of	O
streptonigrin	O
,	O
an	O
antibiotic	O
whose	O
toxicity	O
correlates	O
with	O
levels	O
of	O
free	O
iron	O
,	O
was	O
based	O
on	O
the	O
observation	O
that	O
the	O
intracellular	O
environment	O
of	O
macrophages	O
can	O
induce	O
a	O
iron	O
-	O
scavenging	O
response	O
in	O
mycobacteria	O
[	O
25	O
]	O
,	O
perhaps	O
as	O
a	O
means	O
of	O
maintaining	O
adequate	O
levels	O
of	O
this	O
important	O
growth	O
factor	O
,	O
and	O
that	O
an	O
E	B-Organism
.	I-Organism
coli	E-Organism
USP	O
was	O
shown	O
to	O
regulate	O
iron	O
uptake	O
[	O
9	O
]	O
.	O

The	O
results	O
showed	O
that	O
the	O
mutant	O
strain	O
was	O
no	O
more	O
susceptible	O
to	O
growth	O
inhibition	O
than	O
was	O
wild	O
type	O
Erdman	S-Organism
under	O
all	O
of	O
the	O
stress	O
conditions	O
tested	O
(	O
Figure	O
S2	O
)	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
it	O
is	O
unlikely	O
that	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
is	O
essential	O
for	O
resistance	O
to	O
stresses	O
encountered	O
in	O
the	O
host	O
,	O
which	O
is	O
consistent	O
with	O
the	O
observed	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	O
.	O

M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
is	O
a	O
nucleotide	O
-	O
binding	O
protein	O

We	O
began	O
a	O
biochemical	O
characterization	O
of	O
Rv2623	O
in	O
order	O
to	O
gain	O
insight	O
into	O
the	O
relationship	O
between	O
the	O
molecular	O
structure	O
/	O
function	O
of	O
this	O
USP	O
and	O
it	O
'	O
s	O
growth	O
-	O
regulatory	O
properties	O
.	O

M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
was	O
expressed	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
and	O
purified	O
to	O
homogeneity	O
for	O
biochemical	O
studies	O
.	O

SDS	O
-	O
PAGE	O
analysis	O
of	O
affinity	O
-	O
purified	O
His6	O
-	O
Rv2623	O
revealed	O
a	O
single	O
band	O
that	O
approximates	O
the	O
predicted	O
molecular	O
mass	O
of	O
approximately31	O
.	O
6	O
kDa	O
,	O
which	O
was	O
identified	O
by	O
immunoblotting	O
as	O
Rv2623	O
(	O
Figure	O
S3	O
)	O
.	O

Gel	O
filtration	O
analysis	O
of	O
native	O
His6	O
-	O
Rv2623	O
revealed	O
that	O
the	O
purified	O
protein	O
exists	O
primarily	O
as	O
a	O
single	O
species	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
61	O
+	O
/	O
-	O
1	O
kDa	O
;	O
suggesting	O
that	O
Rv2623	O
is	O
a	O
dimer	O
under	O
native	O
conditions	O
(	O
Figure	O
S3	O
)	O
,	O
an	O
observation	O
that	O
was	O
later	O
confirmed	O
using	O
nano	O
electrospray	O
ionization	O
(	O
nano	O
ESI	O
)	O
mass	O
spectrometry	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
nucleotide	O
-	O
binding	O
capacity	O
of	O
a	O
subset	O
of	O
USPs	O
was	O
discovered	O
following	O
the	O
observation	O
that	O
MJ0577	O
,	O
a	O
single	O
-	O
domain	O
USP	O
from	O
Methanococcus	B-Organism
jannaschii	E-Organism
,	O
co	O
-	O
purifies	O
and	O
co	O
-	O
crystallizes	O
with	O
ATP	O
[	O
26	O
]	O
.	O

On	O
the	O
basis	O
of	O
structures	O
of	O
ATP	O
-	O
binding	O
and	O
non	O
-	O
ATP	O
-	O
binding	O
USPs	O
,	O
a	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motif	O
was	O
suggested	O
to	O
be	O
essential	O
for	O
the	O
binding	O
of	O
ATP	O
[	O
27	O
]	O
.	O

The	O
presence	O
of	O
this	O
motif	O
in	O
each	O
of	O
the	O
two	O
tandem	O
USP	O
domains	O
of	O
Rv2623	O
[	O
7	O
]	O
raised	O
the	O
possibility	O
that	O
this	O
protein	O
possesses	O
ATP	O
binding	O
activity	O
.	O

An	O
HPLC	O
-	O
based	O
examination	O
of	O
supernatants	O
from	O
boiled	O
samples	O
of	O
His6	O
-	O
Rv2623	O
demonstrated	O
that	O
His6	O
-	O
Rv2623	O
co	O
-	O
purifies	O
with	O
both	O
ATP	O
and	O
ADP	O
(	O
Figure	O
5	O
)	O
.	O

Analysis	O
of	O
E	B-Organism
.	I-Organism
coli	E-Organism
-	O
expressed	O
Rv2623	O
using	O
nano	O
ESI	O
mass	O
spectrometry	O
also	O
demonstrated	O
that	O
an	O
ATP	O
-	O
saturated	O
form	O
of	O
dimeric	O
Rv2623	O
(	O
composed	O
of	O
2	O
bound	O
ATP	O
molecules	O
per	O
monomer	O
)	O
constitutes	O
at	O
least	O
half	O
of	O
the	O
purified	O
sample	O
(	O
data	O
not	O
shown	O
)	O
.	O

Measurement	O
of	O
the	O
binding	O
stoichiometry	O
,	O
which	O
comprised	O
HPLC	O
-	O
based	O
quantification	O
of	O
adenine	O
nucleotides	O
from	O
the	O
boiled	O
supernatant	O
and	O
spectral	O
analysis	O
of	O
heat	O
denatured	O
Rv2623	O
following	O
reconstitution	O
in	O
6	O
M	O
guanidine	O
-	O
HCl	O
,	O
yields	O
1	O
.	O
4	O
+	O
/	O
-	O
0	O
.	O
2	O
nucleotide	O
equivalents	O
/	O
monomer	O
with	O
an	O
overall	O
content	O
of	O
86	O
+	O
/	O
-	O
4	O
%	O
ATP	O
(	O
14	O
+	O
/	O
-	O
4	O
%	O
ADP	O
)	O
.	O

Thus	O
,	O
Rv2623	O
binds	O
endogenous	O
adenine	O
nucleotides	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
and	O
the	O
association	O
is	O
sufficiently	O
tight	O
that	O
nearly	O
75	O
%	O
of	O
the	O
nucleotide	O
binding	O
sites	O
are	O
occupied	O
upon	O
purification	O
.	O

Indeed	O
,	O
nucleotide	O
did	O
not	O
completely	O
dissociate	O
from	O
the	O
protein	O
following	O
an	O
extensive	O
,	O
two	O
-	O
week	O
dialysis	O
with	O
multiple	O
changes	O
against	O
nucleotide	O
-	O
free	O
buffer	O
(	O
approximately	O
0	O
.	O
3	O
nucleotide	O
equivalents	O
per	O
monomer	O
remain	O
)	O
.	O

It	O
is	O
conceivable	O
that	O
the	O
presence	O
of	O
ADP	O
is	O
the	O
consequence	O
of	O
an	O
Rv2623	O
-	O
associated	O
ATP	O
activity	O
and	O
this	O
putative	O
ATPase	O
function	O
is	O
currently	O
under	O
investigation	O
.	O

The	O
crystal	O
structure	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
:	O
Dimer	O
assembly	O
and	O
ATP	O
-	O
binding	O
capacity	O

To	O
examine	O
the	O
biochemical	O
mechanisms	O
responsible	O
for	O
Rv2623	O
function	O
,	O
we	O
determined	O
the	O
crystal	O
structure	O
of	O
wild	O
-	O
type	O
Rv2623	O
at	O
a	O
resolution	O
of	O
2	O
.	O
9	O
A	O
.	O

The	O
structure	O
reveals	O
a	O
compact	O
,	O
2	O
-	O
fold	O
symmetric	O
dimer	O
.	O

Each	O
monomer	O
is	O
composed	O
of	O
tandem	O
USP	O
domains	O
[	O
residues	O
6	O
-	O
154	O
(	O
domain	O
1	O
)	O
,	O
155	O
-	O
294	O
(	O
domain2	O
)	O
]	O
that	O
share	O
26	O
%	O
sequence	O
identity	O
and	O
significant	O
structural	O
homology	O
(	O
residues	O
6	O
-	O
154	O
and	O
155	O
-	O
294	O
comprise	O
domains	O
1	O
and	O
2	O
,	O
respectively	O
;	O
interdomain	O
rms	O
=	O
2	O
.	O
04	O
A	O
for	O
140	O
equivalent	O
Calpha	O
'	O
s	O
)	O
.	O

Individual	O
domains	O
,	O
which	O
consist	O
of	O
a	O
twisted	O
,	O
five	O
-	O
stranded	O
,	O
parallel	O
beta	O
sheet	O
flanked	O
by	O
four	O
alpha	O
helices	O
,	O
unite	O
through	O
an	O
antiparallel	O
,	O
cross	O
-	O
strand	O
(	O
beta5	O
-	O
beta10	O
)	O
interaction	O
that	O
produces	O
a	O
central	O
dyad	O
axis	O
between	O
beta5	O
/	O
beta10	O
and	O
a	O
continuous	O
,	O
ten	O
-	O
stranded	O
,	O
mixed	O
beta	O
sheet	O
in	O
the	O
complete	O
monomer	O
.	O

Each	O
domain	O
possesses	O
a	O
pair	O
of	O
conserved	O
betaalphabeta	O
motifs	O
(	O
domain	O
1	O
:	O
beta1	O
-	O
L1	O
-	O
alpha1	O
-	O
beta2	O
,	O
beta4	O
-	O
L2	O
-	O
alpha4	O
-	O
beta5	O
;	O
domain	O
2	O
:	O
beta6	O
-	O
L3	O
-	O
alpha5	O
-	O
beta7	O
,	O
beta9	O
-	O
L4	O
-	O
alpha8	O
-	O
beta10	O
)	O
that	O
encompass	O
four	O
loops	O
(	O
designated	O
L1	O
-	O
L4	O
)	O
responsible	O
for	O
ATP	O
recognition	O
(	O
Figure	O
6A	O
and	O
C	O
)	O
.	O

A	O
"	O
U	O
-	O
shaped	O
"	O
ATP	O
molecule	O
that	O
lies	O
within	O
a	O
cleft	O
near	O
the	O
monomer	O
surface	O
is	O
stabilized	O
by	O
1	O
)	O
a	O
cluster	O
of	O
hydrophobic	O
residues	O
(	O
I14	O
,	O
V41	O
,	O
H42	O
,	O
V116	O
/	O
132	O
/	O
261	O
/	O
277	O
/	O
281	O
,	O
L136	O
,	O
A175	O
)	O
that	O
forge	O
the	O
adenine	O
/	O
ribose	O
-	O
binding	O
scaffold	O
,	O
2	O
)	O
a	O
pair	O
of	O
conserved	O
L1	O
/	O
L3	O
aspartates	O
(	O
D15	O
-	O
L1	O
/	O
D167	O
-	O
L3	O
)	O
,	O
and	O
3	O
)	O
small	O
phosphoryl	O
/	O
ribosyl	O
-	O
binding	O
residues	O
within	O
the	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motifs	O
that	O
comprise	O
L2	O
/	O
L4	O
(	O
G120	O
/	O
265	O
/	O
267	O
/	O
268	O
and	O
S131	O
/	O
276	O
)	O
(	O
Figures	O
6A	O
,	O
C	O
and	O
7A	O
)	O
.	O

Dimerization	O
of	O
Rv2623	O
occurs	O
along	O
a	O
2	O
-	O
fold	O
axis	O
orthogonal	O
to	O
the	O
intramonomer	O
dyad	O
and	O
juxtaposes	O
ATP	O
binding	O
pockets	O
from	O
opposing	O
monomers	O
(	O
Figure	O
6B	O
)	O
.	O

Phylogenomic	O
analysis	O
places	O
Rv2623	O
in	O
a	O
Uniprot	O
/	O
TrEMBL	O
family	O
(	O
Q5YVE7	O
)	O
of	O
370	O
tandem	O
-	O
domain	O
USPs	O
,	O
and	O
a	O
113	O
-	O
member	O
subfamily	O
(	O
N631	O
)	O
that	O
consists	O
almost	O
exclusively	O
of	O
actinobacterial	O
representatives	O
(	O
Text	O
S1	O
)	O
.	O

Structure	O
-	O
based	O
sequence	O
alignments	O
of	O
both	O
Rv2623	O
domains	O
with	O
the	O
N631	O
consensus	O
suggest	O
that	O
domain	O
2	O
,	O
which	O
exhibits	O
significantly	O
higher	O
conservation	O
than	O
domain	O
1	O
across	O
global	O
and	O
ATP	O
-	O
binding	O
subfamily	O
consensus	O
sequences	O
,	O
represents	O
the	O
ancestral	O
domain	O
among	O
ATP	O
-	O
binding	O
USPs	O
with	O
tandem	O
-	O
type	O
architectures	O
.	O

Interestingly	O
,	O
the	O
domain	O
fold	O
and	O
interdomain	O
organization	O
observed	O
for	O
Rv2623	O
is	O
broadly	O
conserved	O
:	O
these	O
features	O
are	O
shared	O
among	O
single	O
domain	O
USP	O
structures	O
,	O
both	O
monomeric	O
and	O
dimeric	O
,	O
that	O
are	O
presently	O
represented	O
within	O
the	O
PDB	O
.	O

As	O
this	O
manuscript	O
was	O
under	O
preparation	O
,	O
a	O
second	O
,	O
lower	O
resolution	O
(	O
3	O
.	O
2	O
A	O
)	O
crystal	O
form	O
of	O
Rv2623	O
(	O
PDB	O
ID	O
2JAX	O
)	O
was	O
released	O
for	O
public	O
access	O
.	O

This	O
structure	O
is	O
nearly	O
identical	O
to	O
the	O
present	O
model	O
as	O
demonstrated	O
by	O
superposition	O
over	O
the	O
ATP	O
ligands	O
and	O
the	O
monomeric	O
and	O
dimeric	O
forms	O
(	O
rmsds	O
are	O
0	O
.	O
57	O
and	O
0	O
.	O
81	O
for	O
258	O
and	O
517	O
matched	O
CA	O
'	O
s	O
,	O
respectively	O
)	O
.	O

The	O
differences	O
localize	O
primarily	O
to	O
flexible	O
loop	O
regions	O
(	O
residues	O
44	O
-	O
58	O
,	O
150	O
-	O
159	O
)	O
that	O
,	O
while	O
disordered	O
in	O
2JAX	O
,	O
are	O
partially	O
stabilized	O
in	O
the	O
present	O
structure	O
by	O
local	O
crystal	O
contacts	O
.	O

To	O
gain	O
insight	O
into	O
the	O
ATP	O
-	O
binding	O
mode	O
(	O
s	O
)	O
exhibited	O
by	O
Rv2623	O
,	O
the	O
structural	O
features	O
of	O
the	O
ATP	O
-	O
binding	O
pocket	O
of	O
domains	O
1	O
/	O
2	O
were	O
compared	O
to	O
the	O
monomer	O
fold	O
of	O
the	O
representative	O
ATP	O
-	O
binding	O
USP	O
,	O
MJ0577	O
(	O
PDBID	O
1MJH	O
)	O
[	O
26	O
]	O
.	O

Overlay	O
of	O
these	O
structures	O
reveals	O
very	O
considerable	O
similarity	O
for	O
the	O
residues	O
that	O
form	O
the	O
binding	O
pockets	O
and	O
the	O
associated	O
ATP	O
molecules	O
,	O
for	O
which	O
the	O
triphosphoryl	O
moieties	O
assume	O
virtually	O
indistinguishable	O
conformations	O
.	O

Relatively	O
subtle	O
structural	O
and	O
phylogenetic	O
differences	O
that	O
exist	O
between	O
the	O
ATP	O
-	O
binding	O
pockets	O
might	O
nevertheless	O
confer	O
divergent	O
binding	O
and	O
/	O
or	O
regulatory	O
properties	O
to	O
the	O
tandem	O
domains	O
.	O

Generation	O
and	O
analysis	O
of	O
ATP	O
-	O
binding	O
-	O
deficient	O
Rv2623	O
mutants	O

To	O
explore	O
the	O
relationship	O
between	O
the	O
putative	O
ATP	O
-	O
dependent	O
biochemical	O
function	O
of	O
Rv2623	O
and	O
the	O
growth	O
-	O
regulating	O
attribute	O
of	O
Rv2623	O
,	O
we	O
engineered	O
mutations	O
within	O
the	O
L1	O
(	O
D15E	O
)	O
and	O
beta4	O
(	O
G117A	O
)	O
conserved	O
residues	O
that	O
were	O
predicted	O
,	O
on	O
the	O
basis	O
of	O
the	O
crystal	O
structure	O
,	O
to	O
disrupt	O
ATP	O
recognition	O
(	O
Figure	O
7A	O
)	O
.	O

In	O
silico	O
replacement	O
of	O
the	O
beta4	O
G117	O
side	O
chain	O
hydrogen	O
with	O
a	O
methyl	O
group	O
suggested	O
that	O
any	O
residue	O
larger	O
than	O
glycine	O
at	O
this	O
position	O
is	O
likely	O
to	O
perturb	O
both	O
of	O
the	O
conserved	O
loop	O
regions	O
in	O
contact	O
with	O
the	O
nucleotide	O
.	O

Similarly	O
,	O
extension	O
of	O
the	O
D15	O
side	O
chain	O
to	O
glutamate	O
was	O
also	O
predicted	O
to	O
interfere	O
with	O
the	O
ATP	O
-	O
binding	O
conformation	O
(	O
Figure	O
7A	O
)	O
.	O

HPLC	O
analysis	O
of	O
nucleotides	O
extracted	O
from	O
Rv2623D15E	O
and	O
Rv2623G117A	O
revealed	O
that	O
the	O
mutant	O
proteins	O
are	O
indeed	O
deficient	O
in	O
ATP	O
-	O
binding	O
,	O
exhibiting	O
approximately34	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
approximately29	O
%	O
(	O
p	O
=	O
0	O
.	O
0018	O
)	O
of	O
the	O
amount	O
of	O
ATP	O
bound	O
by	O
wild	O
-	O
type	O
Rv2623	O
,	O
respectively	O
(	O
Figure	O
7B	O
)	O
.	O

Likewise	O
,	O
following	O
an	O
overnight	O
incubation	O
with	O
[	O
alpha	O
-	O
33P	O
]	O
ATP	O
at	O
4degreesC	O
,	O
the	O
amount	O
of	O
protein	O
-	O
bound	O
radioactivity	O
,	O
which	O
represented	O
a	O
very	O
small	O
fraction	O
of	O
the	O
total	O
ATP	O
binding	O
sites	O
,	O
was	O
significantly	O
less	O
for	O
the	O
mutant	O
proteins	O
than	O
wild	O
-	O
type	O
Rv2623	O
(	O
data	O
not	O
shown	O
)	O
.	O

Importantly	O
,	O
thermal	O
denaturation	O
profiles	O
of	O
wild	O
-	O
type	O
Rv2623	O
,	O
Rv2623D15E	O
and	O
Rv2623G117A	O
demonstrated	O
virtually	O
identical	O
Tm	O
values	O
,	O
implying	O
that	O
the	O
native	O
Rv2623	O
fold	O
was	O
not	O
destabilized	O
by	O
these	O
mutations	O
(	O
Figure	O
7C	O
)	O
.	O

It	O
is	O
therefore	O
likely	O
that	O
the	O
D15E	O
and	O
G117A	O
mutations	O
produced	O
local	O
structural	O
changes	O
in	O
the	O
ATP	O
binding	O
loops	O
that	O
contributed	O
directly	O
to	O
the	O
reduced	O
levels	O
of	O
bound	O
ATP	O
in	O
comparing	O
to	O
wild	O
-	O
type	O
Rv2623	O
.	O

The	O
growth	O
-	O
regulating	O
property	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
is	O
dependent	O
on	O
its	O
ability	O
to	O
bind	O
ATP	O

We	O
next	O
sought	O
to	O
probe	O
the	O
relationship	O
between	O
the	O
nucleotide	O
-	O
binding	O
capacity	O
and	O
growth	O
regulation	O
by	O
this	O
mycobacterial	O
USP	O
.	O

Both	O
the	O
D15E	O
and	O
G117A	O
mutant	O
proteins	O
were	O
overexpressed	O
in	O
M	B-Organism
.	I-Organism
smegmatis	I-Organism
mc2155	E-Organism
at	O
levels	O
equivalent	O
to	O
that	O
of	O
wild	O
-	O
type	O
Rv2623	O
(	O
Figure	O
S4	O
)	O
.	O

Results	O
of	O
these	O
studies	O
demonstrated	O
that	O
while	O
overexpression	O
of	O
wildtype	O
Rv2623	O
retards	O
the	O
growth	O
of	O
the	O
recipient	O
strain	O
relative	O
to	O
cells	O
transformed	O
with	O
vector	O
alone	O
,	O
growth	O
of	O
the	O
strains	O
overexpressing	O
ATP	O
-	O
binding	O
-	O
deficient	O
mutant	O
Rv2623	O
are	O
only	O
minimally	O
affected	O
by	O
overexpression	O
as	O
assessed	O
by	O
spotting	O
serial	O
dilutions	O
of	O
the	O
cultures	O
of	O
the	O
appropriate	O
strains	O
onto	O
solid	O
Middlebrook	O
7H10	O
agar	O
(	O
data	O
not	O
shown	O
)	O
as	O
well	O
as	O
by	O
monitoring	O
the	O
time	O
to	O
detection	O
using	O
the	O
BD	O
BACTEC	O
9000MB	O
system	O
(	O
Figure	O
8A	O
)	O
.	O

The	O
distinct	O
effects	O
exhibited	O
by	O
the	O
wild	B-Organism
type	E-Organism
and	O
the	O
G117A	S-Organism
and	O
D15E	B-Organism
mutants	E-Organism
defective	O
in	O
ATP	O
binding	O
suggests	O
a	O
direct	O
correlation	O
between	O
growth	O
attenuation	O
and	O
ATP	O
binding	O
(	O
Figure	O
7B	O
)	O
.	O

To	O
examine	O
whether	O
the	O
effects	O
of	O
overexpression	O
of	O
Rv2623	O
on	O
M	B-Organism
.	I-Organism
smegmatis	E-Organism
are	O
operative	O
in	O
virulent	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
,	O
the	O
growth	O
kinetics	O
of	O
the	O
Erdman	S-Organism
strain	O
overexpressing	O
wildtype	O
Rv2623	O
,	O
as	O
well	O
as	O
the	O
Rv2623G117A	O
and	O
the	O
Rv2623D15E	O
mutant	O
proteins	O
,	O
were	O
evaluated	O
in	O
vitro	O
using	O
the	O
BACTEC	O
9000MB	O
system	O
(	O
Figure	O
8B	O
)	O
.	O

As	O
in	O
the	O
M	B-Organism
.	I-Organism
smegmatis	E-Organism
studies	O
,	O
the	O
results	O
show	O
that	O
overexpression	O
of	O
Rv2623	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
results	O
in	O
marked	O
retardation	O
of	O
growth	O
.	O

Furthermore	O
,	O
this	O
growth	O
attenuation	O
is	O
not	O
observed	O
in	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
strains	O
overexpressing	O
the	O
G117A	O
or	O
the	O
D15E	O
mutant	O
Rv2623	O
(	O
Figure	O
8B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
ability	O
of	O
Rv2623	O
to	O
regulate	O
growth	O
of	O
M	B-Organism
.	I-Organism
smegmatis	E-Organism
and	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
is	O
dependent	O
on	O
an	O
ATP	O
-	O
dependent	O
process	O
.	O

Discussion	O

Despite	O
the	O
significance	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
latency	O
in	O
pathogenesis	O
,	O
the	O
mechanisms	O
by	O
which	O
the	O
tubercle	B-Organism
bacillus	E-Organism
establishes	O
and	O
maintains	O
the	O
latent	O
state	O
remain	O
incompletely	O
defined	O
.	O

Identification	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
genes	O
that	O
are	O
induced	O
by	O
hypoxia	O
and	O
nitric	O
oxide	O
(	O
NO	O
)	O
in	O
vitro	O
provides	O
a	O
framework	O
for	O
understanding	O
the	O
physiology	O
of	O
dormant	O
bacilli	S-Organism
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

These	O
genes	O
,	O
referred	O
to	O
as	O
the	O
dormancy	O
regulon	O
,	O
are	O
transcriptionally	O
regulated	O
by	O
the	O
mycobacterial	O
two	O
-	O
component	O
system	O
DosR	O
-	O
DosS	O
under	O
hypoxic	O
conditions	O
[	O
4	O
]	O
.	O

Indeed	O
,	O
it	O
has	O
been	O
shown	O
that	O
both	O
the	O
cognate	O
sensor	O
histidine	O
kinase	O
DosS	O
(	O
a	O
member	O
of	O
the	O
dormancy	O
regulon	O
)	O
as	O
well	O
as	O
an	O
"	O
orphan	O
"	O
kinase	O
,	O
DosT	O
,	O
functioning	O
as	O
redox	O
and	O
hypoxia	O
sensors	O
,	O
respectively	O
;	O
can	O
regulate	O
DosR	O
activity	O
,	O
and	O
that	O
O2	O
,	O
NO	O
,	O
and	O
CO	O
can	O
modulate	O
the	O
activity	O
of	O
these	O
two	O
kinases	O
via	O
interaction	O
with	O
a	O
haem	O
prosthetic	O
group	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
.	O

The	O
biological	O
significance	O
of	O
the	O
dormancy	O
regulon	O
has	O
been	O
underscored	O
by	O
in	O
vitro	O
studies	O
of	O
dosR	O
mutants	O
of	O
BCG	O
and	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
,	O
which	O
demonstrated	O
the	O
requirement	O
of	O
this	O
transcription	O
factor	O
for	O
survival	O
under	O
hypoxic	O
conditions	O
[	O
3	O
]	O
,	O
[	O
33	O
]	O
.	O

Further	O
,	O
upregulation	O
of	O
the	O
expression	O
of	O
certain	O
dormancy	O
regulon	O
genes	O
have	O
been	O
implicated	O
in	O
tuberculosis	O
transmission	O
as	O
well	O
as	O
the	O
virulence	O
of	O
the	O
epidemiologically	O
important	O
W	O
-	O
Beijing	O
lineage	O
of	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

There	O
are	O
eight	O
genes	O
in	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
genome	O
annotated	O
to	O
encode	O
USP	O
family	O
proteins	O
[	O
7	O
]	O
.	O

We	O
studied	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
USP	O
rv2623	O
because	O
it	O
is	O
one	O
of	O
the	O
most	O
highly	O
induced	O
genes	O
in	O
the	O
dormancy	O
regulon	O
when	O
bacilli	S-Organism
are	O
subjected	O
to	O
hypoxia	O
and	O
nitrosative	O
stress	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

More	O
important	O
,	O
rv2623	O
was	O
also	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
when	O
the	O
tubercle	B-Organism
bacillus	E-Organism
is	O
internalized	O
by	O
human	S-Organism
and	O
mouse	S-Organism
macrophages	O
[	O
10	O
]	O
,	O
[	O
38	O
]	O
as	O
well	O
as	O
in	O
the	O
lungs	O
of	O
mice	S-Organism
with	O
persistent	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
infection	O
[	O
11	O
]	O
.	O

These	O
latter	O
observations	O
suggest	O
that	O
the	O
induction	O
of	O
rv2623	O
may	O
have	O
biological	O
relevance	O
.	O

The	O
precise	O
mechanisms	O
by	O
which	O
Rv2623	O
expression	O
is	O
regulated	O
remain	O
to	O
be	O
defined	O
.	O

Recent	O
transcriptional	O
analysis	O
of	O
Rv2623	O
,	O
while	O
confirming	O
the	O
essentiality	O
of	O
the	O
two	O
18	O
bp	O
palindromic	O
DosR	O
-	O
binding	O
motifs	O
that	O
are	O
present	O
in	O
the	O
promoter	O
region	O
of	O
this	O
gene	O
[	O
38	O
]	O
for	O
induction	O
of	O
Rv2623	O
under	O
low	O
oxygen	O
conditions	O
,	O
also	O
demonstrated	O
the	O
presence	O
of	O
additional	O
regulatory	O
elements	O
within	O
the	O
rv2623	O
5	O
'	O
-	O
untranslated	O
region	O
[	O
18	O
]	O
.	O

These	O
results	O
suggest	O
that	O
the	O
regulation	O
of	O
Rv2623	O
is	O
likely	O
complex	O
.	O

The	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
dormancy	O
response	O
features	O
a	O
dramatic	O
decrease	O
in	O
metabolic	O
activity	O
,	O
resulting	O
in	O
a	O
rapid	O
decrease	O
in	O
bacterial	O
replication	O
[	O
39	O
]	O
.	O

Therefore	O
,	O
it	O
is	O
possible	O
that	O
deficiency	O
in	O
certain	O
members	O
of	O
the	O
dormancy	O
regulon	O
could	O
result	O
in	O
inability	O
of	O
the	O
tubercle	O
bacillus	O
to	O
enter	O
a	O
latent	O
state	O
in	O
the	O
infected	O
host	O
,	O
leading	O
to	O
unrestrained	O
growth	O
and	O
thus	O
,	O
hypervirulence	O
.	O

Indeed	O
,	O
specific	O
members	O
of	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
dormancy	O
regulon	O
whose	O
insufficiency	O
results	O
in	O
a	O
hypervirulence	O
phenotype	O
have	O
been	O
reported	O
[	O
40	O
]	O
,	O
[	O
41	O
]	O
.	O

In	O
certain	O
experimental	O
tuberculosis	O
animal	O
models	O
,	O
DosR	O
deficiency	O
has	O
been	O
associated	O
with	O
a	O
hypervirulence	O
phenotype	O
[	O
41	O
]	O
.	O

However	O
,	O
DosR	O
deficiency	O
has	O
also	O
been	O
reported	O
to	O
have	O
no	O
effect	O
on	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
virulence	O
or	O
to	O
lead	O
to	O
an	O
attenuated	O
phenotype	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

The	O
discrepancies	O
regarding	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
virulence	O
in	O
these	O
DosR	O
studies	O
are	O
unclear	O
,	O
but	O
could	O
be	O
due	O
to	O
differences	O
in	O
experimental	O
systems	O
employed	O
.	O

Insufficiency	O
of	O
the	O
chaperone	O
-	O
like	O
alpha	O
-	O
crystallin	O
encoded	O
by	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
hspX	O
(	O
acr	O
)	O
has	O
also	O
been	O
shown	O
to	O
be	O
associated	O
with	O
hypervirulence	O
in	O
a	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mouse	E-Organism
model	O
of	O
tuberculosis	O
[	O
40	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
an	O
rv2623	O
knockout	O
mutant	O
of	O
virulent	O
M	B-Organism
.	I-Organism
tuberculosis	I-Organism
Erdman	E-Organism
fails	O
to	O
establish	O
a	O
chronic	O
persistent	O
infection	O
,	O
displaying	O
a	O
hypervirulent	O
phenotype	O
in	O
susceptible	O
hosts	O
,	O
as	O
assessed	O
by	O
lung	O
bacterial	O
burden	O
,	O
histopathology	O
,	O
and	O
mortality	O
.	O

Results	O
of	O
the	O
complementation	O
studies	O
indicate	O
that	O
the	O
phenotype	O
is	O
Rv2623	O
-	O
specific	O
.	O

This	O
growth	O
-	O
regulating	O
phenomenon	O
is	O
echoed	O
by	O
the	O
observation	O
that	O
ectopic	O
overexpression	O
of	O
Rv2623	O
results	O
in	O
attenuation	O
of	O
mycobacterial	O
growth	O
.	O

Together	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
USP	O
Rv2623	O
has	O
the	O
ability	O
to	O
regulate	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
is	O
required	O
for	O
the	O
establishment	O
of	O
a	O
persistent	O
infection	O
.	O

Intriguingly	O
,	O
ectopic	O
overexpression	O
of	O
HspX	O
by	O
the	O
same	O
means	O
employed	O
by	O
our	O
study	O
also	O
resulted	O
in	O
an	O
attenuated	O
growth	O
phenotype	O
compared	O
with	O
LacZ	O
-	O
overexpressing	O
controls	O
[	O
44	O
]	O
,	O
suggesting	O
that	O
these	O
two	O
tightly	O
co	O
-	O
regulated	O
"	O
stress	O
"	O
proteins	O
might	O
have	O
similar	O
growth	O
-	O
regulatory	O
roles	O
during	O
dormancy	O
.	O

Bioinformatic	O
and	O
experimental	O
evidence	O
suggest	O
that	O
nucleotide	O
-	O
binding	O
capacity	O
represents	O
a	O
discriminating	O
biochemical	O
feature	O
that	O
facilitates	O
USP	O
protein	O
classification	O
.	O

Putative	O
functional	O
differences	O
between	O
USPs	O
are	O
implied	O
by	O
their	O
assignment	O
to	O
two	O
subclasses	O
:	O
one	O
whose	O
members	O
do	O
not	O
bind	O
ATP	O
and	O
another	O
whose	O
constituents	O
bind	O
and	O
hydrolyze	O
adenine	O
nucleotide	O
substrates	O
[	O
8	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

A	O
structural	O
comparison	O
between	O
the	O
prototypic	O
members	O
of	O
the	O
two	O
subclasses	O
,	O
the	O
non	O
-	O
ATP	O
-	O
binding	O
UspA	O
homolog	O
(	O
H	B-Organism
.	I-Organism
influenzae	E-Organism
,	O
PDB	O
ID	O
1JMV	O
)	O
and	O
the	O
ATP	O
-	O
binding	O
USP	O
,	O
MJ0577	O
(	O
M	B-Organism
.	I-Organism
jannaschii	E-Organism
,	O
PDB	O
ID	O
1MJH	O
)	O
revealed	O
that	O
while	O
both	O
proteins	O
exhibit	O
a	O
similar	O
fold	O
,	O
conserved	O
glycine	O
residues	O
within	O
the	O
ATP	O
-	O
binding	O
loop	O
of	O
the	O
latter	O
are	O
substituted	O
with	O
bulky	O
amino	O
acids	O
that	O
preclude	O
ATP	O
recognition	O
in	O
the	O
former	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

The	O
unique	O
nucleotide	O
-	O
binding	O
pocket	O
of	O
this	O
protein	O
family	O
is	O
structurally	O
distinct	O
from	O
those	O
commonly	O
encountered	O
in	O
ATP	O
-	O
binding	O
proteins	O
[	O
26	O
]	O
,	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

Specific	O
roles	O
for	O
USP	O
family	O
proteins	O
are	O
just	O
beginning	O
to	O
be	O
characterized	O
,	O
and	O
early	O
functional	O
classifications	O
have	O
been	O
informed	O
by	O
ATP	O
-	O
binding	O
capacity	O
[	O
9	O
]	O
.	O

While	O
the	O
non	O
-	O
ATP	O
-	O
binding	O
UspA	O
homologs	O
appear	O
to	O
play	O
diverse	O
roles	O
in	O
promoting	O
survival	O
under	O
a	O
variety	O
of	O
environmental	O
insults	O
[	O
15	O
]	O
,	O
[	O
49	O
]	O
,	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
the	O
function	O
(	O
s	O
)	O
of	O
ATP	O
-	O
binding	O
type	O
USPs	O
remain	O
unclear	O
[	O
9	O
]	O
.	O

Based	O
on	O
in	O
silico	O
analyses	O
,	O
Florczyk	O
et	O
al	O
.	O
classified	O
Rv2623	O
as	O
belonging	O
to	O
a	O
novel	O
class	O
of	O
ATPases	O
[	O
52	O
]	O
,	O
although	O
formal	O
evidence	O
for	O
ATP	O
binding	O
by	O
this	O
protein	O
has	O
not	O
been	O
reported	O
.	O

This	O
study	O
has	O
provided	O
substantial	O
biochemical	O
and	O
structural	O
evidence	O
that	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
is	O
a	O
bona	O
fide	O
nucleotide	O
-	O
binding	O
USP	O
:	O
i	O
)	O
E	B-Organism
.	I-Organism
coli	E-Organism
-	O
expressed	O
His6	O
-	O
Rv2623	O
co	O
-	O
purifies	O
with	O
tightly	O
bound	O
ATP	O
and	O
ADP	O
;	O
ii	O
)	O
analysis	O
of	O
the	O
2	O
.	O
9	O
A	O
-	O
resolution	O
Rv2623	O
crystal	O
structure	O
,	O
the	O
first	O
molecular	O
model	O
of	O
a	O
tandem	O
-	O
type	O
USP	O
,	O
reveals	O
four	O
ATP	O
-	O
bound	O
nucleotide	O
-	O
binding	O
pockets	O
;	O
and	O
iii	O
)	O
point	O
mutations	O
(	O
D15E	O
,	O
G117A	O
)	O
within	O
the	O
conserved	O
L1	O
(	O
D15E	O
)	O
and	O
beta4	O
(	O
G117A	O
)	O
regions	O
of	O
the	O
structure	O
,	O
which	O
were	O
predicted	O
to	O
disrupt	O
nucleotide	O
-	O
binding	O
,	O
yielded	O
mutant	O
proteins	O
with	O
attenuated	O
ATP	O
-	O
binding	O
capacity	O
.	O

Furthermore	O
,	O
given	O
that	O
the	O
attenuated	O
growth	O
phenotype	O
caused	O
by	O
overexpression	O
of	O
Rv2623	O
could	O
be	O
abrogated	O
by	O
mutations	O
that	O
interfere	O
with	O
the	O
binding	O
of	O
this	O
protein	O
to	O
its	O
nucleotide	O
substrate	O
,	O
it	O
is	O
likely	O
that	O
the	O
mycobacterial	O
growth	O
-	O
regulatory	O
faculty	O
of	O
Rv2623	O
is	O
mediated	O
by	O
an	O
ATP	O
-	O
dependent	O
function	O
.	O

In	O
summary	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
have	O
revealed	O
that	O
the	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
USP	O
Rv2623	O
has	O
the	O
ability	O
to	O
regulate	O
mycobacterial	O
growth	O
,	O
as	O
evident	O
by	O
the	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	O
,	O
which	O
fails	O
to	O
establish	O
a	O
persistent	O
infection	O
in	O
susceptible	O
hosts	O
,	O
as	O
well	O
as	O
the	O
growth	O
attenuation	O
observed	O
in	O
mycobacteria	O
overexpressing	O
this	O
USP	O
.	O

Thus	O
,	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
may	O
serve	O
the	O
function	O
of	O
promoting	O
mycobacterial	O
transition	O
into	O
latency	O
.	O

The	O
latent	O
state	O
allows	O
persistence	O
in	O
infected	O
individuals	O
of	O
tubercle	B-Organism
bacilli	E-Organism
that	O
can	O
reactivate	O
to	O
cause	O
active	O
disease	O
and	O
to	O
disseminate	O
when	O
the	O
immune	O
status	O
of	O
the	O
host	O
is	O
compromised	O
.	O

As	O
a	O
result	O
,	O
Rv2623	O
may	O
contribute	O
significantly	O
to	O
the	O
propagation	O
of	O
the	O
tubercle	O
bacillus	O
in	O
the	O
human	S-Organism
host	O
and	O
the	O
difficulties	O
in	O
eradicating	O
tuberculosis	O
.	O

Mechanistically	O
,	O
results	O
of	O
the	O
mutagenesis	O
studies	O
have	O
shown	O
that	O
Rv2623	O
regulates	O
growth	O
through	O
ATP	O
-	O
dependent	O
function	O
.	O

Clearly	O
,	O
much	O
remains	O
to	O
be	O
learned	O
regarding	O
how	O
the	O
ATP	O
-	O
dependent	O
function	O
of	O
Rv2623	O
contributes	O
to	O
growth	O
regulation	O
.	O

It	O
has	O
been	O
proposed	O
that	O
a	O
nucleotide	O
-	O
binding	O
USP	O
from	O
M	B-Organism
.	I-Organism
jannaschii	E-Organism
,	O
MJ0577	O
,	O
whose	O
ability	O
to	O
hydrolyze	O
ATP	O
is	O
dependent	O
on	O
interaction	O
with	O
factor	O
(	O
s	O
)	O
present	O
in	O
the	O
cell	O
extract	O
of	O
this	O
hyperthermophile	O
[	O
26	O
]	O
,	O
functions	O
as	O
a	O
molecular	O
switch	O
much	O
like	O
the	O
Ras	O
protein	O
family	O
,	O
whose	O
GTP	O
hydrolysis	O
ability	O
is	O
modulated	O
by	O
interaction	O
with	O
a	O
number	O
of	O
regulatory	O
proteins	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

The	O
fact	O
that	O
E	B-Organism
.	I-Organism
coli	E-Organism
-	O
expressed	O
Rv2623	O
co	O
-	O
purifies	O
with	O
ADP	O
as	O
well	O
as	O
ATP	O
suggests	O
the	O
possibility	O
that	O
this	O
mycobacterial	O
USP	O
,	O
like	O
MJ0577	O
,	O
is	O
capable	O
of	O
ATP	O
hydrolysis	O
.	O

It	O
is	O
therefore	O
conceivable	O
that	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
Rv2623	O
,	O
as	O
a	O
component	O
of	O
the	O
yet	O
-	O
to	O
-	O
be	O
defined	O
dormancy	O
signaling	O
pathway	O
(	O
s	O
)	O
,	O
functions	O
as	O
a	O
molecular	O
switch	O
by	O
virtue	O
of	O
its	O
ATP	O
-	O
binding	O
and	O
putative	O
ATP	O
-	O
hydrolyzing	O
properties	O
,	O
to	O
mediate	O
the	O
establishment	O
of	O
tuberculous	O
latency	O
.	O

Experiments	O
designed	O
to	O
investigate	O
the	O
potential	O
ATP	O
-	O
hydrolyzing	O
activity	O
of	O
Rv2623	O
are	O
currently	O
underway	O
.	O

Recent	O
identification	O
of	O
the	O
DosR	O
-	O
dependent	O
dormancy	O
regulon	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
;	O
the	O
DosR	O
-	O
independent	O
enduring	O
hypoxic	O
response	O
,	O
which	O
involves	O
over	O
200	O
mycobacterial	O
genes	O
,	O
including	O
those	O
known	O
to	O
regulate	O
bacteriostasis	O
[	O
42	O
]	O
;	O
and	O
the	O
demonstration	O
that	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
redox	O
and	O
hypoxia	O
sensors	O
can	O
interact	O
with	O
multiple	O
ligands	O
that	O
differentially	O
modulate	O
the	O
activity	O
of	O
these	O
important	O
kinases	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
,	O
predict	O
a	O
complex	O
regulatory	O
network	O
for	O
tuberculous	O
latency	O
.	O

Elucidation	O
of	O
how	O
ATP	O
-	O
binding	O
and	O
,	O
potentially	O
,	O
the	O
hydrolysis	O
of	O
ATP	O
by	O
Rv2623	O
regulate	O
M	B-Organism
.	I-Organism
tuberculosis	E-Organism
dormancy	O
-	O
signaling	O
pathways	O
will	O
likely	O
illuminate	O
the	O
mechanisms	O
by	O
which	O
the	O
tubercle	O
bacillus	O
establishes	O
persistence	O
.	O

A	O
Novel	O
Signaling	O
Network	O
Essential	O
for	O
Regulating	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
Biofilm	O
Development	O

The	O
important	O
human	S-Organism
pathogen	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
has	O
been	O
linked	O
to	O
numerous	O
biofilm	O
-	O
related	O
chronic	O
infections	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
biofilm	O
formation	O
following	O
the	O
transition	O
to	O
the	O
surface	O
attached	O
lifestyle	O
is	O
regulated	O
by	O
three	O
previously	O
undescribed	O
two	O
-	O
component	O
systems	O
:	O
BfiSR	O
(	O
PA4196	O
-	O
4197	O
)	O
harboring	O
an	O
RpoD	O
-	O
like	O
domain	O
,	O
an	O
OmpR	O
-	O
like	O
BfmSR	O
(	O
PA4101	O
-	O
4102	O
)	O
,	O
and	O
MifSR	O
(	O
PA5511	O
-	O
5512	O
)	O
belonging	O
to	O
the	O
family	O
of	O
NtrC	O
-	O
like	O
transcriptional	O
regulators	O
.	O

These	O
two	O
-	O
component	O
systems	O
become	O
sequentially	O
phosphorylated	O
during	O
biofilm	O
formation	O
.	O

Inactivation	O
of	O
bfiS	O
,	O
bfmR	O
,	O
and	O
mifR	O
arrested	O
biofilm	O
formation	O
at	O
the	O
transition	O
to	O
the	O
irreversible	O
attachment	O
,	O
maturation	O
-	O
1	O
and	O
-	O
2	O
stages	O
,	O
respectively	O
,	O
as	O
indicated	O
by	O
analyses	O
of	O
biofilm	O
architecture	O
,	O
and	O
protein	O
and	O
phosphoprotein	O
patterns	O
.	O

Moreover	O
,	O
discontinuation	O
of	O
bfiS	O
,	O
bfmR	O
,	O
and	O
mifR	O
expression	O
in	O
established	O
biofilms	O
resulted	O
in	O
the	O
collapse	O
of	O
biofilms	O
to	O
an	O
earlier	O
developmental	O
stage	O
,	O
indicating	O
a	O
requirement	O
for	O
these	O
regulatory	O
systems	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
normal	O
biofilm	O
architecture	O
.	O

Interestingly	O
,	O
inactivation	O
did	O
not	O
affect	O
planktonic	O
growth	O
,	O
motility	O
,	O
polysaccharide	O
production	O
,	O
or	O
initial	O
attachment	O
.	O

Further	O
,	O
we	O
demonstrate	O
the	O
interdependency	O
of	O
this	O
two	O
-	O
component	O
systems	O
network	O
with	O
GacS	O
(	O
PA0928	O
)	O
,	O
which	O
was	O
found	O
to	O
play	O
a	O
dual	O
role	O
in	O
biofilm	O
formation	O
.	O

This	O
work	O
describes	O
a	O
novel	O
signal	O
transduction	O
network	O
regulating	O
committed	O
biofilm	O
developmental	O
steps	O
following	O
attachment	O
,	O
in	O
which	O
phosphorelays	O
and	O
two	O
sigma	O
factor	O
-	O
dependent	O
response	O
regulators	O
appear	O
to	O
be	O
key	O
components	O
of	O
the	O
regulatory	O
machinery	O
that	O
coordinates	O
gene	O
expression	O
during	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
development	O
in	O
response	O
to	O
environmental	O
cues	O
.	O

Introduction	O

Biofilms	O
are	O
composed	O
of	O
microorganisms	O
attached	O
to	O
a	O
solid	O
surface	O
and	O
encased	O
in	O
a	O
hydrated	O
polymeric	O
matrix	O
of	O
their	O
own	O
synthesis	O
.	O

Biofilms	O
form	O
when	O
bacteria	O
adhere	O
to	O
surfaces	O
in	O
moist	O
environments	O
.	O

Biofilm	O
-	O
associated	O
microorganisms	O
have	O
been	O
shown	O
to	O
colonize	O
a	O
wide	O
variety	O
of	O
medical	O
devices	O
and	O
have	O
been	O
implicated	O
in	O
over	O
80	O
%	O
of	O
chronic	O
inflammatory	O
and	O
infectious	O
diseases	O
including	O
chronic	O
otitis	O
media	O
,	O
native	O
valve	O
endocarditis	O
,	O
gastrointestinal	O
ulcers	O
,	O
urinary	O
tract	O
and	O
middle	O
ear	O
infections	O
,	O
and	O
chronic	O
lung	O
infections	O
in	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
patients	S-Organism
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

The	O
human	S-Organism
pathogen	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
is	O
considered	O
one	O
of	O
the	O
primary	O
causes	O
of	O
mortality	O
in	O
patients	S-Organism
with	O
CF	O
,	O
the	O
most	O
common	O
life	O
-	O
threatening	O
hereditary	O
disease	O
in	O
Caucasians	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

In	O
addition	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
causes	O
a	O
variety	O
of	O
diseases	O
in	O
individuals	O
predisposed	O
to	O
infections	O
as	O
the	O
result	O
of	O
severe	O
burns	O
,	O
wounds	O
,	O
urinary	O
tract	O
or	O
corneal	O
injury	O
,	O
or	O
immunocompromised	O
status	O
[	O
5	O
]	O
-	O
[	O
8	O
]	O
.	O

Biofilm	O
cells	O
differ	O
from	O
their	O
planktonic	O
counterparts	O
in	O
the	O
genes	O
and	O
proteins	O
that	O
they	O
express	O
,	O
resulting	O
in	O
distinct	O
phenotypes	O
including	O
altered	O
resistance	O
to	O
antibiotics	O
and	O
the	O
human	S-Organism
immune	O
system	O
[	O
2	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Thus	O
,	O
it	O
is	O
not	O
surprising	O
that	O
biofilms	O
are	O
considered	O
to	O
be	O
differentiated	O
communities	O
compared	O
to	O
their	O
planktonic	O
counterparts	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

This	O
is	O
supported	O
by	O
the	O
finding	O
that	O
various	O
microorganisms	O
,	O
including	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
have	O
been	O
shown	O
to	O
form	O
biofilms	O
in	O
a	O
stage	O
-	O
specific	O
and	O
coordinated	O
manner	O
.	O

Biofilm	O
formation	O
is	O
initiated	O
with	O
surface	O
attachment	O
by	O
planktonic	O
bacteria	O
,	O
followed	O
by	O
formation	O
of	O
clusters	O
and	O
microcolonies	O
and	O
subsequent	O
development	O
of	O
differentiated	O
structures	O
in	O
which	O
individual	O
bacteria	O
as	O
well	O
as	O
the	O
entire	O
community	O
are	O
surrounded	O
by	O
exopolysaccharides	O
.	O

The	O
biofilm	O
developmental	O
cycle	O
comes	O
full	O
circle	O
when	O
biofilms	O
disperse	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
.	O

This	O
process	O
has	O
been	O
shown	O
to	O
be	O
governed	O
by	O
the	O
activities	O
of	O
regulatory	O
networks	O
that	O
coordinate	O
the	O
temporal	O
expression	O
of	O
various	O
motility	O
,	O
adhesion	O
,	O
and	O
exopolysaccharide	O
genes	O
in	O
response	O
to	O
inter	O
-	O
and	O
intracellular	O
signaling	O
molecules	O
and	O
environmental	O
cues	O
.	O

Vallet	O
et	O
al	O
.	O

[	O
14	O
]	O
described	O
a	O
transcriptional	O
regulator	O
MvaT	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
that	O
represses	O
the	O
expression	O
of	O
cup	O
genes	O
involved	O
in	O
the	O
chaperone	O
-	O
usher	O
fimbrial	O
assembly	O
pathway	O
.	O

MvaT	O
deletion	O
mutants	O
exhibited	O
enhanced	O
attachment	O
.	O

In	O
contrast	O
,	O
type	B-Organism
IV	I-Organism
pili	E-Organism
and	O
flagella	B-Organism
deletion	I-Organism
mutants	E-Organism
exhibited	O
reduced	O
attachment	O
indicating	O
that	O
attachment	O
and	O
biofilm	O
formation	O
are	O
mediated	O
by	O
extracellular	O
appendages	O
[	O
12	O
]	O
,	O
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O

Furthermore	O
,	O
the	O
intracellular	O
signaling	O
molecule	O
bis	O
-	O
(	O
3	O
'	O
-	O
5	O
'	O
)	O
-	O
cyclic	O
diguanylic	O
guanosine	O
monophosphate	O
(	O
cyclic	O
-	O
di	O
-	O
GMP	O
)	O
,	O
first	O
described	O
to	O
control	O
extracellular	O
cellulose	O
biosynthesis	O
in	O
Acetobacter	B-Organism
xylinum	E-Organism
[	O
18	O
]	O
,	O
[	O
19	O
]	O
,	O
has	O
been	O
demonstrated	O
in	O
several	O
microorganisms	O
to	O
modulate	O
biofilm	O
formation	O
via	O
the	O
production	O
of	O
exopolysaccharides	O
or	O
matrix	O
components	O
,	O
control	O
auto	O
-	O
aggregation	O
of	O
planktonic	O
cells	O
,	O
and	O
regulate	O
swarming	O
motility	O
[	O
20	O
]	O
-	O
[	O
32	O
]	O
.	O

In	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
at	O
least	O
two	O
pathways	O
have	O
been	O
identified	O
to	O
modulate	O
cyclic	O
-	O
di	O
-	O
GMP	O
and	O
thus	O
,	O
biofilm	O
formation	O
.	O

These	O
are	O
the	O
wsp	O
chemosensory	O
signal	O
transduction	O
pathway	O
[	O
25	O
]	O
and	O
a	O
genetic	O
pathway	O
composed	O
of	O
the	O
phosphodiesterase	O
BifA	O
,	O
the	O
inner	O
membrane	O
-	O
localized	O
diguanylate	O
cyclase	O
SadC	O
and	O
the	O
cytoplasmic	O
protein	O
SadB	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
33	O
]	O
.	O

Both	O
are	O
involved	O
in	O
the	O
reciprocal	O
cyclic	O
-	O
di	O
-	O
GMP	O
-	O
dependent	O
regulation	O
of	O
Pel	O
and	O
Psl	O
exopolysaccharide	O
production	O
as	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
transitions	O
from	O
a	O
planktonic	O
to	O
a	O
surface	O
associated	O
lifestyle	O
.	O

Both	O
Pel	O
and	O
Psl	O
exopolysaccharides	O
contribute	O
to	O
the	O
overall	O
architecture	O
of	O
biofilms	O
and	O
are	O
essential	O
for	O
surface	O
interaction	O
and	O
biofilm	O
initiation	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

Expression	O
of	O
the	O
pel	O
and	O
psl	O
genes	O
is	O
coordinated	O
by	O
the	O
global	O
regulator	O
RetS	O
,	O
a	O
hybrid	O
sensor	O
kinase	O
-	O
response	O
regulator	O
protein	O
,	O
that	O
plays	O
a	O
key	O
role	O
in	O
the	O
reciprocal	O
regulation	O
of	O
virulence	O
factors	O
and	O
biofilm	O
formation	O
required	O
for	O
acute	O
versus	O
chronic	O
infection	O
[	O
36	O
]	O
.	O

RetS	O
belongs	O
to	O
the	O
family	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCS	O
)	O
which	O
translate	O
external	O
signals	O
into	O
adaptive	O
responses	O
by	O
a	O
variety	O
of	O
mechanisms	O
,	O
including	O
control	O
of	O
gene	O
expression	O
and	O
methylation	O
of	O
target	O
proteins	O
.	O

RetS	O
is	O
postulated	O
to	O
act	O
in	O
concert	O
with	O
two	O
other	O
TCS	O
sensor	O
kinase	O
-	O
response	O
regulator	O
hybrids	O
,	O
GacS	O
and	O
LadS	O
,	O
to	O
coordinate	O
the	O
expression	O
of	O
determinants	O
involved	O
in	O
biofilm	O
formation	O
and	O
the	O
production	O
of	O
determinants	O
required	O
for	O
cytotoxicity	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
via	O
the	O
small	O
regulatory	O
RNA	O
rsmZ	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

Inactivation	O
of	O
RetS	O
results	O
in	O
reduced	O
cytotoxicity	O
but	O
increased	O
attachment	O
and	O
biofilm	O
formation	O
,	O
while	O
inactivation	O
of	O
both	O
LadS	O
and	O
GacS	O
results	O
in	O
increased	O
virulence	O
but	O
decreased	O
biofilm	O
formation	O
capacity	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

This	O
multi	O
-	O
component	O
switch	O
thus	O
orchestrates	O
the	O
transition	O
from	O
the	O
planktonic	O
to	O
the	O
biofilm	O
mode	O
of	O
growth	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
via	O
phosphorylation	O
events	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
GacA	O
/	O
GacS	O
[	O
36	O
]	O
-	O
[	O
38	O
]	O
.	O

Overall	O
,	O
the	O
findings	O
suggest	O
that	O
the	O
transition	O
to	O
a	O
surface	O
associated	O
lifestyle	O
proceeds	O
via	O
several	O
pathways	O
,	O
probably	O
in	O
response	O
to	O
environmental	O
cues	O
or	O
signals	O
present	O
during	O
attachment	O
,	O
and	O
involves	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
via	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCS	O
)	O
.	O

This	O
raises	O
the	O
question	O
of	O
whether	O
the	O
transition	O
to	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
which	O
coincide	O
with	O
distinct	O
phenotypes	O
compared	O
to	O
planktonic	O
and	O
initial	O
attached	O
bacterial	O
cells	O
,	O
also	O
involves	O
sensing	O
of	O
environmental	O
signal	O
(	O
s	O
)	O
and	O
requires	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
(	O
phosphorelays	O
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
exhibits	O
distinct	O
protein	O
phosphorylation	O
patterns	O
at	O
various	O
stages	O
of	O
biofilm	O
development	O
.	O

Furthermore	O
,	O
we	O
report	O
the	O
identification	O
of	O
three	O
novel	O
two	O
-	O
component	O
regulatory	O
systems	O
named	O
BfiRS	O
(	O
PA4196	O
-	O
4197	O
)	O
,	O
BfmRS	O
(	O
PA4101	O
-	O
4102	O
)	O
,	O
and	O
MifRS	O
(	O
PA5511	O
-	O
5512	O
)	O
that	O
coordinate	O
phosphorylation	O
events	O
required	O
for	O
the	O
progression	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

These	O
systems	O
together	O
form	O
a	O
coordinated	O
signaling	O
network	O
that	O
regulates	O
three	O
committed	O
steps	O
of	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
life	O
cycle	O
,	O
in	O
particular	O
the	O
transition	O
to	O
three	O
later	O
biofilm	O
developmental	O
stages	O
following	O
initial	O
attachment	O
,	O
namely	O
initiation	O
of	O
biofilm	O
formation	O
(	O
BfiRS	O
)	O
,	O
biofilm	O
maturation	O
(	O
BfmRS	O
)	O
,	O
and	O
microcolony	O
formation	O
(	O
MifRS	O
)	O
.	O

Results	O

The	O
formation	O
of	O
biofilms	O
has	O
been	O
proposed	O
to	O
be	O
controlled	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
39	O
]	O
.	O

Given	O
that	O
protein	O
phosphorylation	O
is	O
a	O
common	O
modification	O
system	O
used	O
in	O
signal	O
transduction	O
that	O
changes	O
the	O
function	O
of	O
proteins	O
in	O
response	O
to	O
environmental	O
stimuli	O
[	O
38	O
]	O
,	O
we	O
chose	O
a	O
phosphoproteomic	O
approach	O
for	O
the	O
detection	O
and	O
identification	O
of	O
regulatory	O
pathways	O
active	O
following	O
the	O
transition	O
to	O
the	O
surface	O
attached	O
mode	O
of	O
growth	O
.	O

Detection	O
of	O
differentially	O
phosphorylated	O
proteins	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
While	O
phosphoproteomic	O
analyses	O
have	O
become	O
widespread	O
in	O
studies	O
of	O
regulation	O
,	O
signaling	O
,	O
development	O
,	O
the	O
characterization	O
of	O
bacterial	O
species	O
and	O
host	O
responses	O
during	O
pathogenesis	O
[	O
40	O
]	O
-	O
[	O
49	O
]	O
,	O
only	O
a	O
limited	O
number	O
of	O
studies	O
have	O
demonstrated	O
that	O
bacterial	O
phosphoproteomes	O
are	O
dynamic	O
[	O
44	O
]	O
,	O
[	O
46	O
]	O
,	O
[	O
48	O
]	O
.	O

We	O
therefore	O
used	O
a	O
combination	O
of	O
2D	O
/	O
PAGE	O
and	O
immunoblot	O
analysis	O
using	O
commercially	O
available	O
anti	O
-	O
phospho	O
Ser	O
/	O
Thr	O
antibodies	O
(	O
see	O
Suppl	O
.	O
Fig	O
.	O
S1A	O
-	O
B	O
for	O
an	O
example	O
)	O
to	O
probe	O
for	O
the	O
presence	O
of	O
signal	O
transduction	O
events	O
that	O
occur	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
.	O

Immunoblots	O
of	O
whole	O
cell	O
extracts	O
obtained	O
from	O
planktonic	O
cells	O
and	O
biofilm	O
cells	O
representing	O
five	O
developmental	O
stages	O
(	O
reversibly	O
and	O
irreversibly	O
attached	O
cells	O
,	O
maturation	O
-	O
1	O
and	O
-	O
2	O
and	O
dispersion	O
stage	O
;	O
following	O
8	O
,	O
24	O
,	O
72	O
,	O
144	O
,	O
and	O
216	O
hr	O
of	O
growth	O
,	O
respectively	O
,	O
see	O
[	O
12	O
]	O
,	O
[	O
50	O
]	O
for	O
timing	O
of	O
biofilm	O
stages	O
)	O
were	O
thus	O
analyzed	O
for	O
the	O
presence	O
of	O
planktonic	O
-	O
and	O
biofilm	O
-	O
specific	O
phosphorylation	O
events	O
.	O

The	O
planktonic	O
mode	O
of	O
growth	O
coincided	O
with	O
24	O
phosphorylated	O
proteins	O
that	O
were	O
not	O
phosphorylated	O
following	O
the	O
transition	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
to	O
surface	O
-	O
associated	O
mode	O
of	O
growth	O
(	O
Fig	O
.	O
1A	O
,	O
stage	O
-	O
specific	O
events	O
)	O
.	O

Additional	O
stage	O
-	O
specific	O
events	O
were	O
detected	O
for	O
biofilms	O
differing	O
in	O
age	O
.	O

For	O
instance	O
,	O
8	O
hr	O
and	O
24	O
hr	O
old	O
biofilms	O
displayed	O
23	O
and	O
21	O
phosphorylation	O
events	O
,	O
respectively	O
,	O
not	O
detected	O
at	O
any	O
other	O
stage	O
.	O

Regardless	O
of	O
the	O
biofilm	O
developmental	O
stage	O
,	O
7	O
phosphorylation	O
events	O
were	O
detected	O
that	O
were	O
absent	O
in	O
planktonic	O
cells	O
(	O
Fig	O
.	O
1A	O
,	O
biofilm	O
-	O
specific	O
events	O
)	O
.	O

In	O
both	O
modes	O
of	O
growth	O
,	O
26	O
proteins	O
were	O
constitutively	O
phosphorylated	O
.	O

In	O
addition	O
to	O
biofilm	O
stage	O
-	O
specific	O
phosphorylation	O
of	O
proteins	O
,	O
protein	O
phosphorylation	O
events	O
were	O
detectable	O
at	O
more	O
than	O
one	O
biofilm	O
growth	O
stage	O
indicating	O
that	O
the	O
transition	O
to	O
surface	O
-	O
associated	O
growth	O
coincides	O
with	O
distinct	O
protein	O
phosphorylation	O
and	O
dephosphorylation	O
events	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

1A	O
,	O
these	O
phosphorylation	O
events	O
are	O
subcategorized	O
as	O
occurring	O
during	O
the	O
reversible	O
and	O
irreversible	O
attachment	O
,	O
biofilm	O
formation	O
and	O
maturation	O
stage	O
depending	O
on	O
when	O
and	O
for	O
how	O
long	O
protein	O
phosphorylation	O
was	O
detected	O
.	O

For	O
instance	O
,	O
four	O
proteins	O
were	O
phosphorylated	O
both	O
in	O
planktonic	O
and	O
reversible	O
attached	O
cells	O
(	O
8	O
hr	O
biofilms	O
)	O
but	O
not	O
at	O
any	O
other	O
biofilm	O
stage	O
(	O
Fig	O
.	O
1A	O
,	O
reversible	O
attachment	O
)	O
while	O
4	O
different	O
proteins	O
were	O
phosphorylated	O
only	O
in	O
planktonic	O
cells	O
and	O
biofilm	O
cells	O
after	O
8	O
hr	O
and	O
24	O
hr	O
of	O
growth	O
under	O
flowing	O
conditions	O
(	O
Fig	O
.	O
1A	O
,	O
irreversible	O
attachment	O
)	O
.	O

Furthermore	O
,	O
evidence	O
of	O
proteins	O
being	O
dephosphorylated	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
was	O
detected	O
.	O

Multiple	O
proteins	O
were	O
found	O
to	O
be	O
dephosphorylated	O
at	O
either	O
a	O
single	O
or	O
at	O
multiple	O
stages	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
and	O
maturation	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

Moreover	O
,	O
the	O
similarity	O
of	O
the	O
biofilm	O
phosphoproteome	O
to	O
the	O
planktonic	O
phosphorylation	O
patterns	O
decreased	O
from	O
59	O
%	O
in	O
8	O
-	O
hr	O
-	O
old	O
biofilms	O
to	O
35	O
%	O
in	O
144	O
-	O
hr	O
-	O
old	O
,	O
mature	O
biofilms	O
.	O

The	O
reduced	O
similarity	O
in	O
phosphorylation	O
events	O
between	O
biofilms	O
and	O
planktonic	O
cells	O
was	O
mainly	O
due	O
to	O
biofilm	O
specific	O
phosphorylation	O
events	O
detected	O
at	O
one	O
or	O
more	O
stages	O
of	O
development	O
.	O

Dispersion	O
-	O
stage	O
biofilms	O
(	O
216	O
-	O
hr	O
-	O
old	O
)	O
shared	O
43	O
%	O
similarity	O
with	O
the	O
phosphorylation	O
patterns	O
of	O
planktonically	O
-	O
grown	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
cells	O
(	O
not	O
shown	O
)	O
.	O

The	O
increase	O
in	O
similarity	O
between	O
the	O
planktonic	O
and	O
the	O
216	O
-	O
hr	O
-	O
old	O
biofilm	O
phosphoproteomes	O
is	O
consistent	O
with	O
previous	O
reports	O
indicating	O
that	O
cells	O
within	O
dispersion	O
-	O
stage	O
biofilms	O
are	O
returning	O
to	O
the	O
planktonic	O
mode	O
of	O
growth	O
[	O
12	O
]	O
,	O
[	O
50	O
]	O
.	O

Protein	O
phosphorylation	O
in	O
bacteria	O
is	O
not	O
restricted	O
to	O
serine	O
and	O
threonine	O
amino	O
acid	O
residues	O
;	O
however	O
,	O
the	O
analysis	O
of	O
phosphorylation	O
events	O
by	O
immunoblotting	O
is	O
limited	O
to	O
the	O
availability	O
of	O
anti	O
-	O
phospho	O
Ser	O
/	O
Thr	O
(	O
and	O
tyrosine	O
)	O
antibodies	O
.	O

We	O
therefore	O
also	O
purified	O
phosphorylated	O
proteins	O
using	O
metal	O
oxide	O
affinity	O
chromatography	O
(	O
MOAC	O
,	O
see	O
Fig	O
.	O
S1	O
)	O
,	O
a	O
gel	O
-	O
independent	O
approach	O
allowing	O
for	O
the	O
enrichment	O
of	O
phosphoproteins	O
independent	O
of	O
the	O
phosphorylation	O
site	O
with	O
an	O
up	O
to	O
100	O
%	O
specificity	O
[	O
51	O
]	O
,	O
[	O
52	O
]	O
,	O
followed	O
by	O
cleavable	O
isotope	O
coded	O
affinity	O
tag	O
(	O
cICAT	O
)	O
labeling	O
and	O
analysis	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
)	O
.	O

This	O
quantitative	O
mass	O
spectrometric	O
approach	O
was	O
used	O
to	O
analyze	O
protein	O
phosphorylation	O
patterns	O
of	O
biofilm	O
cells	O
grown	O
to	O
the	O
reversible	O
,	O
irreversible	O
,	O
maturation	O
-	O
1	O
and	O
maturation	O
-	O
2	O
biofilm	O
stages	O
(	O
8	O
-	O
,	O
24	O
-	O
,	O
7	O
-	O
2	O
,	O
and	O
144	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
respectively	O
[	O
12	O
]	O
)	O
in	O
comparison	O
to	O
those	O
of	O
planktonic	O
cells	O
.	O

Similarly	O
to	O
the	O
results	O
obtained	O
via	O
immunoblot	O
analysis	O
,	O
the	O
changes	O
in	O
phosphorylation	O
events	O
over	O
the	O
course	O
of	O
biofilm	O
development	O
detected	O
using	O
LC	O
-	O
MS	O
-	O
MS	O
analysis	O
appeared	O
to	O
be	O
stage	O
-	O
specific	O
(	O
two	O
examples	O
are	O
shown	O
in	O
Suppl	O
.	O
Fig	O
.	O
S2	O
)	O
,	O
with	O
the	O
similarity	O
to	O
the	O
planktonic	O
patterns	O
decreasing	O
from	O
72	O
%	O
in	O
8	O
hr	O
biofilms	O
to	O
38	O
%	O
in	O
144	O
hr	O
biofilms	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

The	O
overall	O
stage	O
-	O
specific	O
(	O
de	O
)	O
phosphorylation	O
events	O
as	O
well	O
as	O
the	O
differences	O
in	O
the	O
phosphoproteome	O
were	O
similar	O
to	O
those	O
detected	O
by	O
immunoblot	O
analysis	O
using	O
anti	O
-	O
Ser	O
/	O
Thr	O
antibodies	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
the	O
dynamic	O
changes	O
of	O
the	O
phosphoproteome	O
occurring	O
during	O
biofilm	O
development	O
.	O

The	O
combination	O
of	O
approaches	O
used	O
here	O
has	O
not	O
been	O
previously	O
used	O
to	O
identify	O
phosphorylated	O
proteins	O
in	O
biofilms	O
.	O

Identification	O
of	O
regulatory	O
proteins	O
involved	O
in	O
sensing	O
environmental	O
signals	O
associated	O
with	O
planktonic	O
and	O
biofilm	O
growth	O

The	O
quantitative	O
mass	O
spectrometric	O
approach	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
allowed	O
for	O
the	O
simultaneous	O
determination	O
of	O
peptide	O
amino	O
acid	O
sequences	O
by	O
collision	O
-	O
induced	O
dissociation	O
(	O
CID	O
)	O
in	O
the	O
MS	O
/	O
MS	O
mode	O
.	O

Examples	O
of	O
two	O
CID	O
spectra	O
are	O
shown	O
in	O
Suppl	O
.	O

Fig	O
.	O

S2	O
.	O

Proteins	O
that	O
were	O
confirmed	O
to	O
be	O
phosphorylated	O
by	O
immunoblot	O
analysis	O
were	O
identified	O
using	O
a	O
mass	O
spectrometric	O
approach	O
as	O
well	O
.	O

We	O
thus	O
identified	O
48	O
proteins	O
that	O
were	O
differentially	O
phosphorylated	O
at	O
one	O
or	O
more	O
biofilm	O
developmental	O
stage	O
including	O
elongation	O
factors	O
,	O
ribosomal	O
proteins	O
,	O
several	O
enzymes	O
including	O
reductases	O
and	O
GMP	O
synthase	O
,	O
sigma	O
factor	O
RpoD	O
(	O
Suppl	O
.	O
Table	O
S1	O
)	O
and	O
11	O
regulatory	O
proteins	O
(	O
Table	O
1	O
)	O
.	O

The	O
majority	O
of	O
regulatory	O
proteins	O
found	O
to	O
be	O
uniquely	O
phosphorylated	O
during	O
planktonic	O
growth	O
were	O
transcriptional	O
regulators	O
,	O
while	O
with	O
the	O
exception	O
of	O
PA2096	O
,	O
all	O
regulatory	O
proteins	O
found	O
to	O
be	O
phosphorylated	O
during	O
surface	O
attached	O
growth	O
were	O
identified	O
as	O
belonging	O
to	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
(	O
Table	O
1	O
)	O
.	O

Of	O
those	O
,	O
the	O
sensor	O
/	O
response	O
regulator	O
hybrid	O
GacS	O
and	O
PA4197	O
(	O
BfiS	O
)	O
were	O
found	O
to	O
be	O
phosphorylated	O
as	O
soon	O
as	O
8	O
hr	O
following	O
attachment	O
,	O
and	O
PA2096	O
and	O
PA4101	O
(	O
BfmR	O
)	O
following	O
24	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
(	O
Table	O
1	O
)	O
.	O

Interestingly	O
,	O
PA4102	O
(	O
BfmS	O
)	O
,	O
the	O
cognate	O
sensor	O
of	O
PA4101	O
,	O
was	O
found	O
to	O
be	O
phosphorylated	O
following	O
PA4101	O
phosphorylation	O
after	O
72	O
hr	O
of	O
biofilm	O
growth	O
(	O
Table	O
1	O
)	O
.	O

The	O
reason	O
for	O
the	O
difference	O
in	O
the	O
timing	O
of	O
phosphorylation	O
between	O
sensor	O
and	O
response	O
regulator	O
is	O
unclear	O
.	O

It	O
is	O
possible	O
that	O
this	O
due	O
to	O
the	O
different	O
detection	O
methods	O
used	O
.	O

The	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	O
(	O
MifR	O
)	O
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

The	O
stage	O
-	O
specific	O
detection	O
and	O
phosphorylation	O
of	O
PA5511	O
as	O
determined	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
in	O
conjunction	O
with	O
cICAT	O
as	O
well	O
as	O
the	O
CID	O
spectra	O
of	O
a	O
tryptic	O
peptide	O
of	O
PA5511	O
is	O
shown	O
in	O
Suppl	O
.	O

Fig	O
.	O

S2	O
.	O

Neither	O
the	O
cognate	O
sensory	O
protein	O
PA5512	O
nor	O
the	O
response	O
regulator	O
PA4196	O
were	O
identified	O
in	O
this	O
study	O
.	O

This	O
may	O
be	O
due	O
to	O
detection	O
limitation	O
(	O
low	O
protein	O
concentrations	O
,	O
poor	O
protein	O
solubility	O
,	O
poor	O
ionization	O
)	O
and	O
/	O
or	O
limitation	O
in	O
the	O
number	O
of	O
phosphorylated	O
proteins	O
identified	O
(	O
see	O
Suppl	O
.	O
Tables	O
S1	O
and	O
S2	O
for	O
comparison	O
)	O
.	O

As	O
PA4197	O
,	O
PA4101	O
and	O
GacS	O
were	O
all	O
phosphorylated	O
by	O
24	O
hr	O
of	O
biofilm	O
growth	O
,	O
we	O
asked	O
whether	O
the	O
three	O
proteins	O
are	O
modified	O
simultaneously	O
or	O
in	O
a	O
sequential	O
manner	O
.	O

We	O
reasoned	O
that	O
if	O
protein	O
phosphorylation	O
occurs	O
in	O
sequence	O
,	O
inactivation	O
of	O
one	O
of	O
the	O
proteins	O
would	O
potentially	O
prevent	O
phosphorylation	O
of	O
the	O
other	O
proteins	O
of	O
the	O
phosphorelay	O
.	O

We	O
therefore	O
analyzed	O
GacS	O
,	O
PA4101	O
,	O
and	O
PA4197	O
mutant	O
biofilm	O
phosphorylation	O
patterns	O
for	O
the	O
presence	O
/	O
absence	O
of	O
these	O
regulators	O
.	O

No	O
evidence	O
of	O
phosphorylation	O
of	O
PA4197	O
,	O
PA4101	O
,	O
or	O
GacS	O
was	O
detected	O
in	O
DeltaPA4197	O
mutant	O
biofilm	O
phosphorylation	O
patterns	O
.	O

However	O
,	O
phosphorylation	O
of	O
both	O
GacS	O
and	O
PA4197	O
was	O
detected	O
in	O
DeltaPA4101	O
mutant	O
biofilms	O
,	O
indicating	O
that	O
PA4101	O
phosphorylation	O
may	O
occur	O
downstream	O
of	O
GacS	O
and	O
PA4197	O
.	O

DeltagacS	O
biofilm	O
phosphorylation	O
patterns	O
showed	O
an	O
intermediate	O
phosphorylation	O
phenotype	O
with	O
PA4197	O
being	O
phosphorylated	O
but	O
PA4101	O
phosphorylation	O
lacking	O
(	O
not	O
shown	O
)	O
.	O

PA5511	O
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
mutant	O
biofilms	O
analyzed	O
(	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O

The	O
findings	O
suggest	O
that	O
phosphorylation	O
of	O
regulatory	O
proteins	O
occurs	O
in	O
a	O
sequential	O
(	O
but	O
probably	O
indirect	O
)	O
manner	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
.	O

To	O
determine	O
whether	O
phosphorylation	O
coincided	O
with	O
de	O
novo	O
gene	O
expression	O
or	O
reflected	O
biofilm	O
-	O
specific	O
patterns	O
of	O
posttranslational	O
modification	O
,	O
RT	O
-	O
PCR	O
was	O
used	O
.	O

PA4101	O
expression	O
was	O
detected	O
to	O
be	O
biofilm	O
-	O
specific	O
,	O
while	O
PA4197	O
and	O
PA5511	O
were	O
constitutively	O
expressed	O
regardless	O
of	O
the	O
mode	O
of	O
growth	O
(	O
Suppl	O
.	O
Fig	O
.	O
S4	O
)	O
.	O

Similarly	O
,	O
retS	O
and	O
ladS	O
were	O
also	O
constitutively	O
expressed	O
indicating	O
that	O
posttranslational	O
modifications	O
are	O
essential	O
for	O
their	O
activity	O
.	O

Inactivation	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
that	O
are	O
phosphorylated	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
leads	O
to	O
altered	O
biofilm	O
formation	O

As	O
differential	O
and	O
sequential	O
phosphorylation	O
of	O
regulatory	O
proteins	O
was	O
detected	O
over	O
the	O
course	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
development	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
would	O
alter	O
or	O
affect	O
the	O
stage	O
-	O
specific	O
progression	O
of	O
biofilm	O
formation	O
.	O

We	O
therefore	O
focused	O
on	O
biofilm	O
-	O
specific	O
regulatory	O
proteins	O
.	O

Since	O
the	O
proteins	O
PA4101	O
,	O
PA4197	O
,	O
and	O
PA5511	O
were	O
found	O
to	O
be	O
phosphorylated	O
following	O
8	O
,	O
24	O
,	O
and	O
72	O
hr	O
of	O
biofilm	O
growth	O
,	O
respectively	O
(	O
Table	O
1	O
)	O
,	O
corresponding	O
to	O
three	O
biofilm	O
developmental	O
stages	O
[	O
9	O
]	O
,	O
[	O
12	O
]	O
,	O
mutants	O
in	O
these	O
three	O
genes	O
were	O
chosen	O
and	O
allowed	O
to	O
form	O
biofilms	O
for	O
144	O
hr	O
in	O
flow	O
cells	O
to	O
test	O
for	O
biofilm	O
formation	O
defects	O
.	O

Under	O
the	O
conditions	O
tested	O
,	O
wild	O
type	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
reached	O
maturity	O
following	O
144	O
hr	O
of	O
growth	O
as	O
characterized	O
by	O
biofilms	O
being	O
composed	O
of	O
large	O
microcolonies	O
exceeding	O
100	O
microm	O
in	O
diameter	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

In	O
contrast	O
,	O
PA4197	O
and	O
PA4101	O
mutant	O
biofilms	O
lacked	O
microcolonies	O
after	O
144	O
hr	O
of	O
growth	O
(	O
Fig	O
.	O
2B	O
)	O
and	O
were	O
only	O
composed	O
of	O
a	O
thin	O
layer	O
of	O
cells	O
at	O
the	O
substratum	O
with	O
an	O
average	O
height	O
of	O
0	O
.	O
5	O
and	O
1	O
.	O
4	O
microm	O
,	O
respectively	O
(	O
Table	O
2	O
)	O
.	O

However	O
,	O
in	O
contrast	O
to	O
PA4197	O
mutant	O
biofilms	O
,	O
PA4101	O
mutant	O
biofilms	O
demonstrated	O
the	O
formation	O
of	O
some	O
cellular	O
aggregates	O
which	O
were	O
less	O
than	O
10	O
microm	O
in	O
height	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Furthermore	O
,	O
the	O
mutant	O
biofilms	O
differed	O
significantly	O
from	O
wild	O
type	O
biofilms	O
with	O
respect	O
to	O
biomass	O
,	O
surface	O
coverage	O
,	O
and	O
roughness	O
coefficient	O
.	O

Complementation	O
of	O
both	O
PA4101	O
and	O
PA4197	O
mutants	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

These	O
results	O
allowed	O
us	O
to	O
firmly	O
conclude	O
that	O
the	O
mutant	O
biofilm	O
phenotypes	O
are	O
caused	O
by	O
a	O
defect	O
in	O
the	O
PA4197	O
and	O
PA4101	O
ORF	O
.	O

Based	O
on	O
the	O
role	O
of	O
PA4197	O
in	O
the	O
initiation	O
of	O
biofilm	O
formation	O
,	O
we	O
named	O
the	O
PA4197	O
ORF	O
Biofilm	O
initiation	O
Sensor	O
(	O
BfiS	O
)	O
.	O

BfiS	O
is	O
an	O
unusual	O
sensor	O
that	O
harbors	O
a	O
His	O
kinase	O
A	O
domain	O
typically	O
found	O
in	O
two	O
-	O
component	O
system	O
(	O
TCS	O
)	O
sensor	O
proteins	O
,	O
a	O
Histidine	O
kinase	O
-	O
like	O
ATPase	O
domain	O
involved	O
in	O
autophosphorylation	O
but	O
also	O
in	O
protein	O
dephosphorylation	O
events	O
,	O
and	O
a	O
PAS	O
signal	O
receiver	O
domain	O
[	O
53	O
]	O
.	O

The	O
cognate	O
response	O
regulator	O
BfiR	O
(	O
PA4196	O
)	O
harbors	O
a	O
CheY	O
-	O
like	O
signal	O
receiver	O
domain	O
and	O
a	O
LuxR	O
-	O
like	O
DNA	O
binding	O
domain	O
,	O
which	O
is	O
also	O
present	O
in	O
the	O
quorum	O
-	O
sensing	O
regulatory	O
proteins	O
LasR	O
,	O
RhlR	O
,	O
and	O
QscR	O
and	O
in	O
response	O
regulators	O
with	O
established	O
roles	O
in	O
biofilm	O
formation	O
(	O
GacA	O
,	O
RocA1	O
/	O
SadA	O
)	O
[	O
53	O
]	O
.	O

BfiR	O
also	O
harbors	O
region	O
4	O
of	O
Sigma	O
-	O
70	O
(	O
RpoD	O
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
[	O
53	O
]	O
.	O

Due	O
to	O
its	O
role	O
in	O
biofilm	O
maturation	O
,	O
we	O
named	O
the	O
PA4101	O
ORF	O
Biofilm	O
maturation	O
Regulator	O
(	O
BfmR	O
)	O
.	O

The	O
protein	O
harbors	O
an	O
OmpR	O
-	O
like	O
transcriptional	O
regulator	O
domain	O
encompassing	O
the	O
common	O
signal	O
receiver	O
and	O
DNA	O
-	O
binding	O
effector	O
domains	O
[	O
53	O
]	O
.	O

The	O
cognate	O
sensor	O
BfmS	O
(	O
PA4102	O
)	O
is	O
unusual	O
in	O
that	O
it	O
lacks	O
an	O
autophosphorylation	O
site	O
typically	O
found	O
in	O
sensor	O
kinases	O
[	O
53	O
]	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	O
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

PA5511	O
mutant	O
biofilms	O
grown	O
for	O
144	O
hr	O
lacked	O
clusters	O
and	O
microcolonies	O
typically	O
found	O
in	O
wild	O
type	O
biofilms	O
following	O
72	O
-	O
144	O
hr	O
of	O
growth	O
(	O
Fig	O
.	O
2A	O
-	O
B	O
)	O
.	O

Complementation	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

However	O
,	O
when	O
placed	O
in	O
a	O
PAO1	S-Organism
background	O
(	O
PAO1	B-Organism
/	I-Organism
pJN5511	E-Organism
)	O
,	O
overexpression	O
of	O
PA5511	O
resulted	O
in	O
biofilms	O
composed	O
of	O
large	O
microcolonies	O
exceeding	O
250	O
microm	O
in	O
diameter	O
(	O
compared	O
to	O
an	O
average	O
cluster	O
diameter	O
of	O
150	O
microm	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
PAO1	E-Organism
,	O
Fig	O
.	O
2A	O
,	O
D	O
)	O
.	O

Since	O
cluster	O
formation	O
correlated	O
with	O
PA5511	O
expression	O
levels	O
,	O
we	O
named	O
PA5511	O
Microcolony	O
formation	O
Regulator	O
(	O
MifR	O
)	O
.	O

MifR	O
harbors	O
a	O
CheY	O
-	O
like	O
receiver	O
and	O
a	O
sigma	O
-	O
54	O
interaction	O
domain	O
[	O
53	O
]	O
.	O

The	O
protein	O
is	O
on	O
average	O
30	O
-	O
50	O
%	O
identical	O
to	O
known	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
NtrC	O
-	O
like	O
enhancer	O
binding	O
proteins	O
including	O
PilR	O
,	O
FleQ	O
,	O
FleR	O
,	O
AlgB	O
,	O
CbrB	O
,	O
and	O
NtrC	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O

The	O
cognate	O
sensor	O
(	O
MifS	O
,	O
PA5512	O
)	O
is	O
a	O
typical	O
sensor	O
kinase	O
harboring	O
both	O
a	O
His	O
kinase	O
A	O
and	O
a	O
His	O
kinase	O
-	O
like	O
ATPase	O
domain	O
[	O
53	O
]	O
.	O

Since	O
individual	O
carbon	O
and	O
nitrogen	O
sources	O
have	O
been	O
demonstrated	O
to	O
modulate	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
in	O
vitro	O
biofilm	O
development	O
and	O
architecture	O
[	O
16	O
]	O
,	O
[	O
55	O
]	O
-	O
[	O
58	O
]	O
,	O
surface	O
motility	O
[	O
59	O
]	O
and	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
cell	O
-	O
cell	O
signaling	O
(	O
quorum	O
sensing	O
)	O
[	O
60	O
]	O
-	O
[	O
63	O
]	O
,	O
the	O
biofilm	O
architecture	O
of	O
all	O
four	O
mutant	O
biofilms	O
was	O
tested	O
using	O
three	O
different	O
media	O
including	O
LB	O
medium	O
and	O
two	O
minimal	O
media	O
containing	O
glutamate	O
[	O
17	O
]	O
or	O
citrate	O
[	O
64	O
]	O
as	O
sole	O
carbon	O
source	O
.	O

Under	O
the	O
conditions	O
tested	O
,	O
the	O
biofilm	O
architecture	O
of	O
all	O
three	O
mutants	O
was	O
similar	O
to	O
the	O
biofilm	O
architecture	O
shown	O
in	O
Fig	O
.	O

2	O
independent	O
of	O
the	O
media	O
used	O
.	O

TCS	O
mutant	O
biofilms	O
are	O
arrested	O
in	O
the	O
transition	O
to	O
later	O
biofilm	O
developmental	O
stages	O

To	O
determine	O
whether	O
the	O
altered	O
biofilm	O
structure	O
was	O
due	O
to	O
arrested	O
biofilm	O
formation	O
or	O
attachment	O
defects	O
,	O
we	O
first	O
determined	O
whether	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
mutants	O
are	O
defective	O
in	O
attachment	O
.	O

Inactivation	O
of	O
BfiS	O
,	O
BfmR	O
,	O
and	O
MifR	O
(	O
PA4197	O
,	O
PA4101	O
,	O
PA5511	O
,	O
respectively	O
)	O
did	O
not	O
affect	O
initial	O
attachment	O
to	O
polystyrene	O
compared	O
to	O
wild	O
type	O
biofilms	O
as	O
revealed	O
by	O
the	O
crystal	O
violet	O
microtiter	O
plate	O
assay	O
and	O
confirmed	O
by	O
microscopy	O
(	O
not	O
shown	O
)	O
.	O

Furthermore	O
,	O
no	O
difference	O
in	O
growth	O
in	O
broth	O
or	O
defect	O
with	O
respect	O
to	O
twitching	O
,	O
swimming	O
,	O
and	O
swarming	O
or	O
Pel	O
and	O
Psl	O
polysaccharide	O
production	O
was	O
detected	O
for	O
any	O
of	O
the	O
mutant	O
strains	O
(	O
not	O
shown	O
)	O
.	O

In	O
addition	O
,	O
no	O
difference	O
in	O
transcript	O
abundance	O
,	O
as	O
determined	O
by	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
,	O
of	O
genes	O
involved	O
in	O
Pel	O
and	O
Psl	O
polysaccharide	O
biosynthesis	O
compared	O
to	O
wild	O
type	O
was	O
detected	O
(	O
not	O
shown	O
)	O
.	O

However	O
,	O
a	O
DeltagacS	O
mutant	O
showed	O
10	O
-	O
fold	O
reduced	O
initial	O
attachment	O
compared	O
to	O
the	O
wild	O
type	O
(	O
not	O
shown	O
)	O
,	O
consistent	O
with	O
previous	O
findings	O
by	O
Parkins	O
and	O
colleagues	O
[	O
65	O
]	O
.	O

These	O
findings	O
implied	O
that	O
the	O
novel	O
regulatory	O
proteins	O
were	O
involved	O
in	O
the	O
regulation	O
of	O
biofilm	O
formation	O
at	O
later	O
stages	O
following	O
initial	O
attachment	O
.	O

To	O
determine	O
the	O
stage	O
at	O
which	O
DeltabfiS	O
and	O
DeltabfmR	O
mutant	O
biofilms	O
were	O
arrested	O
,	O
the	O
biofilm	O
architecture	O
of	O
the	O
mutant	O
strains	O
after	O
144	O
hr	O
of	O
growth	O
was	O
compared	O
to	O
the	O
wild	O
type	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
architecture	O
following	O
24	O
,	O
72	O
,	O
and	O
144	O
hr	O
of	O
growth	O
(	O
Table	O
2	O
)	O
.	O

Based	O
on	O
the	O
comparison	O
of	O
5	O
biofilm	O
variables	O
,	O
both	O
mutant	O
biofilms	O
were	O
more	O
similar	O
to	O
24	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
with	O
DeltabfmR	O
forming	O
more	O
substantial	O
biofilms	O
than	O
DeltabfiS	O
or	O
24	O
hr	O
wild	O
type	O
biofilms	O
(	O
Table	O
2	O
)	O
.	O

Arrest	O
of	O
biofilm	O
formation	O
at	O
the	O
1	O
-	O
day	O
time	O
point	O
correlated	O
with	O
the	O
timing	O
of	O
BfiS	O
and	O
BfmR	O
phosphorylation	O
(	O
Tables	O
1	O
-	O
2	O
)	O
.	O

Comparison	O
of	O
the	O
DeltamifR	O
biofilm	O
architecture	O
following	O
144	O
hr	O
of	O
growth	O
to	O
wild	O
type	O
biofilms	O
indicated	O
that	O
DeltamifR	O
biofilms	O
were	O
comparable	O
to	O
72	O
-	O
hr	O
-	O
old	O
biofilms	O
.	O

Since	O
MifR	O
was	O
detected	O
to	O
be	O
phosphorylated	O
following	O
72	O
hr	O
of	O
biofilm	O
growth	O
(	O
Table	O
1	O
)	O
,	O
our	O
findings	O
indicate	O
that	O
phosphorylation	O
of	O
MifR	O
is	O
essential	O
for	O
the	O
progression	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
from	O
the	O
maturation	O
-	O
1	O
stage	O
(	O
72	O
hr	O
)	O
to	O
the	O
maturation	O
-	O
2	O
stage	O
(	O
144	O
hr	O
)	O
.	O

To	O
exclude	O
the	O
possibility	O
that	O
the	O
DeltabfiS	O
,	O
DeltabfmR	O
,	O
and	O
DeltamifR	O
mutant	O
biofilms	O
may	O
have	O
disaggregated	O
prematurely	O
,	O
the	O
formation	O
of	O
mutant	O
biofilms	O
was	O
monitored	O
daily	O
by	O
confocal	O
microscopy	O
over	O
a	O
period	O
of	O
144	O
hr	O
.	O

The	O
DeltabfiS	O
and	O
DeltabfmR	O
biofilms	O
resembled	O
wild	O
type	O
biofilms	O
with	O
respect	O
to	O
biomass	O
and	O
overall	O
architecture	O
at	O
the	O
24	O
hr	O
time	O
point	O
(	O
see	O
Fig	O
.	O
2A	O
-	O
B	O
)	O
.	O

However	O
,	O
while	O
wild	O
type	O
biofilms	O
continued	O
to	O
mature	O
/	O
develop	O
upon	O
prolonged	O
incubation	O
(	O
see	O
Fig	O
.	O
2A	O
)	O
,	O
no	O
additional	O
biomass	O
accumulation	O
or	O
alteration	O
in	O
architecture	O
was	O
observed	O
for	O
DeltabfiS	O
and	O
DeltabfmR	O
biofilms	O
post	O
24	O
hr	O
of	O
growth	O
.	O

Furthermore	O
,	O
for	O
DeltamifR	O
biofilms	O
,	O
the	O
progression	O
of	O
biofilm	O
formation	O
was	O
indistinguishable	O
from	O
wild	O
type	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
formation	O
for	O
the	O
first	O
72	O
hr	O
of	O
growth	O
.	O

However	O
,	O
continued	O
incubation	O
did	O
not	O
result	O
in	O
increased	O
DeltamifR	O
biofilm	O
growth	O
(	O
biomass	O
,	O
thickness	O
)	O
or	O
microcolony	O
formation	O
typically	O
seen	O
in	O
wild	O
type	O
biofilms	O
at	O
the	O
maturation	O
-	O
2	O
stage	O
(	O
post	O
72	O
hr	O
of	O
growth	O
,	O
Table	O
2	O
,	O
Fig	O
.	O
2	O
)	O
.	O

The	O
findings	O
clearly	O
indicate	O
that	O
inactivation	O
of	O
these	O
novel	O
regulatory	O
proteins	O
did	O
not	O
cause	O
biofilm	O
disaggregation	O
.	O

Instead	O
,	O
our	O
findings	O
suggested	O
that	O
the	O
mutant	O
biofilms	O
were	O
incapable	O
of	O
progressing	O
from	O
the	O
initial	O
attachment	O
stage	O
to	O
more	O
mature	O
biofilm	O
stages	O
.	O

GacS	O
plays	O
a	O
dual	O
role	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
development	O

Since	O
GacS	O
was	O
found	O
to	O
be	O
phosphorylated	O
in	O
a	O
BfiS	O
-	O
dependent	O
manner	O
following	O
8	O
hrs	O
of	O
growth	O
,	O
we	O
asked	O
whether	O
a	O
DeltagacS	O
mutant	O
forms	O
biofilms	O
similar	O
in	O
architecture	O
to	O
DeltabfiS	O
biofilms	O
.	O

Inactivation	O
of	O
gacS	O
resulted	O
in	O
the	O
formation	O
of	O
biofilms	O
following	O
144	O
hr	O
of	O
growth	O
that	O
were	O
similar	O
in	O
appearance	O
to	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
.	O

Closer	O
inspection	O
of	O
biofilm	O
formation	O
by	O
DeltagacS	O
over	O
a	O
period	O
of	O
144	O
hr	O
,	O
however	O
,	O
indicated	O
that	O
the	O
biofilm	O
architecture	O
(	O
seen	O
after	O
144	O
hr	O
)	O
was	O
due	O
to	O
accelerated	O
biofilm	O
growth	O
followed	O
by	O
premature	O
disaggregation	O
of	O
biofilms	O
as	O
compared	O
to	O
wild	O
type	O
biofilms	O
.	O

DeltagacS	O
mutant	O
biofilms	O
were	O
significantly	O
thicker	O
than	O
wild	O
type	O
biofilms	O
following	O
1	O
and	O
72	O
hr	O
of	O
growth	O
under	O
flowing	O
conditions	O
,	O
forming	O
microcolonies	O
and	O
clusters	O
exceeding	O
150	O
microm	O
in	O
diameter	O
(	O
Fig	O
.	O
3	O
)	O
.	O

At	O
both	O
time	O
points	O
,	O
DeltagacS	O
biofilms	O
not	O
only	O
exceeded	O
the	O
average	O
microcolony	O
size	O
typically	O
seen	O
for	O
wild	O
type	O
biofilms	O
of	O
the	O
same	O
age	O
,	O
but	O
also	O
the	O
biomass	O
and	O
thickness	O
of	O
wild	O
type	O
biofilms	O
at	O
more	O
mature	O
ages	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
.	O

Continued	O
growth	O
for	O
more	O
than	O
72	O
hr	O
,	O
however	O
,	O
resulted	O
in	O
the	O
disaggregation	O
of	O
DeltagacS	O
mutant	O
biofilms	O
as	O
indicated	O
by	O
the	O
presence	O
of	O
large	O
,	O
detached	O
clusters	O
floating	O
in	O
the	O
bulk	O
liquid	O
,	O
and	O
a	O
significantly	O
reduced	O
attached	O
biofilm	O
biomass	O
and	O
biofilm	O
thickness	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
.	O

Thus	O
,	O
while	O
growth	O
of	O
DeltagacS	O
mutant	O
biofilms	O
following	O
24	O
hr	O
post	O
attachment	O
was	O
accelerated	O
(	O
Fig	O
.	O
3	O
)	O
,	O
initial	O
attachment	O
was	O
significantly	O
reduced	O
in	O
this	O
mutant	O
(	O
not	O
shown	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
GacS	O
may	O
play	O
a	O
dual	O
role	O
in	O
regulating	O
biofilm	O
formation	O
,	O
which	O
in	O
turn	O
may	O
be	O
dependent	O
on	O
the	O
phosphorylation	O
status	O
of	O
GacS	O
(	O
Table	O
1	O
)	O
.	O

Mutant	O
biofilms	O
display	O
protein	O
and	O
phosphorylation	O
patterns	O
indicative	O
of	O
stage	O
-	O
specific	O
arrest	O
of	O
biofilm	O
development	O

Based	O
on	O
qualitative	O
and	O
quantitative	O
analyses	O
,	O
BfiS	O
(	O
PA4197	O
)	O
and	O
BfmR	O
(	O
PA4101	O
)	O
mutant	O
biofilm	O
architecture	O
appeared	O
to	O
be	O
the	O
result	O
of	O
arrested	O
biofilm	O
formation	O
following	O
initial	O
attachment	O
,	O
while	O
inactivation	O
of	O
MifR	O
(	O
PA5511	O
)	O
coincided	O
with	O
biofilms	O
impaired	O
in	O
microcolony	O
formation	O
at	O
the	O
maturation	O
-	O
1	O
stage	O
.	O

Since	O
each	O
of	O
these	O
biofilm	O
developmental	O
stages	O
is	O
characterized	O
by	O
a	O
unique	O
phosphorylation	O
pattern	O
(	O
Figs	O
.	O
1	O
,	O
4	O
,	O
Table	O
1	O
)	O
,	O
we	O
reasoned	O
that	O
if	O
the	O
mutant	O
biofilms	O
are	O
indeed	O
arrested	O
in	O
biofilm	O
development	O
,	O
their	O
phosphoproteomes	O
will	O
correspond	O
to	O
the	O
stage	O
at	O
which	O
they	O
are	O
arrested	O
.	O

We	O
,	O
therefore	O
,	O
analyzed	O
the	O
phosphorylation	O
patterns	O
of	O
DeltabfiS	O
,	O
DeltabfmR	O
,	O
and	O
DeltamifR	O
biofilms	O
grown	O
for	O
144	O
hr	O
in	O
comparison	O
to	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
wild	O
type	O
biofilms	O
grown	O
for	O
8	O
,	O
24	O
,	O
72	O
,	O
and	O
144	O
hr	O
.	O

The	O
phosphoproteomes	O
were	O
analyzed	O
using	O
two	O
approaches	O
,	O
(	O
i	O
)	O
immunoblot	O
analysis	O
of	O
whole	O
biofilm	O
cell	O
extracts	O
and	O
(	O
ii	O
)	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
in	O
conjunction	O
with	O
cICAT	O
labeling	O
following	O
MOAC	O
purification	O
.	O

The	O
phosphoproteome	O
of	O
DeltabfiS	O
biofilms	O
as	O
determined	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
was	O
74	O
%	O
similar	O
(	O
26	O
%	O
difference	O
)	O
to	O
planktonic	O
cells	O
while	O
DeltabfmR	O
biofilms	O
shared	O
60	O
%	O
of	O
all	O
detected	O
phosphorylation	O
events	O
with	O
planktonic	O
cells	O
(	O
40	O
%	O
difference	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
phosphoproteome	O
of	O
144	O
-	O
hr	O
-	O
old	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
wild	O
type	O
biofilms	O
,	O
which	O
was	O
62	O
-	O
65	O
%	O
different	O
from	O
that	O
of	O
planktonic	O
cells	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Furthermore	O
,	O
both	O
mutant	O
biofilms	O
failed	O
to	O
exhibit	O
phosphorylation	O
events	O
typically	O
observed	O
during	O
normal	O
biofilm	O
development	O
following	O
144	O
hr	O
of	O
growth	O
(	O
see	O
Fig	O
.	O
1	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
.	O

For	O
instance	O
,	O
DeltabfiS	O
and	O
DeltabfmR	O
biofilms	O
lacked	O
all	O
phosphorylated	O
proteins	O
typically	O
found	O
in	O
mature	O
,	O
144	O
-	O
hr	O
-	O
old	O
biofilms	O
.	O

In	O
addition	O
,	O
both	O
mutant	O
biofilms	O
lacked	O
evidence	O
for	O
MifR	O
phosphorylation	O
(	O
phosphorylated	O
following	O
72	O
hr	O
of	O
wild	O
type	O
growth	O
,	O
Table	O
1	O
,	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O

Instead	O
,	O
DeltabfiS	O
biofilms	O
exhibited	O
stage	O
-	O
specific	O
phosphorylation	O
events	O
typically	O
detected	O
in	O
8	O
-	O
hr	O
-	O
and	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
:	O
the	O
Ser	O
/	O
Thr	O
phosphoproteome	O
contained	O
15	O
out	O
of	O
23	O
phosphorylated	O
proteins	O
and	O
2	O
out	O
of	O
21	O
phosphorylated	O
proteins	O
that	O
are	O
specific	O
for	O
8	O
-	O
hr	O
-	O
and	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
,	O
respectively	O
(	O
see	O
Fig	O
.	O
1	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
.	O

Similarly	O
,	O
the	O
phosphorylation	O
patterns	O
of	O
DeltabfmR	O
biofilms	O
indicated	O
the	O
presence	O
of	O
24	O
-	O
and	O
72	O
-	O
hr	O
stage	O
-	O
specific	O
phosphorylated	O
proteins	O
(	O
not	O
shown	O
)	O
.	O

The	O
phosphorylation	O
patterns	O
of	O
144	O
-	O
hr	O
-	O
old	O
DeltamifR	O
biofilms	O
were	O
62	O
%	O
different	O
relative	O
to	O
planktonic	O
cells	O
,	O
but	O
only	O
shared	O
58	O
%	O
similarity	O
with	O
mature	O
,	O
144	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Furthermore	O
,	O
DeltamifR	O
biofilms	O
exhibited	O
8	O
out	O
of	O
27	O
maturation	O
-	O
1	O
specific	O
protein	O
phosphorylation	O
events	O
,	O
and	O
only	O
16	O
out	O
of	O
37	O
maturation	O
-	O
2	O
phosphorylation	O
events	O
(	O
Suppl	O
.	O
Table	O
S2	O
,	O
see	O
Fig	O
.	O
1	O
)	O
.	O

We	O
further	O
reasoned	O
that	O
if	O
the	O
mutant	O
biofilms	O
are	O
indeed	O
arrested	O
in	O
biofilm	O
development	O
,	O
their	O
whole	O
proteomes	O
will	O
also	O
correspond	O
to	O
the	O
stage	O
at	O
which	O
they	O
are	O
arrested	O
.	O

We	O
therefore	O
compared	O
the	O
protein	O
production	O
patterns	O
of	O
144	O
-	O
hr	O
-	O
old	O
DeltabfiS	O
,	O
DeltabfmR	O
,	O
and	O
DeltamifR	O
biofilms	O
to	O
the	O
2D	O
-	O
patterns	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
wild	O
type	O
biofilms	O
grown	O
for	O
24	O
,	O
72	O
and	O
144	O
hr	O
using	O
2D	O
/	O
PAGE	O
,	O
2D	O
ImageMaster	O
Platinum	O
software	O
and	O
heuristic	O
clustering	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

4B	O
,	O
cluster	O
analysis	O
based	O
on	O
protein	O
similarity	O
confirmed	O
our	O
previous	O
findings	O
obtained	O
by	O
microscopic	O
and	O
phosphoproteome	O
analyses	O
of	O
mutant	O
biofilms	O
.	O

DeltabfiS	O
biofilms	O
were	O
more	O
similar	O
to	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
than	O
to	O
wild	O
type	O
biofilms	O
at	O
more	O
mature	O
stages	O
.	O

The	O
two	O
protein	O
patterns	O
were	O
more	O
than	O
80	O
%	O
similar	O
.	O

In	O
contrast	O
,	O
DeltabfmR	O
biofilms	O
were	O
most	O
similar	O
to	O
protein	O
patterns	O
obtained	O
from	O
72	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
(	O
85	O
%	O
similarity	O
)	O
,	O
while	O
those	O
of	O
DeltamifR	O
biofilms	O
were	O
similar	O
to	O
both	O
72	O
-	O
and	O
144	O
-	O
hr	O
-	O
old	O
biofilms	O
sharing	O
76	O
and	O
82	O
%	O
similarity	O
,	O
respectively	O
,	O
to	O
both	O
protein	O
patterns	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

Based	O
on	O
analyses	O
of	O
biofilm	O
architecture	O
,	O
as	O
well	O
as	O
of	O
protein	O
production	O
and	O
phosphorylation	O
patterns	O
,	O
our	O
findings	O
indicate	O
that	O
DeltabfiS	O
biofilms	O
are	O
arrested	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
the	O
irreversible	O
attachment	O
stage	O
(	O
8	O
hr	O
to	O
24	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
respectively	O
)	O
.	O

Inactivation	O
of	O
MifR	O
appeared	O
to	O
result	O
in	O
the	O
arrest	O
of	O
biofilm	O
development	O
in	O
the	O
transition	O
between	O
the	O
maturation	O
-	O
1	O
and	O
-	O
2	O
stages	O
(	O
72	O
to	O
144	O
hr	O
)	O
while	O
DeltabfmR	O
biofilms	O
were	O
arrested	O
in	O
the	O
transition	O
between	O
irreversible	O
attachment	O
to	O
maturation	O
-	O
1	O
stage	O
.	O

Expression	O
of	O
bfiS	O
,	O
bfmR	O
,	O
and	O
mifR	O
is	O
required	O
for	O
maintenance	O
of	O
normal	O
biofilm	O
architecture	O
while	O
loss	O
of	O
expression	O
results	O
in	O
biofilm	O
architecture	O
collapse	O

Our	O
observations	O
indicated	O
that	O
BfiS	O
(	O
PA4197	O
)	O
,	O
BfmR	O
(	O
PA4101	O
)	O
and	O
MifR	O
(	O
PA5511	O
)	O
are	O
essential	O
in	O
the	O
stage	O
-	O
specific	O
development	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
formation	O
.	O

To	O
determine	O
whether	O
these	O
regulatory	O
proteins	O
are	O
only	O
essential	O
during	O
biofilm	O
formation	O
or	O
are	O
also	O
necessary	O
for	O
the	O
maintenance	O
of	O
established	O
biofilms	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
in	O
mature	O
biofilms	O
would	O
affect	O
biofilm	O
architecture	O
.	O

Complemented	O
mutant	O
strains	O
,	O
harboring	O
the	O
respective	O
regulator	O
genes	O
under	O
the	O
control	O
of	O
the	O
arabinose	O
-	O
inducible	O
PBAD	O
promoter	O
,	O
were	O
allowed	O
to	O
grow	O
for	O
144	O
hr	O
in	O
flow	O
cells	O
to	O
maturity	O
(	O
Fig	O
.	O
2C	O
,	O
Fig	O
.	O
5	O
-	O
0	O
hr	O
)	O
in	O
the	O
presence	O
of	O
arabinose	O
,	O
after	O
which	O
time	O
arabinose	O
was	O
removed	O
from	O
the	O
growth	O
medium	O
to	O
stop	O
the	O
transcription	O
of	O
the	O
respective	O
genes	O
.	O

The	O
resulting	O
biofilm	O
architecture	O
was	O
viewed	O
over	O
a	O
period	O
of	O
144	O
hr	O
post	O
arabinose	O
removal	O
using	O
confocal	O
microscopy	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	E-Organism
wild	O
type	O
harboring	O
an	O
empty	O
pJN105	O
vector	O
was	O
used	O
as	O
control	O
.	O

Loss	O
of	O
bfiS	O
,	O
bfmR	O
,	O
and	O
mifR	O
expression	O
due	O
to	O
arabinose	O
removal	O
resulted	O
in	O
the	O
collapse	O
of	O
the	O
mutant	O
biofilm	O
architecture	O
within	O
three	O
days	O
.	O

For	O
DeltabfiS	O
and	O
DeltabfmR	O
mutant	O
biofilms	O
,	O
biofilm	O
disaggregation	O
was	O
noticeable	O
as	O
early	O
as	O
24	O
hr	O
post	O
arabinose	O
removal	O
(	O
not	O
shown	O
)	O
.	O

The	O
collapse	O
was	O
apparent	O
by	O
significant	O
reduction	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
of	O
biofilm	O
variables	O
including	O
biofilm	O
biomass	O
and	O
thickness	O
,	O
which	O
further	O
decreased	O
upon	O
continued	O
incubation	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

Post	O
144	O
hr	O
of	O
arabinose	O
removal	O
,	O
the	O
biofilm	O
architecture	O
of	O
the	O
complemented	O
mutants	O
was	O
similar	O
to	O
mutant	O
biofilms	O
lacking	O
the	O
respective	O
regulatory	O
gene	O
(	O
Figs	O
.	O
2	O
,	O
5	O
)	O
.	O

In	O
contrast	O
,	O
no	O
reduction	O
of	O
the	O
wild	O
type	O
biofilm	O
architecture	O
was	O
observed	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

These	O
findings	O
indicated	O
that	O
the	O
three	O
novel	O
regulators	O
are	O
not	O
only	O
essential	O
for	O
the	O
stage	O
-	O
specific	O
progression	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
but	O
also	O
in	O
the	O
maintenance	O
of	O
the	O
biofilm	O
structure	O
.	O

Discussion	O

Evidence	O
showing	O
that	O
biofilm	O
development	O
is	O
a	O
coordinated	O
series	O
of	O
events	O
coinciding	O
with	O
distinct	O
phenotypes	O
has	O
led	O
to	O
the	O
assumption	O
that	O
the	O
formation	O
of	O
biofilms	O
is	O
a	O
regulated	O
progression	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
66	O
]	O
.	O

However	O
,	O
biofilm	O
development	O
has	O
been	O
considered	O
to	O
be	O
distinct	O
from	O
other	O
developmental	O
processes	O
including	O
the	O
programmed	O
differentiation	O
seen	O
in	O
spore	O
formation	O
in	O
Bacillus	B-Organism
subtilis	E-Organism
or	O
fruiting	O
body	O
formation	O
in	O
Myxococcus	B-Organism
xanthus	E-Organism
[	O
11	O
]	O
,	O
mainly	O
because	O
no	O
regulatory	O
pathways	O
have	O
yet	O
been	O
identified	O
that	O
are	O
responsible	O
for	O
regulating	O
committed	O
steps	O
in	O
the	O
formation	O
of	O
biofilms	O
with	O
the	O
exception	O
of	O
attachment	O
.	O

In	O
this	O
study	O
we	O
describe	O
the	O
identification	O
and	O
initial	O
characterization	O
of	O
three	O
novel	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
essential	O
in	O
regulating	O
three	O
committed	O
steps	O
in	O
biofilm	O
development	O
.	O

Mutation	O
in	O
these	O
regulatory	O
pathways	O
did	O
not	O
affect	O
initial	O
attachment	O
,	O
motility	O
,	O
or	O
Pel	O
and	O
Psl	O
polysaccharide	O
production	O
,	O
but	O
instead	O
arrested	O
biofilm	O
development	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
irreversible	O
attachment	O
[	O
8	O
hr	O
to	O
24	O
hr	O
,	O
BfiRS	O
(	O
PA4196	O
-	O
4197	O
)	O
]	O
,	O
from	O
initial	O
attachment	O
to	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
(	O
24	O
hr	O
to	O
72	O
hr	O
,	O
BfmRS	O
(	O
PA4101	O
-	O
4102	O
)	O
]	O
,	O
and	O
following	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
72	O
hr	O
to	O
144	O
hr	O
,	O
MifRS	O
(	O
PA5511	O
-	O
5512	O
)	O
]	O
(	O
Fig	O
.	O
6	O
)	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
description	O
of	O
a	O
regulatory	O
program	O
for	O
stage	O
-	O
specific	O
biofilm	O
development	O
.	O

The	O
stage	O
-	O
specific	O
arrest	O
in	O
biofilm	O
formation	O
of	O
the	O
mutant	O
strains	O
coincided	O
with	O
the	O
timing	O
of	O
phosphorylation	O
of	O
the	O
respective	O
regulatory	O
or	O
sensory	O
proteins	O
indicating	O
that	O
the	O
phosphorylation	O
status	O
of	O
the	O
three	O
novel	O
two	O
-	O
component	O
systems	O
is	O
essential	O
for	O
their	O
function	O
in	O
regulating	O
biofilm	O
development	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
.	O

Furthermore	O
,	O
the	O
phosphorylation	O
of	O
these	O
two	O
-	O
component	O
systems	O
occurred	O
in	O
sequence	O
with	O
BfiS	O
being	O
phosphorylated	O
first	O
,	O
followed	O
by	O
GacS	O
,	O
and	O
lastly	O
,	O
MifR	O
(	O
Table	O
1	O
,	O
Fig	O
.	O
6	O
)	O
.	O

The	O
sequential	O
phosphorylation	O
of	O
sensors	O
/	O
regulatory	O
proteins	O
is	O
reminiscent	O
of	O
a	O
regulatory	O
cascade	O
in	O
which	O
each	O
phosphorylation	O
event	O
acts	O
as	O
a	O
trigger	O
for	O
bacterial	O
biofilm	O
cells	O
to	O
transition	O
to	O
the	O
next	O
developmental	O
stage	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Furthermore	O
,	O
the	O
novel	O
TCS	O
systems	O
described	O
here	O
appear	O
to	O
be	O
linked	O
via	O
GacS	O
to	O
the	O
multicomponent	O
system	O
RetS	O
/	O
LadS	O
/	O
GacAS	O
/	O
RsmA	O
essential	O
for	O
regulating	O
the	O
switch	O
between	O
the	O
planktonic	O
and	O
the	O
sessile	O
mode	O
of	O
growth	O
.	O

While	O
it	O
is	O
not	O
clear	O
how	O
the	O
three	O
two	O
-	O
component	O
systems	O
interact	O
to	O
form	O
the	O
observed	O
sequential	O
phosphorylation	O
cascade	O
,	O
it	O
is	O
apparent	O
from	O
our	O
observations	O
that	O
phosphorylation	O
of	O
each	O
of	O
the	O
three	O
novel	O
TCS	O
has	O
to	O
occur	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilms	O
to	O
mature	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Possible	O
scenarios	O
for	O
the	O
sequential	O
phosphorylation	O
events	O
to	O
occur	O
are	O
by	O
direct	O
interaction	O
or	O
activation	O
of	O
a	O
TCS	O
system	O
by	O
one	O
that	O
is	O
upstream	O
in	O
the	O
cascade	O
(	O
Fig	O
.	O
6	O
)	O
,	O
or	O
indirectly	O
.	O

Since	O
inactivation	O
of	O
each	O
TCS	O
system	O
resulted	O
in	O
altered	O
or	O
arrested	O
biofilms	O
which	O
failed	O
to	O
exhibit	O
stage	O
-	O
specific	O
protein	O
production	O
and	O
phosphorylation	O
events	O
(	O
Figs	O
.	O
1	O
,	O
4	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
,	O
it	O
is	O
likely	O
that	O
the	O
mutant	O
biofilms	O
in	O
turn	O
do	O
not	O
produce	O
the	O
necessary	O
signal	O
(	O
s	O
)	O
to	O
activate	O
or	O
phosphorylate	O
TCS	O
system	O
(	O
s	O
)	O
that	O
are	O
further	O
downstream	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
inactivation	O
of	O
one	O
TCS	O
system	O
(	O
in	O
)	O
directly	O
results	O
in	O
altered	O
or	O
arrested	O
phosphorylation	O
patterns	O
and	O
thus	O
,	O
lack	O
of	O
phosphorylation	O
of	O
downstream	O
TCS	O
systems	O
(	O
as	O
observed	O
here	O
)	O
.	O

Independent	O
of	O
the	O
mechanism	O
,	O
it	O
is	O
evident	O
that	O
inactivation	O
not	O
only	O
disrupts	O
the	O
sequence	O
of	O
phosphorylation	O
events	O
but	O
also	O
leads	O
to	O
the	O
collapse	O
of	O
mature	O
biofilms	O
to	O
an	O
earlier	O
biofilm	O
developmental	O
stage	O
at	O
which	O
the	O
respective	O
regulatory	O
proteins	O
play	O
a	O
role	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

This	O
is	O
even	O
more	O
important	O
as	O
this	O
biofilm	O
collapse	O
was	O
observed	O
under	O
two	O
different	O
nutritional	O
conditions	O
,	O
when	O
grown	O
on	O
minimal	O
medium	O
using	O
either	O
glutamate	O
or	O
citrate	O
as	O
a	O
sole	O
carbon	O
source	O
(	O
see	O
also	O
Figs	O
.	O
2	O
and	O
5	O
for	O
comparison	O
of	O
LB	O
and	O
glutamate	O
minimal	O
medium	O
)	O
.	O

The	O
finding	O
suggests	O
that	O
while	O
biofilm	O
formation	O
,	O
architecture	O
and	O
cell	O
-	O
cell	O
signaling	O
is	O
modulated	O
by	O
environmental	O
and	O
nutritional	O
conditions	O
resulting	O
in	O
biofilm	O
development	O
proceeding	O
via	O
distinctly	O
different	O
pathways	O
[	O
16	O
]	O
,	O
[	O
55	O
]	O
-	O
[	O
63	O
]	O
,	O
it	O
is	O
possible	O
that	O
the	O
novel	O
regulatory	O
proteins	O
identified	O
here	O
play	O
a	O
role	O
under	O
more	O
than	O
one	O
discrete	O
culturing	O
condition	O
or	O
pathway	O
.	O

The	O
novelty	O
of	O
these	O
TCS	O
is	O
further	O
supported	O
by	O
the	O
finding	O
that	O
a	O
search	O
for	O
BfiS	O
(	O
PA4197	O
)	O
and	O
BfmR	O
(	O
PA4101	O
)	O
homologues	O
using	O
BLAST	O
(	O
http	O
:	O
/	O
/	O
blast	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Blast	O
.	O
cgi	O
)	O
and	O
BLINK	O
(	O
precomputed	O
BLAST	O
,	O
[	O
53	O
]	O
)	O
,	O
did	O
not	O
reveal	O
any	O
proteins	O
that	O
have	O
been	O
previously	O
characterized	O
in	O
the	O
literature	O
.	O

However	O
,	O
BfiS	O
-	O
like	O
sensory	O
proteins	O
with	O
identities	O
ranging	O
between	O
28	O
-	O
68	O
%	O
were	O
detected	O
in	O
a	O
variety	O
of	O
Gram	O
-	O
negative	O
bacteria	O
,	O
in	O
particular	O
in	O
alpha	O
-	O
,	O
beta	O
-	O
,	O
and	O
gamma	O
-	O
proteobacteria	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

No	O
homologues	O
,	O
however	O
,	O
were	O
detected	O
in	O
lambda	O
-	O
proteobacteria	O
or	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
Klebsiella	B-Organism
pneumoniae	E-Organism
,	O
and	O
Enterobacter	B-Organism
sp	E-Organism
.	O

Similarly	O
,	O
BfmR	O
homologues	O
were	O
detected	O
among	O
proteobacteria	O
including	O
Yersinia	B-Organism
sp	E-Organism
.	O
,	O
Burkholderia	B-Organism
sp	E-Organism
.	O
,	O
Rhizobium	B-Organism
sp	E-Organism
.	O
,	O
Vibrio	B-Organism
sp	E-Organism
,	O
Geobacter	B-Organism
sp	E-Organism
.	O
,	O
and	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
with	O
identities	O
ranging	O
between	O
50	O
-	O
92	O
%	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

MifR	O
homologues	O
harboring	O
a	O
sigma	O
-	O
54	O
binding	O
domain	O
are	O
present	O
in	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
including	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

The	O
closest	O
MifR	O
homologue	O
in	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
was	O
identified	O
as	O
the	O
NtrC	O
-	O
like	O
chemosensory	O
regulator	O
of	O
development	O
CrdA	O
(	O
48	O
%	O
identity	O
)	O
.	O

Inactivation	O
of	O
crdA	O
has	O
been	O
shown	O
to	O
result	O
in	O
delayed	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
multicellular	O
development	O
[	O
67	O
]	O
.	O

NtrC	O
-	O
like	O
regulators	O
belong	O
to	O
a	O
family	O
of	O
transcriptional	O
activators	O
which	O
control	O
a	O
variety	O
of	O
physiological	O
processes	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
68	O
]	O
.	O

This	O
family	O
of	O
regulators	O
control	O
transcription	O
from	O
-	O
12	O
,	O
-	O
24	O
promoters	O
recognized	O
by	O
RNA	O
polymerase	O
that	O
utilizes	O
the	O
alternative	O
sigma	O
54	O
factor	O
encoded	O
by	O
rpoN	O
and	O
its	O
analogs	O
.	O

At	O
least	O
8	O
NtrC	O
-	O
like	O
transcriptional	O
regulators	O
are	O
involved	O
in	O
coordinating	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
fruiting	O
body	O
formation	O
at	O
distinct	O
stages	O
of	O
the	O
developmental	O
process	O
[	O
69	O
]	O
-	O
[	O
71	O
]	O
.	O

The	O
preponderance	O
of	O
developmental	O
promoters	O
with	O
sigma	O
54	O
hallmarks	O
led	O
to	O
the	O
suggestion	O
that	O
NtrC	O
-	O
like	O
activators	O
are	O
key	O
components	O
of	O
the	O
transcriptional	O
machinery	O
that	O
coordinates	O
gene	O
expression	O
during	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
development	O
[	O
72	O
]	O
.	O

While	O
fruiting	O
body	O
formation	O
is	O
governed	O
by	O
a	O
cascade	O
of	O
RpoN	O
-	O
dependent	O
transcription	O
factors	O
in	O
starving	O
cells	O
,	O
endospore	O
formation	O
in	O
B	B-Organism
.	I-Organism
subtilis	E-Organism
requires	O
the	O
consecutive	O
activity	O
of	O
multiple	O
sigma	O
factors	O
including	O
Sigma	O
E	O
,	O
F	O
,	O
G	O
,	O
and	O
K	O
.	O

Their	O
activity	O
is	O
regulated	O
by	O
posttranslational	O
processes	O
,	O
either	O
by	O
cleaving	O
the	O
precursor	O
molecules	O
or	O
by	O
sequestration	O
of	O
sigma	O
factors	O
by	O
"	O
anti	O
-	O
sigma	O
factor	O
"	O
proteins	O
in	O
response	O
to	O
intercellular	O
cues	O
,	O
and	O
compartmentalization	O
[	O
68	O
]	O
,	O
[	O
73	O
]	O
.	O

Similarly	O
,	O
biofilm	O
developmental	O
processes	O
appear	O
to	O
be	O
controlled	O
by	O
sigma	O
factors	O
.	O

Based	O
on	O
domain	O
structure	O
,	O
two	O
TCS	O
regulatory	O
proteins	O
identified	O
here	O
regulate	O
genes	O
controlled	O
by	O
the	O
sigma	O
factors	O
RpoD	O
and	O
RpoN	O
[	O
53	O
]	O
,	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
.	O

BfiR	O
harbors	O
region	O
4	O
of	O
Sigma	O
-	O
70	O
(	O
RpoD	O
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
.	O

Activation	O
of	O
BfiR	O
coincides	O
with	O
BfiS	O
phosphorylation	O
following	O
8	O
hours	O
of	O
surface	O
attached	O
growth	O
and	O
dephosphorylation	O
of	O
RpoD	O
(	O
Table	O
1	O
)	O
.	O

MifR	O
harbors	O
a	O
sigma	O
-	O
54	O
binding	O
(	O
RpoN	O
)	O
binding	O
domain	O
and	O
is	O
dependent	O
on	O
the	O
consecutive	O
phosphorylation	O
of	O
BfiRS	O
and	O
BfmRS	O
(	O
see	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
idea	O
that	O
biofilm	O
development	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
is	O
orchestrated	O
by	O
a	O
regulatory	O
cascade	O
(	O
Fig	O
.	O
6	O
)	O
that	O
is	O
analogous	O
to	O
other	O
developmental	O
systems	O
including	O
spore	O
formation	O
in	O
B	B-Organism
.	I-Organism
subtilis	E-Organism
or	O
fruiting	O
body	O
formation	O
in	O
M	B-Organism
.	I-Organism
xanthus	E-Organism
,	O
requiring	O
the	O
consecutive	O
action	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
and	O
three	O
two	O
-	O
component	O
regulatory	O
systems	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

In	O
summary	O
,	O
we	O
have	O
evidence	O
of	O
three	O
novel	O
regulatory	O
systems	O
playing	O
a	O
role	O
in	O
the	O
progression	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

The	O
only	O
other	O
regulatory	O
system	O
having	O
been	O
identified	O
to	O
play	O
a	O
role	O
at	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
in	O
particular	O
the	O
formation	O
of	O
large	O
microcolonies	O
and	O
fluid	O
-	O
filled	O
channels	O
,	O
is	O
the	O
three	O
-	O
component	O
system	O
SadARS	O
(	O
RocS1RA1	O
)	O
,	O
probably	O
by	O
controlling	O
the	O
expression	O
of	O
fimbrial	O
cup	O
genes	O
[	O
66	O
]	O
,	O
[	O
76	O
]	O
.	O

In	O
addition	O
,	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
via	O
two	O
-	O
component	O
systems	O
has	O
also	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
attachment	O
.	O

A	O
multi	O
-	O
component	O
switch	O
composed	O
of	O
three	O
unusual	O
hybrid	O
sensor	O
kinases	O
,	O
RetS	O
,	O
LadS	O
,	O
and	O
GacS	O
,	O
has	O
recently	O
been	O
demonstrated	O
to	O
reciprocally	O
orchestrate	O
the	O
transition	O
from	O
acute	O
to	O
chronic	O
infection	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
,	O
as	O
well	O
as	O
to	O
reciprocally	O
regulate	O
the	O
transition	O
between	O
the	O
planktonic	O
and	O
biofilm	O
modes	O
of	O
growth	O
by	O
inversely	O
coordinating	O
repression	O
of	O
genes	O
required	O
for	O
initial	O
colonization	O
,	O
mainly	O
genes	O
responsible	O
for	O
exopolysaccharide	O
components	O
of	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
matrix	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

While	O
our	O
study	O
did	O
not	O
result	O
in	O
the	O
identification	O
of	O
RetS	O
or	O
LadS	O
,	O
we	O
identified	O
GacS	O
by	O
two	O
different	O
approaches	O
and	O
confirmed	O
GacS	O
phosphorylation	O
by	O
immunoblot	O
analysis	O
(	O
Table	O
1	O
)	O
.	O

GacS	O
acts	O
as	O
a	O
suppressor	O
of	O
RetS	O
(	O
and	O
vice	O
versa	O
)	O
with	O
RetS	O
regulating	O
the	O
suppressor	O
activity	O
of	O
the	O
membrane	O
-	O
bound	O
sensor	O
GacS	O
by	O
directly	O
modulating	O
its	O
phosphorylation	O
state	O
[	O
38	O
]	O
.	O

The	O
finding	O
is	O
consistent	O
with	O
our	O
observation	O
of	O
GacS	O
playing	O
a	O
dual	O
role	O
in	O
biofilm	O
formation	O
,	O
with	O
phosphorylation	O
acting	O
as	O
a	O
switch	O
in	O
the	O
function	O
of	O
GacS	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
:	O
GacS	O
participates	O
in	O
the	O
planktonic	O
/	O
biofilm	O
switch	O
in	O
its	O
non	O
-	O
phosphorylated	O
state	O
,	O
but	O
limits	O
/	O
regulates	O
the	O
rate	O
of	O
biomass	O
accumulation	O
and	O
biofilm	O
development	O
when	O
phosphorylated	O
.	O

Since	O
phosphorylation	O
of	O
GacS	O
occurred	O
following	O
8	O
hr	O
of	O
surface	O
attached	O
growth	O
(	O
Table	O
1	O
)	O
and	O
since	O
RetS	O
directly	O
modulates	O
the	O
phosphorylation	O
state	O
of	O
GacS	O
[	O
38	O
]	O
,	O
the	O
findings	O
may	O
suggest	O
that	O
RetS	O
only	O
remains	O
functional	O
for	O
a	O
period	O
of	O
8	O
hours	O
during	O
initial	O
attachment	O
after	O
which	O
RetS	O
is	O
rendered	O
non	O
-	O
functional	O
.	O

Here	O
,	O
GacS	O
was	O
found	O
to	O
be	O
phosphorylated	O
in	O
a	O
BfiS	O
dependent	O
manner	O
.	O

In	O
turn	O
,	O
expression	O
of	O
the	O
BfiS	O
cognate	O
response	O
regulator	O
,	O
BfiR	O
,	O
was	O
found	O
to	O
be	O
RsmA	O
dependent	O
[	O
77	O
]	O
(	O
see	O
Fig	O
.	O
6	O
)	O
.	O

Taken	O
together	O
,	O
our	O
observations	O
suggest	O
a	O
link	O
between	O
the	O
multi	O
-	O
component	O
switch	O
RetS	O
/	O
LadS	O
/	O
GacAS	O
/	O
RsmA	O
which	O
reciprocally	O
regulates	O
virulence	O
and	O
the	O
transition	O
between	O
the	O
planktonic	O
and	O
the	O
surface	O
attached	O
mode	O
of	O
growth	O
and	O
the	O
previously	O
undescribed	O
signaling	O
network	O
which	O
regulates	O
developmental	O
steps	O
once	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
has	O
committed	O
to	O
the	O
surface	O
associated	O
lifestyle	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Taken	O
together	O
,	O
this	O
work	O
identifies	O
a	O
previously	O
undescribed	O
signal	O
transduction	O
network	O
composed	O
of	O
BfiSR	O
(	O
PA4196	O
-	O
4197	O
)	O
,	O
BfmSR	O
PA4101	O
-	O
4102	O
)	O
,	O
and	O
MifSR	O
(	O
PA5511	O
-	O
5512	O
)	O
that	O
sequentially	O
regulates	O
committed	O
biofilm	O
developmental	O
steps	O
following	O
attachment	O
by	O
transcriptional	O
and	O
posttranscriptional	O
mechanisms	O
,	O
which	O
is	O
linked	O
via	O
GacS	O
and	O
RsmA	O
to	O
the	O
previously	O
described	O
multi	O
-	O
component	O
switch	O
RetS	O
/	O
LadS	O
/	O
GacAS	O
/	O
RsmA	O
.	O

Furthermore	O
,	O
the	O
finding	O
of	O
sequential	O
and	O
essential	O
regulatory	O
steps	O
in	O
biofilm	O
formation	O
and	O
the	O
involvement	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
suggests	O
that	O
biofilm	O
development	O
is	O
analogous	O
to	O
other	O
programmed	O
developmental	O
processes	O
.	O

However	O
,	O
in	O
contrast	O
to	O
known	O
developmental	O
processes	O
,	O
our	O
findings	O
suggest	O
that	O
both	O
two	O
-	O
component	O
regulatory	O
systems	O
and	O
sigma	O
factor	O
dependent	O
response	O
regulators	O
are	O
key	O
components	O
of	O
the	O
transcriptional	O
and	O
regulatory	O
machinery	O
that	O
coordinate	O
gene	O
expression	O
during	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
biofilm	O
development	O
.	O

Structural	O
and	O
Biochemical	O
Characterization	O
of	O
SrcA	O
,	O
a	O
Multi	O
-	O
Cargo	O
Type	O
III	O
Secretion	O
Chaperone	O
in	O
Salmonella	S-Organism
Required	O
for	O
Pathogenic	O
Association	O
with	O
a	O
Host	S-Organism

Many	O
Gram	O
-	O
negative	O
bacteria	O
colonize	O
and	O
exploit	O
host	S-Organism
niches	O
using	O
a	O
protein	O
apparatus	O
called	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
that	O
translocates	O
bacterial	O
effector	O
proteins	O
into	O
host	S-Organism
cells	O
where	O
their	O
functions	O
are	O
essential	O
for	O
pathogenesis	O
.	O

A	O
suite	O
of	O
T3SS	O
-	O
associated	O
chaperone	O
proteins	O
bind	O
cargo	O
in	O
the	O
bacterial	O
cytosol	O
,	O
establishing	O
protein	O
interaction	O
networks	O
needed	O
for	O
effector	O
translocation	O
into	O
host	S-Organism
cells	O
.	O

In	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	E-Organism
,	O
a	O
T3SS	O
encoded	O
in	O
a	O
large	O
genomic	O
island	O
(	O
SPI	O
-	O
2	O
)	O
is	O
required	O
for	O
intracellular	O
infection	O
,	O
but	O
the	O
chaperone	O
complement	O
required	O
for	O
effector	O
translocation	O
by	O
this	O
system	O
is	O
not	O
known	O
.	O

Using	O
a	O
reverse	O
genetics	O
approach	O
,	O
we	O
identified	O
a	O
multi	O
-	O
cargo	O
secretion	O
chaperone	O
that	O
is	O
functionally	O
integrated	O
with	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
and	O
required	O
for	O
systemic	O
infection	O
in	O
mice	S-Organism
.	O

Crystallographic	O
analysis	O
of	O
SrcA	O
at	O
a	O
resolution	O
of	O
2	O
.	O
5	O
A	O
revealed	O
a	O
dimer	O
similar	O
to	O
the	O
CesT	O
chaperone	O
from	O
enteropathogenic	O
E	B-Organism
.	I-Organism
coli	E-Organism
but	O
lacking	O
a	O
17	O
-	O
amino	O
acid	O
extension	O
at	O
the	O
carboxyl	O
terminus	O
.	O

Further	O
biochemical	O
and	O
quantitative	O
proteomics	O
data	O
revealed	O
three	O
protein	O
interactions	O
with	O
SrcA	O
,	O
including	O
two	O
effector	O
cargos	O
(	O
SseL	O
and	O
PipB2	O
)	O
and	O
the	O
type	O
III	O
-	O
associated	O
ATPase	O
,	O
SsaN	O
,	O
that	O
increases	O
the	O
efficiency	O
of	O
effector	O
translocation	O
.	O

Using	O
competitive	O
infections	O
in	O
mice	S-Organism
we	O
show	O
that	O
SrcA	O
increases	O
bacterial	O
fitness	O
during	O
host	S-Organism
infection	O
,	O
highlighting	O
the	O
in	O
vivo	O
importance	O
of	O
effector	O
chaperones	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
.	O

Introduction	O

Many	O
Gram	O
-	O
negative	O
bacteria	O
that	O
colonize	O
host	S-Organism
animals	O
use	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
to	O
deliver	O
effector	O
proteins	O
directly	O
into	O
host	S-Organism
cells	O
where	O
their	O
interaction	O
with	O
host	S-Organism
proteins	O
and	O
membranes	O
contribute	O
to	O
pathogenesis	O
.	O

Comprised	O
of	O
over	O
20	O
proteins	O
,	O
T3SS	O
are	O
complex	O
structures	O
with	O
relation	O
to	O
the	O
flagellar	O
T3SS	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
and	O
include	O
several	O
central	O
features	O
;	O
(	O
i	O
)	O
inner	O
and	O
outer	O
membrane	O
ring	O
structures	O
,	O
(	O
ii	O
)	O
an	O
extracellular	O
needle	O
structure	O
with	O
pore	O
-	O
forming	O
proteins	O
at	O
the	O
distal	O
tip	O
that	O
engage	O
a	O
host	S-Organism
cell	O
membrane	O
,	O
(	O
iii	O
)	O
an	O
ATPase	O
at	O
the	O
base	O
of	O
the	O
apparatus	O
with	O
energetic	O
and	O
chaperone	O
-	O
effector	O
recruitment	O
roles	O
,	O
and	O
(	O
iv	O
)	O
a	O
suite	O
of	O
chaperones	O
to	O
coordinate	O
the	O
assembly	O
and	O
function	O
of	O
the	O
apparatus	O
during	O
infection	O
.	O

Secretion	O
chaperones	O
are	O
proteins	O
required	O
for	O
T3SS	O
function	O
with	O
roles	O
in	O
apparatus	O
assembly	O
and	O
effector	O
delivery	O
,	O
but	O
are	O
not	O
themselves	O
subject	O
to	O
secretion	O
[	O
3	O
]	O
.	O

These	O
chaperones	O
often	O
have	O
common	O
physical	O
features	O
such	O
as	O
low	O
molecular	O
weight	O
(	O
<	O
15	O
kDa	O
)	O
,	O
an	O
acidic	O
isoelectric	O
point	O
and	O
a	O
predicted	O
amphipathic	O
helix	O
at	O
the	O
carboxyl	O
terminus	O
.	O

Current	O
literature	O
groups	O
secretion	O
chaperones	O
into	O
three	O
classes	O
based	O
on	O
their	O
physical	O
interactions	O
with	O
cargo	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Class	O
I	O
chaperones	O
bind	O
to	O
translocated	O
effector	O
proteins	O
at	O
a	O
chaperone	O
binding	O
domain	O
(	O
CBD	O
)	O
located	O
in	O
the	O
amino	O
terminus	O
of	O
the	O
effector	O
.	O

Class	O
I	O
chaperones	O
have	O
a	O
structural	O
fold	O
of	O
five	O
beta	O
-	O
strands	O
and	O
three	O
alpha	O
-	O
helices	O
,	O
forming	O
homodimers	O
that	O
bind	O
to	O
the	O
CBD	O
in	O
a	O
horseshoe	O
-	O
like	O
structure	O
.	O

These	O
chaperones	O
have	O
been	O
further	O
sub	O
-	O
classified	O
based	O
on	O
their	O
substrate	O
repertoire	O
and	O
location	O
with	O
respect	O
to	O
the	O
genes	O
encoding	O
the	O
T3SS	O
[	O
3	O
]	O
.	O

Class	O
II	O
chaperones	O
bind	O
to	O
translocon	O
proteins	O
that	O
make	O
up	O
the	O
secretion	O
pore	O
in	O
the	O
host	O
target	O
membrane	O
and	O
class	O
III	O
chaperones	O
bind	O
the	O
extracellular	O
filament	O
proteins	O
(	O
or	O
flagellin	O
rod	O
in	O
the	O
orthologous	O
flagellar	O
system	O
)	O
that	O
polymerize	O
into	O
a	O
helical	O
structure	O
following	O
secretion	O
from	O
the	O
bacterial	O
cell	O
.	O

Secondary	O
structure	O
predictions	O
suggest	O
class	O
III	O
chaperones	O
adopt	O
an	O
extended	O
alpha	O
helical	O
structure	O
,	O
which	O
was	O
confirmed	O
by	O
the	O
crystal	O
structure	O
of	O
the	O
CesA	O
chaperone	O
in	O
enteropathogenic	O
E	B-Organism
.	I-Organism
coli	E-Organism
that	O
binds	O
the	O
EspA	O
filament	O
protein	O
[	O
5	O
]	O
.	O

Much	O
of	O
the	O
virulence	O
potential	O
of	O
Salmonella	B-Organism
enterica	E-Organism
,	O
a	O
group	O
of	O
more	O
than	O
2300	O
serotypes	O
,	O
is	O
attributed	O
to	O
horizontally	O
acquired	O
genomic	O
islands	O
termed	O
Salmonella	O
Pathogenicity	O
Islands	O
(	O
SPI	O
)	O
.	O

SPI	O
-	O
1	O
encodes	O
a	O
T3SS	O
required	O
for	O
host	S-Organism
cell	O
invasion	O
and	O
SPI	O
-	O
2	O
encodes	O
a	O
second	O
T3SS	O
needed	O
for	O
intracellular	O
survival	O
and	O
immune	O
evasion	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

To	O
date	O
,	O
13	O
effectors	O
have	O
been	O
identified	O
as	O
substrates	O
of	O
the	O
SPI	O
-	O
1	O
T3SS	O
and	O
21	O
effectors	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
although	O
the	O
chaperones	O
orchestrating	O
the	O
latter	O
system	O
have	O
been	O
elusive	O
.	O

Whereas	O
80	O
%	O
of	O
the	O
effectors	O
of	O
the	O
SPI	O
-	O
1	O
system	O
have	O
defined	O
chaperones	O
,	O
only	O
two	O
effector	O
-	O
chaperone	O
interactions	O
are	O
known	O
for	O
the	O
SPI	O
-	O
2	O
system	O
.	O

These	O
include	O
the	O
effector	O
-	O
chaperone	O
pair	O
of	O
SseF	O
-	O
SscB	O
,	O
and	O
the	O
chaperone	O
SseA	O
that	O
binds	O
translocon	O
components	O
SseD	O
and	O
SseB	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Crystal	O
structures	O
have	O
been	O
determined	O
for	O
three	O
chaperones	O
that	O
coordinate	O
translocation	O
of	O
effectors	O
through	O
the	O
SPI	O
-	O
1	O
T3SS	O
(	O
InvB	O
[	O
11	O
]	O
,	O
SicP	O
[	O
12	O
]	O
and	O
SigE	O
[	O
13	O
]	O
)	O
.	O

However	O
no	O
structures	O
are	O
available	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
chaperones	O
whose	O
effector	O
repertoire	O
seems	O
considerably	O
larger	O
than	O
that	O
of	O
the	O
SPI	O
-	O
1	O
system	O
.	O

In	O
addition	O
to	O
maintaining	O
a	O
region	O
of	O
localized	O
effector	O
unfolding	O
[	O
12	O
]	O
,	O
T3SS	O
chaperones	O
have	O
an	O
emerging	O
role	O
as	O
escorts	O
that	O
deliver	O
their	O
cargo	O
to	O
the	O
cytoplasmic	O
face	O
of	O
the	O
inner	O
membrane	O
through	O
physical	O
interactions	O
with	O
an	O
ATPase	O
.	O

These	O
ATPases	O
form	O
a	O
hexameric	O
structure	O
at	O
the	O
base	O
of	O
the	O
T3SS	O
[	O
14	O
]	O
and	O
are	O
a	O
conserved	O
feature	O
of	O
both	O
flagellar	O
and	O
non	O
-	O
flagellar	O
type	O
III	O
systems	O
to	O
enhance	O
secretion	O
activity	O
by	O
promoting	O
chaperone	O
release	O
and	O
effector	O
unfolding	O
prior	O
to	O
secretion	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
.	O

A	O
chaperone	O
-	O
ATPase	O
interaction	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
has	O
not	O
been	O
described	O
previously	O
and	O
so	O
whether	O
this	O
system	O
conforms	O
to	O
the	O
emerging	O
escort	O
paradigm	O
is	O
not	O
known	O
.	O

The	O
regulation	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
its	O
associated	O
effector	O
genes	O
is	O
coordinated	O
by	O
environmental	O
cues	O
signifying	O
the	O
intracellular	O
environment	O
[	O
18	O
]	O
.	O

These	O
cues	O
activate	O
a	O
two	O
-	O
component	O
signaling	O
system	O
encoded	O
in	O
the	O
SPI	O
-	O
2	O
island	O
comprising	O
the	O
SsrA	O
sensor	O
kinase	O
and	O
SsrB	O
response	O
regulator	O
.	O

In	O
addition	O
to	O
activating	O
all	O
of	O
the	O
T3SS	O
structural	O
operons	O
,	O
transcriptional	O
profiling	O
has	O
uncovered	O
new	O
genes	O
in	O
the	O
SsrB	O
regulon	O
that	O
are	O
required	O
for	O
bacterial	O
pathogenesis	O
including	O
a	O
translocated	O
effector	O
,	O
SseL	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
,	O
and	O
a	O
gene	O
of	O
unknown	O
function	O
called	O
srfN	O
that	O
is	O
common	O
to	O
the	O
Salmonella	S-Organism
genus	O
[	O
21	O
]	O
.	O

Using	O
a	O
reverse	O
genetics	O
approach	O
we	O
identified	O
an	O
SsrB	O
-	O
regulated	O
gene	O
(	O
STM2138	O
)	O
that	O
we	O
named	O
srcA	O
(	O
SsrB	O
-	O
regulated	O
chaperone	O
A	O
)	O
,	O
whose	O
gene	O
product	O
satisfied	O
several	O
a	O
priori	O
predictions	O
relating	O
to	O
the	O
physical	O
properties	O
associated	O
with	O
T3SS	O
chaperones	O
.	O

We	O
solved	O
the	O
crystal	O
structure	O
of	O
SrcA	O
and	O
performed	O
additional	O
biochemical	O
,	O
proteomic	O
and	O
in	O
vivo	O
experiments	O
that	O
revealed	O
SrcA	O
to	O
be	O
a	O
class	O
I	O
chaperone	O
required	O
for	O
bacterial	O
fitness	O
in	O
the	O
host	O
environment	O
.	O

Despite	O
being	O
genetically	O
disconnected	O
from	O
SPI	O
-	O
2	O
,	O
SrcA	O
is	O
integrated	O
functionally	O
with	O
this	O
system	O
by	O
binding	O
to	O
the	O
T3SS	O
ATPase	O
,	O
SsaN	O
,	O
and	O
providing	O
chaperone	O
activity	O
towards	O
two	O
important	O
effectors	O
,	O
SseL	O
(	O
STM2287	O
)	O
and	O
PipB2	O
(	O
STM2780	O
)	O
,	O
necessary	O
for	O
immune	O
escape	O
and	O
cell	O
-	O
to	O
-	O
cell	O
transmission	O
.	O

These	O
data	O
reveal	O
structural	O
and	O
biochemical	O
insight	O
into	O
a	O
T3SS	O
secretion	O
chaperone	O
required	O
for	O
intracellular	O
pathogenesis	O
of	O
Salmonella	S-Organism
.	O

Results	O

Identification	O
of	O
an	O
SsrB	O
-	O
regulated	O
secretion	O
chaperone	O
Transcriptional	O
profiling	O
of	O
SsrB	O
-	O
regulated	O
genes	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	E-Organism
(	O
S	B-Organism
.	I-Organism
Typhimurium	E-Organism
)	O
[	O
22	O
]	O
identified	O
a	O
hypothetical	O
gene	O
,	O
STM2138	O
(	O
named	O
srcA	O
hereafter	O
)	O
,	O
that	O
was	O
co	O
-	O
regulated	O
with	O
genes	O
in	O
SPI	O
-	O
2	O
and	O
repressed	O
approximately20	O
-	O
fold	O
in	O
an	O
ssrB	O
mutant	O
compared	O
to	O
wild	O
type	O
.	O

This	O
gene	O
was	O
also	O
down	O
regulated	O
in	O
Salmonella	S-Organism
mutants	O
lacking	O
the	O
SsrA	O
sensor	O
kinase	O
[	O
20	O
]	O
,	O
and	O
was	O
predicted	O
to	O
encode	O
a	O
possible	O
chaperone	O
in	O
a	O
bioinformatics	O
-	O
based	O
screen	O
[	O
23	O
]	O
.	O

The	O
srcA	O
gene	O
is	O
not	O
located	O
in	O
the	O
vicinity	O
of	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
(	O
STM1378	O
-	O
STM1425	O
)	O
,	O
but	O
is	O
713	O
genes	O
downstream	O
on	O
the	O
chromosome	O
(	O
STM	O
numbers	O
are	O
based	O
on	O
the	O
LT2	O
genome	O
and	O
ordered	O
sequentially	O
on	O
the	O
chromosome	O
beginning	O
at	O
STM0001	O
,	O
thrL	O
)	O
.	O

The	O
predicted	O
srcA	O
gene	O
product	O
was	O
a	O
small	O
protein	O
approximately16	O
kDa	O
with	O
a	O
pI	O
of	O
4	O
.	O
6	O
,	O
similar	O
to	O
secretion	O
chaperones	O
associated	O
with	O
T3SS	O
.	O

To	O
verify	O
SsrB	O
input	O
on	O
srcA	O
expression	O
,	O
we	O
analyzed	O
SsrB	O
binding	O
in	O
vivo	O
at	O
the	O
region	O
of	O
DNA	O
surrounding	O
srcA	O
using	O
genome	O
-	O
wide	O
ChIP	O
-	O
on	O
-	O
chip	O
[	O
21	O
]	O
(	O
and	O
unpublished	O
data	O
)	O
.	O

This	O
analysis	O
revealed	O
a	O
strong	O
SsrB	O
binding	O
site	O
spanning	O
10	O
syntenic	O
probes	O
within	O
the	O
intergenic	O
region	O
(	O
IGR	O
)	O
upstream	O
of	O
srcA	O
,	O
that	O
together	O
with	O
the	O
transcriptional	O
data	O
corroborated	O
a	O
direct	O
regulatory	O
role	O
for	O
SsrB	O
on	O
srcA	O
expression	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

To	O
determine	O
the	O
cellular	O
distribution	O
of	O
SrcA	O
we	O
constructed	O
a	O
srcA	O
-	O
HA	O
allele	O
and	O
expressed	O
this	O
gene	O
in	O
wild	O
type	O
and	O
in	O
ssrB	O
mutant	O
cells	O
under	O
conditions	O
that	O
activate	O
the	O
SPI	O
-	O
2	O
T3SS	O
[	O
24	O
]	O
.	O

In	O
whole	O
cell	O
lysates	O
,	O
SrcA	O
protein	O
was	O
reduced	O
approximately10	O
-	O
fold	O
in	O
DeltassrB	S-Organism
cells	O
compared	O
to	O
wild	O
type	O
(	O
Fig	O
.	O
1B	O
)	O
and	O
the	O
protein	O
was	O
not	O
detected	O
in	O
the	O
secreted	O
fraction	O
from	O
wild	O
type	O
cells	O
(	O
Fig	O
.	O
1C	O
)	O
,	O
consistent	O
with	O
the	O
expected	O
properties	O
of	O
a	O
T3SS	O
chaperone	O
.	O

As	O
a	O
positive	O
control	O
,	O
SseC	O
,	O
an	O
SsrB	O
-	O
regulated	O
translocon	O
protein	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
was	O
present	O
in	O
the	O
secreted	O
fraction	O
from	O
wild	O
type	O
cells	O
but	O
not	O
from	O
an	O
ssrB	O
mutant	O
.	O

SrcA	O
contributes	O
to	O
Salmonella	S-Organism
fitness	O
in	O
an	O
animal	O
host	S-Organism

Most	O
SsrB	O
-	O
regulated	O
gene	O
products	O
contribute	O
to	O
the	O
intracellular	O
survival	O
of	O
Salmonella	S-Organism
in	O
a	O
host	S-Organism
.	O

In	O
comparative	O
genomics	O
analyses	O
,	O
srcA	O
was	O
found	O
in	O
all	O
virulent	O
strains	O
of	O
Salmonella	B-Organism
enterica	E-Organism
containing	O
SPI	O
-	O
2	O
,	O
but	O
was	O
absent	O
from	O
the	O
cold	O
-	O
blooded	O
animal	O
commensal	O
,	O
S	B-Organism
.	I-Organism
bongori	E-Organism
,	O
which	O
lacks	O
SPI	O
-	O
2	O
(	O
Table	O
S1	O
)	O
.	O

This	O
suggested	O
a	O
co	O
-	O
evolution	O
of	O
srcA	O
with	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
a	O
possible	O
functional	O
relationship	O
.	O

If	O
so	O
,	O
we	O
reasoned	O
that	O
SrcA	O
should	O
contribute	O
to	O
animal	O
colonization	O
because	O
the	O
SPI	O
-	O
2	O
T3SS	O
is	O
essential	O
for	O
host	S-Organism
infection	O
.	O

To	O
determine	O
whether	O
SrcA	O
contributes	O
to	O
Salmonella	S-Organism
fitness	O
in	O
a	O
host	S-Organism
,	O
we	O
created	O
an	O
unmarked	O
in	O
-	O
frame	O
srcA	O
deletion	O
in	O
S	B-Organism
.	E-Organism

Typhimurium	S-Organism
and	O
competed	O
this	O
strain	O
against	O
wild	O
type	O
cells	O
in	O
mixed	O
oral	O
infections	O
of	O
mice	S-Organism
[	O
25	O
]	O
.	O

After	O
three	O
days	O
of	O
infection	O
the	O
geometric	O
mean	O
competitive	O
index	O
(	O
CI	O
)	O
for	O
the	O
mutant	O
was	O
0	O
.	O
20	O
(	O
95	O
%	O
CI	O
0	O
.	O
13	O
-	O
0	O
.	O
29	O
)	O
and	O
0	O
.	O
18	O
(	O
95	O
%	O
CI	O
0	O
.	O
06	O
-	O
0	O
.	O
5	O
)	O
in	O
the	O
spleen	O
and	O
liver	O
respectively	O
(	O
P	O
<	O
0	O
.	O
0001	O
;	O
Fig	O
.	O
1D	O
)	O
indicating	O
that	O
bacteria	O
lacking	O
srcA	O
were	O
significantly	O
out	O
competed	O
by	O
wild	O
type	O
cells	O
during	O
systemic	O
infection	O
.	O

To	O
verify	O
the	O
role	O
of	O
srcA	O
on	O
this	O
phenotype	O
,	O
we	O
complemented	O
the	O
srcA	O
mutant	O
with	O
a	O
wild	O
type	O
srcA	O
gene	O
under	O
the	O
control	O
of	O
its	O
endogenous	O
promoter	O
,	O
which	O
restored	O
in	O
vivo	O
fitness	O
to	O
that	O
of	O
wild	O
type	O
(	O
Fig	O
.	O
1D	O
)	O
.	O

The	O
level	O
of	O
attenuation	O
of	O
the	O
srcA	O
mutant	O
was	O
generally	O
higher	O
than	O
most	O
single	O
effector	O
gene	O
mutants	O
[	O
26	O
]	O
,	O
which	O
suggested	O
to	O
us	O
that	O
SrcA	O
contributes	O
to	O
an	O
important	O
aspect	O
of	O
T3SS	O
function	O
in	O
vivo	O
.	O

Crystal	O
structure	O
of	O
SrcA	O

Sequence	O
analysis	O
showed	O
59	O
%	O
amino	O
acid	O
identity	O
between	O
SrcA	O
and	O
CesT	O
,	O
a	O
secretion	O
chaperone	O
in	O
enteropathogenic	B-Organism
E	I-Organism
.	I-Organism
coli	E-Organism
(	O
EPEC	S-Organism
)	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

As	O
a	O
means	O
to	O
address	O
the	O
biological	O
function	O
of	O
SrcA	O
,	O
we	O
solved	O
the	O
crystal	O
structure	O
at	O
2	O
.	O
5	O
-	O
A	O
resolution	O
(	O
PDB	O
3EPU	O
)	O
.	O

A	O
summary	O
of	O
crystallographic	O
data	O
collection	O
and	O
model	O
refinement	O
statistics	O
is	O
in	O
Table	O
1	O
.	O

The	O
structure	O
was	O
solved	O
by	O
molecular	O
replacement	O
using	O
an	O
initial	O
model	O
based	O
on	O
CesT	O
(	O
PDB	O
1K3E	O
)	O
[	O
13	O
]	O
.	O

SrcA	O
crystallized	O
in	O
space	O
group	O
C2	O
with	O
two	O
molecules	O
related	O
by	O
a	O
2	O
-	O
fold	O
symmetry	O
axis	O
in	O
each	O
asymmetric	O
unit	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Each	O
monomer	O
consisted	O
of	O
a	O
small	O
and	O
large	O
domain	O
.	O

The	O
smaller	O
domain	O
formed	O
by	O
alpha1	O
and	O
the	O
extended	O
loop	O
region	O
preceding	O
beta1	O
adopts	O
a	O
distinct	O
conformation	O
in	O
each	O
subunit	O
.	O

The	O
larger	O
domain	O
mediates	O
dimerization	O
and	O
is	O
comprised	O
of	O
a	O
twisted	O
anti	O
-	O
parallel	O
beta	O
-	O
sheet	O
(	O
beta1	O
-	O
beta2	O
-	O
beta3	O
-	O
beta5	O
-	O
beta4	O
)	O
flanked	O
by	O
alpha	O
-	O
helices	O
alpha2	O
and	O
alpha3	O
.	O

The	O
dimer	O
interface	O
formed	O
between	O
SrcA	O
monomers	O
occurs	O
primarily	O
through	O
reciprocal	O
hydrophobic	O
interactions	O
between	O
alpha2	O
and	O
alpha2	O
'	O
with	O
additional	O
interface	O
-	O
stabilizing	O
interactions	O
occurring	O
between	O
the	O
alpha2	O
helix	O
of	O
one	O
monomer	O
and	O
beta4	O
and	O
beta5	O
strands	O
of	O
the	O
opposing	O
monomer	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

The	O
total	O
surface	O
area	O
buried	O
at	O
the	O
dimer	O
interface	O
is	O
1258	O
A2	O
,	O
suggesting	O
that	O
SrcA	O
would	O
exist	O
as	O
a	O
dimer	O
in	O
solution	O
,	O
which	O
we	O
confirmed	O
by	O
gel	O
filtration	O
analysis	O
(	O
see	O
below	O
)	O
.	O

A	O
structure	O
similarity	O
search	O
with	O
SrcA	O
revealed	O
proteins	O
identified	O
as	O
T3SS	O
secretion	O
chaperones	O
.	O

CesT	O
and	O
SicP	O
were	O
the	O
most	O
structurally	O
similar	O
to	O
SrcA	O
,	O
aligning	O
with	O
RMSD	O
of	O
1	O
.	O
8	O
A	O
and	O
2	O
.	O
2	O
A	O
respectively	O
.	O

With	O
the	O
exception	O
of	O
CesT	O
,	O
SrcA	O
has	O
weak	O
overall	O
sequence	O
identity	O
(	O
<	O
20	O
%	O
)	O
with	O
other	O
T3SS	O
chaperones	O
.	O

CesT	O
,	O
SicP	O
and	O
SrcA	O
contain	O
several	O
clusters	O
of	O
highly	O
conserved	O
amino	O
acids	O
notable	O
on	O
primary	O
sequence	O
alignments	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Most	O
of	O
these	O
conserved	O
sites	O
are	O
located	O
in	O
the	O
alpha2	O
-	O
interface	O
helix	O
and	O
in	O
strands	O
beta4	O
and	O
beta5	O
that	O
help	O
stabilize	O
this	O
interface	O
.	O

Although	O
the	O
N	O
-	O
terminus	O
of	O
these	O
proteins	O
is	O
conserved	O
structurally	O
,	O
the	O
tertiary	O
structures	O
differ	O
for	O
each	O
protein	O
.	O

In	O
CesT	O
,	O
alpha1	O
and	O
beta1	O
adopt	O
an	O
extended	O
conformation	O
while	O
the	O
equivalent	O
domain	O
in	O
SicP	O
remains	O
closely	O
packed	O
against	O
the	O
dimerization	O
domain	O
[	O
12	O
]	O
.	O

In	O
SrcA	O
,	O
both	O
extended	O
and	O
closely	O
packed	O
conformations	O
are	O
observed	O
in	O
separate	O
subunits	O
of	O
the	O
same	O
dimer	O
within	O
the	O
asymmetric	O
unit	O
.	O

In	O
the	O
extended	O
conformation	O
the	O
N	O
-	O
terminal	O
helix	O
from	O
one	O
dimer	O
interacts	O
with	O
the	O
beta4	O
region	O
of	O
an	O
adjacent	O
dimer	O
,	O
similar	O
to	O
a	O
domain	O
swap	O
seen	O
in	O
CesT	O
[	O
13	O
]	O
.	O

At	O
this	O
time	O
,	O
the	O
possible	O
biological	O
relevance	O
for	O
such	O
a	O
domain	O
swap	O
is	O
unclear	O
and	O
may	O
reflect	O
an	O
artifact	O
of	O
crystallization	O
as	O
critically	O
discussed	O
[	O
13	O
]	O
.	O

A	O
comparison	O
of	O
the	O
SrcA	O
dimer	O
interface	O
with	O
other	O
class	O
I	O
chaperone	O
family	O
members	O
indicates	O
the	O
overall	O
similarity	O
of	O
quaternary	O
structure	O
shared	O
between	O
SrcA	O
,	O
CesT	O
and	O
SicP	O
(	O
Fig	O
.	O
3A	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
class	O
II	O
chaperone	O
interface	O
of	O
Spa15	O
,	O
which	O
despite	O
having	O
similar	O
tertiary	O
structure	O
to	O
SrcA	O
adopts	O
a	O
distinct	O
dimer	O
interface	O
.	O

A	O
structural	O
alignment	O
of	O
SrcA	O
and	O
Spa15	O
generated	O
through	O
alignment	O
of	O
single	O
monomers	O
shows	O
the	O
relative	O
difference	O
in	O
subunit	O
orientation	O
between	O
SrcA	O
and	O
Spa15	O
reflected	O
by	O
the	O
positions	O
of	O
each	O
monomer	O
in	O
the	O
dimer	O
configuration	O
.	O

These	O
unique	O
orientations	O
produce	O
an	O
80degrees	O
rotational	O
offset	O
between	O
respective	O
subunits	O
and	O
could	O
be	O
expected	O
to	O
influence	O
the	O
mode	O
of	O
effector	O
interactions	O
utilized	O
by	O
these	O
proteins	O
.	O

To	O
evaluate	O
the	O
potential	O
for	O
an	O
effector	O
-	O
binding	O
surface	O
on	O
SrcA	O
,	O
the	O
structure	O
of	O
SicP	O
in	O
complex	O
with	O
its	O
effector	O
SptP	O
was	O
aligned	O
with	O
SrcA	O
and	O
represented	O
as	O
a	O
space	O
-	O
filling	O
model	O
(	O
Fig	O
.	O
3B	O
)	O
.	O

Binding	O
of	O
SptP	O
occurs	O
primarily	O
in	O
the	O
N	O
-	O
terminus	O
of	O
SicP	O
[	O
12	O
]	O
,	O
which	O
is	O
similar	O
to	O
the	O
effector	O
binding	O
surface	O
for	O
SrcA	O
predicted	O
in	O
silico	O
.	O

This	O
surface	O
contains	O
several	O
conserved	O
hydrophobic	O
residues	O
including	O
L16	O
,	O
D24	O
,	O
N26	O
,	O
and	O
I32	O
(	O
Fig	O
.	O
2A	O
)	O
,	O
which	O
is	O
consistent	O
with	O
SrcA	O
using	O
a	O
similar	O
mechanism	O
for	O
interaction	O
with	O
effectors	O
.	O

SrcA	O
interacts	O
with	O
the	O
SPI	O
-	O
2	O
T3SS	O
ATPase	O

An	O
emerging	O
function	O
for	O
T3SS	O
chaperones	O
is	O
delivery	O
of	O
cargo	O
to	O
the	O
base	O
of	O
the	O
apparatus	O
through	O
interactions	O
with	O
an	O
ATPase	O
.	O

This	O
was	O
shown	O
for	O
the	O
flagellar	O
T3SS	O
[	O
17	O
]	O
and	O
later	O
in	O
the	O
virulence	O
-	O
associated	O
T3SS	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
[	O
16	O
]	O
,	O
[	O
27	O
]	O
and	O
the	O
SPI	O
-	O
1	O
T3SS	O
in	O
Salmonella	S-Organism
[	O
15	O
]	O
.	O

However	O
,	O
analogous	O
interactions	O
have	O
not	O
been	O
described	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
.	O

Since	O
srcA	O
expression	O
was	O
co	O
-	O
regulated	O
with	O
genes	O
in	O
SPI	O
-	O
2	O
,	O
we	O
hypothesized	O
that	O
it	O
had	O
a	O
functional	O
role	O
in	O
this	O
system	O
.	O

To	O
address	O
this	O
biochemically	O
we	O
purified	O
SrcA	O
and	O
the	O
predicted	O
ATPase	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
SsaN	O
,	O
and	O
performed	O
binding	O
experiments	O
and	O
gel	O
filtration	O
chromatography	O
of	O
the	O
protein	O
mixtures	O
.	O

SsaN	O
contains	O
conserved	O
amino	O
acid	O
residues	O
characteristic	O
of	O
Walker	O
-	O
A	O
and	O
Walker	O
-	O
B	O
motifs	O
of	O
P	O
-	O
loop	O
nucleoside	O
triphosphate	O
hydrolases	O
,	O
as	O
well	O
as	O
a	O
number	O
of	O
residues	O
shown	O
to	O
contribute	O
to	O
ATP	O
binding	O
or	O
ring	O
stacking	O
with	O
the	O
adenine	O
base	O
of	O
ATP	O
in	O
the	O
E	B-Organism
.	I-Organism
coli	E-Organism
orthologue	O
,	O
EscN	O
,	O
(	O
Q412	O
,	O
E191	O
,	O
R366	O
)	O
(	O
Fig	O
.	O
S1	O
)	O
.	O

Since	O
SsaN	O
had	O
not	O
been	O
characterized	O
biochemically	O
we	O
first	O
verified	O
that	O
our	O
purified	O
protein	O
had	O
ATPase	O
activity	O
(	O
Fig	O
.	O
S1	O
)	O
.	O

We	O
then	O
mixed	O
SrcA	O
and	O
SsaN	O
proteins	O
and	O
resolved	O
the	O
protein	O
complexes	O
by	O
gel	O
filtration	O
chromatography	O
.	O

By	O
itself	O
,	O
SrcA	O
existed	O
as	O
a	O
dimer	O
in	O
solution	O
(	O
Fig	O
.	O
4A	O
)	O
with	O
no	O
higher	O
oligomers	O
present	O
,	O
substantiating	O
the	O
stoichiometry	O
obtained	O
from	O
our	O
crystal	O
data	O
.	O

SsaN	O
existed	O
as	O
a	O
monomer	O
with	O
a	O
minor	O
population	O
eluting	O
in	O
a	O
volume	O
consistent	O
with	O
a	O
probable	O
dimer	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

When	O
SrcA	O
was	O
mixed	O
with	O
SsaN	O
,	O
a	O
new	O
protein	O
complex	O
of	O
high	O
molecular	O
weight	O
was	O
observed	O
,	O
along	O
with	O
diminished	O
peaks	O
corresponding	O
to	O
the	O
SrcA	O
dimer	O
and	O
SsaN	O
monomer	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

This	O
new	O
complex	O
elutes	O
with	O
a	O
Stokes	O
radius	O
consistent	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
approximately600	O
kDa	O
.	O

We	O
verified	O
the	O
identities	O
of	O
protein	O
originating	O
from	O
each	O
peak	O
by	O
western	O
blot	O
(	O
Fig	O
.	O
4D	O
)	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
,	O
which	O
showed	O
the	O
new	O
complex	O
was	O
comprised	O
of	O
both	O
SsaN	O
and	O
SrcA	O
.	O

SrcA	O
binds	O
effector	O
cargo	O
destined	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O

Since	O
structural	O
and	O
biochemical	O
data	O
unambiguously	O
defined	O
SrcA	O
as	O
a	O
T3SS	O
-	O
associated	O
chaperone	O
,	O
we	O
used	O
two	O
experimental	O
approaches	O
to	O
identify	O
SrcA	O
cargo	O
(	O
s	O
)	O
.	O

First	O
,	O
we	O
used	O
stable	O
isotope	O
labeling	O
of	O
amino	O
acids	O
in	O
cell	O
culture	O
(	O
SILAC	O
)	O
[	O
28	O
]	O
in	O
conjunction	O
with	O
quantitative	O
mass	O
spectrometry	O
-	O
based	O
proteomics	O
to	O
identify	O
cargo	O
immunoprecipitated	O
with	O
SrcA	O
from	O
Salmonella	S-Organism
.	O

For	O
this	O
series	O
of	O
experiments	O
we	O
constructed	O
a	O
mutant	O
in	O
which	O
the	O
srcA	O
gene	O
was	O
replaced	O
on	O
the	O
chromosome	O
with	O
srcA	O
-	O
FLAG	O
to	O
enable	O
immunoprecipitation	O
from	O
cell	O
lysates	O
.	O

Lysates	O
prepared	O
from	O
wild	O
type	O
cells	O
grown	O
in	O
2H4	O
-	O
Lys	O
and	O
13C6	O
-	O
Arg	O
containing	O
SILAC	O
medium	O
(	O
heavy	O
)	O
and	O
srcA	O
mutant	O
cells	O
grown	O
in	O
medium	O
containing	O
natural	O
amino	O
acids	O
of	O
Lys	O
and	O
Arg	O
(	O
light	O
)	O
were	O
mixed	O
and	O
subjected	O
to	O
an	O
immunoprecipitation	O
procedure	O
with	O
an	O
anti	O
-	O
FLAG	O
antibody	O
followed	O
by	O
quantitative	O
mass	O
spectrometry	O
.	O

Peptides	O
originating	O
from	O
wild	O
type	O
cells	O
contained	O
heavy	O
atom	O
-	O
substituted	O
lysine	O
and	O
arginine	O
such	O
that	O
putative	O
SrcA	O
cargo	O
proteins	O
would	O
generate	O
low	O
heavy	O
:	O
light	O
SILAC	O
peptide	O
ratios	O
from	O
the	O
complex	O
mixtures	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

In	O
these	O
experiments	O
the	O
T3SS	O
effector	O
protein	O
SseL	O
was	O
identified	O
by	O
quantitative	O
SILAC	O
mass	O
spectrometry	O
as	O
a	O
specific	O
SrcA	O
cargo	O
protein	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

SseL	O
was	O
immunoprecipitated	O
specifically	O
along	O
with	O
SrcA	O
-	O
FLAG	O
with	O
a	O
SILAC	O
ratio	O
of	O
0	O
.	O
08	O
,	O
whereas	O
additional	O
abundant	O
proteins	O
displayed	O
SILAC	O
ratios	O
closer	O
to	O
approximately1	O
(	O
OmpF	O
is	O
shown	O
,	O
Fig	O
.	O
5B	O
)	O
(	O
mean	O
SILAC	O
ratio	O
of	O
all	O
other	O
peptides	O
identified	O
was	O
0	O
.	O
93	O
(	O
Dataset	O
S1	O
)	O
.	O

Secondly	O
,	O
to	O
verify	O
the	O
mass	O
spectrometry	O
data	O
and	O
to	O
identify	O
other	O
possible	O
effector	O
cargo	O
,	O
we	O
examined	O
the	O
secretion	O
profiles	O
of	O
wild	O
type	O
cells	O
and	O
an	O
srcA	O
mutant	O
that	O
each	O
expressed	O
HA	O
-	O
tagged	O
effector	O
genes	O
,	O
the	O
products	O
of	O
which	O
are	O
secreted	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

Using	O
this	O
approach	O
SseL	O
-	O
HA	O
and	O
PipB2	O
-	O
HA	O
were	O
depleted	O
from	O
the	O
secreted	O
protein	O
fraction	O
of	O
srcA	O
mutant	O
cells	O
(	O
Fig	O
.	O
5C	O
)	O
but	O
reached	O
similar	O
levels	O
in	O
the	O
bacterial	O
cytoplasm	O
(	O
Fig	O
.	O
5D	O
)	O
.	O

As	O
expected	O
from	O
data	O
with	O
the	O
complemented	O
mutant	O
in	O
vivo	O
,	O
expression	O
of	O
srcA	O
in	O
trans	O
restored	O
effector	O
secretion	O
in	O
the	O
srcA	O
mutant	O
(	O
data	O
not	O
shown	O
)	O
.	O

SrcA	O
is	O
required	O
for	O
PipB2	O
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	S-Organism
-	O
containing	O
vacuole	O

To	O
further	O
show	O
a	O
role	O
for	O
SrcA	O
in	O
chaperoning	O
PipB2	O
,	O
we	O
set	O
up	O
experiments	O
to	O
test	O
whether	O
deleting	O
srcA	O
would	O
phenocopy	O
DeltapipB2	S-Organism
cells	O
for	O
PipB2	O
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	S-Organism
containing	O
vacuole	O
(	O
SCV	O
)	O
in	O
epithelial	O
cells	O
,	O
an	O
event	O
linked	O
to	O
cell	O
-	O
to	O
-	O
cell	O
transfer	O
during	O
infection	O
in	O
vitro	O
[	O
29	O
]	O
.	O

At	O
10	O
h	O
after	O
infection	O
the	O
majority	O
of	O
SCVs	O
were	O
situated	O
near	O
the	O
nucleus	O
in	O
accordance	O
with	O
previous	O
work	O
(	O
Fig	O
.	O
6A	O
)	O
[	O
29	O
]	O
.	O

By	O
24	O
h	O
after	O
infection	O
SCVs	O
containing	O
wild	O
type	O
bacteria	O
were	O
displaced	O
centrifugally	O
towards	O
the	O
cell	O
periphery	O
whereas	O
SCVs	O
containing	O
either	O
pipB2	O
or	O
srcA	O
mutant	O
bacteria	O
remained	O
juxtaposed	O
to	O
the	O
nucleus	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

The	O
average	O
distance	O
from	O
the	O
nucleus	O
of	O
LAMP1	O
+	O
SCVs	O
containing	O
wild	O
type	O
bacteria	O
was	O
2	O
.	O
19	O
microm	O
at	O
10h	O
post	O
infection	O
and	O
increased	O
to	O
7	O
.	O
86	O
microm	O
by	O
24	O
h	O
after	O
infection	O
.	O

Conversely	O
,	O
SCVs	O
containing	O
either	O
DeltapipB2	S-Organism
cells	O
or	O
DeltasrcA	S-Organism
cells	O
were	O
1	O
.	O
38	O
microm	O
and	O
2	O
.	O
09	O
microm	O
at	O
10h	O
but	O
lacked	O
centrifugal	O
displacement	O
at	O
24	O
h	O
(	O
2	O
.	O
23	O
microm	O
and	O
2	O
.	O
85	O
microm	O
,	O
respectively	O
)	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Discussion	O

Structural	O
features	O
of	O
SrcA	O
We	O
used	O
a	O
reverse	O
genetics	O
approach	O
to	O
define	O
a	O
new	O
secretion	O
chaperone	O
in	O
S	B-Organism
.	E-Organism

Typhimurium	S-Organism
that	O
is	O
integrated	O
functionally	O
with	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
,	O
a	O
system	O
well	O
described	O
for	O
its	O
role	O
in	O
immune	O
subversion	O
and	O
intracellular	O
infection	O
during	O
host	S-Organism
colonization	O
.	O

Consistent	O
with	O
other	O
class	O
I	O
secretion	O
chaperones	O
,	O
SrcA	O
has	O
extensive	O
electronegative	O
charge	O
distributed	O
over	O
the	O
surface	O
of	O
the	O
molecule	O
.	O

The	O
exact	O
function	O
of	O
this	O
charge	O
distribution	O
is	O
not	O
known	O
,	O
but	O
data	O
from	O
other	O
systems	O
suggests	O
a	O
docking	O
recognition	O
function	O
with	O
other	O
components	O
of	O
the	O
type	O
III	O
apparatus	O
,	O
possibly	O
the	O
T3SS	O
-	O
accociated	O
ATPase	O
.	O

For	O
instance	O
,	O
electronegative	O
surface	O
residues	O
on	O
the	O
SigE	O
chaperone	O
in	O
the	O
SPI	O
-	O
1	O
-	O
encoded	O
T3SS	O
negatively	O
affect	O
cargo	O
secretion	O
,	O
but	O
not	O
cargo	O
stability	O
[	O
30	O
]	O
.	O

In	O
enteropathogenic	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
a	O
surface	O
-	O
exposed	O
electronegative	O
residue	O
in	O
the	O
CesT	O
chaperone	O
(	O
Glu142	O
)	O
likewise	O
contributes	O
to	O
Tir	O
secretion	O
but	O
not	O
Tir	O
binding	O
[	O
16	O
]	O
,	O
suggesting	O
a	O
role	O
in	O
either	O
targeting	O
bound	O
cargo	O
to	O
the	O
T3SS	O
or	O
in	O
the	O
secretion	O
process	O
itself	O
.	O

Interestingly	O
,	O
SrcA	O
lacks	O
17	O
-	O
amino	O
acids	O
that	O
make	O
up	O
the	O
carboxyl	O
terminus	O
of	O
CesT	O
,	O
which	O
includes	O
Glu142	O
,	O
and	O
yet	O
it	O
still	O
retains	O
effector	O
binding	O
,	O
ATPase	O
binding	O
and	O
effector	O
secretion	O
functionalities	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
other	O
surface	O
charged	O
residues	O
of	O
SrcA	O
are	O
involved	O
in	O
these	O
functions	O
or	O
that	O
SrcA	O
targets	O
effector	O
cargo	O
to	O
the	O
secretion	O
apparatus	O
through	O
a	O
mechanism	O
distinct	O
from	O
CesT	O
.	O

The	O
interface	O
for	O
the	O
SrcA	O
homodimer	O
is	O
extensive	O
and	O
is	O
more	O
in	O
keeping	O
with	O
the	O
structural	O
features	O
of	O
single	O
-	O
effector	O
class	O
IA	O
chaperones	O
(	O
approximately1100	O
-	O
1300	O
A2	O
)	O
compared	O
to	O
the	O
reduced	O
dimer	O
interface	O
of	O
Spa15	O
,	O
a	O
multi	O
-	O
cargo	O
class	O
IB	O
chaperone	O
from	O
Shigella	S-Organism
[	O
31	O
]	O
.	O

Similar	O
to	O
CesT	O
and	O
SicP	O
,	O
the	O
dimer	O
interface	O
of	O
SrcA	O
adopts	O
a	O
parallel	O
configuration	O
when	O
comparing	O
alpha2	O
helices	O
of	O
opposing	O
subunits	O
.	O

In	O
contrast	O
,	O
the	O
subunits	O
of	O
Spa15	O
undergo	O
a	O
significant	O
relative	O
rotation	O
(	O
80degrees	O
)	O
about	O
the	O
alpha2	O
-	O
axis	O
resulting	O
in	O
a	O
different	O
interface	O
.	O

These	O
features	O
may	O
relate	O
to	O
biological	O
function	O
in	O
the	O
SPI2	O
T3SS	O
and	O
/	O
or	O
in	O
vetting	O
effector	O
cargo	O
amongst	O
the	O
>	O
30	O
effectors	O
identified	O
in	O
Salmonella	S-Organism
.	O

We	O
found	O
no	O
evidence	O
of	O
interactions	O
between	O
SrcA	O
and	O
translocon	O
components	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
so	O
it	O
appears	O
as	O
though	O
SrcA	O
functions	O
specifically	O
in	O
effector	O
translocation	O
events	O
.	O

Implications	O
for	O
type	O
III	O
secretion	O
function	O

The	O
interaction	O
between	O
SrcA	O
and	O
SsaN	O
supports	O
an	O
emerging	O
paradigm	O
whereby	O
secretion	O
chaperones	O
bring	O
effector	O
cargo	O
to	O
the	O
T3SS	O
through	O
physical	O
interaction	O
with	O
the	O
hexameric	O
ATPase	O
at	O
the	O
base	O
of	O
the	O
apparatus	O
[	O
14	O
]	O
.	O

This	O
was	O
demonstrated	O
for	O
chaperone	O
-	O
ATPase	O
components	O
in	O
the	O
flagellar	O
type	O
III	O
system	O
[	O
17	O
]	O
and	O
in	O
non	O
-	O
flagellar	O
type	O
III	O
systems	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
[	O
27	O
]	O
and	O
the	O
SPI	O
-	O
1	O
system	O
in	O
Salmonella	S-Organism
[	O
15	O
]	O
.	O

Our	O
work	O
shows	O
the	O
first	O
chaperone	O
-	O
ATPase	O
interaction	O
for	O
a	O
T3SS	O
functioning	O
from	O
within	O
an	O
intracellular	O
vacuolar	O
compartment	O
and	O
supports	O
this	O
interaction	O
as	O
a	O
more	O
generalize	O
feature	O
of	O
type	O
III	O
secretion	O
function	O
.	O

In	O
our	O
experiments	O
,	O
we	O
could	O
induce	O
the	O
ATPase	O
domain	O
of	O
SsaN	O
to	O
oligomerize	O
in	O
the	O
presence	O
of	O
SrcA	O
,	O
but	O
not	O
in	O
its	O
absence	O
,	O
which	O
was	O
intriguing	O
because	O
the	O
purified	O
enzyme	O
lacked	O
a	O
domain	O
at	O
the	O
carboxyl	O
terminus	O
thought	O
to	O
be	O
involved	O
in	O
oligomer	O
stability	O
,	O
at	O
least	O
for	O
E	B-Organism
.	I-Organism
coli	E-Organism
EscN	O
[	O
14	O
]	O
.	O

These	O
data	O
suggest	O
that	O
type	O
III	O
chaperones	O
might	O
have	O
an	O
as	O
yet	O
undefined	O
role	O
in	O
assembly	O
of	O
the	O
ATPase	O
homohexamer	O
that	O
gives	O
rise	O
to	O
efficient	O
effector	O
translocation	O
.	O

This	O
will	O
be	O
an	O
important	O
area	O
for	O
further	O
experimentation	O
in	O
this	O
and	O
other	O
systems	O
.	O

Genetic	O
and	O
functional	O
integration	O
of	O
SrcA	O
with	O
type	O
III	O
secretion	O

The	O
genes	O
encoding	O
the	O
srcA	O
chaperone	O
and	O
the	O
effector	O
cargos	O
(	O
pipB2	O
and	O
sseL	O
)	O
are	O
found	O
in	O
all	O
serotypes	O
of	O
Salmonella	B-Organism
enterica	E-Organism
that	O
contain	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

Conversely	O
,	O
these	O
genes	O
are	O
absent	O
from	O
S	B-Organism
.	I-Organism
bongori	E-Organism
,	O
which	O
lacks	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

The	O
expression	O
of	O
srcA	O
is	O
coordinated	O
with	O
T3SS	O
transcriptional	O
activity	O
via	O
the	O
SsrA	O
-	O
SsrB	O
two	O
-	O
component	O
regulatory	O
system	O
encoded	O
in	O
SPI	O
-	O
2	O
.	O

The	O
direct	O
binding	O
of	O
SsrB	O
to	O
the	O
promoter	O
region	O
upstream	O
of	O
srcA	O
,	O
along	O
with	O
SsrB	O
-	O
regulation	O
of	O
both	O
sseL	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
and	O
pipB2	O
[	O
32	O
]	O
is	O
indicative	O
of	O
multiple	O
cis	O
-	O
regulatory	O
mutation	O
events	O
that	O
have	O
allowed	O
for	O
functional	O
coordination	O
of	O
the	O
distributed	O
secretion	O
apparatus	O
,	O
chaperone	O
and	O
effector	O
cargos	O
.	O

We	O
recently	O
described	O
this	O
type	O
of	O
regulatory	O
evolution	O
for	O
pathogenic	O
adaptation	O
of	O
Salmonella	S-Organism
to	O
its	O
host	S-Organism
[	O
21	O
]	O
and	O
srcA	O
is	O
consistent	O
with	O
regulatory	O
evolution	O
of	O
chaperone	O
-	O
effector	O
gene	O
pairs	O
that	O
are	O
not	O
co	O
-	O
transcribed	O
in	O
operons	O
.	O

Due	O
to	O
low	O
G	O
+	O
C	O
base	O
content	O
compared	O
to	O
the	O
genome	O
average	O
of	O
52	O
%	O
,	O
it	O
'	O
s	O
likely	O
that	O
srcA	O
(	O
32	O
%	O
G	O
+	O
C	O
)	O
and	O
an	O
adjacent	O
gene	O
,	O
STM2137	O
(	O
37	O
%	O
G	O
+	O
C	O
)	O
,	O
were	O
acquired	O
as	O
a	O
foreign	O
islet	O
that	O
was	O
retained	O
in	O
organisms	O
containing	O
the	O
SPI	O
-	O
2	O
T3SS	O
due	O
to	O
the	O
selective	O
advantage	O
afforded	O
by	O
the	O
new	O
protein	O
interactions	O
so	O
created	O
.	O

Interestingly	O
,	O
STM2137	O
(	O
also	O
known	O
as	O
SseK2	O
)	O
is	O
a	O
likely	O
paralog	O
of	O
SseK1	O
,	O
an	O
effector	O
translocated	O
by	O
the	O
SPI	O
-	O
2	O
T3SS	O
[	O
33	O
]	O
.	O

SseK2	O
is	O
also	O
regulated	O
by	O
the	O
SsrA	O
-	O
SsrB	O
two	O
-	O
component	O
system	O
but	O
compared	O
to	O
SseK1	O
,	O
it	O
is	O
translocated	O
in	O
much	O
less	O
abundance	O
into	O
host	O
cells	O
[	O
33	O
]	O
.	O

Using	O
the	O
methods	O
described	O
here	O
,	O
we	O
were	O
not	O
able	O
to	O
detect	O
SseK2	O
secretion	O
or	O
a	O
physical	O
interaction	O
with	O
SrcA	O
,	O
however	O
it	O
remains	O
possible	O
that	O
SrcA	O
also	O
chaperones	O
SseK2	O
for	O
low	O
-	O
level	O
translocation	O
.	O

SrcA	O
is	O
unique	O
among	O
other	O
multi	O
-	O
effector	O
chaperones	O
most	O
closely	O
related	O
to	O
it	O
in	O
that	O
it	O
is	O
unlinked	O
from	O
the	O
T3SS	O
genomic	O
island	O
.	O

For	O
example	O
,	O
InvB	O
and	O
SicP	O
(	O
Salmonella	S-Organism
SPI	O
-	O
1	O
)	O
,	O
CesT	O
(	O
enteropathogenic	O
E	B-Organism
.	I-Organism
coli	E-Organism
locus	O
of	O
enterocyte	O
effacement	O
)	O
and	O
Spa15	O
(	O
Shigella	S-Organism
mxi	O
/	O
spa	O
virulence	O
plasmid	O
region	O
)	O
chaperones	O
are	O
all	O
encoded	O
within	O
the	O
T3SS	O
structural	O
operons	O
,	O
implying	O
they	O
have	O
co	O
-	O
evolved	O
as	O
a	O
single	O
genetic	O
entity	O
from	O
a	O
common	O
ancestor	O
.	O

Given	O
its	O
genetic	O
neighborhood	O
,	O
srcA	O
appears	O
to	O
be	O
a	O
genetic	O
acquisition	O
separate	O
from	O
SPI	O
-	O
2	O
that	O
functionally	O
links	O
some	O
effectors	O
to	O
the	O
T3SS	O
apparatus	O
via	O
the	O
ATPase	O
.	O

The	O
role	O
of	O
horizontal	O
gene	O
transfer	O
and	O
regulatory	O
evolution	O
in	O
allowing	O
for	O
uncoupling	O
of	O
chaperones	O
,	O
effectors	O
and	O
the	O
T3SS	O
has	O
many	O
possible	O
implications	O
for	O
T3SS	O
function	O
,	O
including	O
plasticity	O
in	O
chaperone	O
-	O
effector	O
interaction	O
networks	O
,	O
expansion	O
of	O
effector	O
repertoires	O
,	O
and	O
alterations	O
to	O
the	O
kinetics	O
and	O
hierarchical	O
delivery	O
of	O
effectors	O
to	O
a	O
host	O
cell	O
.	O

These	O
events	O
may	O
improve	O
host	O
adaptability	O
or	O
even	O
expand	O
the	O
host	O
range	O
of	O
bacteria	O
that	O
acquire	O
and	O
integrate	O
new	O
functional	O
secretion	O
chaperones	O
.	O

Transit	O
through	O
the	O
Flea	S-Organism
Vector	O
Induces	O
a	O
Pretransmission	O
Innate	O
Immunity	O
Resistance	O
Phenotype	O
in	O
Yersinia	B-Organism
pestis	E-Organism

Yersinia	B-Organism
pestis	E-Organism
,	O
the	O
agent	O
of	O
plague	O
,	O
is	O
transmitted	O
to	O
mammals	O
by	O
infected	O
fleas	S-Organism
.	O

Y	B-Organism
.	I-Organism
pestis	E-Organism
exhibits	O
a	O
distinct	O
life	O
stage	O
in	O
the	O
flea	S-Organism
,	O
where	O
it	O
grows	O
in	O
the	O
form	O
of	O
a	O
cohesive	O
biofilm	O
that	O
promotes	O
transmission	O
.	O

After	O
transmission	O
,	O
the	O
temperature	O
shift	O
to	O
37degreesC	O
induces	O
many	O
known	O
virulence	O
factors	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
that	O
confer	O
resistance	O
to	O
innate	O
immunity	O
.	O

These	O
factors	O
are	O
not	O
produced	O
in	O
the	O
low	O
-	O
temperature	O
environment	O
of	O
the	O
flea	S-Organism
,	O
however	O
,	O
suggesting	O
that	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
is	O
vulnerable	O
to	O
the	O
initial	O
encounter	O
with	O
innate	O
immune	O
cells	O
at	O
the	O
flea	S-Organism
bite	O
site	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
whole	O
-	O
genome	O
microarrays	O
to	O
compare	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
vivo	O
transcriptome	O
in	O
infective	O
fleas	S-Organism
to	O
in	O
vitro	O
transcriptomes	O
in	O
temperature	O
-	O
matched	O
biofilm	O
and	O
planktonic	O
cultures	O
,	O
and	O
to	O
the	O
previously	O
characterized	O
in	O
vivo	O
gene	O
expression	O
profile	O
in	O
the	O
rat	S-Organism
bubo	O
.	O

In	O
addition	O
to	O
genes	O
involved	O
in	O
metabolic	O
adaptation	O
to	O
the	O
flea	S-Organism
gut	O
and	O
biofilm	O
formation	O
,	O
several	O
genes	O
with	O
known	O
or	O
predicted	O
roles	O
in	O
resistance	O
to	O
innate	O
immunity	O
and	O
pathogenicity	O
in	O
the	O
mammal	O
were	O
upregulated	O
in	O
the	O
flea	S-Organism
.	O

Y	B-Organism
.	I-Organism
pestis	E-Organism
from	O
infected	O
fleas	S-Organism
were	O
more	O
resistant	O
to	O
phagocytosis	O
by	O
macrophages	O
than	O
in	O
vitro	O
-	O
grown	O
bacteria	O
,	O
in	O
part	O
attributable	O
to	O
a	O
cluster	O
of	O
insecticidal	O
-	O
like	O
toxin	O
genes	O
that	O
were	O
highly	O
expressed	O
only	O
in	O
the	O
flea	S-Organism
.	O

Our	O
results	O
suggest	O
that	O
transit	O
through	O
the	O
flea	S-Organism
vector	O
induces	O
a	O
phenotype	O
that	O
enhances	O
survival	O
and	O
dissemination	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
after	O
transmission	O
to	O
the	O
mammalian	O
host	S-Organism
.	O

Introduction	O

Arthropod	O
-	O
borne	O
transmission	O
of	O
bacterial	O
pathogens	O
is	O
somewhat	O
rare	O
but	O
has	O
evolved	O
in	O
a	O
phylogenetically	O
diverse	O
group	O
that	O
includes	O
the	O
rickettsiae	S-Organism
,	O
Borrelia	B-Organism
spirochetes	E-Organism
,	O
and	O
the	O
gram	O
-	O
negative	O
bacteria	O
Francisella	B-Organism
tularensis	E-Organism
and	O
Yersinia	B-Organism
pestis	E-Organism
,	O
the	O
plague	O
bacillus	O
.	O

Y	B-Organism
.	I-Organism
pestis	E-Organism
circulates	O
among	O
many	O
species	O
of	O
wild	O
rodents	O
,	O
its	O
primary	O
reservoir	O
hosts	S-Organism
,	O
via	O
flea	S-Organism
bite	O
.	O

As	O
it	O
alternates	O
between	O
fleas	S-Organism
and	O
mammals	O
,	O
it	O
is	O
postulated	O
that	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
regulates	O
gene	O
expression	O
appropriately	O
to	O
adapt	O
to	O
the	O
two	O
disparate	O
host	S-Organism
environments	O
,	O
and	O
that	O
different	O
sets	O
of	O
genes	O
are	O
required	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
the	O
flea	S-Organism
and	O
disease	O
in	O
the	O
mammal	O
.	O

Many	O
important	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
virulence	O
factors	O
that	O
are	O
required	O
for	O
plague	O
in	O
mammals	O
have	O
been	O
identified	O
,	O
and	O
most	O
of	O
them	O
are	O
induced	O
by	O
a	O
temperature	O
shift	O
from	O
<	O
26degreesC	O
to	O
37degreesC	O
,	O
which	O
mimics	O
the	O
transition	O
from	O
a	O
flea	S-Organism
to	O
the	O
warm	O
-	O
blooded	O
host	O
[	O
1	O
]	O
.	O

To	O
date	O
,	O
only	O
three	O
transmission	O
factors	O
(	O
genes	O
specifically	O
required	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
the	O
flea	S-Organism
)	O
have	O
been	O
characterized	O
.	O

One	O
,	O
the	O
yersinia	O
murine	O
toxin	O
(	O
ymt	O
)	O
gene	O
,	O
encodes	O
a	O
phospholipase	O
D	O
that	O
is	O
required	O
for	O
survival	O
in	O
the	O
flea	S-Organism
midgut	O
[	O
2	O
]	O
.	O

The	O
other	O
two	O
,	O
(	O
hmsHFRS	O
and	O
gmhA	O
)	O
,	O
are	O
responsible	O
for	O
an	O
extracellular	O
polysaccharide	O
and	O
a	O
lipopolysaccharide	O
(	O
LPS	O
)	O
core	O
modification	O
that	O
are	O
required	O
for	O
normal	O
biofilm	O
formation	O
and	O
blockage	O
in	O
the	O
flea	S-Organism
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Biofilm	O
development	O
in	O
the	O
flea	S-Organism
digestive	O
tract	O
is	O
important	O
for	O
biological	O
transmission	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

After	O
being	O
taken	O
up	O
in	O
a	O
blood	O
meal	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
proliferates	O
in	O
the	O
lumen	O
of	O
the	O
flea	S-Organism
midgut	O
to	O
form	O
cohesive	O
multicellular	O
biofilm	O
aggregates	O
.	O

In	O
some	O
infected	O
fleas	S-Organism
,	O
the	O
proventricular	O
valve	O
between	O
the	O
midgut	O
and	O
esophagus	O
is	O
colonized	O
.	O

The	O
subsequent	O
growth	O
and	O
consolidation	O
of	O
the	O
adherent	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
biofilm	O
amongst	O
the	O
rows	O
of	O
cuticle	O
-	O
covered	O
spines	O
that	O
line	O
the	O
proventriculus	O
interferes	O
with	O
normal	O
blood	O
feeding	O
,	O
resulting	O
in	O
regurgitation	O
of	O
bacteria	O
and	O
transmission	O
.	O

Fleas	S-Organism
with	O
a	O
completely	O
blocked	O
proventriculus	O
make	O
prolonged	O
,	O
repeated	O
attempts	O
to	O
feed	O
,	O
increasing	O
the	O
opportunities	O
for	O
transmission	O
.	O

Formation	O
of	O
a	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
biofilm	O
in	O
vitro	O
and	O
in	O
the	O
flea	S-Organism
proventriculus	O
depends	O
on	O
synthesis	O
of	O
an	O
extracellular	O
polysaccharide	O
matrix	O
(	O
ECM	O
)	O
that	O
is	O
synthesized	O
only	O
at	O
temperatures	O
below	O
26degreesC	O
[	O
3	O
]	O
,	O
[	O
7	O
]	O
.	O

In	O
common	O
with	O
many	O
other	O
bacteria	O
,	O
ECM	O
synthesis	O
in	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
is	O
controlled	O
by	O
intracellular	O
levels	O
of	O
cyclic	O
di	O
-	O
GMP	O
,	O
which	O
are	O
determined	O
by	O
competing	O
activities	O
of	O
the	O
hmsT	O
diguanylate	O
cyclase	O
and	O
hmsP	O
phosphodiesterase	O
gene	O
products	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

Bacterial	O
adhesins	O
are	O
typically	O
required	O
for	O
initial	O
adherence	O
and	O
autoaggregation	O
in	O
biofilm	O
development	O
[	O
10	O
]	O
,	O
but	O
such	O
factors	O
have	O
yet	O
to	O
be	O
identified	O
in	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
reported	O
the	O
in	O
vivo	O
gene	O
expression	O
profile	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
during	O
bubonic	O
plague	O
in	O
rats	S-Organism
[	O
11	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
transcriptome	O
in	O
blocked	O
Xenopsylla	B-Organism
cheopis	I-Organism
rat	I-Organism
fleas	E-Organism
,	O
an	O
important	O
vector	O
of	O
plague	O
to	O
humans	S-Organism
.	O

Comparing	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
gene	O
expression	O
profile	O
in	O
the	O
flea	S-Organism
to	O
those	O
of	O
in	O
vitro	O
biofilm	O
and	O
planktonic	O
cells	O
cultured	O
at	O
the	O
low	O
temperature	O
typical	O
of	O
the	O
flea	S-Organism
implicated	O
several	O
genes	O
in	O
a	O
flea	S-Organism
-	O
specific	O
adaptive	O
response	O
and	O
in	O
proventricular	O
blockage	O
.	O

In	O
addition	O
,	O
comparing	O
the	O
gene	O
expression	O
patterns	O
in	O
the	O
flea	S-Organism
and	O
in	O
the	O
rat	S-Organism
bubo	O
confirmed	O
that	O
distinct	O
subsets	O
of	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
life	O
cycle	O
.	O

Notably	O
,	O
several	O
genes	O
with	O
known	O
or	O
predicted	O
roles	O
in	O
protection	O
against	O
the	O
mammalian	O
innate	O
immune	O
system	O
and	O
in	O
pathogenesis	O
were	O
upregulated	O
in	O
the	O
flea	S-Organism
,	O
suggesting	O
that	O
transit	O
through	O
the	O
insect	O
vector	O
preinduces	O
a	O
phenotype	O
that	O
enhances	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
survival	O
and	O
dissemination	O
in	O
the	O
mammal	O
after	O
flea	S-Organism
-	O
borne	O
transmission	O
.	O

Results	O
/	O
Discussion	O

Transcriptional	O
profile	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
the	O
flea	S-Organism
Little	O
is	O
known	O
about	O
the	O
environmental	O
conditions	O
in	O
the	O
flea	S-Organism
digestive	O
tract	O
,	O
how	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
adapts	O
to	O
them	O
,	O
or	O
the	O
physiological	O
state	O
of	O
the	O
bacteria	O
at	O
transmission	O
when	O
they	O
exit	O
the	O
flea	S-Organism
and	O
enter	O
the	O
mammal	O
.	O

Adult	O
fleas	S-Organism
are	O
obligate	O
blood	O
feeders	O
and	O
take	O
frequent	O
blood	O
meals	O
,	O
consisting	O
primarily	O
of	O
protein	O
and	O
lipid	O
with	O
relatively	O
little	O
carbohydrate	O
.	O

Flea	S-Organism
proteases	O
,	O
lipases	O
,	O
and	O
other	O
digestive	O
enzymes	O
begin	O
to	O
process	O
the	O
blood	O
meal	O
in	O
the	O
midgut	O
immediately	O
after	O
feeding	O
,	O
yielding	O
amino	O
acids	O
and	O
peptides	O
,	O
glycerol	O
,	O
fatty	O
acids	O
,	O
and	O
simple	O
carbohydrates	O
[	O
12	O
]	O
.	O

This	O
provides	O
the	O
"	O
medium	O
"	O
for	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
growth	O
,	O
but	O
these	O
and	O
other	O
factors	O
such	O
as	O
pH	O
,	O
oxygen	O
tension	O
,	O
osmolarity	O
,	O
and	O
flea	S-Organism
antibacterial	O
immune	O
components	O
are	O
poorly	O
defined	O
.	O

During	O
the	O
first	O
week	O
after	O
being	O
ingested	O
in	O
an	O
infectious	O
blood	O
meal	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
grows	O
rapidly	O
in	O
the	O
flea	S-Organism
midgut	O
to	O
form	O
large	O
bacterial	O
aggregates	O
.	O

Bacterial	O
load	O
peaks	O
at	O
about	O
106	O
cells	O
per	O
flea	S-Organism
as	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
biofilm	O
accumulates	O
in	O
the	O
proventriculus	O
to	O
cause	O
blockage	O
,	O
and	O
then	O
plateaus	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
gene	O
expression	O
profile	O
in	O
infective	O
,	O
blocked	O
fleas	S-Organism
,	O
in	O
which	O
the	O
proventriculus	O
was	O
occluded	O
with	O
a	O
mature	O
bacterial	O
biofilm	O
.	O

Y	B-Organism
.	I-Organism
pestis	I-Organism
KIM6	I-Organism
+	E-Organism
,	O
which	O
lacks	O
the	O
70	O
-	O
kb	O
virulence	O
plasmid	O
that	O
is	O
not	O
required	O
for	O
flea	S-Organism
infection	O
or	O
blockage	O
[	O
3	O
]	O
was	O
used	O
for	O
this	O
analysis	O
.	O

Blockage	O
occurred	O
between	O
1	O
.	O
5	O
and	O
3	O
.	O
5	O
weeks	O
after	O
the	O
initial	O
infectious	O
blood	O
meal	O
,	O
during	O
which	O
time	O
the	O
fleas	S-Organism
fed	O
on	O
uninfected	O
mice	S-Organism
twice	O
weekly	O
.	O

The	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
vivo	O
biofilm	O
transcriptome	O
was	O
compared	O
to	O
the	O
transcriptomes	O
of	O
in	O
vitro	O
biofilm	O
and	O
planktonic	O
cultures	O
grown	O
at	O
21degreesC	O
,	O
the	O
same	O
temperature	O
at	O
which	O
the	O
fleas	S-Organism
were	O
maintained	O
.	O

Expression	O
of	O
55	O
%	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
ORFs	O
was	O
detected	O
in	O
the	O
flea	S-Organism
samples	O
;	O
and	O
74	O
to	O
79	O
%	O
in	O
the	O
in	O
vitro	O
biofilm	O
,	O
exponential	O
phase	O
planktonic	O
and	O
stationary	O
phase	O
planktonic	O
cultures	O
.	O

Principal	O
component	O
analysis	O
to	O
visualize	O
overall	O
clustering	O
of	O
the	O
microarray	O
data	O
showed	O
that	O
the	O
transcriptional	O
profiles	O
were	O
reproducible	O
and	O
discrete	O
for	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
conditions	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

Profiles	O
of	O
the	O
exponential	O
and	O
stationary	O
phase	O
planktonic	O
cultures	O
clustered	O
most	O
closely	O
,	O
whereas	O
the	O
profiles	O
from	O
in	O
vitro	O
and	O
in	O
vivo	O
biofilm	O
growth	O
were	O
more	O
distinct	O
from	O
each	O
other	O
and	O
from	O
the	O
planktonic	O
culture	O
profiles	O
.	O

There	O
were	O
214	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
genes	O
whose	O
expression	O
was	O
significantly	O
upregulated	O
and	O
56	O
genes	O
downregulated	O
in	O
the	O
flea	S-Organism
compared	O
to	O
all	O
in	O
vitro	O
growth	O
conditions	O
(	O
Fig	O
.	O
1B	O
;	O
Tables	O
S1	O
and	O
S2	O
)	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
analysis	O
of	O
a	O
subset	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
genes	O
differentially	O
expressed	O
in	O
the	O
flea	S-Organism
was	O
confirmatory	O
of	O
the	O
microarray	O
results	O
(	O
Fig	O
.	O
S2	O
)	O
.	O

Y	B-Organism
.	I-Organism
pestis	E-Organism
metabolic	O
adaptation	O
to	O
the	O
flea	S-Organism
gut	O
environment	O

Of	O
the	O
214	O
genes	O
upregulated	O
in	O
the	O
flea	S-Organism
gut	O
compared	O
to	O
all	O
in	O
vitro	O
conditions	O
,	O
78	O
are	O
metabolic	O
genes	O
,	O
60	O
of	O
which	O
are	O
involved	O
in	O
uptake	O
and	O
catabolism	O
of	O
amino	O
acids	O
and	O
carbohydrates	O
(	O
Table	O
S1	O
)	O
.	O

In	O
particular	O
,	O
genes	O
involved	O
in	O
transport	O
and	O
catabolism	O
of	O
the	O
L	O
-	O
glutamate	O
group	O
of	O
amino	O
acids	O
(	O
Gln	O
,	O
His	O
,	O
Arg	O
,	O
and	O
Pro	O
)	O
were	O
specifically	O
upregulated	O
in	O
the	O
flea	S-Organism
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
degradation	O
of	O
these	O
amino	O
acids	O
gives	O
rise	O
to	O
L	O
-	O
glutamate	O
and	O
the	O
TCA	O
cycle	O
intermediates	O
succinate	O
,	O
formate	O
,	O
and	O
alpha	O
-	O
ketoglutarate	O
.	O

The	O
gabD	O
and	O
gabT	O
genes	O
involved	O
in	O
the	O
production	O
of	O
succinate	O
from	O
gamma	O
-	O
aminobutyrate	O
(	O
GABA	O
)	O
,	O
another	O
member	O
of	O
the	O
L	O
-	O
glutamate	O
group	O
,	O
were	O
also	O
highly	O
induced	O
in	O
the	O
flea	S-Organism
.	O

The	O
gabD	O
gene	O
functions	O
to	O
produce	O
succinate	O
from	O
both	O
GABA	O
and	O
hydroxyphenylacetate	O
(	O
HPA	O
)	O
,	O
an	O
aromatic	O
degradation	O
product	O
of	O
Tyr	O
and	O
Phe	O
;	O
and	O
the	O
HPA	O
transport	O
(	O
hpaX	O
)	O
and	O
catabolism	O
(	O
hpaCBIFHDE	O
)	O
genes	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
were	O
also	O
highly	O
upregulated	O
in	O
the	O
flea	S-Organism
gut	O
(	O
Table	O
S1	O
,	O
Fig	O
.	O
2	O
)	O
.	O

As	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
does	O
not	O
have	O
homologs	O
of	O
genes	O
required	O
to	O
produce	O
GABA	O
or	O
HPA	O
,	O
these	O
metabolites	O
may	O
be	O
taken	O
up	O
from	O
the	O
flea	S-Organism
digestive	O
tract	O
.	O

Alternatively	O
,	O
the	O
gabD	O
and	O
gabT	O
gene	O
products	O
might	O
act	O
in	O
the	O
reverse	O
direction	O
to	O
synthesize	O
GABA	O
,	O
which	O
has	O
osmoprotective	O
properties	O
[	O
13	O
]	O
.	O

The	O
central	O
role	O
of	O
the	O
L	O
-	O
glutamate	O
family	O
of	O
amino	O
acids	O
may	O
also	O
confer	O
this	O
advantage	O
in	O
the	O
flea	S-Organism
gut	O
,	O
because	O
Glu	O
and	O
Pro	O
are	O
osmoprotectants	O
.	O

Interestingly	O
,	O
both	O
glutamate	O
and	O
GABA	O
are	O
important	O
neurotransmitters	O
at	O
the	O
neuromuscular	O
junction	O
of	O
insects	O
,	O
and	O
the	O
concentration	O
of	O
glutamate	O
is	O
very	O
low	O
in	O
insect	O
hemolymph	O
,	O
suggesting	O
that	O
it	O
is	O
converted	O
to	O
glutamine	O
before	O
it	O
is	O
absorbed	O
[	O
14	O
]	O
.	O

Insect	O
midgut	O
epithelium	O
is	O
typified	O
by	O
multiple	O
amino	O
acid	O
transporters	O
with	O
specific	O
substrates	O
and	O
rapid	O
absorption	O
kinetics	O
,	O
but	O
different	O
amino	O
acids	O
enter	O
the	O
hemocoel	O
at	O
different	O
rates	O
and	O
amounts	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

Thus	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
metabolism	O
in	O
the	O
flea	S-Organism
may	O
reflect	O
the	O
available	O
pool	O
of	O
amino	O
acids	O
in	O
the	O
midgut	O
.	O

In	O
contrast	O
to	O
the	O
amino	O
acids	O
,	O
hexoses	O
do	O
not	O
appear	O
to	O
be	O
an	O
important	O
energy	O
source	O
during	O
infection	O
of	O
the	O
flea	S-Organism
.	O

Only	O
the	O
genes	O
encoding	O
for	O
chitobiose	O
phosphotransferase	O
(	O
PTS	O
)	O
uptake	O
and	O
utilization	O
systems	O
(	O
chbBC	O
;	O
chbF	O
)	O
,	O
and	O
for	O
a	O
PTS	O
system	O
of	O
unknown	O
specificity	O
(	O
frwBCD	O
)	O
were	O
significantly	O
upregulated	O
in	O
the	O
flea	S-Organism
[	O
16	O
]	O
,	O
[	O
17	O
]	O
.	O

Chitobiose	O
could	O
be	O
present	O
in	O
the	O
flea	S-Organism
gut	O
due	O
to	O
turnover	O
of	O
the	O
chitin	O
layer	O
on	O
the	O
proventricular	O
spines	O
.	O

Expression	O
of	O
the	O
glucose	O
PTS	O
system	O
was	O
only	O
slightly	O
increased	O
relative	O
to	O
LB	O
cultures	O
,	O
and	O
other	O
PTS	O
systems	O
were	O
downregulated	O
(	O
Table	O
S2	O
)	O
.	O

Glycolytic	O
pathways	O
were	O
not	O
upregulated	O
in	O
the	O
flea	S-Organism
;	O
instead	O
,	O
available	O
hexoses	O
and	O
the	O
gluconeogenesis	O
pathway	O
may	O
be	O
used	O
to	O
synthesize	O
polysaccharide	O
components	O
required	O
for	O
cell	O
growth	O
.	O

Upregulation	O
of	O
the	O
actP	O
and	O
acs	O
genes	O
in	O
the	O
flea	S-Organism
,	O
which	O
direct	O
the	O
uptake	O
of	O
acetate	O
and	O
its	O
conversion	O
to	O
acetyl	O
-	O
CoA	O
,	O
also	O
suggests	O
that	O
insufficient	O
acetyl	O
-	O
CoA	O
is	O
produced	O
by	O
glycolysis	O
to	O
potentiate	O
the	O
TCA	O
cycle	O
.	O

The	O
switch	O
from	O
acetate	O
secretion	O
to	O
acetate	O
uptake	O
is	O
typical	O
of	O
growth	O
in	O
a	O
glucose	O
-	O
limited	O
,	O
amino	O
acid	O
rich	O
environment	O
[	O
18	O
]	O
.	O

In	O
contrast	O
to	O
hexose	O
uptake	O
systems	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
genes	O
that	O
encode	O
permeases	O
for	O
the	O
pentoses	O
ribose	O
,	O
xylose	O
,	O
and	O
arabinose	O
were	O
induced	O
in	O
the	O
flea	S-Organism
gut	O
.	O

Acquisition	O
of	O
pentoses	O
from	O
the	O
environment	O
may	O
be	O
important	O
because	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
does	O
not	O
possess	O
glucose	O
6	O
-	O
phosphate	O
dehydrogenase	O
activity	O
,	O
the	O
first	O
step	O
of	O
the	O
pentose	O
phosphate	O
pathway	O
[	O
19	O
]	O
.	O

Although	O
the	O
flea	S-Organism
gut	O
contains	O
lipid	O
derived	O
from	O
the	O
blood	O
meal	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
does	O
not	O
appear	O
to	O
use	O
it	O
as	O
a	O
major	O
energy	O
source	O
.	O

None	O
of	O
the	O
fatty	O
acid	O
uptake	O
or	O
catabolism	O
genes	O
were	O
upregulated	O
in	O
the	O
flea	S-Organism
compared	O
to	O
growth	O
in	O
LB	O
.	O

However	O
,	O
genes	O
for	O
glycerol	O
and	O
glycerol	O
-	O
3	O
-	O
phosphate	O
uptake	O
and	O
utilization	O
were	O
upregulated	O
,	O
suggesting	O
that	O
flea	S-Organism
digestion	O
products	O
derived	O
from	O
blood	O
glycerolipids	O
may	O
be	O
used	O
by	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
.	O

In	O
summary	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
appears	O
to	O
use	O
amino	O
acids	O
,	O
particularly	O
the	O
L	O
-	O
glutamate	O
family	O
,	O
as	O
primary	O
carbon	O
,	O
nitrogen	O
,	O
and	O
energy	O
sources	O
in	O
the	O
flea	S-Organism
.	O

Amino	O
acid	O
carbon	O
is	O
presumably	O
funneled	O
into	O
the	O
TCA	O
cycle	O
,	O
the	O
genes	O
for	O
which	O
are	O
highly	O
expressed	O
in	O
the	O
flea	S-Organism
(	O
Table	O
S3	O
)	O
.	O

Y	B-Organism
.	I-Organism
pestis	E-Organism
genes	O
involved	O
in	O
infection	O
and	O
biofilm	O
formation	O
in	O
the	O
flea	S-Organism

Because	O
blockage	O
of	O
the	O
flea	S-Organism
vector	O
is	O
essentially	O
a	O
biofilm	O
phenomenon	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
genes	O
whose	O
expression	O
patterns	O
are	O
significantly	O
upregulated	O
in	O
the	O
flea	S-Organism
and	O
flowcell	O
biofilms	O
relative	O
to	O
planktonic	O
cultures	O
(	O
Table	O
S4	O
)	O
might	O
indicate	O
that	O
they	O
are	O
transmission	O
factors	O
.	O

Several	O
studies	O
comparing	O
the	O
transcriptional	O
profiles	O
of	O
Escherichia	B-Organism
coli	E-Organism
and	O
other	O
gram	O
negative	O
bacteria	O
during	O
biofilm	O
and	O
planktonic	O
growth	O
in	O
vitro	O
have	O
been	O
published	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

Certain	O
genes	O
whose	O
mutational	O
loss	O
resulted	O
in	O
an	O
altered	O
biofilm	O
phenotype	O
have	O
been	O
identified	O
in	O
these	O
studies	O
;	O
but	O
in	O
general	O
a	O
consistent	O
,	O
distinct	O
biofilm	O
gene	O
expression	O
profile	O
has	O
not	O
emerged	O
.	O

This	O
is	O
probably	O
because	O
different	O
media	O
and	O
experimental	O
systems	O
have	O
been	O
employed	O
and	O
the	O
fact	O
that	O
a	O
biofilm	O
consists	O
of	O
a	O
physiologically	O
heterogeneous	O
community	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
.	O

Nevertheless	O
,	O
common	O
biofilm	O
-	O
related	O
adaptations	O
include	O
the	O
repression	O
of	O
motility	O
and	O
the	O
induction	O
of	O
specific	O
adhesins	O
,	O
an	O
extracellular	O
polysaccharide	O
matrix	O
(	O
ECM	O
)	O
,	O
and	O
an	O
envelope	O
stress	O
response	O
(	O
ESR	O
)	O
[	O
10	O
]	O
,	O
[	O
23	O
]	O
.	O

However	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
is	O
constitutively	O
nonmotile	O
,	O
and	O
synthesis	O
of	O
the	O
Hms	O
-	O
dependent	O
biofilm	O
ECM	O
is	O
regulated	O
post	O
-	O
translationally	O
[	O
26	O
]	O
.	O

The	O
ymt	O
gene	O
was	O
among	O
the	O
most	O
highly	O
expressed	O
genes	O
in	O
the	O
flea	S-Organism
(	O
Table	O
S3	O
)	O
,	O
but	O
neither	O
it	O
nor	O
the	O
known	O
transmission	O
factors	O
(	O
hmsHFRS	O
,	O
hmsT	O
,	O
hmsP	O
,	O
and	O
gmhA	O
)	O
showed	O
significantly	O
higher	O
expression	O
in	O
the	O
flea	S-Organism
than	O
in	O
vitro	O
at	O
21degreesC	O
,	O
indicating	O
that	O
they	O
are	O
induced	O
primarily	O
by	O
low	O
temperature	O
,	O
and	O
not	O
by	O
environmental	O
factors	O
specific	O
to	O
the	O
flea	S-Organism
gut	O
.	O

Y	B-Organism
.	I-Organism
pestis	E-Organism
homologs	O
of	O
two	O
genes	O
with	O
previously	O
identified	O
roles	O
in	O
biofilm	O
,	O
yidE	O
,	O
which	O
encodes	O
a	O
hyperadherence	O
factor	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
[	O
27	O
]	O
,	O
and	O
cpxP	O
,	O
a	O
member	O
of	O
the	O
cpxPAR	O
ESR	O
system	O
,	O
were	O
upregulated	O
in	O
the	O
flowcell	O
;	O
but	O
predicted	O
adhesin	O
genes	O
were	O
not	O
upregulated	O
.	O

The	O
transcriptional	O
profile	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
blocked	O
fleas	S-Organism
showed	O
greater	O
similarity	O
to	O
the	O
transcriptional	O
profile	O
reported	O
for	O
E	B-Organism
.	I-Organism
coli	E-Organism
in	O
mature	O
,	O
four	O
-	O
day	O
-	O
old	O
in	O
vitro	O
biofilms	O
[	O
23	O
]	O
.	O

In	O
addition	O
to	O
yidE	O
and	O
cpxP	O
,	O
other	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
predicted	O
adhesins	O
and	O
components	O
of	O
an	O
ESR	O
were	O
upregulated	O
in	O
the	O
flea	S-Organism
.	O

The	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
homologs	O
of	O
Pseudomonas	B-Organism
aeruginosa	E-Organism
cupA1	O
and	O
cupA3	O
in	O
a	O
predicted	O
fimbrial	O
biosynthesis	O
operon	O
and	O
yapL	O
,	O
a	O
predicted	O
autotransporter	O
adhesin	O
similar	O
to	O
E	B-Organism
.	I-Organism
coli	E-Organism
tibA	O
,	O
were	O
specifically	O
upregulated	O
in	O
the	O
flea	S-Organism
(	O
Table	O
S1	O
)	O
.	O

The	O
cupA	O
fimbrial	O
locus	O
and	O
tibA	O
are	O
important	O
for	O
surface	O
adherence	O
and	O
for	O
biofilm	O
formation	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	E-Organism
and	O
E	B-Organism
.	I-Organism
coli	E-Organism
,	O
respectively	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

Evidence	O
for	O
induction	O
of	O
an	O
ESR	O
in	O
the	O
flea	S-Organism
included	O
the	O
high	O
expression	O
levels	O
of	O
rpoE	O
,	O
the	O
gene	O
for	O
the	O
alternate	O
transcription	O
factor	O
sigmaE	O
(	O
as	O
well	O
as	O
the	O
anti	O
-	O
sigmaE	O
negative	O
regulator	O
genes	O
rseA	O
and	O
rseB	O
)	O
,	O
cpxP	O
;	O
and	O
pspA	O
and	O
pspG	O
,	O
components	O
of	O
the	O
phage	O
-	O
shock	O
protein	O
(	O
Psp	O
)	O
response	O
(	O
Tables	O
S1	O
and	O
S3	O
)	O
.	O

These	O
genes	O
were	O
also	O
found	O
to	O
be	O
upregulated	O
in	O
mature	O
E	B-Organism
.	I-Organism
coli	E-Organism
biofilms	O
[	O
23	O
]	O
,	O
suggesting	O
that	O
the	O
three	O
prominent	O
ESR	O
systems	O
are	O
important	O
for	O
integrating	O
signals	O
required	O
for	O
survival	O
in	O
a	O
biofilm	O
.	O

Because	O
homologs	O
of	O
the	O
yidE	O
,	O
cpxP	O
,	O
tibA	O
(	O
yapL	O
)	O
,	O
cupA	O
fimbriae	O
,	O
and	O
pspABC	O
genes	O
were	O
upregulated	O
in	O
the	O
flea	S-Organism
and	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
biofilm	O
formation	O
in	O
other	O
bacteria	O
[	O
23	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
we	O
made	O
a	O
series	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
strains	O
containing	O
deletions	O
of	O
these	O
loci	O
.	O

However	O
,	O
the	O
single	O
loss	O
of	O
any	O
of	O
these	O
genes	O
did	O
not	O
result	O
in	O
a	O
noticeable	O
defect	O
in	O
biofilm	O
formation	O
in	O
vitro	O
,	O
or	O
in	O
flea	S-Organism
infection	O
or	O
blockage	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
genes	O
may	O
contribute	O
to	O
biofilm	O
formation	O
,	O
but	O
are	O
not	O
individually	O
essential	O
for	O
this	O
phenotype	O
.	O

Although	O
genes	O
in	O
the	O
polyamine	O
transport	O
gabTpotDBC	O
locus	O
are	O
among	O
the	O
most	O
highly	O
induced	O
genes	O
in	O
the	O
flea	S-Organism
(	O
Table	O
S1	O
)	O
and	O
polyamines	O
are	O
essential	O
for	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
biofilm	O
formation	O
[	O
30	O
]	O
,	O
we	O
have	O
previously	O
reported	O
that	O
a	O
Y	B-Organism
.	I-Organism
pestis	I-Organism
Deltapot	E-Organism
mutant	O
has	O
no	O
defect	O
in	O
flea	S-Organism
infection	O
or	O
blockage	O
[	O
31	O
]	O
.	O

This	O
is	O
likely	O
due	O
to	O
the	O
fact	O
that	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
is	O
able	O
to	O
synthesize	O
polyamines	O
de	O
novo	O
.	O

Differential	O
gene	O
expression	O
during	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
life	O
cycle	O

With	O
this	O
study	O
,	O
the	O
in	O
vivo	O
transcriptome	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
blocked	O
fleas	S-Organism
and	O
in	O
the	O
rat	S-Organism
bubo	O
[	O
11	O
]	O
have	O
now	O
both	O
been	O
characterized	O
.	O

A	O
comparison	O
of	O
normalized	O
gene	O
expression	O
levels	O
from	O
the	O
two	O
data	O
sets	O
provides	O
insight	O
into	O
the	O
biology	O
of	O
the	O
flea	S-Organism
-	O
mammal	O
life	O
cycle	O
.	O

About	O
15	O
%	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
genes	O
showed	O
significantly	O
higher	O
relative	O
expression	O
levels	O
or	O
expression	O
only	O
in	O
the	O
flea	S-Organism
than	O
in	O
the	O
bubo	O
;	O
24	O
%	O
were	O
more	O
highly	O
expressed	O
in	O
the	O
bubo	O
than	O
in	O
the	O
flea	S-Organism
;	O
and	O
61	O
%	O
were	O
not	O
differentially	O
expressed	O
in	O
the	O
two	O
hosts	S-Organism
(	O
Fig	O
.	O
3	O
)	O
.	O

Several	O
virulence	O
factors	O
were	O
differentially	O
regulated	O
in	O
the	O
two	O
hosts	S-Organism
,	O
but	O
others	O
were	O
not	O
(	O
Table	O
1	O
)	O
.	O

In	O
addition	O
to	O
the	O
known	O
temperature	O
-	O
induced	O
virulence	O
factors	O
,	O
iron	O
acquisition	O
systems	O
,	O
including	O
the	O
ybt	O
and	O
yfe	O
operons	O
that	O
are	O
required	O
for	O
virulence	O
;	O
and	O
oxidative	O
and	O
nitrosative	O
stress	O
response	O
genes	O
,	O
including	O
the	O
hmp	O
virulence	O
factor	O
,	O
are	O
highly	O
upregulated	O
in	O
the	O
rat	S-Organism
bubo	O
,	O
but	O
not	O
the	O
flea	S-Organism
.	O

The	O
analysis	O
also	O
reinforces	O
the	O
model	O
that	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
produces	O
a	O
hexaacylated	O
lipid	O
A	O
in	O
the	O
flea	S-Organism
,	O
and	O
that	O
the	O
change	O
to	O
the	O
less	O
immunostimulatory	O
tetraacylated	O
form	O
occurs	O
only	O
after	O
transmission	O
[	O
32	O
]	O
.	O

Other	O
virulence	O
and	O
transmission	O
factors	O
were	O
not	O
differentially	O
regulated	O
,	O
including	O
the	O
hms	O
genes	O
;	O
and	O
the	O
Y	O
.	O
pestis	O
plasminogen	O
activator	O
(	O
pla	O
)	O
,	O
critical	O
for	O
dissemination	O
from	O
extravascular	O
tissue	O
at	O
the	O
fleabite	O
site	O
[	O
33	O
]	O
,	O
and	O
ymt	O
were	O
highly	O
expressed	O
in	O
both	O
hosts	S-Organism
(	O
Table	O
S3	O
and	O
[	O
11	O
]	O
)	O
.	O

The	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
outer	O
surface	O
protein	O
gene	O
yadB	O
,	O
recently	O
shown	O
to	O
be	O
required	O
for	O
dissemination	O
and	O
bubonic	O
plague	O
pathogenesis	O
from	O
a	O
subcutaneous	O
inoculation	O
site	O
[	O
34	O
]	O
,	O
was	O
significantly	O
upregulated	O
in	O
both	O
the	O
flea	S-Organism
and	O
the	O
bubo	O
compared	O
to	O
in	O
vitro	O
conditions	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

Expression	O
of	O
genes	O
in	O
the	O
pH	O
6	O
antigen	O
locus	O
(	O
psaEFABC	O
)	O
,	O
responsible	O
for	O
the	O
synthesis	O
and	O
transport	O
of	O
the	O
PsaA	O
fimbriae	O
that	O
enhance	O
resistance	O
to	O
phagocytosis	O
by	O
macrophages	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
were	O
higher	O
in	O
the	O
bubo	O
than	O
the	O
flea	S-Organism
,	O
although	O
the	O
usher	O
protein	O
gene	O
psaC	O
was	O
upregulated	O
in	O
the	O
flea	S-Organism
compared	O
to	O
in	O
vitro	O
growth	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

The	O
psa	O
locus	O
is	O
regulated	O
by	O
RovA	O
[	O
36	O
]	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
rovA	O
expression	O
was	O
downregulated	O
in	O
the	O
flea	S-Organism
;	O
whereas	O
expression	O
of	O
rovM	O
,	O
a	O
negative	O
regulator	O
of	O
rovA	O
[	O
37	O
]	O
,	O
was	O
upregulated	O
.	O

The	O
transcriptional	O
regulator	O
gene	O
phoP	O
of	O
the	O
PhoPQ	O
two	O
-	O
component	O
regulatory	O
system	O
and	O
the	O
PhoP	O
-	O
regulated	O
mgtC	O
gene	O
were	O
expressed	O
at	O
levels	O
>	O
2	O
-	O
fold	O
higher	O
in	O
fleas	S-Organism
than	O
in	O
any	O
other	O
condition	O
(	O
Tables	O
1	O
,	O
S1	O
,	O
S3	O
)	O
.	O

PhoP	O
and	O
MgtC	O
are	O
established	O
virulence	O
factors	O
known	O
to	O
be	O
important	O
for	O
survival	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
and	O
other	O
gram	O
-	O
negative	O
bacteria	O
in	O
macrophages	O
and	O
for	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAMPs	O
)	O
of	O
the	O
mammalian	O
innate	O
immune	O
response	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

The	O
PhoPQ	O
system	O
is	O
induced	O
in	O
low	O
Mg2	O
+	O
or	O
low	O
pH	O
environments	O
,	O
or	O
by	O
exposure	O
to	O
CAMPs	O
[	O
41	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

The	O
Mg2	O
+	O
concentration	O
and	O
pH	O
of	O
the	O
flea	S-Organism
digestive	O
tract	O
have	O
not	O
been	O
defined	O
,	O
so	O
the	O
inducing	O
stimulus	O
is	O
unknown	O
,	O
but	O
CAMPs	O
are	O
induced	O
and	O
secreted	O
into	O
the	O
gut	O
by	O
blood	O
feeding	O
insects	O
when	O
they	O
take	O
a	O
blood	O
meal	O
containing	O
bacteria	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
.	O

X	B-Organism
.	I-Organism
cheopis	I-Organism
fleas	E-Organism
encode	O
homologs	O
of	O
the	O
insect	O
CAMPs	O
cecropin	O
and	O
defensin	O
,	O
and	O
mount	O
an	O
inducible	O
antibacterial	O
response	O
to	O
infection	O
(	O
unpublished	O
data	O
)	O
.	O

Thus	O
,	O
the	O
PhoPQ	O
regulatory	O
system	O
may	O
be	O
induced	O
by	O
the	O
flea	S-Organism
'	O
s	O
immune	O
system	O
in	O
response	O
to	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
the	O
midgut	O
.	O

Despite	O
the	O
upregulation	O
of	O
phoP	O
in	O
the	O
flea	S-Organism
,	O
with	O
the	O
notable	O
exception	O
of	O
mgtC	O
there	O
was	O
little	O
correlation	O
between	O
predicted	O
PhoP	O
-	O
regulated	O
genes	O
in	O
vitro	O
and	O
genes	O
upregulated	O
in	O
the	O
flea	S-Organism
[	O
39	O
]	O
,	O
[	O
46	O
]	O
,	O
[	O
47	O
]	O
.	O

Differential	O
regulation	O
of	O
members	O
of	O
the	O
PhoP	O
regulon	O
may	O
occur	O
depending	O
on	O
the	O
inducing	O
stimulus	O
,	O
however	O
[	O
48	O
]	O
.	O

Induction	O
of	O
a	O
phagocytosis	O
-	O
resistant	O
phenotype	O
in	O
the	O
flea	S-Organism

Soon	O
after	O
transmission	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
would	O
be	O
expected	O
to	O
encounter	O
rapidly	O
-	O
responding	O
phagocytic	O
cells	O
in	O
the	O
dermis	O
.	O

To	O
assess	O
the	O
overall	O
effect	O
of	O
the	O
flea	S-Organism
-	O
specific	O
phenotype	O
on	O
this	O
encounter	O
,	O
we	O
compared	O
the	O
interaction	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
recovered	O
from	O
infected	O
fleas	S-Organism
and	O
from	O
in	O
vitro	O
cultures	O
with	O
murine	S-Organism
bone	O
marrow	O
macrophages	O
.	O

Bacteria	O
from	O
fleas	S-Organism
showed	O
significantly	O
lower	O
levels	O
of	O
phagocytosis	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

We	O
have	O
previously	O
reported	O
analogous	O
findings	O
using	O
human	S-Organism
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
[	O
7	O
]	O
.	O

The	O
yit	O
and	O
yip	O
genes	O
in	O
a	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
locus	O
(	O
y0181	O
-	O
0191	O
)	O
that	O
encode	O
predicted	O
insecticidal	O
-	O
like	O
toxins	O
of	O
the	O
toxin	O
complex	O
(	O
Tc	O
)	O
family	O
and	O
three	O
linked	O
phage	O
-	O
related	O
genes	O
were	O
upregulated	O
4	O
-	O
to	O
50	O
-	O
fold	O
in	O
the	O
flea	S-Organism
midgut	O
(	O
Tables	O
1	O
and	O
S1	O
)	O
.	O

We	O
previously	O
reported	O
that	O
the	O
genes	O
for	O
these	O
Tc	O
-	O
like	O
proteins	O
are	O
highly	O
expressed	O
in	O
fleas	S-Organism
,	O
but	O
that	O
their	O
products	O
are	O
nontoxic	O
to	O
fleas	S-Organism
[	O
49	O
]	O
.	O

yitR	O
,	O
a	O
LysR	O
-	O
type	O
regulator	O
that	O
activates	O
the	O
Tc	O
-	O
like	O
yit	O
genes	O
[	O
50	O
]	O
,	O
was	O
upregulated	O
>	O
10	O
-	O
fold	O
in	O
the	O
flea	S-Organism
,	O
but	O
its	O
expression	O
was	O
not	O
detected	O
in	O
the	O
rat	S-Organism
bubo	O
(	O
Table	O
1	O
)	O
.	O

The	O
specific	O
induction	O
in	O
the	O
flea	S-Organism
of	O
yitR	O
and	O
genes	O
in	O
the	O
adjacent	O
Tc	O
-	O
like	O
yit	O
and	O
yip	O
loci	O
suggests	O
that	O
they	O
are	O
involved	O
in	O
adaptation	O
to	O
and	O
colonization	O
of	O
the	O
flea	S-Organism
.	O

However	O
,	O
deletion	O
of	O
yitR	O
or	O
yitA	O
-	O
yipB	O
(	O
y0183	O
-	O
y0191	O
)	O
does	O
not	O
affect	O
the	O
ability	O
of	O
Y	B-Organism
.	I-Organism
pestis	I-Organism
KIM6	I-Organism
+	E-Organism
to	O
infect	O
or	O
block	O
fleas	S-Organism
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
observations	O
,	O
and	O
the	O
fact	O
that	O
the	O
Yersinia	O
Tc	O
proteins	O
have	O
toxicity	O
to	O
certain	O
eukaryotic	O
cell	O
lines	O
in	O
vitro	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
prompted	O
us	O
to	O
investigate	O
a	O
possible	O
post	O
-	O
transmission	O
antiphagocytic	O
role	O
for	O
these	O
proteins	O
in	O
the	O
mammalian	O
host	S-Organism
.	O

To	O
determine	O
if	O
the	O
insecticidal	O
-	O
like	O
toxins	O
were	O
involved	O
in	O
resistance	O
to	O
phagocytosis	O
,	O
we	O
repeated	O
the	O
macrophage	O
experiments	O
with	O
a	O
Y	B-Organism
.	I-Organism
pestis	I-Organism
DeltayitR	E-Organism
mutant	O
,	O
which	O
as	O
expected	O
showed	O
greatly	O
reduced	O
expression	O
of	O
the	O
yit	O
and	O
yip	O
genes	O
in	O
vitro	O
and	O
in	O
the	O
flea	S-Organism
(	O
Fig	O
.	O
4B	O
)	O
.	O

Loss	O
of	O
yitR	O
significantly	O
reduced	O
the	O
increased	O
resistance	O
to	O
phagocytosis	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
isolated	O
from	O
infected	O
fleas	S-Organism
(	O
Fig	O
.	O
4C	O
)	O
.	O

Since	O
the	O
yit	O
and	O
yip	O
genes	O
are	O
not	O
required	O
for	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
fleas	S-Organism
,	O
it	O
was	O
possible	O
to	O
compare	O
the	O
virulence	O
of	O
wild	O
-	O
type	O
and	O
DeltayitR	B-Organism
Y	I-Organism
.	I-Organism
pestis	E-Organism
following	O
transmission	O
by	O
fleabite	O
.	O

The	O
incidence	O
rate	O
and	O
time	O
to	O
disease	O
onset	O
were	O
identical	O
for	O
both	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
strains	O
,	O
demonstrating	O
that	O
expression	O
of	O
yit	O
and	O
yip	O
is	O
not	O
essential	O
for	O
flea	S-Organism
-	O
borne	O
transmission	O
or	O
disease	O
(	O
data	O
not	O
shown	O
)	O
.	O

On	O
average	O
,	O
the	O
mice	S-Organism
challenged	O
with	O
Y	B-Organism
.	I-Organism
pestis	I-Organism
DeltayitR	I-Organism
-	I-Organism
infected	I-Organism
fleas	E-Organism
,	O
both	O
those	O
that	O
developed	O
disease	O
and	O
those	O
that	O
did	O
not	O
,	O
received	O
a	O
higher	O
cumulative	O
number	O
of	O
bites	O
from	O
blocked	O
fleas	S-Organism
than	O
the	O
mice	S-Organism
challenged	O
with	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
-	O
infected	O
fleas	S-Organism
,	O
but	O
this	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
Fig	O
.	O
5	O
)	O
.	O

However	O
,	O
it	O
was	O
not	O
possible	O
to	O
detect	O
any	O
relatively	O
minor	O
difference	O
in	O
LD50	O
because	O
the	O
number	O
of	O
bacteria	O
transmitted	O
by	O
a	O
blocked	O
flea	S-Organism
varies	O
widely	O
[	O
1	O
]	O
,	O
[	O
52	O
]	O
.	O

Even	O
a	O
small	O
decrease	O
in	O
LD50	O
provided	O
by	O
the	O
Yit	O
-	O
Yip	O
proteins	O
would	O
be	O
significant	O
at	O
the	O
ecological	O
level	O
in	O
the	O
maintenance	O
of	O
plague	O
transmission	O
cycles	O
,	O
because	O
the	O
transmission	O
efficiency	O
of	O
blocked	O
fleas	S-Organism
is	O
very	O
low	O
-	O
often	O
only	O
a	O
few	O
or	O
no	O
bacterial	O
cells	O
are	O
transmitted	O
in	O
an	O
individual	O
fleabite	O
[	O
52	O
]	O
.	O

Because	O
phoP	O
is	O
required	O
by	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
fleas	S-Organism
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
not	O
possible	O
to	O
similarly	O
assess	O
the	O
effect	O
on	O
disease	O
transmission	O
of	O
phoP	O
induction	O
in	O
the	O
flea	S-Organism
.	O

Does	O
transit	O
through	O
the	O
flea	S-Organism
vector	O
preadapt	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
to	O
resist	O
mammalian	O
innate	O
immunity	O
?	O

When	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
is	O
transmitted	O
into	O
the	O
dermis	O
by	O
an	O
infected	O
flea	S-Organism
,	O
it	O
is	O
immediately	O
exposed	O
to	O
the	O
mammalian	O
innate	O
immune	O
system	O
.	O

The	O
most	O
important	O
antiphagocytic	O
virulence	O
factors	O
,	O
the	O
cytotoxic	O
Yersinia	O
outer	O
proteins	O
(	O
Yops	O
)	O
,	O
part	O
of	O
the	O
T3SS	O
encoded	O
by	O
the	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
virulence	O
plasmid	O
and	O
the	O
F1	O
capsule	O
encoded	O
by	O
the	O
pMT1	O
plasmid	O
,	O
are	O
not	O
present	O
at	O
this	O
initial	O
stage	O
of	O
infection	O
.	O

Their	O
expression	O
is	O
strictly	O
temperature	O
-	O
regulated	O
and	O
are	O
not	O
produced	O
in	O
vivo	O
until	O
3	O
-	O
5	O
hours	O
after	O
the	O
temperature	O
shift	O
to	O
37degreesC	O
that	O
accompanies	O
transmission	O
[	O
1	O
]	O
,	O
[	O
3	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O

Consequently	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
grown	O
at	O
<	O
28degreesC	O
in	O
vitro	O
are	O
initially	O
susceptible	O
to	O
in	O
vivo	O
uptake	O
and	O
killing	O
by	O
phagocytes	O
until	O
the	O
Yop	O
and	O
F1	O
virulence	O
factors	O
are	O
produced	O
,	O
effectively	O
preventing	O
further	O
phagocytosis	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O

Our	O
results	O
indicate	O
that	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
entering	O
the	O
mammal	O
from	O
an	O
infective	O
flea	S-Organism
is	O
relatively	O
resistant	O
to	O
macrophages	O
,	O
as	O
well	O
as	O
PMNs	O
[	O
7	O
]	O
;	O
a	O
vector	O
-	O
specific	O
phenotype	O
that	O
is	O
not	O
related	O
to	O
the	O
T3SS	O
or	O
capsule	O
.	O

Coming	O
from	O
the	O
flea	S-Organism
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
is	O
also	O
associated	O
with	O
the	O
biofilm	O
ECM	O
,	O
identical	O
or	O
closely	O
related	O
to	O
the	O
poly	O
-	O
beta	O
-	O
1	O
,	O
6	O
-	O
N	O
-	O
acetyl	O
glucosamine	O
ECM	O
of	O
staphylococcal	S-Organism
biofilms	O
,	O
which	O
has	O
been	O
shown	O
to	O
provide	O
protection	O
from	O
innate	O
immune	O
components	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

In	O
addition	O
,	O
although	O
the	O
antiphagocytic	O
F1	O
capsule	O
and	O
Psa	O
fimbriae	O
do	O
not	O
appear	O
to	O
be	O
produced	O
in	O
the	O
flea	S-Organism
,	O
upregulation	O
in	O
the	O
flea	S-Organism
of	O
most	O
F1	O
genes	O
in	O
the	O
cafRcaf1M1A1	O
locus	O
and	O
the	O
Psa	O
usher	O
protein	O
gene	O
psaC	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
suggests	O
that	O
components	O
of	O
the	O
F1	O
and	O
Psa	O
translocation	O
system	O
are	O
made	O
,	O
which	O
may	O
prime	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
for	O
rapid	O
secretion	O
of	O
these	O
extracellular	O
virulence	O
factors	O
after	O
transmission	O
.	O

The	O
upregulation	O
of	O
the	O
innate	O
immunity	O
resistance	O
genes	O
phoP	O
and	O
mgtC	O
suggest	O
that	O
those	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
that	O
are	O
phagocytized	O
may	O
be	O
prepared	O
for	O
resistance	O
to	O
CAMPs	O
and	O
intracellular	O
survival	O
while	O
still	O
in	O
the	O
flea	S-Organism
vector	O
.	O

Finally	O
,	O
the	O
major	O
essential	O
virulence	O
factors	O
yadBC	O
and	O
pla	O
,	O
essential	O
for	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
dissemination	O
from	O
the	O
dermis	O
,	O
were	O
maximally	O
or	O
very	O
highly	O
expressed	O
in	O
the	O
flea	S-Organism
(	O
Tables	O
1	O
,	O
S3	O
)	O
.	O

Besides	O
degrading	O
plasminogen	O
,	O
the	O
Pla	O
protease	O
may	O
also	O
inactivate	O
CAMPs	O
,	O
particularly	O
when	O
the	O
F1	O
capsule	O
is	O
not	O
present	O
[	O
57	O
]	O
,	O
which	O
matches	O
the	O
phenotype	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
in	O
the	O
flea	S-Organism
.	O

In	O
summary	O
,	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
appears	O
to	O
be	O
prepared	O
for	O
pathogenesis	O
in	O
the	O
mammal	O
while	O
still	O
in	O
the	O
flea	S-Organism
vector	O
.	O

The	O
biofilm	O
phenotype	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
and	O
the	O
virulence	O
factors	O
upregulated	O
or	O
highly	O
expressed	O
in	O
the	O
flea	S-Organism
may	O
enhance	O
the	O
earliest	O
stages	O
of	O
plague	O
pathogenesis	O
while	O
the	O
full	O
complement	O
of	O
temperature	O
-	O
shift	O
-	O
regulated	O
virulence	O
factors	O
is	O
still	O
being	O
induced	O
.	O

Increased	O
resistance	O
to	O
innate	O
immunity	O
that	O
is	O
preinduced	O
in	O
the	O
flea	S-Organism
vector	O
may	O
be	O
critical	O
to	O
productive	O
transmission	O
because	O
blocked	O
fleas	S-Organism
transmit	O
relatively	O
few	O
bacteria	O
,	O
often	O
below	O
the	O
LD50	O
of	O
Y	B-Organism
.	I-Organism
pestis	E-Organism
grown	O
in	O
vitro	O
at	O
<	O
28degreesC	O
[	O
1	O
]	O
,	O
[	O
52	O
]	O
.	O

Transcriptome	O
Analysis	O
of	O
the	O
Brucella	B-Organism
abortus	E-Organism
BvrR	O
/	O
BvrS	O
Two	O
-	O
Component	O
Regulatory	O
System	O

Background	O
The	O
two	O
-	O
component	O
BvrR	O
/	O
BvrS	O
system	O
is	O
essential	O
for	O
Brucella	B-Organism
abortus	E-Organism
virulence	O
.	O

It	O
was	O
shown	O
previously	O
that	O
its	O
dysfunction	O
alters	O
the	O
expression	O
of	O
some	O
major	O
outer	O
membrane	O
proteins	O
and	O
the	O
pattern	O
of	O
lipid	O
A	O
acylation	O
.	O

To	O
determine	O
the	O
genes	O
regulated	O
by	O
BvrR	O
/	O
BvrS	O
,	O
we	O
performed	O
a	O
whole	O
-	O
genome	O
microarray	O
analysis	O
using	O
B	B-Organism
.	I-Organism
abortus	E-Organism
RNA	O
obtained	O
from	O
wild	O
type	O
and	O
bvrR	O
mutant	O
cells	O
grown	O
in	O
the	O
same	O
conditions	O
.	O

Methodology	O
/	O
Principal	O
Findings	O
A	O
total	O
of	O
127	O
differentially	O
expressed	O
genes	O
were	O
found	O
:	O
83	O
were	O
over	O
expressed	O
and	O
44	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

Two	O
operons	O
,	O
the	O
phosphotransferase	O
system	O
and	O
the	O
maltose	O
transport	O
system	O
,	O
were	O
down	O
-	O
regulated	O
.	O

Several	O
genes	O
involved	O
in	O
cell	O
envelope	O
or	O
outer	O
membrane	O
biogenesis	O
were	O
differentially	O
expressed	O
:	O
genes	O
for	O
outer	O
membrane	O
proteins	O
(	O
omp25a	O
,	O
omp25d	O
)	O
,	O
lipoproteins	O
,	O
LPS	O
and	O
fatty	O
acid	O
biosynthesis	O
,	O
stress	O
response	O
proteins	O
,	O
chaperones	O
,	O
flagellar	O
genes	O
,	O
and	O
twelve	O
genes	O
encoding	O
ABC	O
transport	O
systems	O
.	O

Ten	O
genes	O
related	O
with	O
carbon	O
metabolism	O
(	O
pckA	O
and	O
fumB	O
among	O
others	O
)	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	O
mutant	O
,	O
and	O
denitrification	O
genes	O
(	O
nirK	O
,	O
norC	O
and	O
nosZ	O
)	O
were	O
also	O
regulated	O
.	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
were	O
affected	O
,	O
including	O
VjbR	O
,	O
ExoR	O
and	O
OmpR	O
that	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

Finally	O
,	O
the	O
expression	O
of	O
eleven	O
genes	O
which	O
have	O
been	O
previously	O
related	O
with	O
Brucella	S-Organism
virulence	O
was	O
also	O
altered	O
.	O

Conclusions	O
/	O
Significance	O
All	O
these	O
data	O
corroborate	O
the	O
impact	O
of	O
BvrR	O
/	O
BvrS	O
on	O
cell	O
envelope	O
modulation	O
,	O
confirm	O
that	O
this	O
system	O
controls	O
the	O
carbon	O
and	O
nitrogen	O
metabolism	O
,	O
and	O
suggest	O
a	O
cross	O
-	O
talk	O
among	O
some	O
regulators	O
to	O
adjust	O
the	O
Brucella	S-Organism
physiology	O
to	O
the	O
shift	O
expected	O
to	O
occur	O
during	O
the	O
transit	O
from	O
the	O
extracellular	O
to	O
the	O
intracellular	O
niche	O
.	O

Introduction	O

Facultative	O
intracellular	O
bacteria	O
such	O
as	O
Brucella	S-Organism
must	O
survive	O
in	O
varied	O
and	O
changing	O
conditions	O
ranging	O
from	O
the	O
open	O
environment	O
to	O
the	O
intracellular	O
medium	O
.	O

For	O
this	O
,	O
the	O
bacterium	O
must	O
coordinate	O
an	O
intricate	O
network	O
of	O
factors	O
to	O
generate	O
a	O
suitable	O
adaptive	O
response	O
to	O
the	O
various	O
signals	O
.	O

This	O
attribute	O
is	O
often	O
accomplished	O
by	O
two	O
-	O
component	O
transduction	O
systems	O
,	O
consisting	O
of	O
a	O
sensor	O
kinase	O
and	O
a	O
response	O
regulator	O
.	O

These	O
regulatory	O
systems	O
are	O
highly	O
conserved	O
among	O
bacteria	O
and	O
widely	O
used	O
for	O
controlling	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

In	O
response	O
to	O
stimuli	O
,	O
the	O
sensor	O
kinase	O
autophosphorylates	O
,	O
then	O
transfers	O
its	O
phosphate	O
to	O
its	O
cognate	O
response	O
regulator	O
to	O
control	O
the	O
transcription	O
of	O
target	O
genes	O
[	O
1	O
]	O
.	O

Up	O
to	O
now	O
,	O
BvrR	O
/	O
BvrS	O
is	O
the	O
best	O
characterized	O
two	O
-	O
component	O
regulatory	O
system	O
of	O
Brucella	S-Organism
[	O
2	O
]	O
-	O
[	O
4	O
]	O
.	O

BvrS	O
is	O
a	O
membrane	O
-	O
bound	O
homodimeric	O
protein	O
that	O
has	O
three	O
conserved	O
regions	O
frequently	O
found	O
in	O
members	O
of	O
the	O
histidine	O
protein	O
kinase	O
superfamily	O
:	O
an	O
amino	O
-	O
terminal	O
periplasmic	O
sensing	O
domain	O
with	O
transmembrane	O
segments	O
,	O
a	O
cytoplasmic	O
dimerisation	O
domain	O
with	O
a	O
specific	O
His	O
residue	O
,	O
and	O
the	O
carboxy	O
-	O
terminal	O
ATP	O
-	O
binding	O
kinase	O
domain	O
[	O
5	O
]	O
.	O

BvrR	O
is	O
a	O
cytoplasmic	O
protein	O
that	O
shows	O
significant	O
similarity	O
to	O
OmpR	O
/	O
PhoB	O
subfamily	O
of	O
response	O
regulator	O
proteins	O
with	O
a	O
specific	O
Asp	O
residue	O
located	O
within	O
a	O
conserved	O
regulatory	O
domain	O
and	O
an	O
effector	O
domain	O
with	O
DNA	O
-	O
binding	O
activity	O
[	O
5	O
]	O
.	O

Although	O
genome	O
sequencing	O
has	O
revealed	O
21	O
putative	O
two	O
-	O
component	O
regulatory	O
systems	O
in	O
the	O
Brucella	S-Organism
genus	O
,	O
the	O
best	O
characterized	O
one	O
implicated	O
in	O
virulence	O
is	O
the	O
BvrR	O
/	O
BvrS	O
system	O
.	O

BvrR	O
/	O
bvrS	O
mutants	O
are	O
avirulent	O
in	O
mice	S-Organism
,	O
have	O
increased	O
susceptibility	O
to	O
killing	O
by	O
nonimmune	O
serum	O
,	O
show	O
reduced	O
invasiveness	O
to	O
epithelial	O
cells	O
and	O
macrophages	O
,	O
and	O
are	O
incapable	O
of	O
inhibiting	O
lysosome	O
fusion	O
and	O
of	O
intracellular	O
replication	O
[	O
4	O
]	O
.	O

As	O
demonstrated	O
for	O
other	O
two	O
-	O
component	O
systems	O
,	O
multiple	O
genes	O
are	O
expected	O
to	O
be	O
under	O
the	O
control	O
of	O
BvrR	O
/	O
BvrS	O
[	O
1	O
]	O
.	O

B	B-Organism
.	I-Organism
abortus	I-Organism
mutants	E-Organism
in	O
this	O
system	O
were	O
more	O
susceptible	O
to	O
bactericidal	O
polycationic	O
substances	O
like	O
polymyxin	O
B	O
,	O
melittin	O
or	O
poly	O
-	O
L	O
-	O
lysine	O
,	O
and	O
displayed	O
a	O
more	O
hydrophobic	O
outer	O
membrane	O
surface	O
than	O
the	O
parental	O
strain	O
[	O
4	O
]	O
.	O

This	O
evidence	O
suggests	O
an	O
altered	O
outer	O
membrane	O
structure	O
.	O

Later	O
studies	O
demonstrated	O
that	O
the	O
BvrR	O
/	O
BvrS	O
system	O
regulates	O
transcription	O
of	O
at	O
least	O
two	O
major	O
outer	O
membrane	O
proteins	O
,	O
Omp22	O
(	O
Omp3b	O
)	O
and	O
Omp25a	O
(	O
Omp3a	O
)	O
.	O

Changes	O
in	O
non	O
-	O
protein	O
envelope	O
molecules	O
such	O
as	O
lipid	O
A	O
underacylation	O
and	O
increased	O
LPS	O
acyl	O
-	O
chain	O
fluidity	O
have	O
been	O
also	O
found	O
in	O
these	O
mutants	O
[	O
3	O
]	O
.	O

To	O
further	O
understand	O
the	O
role	O
of	O
the	O
BvrR	O
/	O
BvrS	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
,	O
global	O
gene	O
expression	O
profiles	O
were	O
analyzed	O
by	O
using	O
ORFeome	O
-	O
based	O
Brucella	S-Organism
whole	O
-	O
genome	O
DNA	O
microarrays	O
and	O
confirmed	O
by	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

Our	O
results	O
link	O
the	O
regulation	O
of	O
carbon	O
and	O
nitrogen	O
metabolism	O
to	O
the	O
expression	O
of	O
cell	O
envelope	O
components	O
and	O
suggest	O
the	O
existence	O
of	O
a	O
complex	O
regulatory	O
network	O
with	O
the	O
interplay	O
of	O
several	O
transcriptional	O
regulators	O
.	O

Results	O
and	O
Discussion	O

Brucella	B-Organism
mutants	E-Organism
in	O
the	O
BvrR	O
/	O
BvrS	O
two	O
-	O
component	O
regulatory	O
system	O
are	O
pleiotropic	O
[	O
3	O
]	O
-	O
[	O
6	O
]	O
.	O

Whole	O
-	O
genome	O
microarray	O
analysis	O
was	O
made	O
to	O
determine	O
the	O
effect	O
of	O
the	O
mutation	O
in	O
BvrR	O
/	O
BvrS	O
in	O
the	O
gene	O
expression	O
pattern	O
of	O
Brucella	S-Organism
.	O

B	B-Organism
.	I-Organism
abortus	E-Organism
RNA	O
was	O
obtained	O
from	O
three	O
independent	O
cultures	O
of	O
each	O
wild	O
type	O
and	O
bvrR	O
mutant	O
cells	O
grown	O
in	O
the	O
same	O
conditions	O
.	O

To	O
confirm	O
the	O
reproducibility	O
of	O
the	O
gene	O
expression	O
data	O
,	O
the	O
array	O
experiment	O
was	O
composed	O
of	O
six	O
slides	O
(	O
three	O
for	O
each	O
type	O
of	O
cells	O
)	O
yielding	O
six	O
measurements	O
per	O
gene	O
,	O
representing	O
three	O
biological	O
replicates	O
(	O
since	O
each	O
gene	O
is	O
present	O
twice	O
on	O
each	O
slide	O
)	O
.	O

The	O
ORFeome	O
-	O
based	O
Brucella	S-Organism
whole	O
-	O
genome	O
DNA	O
microarray	O
used	O
in	O
this	O
study	O
has	O
been	O
previously	O
validated	O
for	O
the	O
analysis	O
of	O
gene	O
expression	O
under	O
any	O
experimental	O
conditions	O
[	O
7	O
]	O
.	O

The	O
microarray	O
experimental	O
design	O
was	O
made	O
according	O
to	O
the	O
MIAME	O
recommendations	O
[	O
8	O
]	O
.	O

A	O
change	O
in	O
gene	O
expression	O
was	O
considered	O
both	O
statistically	O
and	O
biologically	O
significant	O
if	O
the	O
p	O
-	O
value	O
was	O
less	O
than	O
0	O
.	O
01	O
.	O

The	O
statistical	O
analysis	O
resulted	O
in	O
the	O
identification	O
of	O
a	O
total	O
of	O
127	O
genes	O
differentially	O
transcribed	O
in	O
the	O
bvrR	O
mutant	O
versus	O
the	O
wild	O
type	O
.	O

Eighty	O
three	O
genes	O
(	O
65	O
%	O
)	O
were	O
up	O
-	O
and	O
44	O
(	O
35	O
%	O
)	O
were	O
down	O
-	O
regulated	O
(	O
the	O
complete	O
list	O
of	O
differentially	O
expressed	O
genes	O
in	O
the	O
bvrR	O
mutant	O
versus	O
the	O
wild	O
type	O
is	O
show	O
in	O
Table	O
S1	O
)	O
.	O

Twenty	O
three	O
%	O
of	O
the	O
differentially	O
transcribed	O
genes	O
(	O
30	O
)	O
encoded	O
for	O
hypothetical	O
proteins	O
.	O

For	O
genes	O
of	O
annotated	O
function	O
,	O
59	O
appeared	O
to	O
be	O
up	O
regulated	O
and	O
38	O
down	O
regulated	O
in	O
the	O
bvrR	O
mutant	O
.	O

Genes	O
encoding	O
proteins	O
involved	O
in	O
metabolism	O
and	O
cellular	O
process	O
are	O
among	O
the	O
most	O
up	O
regulated	O
genes	O
,	O
and	O
those	O
encoding	O
proteins	O
involved	O
in	O
membrane	O
transport	O
are	O
among	O
the	O
most	O
down	O
regulated	O
(	O
Figure	O
1	O
)	O
.	O

To	O
further	O
validate	O
some	O
data	O
generated	O
in	O
the	O
microarray	O
experiment	O
,	O
forty	O
-	O
eight	O
differentially	O
expressed	O
genes	O
were	O
chosen	O
to	O
be	O
analyzed	O
by	O
real	O
-	O
time	O
quantitative	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

Total	O
RNA	O
from	O
both	O
Brucella	S-Organism
strains	O
were	O
reverse	O
transcribed	O
into	O
cDNA	O
.	O

The	O
reactions	O
were	O
made	O
by	O
triplicate	O
from	O
at	O
least	O
two	O
independent	O
cultures	O
,	O
and	O
the	O
cycle	O
of	O
threshold	O
(	O
Ct	O
)	O
was	O
determined	O
for	O
each	O
reaction	O
.	O

Data	O
were	O
normalized	O
by	O
the	O
2	O
-	O
DeltaDeltaCt	O
method	O
[	O
9	O
]	O
using	O
the	O
IF	O
-	O
1	O
housekeeping	O
gene	O
of	O
Brucella	S-Organism
as	O
reference	O
(	O
Table	O
1	O
)	O
.	O

Transcriptional	O
data	O
of	O
forty	O
-	O
one	O
(	O
85	O
%	O
)	O
of	O
the	O
genes	O
selected	O
gave	O
identical	O
tendency	O
by	O
both	O
methods	O
microarray	O
and	O
RT	O
-	O
PCR	O
:	O
22	O
were	O
up	O
and	O
19	O
were	O
down	O
regulated	O
in	O
the	O
bvrR	O
mutant	O
.	O

Interestingly	O
,	O
the	O
level	O
of	O
transcription	O
obtained	O
by	O
RT	O
-	O
PCR	O
of	O
the	O
flagellar	O
genes	O
fliM	O
(	O
BAB2	O
_	O
0124	O
)	O
and	O
motB	O
(	O
BAB2	O
_	O
1103	O
)	O
,	O
and	O
the	O
pckA	O
gene	O
(	O
BAB1	O
_	O
2091	O
)	O
were	O
the	O
highest	O
in	O
the	O
bvrR	O
mutant	O
.	O

On	O
the	O
other	O
hand	O
,	O
exoR	O
(	O
BAB1	O
_	O
0891	O
)	O
,	O
omp25a	O
(	O
BAB1	O
_	O
0722	O
)	O
,	O
hpr	O
-	O
K	O
(	O
BAB1	O
_	O
2094	O
)	O
,	O
bvrS	O
(	O
BAB1	O
_	O
2093	O
)	O
and	O
the	O
lipoproteins	O
(	O
BAB1	O
_	O
2147	O
,	O
BAB1	O
_	O
0589	O
,	O
BAB1	O
_	O
0358	O
)	O
were	O
among	O
the	O
less	O
expressed	O
genes	O
(	O
Table	O
1	O
)	O
.	O

These	O
results	O
confirmed	O
a	O
good	O
correlation	O
between	O
microarray	O
and	O
RT	O
-	O
PCR	O
data	O
,	O
thus	O
validating	O
the	O
model	O
.	O

Next	O
,	O
we	O
will	O
focus	O
on	O
the	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
(	O
a	O
complete	O
representation	O
of	O
the	O
differentially	O
expressed	O
genes	O
is	O
show	O
in	O
Figure	O
2	O
)	O
.	O

Cell	O
envelope	O
modulation	O
It	O
is	O
well	O
know	O
that	O
the	O
transcription	O
of	O
omp25a	O
y	O
omp22	O
genes	O
is	O
under	O
the	O
control	O
of	O
the	O
BvrR	O
/	O
BvrS	O
system	O
,	O
and	O
that	O
bvrR	O
/	O
bvrS	O
mutants	O
have	O
increased	O
amount	O
of	O
underacylated	O
lipid	O
A	O
species	O
in	O
the	O
LPS	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

In	O
addition	O
,	O
proteomic	O
analysis	O
of	O
Brucella	S-Organism
outer	O
membrane	O
fragments	O
demonstrated	O
that	O
the	O
expression	O
of	O
several	O
OMPs	O
,	O
lipoproteins	O
and	O
chaperones	O
was	O
altered	O
in	O
these	O
mutants	O
[	O
6	O
]	O
.	O

These	O
observations	O
led	O
to	O
the	O
hypothesis	O
that	O
the	O
BvrR	O
/	O
BvrS	O
system	O
is	O
involved	O
in	O
cell	O
envelope	O
changes	O
required	O
for	O
adaptation	O
to	O
the	O
intracellular	O
environment	O
.	O

Our	O
microarray	O
results	O
demonstrated	O
several	O
genes	O
directly	O
involved	O
in	O
cell	O
envelope	O
or	O
outer	O
membrane	O
biogenesis	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

As	O
expected	O
,	O
these	O
included	O
genes	O
that	O
encoded	O
OMPs	O
like	O
Omp25a	O
(	O
BAB1	O
_	O
0722	O
)	O
and	O
Omp25d	O
(	O
BAB1	O
_	O
0115	O
)	O
which	O
were	O
down	O
-	O
regulated	O
.	O

Other	O
bvrR	O
regulated	O
genes	O
related	O
with	O
cell	O
envelope	O
were	O
:	O
three	O
lipoprotein	O
genes	O
(	O
BAB1	O
_	O
0358	O
;	O
BAB1	O
_	O
0589	O
;	O
BAB1	O
_	O
2147	O
)	O
,	O
which	O
were	O
down	O
-	O
regulated	O
;	O
six	O
genes	O
for	O
periplasmic	O
proteins	O
and	O
chaperones	O
(	O
htpX	O
,	O
heat	O
shock	O
protein	O
,	O
BAB1	O
_	O
1821	O
;	O
clpA	O
and	O
clpB	O
,	O
stress	O
response	O
proteins	O
,	O
BAB1	O
_	O
1573	O
and	O
BAB1	O
_	O
1868	O
,	O
respectively	O
;	O
BAB2	O
_	O
1107	O
;	O
BAB1	O
_	O
0505	O
;	O
BAB1	O
_	O
1022	O
)	O
,	O
which	O
were	O
all	O
up	O
-	O
regulated	O
;	O
one	O
gene	O
related	O
with	O
LPS	O
biosynthesis	O
(	O
glycosyl	O
transferase	O
,	O
BAB1	O
_	O
1620	O
)	O
,	O
which	O
was	O
up	O
-	O
regulated	O
;	O
and	O
five	O
genes	O
for	O
fatty	O
acids	O
biosynthesis	O
(	O
fabG	O
,	O
ketoacyl	O
-	O
acyl	O
-	O
carrier	O
-	O
protein	O
reductase	O
,	O
BAB1	O
_	O
2043	O
;	O
fabF	O
,	O
oxoacyl	O
-	O
acyl	O
-	O
carrier	O
-	O
protein	O
synthase	O
,	O
BAB1	O
_	O
0872	O
;	O
fadD	O
,	O
fatty	O
-	O
acyl	O
-	O
CoA	O
synthase	O
,	O
BAB1	O
_	O
0320	O
;	O
cfa	O
,	O
cyclopropane	O
-	O
fatty	O
-	O
acyl	O
-	O
phospholipid	O
synthase	O
,	O
BAB1	O
_	O
0476	O
;	O
BAB1	O
_	O
1357	O
)	O
.	O

These	O
data	O
confirm	O
that	O
BvrR	O
/	O
BvrS	O
regulates	O
bacterial	O
envelope	O
changes	O
that	O
could	O
modify	O
surface	O
properties	O
relevant	O
for	O
Brucella	S-Organism
virulence	O
[	O
6	O
]	O
.	O

Regulation	O
of	O
carbon	O
and	O
nitrogen	O
metabolism	O

One	O
of	O
the	O
remarkable	O
findings	O
observed	O
in	O
our	O
microarray	O
analysis	O
was	O
that	O
several	O
genes	O
related	O
with	O
metabolism	O
were	O
also	O
differentially	O
expressed	O
.	O

These	O
included	O
twelve	O
genes	O
encoding	O
ABC	O
transport	O
systems	O
(	O
matE	O
,	O
BAB1	O
_	O
0340	O
;	O
dctM	O
,	O
BAB1	O
_	O
0372	O
;	O
fhuD	O
,	O
BAB1	O
_	O
1366	O
;	O
yadH	O
,	O
BAB1	O
_	O
1368	O
;	O
oppA	O
,	O
BAB1	O
_	O
1601	O
;	O
oppC	O
,	O
BAB2	O
_	O
1051	O
;	O
oppD	O
,	O
BAB2	O
_	O
0817	O
;	O
potC	O
,	O
BAB1	O
_	O
1624	O
;	O
ssuB	O
,	O
BAB2	O
_	O
0917	O
;	O
ugpC	O
,	O
BAB2	O
_	O
1143	O
;	O
BAB2	O
_	O
0794	O
;	O
BAB2	O
_	O
1139	O
)	O
,	O
ten	O
genes	O
related	O
with	O
carbohydrate	O
,	O
amino	O
or	O
fatty	O
acids	O
metabolism	O
and	O
five	O
related	O
with	O
nitrogen	O
metabolism	O
.	O

Interestingly	O
,	O
all	O
genes	O
related	O
with	O
carbohydrate	O
,	O
amino	O
or	O
fatty	O
acids	O
metabolism	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	O
mutant	O
.	O

These	O
included	O
the	O
first	O
enzyme	O
in	O
gluconeogenesis	O
(	O
pckA	O
,	O
phosphoenolpyruvate	O
carboxykinase	O
,	O
BAB1	O
_	O
2091	O
)	O
,	O
four	O
genes	O
involved	O
in	O
TCA	O
cycle	O
and	O
pyruvate	O
metabolism	O
(	O
fumB	O
,	O
fumarate	O
hydratase	O
,	O
BAB1	O
_	O
0977	O
;	O
lpdA	O
,	O
dihydrolipoamide	O
dehydrogenase	O
,	O
BAB2	O
_	O
0712	O
;	O
pyruvate	O
dehydrogenase	O
,	O
BAB2	O
_	O
0032	O
;	O
acetyl	O
-	O
CoA	O
acetyltransferase	O
,	O
BAB2	O
_	O
0443	O
)	O
,	O
three	O
genes	O
involved	O
in	O
amino	O
or	O
fatty	O
acid	O
metabolism	O
(	O
aldehyde	O
dehydrogenases	O
,	O
BAB2	O
_	O
1130	O
,	O
BAB2	O
_	O
1114	O
;	O
hydroxymethylglutaryl	O
-	O
CoA	O
lyase	O
,	O
BAB1	O
_	O
0017	O
)	O
,	O
and	O
two	O
genes	O
involve	O
in	O
benzoate	O
degradation	O
(	O
pcaC	O
,	O
carboxymuconolactone	O
decarboxylase	O
,	O
BAB2	O
_	O
0597	O
;	O
pcaI	O
,	O
coenzyme	O
A	O
transferase	O
,	O
BAB2	O
_	O
0604	O
)	O
.	O

In	O
addition	O
,	O
the	O
complete	O
maltose	O
transport	O
system	O
of	O
Brucella	S-Organism
,	O
which	O
consists	O
in	O
a	O
large	O
operon	O
containing	O
thirteen	O
genes	O
(	O
BAB1	O
_	O
0236	O
-	O
0248	O
)	O
was	O
also	O
affected	O
.	O

Ten	O
of	O
these	O
genes	O
,	O
including	O
malK	O
,	O
malG	O
,	O
malF	O
,	O
malE	O
and	O
an	O
iclR	O
regulator	O
,	O
were	O
down	O
-	O
regulated	O
suggesting	O
that	O
the	O
complete	O
operon	O
was	O
negatively	O
regulated	O
in	O
the	O
bvrR	O
mutant	O
.	O

Although	O
it	O
has	O
been	O
showed	O
that	O
the	O
mutants	O
in	O
the	O
BvrR	O
/	O
BvrS	O
system	O
have	O
no	O
obvious	O
defects	O
with	O
regard	O
to	O
the	O
ability	O
to	O
grow	O
on	O
standard	O
media	O
[	O
4	O
]	O
,	O
our	O
microarray	O
results	O
suggests	O
that	O
the	O
BvrR	O
/	O
BvrS	O
system	O
controls	O
elements	O
directly	O
involved	O
in	O
adjusting	O
the	O
Brucella	S-Organism
metabolism	O
to	O
the	O
nutrient	O
shift	O
expected	O
to	O
occur	O
during	O
the	O
transit	O
to	O
the	O
intracellular	O
niche	O
.	O

To	O
determine	O
if	O
the	O
BvrR	O
/	O
BvrS	O
system	O
affects	O
the	O
metabolism	O
,	O
bvrR	O
mutant	O
and	O
wild	O
type	O
strains	O
were	O
grown	O
in	O
synthetic	O
minimal	O
media	O
.	O

As	O
show	O
in	O
Figure	O
3	O
,	O
growth	O
of	O
the	O
bvrR	O
mutant	O
was	O
significantly	O
reduced	O
in	O
minimal	O
media	O
.	O

Other	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
included	O
denitrification	O
genes	O
.	O

The	O
nitrite	O
reductase	O
gene	O
(	O
nirK	O
,	O
BAB2	O
_	O
0943	O
)	O
was	O
down	O
regulated	O
and	O
the	O
nitric	O
oxide	O
and	O
nitrous	O
oxide	O
reductases	O
genes	O
(	O
nor	O
C	O
,	O
BAB2	O
_	O
0955	O
;	O
nosZ	O
,	O
BAB2	O
_	O
0928	O
)	O
were	O
up	O
regulated	O
.	O

On	O
the	O
other	O
hand	O
,	O
two	O
deaminases	O
(	O
glutaminase	O
,	O
BAB2	O
_	O
0863	O
;	O
guanine	O
deaminase	O
,	O
BAB1	O
_	O
0383	O
)	O
were	O
also	O
affected	O
.	O

Since	O
Brucella	S-Organism
is	O
an	O
intracellular	O
facultative	O
pathogen	O
,	O
the	O
bacteria	O
could	O
use	O
these	O
denitrification	O
reactions	O
to	O
grow	O
under	O
low	O
-	O
oxygen	O
condition	O
by	O
respiration	O
of	O
nitrate	O
.	O

Brucella	S-Organism
may	O
also	O
take	O
advantage	O
of	O
denitrification	O
to	O
cope	O
with	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
in	O
the	O
macrophage	O
during	O
the	O
innate	O
response	O
against	O
infection	O
.	O

In	O
fact	O
,	O
some	O
of	O
these	O
denitrification	O
genes	O
have	O
been	O
related	O
with	O
the	O
virulence	O
in	O
mice	S-Organism
[	O
10	O
]	O
,	O
[	O
11	O
]	O
.	O

Interestingly	O
,	O
our	O
experiments	O
to	O
study	O
the	O
intracellular	O
transcriptional	O
level	O
of	O
BvrR	O
/	O
BvrS	O
controlled	O
genes	O
(	O
see	O
below	O
)	O
showed	O
that	O
whereas	O
norC	O
was	O
induced	O
intracellularly	O
,	O
nirK	O
and	O
nosZ	O
were	O
less	O
expressed	O
.	O

Taken	O
together	O
all	O
these	O
data	O
support	O
the	O
proposal	O
that	O
one	O
role	O
of	O
the	O
BvrR	O
/	O
BvrS	O
system	O
could	O
be	O
neutralize	O
the	O
production	O
of	O
toxic	O
reactive	O
nitrogen	O
molecules	O
,	O
as	O
NO	O
,	O
by	O
the	O
host	O
.	O

These	O
results	O
also	O
demonstrated	O
a	O
connection	O
between	O
carbon	O
and	O
nitrogen	O
metabolism	O
and	O
BvrR	O
/	O
BvrS	O
in	O
Brucella	S-Organism
.	O

Our	O
results	O
also	O
demonstrated	O
that	O
gene	O
hpr	O
-	O
K	O
(	O
BAB1	O
_	O
2094	O
)	O
,	O
a	O
member	O
of	O
the	O
Brucella	S-Organism
phosphotransferase	O
system	O
(	O
PTS	O
;	O
BAB1	O
_	O
2097	O
-	O
2094	O
)	O
adjacent	O
to	O
the	O
bvrR	O
/	O
bvrS	O
,	O
was	O
down	O
-	O
regulated	O
.	O

As	O
mentioned	O
before	O
,	O
phosphoenolpyruvate	O
carboxykinase	O
gene	O
(	O
pckA	O
,	O
BAB1	O
_	O
2091	O
)	O
which	O
is	O
located	O
upstream	O
of	O
the	O
regulatory	O
gene	O
bvrR	O
and	O
divergently	O
expressed	O
was	O
up	O
-	O
regulated	O
.	O

Comparative	O
genome	O
analysis	O
revealed	O
that	O
in	O
addition	O
to	O
the	O
bvrR	O
/	O
bvrS	O
genes	O
,	O
the	O
genome	O
structure	O
around	O
these	O
genes	O
is	O
essentially	O
the	O
same	O
for	O
all	O
the	O
alpha	O
-	O
proteobacteria	O
[	O
5	O
]	O
.	O

Genes	O
encoding	O
proteins	O
related	O
to	O
the	O
PTS	O
,	O
including	O
a	O
HPr	O
Ser	O
-	O
kinase	O
,	O
an	O
EIIA	O
permease	O
of	O
the	O
mannose	O
family	O
and	O
a	O
HPr	O
homologue	O
precede	O
those	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
.	O

In	O
most	O
of	O
these	O
loci	O
,	O
upstream	O
of	O
the	O
regulatory	O
gene	O
the	O
pckA	O
is	O
divergently	O
expressed	O
(	O
Figure	O
2	O
)	O
.	O

This	O
gene	O
catalyzes	O
the	O
reversible	O
decarboxylation	O
and	O
phosphorylation	O
of	O
oxaloacetate	O
to	O
form	O
phosphoenolpyruvate	O
.	O

In	O
alpha	O
-	O
proteobacteria	O
,	O
it	O
has	O
been	O
proposed	O
that	O
HPr	O
might	O
control	O
the	O
phosphorylation	O
state	O
of	O
the	O
transcription	O
regulator	O
[	O
12	O
]	O
-	O
[	O
14	O
]	O
.	O

In	O
this	O
regard	O
,	O
Letesson	O
and	O
col	O
.	O

[	O
15	O
]	O
have	O
suggested	O
that	O
in	O
Brucella	S-Organism
the	O
PTS	O
could	O
interact	O
with	O
the	O
BvrS	O
sensor	O
kinase	O
,	O
which	O
in	O
turn	O
phosphorylates	O
the	O
response	O
regulator	O
.	O

Then	O
,	O
the	O
BvrR	O
could	O
control	O
transcription	O
of	O
the	O
pckA	O
gene	O
,	O
which	O
encodes	O
an	O
essential	O
control	O
enzyme	O
of	O
the	O
gluconeogenesis	O
and	O
Krebs	O
cycle	O
.	O

This	O
hypothesis	O
could	O
explain	O
the	O
observation	O
that	O
mutants	O
in	O
the	O
regulatory	O
gene	O
bvrR	O
were	O
inhibited	O
in	O
minimal	O
media	O
(	O
see	O
above	O
)	O
.	O

According	O
to	O
this	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
in	O
A	B-Organism
.	I-Organism
tumefaciens	E-Organism
the	O
pckA	O
genes	O
is	O
indeed	O
under	O
the	O
control	O
of	O
ChvG	O
/	O
ChvI	O
[	O
16	O
]	O
and	O
that	O
null	O
mutants	O
in	O
S	B-Organism
.	I-Organism
meliloti	E-Organism
exoS	O
and	O
chvI	O
have	O
pleiotropic	O
growth	O
defects	O
and	O
were	O
unable	O
to	O
grow	O
on	O
several	O
carbon	O
sources	O
[	O
17	O
]	O
.	O

A	O
link	O
between	O
carbon	O
and	O
nitrogen	O
metabolism	O
,	O
PTS	O
and	O
two	O
-	O
component	O
regulatory	O
systems	O
have	O
been	O
proposed	O
for	O
some	O
bacteria	O
[	O
18	O
]	O
,	O
and	O
our	O
microarray	O
results	O
strongly	O
suggest	O
that	O
same	O
relationship	O
could	O
be	O
made	O
for	O
Brucella	S-Organism
.	O

BvrR	O
/	O
BvrS	O
and	O
the	O
expression	O
of	O
other	O
transcriptional	O
regulators	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
genes	O
were	O
also	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
compared	O
to	O
parental	O
strain	O
:	O
BAB1	O
_	O
0237	O
,	O
BAB1	O
_	O
0891	O
(	O
exoR	O
)	O
,	O
BAB1	O
_	O
1397	O
,	O
BAB2	O
_	O
0118	O
(	O
vjbR	O
)	O
,	O
BAB2	O
_	O
0762	O
(	O
ompR	O
)	O
,	O
BAB2	O
_	O
1127	O
and	O
BAB2	O
_	O
1152	O
.	O

Three	O
of	O
these	O
,	O
namely	O
exoR	O
,	O
ompR	O
and	O
vjbR	O
are	O
down	O
regulated	O
and	O
have	O
been	O
previously	O
implicated	O
in	O
Brucella	S-Organism
virulence	O
.	O

B	O
.	O
melitensis	O
vjbR	O
mutant	O
is	O
highly	O
attenuated	O
in	O
both	O
cellular	O
and	O
mouse	S-Organism
models	O
of	O
infection	O
[	O
19	O
]	O
.	O

VjbR	O
has	O
been	O
described	O
as	O
a	O
transcriptional	O
regulator	O
able	O
to	O
activate	O
directly	O
the	O
secretion	O
system	O
virB	O
operon	O
and	O
the	O
flagellar	O
genes	O
,	O
both	O
virulence	O
factors	O
associated	O
to	O
the	O
surface	O
of	O
the	O
bacteria	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

Moreover	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
VjbR	O
controls	O
the	O
synthesis	O
of	O
exopolysaccharides	O
and	O
the	O
productions	O
of	O
several	O
OMPs	O
,	O
some	O
of	O
which	O
are	O
also	O
involved	O
in	O
virulence	O
[	O
22	O
]	O
.	O

Interestingly	O
,	O
our	O
results	O
also	O
showed	O
that	O
the	O
expression	O
of	O
vjbR	O
was	O
also	O
induced	O
intracellularly	O
(	O
see	O
below	O
)	O
.	O

All	O
these	O
data	O
suggest	O
that	O
VjbR	O
,	O
similarly	O
to	O
the	O
BvrR	O
/	O
BvrS	O
system	O
,	O
is	O
involved	O
in	O
the	O
control	O
of	O
outer	O
membrane	O
composition	O
and	O
virulence	O
.	O

In	O
addition	O
,	O
DeJong	O
and	O
col	O
[	O
20	O
]	O
have	O
demonstrated	O
that	O
among	O
the	O
promoters	O
which	O
expression	O
is	O
dependent	O
of	O
the	O
VjbR	O
regulator	O
,	O
is	O
the	O
ompR	O
gene	O
,	O
the	O
regulator	O
of	O
the	O
OmpR	O
/	O
EnvZ	O
two	O
component	O
system	O
.	O

E	B-Organism
.	I-Organism
coli	E-Organism
OmpR	O
/	O
EnvZ	O
system	O
controls	O
the	O
transcription	O
of	O
the	O
outer	O
membrane	O
porins	O
OmpF	O
and	O
OmpC	O
in	O
response	O
to	O
osmolarity	O
[	O
23	O
]	O
.	O

Moreover	O
,	O
a	O
systematically	O
transcriptome	O
analysis	O
of	O
all	O
two	O
component	O
regulatory	O
systems	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
has	O
demonstrated	O
that	O
the	O
OmpR	O
/	O
EnvZ	O
system	O
also	O
controls	O
the	O
metabolism	O
of	O
amino	O
acids	O
,	O
flagellar	O
synthesis	O
and	O
nutrient	O
transport	O
[	O
24	O
]	O
.	O

As	O
we	O
have	O
show	O
in	O
this	O
study	O
,	O
the	O
expression	O
of	O
at	O
least	O
three	O
flagellar	O
genes	O
(	O
fliM	O
,	O
BAB2	O
_	O
0124	O
/	O
5	O
;	O
flgJ	O
,	O
BAB1	O
_	O
0260	O
;	O
motB	O
,	O
BAB2	O
_	O
1103	O
)	O
were	O
increased	O
also	O
in	O
the	O
bvrR	O
mutant	O
(	O
Figure	O
2	O
)	O
.	O

The	O
two	O
-	O
regulatory	O
systems	O
ChvG	O
(	O
ExoS	O
)	O
/	O
ChvI	O
in	O
S	B-Organism
.	I-Organism
meliloti	E-Organism
and	O
A	B-Organism
.	I-Organism
tumefaciens	E-Organism
posses	O
a	O
high	O
level	O
of	O
identity	O
with	O
the	O
Brucella	S-Organism
BvrR	O
/	O
BvrS	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Chaves	O
-	O
Olarte	O
et	O
al	O
have	O
reported	O
that	O
B	B-Organism
.	I-Organism
abortus	E-Organism
bvrS	O
mutant	O
complemented	O
with	O
the	O
ExoS	O
protein	O
recuperated	O
the	O
ability	O
to	O
invade	O
and	O
replicated	O
successfully	O
in	O
HeLa	O
and	O
macrophage	O
cells	O
[	O
27	O
]	O
,	O
suggesting	O
that	O
the	O
BvrR	O
/	O
BvrS	O
system	O
is	O
functionally	O
interchangeable	O
with	O
the	O
ExoS	O
/	O
ChvI	O
system	O
.	O

A	B-Organism
.	I-Organism
tumefaciens	E-Organism
ChvI	O
/	O
ChvG	O
system	O
controls	O
the	O
expression	O
of	O
the	O
Aop	O
,	O
an	O
OMP	O
homologous	O
to	O
Brucella	S-Organism
Omp25a	O
[	O
28	O
]	O
,	O
and	O
in	O
S	B-Organism
.	I-Organism
meliloti	E-Organism
,	O
ExoS	O
/	O
ChvI	O
is	O
a	O
key	O
regulator	O
of	O
gene	O
expression	O
for	O
exopolysaccharide	O
synthesis	O
,	O
motility	O
and	O
nutrient	O
utilization	O
[	O
26	O
]	O
.	O

It	O
has	O
been	O
described	O
in	O
S	B-Organism
.	I-Organism
meliloti	E-Organism
that	O
exoR	O
gene	O
encodes	O
a	O
global	O
regulator	O
of	O
transcription	O
and	O
that	O
ExoR	O
interacts	O
genetically	O
with	O
both	O
ExoS	O
and	O
ChvI	O
and	O
inhibits	O
ExoS	O
/	O
ChvI	O
activity	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
.	O

Further	O
analysis	O
indicated	O
that	O
both	O
the	O
ExoR	O
protein	O
and	O
the	O
ExoS	O
/	O
ChvI	O
two	O
-	O
component	O
regulatory	O
system	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
both	O
polysaccharides	O
and	O
flagellum	O
biosynthesis	O
[	O
31	O
]	O
.	O

In	O
addition	O
,	O
the	O
transcription	O
of	O
the	O
S	B-Organism
.	I-Organism
meliloti	E-Organism
lpsS	O
gene	O
,	O
that	O
encodes	O
a	O
sulfotransferase	O
that	O
modifies	O
LPS	O
,	O
is	O
dependent	O
on	O
the	O
exoR	O
gene	O
[	O
32	O
]	O
.	O

Other	O
authors	O
[	O
29	O
]	O
suggest	O
that	O
ExoR	O
is	O
an	O
inhibitor	O
of	O
two	O
-	O
component	O
signaling	O
that	O
may	O
be	O
conserved	O
in	O
a	O
large	O
number	O
of	O
alpha	O
-	O
proteobacteria	O
.	O

Our	O
results	O
also	O
support	O
this	O
hypothesis	O
:	O
the	O
functional	O
relationship	O
between	O
the	O
exoR	O
gene	O
and	O
the	O
BvrR	O
/	O
BvrS	O
system	O
.	O

Based	O
on	O
all	O
these	O
findings	O
,	O
obvious	O
comparison	O
about	O
the	O
function	O
of	O
all	O
these	O
regulators	O
in	O
Brucella	S-Organism
could	O
be	O
made	O
.	O

The	O
fact	O
that	O
the	O
expression	O
of	O
VjbR	O
,	O
OmpR	O
and	O
ExoR	O
was	O
altered	O
in	O
the	O
bvrR	O
mutant	O
demonstrated	O
for	O
the	O
first	O
time	O
an	O
interaction	O
or	O
cross	O
-	O
talk	O
among	O
these	O
global	O
regulators	O
,	O
all	O
involved	O
in	O
the	O
control	O
of	O
composition	O
and	O
structure	O
of	O
the	O
cell	O
envelope	O
(	O
OMPs	O
,	O
LPS	O
,	O
chaperones	O
,	O
flagella	O
,	O
em	O
)	O
.	O

Virulence	O
and	O
the	O
adaptation	O
to	O
intracellular	O
growth	O

BvrR	O
/	O
bvrS	O
mutants	O
are	O
unable	O
to	O
multiply	O
intracellularly	O
and	O
are	O
avirulent	O
in	O
the	O
mouse	S-Organism
model	O
[	O
4	O
]	O
.	O

Our	O
microarray	O
results	O
demonstrated	O
that	O
at	O
least	O
127	O
genes	O
were	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

Although	O
this	O
general	O
expression	O
changes	O
could	O
explain	O
the	O
complete	O
loss	O
of	O
virulence	O
of	O
these	O
mutants	O
,	O
it	O
was	O
remarkable	O
the	O
presence	O
among	O
them	O
of	O
ten	O
genes	O
,	O
in	O
addition	O
to	O
bvrS	O
,	O
whose	O
products	O
are	O
already	O
known	O
to	O
be	O
associated	O
with	O
Brucella	S-Organism
virulence	O
[	O
10	O
]	O
,	O
[	O
11	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

These	O
included	O
the	O
already	O
mentioned	O
vjbR	O
,	O
but	O
also	O
motB	O
(	O
BAB2	O
_	O
1103	O
)	O
,	O
malK	O
(	O
BAB1	O
_	O
0241	O
)	O
,	O
norC	O
(	O
BAB2	O
_	O
0955	O
)	O
,	O
oppA	O
(	O
BAB1	O
_	O
1601	O
)	O
,	O
aspB	O
(	O
BAB1	O
_	O
1397	O
)	O
,	O
mosA	O
(	O
BAB1	O
_	O
0666	O
)	O
and	O
three	O
genes	O
encoding	O
hypothetical	O
proteins	O
(	O
BAB1	O
_	O
1717	O
,	O
BAB1	O
_	O
0597	O
y	O
BAB2	O
_	O
1127	O
)	O
.	O

B	O
.	O
melitensis	O
malK	O
mutant	O
and	O
B	O
.	O
suis	O
aspB	O
mutant	O
were	O
attenuated	O
in	O
cellular	O
model	O
of	O
infection	O
,	O
and	O
B	B-Organism
.	I-Organism
melitensis	I-Organism
mutants	E-Organism
in	O
vjbR	O
,	O
motB	O
,	O
oppA	O
,	O
mosA	O
and	O
the	O
hypothetical	O
proteins	O
BAB1	O
_	O
0597	O
,	O
BAB1	O
_	O
1717	O
,	O
BAB2	O
_	O
1127	O
were	O
attenuated	O
in	O
both	O
cellular	O
and	O
mouse	S-Organism
models	O
of	O
infection	O
(	O
for	O
a	O
review	O
see	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
)	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
some	O
denitrification	O
genes	O
of	O
the	O
nor	O
operon	O
are	O
required	O
for	O
Brucella	S-Organism
virulence	O
:	O
norD	O
in	O
B	B-Organism
.	I-Organism
suis	E-Organism
and	O
norB	O
in	O
B	B-Organism
.	I-Organism
melitensis	E-Organism
[	O
10	O
]	O
,	O
[	O
11	O
]	O
.	O

Most	O
of	O
the	O
genes	O
candidate	O
to	O
be	O
regulated	O
by	O
BvrR	O
/	O
BvrS	O
identified	O
in	O
our	O
microarray	O
experiments	O
can	O
be	O
involved	O
with	O
the	O
changes	O
needed	O
for	O
intracellular	O
survival	O
of	O
Brucella	S-Organism
.	O

In	O
order	O
to	O
investigate	O
if	O
the	O
BvrR	O
/	O
BvrS	O
controlled	O
genes	O
were	O
expressed	O
intracellularly	O
,	O
bacterial	O
RNA	O
was	O
obtained	O
from	O
B	B-Organism
.	I-Organism
abortus	E-Organism
wild	O
type	O
recovered	O
from	O
infected	O
cells	O
as	O
described	O
in	O
Material	O
and	O
Methods	O
.	O

The	O
amount	O
of	O
bacterial	O
RNA	O
was	O
not	O
enough	O
to	O
perform	O
microarray	O
hybridizations	O
.	O

For	O
this	O
reason	O
,	O
the	O
analysis	O
of	O
intracellular	O
expression	O
of	O
32	O
selected	O
genes	O
was	O
done	O
by	O
RT	O
-	O
PCR	O
by	O
using	O
total	O
RNA	O
from	O
intracellular	O
bacteria	O
and	O
from	O
the	O
same	O
strain	O
(	O
B	B-Organism
.	I-Organism
abortus	I-Organism
2308	E-Organism
)	O
grown	O
in	O
laboratory	O
conditions	O
(	O
Table	O
2	O
)	O
.	O

VirB8	O
(	O
BAB2	O
_	O
0061	O
)	O
was	O
used	O
as	O
control	O
of	O
intracellularly	O
expressed	O
gene	O
[	O
35	O
]	O
.	O

The	O
results	O
showed	O
significant	O
differences	O
in	O
the	O
expression	O
of	O
at	O
least	O
fifteen	O
genes	O
controlled	O
by	O
BvrR	O
/	O
BvrS	O
.	O

The	O
expression	O
of	O
genes	O
vjbR	O
,	O
malF	O
,	O
norC	O
,	O
pckA	O
,	O
fumB	O
,	O
BAB1	O
_	O
0017	O
(	O
fatty	O
acids	O
metabolism	O
)	O
and	O
BAB1	O
_	O
1620	O
(	O
LPS	O
glycosyl	O
transferase	O
)	O
were	O
induced	O
intracellularly	O
.	O

On	O
the	O
other	O
hand	O
,	O
two	O
genes	O
for	O
cell	O
envelope	O
proteins	O
(	O
omp25d	O
and	O
one	O
lipoprotein	O
)	O
and	O
three	O
denitrification	O
genes	O
(	O
norC	O
,	O
nirK	O
and	O
glutaminase	O
BAB2	O
_	O
0863	O
)	O
were	O
less	O
expressed	O
intracellularly	O
.	O

In	O
conclusion	O
,	O
all	O
these	O
results	O
and	O
previous	O
findings	O
support	O
the	O
proposal	O
that	O
BvrR	O
/	O
BvrS	O
controls	O
a	O
significantly	O
broad	O
set	O
of	O
phenotypes	O
and	O
define	O
an	O
important	O
and	O
coordinate	O
gateway	O
between	O
the	O
free	O
-	O
living	O
and	O
intracellular	O
states	O
of	O
Brucella	S-Organism
.	O

However	O
,	O
30	O
of	O
the	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
compared	O
with	O
the	O
parental	O
strain	O
have	O
a	O
yet	O
uncharacterized	O
function	O
.	O

This	O
group	O
may	O
contain	O
unknown	O
essential	O
information	O
to	O
completely	O
understand	O
the	O
regulatory	O
role	O
of	O
the	O
BvrR	O
/	O
BvrS	O
two	O
-	O
component	O
regulatory	O
system	O
.	O

IgG	O
Endopeptidase	O
SeMac	O
does	O
not	O
Inhibit	O
Opsonophagocytosis	O
of	O
Streptococcus	B-Organism
equi	I-Organism
Subspecies	I-Organism
equi	E-Organism
by	O
Horse	S-Organism
Polymorphonuclear	O
Leukocytes	O

The	O
secreted	O
Mac	O
protein	O
made	O
by	O
group	B-Organism
A	I-Organism
Streptococcus	E-Organism
(	O
GAS	S-Organism
)	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	S-Organism
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
.	O

This	O
protein	O
also	O
has	O
the	O
endopeptidase	O
activity	O
against	O
human	S-Organism
immunoglobulin	O
G	O
(	O
IgG	O
)	O
,	O
and	O
the	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
are	O
critical	O
for	O
the	O
enzymatic	O
activity	O
.	O

The	O
horse	S-Organism
pathogen	O
Streptococcus	B-Organism
equi	I-Organism
subspecies	I-Organism
equi	E-Organism
produces	O
a	O
homologue	O
of	O
Mac	O
(	O
SeMac	O
)	O
.	O

SeMac	O
was	O
characterized	O
to	O
determine	O
whether	O
SeMac	O
has	O
IgG	O
endopeptidase	O
activity	O
and	O
inhibits	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
.	O

The	O
gene	O
was	O
cloned	O
and	O
recombinant	O
SeMac	O
was	O
overexpressed	O
in	O
Escherichia	B-Organism
coli	E-Organism
and	O
purified	O
to	O
homogeneity	O
.	O

Mice	S-Organism
with	O
experimental	O
S	B-Organism
.	I-Organism
equi	E-Organism
infection	O
and	O
horses	S-Organism
with	O
strangles	O
caused	O
by	O
S	B-Organism
.	I-Organism
equi	E-Organism
seroconverted	O
to	O
SeMac	O
,	O
indicating	O
that	O
SeMac	O
is	O
produced	O
in	O
vivo	O
during	O
infection	O
.	O

SeMac	O
has	O
endopeptidase	O
activity	O
against	O
human	S-Organism
IgG	O
.	O

However	O
,	O
the	O
protein	O
just	O
cleaves	O
a	O
small	O
fraction	O
,	O
which	O
may	O
be	O
IgG1	O
only	O
,	O
of	O
horse	S-Organism
IgG	O
.	O

Replacement	O
of	O
Cys102	O
with	O
Ser	O
or	O
His272	O
with	O
Ala	O
abolishes	O
the	O
enzymatic	O
activity	O
of	O
SeMac	O
,	O
and	O
the	O
Asp294Ala	O
mutation	O
greatly	O
decreases	O
the	O
enzymatic	O
activity	O
.	O

SeMac	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
but	O
opsonophagocytosis	O
of	O
GAS	S-Organism
by	O
human	S-Organism
PMNs	O
.	O

Thus	O
,	O
SeMac	O
is	O
a	O
cysteine	O
endopeptidase	O
with	O
a	O
limited	O
activity	O
against	O
horse	S-Organism
IgG	O
and	O
must	O
have	O
other	O
function	O
.	O

INTRODUCTION	O

Gram	O
-	O
positive	O
bacterium	O
Streptococcus	B-Organism
equi	I-Organism
subspeices	I-Organism
equi	E-Organism
(	O
S	B-Organism
.	I-Organism
equi	E-Organism
)	O
causes	O
equine	S-Organism
strangles	O
,	O
a	O
highly	O
contagious	O
purulent	O
lymphadenitis	O
and	O
one	O
of	O
the	O
most	O
common	O
infectious	O
diseases	O
in	O
horses	S-Organism
[	O
1	O
,	O
2	O
]	O
.	O

The	O
infection	O
initially	O
causes	O
nasal	O
discharge	O
and	O
fever	O
and	O
,	O
then	O
,	O
leads	O
to	O
abscess	O
formation	O
in	O
local	O
lymph	O
nodes	O
,	O
causing	O
enormous	O
pain	O
and	O
respiratory	O
difficulty	O
.	O

There	O
is	O
massive	O
infiltration	O
of	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
to	O
the	O
infection	O
site	O
.	O

However	O
,	O
S	B-Organism
.	I-Organism
equi	E-Organism
effectively	O
evades	O
the	O
horse	S-Organism
innate	O
immunity	O
by	O
being	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

Horses	S-Organism
recovered	O
from	O
strangles	O
acquire	O
immunity	O
against	O
S	B-Organism
.	I-Organism
equi	E-Organism
reinfection	O
[	O
3	O
]	O
.	O

The	O
immunity	O
is	O
primarily	O
mediated	O
by	O
protective	O
antibodies	O
[	O
4	O
]	O
,	O
which	O
opsonize	O
and	O
thus	O
enhance	O
phagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
.	O

To	O
survive	O
in	O
hosts	O
,	O
bacterial	O
pathogens	O
have	O
evolved	O
multiple	O
mechanisms	O
to	O
evade	O
host	O
defense	O
.	O

For	O
examples	O
,	O
both	O
S	B-Organism
.	I-Organism
equi	E-Organism
and	O
group	B-Organism
A	I-Organism
Streptococcus	E-Organism
(	O
GAS	S-Organism
)	O
produce	O
the	O
hyaluronic	O
acid	O
capsule	O
and	O
surface	O
protein	O
M	O
protein	O
to	O
contribute	O
to	O
resistance	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

We	O
found	O
that	O
GAS	S-Organism
produces	O
a	O
secreted	O
Mac	O
protein	O
(	O
also	O
known	O
as	O
IdeE	O
)	O
,	O
which	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	S-Organism
by	O
human	S-Organism
PMNs	O
[	O
5	O
]	O
.	O

This	O
protein	O
can	O
cleave	O
the	O
heavy	O
chain	O
of	O
human	S-Organism
immunoglobulin	O
G	O
(	O
IgG	O
)	O
using	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
as	O
its	O
catalytic	O
triad	O
[	O
6	O
-	O
8	O
]	O
.	O

There	O
are	O
two	O
kinds	O
of	O
Mac	O
produced	O
by	O
GAS	S-Organism
isolates	O
[	O
7	O
]	O
,	O
which	O
use	O
different	O
mechanisms	O
to	O
block	O
the	O
interaction	O
between	O
IgG	O
and	O
Fc	O
receptor	O
on	O
the	O
surface	O
of	O
PMNs	O
.	O

The	O
type	O
-	O
1	O
Mac	O
,	O
such	O
as	O
M1	O
Mac	O
produced	O
by	O
serotype	B-Organism
M1	I-Organism
GAS	E-Organism
strains	O
,	O
has	O
high	O
enzymatic	O
activity	O
and	O
low	O
affinity	O
to	O
Fc	O
receptor	O
on	O
the	O
surface	O
of	O
PMNs	O
,	O
while	O
the	O
type	O
-	O
2	O
Mac	O
can	O
bind	O
to	O
the	O
Fc	O
receptor	O
and	O
has	O
lower	O
enzymatic	O
activity	O
[	O
9	O
]	O
.	O

S	B-Organism
.	I-Organism
equi	E-Organism
has	O
a	O
homologue	O
of	O
GAS	S-Organism
M1	O
Mac	O
(	O
designated	O
SeMac	O
)	O
.	O

In	O
this	O
study	O
,	O
SeMac	O
was	O
prepared	O
and	O
characterized	O
.	O

The	O
results	O
indicate	O
that	O
SeMac	O
is	O
a	O
cysteine	O
endopeptidase	O
but	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
,	O
suggesting	O
that	O
SeMac	O
has	O
function	O
other	O
than	O
evading	O
horse	S-Organism
acquired	O
immunity	O
against	O
S	B-Organism
.	I-Organism
equi	E-Organism
infection	O
.	O

RESULTS	O

S	B-Organism
.	I-Organism
equi	E-Organism
Mac	O
Gene	O
S	B-Organism
.	I-Organism
equi	E-Organism
genome	O
encodes	O
a	O
Mac	O
homologue	O
SeMac	O
.	O

The	O
protein	O
shares	O
62	O
.	O
4	O
%	O
identity	O
in	O
amino	O
acid	O
sequence	O
with	O
Mac	O
made	O
by	O
serotype	B-Organism
M1	I-Organism
GAS	E-Organism
and	O
a	O
putative	O
secretion	O
signal	O
sequence	O
(	O
amino	O
acids	O
1	O
-	O
34	O
)	O
,	O
and	O
the	O
catalytic	O
residues	O
of	O
GAS	S-Organism
Mac	O
consisting	O
of	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
are	O
conserved	O
in	O
SeMac	O
(	O
Cys102	O
,	O
His272	O
and	O
Asp	O
294	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

To	O
test	O
whether	O
other	O
S	B-Organism
.	I-Organism
equi	E-Organism
strains	O
have	O
the	O
mac	O
gene	O
,	O
10	O
S	B-Organism
.	I-Organism
equi	E-Organism
isolates	O
representing	O
various	O
geographic	O
locations	O
were	O
tested	O
with	O
PCR	O
using	O
mac	O
-	O
specific	O
primers	O
.	O

All	O
the	O
strains	O
tested	O
had	O
the	O
mac	O
gene	O
(	O
Fig	O
.	O
2	O
)	O
.	O

DNA	O
sequencing	O
found	O
that	O
the	O
mac	O
gene	O
is	O
100	O
%	O
conserved	O
in	O
DNA	O
sequence	O
in	O
these	O
strains	O
.	O

Recombinant	O
SeMac	O
and	O
In	O
Vitro	O
and	O
In	O
Vivo	O
Expression	O
of	O
SeMac	O

To	O
characterize	O
SeMac	O
,	O
the	O
fragment	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
mac	O
gene	O
encoding	O
mature	O
SeMac	O
was	O
cloned	O
,	O
and	O
recombinant	O
SeMac	O
was	O
purified	O
to	O
>	O
95	O
%	O
purity	O
as	O
assessed	O
by	O
SDS	O
-	O
PAGE	O
(	O
Fig	O
.	O
3A	O
)	O
.	O

To	O
assess	O
the	O
in	O
vitro	O
production	O
of	O
SeMac	O
,	O
culture	O
supernatant	O
of	O
the	O
10	O
S	B-Organism
.	I-Organism
equi	E-Organism
strains	O
was	O
prepared	O
by	O
the	O
method	O
of	O
Lei	O
et	O
al	O
.	O

[	O
16	O
]	O
,	O
resolved	O
by	O
SDS	O
-	O
PAGE	O
,	O
and	O
probed	O
by	O
Western	O
immunoblot	O
with	O
anti	O
-	O
SeMac	O
mouse	S-Organism
antisera	O
.	O

No	O
SeMac	O
was	O
detected	O
in	O
all	O
the	O
samples	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
SeMac	O
is	O
not	O
produced	O
in	O
vitro	O
.	O

To	O
test	O
whether	O
SeMac	O
is	O
produced	O
in	O
vivo	O
during	O
S	B-Organism
.	I-Organism
equi	E-Organism
infection	O
,	O
the	O
presence	O
of	O
SeMac	O
-	O
specific	O
antibody	O
was	O
assessed	O
by	O
Western	O
immunoblot	O
analysis	O
with	O
convalescent	O
sera	O
from	O
3	O
horses	S-Organism
suffered	O
from	O
strangles	O
and	O
mice	S-Organism
with	O
experimental	O
S	B-Organism
.	I-Organism
equi	E-Organism
infection	O
.	O

All	O
the	O
convalescent	O
sera	O
tested	O
had	O
SeMac	O
-	O
specific	O
antibody	O
(	O
Fig	O
.	O
3B	O
)	O
,	O
indicating	O
that	O
SeMac	O
is	O
produced	O
in	O
vivo	O
during	O
infection	O
.	O

Endopeptidase	O
Activity	O
of	O
SeMac	O
against	O
Horse	S-Organism
IgG1	O
and	O
Human	S-Organism
IgG	O

GAS	S-Organism
Mac	O
can	O
cleave	O
the	O
heavy	O
chain	O
of	O
human	S-Organism
IgG	O
at	O
the	O
lower	O
hinge	O
region	O
between	O
Fab	O
and	O
Fc	O
fragments	O
.	O

A	O
catalytic	O
triad	O
of	O
Cys94	O
,	O
His262	O
,	O
and	O
Asp284	O
residues	O
is	O
critical	O
for	O
the	O
enzymatic	O
activity	O
of	O
GAS	S-Organism
Mac	O
[	O
7	O
,	O
8	O
]	O
.	O

SeMac	O
possesses	O
putative	O
catalytic	O
residues	O
of	O
Cys102	O
,	O
His272	O
,	O
and	O
Asp294	O
(	O
Fig	O
.	O
1	O
)	O
.	O

To	O
determine	O
whether	O
SeMac	O
also	O
is	O
a	O
cysteine	O
endopeptidase	O
targeting	O
IgG	O
,	O
Cys102	O
and	O
His272	O
or	O
Asp294	O
of	O
SeMac	O
were	O
replaced	O
with	O
Ser	O
and	O
Ala	O
,	O
respectively	O
,	O
by	O
site	O
-	O
directed	O
mutagenesis	O
,	O
and	O
wild	O
-	O
type	O
and	O
mutant	O
(	O
SeMacCys102Ser	O
,	O
SeMacHis272Ala	O
and	O
SeMacAsp294Ala	O
)	O
SeMac	O
proteins	O
expressed	O
in	O
E	B-Organism
.	I-Organism
coli	E-Organism
were	O
tested	O
for	O
IgG	O
endopeptidase	O
activity	O
using	O
human	S-Organism
IgG	O
.	O

Wild	O
-	O
type	O
SeMac	O
cleaved	O
the	O
heavy	O
chain	O
of	O
human	S-Organism
IgG	O
,	O
while	O
SeMacCys102Ser	O
and	O
SeMacHis272Ala	O
completely	O
lost	O
the	O
IgG	O
endopeptidase	O
activity	O
,	O
and	O
SeMacAsp294Ala	O
had	O
dramatically	O
lower	O
enzymatic	O
activity	O
than	O
the	O
wild	O
-	O
type	O
protein	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

The	O
results	O
indicate	O
that	O
SeMac	O
is	O
a	O
cysteine	O
endopeptidase	O
,	O
which	O
uses	O
Cys102	O
,	O
His272	O
and	O
Asp294	O
as	O
its	O
catalytic	O
triad	O
to	O
cleave	O
human	S-Organism
IgG	O
.	O

Purified	O
recombinant	O
SeMac	O
and	O
GAS	S-Organism
Mac	O
were	O
then	O
tested	O
for	O
activity	O
to	O
cleave	O
horse	S-Organism
IgG	O
.	O

While	O
both	O
proteins	O
cleaved	O
human	S-Organism
IgG	O
efficiently	O
,	O
only	O
a	O
small	O
fraction	O
of	O
horse	S-Organism
IgG	O
was	O
cleaved	O
by	O
either	O
protein	O
(	O
Fig	O
.	O
4B	O
)	O
,	O
suggesting	O
that	O
SeMac	O
or	O
GAS	S-Organism
Mac	O
cannot	O
digest	O
all	O
subgroups	O
of	O
horse	S-Organism
IgG	O
.	O

To	O
test	O
this	O
possibility	O
,	O
available	O
horse	S-Organism
IgG1	O
and	O
a	O
mixture	O
of	O
IgG1	O
and	O
IgG4	O
were	O
treated	O
with	O
SeMac	O
or	O
GAS	S-Organism
Mac	O
.	O

SeMac	O
or	O
GAS	S-Organism
Mac	O
cleaved	O
a	O
small	O
portion	O
of	O
the	O
IgG1	O
/	O
IgG4	O
mixture	O
,	O
but	O
not	O
IgG4	O
.	O

Therefore	O
,	O
the	O
Mac	O
proteins	O
can	O
cleave	O
IgG1	O
but	O
not	O
IgG4	O
.	O

Due	O
to	O
the	O
unavailability	O
of	O
other	O
purified	O
subgroup	O
IgG	O
,	O
it	O
is	O
not	O
known	O
whether	O
SeMac	O
cleaves	O
the	O
other	O
IgG	O
subgroups	O
.	O

SeMac	O
does	O
not	O
Inhibit	O
Opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
Horse	S-Organism
PMN	O

A	O
whole	O
blood	O
based	O
phagocytosis	O
assay	O
[	O
13	O
,	O
14	O
]	O
was	O
used	O
to	O
test	O
whether	O
SeMac	O
inhibits	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
.	O

The	O
bacteria	O
were	O
labeled	O
with	O
FITC	O
,	O
treated	O
with	O
S	B-Organism
.	I-Organism
equi	E-Organism
-	O
specific	O
horse	S-Organism
convalescent	O
serum	O
in	O
the	O
absence	O
or	O
presence	O
of	O
SeMac	O
,	O
and	O
incubated	O
with	O
horse	S-Organism
blood	O
.	O

Percentage	O
of	O
PMNs	O
with	O
phagocytosed	O
S	B-Organism
.	I-Organism
equi	E-Organism
was	O
determined	O
by	O
flow	O
cytometry	O
.	O

As	O
expected	O
,	O
percentage	O
of	O
PMNs	O
with	O
phagocytosed	O
S	B-Organism
.	I-Organism
equi	E-Organism
with	O
the	O
serum	O
treatment	O
was	O
significantly	O
higher	O
than	O
that	O
for	O
S	B-Organism
.	I-Organism
equi	E-Organism
without	O
serum	O
treatment	O
.	O

But	O
the	O
inclusion	O
of	O
SeMac	O
in	O
the	O
assay	O
did	O
not	O
affect	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
(	O
Fig	O
.	O
5A	O
)	O
,	O
suggesting	O
that	O
SeMac	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
.	O

The	O
inability	O
of	O
SeMac	O
to	O
inhibit	O
S	B-Organism
.	I-Organism
equi	E-Organism
opsonophagocytosis	O
by	O
horse	S-Organism
PMNs	O
may	O
be	O
due	O
to	O
its	O
inability	O
to	O
cleave	O
the	O
majority	O
of	O
horse	S-Organism
IgG	O
.	O

If	O
this	O
is	O
true	O
,	O
SeMac	O
should	O
inhibit	O
opsonophagocytosis	O
of	O
GAS	S-Organism
by	O
human	S-Organism
PMNs	O
,	O
since	O
SeMac	O
efficiently	O
cleaves	O
human	S-Organism
IgG	O
.	O

To	O
test	O
this	O
idea	O
,	O
the	O
phagocytosis	O
assay	O
was	O
repeated	O
using	O
GAS	S-Organism
and	O
human	S-Organism
blood	O
.	O

SeMac	O
indeed	O
inhibits	O
the	O
opsonophagocytosis	O
of	O
GAS	S-Organism
by	O
human	S-Organism
PMNs	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

These	O
results	O
suggest	O
that	O
IgG	O
endopeptidase	O
activity	O
of	O
SeMac	O
is	O
critical	O
for	O
inhibition	O
of	O
phagocytosis	O
.	O

DISCUSSION	O

In	O
this	O
study	O
we	O
describe	O
that	O
SeMac	O
is	O
a	O
cysteine	O
endopeptidase	O
with	O
limited	O
activity	O
against	O
horse	S-Organism
IgG	O
and	O
is	O
unable	O
to	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
in	O
a	O
whole	O
blood	O
assay	O
.	O

SeMac	O
efficiently	O
cleaves	O
the	O
heavy	O
chain	O
of	O
human	S-Organism
IgG	O
.	O

The	O
residues	O
of	O
Cys102	O
and	O
His272	O
are	O
essential	O
and	O
Asp294	O
important	O
for	O
the	O
enzymatic	O
activity	O
of	O
SeMac	O
.	O

Thus	O
,	O
like	O
GAS	S-Organism
M1	O
Mac	O
[	O
7	O
,	O
8	O
]	O
,	O
SeMac	O
is	O
a	O
cysteine	O
endopeptidase	O
.	O

Although	O
both	O
SeMac	O
and	O
GAS	S-Organism
Mac	O
efficiently	O
cleave	O
human	S-Organism
IgG	O
,	O
they	O
cannot	O
cleave	O
the	O
majority	O
of	O
total	O
horse	S-Organism
IgG	O
.	O

The	O
peptide	O
fragment	O
,	O
PELLGG	O
,	O
in	O
the	O
lower	O
hinge	O
region	O
is	O
proposed	O
to	O
bind	O
to	O
the	O
active	O
site	O
of	O
Mac	O
[	O
9	O
]	O
,	O
and	O
the	O
cleavage	O
occurs	O
between	O
the	O
two	O
Gly	O
residues	O
(	O
Table	O
1	O
)	O
.	O

This	O
lower	O
hinge	O
region	O
is	O
not	O
well	O
conserved	O
in	O
the	O
seven	O
subgroups	O
of	O
horse	S-Organism
IgG	O
[	O
17	O
]	O
(	O
Table	O
1	O
)	O
.	O

Cleavable	O
horse	S-Organism
IgG1	O
has	O
PELLGG	O
,	O
while	O
the	O
non	O
-	O
cleavable	O
horse	S-Organism
IgG4	O
has	O
PECLSVG	O
in	O
the	O
same	O
region	O
,	O
suggesting	O
that	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
lower	O
hinge	O
region	O
are	O
important	O
for	O
cleavability	O
by	O
SeMac	O
and	O
GAS	S-Organism
Mac	O
.	O

If	O
this	O
is	O
true	O
,	O
horse	S-Organism
IgG3	O
may	O
be	O
also	O
cleavable	O
by	O
SeMac	O
,	O
while	O
the	O
other	O
five	O
horse	S-Organism
IgG	O
subgroups	O
may	O
not	O
be	O
cleaved	O
.	O

These	O
horse	S-Organism
IgG	O
antibodies	O
that	O
cannot	O
be	O
cleaved	O
by	O
SeMac	O
thus	O
still	O
can	O
mediate	O
the	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
.	O

SeMac	O
and	O
GAS	S-Organism
M1	O
Mac	O
show	O
similar	O
enzymatic	O
specificity	O
(	O
Fig	O
.	O
4	O
and	O
Table	O
1	O
)	O
,	O
confirming	O
the	O
previous	O
finding	O
[	O
18	O
]	O
.	O

SeMac	O
can	O
cleave	O
human	S-Organism
IgG	O
and	O
inhibit	O
the	O
opsonophagocytosis	O
of	O
GAS	S-Organism
by	O
human	S-Organism
PMNs	O
,	O
but	O
it	O
has	O
limited	O
enzymatic	O
activity	O
against	O
horse	S-Organism
IgG	O
and	O
is	O
unable	O
to	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
.	O

Thus	O
,	O
there	O
is	O
a	O
correlation	O
between	O
the	O
enzymatic	O
activity	O
of	O
SeMac	O
and	O
its	O
ability	O
to	O
inhibit	O
opsonophagocytosis	O
,	O
suggesting	O
that	O
SeMac	O
functions	O
like	O
GAS	S-Organism
M1	O
Mac	O
in	O
the	O
inhibition	O
of	O
opsonophagocytosis	O
of	O
GAS	S-Organism
by	O
human	S-Organism
PMNs	O
.	O

Timoney	O
et	O
al	O
.	O
recently	O
reported	O
that	O
IdeE	O
/	O
SeMac	O
reduces	O
the	O
bactericidal	O
activity	O
of	O
isolated	O
equine	S-Organism
PMNs	O
for	O
S	B-Organism
.	I-Organism
equi	E-Organism
[	O
19	O
]	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
inhibition	O
of	O
the	O
bactericidal	O
activity	O
of	O
PMNs	O
may	O
not	O
be	O
mediated	O
by	O
opsonophagocytosis	O
or	O
may	O
be	O
insignificant	O
in	O
whole	O
blood	O
.	O

SeMac	O
is	O
not	O
produced	O
in	O
vitro	O
,	O
whereas	O
GAS	S-Organism
Mac	O
is	O
[	O
16	O
]	O
.	O

The	O
mac	O
gene	O
is	O
controlled	O
by	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
CovRS	O
[	O
5	O
]	O
,	O
which	O
also	O
controls	O
the	O
expression	O
of	O
many	O
virulence	O
factors	O
including	O
the	O
hyaluronic	O
capsule	O
[	O
20	O
]	O
.	O

The	O
hyaluronic	O
capsule	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
is	O
highly	O
produced	O
in	O
vitro	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
semac	O
and	O
mac	O
genes	O
are	O
regulated	O
by	O
different	O
mechanisms	O
.	O

This	O
suggestion	O
is	O
supported	O
by	O
only	O
29	O
%	O
DNA	O
sequence	O
identity	O
between	O
S	B-Organism
.	I-Organism
equi	E-Organism
and	O
M1	O
GAS	S-Organism
in	O
the	O
upstream	O
region	O
of	O
the	O
semac	O
and	O
mac	O
genes	O
.	O

S	B-Organism
.	I-Organism
equi	E-Organism
is	O
a	O
horse	S-Organism
pathogen	O
.	O

The	O
fact	O
that	O
SeMac	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Organism
.	I-Organism
equi	E-Organism
by	O
horse	S-Organism
PMNs	O
indicates	O
that	O
SeMac	O
is	O
not	O
involved	O
in	O
the	O
evasion	O
of	O
the	O
acquired	O
horse	S-Organism
immunity	O
against	O
S	B-Organism
.	I-Organism
equi	E-Organism
.	O

This	O
suggests	O
that	O
SeMac	O
has	O
other	O
unknown	O
function	O
.	O
